<SEC-DOCUMENT>0001628279-24-000102.txt : 20240313
<SEC-HEADER>0001628279-24-000102.hdr.sgml : 20240313
<ACCEPTANCE-DATETIME>20240213160115
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001628279-24-000102
CONFORMED SUBMISSION TYPE:	DRS/A
PUBLIC DOCUMENT COUNT:		9
FILED AS OF DATE:		20240213
<PUBLIC-REL-DATE>20240313
DATE AS OF CHANGE:		20240213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PACS Group, Inc.
		CENTRAL INDEX KEY:			0002001184
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-SKILLED NURSING CARE FACILITIES [8051]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				923144268
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DRS/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	377-06990
		FILM NUMBER:		24625520

	BUSINESS ADDRESS:	
		STREET 1:		262 N. UNIVERSITY AVENUE
		CITY:			FARMINGTON
		STATE:			UT
		ZIP:			84025
		BUSINESS PHONE:		(801) 447-9829

	MAIL ADDRESS:	
		STREET 1:		262 N. UNIVERSITY AVENUE
		CITY:			FARMINGTON
		STATE:			UT
		ZIP:			84025
</SEC-HEADER>
<DOCUMENT>
<TYPE>DRS/A
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i2baa8a1031f44c51b1664e00d256c582_637"></div><div style="min-height:9pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As confidentially submitted to the U.S. Securities and Exchange Commission on February 13, 2024 as Amendment No. 2 to the draft registration statement submitted on December 8, 2023.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">This Amendment No. 2 to the draft registration statement has not been publicly filed with the U.S. Securities and Exchange Commission and all information herein remains strictly confidential.</font></div><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Registration No. 333-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM S-1</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">REGISTRATION STATEMENT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Under The Securities Act of 1933</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">PACS Group, Inc.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Delaware</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">8051</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">92-3144268</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">incorporation or organization)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Primary Standard Industrial</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification Code Number)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</font></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">262 N. University Ave.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Farmington, Utah 84025</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(801) 447-9829</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">offices)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Jason Murray</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Chief Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PACS Group, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">262 N. University Ave.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Farmington, Utah 84025</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(801) 447-9829</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Name, address, including zip code, and telephone number, including area code, of agent for service)</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">Copies to&#58;</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">B. Shayne Kennedy</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">J. Ross McAloon</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Latham &#38; Watkins LLP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">650 Town Center Drive, 20th Floor</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Costa Mesa, CA 92626</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(714) 540-1235</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">John Mitchell</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Chief Legal Officer and General Counsel</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">262 N. University Ave.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Farmington, Utah 84025</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(801) 447-9829</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Benjamin K. Marsh</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adam V. Johnson</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Goodwin Procter LLP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">The New York Times Building</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">620 Eighth Avenue</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">New York, NY 10018</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(212) 813-8800</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Approximate date of commencement of proposed sale to the public&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> As soon as practicable after the effective date of this Registration Statement.</font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. </font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. </font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. </font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. </font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</font></div><div style="margin-bottom:9pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</font></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.129%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Large accelerated filer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</font></div></td></tr></table></div><div style="margin-bottom:9pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. </font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</font></div><div style="margin-bottom:6pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">The registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.</font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font><br></font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_1330"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="text-align:justify"><font style="color:#f1665f;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The information in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities, and we are not soliciting offers to buy these securities in any jurisdiction where the offer or sale is not permitted. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#f1665f;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subject to Completion. Dated&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,&#160;2024.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#f1665f;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRELIMINARY PROSPECTUS</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Shares</font></div><div style="margin-bottom:12pt;text-align:center"><img alt="companylogo1a1.jpg" src="companylogo1a1.jpg" style="height:61px;margin-bottom:5pt;vertical-align:text-bottom;width:248px"></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Common Stock</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This is an initial public offering of common stock of PACS Group, Inc. We are offering &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock. Prior to this offering, there has been no public market for our common stock. It is currently estimated that the initial public offering price will be between $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; and $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share of our common stock. We have applied to list our common stock on the New York Stock Exchange&#160;under the symbol &#8220;PACS.&#8221; If our listing application is not approved, we will not proceed with this offering.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following this offering, our founders will collectively own approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; % of our common stock (or approximately      % if the underwriters exercise their option to purchase additional shares of our common stock from us in full) and, pursuant to our Stockholders Agreement (as defined herein), will control a majority of the voting power of shares of our common stock eligible to vote in the election of our directors. As a result, we expect to be a &#8220;controlled company&#8221; within the meaning of the corporate governance standards of the New York Stock Exchange. See the section titled &#8220;Management&#8212;Director Independence and Controlled Company Exception&#8221; and &#8220;Certain Relationships and Related Party Transactions&#8212;Stockholders Agreement.&#8221;</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investing in our common stock involves risks. See the section titled &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_660" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Risk Factors</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221; beginning on page </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_660" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">19</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> to read about the factors you should consider before buying shares of our common stock.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.177%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Per Share</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Initial public offering price</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwriting discounts and commissions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds, before expenses, to us</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">We have agreed to reimburse the underwriters for certain expenses in connection with this offering. See the section titled &#8220;Underwriters&#8221; for a description of the compensation payable to the underwriters.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have granted the underwriters an option for a period of up to 30 days to purchase up to an additional &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares of our common stock from us at the initial public offering price, less the underwriting discounts and commissions.</font></div><div style="margin-bottom:21pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters expect to deliver the shares of common stock to purchasers on or about &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2024.</font></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:32.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.281%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Citigroup</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">J.P. Morgan</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Truist Securities</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prospectus dated&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2024.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-indent:18pt"><font><br></font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_2395"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXPLANATORY NOTE</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the applicable provisions of the Fixing America&#8217;s Surface Transportation Act, we are omitting our consolidated financial statements as of and for the year ended December 31, 2020 and as of and for the nine months ended September 30, 2022 and 2023 because they relate to historical periods that we believe will not be required to be included in the registration statement at the time of the first public filing of the registration statement. We intend to include all financial information required by Regulation S-X at the date of such public filing of the registration statement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-indent:18pt"><font><br></font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_643"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1347" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">GENERAL INFORMATION</a></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1347" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ii</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_653" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PROSPECTUS SUMMARY</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_653" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1355" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">THE OFFERING</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1355" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">14</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_660" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">RISK FACTORS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_660" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">19</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_682" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_682" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">62</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_692" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">USE OF PROCEEDS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_692" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">64</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_702" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">DIVIDEND POLICY</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_702" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">65</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_712" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">CAPITALIZATION</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_712" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">66</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_722" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">DILUTION</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_722" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">68</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1950" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1950" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">70</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_914" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">BUSINESS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_914" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">91</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_929" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">MANAGEMENT</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_929" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">115</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1059" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">COMPENSATION DISCUSSION AND ANALYSIS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1059" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">122</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_979" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_979" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">134</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_993" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PRINCIPAL STOCKHOLDERS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_993" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">136</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1428" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">DESCRIPTION OF CAPITAL STOCK</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1428" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">137</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1454" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">SHARES ELIGIBLE FOR FUTURE SALE</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1454" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">143</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1463" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1463" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">146</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1071" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">UNDERWRIT</a><a href="#i2baa8a1031f44c51b1664e00d256c582_1071" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">ING</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1071" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">150</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1083" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">LEGAL MATTERS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1083" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">159</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1095" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">EXPERTS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1095" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">159</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1107" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">WHERE YOU CAN FIND MORE INFORMATION</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_1107" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">159</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_4" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_4" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-</a><a href="#i2baa8a1031f44c51b1664e00d256c582_4" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1</a></font></div></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should rely only on the information contained in this prospectus or contained in any free writing prospectus filed with the Securities and Exchange Commission (SEC) prepared by or on behalf of us that we have referred to you. Neither we nor the underwriters have authorized anyone to provide you with any information other than that contained in this prospectus, any amendment or supplement to this prospectus or in any free writing prospectus we may authorize to be delivered or made available to you. Neither we nor the underwriters take responsibility for, and can provide assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the shares of our common stock offered by this prospectus, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of shares of our common stock. Our business, financial condition, results of operations, and prospects may have changed since such date.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For investors outside of the United States&#58; We have not, and the underwriters have not, done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside of the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, this offering and the distribution of this prospectus outside of the United States.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_1347"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL INFORMATION</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Industry, Market and Other Data</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus contains estimates, projections and information concerning our industry, our business and data regarding the market size and growth rates of the markets in which we participate. Some data and statistical and other information are based on independent reports from third parties, as well as industry and general publications and research, surveys and studies conducted by third parties. Some data and statistical and other information are based on internal estimates and calculations that are derived from publicly available information, research we conducted, internal surveys, our management&#8217;s knowledge of our industry and their assumptions based on such information and knowledge, which we believe to be reasonable.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In each case, this information and data involves a number of assumptions and limitations. Industry publications and other reports we have obtained from independent parties may state that the data contained in these publications or other reports have been obtained in good faith or from sources considered to be reliable, but they do not guarantee the accuracy or completeness of such data. In addition, projections, assumptions and estimates of the future performance of the industry in which we operate and our future performance are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in &#8220;Risk Factors&#8221; and &#8220;Special Note Regarding Forward-Looking Statements.&#8221; These and other factors could cause our future performance to differ materially from the assumptions and estimates made by third parties and us.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trademarks, Trade Names and Service Marks</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PACS, our logos and our other registered or common law trade names, trademarks or service marks appearing in this prospectus are the property of PACS Group, Inc. or our subsidiaries. This prospectus contains additional trade names, trademarks and service marks of other companies that are the property of their respective owners. We do not intend our use or display of other companies&#8217; trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, these other companies. Solely for convenience, the trade names, trademarks and service marks referred to in this prospectus may appear without the &#174;, &#8482; or SM symbols, but the omission of such references is not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights thereto or that the applicable owner of these trade names, trademarks and service marks will not assert, to the fullest extent under applicable law, its rights thereto.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain monetary amounts, percentages and other figures included elsewhere in this prospectus have been subject to rounding adjustments. Percentage amounts included in this prospectus have not in all cases been calculated on the basis of such rounded figures, but on the basis of such amounts prior to rounding. For this reason, percentage amounts in this prospectus may vary from those obtained by performing the same calculations using the figures in our consolidated financial statements included elsewhere in this prospectus. Accordingly, certain other figures and amounts that appear as totals in this prospectus may not be the arithmetic aggregation of the figures or amounts that precede them, and figures or amounts expressed as a percentage may not total 100% or be the arithmetic aggregation of the percentages that precede them.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_653"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROSPECTUS SUMMARY</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This summary highlights selected information contained in more detail elsewhere in this prospectus. This summary does not contain all of the information you should consider before investing in our common stock. You should carefully read this prospectus in its entirety before investing in our common stock, including the sections titled &#8220;Risk Factors,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; and &#8220;Special Note Regarding Forward-Looking Statements,&#8221; and our audited consolidated financial statements and the related notes included elsewhere in this prospectus, before making an investment decision. Unless the context otherwise requires, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Company,&#8221; &#8220;PACS&#8221; and similar references in this prospectus refer to PACS Group, Inc. together with its consolidated subsidiaries.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Overview</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities. Founded in 2013, we are one of the largest skilled nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. We also provide senior care, assisted living, and independent living options in some of our communities. Our significant historical growth has been primarily driven by our expertise in acquiring underperforming long-term custodial care skilled nursing facilities and transforming them into higher acuity, high value-add short-term transitional care skilled nursing facilities. We believe our success is driven in significant part by our decentralized, local operating model, through which we empower local leaders at each facility to operate their facility autonomously and deliver excellence in clinical quality and a superior experience for our patients. We provide our independently operated facilities with a comprehensive suite of technology, support, and back-office services that allow local leadership teams to focus more of their time and effort on providing quality care to patients. We believe our operating model delivers value to all of our healthcare stakeholders, including patients and families, referring providers, payors, and administrators and clinicians.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after they have been discharged from the hospital. This ecosystem ranges from higher acuity, higher-cost settings, such as long-term acute care hospitals and inpatient rehabilitation facilities, to lower acuity, lower-cost settings, such as assisted living facilities, and home health. Skilled nursing facilities (SNFs) are positioned at the center of this ecosystem and play an essential role in providing cost efficient facility-based care to patients that have been discharged from hospitals but still require 24-hour in-patient services. SNFs can provide both long-term custodial care and higher value short-term transitional care. The SNF industry is large and growing, with the Centers for Medicare &#38; Medicaid Services (CMS) expecting total industry expenditures to increase from $193.6 billion in 2022 to $283.3 billion in 2031, representing a compound annual growth rate (CAGR) of 4.3%. Based on the number of facilities as reported by CMS, we are one of the largest SNF operators in the United States. We are primarily focused on providing higher value short-term transitional care and believe we are uniquely positioned to capitalize on the current underlying trends within the SNF industry and to capture a growing portion of the expected demand.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that healthcare is local and we operate through a decentralized model, recognizing that each patient, facility, and community is unique. To that end, we believe that our local leaders and employees understand the distinct needs and priorities of their patients, staff, and facilities and are best positioned to make clinical and operational decisions in order to optimize patient outcomes and experience. To facilitate this, each of our facilities operates independently, led by a facility administrator and his or her interdisciplinary team of medical directors, nurses, therapists, specialty consultants, and operators. To assist these local teams in achieving their best clinical and operating potential, we provide each facility with access to PACS Services. PACS Services is a comprehensive suite of offerings, including accounting, finance, human resources, payroll, accounts receivable and payable, legal, and risk management services, as well as a robust suite of technology tools. We operate in a highly regulated industry with stringent regulatory compliance obligations, which requires robust regulatory compliance operations. Failure to operate in compliance with applicable laws and regulations could require significant expenditures and result in regulatory deficiencies and other regulatory penalties. PACS Services functions to support our regulatory compliance obligations across our organization, including through controlled billing and cost reporting practices and </font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">legal, risk management, and compliance support. PACS Services also provides teams of regional professionals available as resources to each facility, including a regional vice president (RVP) and regional clinical and non-clinical directors and consultants. We developed PACS Services to be a resource to help reduce administrative burden so that local leadership teams can focus on making decisions that improve the care, well-being, and quality of life of their patients.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that talented local leadership is critical to the success of our model of independently operated, centrally supported facilities. At the facility level, administrators are effectively the chief executive officers, and together with other local licensed professionals, are ultimately responsible for the operations of their respective facilities. We seek to recruit, train, and reward dynamic administrators for our facilities, and rely on them to work with their interdisciplinary teams to implement policies and procedures that are appropriate and effective and result in positive outcomes. We support the delivery of excellent care by building excellent teams. We believe our model attracts high caliber, entrepreneurial professionals who value having considerable autonomy, accountability, and aligned incentives. We provide these professionals with leadership and industry training, guidance, and operational support. Our model is intended to align local leaders&#8217; incentives with facility and organizational success, encouraging them to dedicate themselves to the long-term future of their facilities. To create such alignment, we have developed an administrator compensation structure that prioritizes quality of care and operational and financial performance. Our administrators understand that a well-performing facility is the result of providing quality care in an environment of healing and caring, and one that is appropriately staffed, supplied, and equipped to meet the needs of its patients. This dedicated focus by our administrators and their local teams on patient outcomes drives demand for our services and can ultimately result in higher patient census and profitability. We also seek to provide opportunities for upward career mobility, with many of our administrators being promoted from within our company to roles of increasing levels of responsibility. Our culture of meritocracy and pride of ownership has helped us retain experienced facility administrators as well as RVPs who had average industry experience of&#160;12.1&#160;years, as of December 31, 2023. For the year ended December 31, 2023, we had a voluntary turnover rate of&#160;3.1%&#160;among our facility administrators.  </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excellence in clinical quality and experience for our patients is at the forefront of our mission. We believe our focus on quality is reflected in our CMS Quality Measures (QM) Star rating, occupancy rate, and skilled mix by nursing patient days (which refers to the number of days our Medicare and managed care patients receive skilled nursing services at SNFs as a percentage of the total number of days that patients from all payor sources receive skilled nursing services at SNFs for any given period). The QM Star rating is a number between 1 and 5 that is assigned to SNFs that participate in Medicare or Medicaid, and is based on an aggregate score across a range of quality reporting program requirements. As of December 31, 2023, our average QM Star rating across all our facilities was&#160;4.1&#160;Stars, compared to the industry average of&#160;3.6&#160;Stars. For the years ended December 31, 2023, 2022 and 2021 our average occupancy rate across our Mature facilities, which we define as facilities purchased more than 36 months prior to the measurement date, was&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 92%, and 88%, respectively, compared to the industry average of 76%, 74% and 71%. For the year ended December 31, 2023, our skilled mix by nursing patient days was &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically grown primarily through our disciplined and balanced acquisition strategy. We aim to create value by identifying and acquiring underperforming custodial care facilities and converting them into higher-value short-term transitional care facilities by investing in clinical teams and processes and upgrading technology, equipment, training, staffing, aesthetics, and other aspects of the business. The resources and guidance offered by PACS Services is key to rapid integration of new facilities and provides our local leadership teams with an effective technology infrastructure, support tools, and regional support teams that allow local leadership to focus on operational improvements. Our facilities generally undergo an up to three-year post-acquisition transition period. During this period, we seek to implement best practices designed to realize and sustain the facility&#8217;s full potential. These practices often result in significant improvements to clinical quality and other operational metrics, including skilled mix, occupancy rates and payor contracting. We believe the results of our acquisition strategy are demonstrated by our high average QM Star rating and occupancy rate for Mature facilities of 4.2&#160;and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, respectively, as of December 31, 2023. As of December 31, 2023, the average QM Star rating and occupancy rate for New facilities, which we define as facilities purchased less than 18 months prior to the measurement date, was&#160;3.9&#160;and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, respectively.</font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our portfolio of owned and leased properties is strategically located in nine states&#58; Arizona, California, Colorado, Kentucky, Missouri, Nevada, Ohio, South Carolina and Texas. We anticipate that available acquisition opportunities will enable us to further penetrate our reach into these nine states and to enter new states in the future. We believe our current markets are attractive and that the states in which we operate each has unique benefits, such as favorable reimbursement dynamics, high barriers to entry, or population growth of adults aged 65 and older, which is our primary patient demographic. We generally look for similar attributes in new markets that we enter. As of December 31, 2023, we leased&#160;165 facilities, directly owned the real estate at 29 facilities, and owned partial interests in an additional&#160;14&#160;facilities through joint ventures managed by third parties. As we continue to grow, we intend to explore additional purchases of real-estate assets, through purchase options or right-of-first refusals in existing leases, as well as acquisitions and de novo construction of purpose-built facilities.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2023, we generated total revenue of $ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, representing a CAGR of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% over the last five years. A substantial portion of our revenue is generated from payments from third-party payors, including Medicare and Medicaid, which represent our largest sources of revenue and accounted for&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% and &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; % of our routine revenue for the year ended December 31, 2023, respectively. For the year ended December 31, 2022, we generated revenue of $2.4 billion, and Medicare and Medicaid accounted for 47.6% and 30.2% of our total revenue, respectively. For the year ended December 31, 2023, we generated total net income of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , total operating expense of $                    and Adjusted EBITDA of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , representing a CAGR of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;%,               %, and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; %, respectively, over the last five years. For the year ended December 31, 2022, our total operating expenses were $2,192.6 million and we generated net income of $150.5 million and Adjusted EBITDA of $255.5 million, respectively. As of December 31, 2023, we had total long-term liabilities of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. Adjusted EBITDA is a non-GAAP financial measure. For a reconciliation of Adjusted EBITDA to the most directly comparable GAAP financial measure, see the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Conditions and Results of Operations&#8212;Key Skilled Services Metrics and Non-GAAP Financial Measures&#8212;Non-GAAP Financial Measures.&#8221;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Value Proposition </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our operating model creates meaningful value for patients and their families, our referring providers, our payors, and our administrators and clinicians. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Value Proposition for Patients and Families</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Coordinated care.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We empower team members at every level through skillful training, shared resources, and a collaborative spirit. We help deliver coordinated care before, during, and after a patient&#8217;s stay with us. Prior to admission, our administrators or other facility leaders meet with patients and their families, as well as hospital discharge planners, to plan for the patient&#8217;s discharge and enable a seamless transition to our facility. During a stay with us, our local facility team coordinates closely with physicians to deliver high-touch, high-quality care for patients. As care nears completion, we meet with our patients, their families, home health agencies and downstream care providers to plan for and ensure a smooth transition. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Outstanding patient experience.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our goal is to provide each patient with superior care and an outstanding experience. When patients arrive at our facilities they are greeted by a warm, inviting, and modern environment. We often upgrade facility infrastructure shortly after acquisition and perform periodic refreshes, to ensure our facilities are comfortable and well-equipped to serve patients across a wide range of acuities with a primary focus on high acuity patients. High acuity patients generally require higher levels of medical care or monitoring due to conditions or complications that cannot be easily managed, and often need more nursing resources and attention to maintain their quality of life. We believe our investment in modern equipment and technology allows our facility care teams to identify and respond to patient needs and provide them high quality care in a timely manner. Moreover, our clinicians are highly trained, have significant experience, and are able to leverage bespoke care plans to help ensure that patients receive care tailored to their particular needs. </font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Value Proposition for Referring Providers </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Strategic and seamless transitions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our administrators and their interdisciplinary teams seek to become a preferred partner by developing a deep understanding of local referring providers&#8217; and their patients&#8217; needs. Administrators often visit with patients and their families prior to discharge to plan for and map out a smooth admission to our facility. Once a plan is set, the facility team endeavors to quickly and seamlessly transition new patients to the facility with a focus on ensuring continuity of care in the transition. We believe that hospitals and other referral sources consider our facilities to be attractive discharge options because we are able to care for a wide variety of patient needs, and are often able to accept admissions on short notice, including on nights and weekends. Our flexibility helps hospitals maintain adequate bed availability to meet their other patients' needs.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Trusted partner with quality care.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our ability to care for higher acuity patients allows referring providers to have confidence that we will be able to adequately care for their patients and assist them in their recovery. Our facilities seek to work with patients&#8217; doctors to create personalized care plans to help ensure that patients stay on track in their recovery and to reduce the likelihood of their readmission to the hospital. Our facility teams also seek to coordinate closely with a patient&#8217;s home health agency or other post-SNF caregivers to try to ensure the patient&#8217;s transition home or to their next care setting is successful. This close coordination allows us, where warranted, to directly readmit patients back to our facility who would have otherwise been readmitted to an acute care hospital in the event they have a change of condition after leaving our facility.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Value Proposition for Payors</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Higher value site of care.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We believe we provide high acuity care in a cost-effective setting and are able to quickly transition patients from the acute care setting, reducing length of stay and delivering more overall value for payors. Moreover, we believe we provide payors with a high-quality alternative to higher cost post-acute sites of care. For example, according to MedPAC, SNFs are the lowest cost facility-based post-acute healthcare, costing an average of $550 per covered day compared to $1,850 and $1,753 per covered day for inpatient rehabilitation facilities and long-term acute care hospitals, respectively.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Robust culture of compliance.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We focus on instilling a unified, cohesive culture of innovation and compliance that we believe provides consistency in our results and confidence in our facilities as an attractive care option for patients. Our rigorous approach to billing integrity, our independent internal compliance function, and our regular facility billing audits are intended to provide a foundation of trust and collaboration that makes us a natural choice for payors.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Value Proposition for Administrators and Clinicians</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Autonomy and aligned compensation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Each facility administrator is, in effect, the local &#8220;CEO&#8221; and dedicated leader of their facility. Alongside their local interdisciplinary team, they are empowered to make real-time decisions locally around all aspects of their business and to manage their individual facility in a way that they believe is best suited to address their local market and its needs. We have designed a transparent incentive model for our administrators that is intended to align their compensation with the quality of care and operational and financial performance of their facility. We provide them the tools and the autonomy to optimize the performance of their facility, and we reward them for success in their efforts. We believe that a well-performing facility is the result of providing quality care in an environment of healing and caring and one that is appropriately staffed, supplied, and equipped to meet the needs of its patients. This dedicated focus by our administrators and their local teams on patient outcomes drives demand for our services and can ultimately result in higher patient census and profitability. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Robust technology enabled operating infrastructure.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We developed PACS Services to reduce the managerial and operational burden on our administrators, allowing them to focus on leading their facilities and spending more time with patients and staff. PACS Services includes a robust suite of technology tools </font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that provide detailed real-time data and trends that local clinicians and leadership teams can use to monitor and improve operational performance. PACS Services also includes regional support teams that leverage their deep tenure and experience across markets to provide higher-level support to local leaders on complex issues, including billing and cost reporting practices and regulatory compliance obligations. The regional teams are connected to and support the facilities within their designated region, which enables them to identify best practices and trends within the region, communicate those across their region, and provide facility-level support as needed. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Highly entrepreneurial career development.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> By providing our administrators with autonomy in the operation of their facility, we believe we create a highly entrepreneurial environment that encourages and rewards leaders to optimize operational performance. We empower our clinicians to do the same and provide top performers the opportunity to progress via training for higher skill licenses and certifications. People are provided the opportunity to advance to become an administrator through our Administrator-in-Training program, and to join a regional leadership team. For example, in the year ended December 31, 2023, we promoted&#160;26&#160;of our administrators from within our organization after participating in our Administrator-in-Training program, and&#160;12&#160;of our RVPs were previously successful administrators with us. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Competitive Strengths</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our success is driven by the following competitive strengths&#58; </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Superior Overall Quality</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excellence in clinical quality and experience for our patients is at the forefront of our mission and is reflected in our above-industry average QM Star rating and occupancy rate. Our facilities employ skilled administrators and clinicians and equip them with purpose-built technology and support so they can operate at the top of their professional capacity and deliver high-quality care for patients. We continuously invest in our people, processes, and facilities to promote an excellent patient experience. We believe we deliver superior overall quality that has contributed to our reputation as a provider-of-choice in our communities, driving greater referral volumes from referring providers who value our high standards. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Decentralized Market-Driven Operating Model</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our decentralized model emphasizes local operational autonomy. We believe that placing decision-making power at the local level with teams who understand the needs of their patients and their communities facilitates responsiveness and adaptability to evolving patient needs and facility and community factors. We believe the empowerment of local leadership promotes improved quality care for patients, greater referral volumes and higher occupancy rates. Our operating model is highly transferable to new markets, and enable us to quickly integrate and enhance new facilities. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transparent and Meritocratic Leadership Culture</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have built a transparent, competitive, and collegial culture that promotes individual growth both personally and professionally and prioritizes a deep commitment to our patients, families, and team members. We promote transparency in performance, which we believe encourages collaboration and healthy competition among local leadership that in turn drives best practices. We believe this meritocratic culture, supported by highly seasoned industry veterans, helps optimize clinical and financial outcomes at facilities and instills accountability throughout the organization. This leadership mindset has empowered us to develop a deep bench of leaders capable of supporting our existing and future facilities.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employer-of-Choice with Directly Aligned Incentive Model</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we are an employer-of-choice in the post-acute care industry, which enables us to attract and retain highly motivated, entrepreneurial individuals who value operational independence and financial opportunity. </font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This has allowed us to attract enterprising individuals from diverse backgrounds who may not have otherwise considered careers in skilled nursing. Our unique compensation model is designed to align local individual incentives with the long-term clinical quality and operational performance of the facility, which we believe fosters a shared ownership mentality. We believe this directly aligned incentive model has played a critical role in successfully attracting, incentivizing, and retaining our industry veterans. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Robust Suite of Technology-Enabled Services</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology focus delivers real-time data access to caregivers and administrators, facilitating delivery of the right care at the right time. Our technology tools enable our local leadership teams to focus on their first priority, providing the highest quality care possible to patients. We believe our suite of technologies helps drive decision-making and enhances operating efficiencies that can improve clinical quality, operational metrics, and the financial performance of our facilities. While other facility administrators may spend considerable time on paperwork and low-value activities, we strive to reduce the administrative burden on our facility administrators so they can walk the halls, personally meet patients, and provide a bespoke, concierge-level customer service experience. We equip our clinicians with industry-leading technology, including point-of-care and digital charting technologies, which streamlines charting and paperwork, so they can spend more time with patients and focus on providing high quality care. We believe our technology and internally developed dashboards help to facilitate better patient care, risk management, regulatory compliance, staffing, and resource allocation. We have designed our technology to be easily integrated into new facilities and allow us to scale quickly and efficiently.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Differentiated, Multi-faceted, and Disciplined Acquisition Playbook</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the past 9 years, we have demonstrated the effectiveness of our disciplined, multi-faceted playbook of acquiring and improving underperforming facilities, having successfully acquired and integrated over 195 facilities to date. We believe we have established a reputation as an acquiror-of-choice, which has led to several inbound opportunities, and has helped us build an extensive opportunity pipeline. Our balanced approach to evaluation allows us to selectively pursue opportunities that meet our strategic priorities and criteria and grow in a responsible manner. Through our investment into facilities and our integration process, we are able to transition new underperforming facilities to higher-value short-term transitional care facilities. We believe our success is evidenced by our robust QM Star ratings, occupancy rates, and profitability at our Mature facilities.  </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our High-Quality Facilities </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to providing a high-quality experience for all of our patients, which is why we invest in capital improvements and ongoing maintenance to all of our facilities, regardless of whether we lease or own. Our investment into facilities is differentiated from traditional industry operators who we believe are often hesitant to make physical plant investments into facilities and who often seek to extract value through cost-cutting or other limitations on facility resources. Our renovations are intended to improve the look and feel of facilities in order to provide an excellent experience. Our investments into medical beds, vitals monitors, physical therapy equipment, and other improvements allows us to provide services to higher acuity patients. We believe our high-quality facilities lead to sustained referral volumes, more admissions, and high skilled mix at our facilities, ultimately leading to higher occupancy rates and revenue per patient day. We also believe our investment into leased facilities makes us a preferred tenant with our landlords and provides us leverage in negotiating favorable lease terms. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Size and Scale</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our market density in key regions offers strategic advantages, such as brand recognition with referring providers, including hospitals and health systems, and consistency and continuity of referrals of patients. For example, our ability to accommodate a high volume of patients within our markets allows us to accept referrals without turning patients away to competitors, and can also further our reputation as a reliable, go-to provider of care for referring providers. We also believe our size and scale has provided us with the ability to negotiate favorable contracts with managed care and other payor sources, the ability to navigate stringent regulatory compliance </font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">obligations and withstand potential reimbursement and regulatory industry dynamics, and the ability to leverage real estate value for liquidity and growth. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Industry Overview and Market Opportunity</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Post-Acute Care Continuum is Essential to the Healthcare Ecosystem</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in the post-acute care industry, which is an essential component of the healthcare delivery ecosystem, serving high need, medically fragile patients. Post-acute care encompasses multiple care settings outside of acute care hospitals that are differentiated by the acuity level of patients and the services they require. While services may overlap across each distinct post-acute offering, post-acute rehab or SNFs provide the most comprehensive array of services. Upstream care providers, such as acute care hospitals, generally discharge patients to post-acute facilities where patients can receive key services at lower costs. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SNFs are an Integral and Essential Part of the Post-Acute Care Continuum</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SNFs play an essential role in post-acute patient care. SNFs provide higher-acuity skilled nursing care to patients that cannot be adequately treated in community-based care settings, such as assisted living or independent living facilities, and who are no longer appropriate candidates for hospital care. Patients referred to a SNF are typically recovering from surgery or non-critical conditions, such as strokes, joint replacements, and acute infections, and are admitted to a SNF within 30 days of being discharged from a hospital where they spent at least three days as an inpatient. In many instances, patients are treated at SNFs prior to receiving home health nursing care and therapy services. The majority of SNF patients are aged 65 years or older. Despite the wide array of services and variety of needs addressed, MedPAC reports that SNFs are the lowest cost facility-based post-acute healthcare, costing on average $550 per covered day compared to $1,850 and $1,753 per covered day for inpatient rehabilitation facilities and long-term acute care hospitals, respectively. According to CMS MedPAC data, SNFs accounted for approximately 44% of the total post-acute care continuum spend. According to CMS Inpatient Hospital discharge data, in 2022, approximately 22% of Medicare patients over 65 years old were discharged to SNFs, representing more than any other facility type, including inpatient rehabilitation facilities and long-term acute care hospitals (approximately 6%), and more than home health nursing care (21%) or hospice (5%). As reimbursement and coverage continues to shift toward value-based models with greater emphasis on controlling costs, SNFs are integral to post-acute care and will continue to drive high-quality outcomes in low-cost settings. Furthermore, during the COVID-19 pandemic, SNFs were widely utilized to treat medically fragile patients, reinforcing the importance of SNFs to the healthcare ecosystem.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Large, Fragmented Industry Comprised of Mostly Small and Independent Operators</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to the National Center for Health Statistics (NCHS) 2020 National Post-acute and Long-term Care Study</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the SNF industry in the United States encompasses approximately 15,000 facilities and serves approximately 1.3 million patients annually. The industry is highly fragmented, with the top 10 operators, each having greater than 100 facilities, representing approximately 11% of total number of SNFs in the United States, according to CMS data as of September 2022, approximately 5,000 smaller and independent operators of less than 100 facilities making up the remainder. According to this data, of the approximately 15,000 facilities, approximately 13,200 facilities have less than 100 beds, and approximately 74% and 26% of SNFs are located in urban and rural areas, respectively. In addition, approximately 72%, 23%, and 6% of SNFs are operated as for-profit, as non-profit, and by the government, respectively, according to such data. We believe this fragmented landscape creates opportunities for larger providers with greater scale to serve patients better and meet regulatory requirements nation-wide by effectively addressing staffing, quality standards, and billing processes. Moreover, many small and independent operators face pressure due to billing requirements, regulations, competition on quality of care and facilities, staffing shortages and competition, and the cessation of COVID-related provider relief funding, which has led them to pursue sales of their facilities or businesses. This provides additional opportunity for well-managed, high-quality operators to grow through acquisitions. </font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Growing Demand Outpacing Supply of Skilled Nursing Facilities</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The demand for healthcare services in the United States has increased in recent years and is expected to continue growing, largely due to a rapidly aging population and an increasing prevalence of chronic conditions. According to the U.S. Census Bureau, the U.S. population aged 65 and older is expected to nearly double from 2020 to 2060 and reach 95 million in 2060, which exceeds the expected increase in the general population during that same period, and comprise one fifth of the total U.S. population in 2030. Moreover, according to the U.S. Census Bureau, the U.S. population aged 85 and older is expected to nearly triple from 2020 to 2060 and reach 19 million in 2060. Additionally, according to an article published in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Frontiers in Public Health</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2022, the percentage of people in the United States aged 50 and older with at least one chronic condition is estimated to increase by 99.5% from 2020 to 2050. According to CMS data as of September 2022, approximately 82% of SNF patients were 65 years of age or older.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As demand has increased for SNFs, the number of SNFs has declined in recent years from approximately 15,650 in 2017 to approximately 14,900 in 2023. We believe this is due to a variety of factors, including an inability of many facilities to comply with the industry&#8217;s stringent regulatory compliance obligations and with quality standards, rigorous staffing, and billing requirements, as well as a lack of technology and sophistication at small and independent operators. Furthermore, new operators to this highly regulated industry face multiple barriers to entry, including the requirements to obtain a Certificate of Need, complex licensure and regulatory compliance requirements, lack of operating experience, and significant capital requirements. As a result, the addition of new SNFs has not kept pace with the number of SNFs exiting the market, amplifying the need for skilled nursing to serve an aging population. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Favorable Reimbursement Environment</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to CMS, approximately 72% of SNF revenue in 2022 was derived from government sources, including Medicaid and Medicare. Medicaid represents 51% of industry revenue, while Medicare represents approximately 21%. The remainder comprises managed care, private pay, and other payors. Medicare and Medicaid reimbursement has steadily increased over the past few years. Medicare reimbursement per patient day increased at a CAGR of approximately 3.6% from 2012 to 2021, while Medicaid reimbursement per patient day increased at a CAGR of approximately 1.9% from 2012 to 2021. The industry has experienced over 9 years of growth in reimbursement rates. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Environment</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SNF industry is highly regulated with stringent regulatory compliance obligations. In the ordinary course of business, providers are subject to federal, state and local laws and regulations relating to, among other things, billing and reimbursement, relationships with vendors, business relationships with physicians and other healthcare providers and facilities, as well as licensure, accreditation, enrollment, quality, adequacy of care, physical plant, life safety, personnel, staffing and operating requirements. Changes in or new interpretations of existing laws and regulations may have a significant impact on revenue, costs and business operations of providers and other industry participants. In addition, governmental and other authorities periodically inspect the SNFs, senior living facilities and outpatient rehabilitation agencies to verify continued compliance with applicable regulations and standards, and may impose citations and other regulatory penalties for regulatory deficiencies. Such regulatory penalties include but are not limited to civil monetary penalties, temporary payment bans, suspension or revocation of a state operating license and loss of certification as a provider in the Medicare or Medicaid program, any of which may be temporary or permanent in nature. This regulatory environment and related enforcement can have an adverse effect on providers and other industry participants.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Market Opportunity</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the decline in the number of SNFs, the industry is large and growing, with CMS expecting total industry expenditures to increase from $193.6 billion in 2022 to $283.3 billion in 2031, representing CAGR of 4.3%. Based on the number of facilities as reported by CMS, we are one of the largest SNF operators in the United States </font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and believe our scale and other competitive strengths uniquely position us to capitalize on the current underlying trends within the SNF industry and capture a growing portion of this expected growth.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Growth Strategies</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have built a multi-faceted growth strategy with multiple organic and inorganic levers to help drive our growth and capitalize on the favorable industry dynamics. To continue our growth, we intend to&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Expand our presence in existing and new markets.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have a robust pipeline of potential single-facility tuck-in acquisitions, larger multi-facility portfolio acquisitions and select new facility builds across existing and new markets. We have historically completed an average of approximately 20 acquisitions and one de-novo, or new-build, facility per year, but have the flexibility to increase or decrease this cadence from period to period in line with our business priorities and as strategic opportunities arise. We plan to continue to strategically pursue opportunities within our pipeline to supplement our organic growth and have entered into contracts to acquire up to 10 facilities that we expect to close in the first quarter of 2024. While we expect to continue to execute on this strategy, we do not have binding agreements or commitments for any material investments at this time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Leverage operational upside within our existing footprint.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our portfolio has a healthy foundation for strong embedded organic growth. We are focused on driving higher occupancy and increasing skilled mix in an effort to fill unused capacity with higher acuity patients, which can improve our revenue per patient day and our profitability, which in turn drive growth. Historically, we have found that it takes up to 3 years for a New facility to scale to performance similar to that of a Mature facility. As of December 31, 2023, we had&#160;66&#160;New facilities and&#160;77&#160;Ramping facilities, which we define as facilities purchased within 18 to 36 months prior to the measurement date. We believe these facilities provide us some degree of near-term visibility into expected organic growth within our footprint.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Continue to grow our pipeline of leaders.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our rapid growth in size and scale can be attributed to our deep bench of talented leaders. Our administrators in training provide us with leadership resources that we can use to quickly staff new facilities with qualified operators. Similarly, our RVPs enable us to scale within regions. We intend to invest heavily in training existing leaders and expanding our bench of new administrators and RVPs to support our future growth.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Extract embedded value from real estate ownership.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We plan to continue to evaluate our real estate purchase options in an effort to reduce our rent burden and grow the underlying earnings of our business. We have executed 17 purchase options since 2013 and had&#160;14 additional options available to us as of December 31, 2023. We intend to continue to selectively exercise purchase options and continue structuring additional purchase options to provide an additional lever to grow net margins and enhance stockholder value. Moreover, we believe that our real estate ownership provides balance sheet support as an inflationary hedge, provides capital flexibility as a source of asset collateral, reduces the burden of leases and restrictive agreements, and allows us the opportunity to create additional value in improving distressed assets. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Ancillary opportunities.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have identified and continue to evaluate multiple investment opportunities that have the potential to improve our post-acute patient experience by augmenting the services we provide. We may capitalize on these investment opportunities that are ancillary to our core business, such as pharmacy services, laboratory services, transportation, and imaging, which have the potential to be additional sources of revenue and operating income over time. We refer to these efforts to build a strategic mix of investments in ancillary business lines as &#8220;PACS Ventures.&#8221; We continue to evaluate opportunities to in-source, acquire, and commercialize these ancillary opportunities. Additionally, we may choose to monetize our PACS Services by offering it to third-party SNF operators in the future. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Expand into other post-acute sites of care.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We believe that our proven operational playbook and focus on delivering high-quality care have the potential to be utilized in additional post-acute sites of care, including </font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">home health and hospice as well as within broader senior living communities. As of December 31, 2023, we had&#160;one&#160;independent living facility and&#160;four&#160;assisted living facilities which provide a foundation for further expansion.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary Risk Factors</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of risks that you should understand before making an investment decision regarding this offering. You should carefully consider all of the information in this prospectus, including risks and uncertainties described in the sections titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and &#8220;Risk Factors,&#8221; before making a decision to invest in our common stock. If any of these risks actually occur, it could have a material adverse effect on our business, financial condition, and results of operations. In such case, the trading price of our common stock would likely decline, and you could lose all or part of your investment. These risks include, but are not limited to&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We depend upon reimbursement from third&#8209;party payors, and our revenue, financial condition and results of operations could be negatively impacted by any changes in the acuity mix of patients in our facilities as well as changes in payor mix and payment methodologies and new cost containment initiatives by third-party payors&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be fully reimbursed for all services for which each facility bills through consolidated billing or bundled payments, which could have an adverse effect on our revenue, financial condition and results of operations. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased competition for, or a shortage of, nurses, nurse assistants and other skilled personnel could increase our staffing and labor costs and subject us to monetary fines.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We rely on payments from third-party payors, including Medicare, Medicaid and other governmental healthcare programs and private insurance organizations. If coverage or reimbursement for services are changed, reduced or eliminated, including through cost-containment efforts, spending requirements are changed, data reporting, measurement and evaluation standards are enhanced and changed, our operations, revenue and profitability could be materially and adversely affected.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reforms to the U.S. healthcare system, including new regulations under the Affordable Care Act (ACA), continue to impose new requirements upon us that could materially impact our business.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to various government and third-party payor reviews, audits and investigations that could adversely affect our business, including an obligation to refund amounts previously paid to us, potential criminal charges, the imposition of fines, and&#47;or the loss of our right to participate in Medicare and Medicaid programs or other third-party payor programs.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">State efforts to regulate or deregulate the healthcare services industry or the construction expansion, or acquisition of healthcare facilities could impair our ability to expand our operations, or could result in increased competition.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We face numerous risks related to expiration of the COVID&#8209;19 public health emergency (PHE) expiration and surrounding wind down and uncertainty, which could, individually or in the aggregate, have a material adverse effect on our business, financial condition, liquidity, results of operations and prospects.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we fail to attract patients and residents and to compete effectively with other healthcare providers, our revenue and profitability may decline and we may incur losses.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We review and audit the care delivery, recordkeeping and billing processes of our operating subsidiaries. These reviews from time to time detect instances of noncompliance that we attempt to correct, which in some instances requires reduced or repayment of billed amounts or other costs.</font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to litigation, which is commonplace in our industry, which could result in significant legal costs and large settlement amounts or damage awards, and our self-insurance programs may expose us to significant and unexpected costs and losses.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We rely significantly on information technology, and any failure, inadequacy or interruption of that technology could harm our ability to effectively operate our business.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be unable to complete future facility or business acquisitions at attractive prices or at all, which may adversely affect our revenue&#59; we may also elect to dispose of underperforming or non&#8209;strategic operating subsidiaries, which would decrease our revenue. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In undertaking acquisitions, we may be adversely impacted by costs, liabilities and regulatory issues that may adversely affect our operations, and we may not be able to successfully integrate acquired facilities and properties into our operations, or achieve the benefits we expect from any of our facility acquisitions. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Because we lease the majority of our facilities, we are subject to risks associated with leased real property, including risks relating to lease termination, lease extensions and special charges, any of which could have an adverse effect on our business, financial condition and results of operations. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We identified a material weakness in our internal control over financial reporting related to the review process of the work performed by a third-party tax credit consulting firm. We may identify additional material weaknesses in the future or otherwise fail to maintain an effective system of internal controls, which may result in material misstatements of our financial statements or cause us to fail to meet our reporting obligations.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We operate in a highly regulated industry with stringent regulatory compliance obligations, and are subject to extensive and complex laws and government regulations. If we are not operating in compliance with these laws and regulations or if these laws and regulations change, we could be required to make significant expenditures or change our operations in order to bring our facilities and operations into compliance. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Information</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were initially incorporated on December 17, 2012 as Providence Group, Inc., a California corporation. On June 30, 2023, we undertook a reorganization in connection with our entry into a new credit agreement described in more detail in the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Conditions and Results of Operations&#8212;Liquidity &#38; Capital Resources&#8212;Credit Facilities.&#8221; Pursuant to this reorganization, PACS Group, Inc., which was incorporated on March 24, 2023 as a Delaware corporation, became the parent entity for our organization. The following diagram sets forth a simplified view of our corporate structure as of December 31, 2023. </font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This chart is for illustrative purposes only and does not represent all legal entities affiliated with the entities depicted. The operating subsidiaries that represent our various facilities are omitted.</font></div><div style="margin-bottom:12pt;text-align:center"><img alt="summary1a.jpg" src="summary1a.jpg" style="height:337px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PACS Group, Inc. is a holding company with operating subsidiaries that provide skilled nursing, senior living, as well as other ancillary businesses. Each facility is structured as an operating subsidiary under one of our two subsidiary holding companies&#58; Providence Group, Inc. and Providence Group NH, LLC. Subsidiaries of Providence Group, Inc. are currently operating subsidiaries (facilities) with mortgage loans insured by the U.S. Department of Housing and Urban Affairs. Subsidiaries of Providence Group NH, LLC are currently operating subsidiaries (facilities) without such mortgage loans. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PACS Group, Inc. and its subsidiaries that are not licensed healthcare providers do not provide healthcare services to patients, residents or any other person, and do not direct or control the provision of services provided. All healthcare services are provided solely by applicable subsidiaries that are licensed healthcare providers, under the direction and control of licensed healthcare professionals in accordance with applicable law.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive offices are located at 262 N. University Ave, Farmington, Utah 84025, and our telephone number is (801) 447-9829. Our website address is www.pacs.com. Information contained on, or that can be accessed through, our website is deemed not to be incorporated in this prospectus and does not constitute part of this prospectus, and the inclusion of our website address in this prospectus is an inactive textual reference only. Investors should not rely on any such information in deciding whether to purchase our common stock.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Stockholders Agreement</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this offering, we intend to enter into a new stockholders agreement (Stockholders Agreement) with Jason Murray and Mark Hancock. Subject to certain limitations and exceptions, the Stockholders Agreement will grant each of Messrs. Murray and Hancock certain board designation rights for so long as they each beneficially own at least 5% of the aggregate number of shares of common stock outstanding immediately following this offering. In addition, Messrs. Murray and Hancock will agree to elect a certain number of directors who are not affiliated with any party to the Stockholders Agreement and who satisfy the independence requirements applicable to audit committee members established pursuant to Rule 10A-3 under the Exchange Act.</font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of Messrs. Murray and Hancock will also agree to vote, or cause to vote, all of their outstanding shares of our common stock at any annual or special meeting of stockholders in which directors are elected, so as to cause the election of their respective designees, in each case to the extent that each or any of Messrs. Murray and Hancock have exercised their right to designate individuals for election to the board of directors.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Stockholders Agreement additionally provides certain registration rights to Messrs. Murray and Hancock. See the section titled &#8220;Description of Capital Stock&#8212;Registration Rights.&#8221;</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding the Stockholders Agreement, please see the section titled &#8220;Certain Relationships and Related Party Transactions&#8212;Stockholders Agreement.&#8221;</font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_1355"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE OFFERING</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.489%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock offered by us</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares.</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwriters&#8217; option to purchase additional shares of common stock from us</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have granted the underwriters an option for a period of 30 days from the date of this prospectus to purchase up to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;additional shares of our common stock.</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock to be outstanding after this offering</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">shares (or &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares if the underwriters exercise their option to purchase additional shares of our common stock from us in full).</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Use of proceeds</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We estimate that we will receive net proceeds from this offering of approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million (or $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million if the underwriters exercise their option to purchase additional shares of our common stock from us in full), based upon an assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share (which is the midpoint of the price range set forth on the cover page of this prospectus) and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We intend to use the net proceeds from this offering for general corporate purposes to support the growth of our business. Additionally, we may use a portion of the net proceeds to acquire or invest in additional nursing facilities or other businesses and service offerings, although we do not have binding agreements or commitments with respect to any acquisitions or investments at this time. We will have broad discretion in the way that we use the net proceeds of this offering. See the section titled &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_692" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Use of Proceeds</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; for additional information.</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Controlled company</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Following this offering, we expect to be a &#8220;controlled company&#8221; within the meaning of the corporate governance rules of the New York Stock Exchange. See the section titled &#8220;Management&#8212;Director Independence and Controlled Company Exception.&#8221;</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend policy</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have no current plans to pay dividends or other distributions on our common stock in the foreseeable future. Any decision to declare and pay dividends in the future will be made at the sole discretion of our board of directors and will depend on, among other things, our results of operations, cash requirements, financial condition, contractual restrictions and other factors that our board of directors may deem relevant. See the section titled &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_702" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Dividend Policy</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.&#8221;</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk factors</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing in our common stock involves a high degree of risk. See the section titled &#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_660" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Risk Factors</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221; and the other information included in this prospectus for a discussion of factors you should carefully consider before deciding to invest in shares of our common stock.</font></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proposed New York Stock Exchange&#160;trading symbol</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have applied to list shares of our common stock on the New York Stock Exchange under the symbol &#8220;PACS.&#8221;</font></div></td></tr></table></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of our common stock to be outstanding after this offering is based on&#160;20,000&#160;shares of our common stock outstanding as of&#160;December 31, 2023, and excludes&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares of our common stock reserved for future issuance under our 2024 Incentive Award Plan (2024 Plan), which will become effective in connection with the completion of this offering, including approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares of common stock issuable upon the settlement of restricted stock units that we intend to grant to certain of our directors, executive officers and other employees in connection with this offering as described under &#8220;Compensation Discussion and Analysis&#8212;Equity Compensation,&#8221; as well as any annual automatic &#8220;evergreen&#8221; increases in the number of shares of our common stock reserved for future issuance thereunder pursuant to the terms of the 2024 Plan&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares of our common stock reserved for future issuance under our 2024 Employee Stock Purchase Plan (ESPP), which will become effective in connection with the completion of this offering, as well as any annual automatic &#8220;evergreen&#8221; increases in the number of shares of our common stock reserved for future issuance thereunder pursuant to the terms of the ESPP.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise indicated, all information in this prospectus, including the number of shares of our common stock that will be outstanding after this offering, reflects and assumes&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a 1-for-&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;split of our common stock effected on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2024&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the filing and effectiveness of our amended and restated certificate of incorporation (Amended and Restated Charter) and the effectiveness of our amended and restated bylaws (Amended and Restated Bylaws), each of which will occur immediately prior to the completion of this offering&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">no exercise by the underwriters of their option to purchase additional shares of our common stock from us&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an initial public offering price of $ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share, which is the midpoint of the price range set forth on the cover of this prospectus.</font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_1372"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUMMARY CONSOLIDATED FINANCIAL AND OTHER DATA</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our consolidated financial and other data for the periods and as of the dates indicated. The summary consolidated statements of income for the years ended December 31, 2023, 2022 and 2021 and the consolidated balance sheet data as of December 31, 2023 have been derived from our audited consolidated financial statements included elsewhere in this prospectus. The summary consolidated financial and other data set forth below should be read together with the section of this prospectus titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and the audited consolidated financial statements and the related notes included elsewhere in this prospectus. The summary consolidated financial and other data in this section are not intended to replace our audited consolidated financial statements and the related notes and are qualified in their entirety by our audited consolidated financial statements and the related notes included elsewhere in this prospectus. Our historical results are not necessarily indicative of the results to be expected in the future. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Income</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:5.8pt;padding-right:1.6pt;text-indent:-4.2pt"><font><br></font></div></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:5.8pt;padding-right:1.6pt;text-indent:-4.2pt"><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient and resident service revenue</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,399,155&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,135,909&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional funding</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,482&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,563&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,091&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue </font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,421,994&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166,563&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861,314&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901,095&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent-cost of services</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,003&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,122&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,006&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,834&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,311&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,153&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Operating Expenses </font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,192,634&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083,204&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,360&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,359&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,538)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,278)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,223&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,345&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Other Expense, net </font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,315)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,933)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,045&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,426&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56,549)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,479)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,496&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,947&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share - basic and diluted</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,525&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing net income per share - basic and diluted</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheet Data</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2023</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Actual</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Adjusted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(2)</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The as adjusted consolidated balance sheet data gives effect to the sale and issuance of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock by us in this offering, based on an assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share (which is the midpoint of the price range set forth on the cover page of this prospectus), after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Each $1.00 increase or decrease in the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, which is the midpoint of the price range set forth on the cover page of this prospectus, would increase or decrease, as applicable, the as adjusted amount of each of our cash and cash equivalents, working capital, total assets, and total stockholders&#8217; equity by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same, after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us. Similarly, an increase or decrease of 1.0 million shares in the number of shares of common stock offered would increase or decrease, as applicable, each of our cash and cash equivalents, working capital, total assets, and total stockholders&#8217; equity by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, assuming the initial public offering price remains the same, after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us. The as adjusted consolidated balance sheet data discussed above is illustrative only and will depend on the actual initial public offering price and other terms of this offering determined at pricing.</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">We define working capital as current assets less current liabilities. See our audited consolidated financial statements and the related notes included elsewhere in this prospectus for further details regarding our current assets and current liabilities.</font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="border-color:#000000;border-style:solid;border-width:1.00pt;padding:36.00pt 36.00pt 36.00pt 36.00pt"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Skilled Services Metrics and Non-GAAP Financial Measures</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the following key skilled services metrics and non-GAAP financial measures to help us evaluate our business, identify trends that affect our financial performance, and make strategic decisions. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:5.8pt;padding-right:1.6pt;text-indent:-4.2pt"><font><br></font></div></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:5.8pt;padding-right:1.6pt;text-indent:-4.2pt"><font><br></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in thousands)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Key Skilled Services Metrics</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled nursing services revenue</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,391,309&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133,103&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled mix by revenue</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled mix by nursing patient days</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Occupancy for skilled nursing services&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available patient days</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,719,689</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,106,602</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual patient days</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,139,736</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,681,927</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Occupancy rate (operational beds)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of facilities at period end</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of operational beds at period end</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,345</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,841</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-GAAP Financial Measures</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Performance Measures</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,894&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,857&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,516&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,073&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Valuation Measure</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDAR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">EBITDA, Adjusted EBITDA and Adjusted EBITDAR are non-GAAP financial measures and should be considered in addition to, not as a substitute for or in isolation from, our financial results prepared in accordance with U.S. GAAP. EBITDA and Adjusted EBITDA are performance measures and Adjusted EBITDAR is a valuation measure therefore presented only for the current period. Other companies, including companies in our industry, may calculate these measures differently or not at all, which reduces their usefulness as comparative measures. For a reconciliation of each of EBITDA, Adjusted EBITDA, and Adjusted EBITDAR to the most directly comparable U.S. GAAP financial measure, information about why we consider these measures useful and a discussion of the material risks and limitations of these measures, please see the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Key Skilled Services Metrics and Non-GAAP Financial Measures&#8212;Non-GAAP Financial Measures.&#8221; </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Conditions and Results of Operations&#8212;Key Skilled Services Metrics and Non-GAAP Financial Measures&#8221; included elsewhere in this prospectus for a description of, and additional information about, these key skilled services metrics and non-GAAP financial measures. </font></div></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_660"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISK FACTORS</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing in our common stock involves a high degree of risk. You should carefully consider each of the following risk factors and all other information set forth in this prospectus. Based on the information currently known to us, we believe that the following information identifies the most significant risk factors affecting our company. However, the risks and uncertainties we face are not limited to those set forth in the risk factors described below. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business. In addition, past financial performance may not be a reliable indicator of future performance and historical trends should not be used to anticipate results or trends in future periods.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If any of the following risks and uncertainties develops into actual events or circumstances, they could have a material adverse effect on our business, financial condition and results of operations. In such case, the market price of our common stock could decline. You should carefully read the following risk factors, together with our audited consolidated financial statements and the related notes and all other information included in this prospectus. This prospectus contains forward-looking statements that contain risks and uncertainties. See the section titled &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221; in connection with your consideration of the risk factors and other important factors that may affect future results described below.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business and Industry</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend upon reimbursement from third&#8209;party payors, and our revenue, financial condition and results of operations could be negatively impacted by any changes in the acuity mix of patients in our facilities as well as changes in payor mix and payment methodologies and new cost containment initiatives by third-party payors.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is affected by the percentage of the patients of our operating subsidiaries who require a high level of skilled nursing and rehabilitative care, whom we refer to as high acuity patients or skilled patients, and by our mix of payment sources. Changes in the acuity level of patients we attract, as well as our payor mix among Medicaid, Medicare, private payors and managed care companies, significantly affect our revenue. Because high acuity patients require more skilled nursing services and a higher level of care, we generally receive higher reimbursement rates for providing care to them. Lower acuity patients, who are typically Medicaid beneficiaries, typically require fewer skilled nursing services and thus we are typically paid lower rates by Medicaid for caring for them, sometimes at rates that do not cover our costs of providing care to the patient. Reimbursement rates provided for caring for skilled patients are more likely to meet or exceed the costs of providing care to those patients, thus allowing the facility to be fiscally sustainable. Given the generally predetermined nature of the reimbursement rates that we are paid for caring for patients, depending on their acuity level, if our labor or other operating costs increase disproportionately compared to the reimbursement rates we are paid for providing services, particularly with Medicaid patients, we will generally be unable to recover the increased costs from payors unless and until reimbursement rates are adjusted, and even then they may not be adjusted in full, in a timely manner, and are typically only adjusted on a prospective basis. Accordingly, if we fail to maintain our proportion of high acuity patients or if there is any significant increase in the percentage of the patients of our operating subsidiaries for whom we receive Medicaid reimbursement, it could have a material adverse effect on our business, financial condition, and results of operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Initiatives undertaken by major insurers and managed care companies, including companies who run plans commonly referred to as Managed-Medicare and Managed-Medicaid, to reduce their costs and the amounts they pay providers may adversely affect our business. These tactics include contracting with healthcare providers to obtain services on a discounted basis. We believe that this trend will continue and may limit reimbursements for healthcare services. If insurers or managed care companies from whom we receive substantial payments were to reduce the amounts they pay for services and we did not wish to accept such reductions, we may lose patients if we choose not to renew our contracts with these insurers at their lower offered rates. Additionally, some payors have used the federal &#8220;No Surprises Act&#8221; or similar state legislation as a means to initiate re&#8209;negotiation of reimbursement rates for providers and facilities, leading to litigation between these providers and&#47;or facilities against payors and it may adversely affect us as well. In addition, sustained unfavorable economic conditions may affect the number of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">patients enrolled in managed care programs and the profitability of managed care companies, which could result in reduced payment rates.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be fully reimbursed for all services for which each facility bills through consolidated billing or bundled payments, which could have an adverse effect on our revenue, financial condition and results of operations. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the per diem prospective payments paid to SNFs, SNFs are required to perform consolidated billing for certain items and services furnished to patients and residents. Consolidated billing generally requires the SNF to bill a single daily amount for the entire package of care that its patients receive during a SNF stay covered by Medicare Part A or Medicare Advantage plans.   Given the generally predetermined nature of the reimbursement rates that SNFs are paid for caring for patients, if our operating costs increase disproportionately compared to the reimbursement rates we are paid for providing services under consolidated billing, there could be a material adverse effect on our business, financial condition, and results of operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, CMS has implemented certain payment initiatives that bundle acute care and post-acute care reimbursement. Post&#8209;hospitalization skilled nursing services must be &#8220;bundled&#8221; into the hospital&#8217;s diagnostic related group payment in certain limited circumstances, in which case the hospital and SNF must effectively divide the payment that otherwise would have been made to the hospital and no additional funds are paid by Medicare for the skilled nursing care of the patient. Although this practice applies to only a limited number of DRGs and is uncommon at our SNFs currently, it could adversely affect SNF utilization and payments, whether due to the practical difficulty of this apportionment or hospitals being reluctant to lose revenue by discharging patients to a SNF. If more payments are required to be bundled in the future, or if there is any significant increase in patients for whom we receive bundled payments, our SNFs may not receive full reimbursement for all the services they provide, which could have a further adverse effect on SNF utilization and our revenue, financial condition and results of operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increased competition for, or a shortage of, nurses, nurse assistants and other skilled personnel could increase our staffing and labor costs and subject us to monetary fines.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends upon our ability to retain and attract nurses and other skilled personnel, such as registered nurses, licensed vocational nurses, licensed practical nurses, certified nurse assistants, social workers and speech, physical and occupational therapists, as well as skilled management personnel responsible for day&#8209;to&#8209;day facility operation. Each facility has a facility administrator who is ultimately responsible for the overall day&#8209;to&#8209;day operations of the facility, including quality of care, social services and financial performance. Each facility administrator leads a team of facility staff who are directly responsible for day&#8209;to&#8209;day care of the facility residents, as well as other operational functions of the facility including marketing and community outreach programs. Other key positions supporting each facility may include individuals responsible for physical, occupational and speech therapy, food service and maintenance. We compete with various healthcare service providers, including other skilled nursing providers, in retaining and attracting qualified and skilled personnel. We also compete with businesses outside of healthcare in our efforts to attract and retain talented employees.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our subsidiaries operate SNFs in Arizona, California, Colorado, Kentucky, Missouri, Nevada, Ohio, South Carolina and Texas. Some states have established minimum staffing requirements for facilities operating in that state, and other states may do the same in the future, or existing requirements may become more stringent. Failure to comply with these requirements due to competition for, a shortage of or an inability to hire required personnel can, among other things, jeopardize a facility&#8217;s compliance with the conditions of participation under relevant state and federal healthcare programs. If a facility is determined to be out of compliance with these requirements, it may be subject to a notice of deficiency, a citation, or a significant fine or litigation risk, with penalties including the suspension of patient admissions and the termination of Medicaid participation, or the suspension, revocation or non&#8209;renewal of the SNF&#8217;s license, and may also disqualify the facility from participation in state programs that reward facilities for meeting applicable quality criteria. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If federal or state governments were to materially change the way compliance with applicable staffing standards is calculated or enforced, our labor or other operating costs could increase and the current shortage of healthcare workers could impact us more significantly. The local labor markets where we compete are sometimes in a state of disequilibrium where the needs of businesses such as ours outstrip the supply of available and willing workers, which can make it challenging to hire sufficient quantities of staff locally and may require us to use third-party staffing companies to provide healthcare workers at an even higher cost. There is additional upward pressure on wages in many of our markets from different industries and more generally due to the current rate of inflation. Some of these industries compete with us for labor, which makes it difficult to make significant hourly wage and salary increases due to the fixed nature of our reimbursement under insurance contracts as well as Medicare and Medicaid, in addition to our increasing fixed and variable costs. Due to the generally limited supply of qualified applicants who seek or are willing to accept employment in certain of our markets, these broader trends may increase our labor costs or lead to potential staffing shortages, reduced operations to comply with applicable laws and regulations, or difficulty complying with those laws and regulations at current operational levels, or limit our ability to admit all residents who would like to receive care at our facilities. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Existing or future federal, state or local laws and regulations may increase our costs of maintaining qualified nursing and skilled personnel, or make it more difficult for us to attract or retain qualified nurses and skilled staff members. For instance, the Center for Medicare and Medicaid Services (CMS) has proposed regulations that will impose minimum staffing mandates on nursing facilities nationwide. If those regulations are implemented in the proposed form, or even with less prescriptive requirements, many skilled nursing facilities nationwide may experience significantly increased staffing costs, even if sufficient numbers of applicants are available to meet the staffing mandate. Due to labor shortages and other opportunities available to qualified workers, there can also be no assurance that sufficient numbers of applicants will be available to fulfill any staffing requirements that may be imposed, whether at pay rates that companies can afford or otherwise. Furthermore, CMS and some states have published guidance to surveyors addressing topics that specifically include nurse staffing and collection of payroll data to evaluate staffing levels, which may lead to future regulation that increase our staffing requirements and labor costs or lower revenues.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increased competition for, or a shortage of, nurses or other qualified personnel, or general ongoing inflationary pressures may require that we enhance our pay and benefits packages, potentially beyond what we can afford in light of applicable reimbursement rates and other cost pressures, to compete effectively for such personnel. Turnover rates and the magnitude of the shortage of nurses or other trained personnel vary substantially from market to market and facility to facility, and may adversely affect the applicable facilities&#8217; quality and other ratings based on data reported to CMS. In addition, if we fail to attract and retain qualified and skilled personnel, our ability to conduct our business operations could be harmed. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State efforts to regulate or deregulate the healthcare services industry or the construction expansion, or acquisition of healthcare facilities could impair our ability to expand our operations, or could result in increased competition.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some states require healthcare providers, including SNFs, to obtain prior approval, commonly known as a certificate of need, for&#58; (1) the purchase, construction or expansion of healthcare facilities&#59; (2) capital expenditures exceeding a prescribed amount&#59; or (3) changes in services or bed capacity.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other states that do not require certificates of need have effectively limited the expansion of existing facilities and the establishment of new ones by placing partial or complete moratoria on the number of new Medicaid beds those states will certify in certain areas or throughout the entire state. Still other states have established such stringent development standards and approval procedures for constructing new healthcare facilities that the construction of new facilities, or the expansion or renovation of existing facilities, may become cost&#8209;prohibitive, excessively time&#8209;consuming or otherwise unfeasible. In addition, some states require the approval of the state Attorney General for acquisition of a facility being operated by a non&#8209;profit organization.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to acquire or construct new facilities or expand or provide new services at existing facilities would be adversely affected if we are unable to obtain the necessary approvals, if there are changes in the standards </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applicable to those approvals, or if we experience delays and increased expenses associated with obtaining those approvals. We may not be able to obtain licensure, certificate of need approval, Medicaid certification, state Attorney General approval or other necessary approvals for future expansion projects or acquisitions. Conversely, the elimination or reduction of state regulations that limit the construction, expansion or renovation of new or existing facilities could result in increased competition to us or result in overbuilding of facilities in some of our markets. If overbuilding in the skilled nursing industry in the markets in which we operate were to occur, it could reduce the occupancy rates of existing facilities and, in some cases, might reduce the private rates that we charge for our services.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face numerous risks related to expiration of the COVID&#8209;19 public health emergency (PHE) expiration and surrounding wind&#8209;down and uncertainty, which could, individually or in the aggregate, have a material adverse effect on our business, financial condition, liquidity, results of operations and prospects.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which the expiration and wind down of the COVID&#8209;19 PHE will affect our operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence. There remains uncertainty as to what changes will be made to the United States Department of Health and Human Services&#8217; (HHS&#8217;s) emergency response requirements or other laws and regulations for our SNFs in order to better respond to the issues experienced during the COVID&#8209;19 PHE or that continue to exist due to COVID-19 or other infectious diseases. Additionally, the expiration of the Emergency Waivers and other flexibilities allowed under the COVID&#8209;19 PHE, which ended as of May 11, 2023, have required, and may continue to require, operational changes, sometimes on short notices, and these reinstatements have not occurred simultaneously, requiring heightened monitoring to ensure compliance. These reinstatements of waived state and federal regulations create the risk of non&#8209;compliance and delays in operation as more attention is required to ensure that our operations comply with applicable laws and regulations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent COVID&#8209;19 or other infectious diseases are endemic in nature, we and our independent operating subsidiaries may face continued challenges from ongoing infection control and emergency preparedness requirements made part of state laws or regulations. Additionally, the long&#8209;term effects of the COVID&#8209;19 pandemic may include long&#8209;term decline in demand for care in SNFs, which will be borne out only through time. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our patients are older individuals and&#47;or individuals with complex medical challenges or multiple ongoing diseases, many of whom may be more vulnerable than the general public during a pandemic or in a public health emergency. Our employees are also at greater risk of contracting contagious diseases due to their increased exposure to vulnerable individuals. Our employees could have difficulty attending to our patients if a program of social distancing or quarantine is instituted in response to a public health emergency. Healthcare providers may have heightened exposure to contagious diseases or may be impacted due to prioritization of hospital resources toward any resurgence of the COVID-19 pandemic or any future pandemic and restrictions on travel. Furthermore, as a result of supply chain, labor market and other disruptions driven by the COVID-19 pandemic and the post-COVID environment, COVID-19 or any future pandemic may further negatively affect our operations or the operations of our landlords, lenders, vendors, suppliers and other business partners that we rely upon to carry out our operations, which could have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, we may expand existing internal policies in a manner that may have a similar effect. If there is a resurgence of COVID-19, or any variants thereof, or any other pandemic contagious diseases were to occur, we could suffer significant losses to our patient population or a reduction in the availability of our employees and caregivers, and we could be required to hire replacements for affected workers at an inflated cost. Accordingly, public health emergencies could have a disproportionate material adverse effect on our financial condition and results of operations. Further, litigation and&#47;or investigations regarding COVID-19 or similar widespread public health emergencies could materially and adversely affect our business, financial condition, results of operations, compliance with financial covenants and liquidity. Other unforeseen events, including acts of violence, war, terrorism and other international, regional or local instability or conflicts (including labor issues), embargoes, natural disasters such as earthquakes, whether occurring in the United States or abroad, could restrict or disrupt our operations. We cannot presently predict the scope and severity of any potential business shutdowns or disruptions, but if we or any of the third parties with whom we engage were to experience prolonged business shutdowns or other disruptions, our ability to conduct our business in the manner and on the timelines presently planned could be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">materially and negatively affected, which could have a material adverse impact on our business, financial condition and results of operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to attract patients and residents and to compete effectively with other healthcare providers, our revenue and profitability may decline and we may incur losses.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely significantly on appropriate referrals from physicians, hospitals and other healthcare providers in the communities in which we deliver our services to attract appropriate residents and patients to our facilities. Our referral sources are not obligated to refer business to us and may refer business to other healthcare providers. We believe many of our referral sources refer business to us as a result of the quality of our patient care and our efforts to establish and build a relationship with our referral sources. If we lose, or fail to maintain, existing relationships with our referral resources, fail to develop new relationships, or if we are perceived by our referral sources as not providing high quality patient care, our occupancy rate and the quality of our patient mix could suffer. The establishment of joint ventures or networks between referral sources, such as acute-care hospitals, and other post-acute providers may hinder patient referrals to us. The growing emphasis on integrated care delivery across the healthcare continuum increases that risk. In addition, if any of our referral sources have a reduction in patients whom they can refer due to a decrease in their business, our occupancy rate and the quality of our patient mix could suffer.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare services industry is highly competitive. Our skilled nursing facilities compete primarily on a local and regional basis with other skilled nursing facilities and with assisted&#47;senior living facilities, from national and regional chains to smaller providers owning as few as a single facility. Competitors include other for-profit providers as well as non-profits, religiously-affiliated facilities, and government-owned facilities. We also compete under certain circumstances with inpatient rehabilitation facilities and long-term acute care hospitals. Our ability to compete successfully varies from location to location and depends on a number of factors, including the number of competing facilities in the local market and the types of services available at those facilities, our local reputation for quality care of patients, the commitment and expertise of our caregivers, our local service offerings and treatment programs, the cost of care in each locality, and the physical appearance, location, age and condition of our facilities. If we are unable to attract patients to our facilities and agencies, particularly high-acuity patients, then our revenue and profitability will be adversely affected. Some of our competitors may have greater recognition and be more established in their respective communities than we are, and may have greater financial and other resources than we have. Competing long-term care companies may also offer newer facilities or different programs or services than we do, which, combined with the foregoing factors, may result in our competitors being more attractive to our current patients, to potential patients and to referral sources. Furthermore, while we budget for routine capital expenditures at our facilities to keep them competitive in their respective markets, to the extent that competitive forces cause those expenditures to increase in the future, our financial condition may be negatively affected.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe we utilize a conservative approach in complying with laws prohibiting kickbacks and referral payments to referral sources. If our competitors use more aggressive methods than we do with respect to obtaining patient referrals, our competitors may from time to time obtain patient referrals that are not otherwise available to us.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary competitive factors for our assisted and senior living services are similar to those for our skilled nursing businesses and include reputation, the cost of services, the quality of services, responsiveness to patient&#47;resident needs and the ability to provide support in other areas such as third-party reimbursement, information management and patient recordkeeping. Furthermore, given the relatively low barriers to entry and continuing healthcare cost containment pressures, we expect that the markets we service will become increasingly competitive in the future. Increased competition in the future could limit our ability to attract and retain patients and residents, maintain or increase our fees, or expand our business.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We review and audit the care delivery, recordkeeping and billing processes of our operating subsidiaries. These reviews from time to time detect instances of noncompliance that we attempt to correct, which in some instances requires reduced or repayment of billed amounts or other costs.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have internal compliance professionals and invest in other resources to help us comply with various requirements of federal and private healthcare programs. Our compliance program includes, among other things, (1) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">policies and procedures that take into account applicable laws, regulations, sub&#8209;regulatory guidance and industry practices and customs that govern the clinical, reimbursement and operational aspects of our operating subsidiaries&#59; (2) training about our compliance process for employees throughout our organization, our directors and officers, and training about Medicare and Medicaid laws, fraud and abuse prevention, clinical standards and practices, and claim submission and reimbursement policies and procedures for appropriate employees&#59; and (3) internal controls that monitor, among other things, the accuracy of claims, reimbursement submissions, cost reports and source documents, provision of patient care, services, and supplies as required by applicable standards and laws, accuracy of clinical assessment and treatment documentation, and implementation of judicial and regulatory requirements (i.e., background checks, licensing and training).</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have not experienced any material compliance issues to date, from time to time, our systems and internal controls highlight potential compliance issues, which we investigate as they arise. We similarly investigate concerns that are reported to us by employees or other persons. When errors or compliance failures are identified, we seek to rectify them as appropriate. Depending on the circumstances, in order to rectify a failure, we may be required to take certain actions, including but not limited to self-reporting them to applicable federal and state regulators, government agencies or other third parties, disgorging or paying money to the government or other third parties, and implementing changes to systems, personnel or other resources in order to mitigate the risk of recurrence, all of which could result in significant costs. Such issues, and any failure to properly remediate such issues or to timely identify and refund overpayments, for instance, could result in potential federal False Claims Act (FCA) liability and could have a material adverse effect on our business, financial condition and results of operations. Other significant compliance failures could have similar negative impacts. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to litigation, which is commonplace in our industry, which could result in significant legal costs and large settlement amounts or damage awards.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The skilled nursing business involves a significant risk of liability given the age and health of the patients and residents of our operating subsidiaries and the services we provide, and malpractice and other lawsuits against providers in our industry are endemic. The industry has experienced an increased trend in the number and severity of litigation claims, particularly patient-related litigation, due in part to the number of large verdicts, including large punitive damage awards. These claims are filed based upon a wide variety of claims and theories that they allege led to patient harm, including for state healthcare survey deficiencies received, allegations of insufficient staffing, allegations of insufficient training, allegations that companies put financial considerations over patient needs, and other claims. Plaintiffs&#8217; attorneys have become increasingly more aggressive in their pursuit of claims against healthcare providers, including skilled nursing providers, employing a wide variety of advertising and solicitation activities to generate more claims. Increased caps on damages that may be awarded in such actions has and may continue to lead to a larger frequency and severity of these lawsuits against our independent operating subsidiaries, particularly those who operate in California and other states that adopt similar legislation. We, and others in the industry, have been, and continue to be, subject to an increasing number of claims and lawsuits, including professional liability claims, alleging that services provided have resulted in personal injury, elder abuse, wrongful death or other related claims. For instance, in early 2023, we were subject to approximately $36 million in damages and fees awarded in a California jury verdict in a patient-care case that we inherited as part of an acquisition in late 2021. While we attempt to manage our patient care risks to the extent reasonably possible, there can be no assurance that we will not be subject to similar or larger verdicts in the future, particularly in light of the fact that large tort verdicts have become somewhat common throughout the United States, particularly in comparatively litigious states such as California and Kentucky. We may in the future do business in similarly or more litigious states as well. The defense of lawsuits has in the past, and may in the future, result in significant legal costs, regardless of the outcome, particularly as we and other providers have had to take on higher insurance deductibles and premiums. Additionally, increases to the frequency and&#47;or severity of losses from such claims and suits may result in increased liability insurance premiums, increases in deductibles, a decline in available insurance coverage levels, or other negative impacts on the availability and cost of insurance, which could materially and adversely affect our business, financial condition and results of operations. In addition to carrying third-party liability insurance, starting in January 2022, we formed a wholly-owned captive insurance subsidiary, Welsch Insurance Ltd. (Welsch), that provides professional liability and general liability insurance to various consolidated operating subsidiaries. See the risk factor titled &#8220;Our self-insurance programs may expose us to significant and unexpected costs and losses.&#8221; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, class action claims related to patient care, employment practices or other matters could be brought alleging legal violations that may materially affect our business, financial condition and results of operations. These types of claims have been filed against us and other companies in our industry in the past, and are likely to continue. For example, in recent years there has been a general increase in the number of suits filed against us and other companies in California, across industries, that purport to be wage and hour class action claims. They are typically based on alleged failures to permit or properly compensate for meal and rest periods, failure to pay for all time worked, and other alleged failures of California&#8217;s extensive wage and hour laws and regulations. While we have not had a similar experience in other states, circumstances could change in those states, or we could in the future operate in other states with litigation risks similar to California. If there were a significant increase in the number of these claims against us or an increase in amounts owing should plaintiffs be successful in their claims, this could have a material adverse effect to our business, financial condition, results of operations and cash flows.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we contract with a variety of landlords, lenders, vendors, suppliers, consultants and other individuals and businesses. These contracts typically contain covenants and default provisions. If the other party to one or more of our contracts were to allege that we have violated the contract terms, we could be subject to civil liabilities which could have a material adverse effect on our financial condition and results of operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If litigation is instituted against one or more of our subsidiaries, a successful plaintiff might attempt to hold us or one or more of our other subsidiaries liable for the alleged wrongdoing of the subsidiary principally targeted by the litigation. If a court in such litigation decided to disregard the corporate form and find that we or other entities are vicariously liable, the resulting judgment could increase our liability and adversely affect our financial condition and results of operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independently operating subsidiaries offer arbitration agreements to residents on admission, and require employees to enter into arbitration agreements as a condition of employment. While arbitration agreements have generally been favored by the courts, have been validated by the United States Supreme Court, and are believed to streamline the dispute resolution process and reduce the parties&#8217; exposure to excessive legal fees and jury awards, courts in some states, as well as regulators in some states and on the federal level, have showed increasing opposition to the use and enforcement of arbitration agreements, particularly in consumer and employment contexts. Current CMS regulations prohibit nursing facility providers from requiring patients to enter into arbitration agreements as a condition of admission, and there have been prior legislative efforts on both state and federal levels to codify similar prohibitions. Furthermore, prior CMS proposals sought to prohibit any use of arbitration agreements between nursing homes and their patients. In light of its continuing negative view on arbitration, CMS has identified arbitration agreements as an area of focus and has issued guidance to state surveyors regarding federal requirements for the use of arbitration agreements in nursing home care, with non&#8209;compliance potentially resulting in fines and other sanctions. If we are not able to secure voluntary pre&#8209;admission arbitration agreements from our patients, our litigation exposure and costs of defense in patient liability actions could increase, our liability insurance premiums could increase, and our business may be adversely affected. We would be subject to similar risks if we are at some point prohibited from requiring employees to enter into arbitration agreements.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely significantly on information technology, and any failure, inadequacy or interruption of that technology could harm our ability to effectively operate our business.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business relies on information technology. Our ability to effectively manage our business depends significantly information systems, including those operated by certain of our third-party partners. We also heavily rely on information systems to process financial and accounting information for financial reporting purposes. Any of these information systems could fail or experience a service interruption for a number of reasons, including computer viruses, programming errors, hacking or other unlawful activities, disasters or our failure to properly maintain system redundancy or protect, repair, maintain or upgrade our systems. The failure of our third-party partners&#8217; information systems to operate effectively or to integrate with other systems, or a breach in security of these systems, could negatively impact our financial results. If we experience any significant disruption to our financial information systems that we are unable to mitigate, our ability to timely report our financial results could be impacted, which could negatively impact our stock price. We also communicate electronically throughout the United States with our employees and with third parties, such as patients. A service interruption or shutdown could </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have a materially adverse impact on our operating activities and could result in reputational, competitive, and business harm. Furthermore, remediation and repair of any failure, problem or breach of our key information systems could require significant capital investments. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We calculate certain operational metrics using internal systems and tools and do not independently verify such metrics. Certain metrics are subject to inherent challenges in measurement, and real or perceived inaccuracies in such metrics may harm our reputation and negatively affect our business.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We refer to a number of operational metrics herein, including, but not limited to, skilled mix, average daily rates, occupancy percentage, and other metrics. We use these metrics to monitor and evaluate our business as well as the various facilities that we own and operate, and these metrics have an influence on our strategy, operational decision-making, budgeting, and planning. We calculate these metrics using internal systems and tools that are not independently verified by any third-party. These metrics may differ from estimates or similar metrics published by third parties or other companies due to differences in sources, methodologies or the assumptions on which we rely. Our internal systems and tools have a number of limitations, and our methodologies for tracking these metrics may change over time, which could result in unexpected changes to our metrics, including the metrics we publicly disclose on an ongoing basis. If the internal systems and tools we use to track these metrics under count or over count performance or contain algorithmic or other technical errors, the data we present may not be accurate. While these numbers are based on what we believe to be reasonable estimates of our metrics for the applicable period of measurement, there are inherent challenges in measuring savings, the use of our solutions, services and offerings and other metrics. In addition, limitations or errors with respect to how we measure data or with respect to the data that we measure may affect our understanding of certain details of our business, which would affect our long-term strategies. If our operating metrics or our estimates are not accurate representations of our business, or if investors do not perceive our operating metrics to be accurate, or if we discover material inaccuracies with respect to these figures, our reputation may be significantly harmed, and our operating and financial results could be adversely affected.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to complete future facility or business acquisitions at attractive prices or at all, which may adversely affect our revenue&#59; we may also elect to dispose of underperforming or non&#8209;strategic operating subsidiaries, which would decrease our revenue. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, our revenue growth has been significantly impacted by our acquisition of new facilities and properties. Subject to general market conditions and the availability of essential resources and leadership within our company, we continue to seek both single&#8209;and multi&#8209;facility acquisition and property acquisition opportunities that are consistent with our strategic objectives.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face competition for the acquisition of facilities and properties and expect this competition to continue and potentially increase. Based upon factors such as our ability to identify suitable acquisition candidates, future regulations affecting our ability to acquire new facility operations and related real estate, the purchase or lease price of the facilities, increasing interest rates for debt&#8209;financed purchases, prevailing market conditions, the availability of leadership to manage new facilities and our own willingness to take on new operations, the rate at which we have historically acquired facilities has fluctuated significantly. In the future, we anticipate the rate at which we may acquire facilities will continue to fluctuate, which may affect our revenue and profitability.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also previously acquired facilities, which over time became non&#8209;strategic or less desirable, and have divested them. In the future we may consider divesting similar facilities that we determine at that time to be non-strategic or less desirable. Divesting facilities will typically negatively impact our revenue, may divert management and other resources from acquisitions or other efforts, and may have other adverse effects on our business, financial condition and results of operation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to successfully integrate acquired facilities and properties into our operations, and we may not achieve the benefits we expect from any of our facility acquisitions. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to successfully or efficiently integrate new acquisitions with our existing operating subsidiaries, culture and systems. The process of integrating acquisitions into our existing operations may result in unforeseen operating difficulties, divert management&#8217;s attention from existing operations, or require an unexpected commitment of staff and financial resources, and may ultimately be unsuccessful. Integrating larger portfolios of acquired facilities concurrently may present similar but more acute challenges than integrating fewer facilities. Existing operations available for acquisition frequently serve or target different markets than those that we currently serve. We also may determine that renovations of acquired facilities and changes in staff and operating management personnel are necessary to successfully integrate those acquisitions into our existing operations. We may not be able to recover the costs incurred to reposition or renovate newly operating subsidiaries. The financial benefits we expect to realize from many of our acquisitions are largely dependent upon our ability to improve clinical performance, overcome regulatory deficiencies, rehabilitate or improve the reputation of the operations in the community, increase and maintain occupancy, control costs, and in some cases change the patient acuity mix. If we are unable to accomplish any of these objectives at the operating subsidiaries we acquire, we will not realize the anticipated benefits and we may experience lower than anticipated profits, or even losses.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2023 and 2022, we added&#160;58&#160;and nine stand-alone skilled nursing, assisted living, and subacute facilities, respectively. This growth, as well as growth in the current year and future years, has placed and will continue to place significant demands on our current management resources. Our ability to manage our growth effectively and to successfully integrate new acquisitions into our existing business will require us to continue to expand our operational, financial and management information systems and to continue to retain, attract, train, motivate and manage key employees, including facility&#8209;level leaders and our local directors of nursing. We may not be successful in attracting qualified individuals necessary for future acquisitions to be successful, and our management team may expend significant time and energy working to attract qualified personnel to manage facilities we may acquire in the future. Also, the newly acquired facilities may require us to spend significant time improving services at the facilities, and if we are unable to improve them quickly enough, we may be subject to litigation and&#47;or loss of licensure or certification. If we are not able to successfully overcome these and other integration challenges, we may not achieve the benefits we expect from any of our acquisitions, which could have an adverse effect on our business, financial condition and results of operation. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In undertaking acquisitions, we may be adversely impacted by costs, liabilities and regulatory issues that may adversely affect our operations. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In undertaking acquisitions, we also may be adversely impacted by unforeseen liabilities attributable to the prior providers who operated those facilities, against whom we may have little or no recourse. Many facilities we have historically acquired were underperforming financially and had issues, including but not limited to, clinical, regulatory and litigation, prior to and at the time of acquisition. Even where we have improved patient care and operations at facilities that we have acquired, we still may face post&#8209;acquisition regulatory issues related to pre&#8209;acquisition events. These may include, without limitation, payment recoupment related to our predecessors&#8217; prior noncompliance, the imposition of fines, penalties, operational restrictions or special regulatory status. Further, we may incur post&#8209;acquisition compliance risk due to the difficulty or impossibility of immediately or quickly bringing non&#8209;compliant facilities into substantial compliance with applicable healthcare regulations. Diligence materials pertaining to acquisition targets, especially the underperforming facilities that often represent the greatest opportunity for operational and financial improvement, are often inadequate, inaccurate or impossible to obtain, sometimes requiring us to make acquisition decisions with incomplete information. Despite our due diligence procedures, facilities that we have acquired or may acquire in the future may generate unexpectedly low returns, may cause us to incur substantial losses, may require unexpected expenditures or other resources, or may otherwise not meet a risk profile that our investors find acceptable. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we might encounter unanticipated difficulties and expenditures relating to any of the acquired facilities, including contingent liabilities. For example, when we acquire a facility, we generally assume the facility&#8217;s existing Medicare provider number for purposes of billing Medicare for services. If CMS later determines that the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prior owner of the facility had received overpayments from Medicare for the period of time during which it operated the facility, or had incurred fines in connection with the operation of the facility, CMS could hold us liable for repayment of the overpayments or fines. We may be unable to improve every facility that we acquire. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also incur regulatory risk in acquiring certain facilities due to the licensing, certification and other regulatory requirements affecting our right to operate the acquired facilities. For example, in order to acquire facilities on a predictable schedule, or to acquire declining operations quickly to prevent further pre&#8209;acquisition declines, we frequently acquire such facilities prior to receiving license approval or provider certification. We operate such facilities as the interim manager for the outgoing licensee, assuming financial responsibility and other obligations for the facility. To the extent that we may be unable or delayed in obtaining a license, we may need to operate the facility under a management agreement from the prior operator. If we were subsequently denied licensure or certification for any reason, we might not realize the expected benefits of the acquisition and would likely incur unanticipated costs and other challenges which could cause our business to suffer.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may have difficulty completing joint ventures that increase our capacity consistent with our growth strategy.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may selectively pursue strategic acquisitions of, and we frequently pursue joint ventures with, other healthcare providers. We may face limitations on our ability to identify sufficient joint venture, acquisition or other development targets and to complete those transactions to meet goals. These joint ventures may not be profitable or may not achieve the profitability that justifies the investments made. Furthermore, the nature of a joint venture requires us to consult with and share certain decision-making powers with unaffiliated third parties, some of which may be not-for-profit health systems. We do not manage any of the joint ventures in which we invest, and operational and strategic decision making power is held by entities that we do not control. If our joint venture partners do not fulfill their obligations, the affected joint venture may not be able to operate according to its business or strategic plans, which could have a material adverse effect on our results of operations, or require us to increase our level of financial commitment to the joint venture. Moreover, differences in economic or business interests or goals among joint venture participants could result in delayed decisions, failures to agree on major issues and even litigation. If these differences cause the joint ventures to deviate from their business or strategic plans, or if our joint venture partners take actions contrary to our policies, objectives or the best interests of the joint venture, it could have a material adverse effect on our business, financial condition and results of operations. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not achieve or maintain competitive quality of care ratings from CMS or private organizations engaged in similar rating activities, our business may be negatively affected. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS provides comparative public data, rating every SNF operating in each state based upon quality&#8209;of&#8209;care indicators. Certain private organizations engage in similar monitoring and ranking activities. CMS&#8217;s system is commonly known as the Five&#8209;Star Quality Rating System. It gives each nursing home a rating of between one and five stars in various categories, with five&#8209;star ratings harder to obtain over time. The ratings are available on a publicly available website maintained by CMS currently called Care Compare. In cases of acquisitions, the previous operator&#8217;s clinical ratings are included in our overall Five&#8209;Star Quality Rating and the rating may not reflect the improvements we were able to make until it is recalculated. Some of the ratings include a multi-year lookback period, which causes the prior operator&#8217;s data to be factored into our ratings for some period of time. Based on CMS&#8217;s guidance and regulations, we expect more data to be collected by CMS and reported on their website in the future. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS continues to increase quality measure thresholds, making it more difficult to achieve upward and five&#8209;star ratings. For instance, CMS increased its quality measure thresholds in October of 2022, making it more difficult for facilities to obtain or maintain four&#8209; and five&#8209;star ratings, allowing only 10% of nursing facilities within a state to receive a five&#8209;star rating. CMS discloses the increasing standards for four&#8209; and five&#8209;star ratings in its star rating cut point table, which discloses the points needed for each star rating within every state. CMS has indicated that it will increase these quality measure thresholds every six months. Some facilities may see a decline in their overall five&#8209;star rating absent any new inspection information, and as a result the five&#8209;star ratings of affected facilities may decline even as their quality measures remain unchanged or improve. Additionally, CMS displays on the Care </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compare website a consumer alert icon for nursing homes that have been cited on inspection reports for incidents of abuse, neglect, or exploitation. If our facilities fail to have attractive or otherwise acceptable ratings on the Care Compare website it could negatively impact their operations, including their ability to attract or retain patients and an increase in expenses to improve such ratings. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Providing quality patient care is the cornerstone of our business. We believe that patients and their families choose our facilities, and hospitals, physicians and other referral sources refer patients to us, in large part because of our facilities&#8217; reputation for delivering quality care. If our facilities fail to achieve their rating goals or otherwise maintain positive reputations in their local communities, due to nursing and administrative staffing and turnover or otherwise, or if they receive a consumer alert icon for incidents of abuse, neglect, or exploitation or other negative ratings on Care Compare, it may affect our ability to attract patients, which could have a material adverse effect upon our business and consolidated financial condition, results of operations and cash flows. See the section titled &#8220;Business&#8212;Regulatory Matters.&#8221; </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to obtain insurance, or if insurance becomes more costly for us to obtain, our business may be adversely affected. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It may become more difficult and costly for us to obtain coverage for resident care liabilities and other risks, including property, automobile and casualty insurance. For example, the following circumstances may adversely affect our ability to obtain insurance at favorable rates&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we experience higher&#8209;than&#8209;expected professional liability, property and casualty, or other types of claims or losses&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we receive survey deficiencies or citations of higher&#8209;than&#8209;normal scope or severity or experience higher-than-expected number of deficiencies or citations&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we acquire especially troubled operations or facilities that present unattractive risks to current or prospective insurers&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">insurers tighten underwriting standards applicable to us or our industry&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">insurers or reinsurers are unable or unwilling to insure us or the industry at historical premiums and coverage levels.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of these potential circumstances were to occur, our insurance carriers may require us to significantly increase our self&#8209;insured retention or deductible levels or pay substantially higher premiums for the same or reduced coverage for insurance, including workers compensation, property and casualty, automobile, employment practices liability, directors and officers liability, employee healthcare and general and professional liability coverages.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some states, the law prohibits or limits insurance coverage for the risk of punitive damages arising from professional liability and general liability claims or litigation. Coverage for punitive damages is also excluded under some insurance policies. As a result, we may be liable for punitive damage awards in these states that either are not covered or are in excess of our insurance policy limits. Claims against us, regardless of their merit or eventual outcome, could also inhibit our ability to attract patients or expand our business and could require our management to devote time to matters unrelated to the day&#8209;to&#8209;day operation of our business.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With few exceptions, workers compensation and employee health insurance costs have also increased markedly in recent years. Due to the nature of our business and the residents we serve, including the risk of claims from residents as well as potential governmental action, it may be difficult to complete the underwriting process and obtain insurance at commercially reasonable rates. If we are unable to obtain insurance, or if insurance becomes more costly for us to obtain, or if the coverage levels we can economically obtain decline, our business may be adversely affected.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not carry insurance for all categories of risk that our business may encounter. Some of the policies we currently maintain include property, general liability, employment benefits liability, business automobile, workers&#8217; compensation, and directors&#8217; and officers&#8217;, employment practices and fiduciary liability insurance. We do not know, however, if we will be able to maintain insurance with adequate levels of coverage. Any significant uninsured liability may require us to pay substantial amounts, which would have an adverse effect on our financial condition and results of operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our self-insurance programs may expose us to significant and unexpected costs and losses.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are self-insured up to certain limits for workers compensation, property and casualty, automobile, employment practices liability, directors and officers liability, employee healthcare and general and professional liability coverages. The types and amounts of insurance may vary from time to time based on our decisions with respect to risk retention and regulatory requirements. We establish the insurance loss reserves based on an estimation process that uses information obtained from both company-specific and industry data. Estimated costs are subject to a variety of assumptions and other factors including the severity, duration and frequency of claims, legal costs associated with claims, healthcare trends and projected inflation of related factors. Material increases in the number of insurance claims, changes to healthcare costs, accident frequency and severity, legal expenses and other factors could result in unfavorable difference between actual self-insurance costs and our reserve estimates. As a result, our self-insurance costs could increase which may have a material adverse effect upon our business and consolidated financial condition, results of operations and cash flows.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The geographic concentration of our facilities could leave us vulnerable to an economic downturn, regulatory changes or acts of nature in those areas. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our facilities located in California account for a significant majority of our total revenue. As a result of this concentration, the conditions of local economies, changes in governmental rules, regulations and reimbursement rates or criteria, changes in demographics, state funding, acts of nature and other factors that may result in a decrease in demand and&#47;or reimbursement for skilled nursing services in these states could have a disproportionately adverse effect on our revenue, costs and results of operations. Moreover, since approximately&#160;63% of our skilled nursing beds are located in California as of December 31, 2023, we are particularly susceptible to revenue loss, cost increase or damage caused by natural disasters such as electrical power shortages, fires, earthquakes or mudslides, or increased liabilities that may arise from regulations. See the section titled &#8220;Business&#8212;Regulatory Matters.&#8221;</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our facilities in Kentucky, South Carolina, Missouri, Ohio and Texas are more susceptible to revenue loss, cost increases or damage caused by natural disasters including hurricanes, tornadoes and flooding. These acts of nature may cause disruption to us, the employees of our operating subsidiaries and our facilities, which could have an adverse impact on the patients of our operating subsidiaries and our business. In order to provide care for the patients of our operating subsidiaries, we are dependent on consistent and reliable delivery of food, pharmaceuticals, utilities and other goods to our facilities, and the availability of qualified employees to provide services at our facilities. If the delivery of goods or the ability of employees to reach our facilities were interrupted in any material respect due to a natural disaster or other reasons, it would have a significant impact on our facilities and our business. Furthermore, the impact, or impending threat, of a natural disaster may require that we evacuate one or more facilities, which would be costly and would involve risks, including potentially fatal risks, for the patients. The impact of disasters and similar events is inherently uncertain. Furthermore, due to the concentration of our operations in these states, our business may be adversely affected by economic conditions, contagious disease outbreaks, including COVID-19, political unrest, and other conditions over which we have no control that disproportionately affect these states as compared to other states. Such events could harm the patients and employees of our operating subsidiaries, severely damage or destroy one or more of our facilities, adversely affect our business, reputation and financial condition, or otherwise cause our business to suffer in ways that we currently cannot predict.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The actions of national labor unions may adversely affect our revenue and our profitability. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our facilities are parties to collective bargaining agreements with labor unions, and we anticipate that additional facilities will enter into collective bargaining agreements in the future. Forthcoming proposed rules from CMS, which, based on the Biden Administration&#8217;s executive orders, as well as potential legislation such as the HCBS Access Act aimed toward providing more resources to those considering care&#8209;based careers, may increase the likelihood of employee unionization due to increased emphasis on care&#8209;based careers in SNF facilities. If employees decide to unionize, our cost of doing business could increase, and we could experience contract delays, difficulty in adapting to a changing regulatory and economic environment, cultural conflicts between unionized and non&#8209;unionized employees, strikes and work stoppages, and we may conclude that affected facilities or operations would be uneconomical to continue operating. See the section titled &#8220;Business&#8212;Regulatory Matters.&#8221;</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because we lease the majority of our facilities, we are subject to risks associated with leased real property, including risks relating to lease termination, lease extensions and special charges, any of which could have an adverse effect on our business, financial condition and results of operations. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, we leased&#160;165&#160;of our facilities. Most of our leases are triple&#8209;net leases, which means that, in addition to rent, we are required to pay for the costs related to the property (including property taxes, insurance, and maintenance and repair costs). Some of our leases cover more than one facility, including some leases that cover 25 or more facilities on a single master lease. We are responsible for paying these costs notwithstanding the fact that some of the benefits associated with paying these costs accrue to the landlords as owners of the associated facilities.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each lease provides that the landlord may terminate the lease for a variety of reasons, including the default in any payment of rent, taxes or other payment obligations or the breach of any other covenant or agreement in the lease. Termination of a lease could result in a default under our debt agreements and could have an adverse effect on our business, financial condition and results of operations. There can be no assurance that we will be able to comply with all of our obligations under the leases in the future. Furthermore, there may be disputes with landlords regarding the obligations under such lease, or the ability of the landlord to terminate the lease, which could disrupt our business operations and increase expenses.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to generate sufficient cash flow to cover required payments or meet operating covenants under our long&#8209;term debt, mortgages and long&#8209;term operating leases could result in defaults under those agreements and cross&#8209;defaults under other debt, mortgage or operating lease arrangements, which could harm our operating subsidiaries and cause us to lose facilities or experience foreclosures. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not generate sufficient cash flow from operations to cover interest, principal and lease payments. Additionally, under the terms of our amended and restated credit agreement with Truist Bank and a syndicate of lenders (Amended and Restated 2023 Credit Facility), we are subject to certain affirmative and negative covenants customary for credit facilities of this type as well as two financial covenants, a total leverage financial covenant and a fixed charge coverage ratio financial covenant. These restrictions may interfere with our ability to obtain additional advances under our Amended and Restated 2023 Credit Facility or to obtain new financing or to engage in other business activities, which may inhibit our ability to grow our business and increase revenue. See the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity &#38; Capital Resources&#8212;Credit Facilities.&#8221;</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the financial performance of one or more of our mortgaged facilities may not comply with the required operating covenants under the terms of the mortgage. Any non&#8209;payment, noncompliance or other default under our financing arrangements could, subject to cure provisions, cause the lender to foreclose upon the facility or facilities securing such indebtedness or, in the case of a lease, cause the lessor to terminate the lease, each with a consequent loss of revenue and asset value to us or a loss of property. Furthermore, in many cases, indebtedness is secured by both a mortgage on one or more facilities, and a guaranty by us. In the event of a default under one of these scenarios, the lender could avoid judicial procedures required to foreclose on real property by declaring all amounts outstanding under the guaranty immediately due and payable, and requiring us to fulfill our </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">obligations to make such payments. If any of these scenarios were to occur, our financial condition would be adversely affected. For tax purposes, a foreclosure on any of our properties would be treated as a sale of the property for a price equal to the outstanding balance of the debt secured by the mortgage. If the outstanding balance of the debt secured by the mortgage exceeds our tax basis in the property, we would recognize taxable income on foreclosure, but would not receive any cash proceeds, which would negatively impact our earnings and cash position. Further, because our mortgages and operating leases generally contain cross&#8209;default and cross&#8209;collateralization provisions, a default by us related to one facility could affect a significant number of other facilities and their corresponding financing arrangements and operating leases.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because our Amended and Restated 2023 Credit Facility, mortgages and lease obligations are fixed expenses and secured by specific assets, and because our revolving loan obligations are secured by virtually all of our assets, if reimbursement rates, patient acuity mix or occupancy levels decline, or if for any reason we are unable to meet our loan or lease obligations, we may not be able to cover our costs and some or all of our assets may become at risk. Our ability to make payments of principal and interest on our indebtedness and to make lease payments on our operating leases depends upon our future performance, which will be subject to general economic conditions, industry cycles and financial, business and other factors affecting our operating subsidiaries, many of which are beyond our control. If we are unable to generate sufficient cash flow from operations in the future to service our debt or to make lease payments on our operating leases, we may be required, among other things, to seek additional financing in the debt or equity markets, refinance or restructure all or a portion of our indebtedness, sell selected assets, reduce or delay planned capital expenditures or delay or abandon desirable acquisitions. Such measures might not be sufficient to enable us to service our debt or to make lease payments on our operating leases. The failure to make required payments on our debt or operating leases or the delay or abandonment of our planned growth strategy could result in an adverse effect on our future ability to generate revenue and sustain profitability. In addition, any such financing, refinancing or sale of assets might not be available on terms that are economically favorable to us, or at all.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our founders have personal guarantees under certain of our leases, which subjects them to increased risk of default. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our founders have provided personal guarantees under certain of our leases using their personal property. Under the personal guarantees provided by our founders, our founders have agreed to satisfy our obligations under the leases in the event that we are unable to perform our obligations thereunder. In the event that the guarantee is enforced against either or both of our founders, they could be obliged to use their personal property to fulfill their obligations under the leases. If our founders are subject to personal bankruptcy or refute the guarantees, we may be subject to an increased risk of default under our leases. Our founders owe a fiduciary duty of loyalty to us. However, there is potential for conflicts of interest between each of their personal interests and ours whether their respective guaranty is called upon or not. No assurance can be given that material conflicts will not arise that could be detrimental to our operations and financial prospects.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may need additional capital to fund our operating subsidiaries and finance our growth, and we may not be able to obtain it on terms acceptable to us, or at all, which may limit our ability to grow. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to maintain and enhance our operating subsidiaries and facilities in a suitable condition to meet regulatory standards, operate efficiently and remain competitive in our markets requires us to commit substantial resources to continued investment in our facilities and equipment. We are sometimes more aggressive than our competitors in capital spending to address issues that arise in connection with aging and obsolete facilities and equipment, and to otherwise make our facilities more attractive in their local markets. In addition, continued expansion of our business through the acquisition of existing facilities, expansion of our existing facilities and construction of new facilities may require additional capital, particularly if we were to accelerate our acquisition and expansion plans. Financing may not be available to us or may be available to us only on terms that are not favorable, including being subject to interest rates that are higher than those incurred in the past. In addition, some of our outstanding indebtedness and long&#8209;term leases restrict, among other things, our ability to incur additional debt. If we are unable to raise additional funds or obtain additional funds on terms acceptable to us, we may have to delay or abandon some or all of our growth strategies. Further, if additional funds are raised through the issuance of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">additional equity securities, the percentage ownership of our stockholders would be diluted. Any newly issued equity securities may have rights, preferences or privileges senior to those of our common stock.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We identified a material weakness in our internal control over financial reporting related to the review process of the work performed by a third-party tax credit consulting firm. We may identify additional material weaknesses in the future or otherwise fail to maintain an effective system of internal controls, which may result in material misstatements of our financial statements or cause us to fail to meet our reporting obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our financial statements will not be prevented or detected on a timely basis. During 2021 and 2020, we recorded tax credits as calculated by a third-party consulting firm. A subsequent review of those calculations, when also considering additional guidance issued by the Internal Revenue Service, caused management to conclude that the claimed credits may not be fully supportable and, accordingly, no tax benefits should have been recognized for those periods. This represents a material weakness in our internal controls for which management is implementing a remediation plan to address the control deficiency that led to the material weakness. The remediation plan will include implementing specific review procedures for tax credit calculations performed by a third-party and ensuring we have personnel with the technical expertise to perform timely review of such calculations to properly conclude on their accounting treatment. While we believe these efforts will remediate the material weakness, we may not be able to complete our evaluation, testing or any required remediation in a timely fashion. We cannot assure you that the measures we have taken to date and actions we may take in the future, will be sufficient to remediate the control deficiency that led to our material weakness in our internal control over financial reporting or that they will prevent or avoid potential future material weaknesses. Any failure to maintain effective internal control over financial reporting could severely inhibit our ability to accurately report our financial condition or results of operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective internal controls are necessary for us to provide reliable financial reports and prevent fraud. If we are unable to successfully remediate our existing or any future material weakness in our internal control over financial reporting, or identify any additional material weaknesses that may exist, the accuracy and timing of our financial reporting may be adversely affected. Additionally, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports as well as applicable stock exchange listing requirements. We may be unable to prevent fraud, investors may lose confidence in our financial reporting, and our stock price may also decline. Our reporting obligations as a public company could place a significant strain on our management, operational and financial resources and systems for the foreseeable future and may cause us to fail to timely achieve and maintain the adequacy of our internal control over financial reporting.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adverse market or macroeconomic conditions or market volatility resulting from global economic developments, political unrest, high inflation, rising interest rates, the post-COVID environment or other factors, could materially and adversely affect our business operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverse market or macroeconomic conditions or market volatility resulting from global economic developments, political unrest, high inflation, rising interest rates, the post-COVID environment or other factors, could materially and adversely affect our business operations. For instance, actual events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. For example, on March 10, 2023, Silicon Valley Bank was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (FDIC), as receiver. Similarly, on March 12, 2023, Signature Bank Corp. and Silvergate Capital Corp. were each swept into receivership, and uncertainty remains over liquidity concerns in the broader financial services industry. We may maintain cash balances at third-party financial institutions in excess of the FDIC standard insurance limit. Although the U.S. Department of Treasury, FDIC and Federal Reserve Board announced a program to provide up to $25.0 billion of loans to financial institutions secured by certain of such government securities held by financial institutions, widespread demands for customer withdrawals or other liquidity needs of financial institutions may exceed the capacity of such program, and there is no guarantee that the U.S. Department of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Treasury, FDIC and Federal Reserve Board will provide access to uninsured funds in the future in the event of the closure of such banks or financial institutions, or that they would do so in a timely fashion. These events could result in a variety of material and adverse impacts on our current and projected business operations and our financial condition and results of operations, including, but not limited to, the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delayed access to deposits or other financial assets or the uninsured loss of deposits or other financial assets&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential or actual breach of statutory, regulatory or contractual obligations, including obligations that require us to maintain letters of credit or other credit support arrangements&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">termination of cash management arrangements and&#47;or delays in accessing or actual loss of funds subject to cash management arrangements. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any further deterioration in the macroeconomic economy or financial services industry could lead to losses or defaults by our partners, vendors or suppliers, which in turn, could have a material adverse effect on our current and&#47;or projected business operations and results of operations and financial condition. For example, a partner may fail to make payments when due, default under their agreements with us, become insolvent or declare bankruptcy, or a supplier may determine that it will no longer deal with us as a customer. In addition, a vendor or supplier could be adversely affected by any of the liquidity or other risks that are described above as factors that could result in material adverse impacts on us, including but not limited to delayed access or loss of access to uninsured deposits or loss of the ability to draw on existing credit facilities involving a troubled or failed financial institution. The bankruptcy or insolvency of any partner, vendor or supplier, or the failure of any partner to make payments when due, or any breach or default by a partner, vendor or supplier, or the loss of any significant supplier relationships, could cause us to suffer material losses and may have a material adverse impact on our business. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The condition of the financial markets, including volatility and deterioration in the capital and credit markets, could limit the availability of debt and equity financing sources to fund the capital and liquidity requirements of our business, as well as negatively impact or impair the value of our current portfolio of cash, cash equivalents and investments, including U.S.&#8209;backed investments.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents are held in a mixture of bank accounts, overnight investments, and other interest-bearing accounts. As a result of the uncertain domestic and global political, economic, credit and financial market conditions, including the significant increases in interest rates and inflation in 2023 as compared to 2022 and prior years, investments in these types of financial instruments pose risks arising from liquidity and credit concerns. Given that future deterioration in the U.S. and global credit and financial markets is a possibility, no assurance can be made that losses or significant deterioration in the fair value of our cash, cash equivalents, or investments will not occur. Uncertainty surrounding the trading market for U.S. government securities or impairment of the U.S. government&#8217;s ability to satisfy its obligations under such treasury securities could impact the liquidity or valuation of our current portfolio of cash, cash equivalents, and investments. Further, continued domestic and international political uncertainty, along with credit, and financial market uncertainty, may make it difficult for us to liquidate our investments prior to their maturity without incurring a loss, which could have a material adverse effect on our business financial condition, results of operations and cash flows.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may need additional capital if a substantial acquisition or other growth opportunity becomes available, or if other unexpected challenges or opportunities arise. U.S. capital markets can be volatile. We cannot assure you that additional capital will be available or available on terms acceptable to us. If capital is not available, we may not be able to fund internal or external business expansion or respond to competitive pressures or other market conditions.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delays in reimbursement may cause liquidity problems. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we experience problems with our billing information systems or if issues arise with Medicare, Medicaid or other payors, we may encounter delays in our payment cycle. In addition, third-party payors may not make timely payment to us. From time to time, we have experienced such delays as a result of government payors instituting </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">planned reimbursement delays for budget balancing purposes or as a result of prepayment reviews. Delays also happen from time to time with managed care organizations and other insurance companies who are payors for our patients.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some states in which we operate are operating with budget deficits or could have budget deficit in the future, which may delay reimbursement in a manner that would adversely affect our liquidity. In addition, from time to time, procedural issues require us to resubmit or appeal claims before payment is remitted, which contributes to our aged receivables. Unanticipated delays in receiving reimbursement from state programs or commercial payors due to changes in their policies or billing or audit procedures may adversely impact our liquidity and working capital.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The continued use and growth of managed care organizations (MCOs) may contribute to delays or reductions in our reimbursement, including Managed Medicaid.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In many states, including some of the largest where we operate, including California, state Medicaid benefits are administered through MCOs. Typically, these MCOs manage commercial health and federal Medicare Advantage benefits under a managed care contract. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MCOs and other third-party payors have continued to consolidate in order to enhance their ability to influence the delivery and cost structure of healthcare services. Consequently, the healthcare needs of a large percentage of the U.S. population are increasingly served by a smaller number of managed care organizations. These organizations generally enter into service agreements with a limited number of providers for needed services. In addition, third-party payors, including managed care payors, increasingly are demanding discounted fee structures. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nationally, MCOs cover increasingly large numbers of Medicaid and Medicare Advantage beneficiaries, respectively. MCOs may be more aggressive than state Medicaid and federal Medicare agencies in denying claims or seeking recoupment of payments so that their services under these managed contracts are profitable. The additional steps created by the use of MCOs in disbursement of funds creates more risk of delayed, reduced, or recouped payments for our independent operating subsidiaries, and additional avenues for risks that include fines and other sanctions, including suspension or exclusion from participation in various governmental programs. To the extent that these organizations terminate us as a preferred provider, engage our competitors as a preferred or exclusive provider, demand discounted fee structures, limit the patients eligible for our services, or seek our assumption of all or a portion of the financial risk through a prepaid capitation arrangement, it could have a material adverse effect on our business, financial condition, results of operations and liquidity.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with the regulations of the Department of Housing and Urban Development (HUD) may require us to make unanticipated expenditures which could increase our costs. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our facilities are currently subject to regulatory agreements with HUD that give the Commissioner of HUD broad authority to require us to be replaced as the operator of those facilities in the event that the Commissioner determines there are operational deficiencies at such facilities under HUD regulations. Compliance with HUD&#8217;s requirements can often be difficult because these requirements are not always consistent with the requirements of other federal and state agencies. Appealing a failed inspection can be costly and time&#8209;consuming and, if we do not successfully remediate the failed inspection, we could be precluded from obtaining HUD financing in the future or we may encounter limitations or prohibitions on our operation of HUD&#8209;insured facilities. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to safeguard the monies held in our patient trust funds, we will be required to reimburse those monies, and we may be subject to citations, fines and penalties. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of our facilities is required by federal law to maintain a patient trust fund to safeguard certain assets of their residents and patients. If any money held in a patient trust fund is misappropriated, we are required to reimburse the patient trust fund for the misappropriated money. If any monies held in our patient trust funds are misappropriated in the future and are unrecoverable, we will be required to reimburse those monies, and we may also be subject to citations, fines and penalties pursuant to federal and state laws.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Security breaches, cyber&#8209;security incidents, or our inability to effectively integrate, manage and keep our information systems secure and operational could violate security laws, disrupt our operations, and subject us to significant liability.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare businesses are increasingly the target of cyberattacks whereby hackers disrupt business operations or obtain protected health information, often demanding large ransoms. Our business is dependent on the proper functioning and availability of our computer systems and networks. While we have taken steps to protect the safety and security of our information systems and the patient health information and other data maintained within those systems, we cannot assure you that our safety and security measures and disaster recovery plan will prevent damage, interruption or breach of our information systems and operations. Additionally, we cannot control the safety and security of our information held by third&#8209;party vendors with whom we contract. The techniques used to obtain unauthorized access, disable or degrade service, or sabotage systems change frequently and may be difficult to detect, and as such we (or third&#8209;party vendors) may be unable to anticipate these techniques or implement adequate preventive measures. In addition, hardware, software or applications we (or third&#8209;party vendors) develop or procure from third parties may contain defects in design or manufacture or other problems that could unexpectedly compromise the security of information systems. Unauthorized parties may attempt to gain access to our systems or facilities, or those of third parties with whom we do business, through fraud or other forms of deception.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On occasion, we have acquired additional information systems through our business acquisitions, and these acquired systems may expose us to risk. We also license certain third&#8209;party software to support our operations and information systems. Our inability, or the inability of third&#8209;party vendors, to continue to maintain and upgrade information systems and software could disrupt or reduce the efficiency of our operations. In addition, costs and potential problems and interruptions associated with the implementation of new or upgraded systems and technology or with maintenance or adequate support of existing systems also could disrupt or reduce the efficiency of our operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A cyber&#8209;attack or other incident that bypasses the security measures of our information systems could cause a security breach, which may lead to a material disruption to our information systems infrastructure or business, significant costs to remediate (e.g., data recovery) and may involve a significant loss of business or patient health information. If a cyber&#8209;attack or other unauthorized attempt to access our systems or facilities were successful, it could also result in the theft, destruction, loss, misappropriation or release of confidential information or intellectual property, could cause operational or business delays that may materially impact our ability to provide various healthcare services and otherwise conduct our business operations, and could require us to expend significant costs to remediate the breach and retrieve our data or access to our systems. Any successful cyber&#8209;attack or other unauthorized attempt to access our systems or facilities also could result in negative publicity which could damage our reputation or brand with our patients, referral sources, payors or other third parties and could subject us to a number of adverse consequences, the vast majority of which are not insurable, including but not limited to, disruptions in our operations, regulatory and other civil and criminal penalties, fines, investigations and enforcement actions (including, but not limited to, those arising from the SEC, Federal Trade Commission, Office of Civil Rights, the Office of the Inspector General (OIG) or state attorneys general), fines, private litigation with those affected by the data breach (including class action litigation), loss of customers, disputes with payors and increased operating expense, which either individually or in the aggregate could have a material adverse effect on our business, financial condition, results of operations and liquidity.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to obtain, maintain and enforce intellectual property protection for our technology or if the scope of our intellectual property protection is not sufficiently broad, our ability to successfully compete and utilize our technology may be adversely affected. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business depends, in part, on internally developed technology and content, including software and know-how, the protection of which is important to the success of our business and strategy. We rely on a combination of trademark, trade-secret, and copyright laws and confidentiality procedures and contractual provisions to protect our intellectual property rights. We may, over time, increase our investment in protecting our intellectual property through additional trademark, patent and other intellectual property filings. These measures, however, may not be sufficient to offer us meaningful protection. If we are unable to establish or protect our intellectual property and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other rights, our competitive position and our business could be harmed, as third parties may be able to develop technologies that are substantially the same as ours or challenge our ability to use our existing technologies.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, some of our services rely on technologies and software developed by or licensed from third parties, and we may not be able to maintain our relationships with such third parties or enter into similar relationships in the future on reasonable terms or at all. Our failure to obtain, maintain and enforce our intellectual property rights could have a material adverse effect on our business, financial condition and results of operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are a holding company with no operations and rely upon our multiple independent operating subsidiaries to provide us with the funds necessary to meet our financial obligations. Liabilities of any one or more of our subsidiaries could be imposed upon us or our other subsidiaries. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a holding company with no direct operating assets, employees or revenue. Each of our facilities is operated through a separate, wholly owned, independent subsidiary, which has its own local management, employees and assets. Our principal assets are the equity interests we directly or indirectly hold in our multiple operating and real estate holding subsidiaries. As a result, we are dependent upon distributions from our subsidiaries to generate the funds necessary to meet our financial obligations and pay dividends. Our subsidiaries are legally distinct from us and have no obligation to make funds available to us. The ability of our subsidiaries to make distributions to us will depend substantially on their respective operating results and will be subject to restrictions under, among other things, the laws of their jurisdiction of organization, which may limit the amount of funds available for distribution to investors or stockholders, agreements of those subsidiaries, the terms of our financing arrangements and the terms of any future financing arrangements of our subsidiaries. If the cash distributions we receive from our subsidiaries are insufficient for us to fund our financial obligations, we may be required to raise cash through the incurrence of debt, the issuance of equity or the sale of assets to fund. However, there is no assurance that we would be able to raise cash by these means. If the ability of any of our subsidiaries to pay dividends or make distributions or payments to us is materially restricted by regulatory or legal requirements, bankruptcy or insolvency, or our need to maintain our financial strength ratings, or is limited due to operating results or other factors, it could adversely affect our ability to meet our financial obligations and to pay dividends or make distributions to our stockholders.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future success depends on the continuing efforts of our management and key employees, and on our ability to attract and retain highly skilled personnel and senior management.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on the talents and continued efforts of our senior management and key employees. The loss of members of our management or key employees may disrupt our business and harm our results of operations. Furthermore, our ability to manage further expansion will require us to continue to attract, motivate, and retain additional qualified personnel. Competition for this type of personnel is intense, and we may not be successful in attracting, integrating, and retaining the personnel required to grow and operate our business effectively. There can be no assurance that our current management team or any new members of our management team will be able to successfully execute our business and operating strategies.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Government Regulation</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on payments from third-party payors, including Medicare, Medicaid and other governmental healthcare programs and private insurance organizations. If coverage or reimbursement for services are changed, reduced or eliminated, including through cost-containment efforts, spending requirements are changed, data reporting, measurement and evaluation standards are enhanced and changed, our operations, revenue and profitability could be materially and adversely affected.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive substantial revenue from government healthcare programs, primarily Medicare and state Medicaid programs. Medicare is our largest source of total revenue, accounting for&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% and 47.6% of total revenue for the years ended December 31, 2023 and 2022, respectively. Additionally, we derived&#160;&#160;&#160;&#160;% and 30.2% of our total revenue from the Medicaid program for the years ended December 31, 2023 and 2022, respectively. Many other payors may use published Medicare rates as a basis for reimbursements. Accordingly, if Medicare reimbursement </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rates are reduced or fail to increase as quickly as our costs, if there are changes in the rules governing the Medicare program that are disadvantageous to our business or industry, or if there are delays in Medicare, Medicaid and other third-party payors payments, it could have a material adverse effect on our business, financial condition and results of operations. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Congress and the CMS often change the rules governing the Medicare program, including those governing reimbursement. Payments received from state Medicaid programs vary from state to state. These payments and programs are subject to statutory and regulatory changes, administrative rulings, interpretations, budgetary and funding constraints, and changes to the methods of calculating payments and reimbursements and requirements to participate in the programs. When these changes are implemented, we must also modify our operations and internal billing processes and procedures accordingly, which can require significant time and expense. As federal healthcare expenditures continue to increase and state governments may face budgetary shortfalls, federal and state governments have made, and may continue to make, significant changes to the Medicare and Medicaid programs and reimbursement received for services rendered to beneficiaries of such programs. The U.S. federal budget is subject to change, including reductions in federal spending, and the Medicare program is frequently mentioned as a target for spending cuts. The full impact on our business of any changes is uncertain. Changes to the Medicare program, state Medicaid programs and other third-party payor program that could adversely affect our business include&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">statutory and regulatory changes, including policy interpretations and changes that impact state reimbursement programs, particularly Medicaid reimbursement and managed care payments&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">administrative or legislative changes to base rates or the bases for payment&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the reduction or elimination of annual rate increases, or the end of the reduced payments deferment&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limits on the services or types of providers for which Medicare will provide reimbursement&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in methodology for patient assessment and&#47;or determination of payment levels&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">payment or other delays by fiscal intermediaries, carriers or payors&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">redefining enrollment standards and participation in government healthcare programs&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in staff requirements (i.e., requiring all workers to be vaccinated against COVID&#8209;19 and receive booster injections for those vaccinations) as a condition of payment or eligibility for Medicare reimbursement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduced reimbursement rates and changes in coverage under commercial and managed care contracts&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in reimbursement rates, methods, or timing under governmental reimbursement programs, including reductions in annual reimbursement updates due to budgetary or other pressures&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interruption or delays in payments due to any ongoing governmental investigations and audits or due to a partial or total federal or state government shutdown for a prolonged period of time&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in co&#8209;payments or deductibles payable by beneficiaries&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">recoupment efforts and recovery of overpayments&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal, state, and local litigation, administrative proceedings, and enforcement actions, including those relating to false claims, COVID-19 or future pandemics and the failure to satisfy the terms and conditions of financial relief&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reputational harm of publicly disclosed enforcement actions, audits, or investigations related to quality of care, patient harm and abuse, billing and reimbursement.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry broadly, including government and commercial payors, is initiating cost containment efforts. The Medicare program and its reimbursement rates and rules are subject to frequent change, including statutory and regulatory changes, rate adjustments (including retroactive adjustments), annual caps that limit the amount that can be paid (including deductible and coinsurance amounts), administrative or executive orders and government funding restrictions, all of which may materially adversely affect the rates at which Medicare reimburses us for our services. Additionally, payments can be delayed or declined due to determinations that certain costs are not reimbursable or reasonable because either adequate or additional documentation was not provided or because certain services were not covered or considered medically necessary. Revenue from these payors can be retroactively adjusted after a new examination during the claims settlement process or as a result of post&#8209;payment audits. Additionally, both government and private payors are increasingly looking to value-based purchasing to contain costs. Value-based purchasing focuses on quality of outcomes and efficiency of care, rather than quantity of care. Reductions in reimbursement rates or the scope of services being reimbursed could have a material, adverse effect on our business, financial condition and results of operations or even result in reimbursement rates that are insufficient to cover our operating costs. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal year 2024, SNF prospective payment system (PPS) rule issued on July 31, 2023, Medicare Part A reimbursement for SNFs will increase by 4% in the next fiscal year. CMS also added new quality measures to take effect in fiscal years 2024 through 2027 that assess staff turnover, discharge success, res&#8209;hospitalization, and resident falls with injuries, which may adversely affect revenues obtained through the Medicare program. CMS&#8217;s changes to the SNF Value-Based Purchasing (VBP) program, such as the SNF healthcare&#8209;associated infections measure, total nursing hours per resident day measures, discharge to community &#8211; post acute care measure, and replacement of the SNF 30&#8209;day All&#8209;Cause Readmission Measure with the SNF Within-Stay Potentially Preventable Readmission Measure beginning in fiscal year 2028, may reduce the compensation our independent operating subsidiaries may receive under the SNF VBP program.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS implemented a final rule in October 2019 implementing a new case&#8209;mix classification system, PDPM (patient-driven payment model), that focuses on the clinical condition of the patient. CMS may make future adjustments to reimbursement levels and underlying reimbursement formulae as it continues to monitor the impact of PDPM on patient outcomes and budget neutrality. The Biden Administration continues to study the nursing home industry and to call for HHS to issue proposed rules based on those studies.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss of Medicare reimbursement, or a delay or default by the government in making Medicare payments, would also have a material adverse effect on our revenue. Non&#8209;compliance with Medicare regulations exist, and any penalty, suspension, termination, or other sanction under any state&#8217;s Medicaid program could lead to reciprocal and commensurate penalties being imposed under the Medicare program, up to termination or rescission of our Medicare participation and payor agreements as noted above. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of reimbursement for skilled nursing services comes from Medicaid. Medicaid is a state&#8209;administered program financed by both state funds and matching federal funds. Medicaid spending has increased rapidly in recent years, becoming a significant component of state budgets, which has led both the federal government and many states to institute measures aimed at controlling the growth of Medicaid spending, and in some instances reducing aggregate Medicaid spending. Since a significant majority of our total revenue is generated from our skilled nursing operating subsidiaries in California, any budget reductions or delays in California could adversely affect our net patient service revenue and profitability. Despite present state budget surpluses in many of the states in which we operate, we can expect continuing cost containment pressures on Medicaid outlays for SNFs, and any such decline could have an adverse effect on our business financial condition and results of operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicaid program and its reimbursement rates and rules are subject to frequent change at both the federal and state level, including through changes in laws, regulations, rate adjustments (including retroactive adjustments), administrative or executive orders and government funding restrictions, all of which may materially adversely affect the rates at which our services are reimbursed by state Medicaid plans or the amount of expense we incur. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To generate funds to pay for the increasing costs of the Medicaid program, many states utilize financial arrangements commonly referred to as provider taxes. Under provider tax arrangements, states collect taxes from healthcare providers and then use the revenue to pay the providers as a Medicaid expenditure, which allows the states to then claim additional federal matching funds on the additional reimbursements. Current federal law provides for a cap on the maximum allowable provider tax as a percentage of the providers&#8217; net patient revenue. There can be no assurance that federal law will continue to provide matching federal funds on state Medicaid expenditures funded through provider taxes, or that the current caps on provider taxes will not be reduced. Any discontinuance or reduction in federal matching of provider tax&#8209;related Medicaid expenditures could have a significant and adverse effect on states&#8217; Medicaid expenditures, and as a result could have a material adverse effect on our business, financial condition or results of operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CAA 2023 provided for the wind&#8209;down and termination of increased Federal Medicaid Assistance Percentage (FMAP) payments under the Families First Coronavirus Relief Act (FFCRA), and also provided for the disenrollment of Medicaid beneficiaries who have participated in the program since early in the COVID&#8209;19 pandemic. CMS&#8217;s increased FMAP payments declined from 5% in the second quarter of 2023 to 2.5% in the third quarter, and to 1.5% in the fourth quarter. The increased FMAP payments will be discontinued in 2024. The CAA 2023 granted CMS the authority to impose fines, penalties, and other sanctions upon states that did not comply with this law&#8217;s requirements for the unwinding of increased FMAP payments. As a result, these reductions may impose further burdens on the Medicaid programs in states where we operate in the form of fines and penalties, which may result in reduced payments.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning on April 1, 2023, states were allowed to begin disenrolling Medicaid beneficiaries. CMS guidance allowing for a return to Medicaid&#8217;s historical renewal, enrollment, and eligibility determination practices permits states up to 14 months to initiate and process traditional Medicaid renewals. The CAA 2023&#8217;s allowance of disenrollment and return to traditional Medicaid renewal processes, which includes pre&#8209;COVID eligibility determinations, may result in a reduction of the number of Medicaid beneficiaries and may result in a reduction of our current and potential patient population. As a result, there may be fewer current or potential patients able to pay for our operating subsidiaries&#8217; services, and increased competition for Medicaid beneficiaries able to provide reimbursement for those services.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS is monitoring the disenrollment process in an effort to protect eligible beneficiaries from inappropriate coverage losses during the return to Medicaid&#8217;s historical renewal, enrollment and eligibility determination practices, and has required certain states to pause disenrollments unless they could ensure all eligible people are not improperly disenrolled. CMS is continuing to monitor states&#8217; compliance with federal requirements and is working with the affected states to address issues related to renewal requirements. States risk losing federal Medicaid matching funds for non&#8209;compliance with CMS&#8217;s instructions, which could result in reduced Medicaid funds available for timely reimbursement of our operating subsidiaries for their operations. Certain estimates suggest that roughly 17 million people may lose Medicaid coverage during the redetermination process through their scheduled completion in May of 2024. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 16, 2024, with disclosure requirements taking effect once CMS develops and publishes the required forms, Medicare and Medicaid nursing facilities are required to disclose new data about the facility&#8217;s ownership, management and the owners of real property lessors upon initial enrollment and revalidation. In addition, the nursing facilities are required to timely report any changes, including in connection with any change of ownership. CMS defines the new disclosable parties to include members of the facility&#8217;s governing body, persons or entities who are an officer, director, member, partner, trustee or managing employee of the facility, persons or entities that exercise operational, financial or managerial control, lease or sublease real property to the facility, own a direct or indirect interest of five percent or greater of the real property or provide management or administrative services to the facility. Additionally, for any disclosable party that is a corporation, the disclosure must include the stockholders who have a five percent or greater direct or indirect ownership interest. Additionally, facilities will be required to disclose whether any entity on the form is a private equity company or real estate investment trust (REIT). CMS will make the information that is provided publicly available. This new disclosure requirement involves reporting extensive information and may complicate our efforts to comply with Medicare and Medicaid </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requirements. Failure to comply with the new disclosure requirements could affect our participation in Medicare and state Medicaid programs and adversely impact our business and financial condition.  </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid is an important source of funding for our independent operating subsidiaries. We may be adversely affected by the disenrollment of Medicaid beneficiaries, which may lead to a reduction in reimbursement that may adversely impact our revenue and profit. The temporary restoration of Medicaid benefits in states where redetermination has been paused can help relieve some of these economic concerns. The disruption caused by the temporary pauses and restoration of Medicaid coverage for beneficiaries can also create operational challenges for our independent operating subsidiaries, including adverse effects on cash flow, available funds to pay wages for staffing, and overall financial stability. The ultimate impact of Medicaid disenrollment on our finances and operations will depend on individual states&#8217; specific circumstances and actions. See the section titled &#8220;Business&#8212;Regulatory Matters.&#8221;</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reforms to the U.S. healthcare system, including new regulations under the Affordable Care Act (ACA), continue to impose new requirements upon us that could materially impact our business.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA has resulted in significant changes to our operations and reimbursement models for services we provide. CMS continues to issue rules to implement the ACA, including most recently, new rules regarding the implementation of the anti&#8209;discrimination provisions and new rules requiring the disclosure of SNF ownership, organization, management and the identity of the real property owners from which the SNF leases or subleases its operating space. With the passage of the Inflation Reduction Act of 2022 (IRA) in August of 2022, Congress continues to expand and supplement the ACA, including through the continuation of federally funded insurance premium subsidies. This modification of the ACA by the IRA indicates that Congress may continue to change and expand the ACA in the future. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The efficacy of the ACA is the subject of much debate among members of Congress and the public and it has been the subject of extensive litigation before numerous courts, including the United States Supreme Court, with varying outcomes &#8209; some expanding and others limiting the ACA. In the event that the ACA is repealed or any elements of the ACA that are beneficial to our business are materially amended or changed, such as provisions regarding the health insurance industry, reimbursement and insurance coverage by payers, our business, operating results and financial condition could be harmed. Thus, the future impact of the ACA on our business is difficult to predict and its continued uncertain future may negatively impact our business. However, any material changes to the ACA or its implementing regulations may negatively impact our operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While it is not possible to predict whether and when any such changes will occur, specific proposals discussed during and after the election, including a repeal or material amendment of the ACA, could harm our business, operating results and financial condition. In addition, even if the ACA is not amended or repealed, the President and the executive branch of the federal government, as well as CMS and HHS have a significant impact on the implementation of the provisions of the ACA, and a new administration could make changes impacting the implementation and enforcement of the ACA, which could harm our business, operating results and financial condition. We have already seen this with regulatory activity promulgating rules regarding anti&#8209;discrimination under Section 1557 of the ACA and the disclosure of SNF ownership and service providers under Section 6101 of the ACA. If we are slow or unable to adapt to any such changes, our business, operating results and financial condition could be adversely affected.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the ACA, there have been healthcare reform proposals and we expect that other healthcare reform legislative and regulatory changes will be proposed and enacted, including reductions in payments to SNFs and impose the staffing and reporting requirements. We cannot predict what effect future reforms to the U.S. healthcare system will have on our business, including the demand for our services, the cost of our operations, or the amount of reimbursement available for those services. However, it is possible these new laws may lower reimbursement or increase the cost of doing business and adversely affect our business. See the section titled &#8220;Business&#8212;Regulatory Matters.&#8221; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to various government and third-party payor reviews, audits and investigations that could adversely affect our business, including an obligation to refund amounts previously paid to us, potential criminal charges, the imposition of fines, and&#47;or the loss of our right to participate in Medicare and Medicaid programs or other third-party payor programs.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulators and third-party payors are increasing scrutiny of claims, which may require additional resources to response to audits and may cause additional delays or denials in receiving payment. As a result of our participation in the Medicaid and Medicare programs, we and other program participants are subject to various governmental reviews, audits and investigations to verify compliance with the rules associated with these programs and related applicable laws and regulations, including claims for payments submitted to those programs, which are subject to reviews by Recovery Audit Contractors, Zone Program Integrity Contractors, Program Safeguard Contractors, Unified Program Integrity Contractors, Supplemental Medical Review Contractors and Medicaid Integrity Contractors programs (collectively referred to as Reviews). In these Reviews, third-party firms engaged by CMS conduct extensive analysis of claims data and medical and other records to identify potential improper payments under the Federal and State programs. Although we have always been subject to post&#8209;payment audits and Reviews, more intensive &#8220;probe reviews&#8221; performed by Medicare administrative contractors in recent years appear to be a regular procedure with our fiscal intermediaries. Managed care and other third-party payors also often reserve the right to conduct audits and do on a regular basis. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that billing and reimbursement errors and disagreements are common in our industry, and thus we are regularly engaged in reviews, audits and appeals of our claims for reimbursement due to the subjectivities inherent in the process related to patient diagnosis and care, record keeping, claims processing and other aspects of the patient service and reimbursement processes, and the errors and disagreements those subjectivities can produce. An adverse review, audit or investigation could result in&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an obligation to refund amounts previously paid to us pursuant to the Medicare or Medicaid programs or from private payors, in amounts that could be material to our business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">state or federal agencies imposing fines, penalties or other sanctions on us&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">temporary or permanent loss of our right to participate in the Medicare or Medicaid programs or one or more private payor networks or admission bans or moratoriums&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">protracted regulatory oversight, including education and sampling of claims, extended pre&#8209;payment review, referral of the operating business to recovery audit or integrity contractors, or extrapolation of an error rate to other reimbursement made outside of specifically reviewed claims&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in private litigation against us&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">damage to our reputation in the geographies served by our independent operating subsidiaries.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both federal and state government continue to pursue intensive enforcement polices resulting in a significant number of investigations, audits, citations or regulatory deficiencies and other regulatory actions. Federal and state agencies have heightened and coordinated civil and criminal enforcement efforts as part of numerous ongoing audits, inquiries and investigations of healthcare companies and, in particular, SNFs. The focus of these investigations includes, among other things, billing and cost reporting practices&#59; quality of care provided&#59; and the medical necessity of rendered services. CMS announced a new nationwide audit, the &#8220;SNF 5&#8209;Claim Probe &#38; Educate Review,&#8221; in which the Medicare Administrative Contractors will review five claims from each of the facilities to check for compliance with PDPM billings, which could result in individual claim payment denials if errors are identified. All facilities that are not undergoing Targeted Probe and Educate (TPE) reviews, or have not recently passed a TPE review, will be subject to the nationwide audit. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to comply with these extensive laws, regulations and prohibitions to our business, we and certain officers could become subject to demands for refund of alleged overpayments, civil and criminal penalties, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">termination, exclusion or payment suspensions from the Medicare and Medicaid program, loss of Medicare or Medicaid certification, bans on Medicare and Medicaid payments for new admissions, admission moratoriums. We may also become subject to corporate integrity agreements or extensive monitoring by regulatory agencies. We could be forced to expend considerable resources responding to investigations, audits and other enforcement actions diverting material time, resources and attention away from our management team and our staff, and could have a materially detrimental impact on our results of operations during and after any such investigation or proceedings, regardless of whether we prevail on the underlying claim.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to extensive and complex laws and government regulations. If we are not operating in compliance with these laws and regulations or if these laws and regulations change, we could be required to make significant expenditures or change our operations in order to bring our facilities and operations into compliance. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws and regulations governing our operations, along with the terms of participation in various government programs, regulate how we conduct our business, the services we offer, the manner in which we provide and bill for services and collect reimbursement from governmental programs and private payors, and our interactions with patients, healthcare providers and referral sources, our marketing activities, and other aspects of our operations. These laws and regulations are subject to frequent change. We, along with other companies in the healthcare industry, are required to comply with extensive and complex laws and regulations at the federal, state and local government levels. Restrictions under applicable federal and state laws and regulations that may affect our ability to operate include the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Anti-Kickback Statute (AKS) that prohibits the knowing and willful offer, payment, solicitation or receipt of any bribe, kickback, rebate or other remuneration for referring an individual, in return for ordering, leasing, purchasing or recommending or arranging for or to induce the referral of an individual or the ordering, purchasing or leasing of items or services covered, in whole or in part, by any federal healthcare program, such as Medicare and Medicaid. &#8220;Remuneration&#8221; includes the transfer of anything of value, in cash or in kind and directly or indirectly. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it to have committed a violation&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal physician self-referral law (Stark Law), that, subject to limited exceptions, prohibits physicians, which includes a doctor of medicine, from referring Medicare or Medicaid patients to an entity for the provision of certain designated health services if the physician or a member of such physician&#8217;s immediate family has a direct or indirect financial relationship (including an ownership interest or a compensation arrangement) with the entity, and prohibit the entity from billing Medicare or Medicaid for such designated health services. Unlike the AKS, the Stark Law is violated if the financial arrangement does not meet an applicable exception, regardless of any intent by the parties to induce or reward referrals or the reasons for the financial relationship and the referral&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal False Claims Act (FCA), that imposes civil and criminal liability on individuals or entities that knowingly submit false or fraudulent claims for payment to the government or knowingly making, or causing to be made, a false statement in order to have a false claim paid. There are many potential bases for liability under the FCA. The government has used the FCA to prosecute Medicare and other government healthcare program fraud such as coding errors, billing for services not provided, and providing care that is not medically necessary or that is substandard in quality. In addition, the government may assert that a claim including items or services resulting from a violation of the federal AKS or Stark Law constitutes a false or fraudulent claim for purposes of the FCA. Actions under the FCA may be brought by the Attorney General, the U.S. Department of Justice (DOJ), the United States Attorney Offices, or as a qui tam action by a private individual in the name of the government. These private parties, often referred to as relators or whistleblowers, are entitled to share in any amounts recovered by the government through trial or settlement, and these qui tam cases are sealed by the court at the time of filing&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the criminal healthcare fraud provisions of HIPAA and related rules that prohibit knowingly and willfully executing a scheme or artifice to defraud any healthcare benefit program or falsifying, concealing or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services. Similar to the AKS, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it to have committed a violation&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">similar state law provisions pertaining to anti-kickback, self-referral and false claims issues, some of which may apply to items or services reimbursed by any payor, including patients and commercial insurers&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">state corporate practice and fee-splitting laws that prohibit general business corporations such as us, from practicing medicine or other healthcare professionals, controlling licensed healthcare professionals&#8217; medical decisions or engaging in some practices, such as spitting fees with licensed healthcare professionals&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws that regulate debt collection practices&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal and state antitrust laws that prohibit or limit exclusive contracting relationships with healthcare providers, prohibit or limit the sharing of cost and pricing data, prohibit competitors from taking collective action to set commercial payer reimbursement rates, and determine when a joint venture or healthcare network is sufficiently integrated, by either sharing substantial financial risk or substantial clinical integration, to jointly contract with commercial payers&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws that impose criminal penalties on healthcare providers who fail to disclose or refund known overpayments&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws that require maintenance of licensure, certification and accreditation&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws relating to adequacy and quality of healthcare services, quality and maintenance of medical equipment and facilities&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws that impose reporting, transparency and disclosure requirements of the ownership, management. managing employees and the owners of real property lessors or sublessors, including any private equity companies or REITs&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws relating to staffing levels and qualifications and vaccination (including boosting) of healthcare and support personnel&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">confidentiality, maintenance and security issues associated with medical records and claims processing&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">constraints on protective contractual provisions with patients and third&#8209;party payors.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws and regulations are complex, and we do not always have the benefit of significant regulatory or judicial interpretation of these laws and regulations. We are unable to predict the future course of federal, state and local regulation or legislation, including as it pertains to Medicare, Medicaid, or fraud and abuse laws, and how they are enforced. Additionally, in the future, different interpretations or enforcement of these laws and regulations could subject our current or past practices to allegations of impropriety or illegality or could require us to make changes in our facilities, equipment, personnel, services, operations, capital expenditure programs and operating expenses. Our efforts to comply with these laws and regulations could be costly and result in diversion of management time and effort and may still not guarantee compliance. Regulators continue to increase their scrutiny of compliance with these obligations, which may require us to further revise or expand our compliance program. While we do not believe we are in violation of these laws, we cannot assure you that governmental officials charged with the responsibility for enforcing these prohibitions will not assert that we are violating the provisions of such laws and regulations. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to comply with these applicable laws and regulations, or their interpretations as determined by courts or enforced by regulators, we could suffer civil or criminal penalties, sanctions, remedial measures and other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">detrimental consequences, including denial of reimbursement, imposition of fines, temporary suspension of admission of new patients, suspension or decertification from the Medicaid and Medicare programs, restrictions on our ability to acquire new facilities or expand or operate existing facilities, the loss of our licenses to operate and the loss of our ability to participate in federal and state reimbursement programs. In addition, if we fail to comply, even inadvertently, with any of these requirements, we could be required to alter our operations and enter into a corporate integrity agreement, deferred prosecution or similar agreements with state or federal government agencies. Furthermore, should we lose licenses or certifications for a number of our facilities or other businesses as a result of regulatory action or legal proceedings, we could be deemed to be in default under some of our agreements, including agreements governing outstanding indebtedness. See the section titled &#8220;Business&#8212;Regulatory Matters.&#8221; </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face and are currently subject to surveys, investigations, and other proceedings relating to our licenses and certification and potential sanctions and remedies based upon alleged regulatory deficiencies could negatively affect our financial condition and results of operations. Public and government calls for increased survey and enforcement efforts toward SNFs, and potential rulemaking that may result in enhanced enforcement and penalties, could result in increased scrutiny by state and federal survey agencies. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our facilities must comply with required conditions of participation in the Medicare program and state Medicaid programs and state licensure requirements. We are subject to surveys and investigations from federal and state agencies as well as accreditation organizations. We receive deficiency reports from state and federal regulatory bodies resulting from such inspections or surveys. If we fail to meet the conditions of participation or licensure standards, we may receive a notice of deficiency from the applicable surveyor. Although most inspection deficiencies are resolved through an agreed&#8209;upon plan of corrective action, the reviewing agency typically has the authority to take further action against a licensed or certified facility. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received notices of potential sanctions and remedies based upon alleged regulatory deficiencies from time to time, and such sanctions have been imposed on some of our facilities. No material remedial actions have been taken against us to date, however, we have had facilities placed on special focus facility status in the past, continue to have some facilities on this status currently and other operating subsidiaries may be identified for such status in the future. In particular, as our strategy includes the targeted acquisition of underperforming SNFs, we from time to time acquire facilities with special focus facility status. As of December 31, 2023, we had two facilities with special focus facility status. One such facility was acquired with this status and one was placed on such status following our acquisition of the facility. These facilities received such status as a result of accumulating an above average number survey deficiency points over the course of multiple surveys, some of which occurred prior to their acquisition. Survey deficiency points are issued by the government survey agency when inspecting a nursing facility to reflect the deficiencies that the facility is cited for in the survey, which include, but are not limited to, quality of life and care, freedom from abuse, neglect and exploitation deficiencies. The two facilities with special focus facility status accumulated 630 and 188 survey deficiency points, respectively, in 2023.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a facility then fails to institute an acceptable plan of correction to remediate the deficiency within the correction period provided by the state surveyor, that facility could be subject to remedial action. These actions include the imposition of fines, imposition of a license to a conditional or provisional status, admission holds, suspension or revocation of a license, payment suspension, loss of certification as a provider under state or federal healthcare programs, or imposition of other sanctions, including civil monetary penalties and criminal penalties. Termination of one or more of our facilities from the Medicare or state Medicaid programs for failure to satisfy conditions of participation, or the imposition of alternative sanctions, could disrupt operations, require significant attention by management or have a material adverse effect on our business and reputation and consolidated financial condition, results of operations and cash flows.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we have opted to voluntarily stop accepting new patients pending completion of a new state survey, in order to avoid possible denial of payment for new admissions during the deficiency cure period, or simply to avoid straining staff and other resources while retraining staff, upgrading operating systems or making other operational improvements. If we elect to voluntary close any operations in the future or to opt to stop accepting new patients pending completion of a state or federal survey, it could negatively impact our financial condition and results of operation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, in some states, citation of one affiliated facility could negatively impact other facilities in the same state. Revocation of a license at a given facility could therefore impair our ability to obtain new licenses or to renew, or maintain, existing licenses at other facilities, which may also trigger defaults or cross&#8209;defaults under our leases and our credit arrangements, or adversely affect our ability to operate or obtain financing in the future. CMS&#8217;s rules requiring disclosure of ownership, management and the owners of real property lessors or sublessors, heighten this risk. Our failure to comply with applicable legal and regulatory requirements in any single facility could negatively impact our financial condition and results of operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As CMS turns its attention to enhancing enforcement activities towards SNFs, state survey agencies will have more accountability for their survey and enforcement efforts. In addition, the Biden Administration has called for HHS and CMS to increase the level of scrutiny of SNF facilities and requested those agencies to adopt rules that would impose greater penalties upon non&#8209;compliant SNF operators. The Biden Administration&#8217;s fact sheet regarding enhanced penalties against special focus facilities (SFFs) represents further federal calls for oversight and penalties for low&#8209;ranked and underperforming SNFs. This fact sheet precedes greater focus by CMS in obtaining oversight over SFFs, and continuing that oversight even after those SFFs improve, and subjecting them to more exacting and routine oversight. The likely result may be more frequent surveys of our facilities, with more substantial penalties, fines and consequences if they do not perform well. For low&#8209;performing facilities in the SFF program, the standards for successfully emerging from that program and not being subject to ongoing and enhanced government oversight will be higher and measured over a longer period of time, prolonging the risks of monetary penalties, fines and potential suspension or exclusion from the Medicare and Medicaid programs. Additionally, CMS recently updated the survey resources that CMS and state surveyors use in evaluating our SNFs&#8217; compliance with federal Requirements for Participation. The application of CMS&#8217;s new guidance could result in more aggressive and stringent surveys, and potential fines, penalties, sanctions, or administrative actions taken against our independent operating subsidiaries. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anticipated federal minimum staffing mandates may adversely affect our labor costs, ability to maintain desired levels of patient or resident capacity, and profitability.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 1, 2023, the Biden Administration proposed a minimum staffing standard through CMS. While the full effect of federal staff level minimums, if they are ultimately implemented in the proposed or another form, is not fully known at this time, we expect that such a mandate would have adverse financial consequences upon our business. Depending on the requirements of such a mandate, we may be required to hire substantially more staff members, particularly nurse practitioners, registered nurses, licensed practical nurses and nursing aides than currently staffed. Additionally, a federal mandate of this nature would place similar pressure on our competitors and result in sudden, expanded demand for nursing staff across the SNF industry. This sudden demand across the SNF industry may exacerbate an already difficult labor market, with demand for nursing staff far outstripping the supply of qualified individuals, and the compensation requirements of both current and prospective staff increasing markedly to increase the likelihood of recruiting and retaining skilled caregivers. Changes in Medicare reimbursements for physician and non&#8209;physician services could impact reimbursement for medical professionals. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) revised the payment system for physician and non&#8209;physician services. The changes to the therapy caps imposed on Medicare Part B outpatient therapy from this law have been changed by the Bipartisan Budget Act of 2018 (BBA), and are subject to future budgetary changes through rulemaking and legislation, resulting in ongoing uncertainty regarding payment for these Medicare Part B services. Under the proposed Current Year (CY) 2024 Physician Fee Schedule (PFS) Final Rule, reductions in payment and conditions imposed in exchange for higher payments may impose operational requirements and working conditions that further detract from and reduce our financial performance. Similarly, new final rules concerning the Programs of All-Inclusive Care for the Elderly (PACE) program and the information it will collect may adversely affect the risk&#8209;adjusted reimbursement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to increased investigation and enforcement activities related to the Health Insurance Portability and Accountability Act of 1996 (HIPAA) violations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health (HITECH) Act, requires us to adopt and maintain business procedures and systems designed to protect the privacy, security and integrity of patients&#8217; individual health information, in addition to state laws governing the privacy of patient information. We must comply with these state privacy laws to the extent that they are more protective of healthcare information or provide additional protections not afforded by HIPAA. HIPAA and other comparable state and federal laws and regulations change periodically. If we fail to comply with these state and federal laws and regulations, we could be subject to criminal penalties, civil sanctions, litigation, and be forced to modify our policies and procedures, in addition to undertaking costly breach notification and remediation efforts, as well as sustaining reputational harm. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to breaches of protected patient information, under HIPAA and other federal and state laws and regulations, healthcare entities are also required to afford patients with certain rights of access to their health information and to promote sharing of patient data between and among healthcare providers involved in the same patient&#8217;s course of care. Recently, the Office for Civil Rights, the agency responsible for HIPAA enforcement, has targeted investigative and enforcement efforts on violations of patients&#8217; rights of access, imposing significant fines for violations largely initiated from patient complaints. If we fail to comply with our obligations under HIPAA or other comparable federal or state laws and regulations, we could face significant fines and penalties. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Annual caps and other cost&#8209;reductions for outpatient therapy services may reduce our future revenue and profitability or cause us to incur losses.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several government actions have been taken in recent years to try and contain the costs of rehabilitation therapy services provided under Medicare Part B, including the Multiple Procedure Payment Reduction (MPPR), institution of annual caps, mandatory medical reviews for annual claims beyond a certain monetary threshold, and a reduction in reimbursement rates for therapy assistant claim modifiers. Of specific concern has been CMS&#8217;s efforts to lower Medicare Part B reimbursement rates for outpatient therapy services in 2021, 2022, and 2023. Such cost&#8209;containment measures and ongoing payment changes could have an adverse effect on our revenue. The Office of the Inspector General (OIG) or other regulatory authorities may choose to more closely scrutinize billing practices in areas where we operate or propose to expand, which could result in an increase in regulatory monitoring and oversight, decreased reimbursement rates, or otherwise adversely affect our business, financial condition and results of operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The OIG regularly conducts investigations regarding certain payment or compliance issues within the healthcare industry. The OIG identified SNF compliance as an issue of concern in its 2021 and 2022 semi&#8209;annual reports to Congress, and its January 2023 study regarding SNF emergency preparedness identified the need for further oversight and addition of SNF emergency readiness to the OIG&#8217;s 2023 work plan. Nursing homes were also a topic of discussion in the OIG&#8217;s 2023 semiannual report to Congress, which emphasized the continued protection and oversight of care that nursing facilities provide to residents. Among other things, the OIG recommended a reduction in the use of psychotropic drugs in nursing homes and urged CMS to evaluate the appropriateness of psychotropic drug use among residents, including the use of data to identify nursing homes with higher rates of use for potential further scrutiny and action. Based on this information, SNFs in particular are potential targets for more robust scrutiny and examination by regulators. Recent publications and statements by the Biden Administration have also called for greater scrutiny of SNF facilities.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business model, like those of some other for&#8209;profit operators, is based in part on attracting higher&#8209;acuity patients whom we believe provide us more opportunity to be profitable due to the higher level of services they need and accordingly higher reimbursement rates, and over time our overall patient mix has consistently shifted to higher&#8209;acuity and higher&#8209;resource utilization patients in most facilities we operate. These efforts may place us under greater scrutiny with the OIG, CMS, our fiscal intermediaries, recovery audit contractors and others. See the section titled &#8220;Business&#8212;Regulatory Matters.&#8221; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Newly enacted and proposed legislation in the states where our independently operating entities are located may affect our operations in terms of individual litigation and the broader regulatory environment. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, a bill in the State of California, where a significant majority of our facilities are located, was recently signed into law which increases the cap of non&#8209;economic damages awarded to plaintiffs who are successful in medical malpractice litigation. The cap increased from $250,000 to $350,000 beginning on January 1, 2023, then increases over the following 10 years until the cap reaches a maximum of $750,000, with further adjustments for inflation. In wrongful death cases, the cap increased from $250,000 to $500,000 on January 1, 2023, with incremental increases over the following 10 years until the cap reaches a maximum of $1,000,000, with adjustments for inflation. Due to California&#8217;s influence on other states, other jurisdictions where we operate may enact similar laws. Similar to the potential incentive of increased damages caps, the Supreme Court&#8217;s recent decision in Health and Hospital Corporation of Marion City v. Talevskimay increase public interest in potential claims against SNFs, particularly pertaining to specific civil rights claims against governmental actors rather than general liability claims against privately owned SNFs such as those operated by our independent operating subsidiaries.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As another example, California&#8217;s adoption of the Skilled Nursing Facility Ownership and Management Reform Act of 2022 imposes new requirements for obtaining licenses to operate SNFs. These new requirements may delay or limit the ability to obtain new SNF licenses within that state, whether through acquisition of existing facilities or opening a new facility. This new law&#8217;s obligations may increase the costs of obtaining licensure, make applications more time&#8209;consuming and complex, and may result in civil penalties and other sanctions against our facilities in the event they are not compliant with these new licensure application requirements. As a result, this new law may delay or impede growth within California. As with the bill that increases the cap of non&#8209;economic damages for medical malpractice litigation, California&#8217;s influence on other states may result in this legislation becoming a model for other states and having similar, potentially adverse effects within those jurisdictions as well.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More recently, California&#8217;s legislature has proposed, including but not limited to, proposed or potential bills related to increasing the minimum wage for workers, spending requirements and increased disclosure. Bills would create new and costly obligations on our independent operating subsidiaries if they became law and if enacted, bills would adversely affect our business, operations, and profitability. In October 2023, California adopted legislation that requires, if and when a minimum spending bill is later enacted with respect to skilled nursing facilities, workers at skilled nursing facilities, as well as most other healthcare facilities throughout the state, be paid a minimum wage that begins at $21 per hour beginning June 1, 2024, increasing to $23 per hour beginning June 1, 2026, and then increasing to $25 per hour beginning June 1, 2028. While California&#8217;s state Medicaid reimbursement program will, barring intervening changes to the program, reimburse providers for some of the increased operating costs, there can be no assurance that they will be reimbursed for the full increase, or that they will be reimbursed in a timely manner.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As another example, Texas passed a bill which partially restored Medicaid state relief funding for SNFs through August 31, 2023&#59; it also considered regulation, which contained direct care spending requirements and ownership. While this bill provides financial relief to our independent operating subsidiaries in Texas, other proposed bills may impose the same regulatory requirements and limitations inherent in both the proposed legislation in other states and the federal rule requiring disclosure of such information in applications and change&#8209;of&#8209;ownership disclosures, which may adversely affect our business, operations, and profitability. See the section titled &#8220;Business&#8212;Regulatory Matters.&#8221; </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes to federal and state employment&#8209;related laws and regulations could increase our cost of doing business.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating subsidiaries are subject to a variety of federal and state employment&#8209;related laws and regulations, including, but not limited to, the U.S. Fair Labor Standards Act that governs such matters as minimum wages, overtime and other working conditions, the Americans with Disabilities Act (ADA) and similar state laws that provide civil rights protections to individuals with disabilities in the context of employment, public accommodations and other areas, the National Labor Relations Act, regulations of the U.S. Equal Employment Opportunity Commission (EEOC), regulations of the Office of Civil Rights, regulations of state attorney generals, family leave </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mandates and a variety of similar laws enacted by the federal and state governments that govern these and other employment law matters. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 5, 2023, CMS published the Omnibus Final Rule, withdrawing the COVID&#8209;19 vaccination IFR 60 days after the rule&#8217;s publication. At present, there is no nationally significant litigation concerning such mandates. The effects of the COVID&#8209;19 vaccination IFR&#8217;s withdrawal on our operations and the labor pool for nursing and administrative staff is unknown, but may have an impact on our business, operations, and profitability.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, the Biden Administration has requested HHS and CMS study and issue proposed rules regarding care&#8209;based careers, including improving access to training, increasing the attractiveness of compensation in care&#8209;based positions, and improving the retention and career progression of care workers. The Biden Administration has sought proposed rules that tie some of these issues, such as wages and retention, to Medicare reimbursement for facilities. Other pending legislation, such as the HCBS Access Act, indicate a legislative priority of providing funding for care&#8209;based careers that may affect our pool of desired workers. Rising operating costs due to labor shortages, greater compensation and incentives required to attract and retain qualified personnel and higher&#8209;than&#8209;usual inflation on items including energy, utilities, food and other goods used in our facilities and the costs for transporting these items could increase our cost and decrease our profits.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compliance costs associated with these laws and evolving regulations could be substantial. By way of example, all of our facilities are required to comply with the ADA, which has separate compliance requirements for &#8220;public accommodations&#8221; and &#8220;commercial properties,&#8221; but generally requires that buildings be made accessible to people with disabilities. Compliance with ADA requirements could require removal of access barriers and non&#8209;compliance could result in imposition of government fines or an award of damages to private litigants. Further legislation may impose additional burdens or restrictions with respect to access by disabled persons. In addition, federal proposals to introduce a system of mandated health insurance and flexible work time and other similar initiatives could, if implemented, adversely affect our operations. We also may be subject to employee&#8209;related claims such as wrongful discharge, discrimination or violation of equal employment law. While we are insured for these types of claims, we could be subject to damages that are not covered by our insurance policies or that exceed our insurance limits, and we may be required to pay such damages directly, which would negatively impact our cash flow from operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, there currently is pending legislation in California to raise the minimum wage to $25 per hour for all healthcare workers and require SNFs to maintain a minimum spend of 85% of revenue on direct care costs. As of December 31, 2023, approximately&#160;63% of our skilled nursing beds are located in California. Although there currently is no similar proposed legislation in the other states in which we operate, if we expand to other states, we may be subject to similar legislation. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Required regulatory approvals could delay or prohibit transfers of our healthcare operations, which could result in periods in which we are unable to receive reimbursement for such properties.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operations of our operating subsidiaries must be licensed under applicable state law and, depending upon the type of operation, certified or approved as providers under the Medicare and&#47;or Medicaid programs. In the process of acquiring or transferring operating assets, our operations must receive change of ownership approvals from state certificate of need boards, licensing agencies, Medicare and Medicaid as well as third-party payors. Rules regarding the disclosure of SNF facility ownership may increase the scrutiny placed on companies that operate, directly or indirectly, multiple SNFs, and may subject our licensing and approval process to additional scrutiny or delays. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, states including California, Connecticut, Illinois, Massachusetts, Minnesota, Nevada, New York, Oregon, Rhode Island and Washington have become increasingly interested in the review of healthcare transactions for impacts on costs, access to care and quality, and certain states are particularly focused on transactions involving private equity investments. Transactions involving single multi-state organizations with hundreds of healthcare providers and facilities across the country are and may be in the future subject to state reviews because one or more providers or facilities derive revenue from patients within the state. Certain state </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">review processes can involve lengthy review and approval periods, require enhanced disclosure obligations and impact analysis, public notices and hearings, and approval conditions and post-closing oversight, including ongoing reporting obligations. Overall, these state laws regulating costs, access to care and quality, in effect and those that may go into effect in the future, may delay or burden our transactions, including future add-on acquisitions, increase costs associated with expansion, require intrusive disclosures, and impose onerous, ongoing reporting obligations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If there are any delays in receiving regulatory approvals from the applicable federal, state or local government agencies, or the inability to receive such approvals, such delays or denials could result in delayed or lost reimbursement related to periods of service prior to the receipt of such approvals, which could negatively impact our cash position. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with federal and state fair housing, fire, safety and other regulations may require us to make unanticipated expenditures, which could be costly to us.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must comply with the federal Fair Housing Act and similar state laws, which prohibit us from discriminating against individuals if it would cause such individuals to face barriers in gaining residency in any of our facilities. Additionally, the Fair Housing Act and other similar state laws require that we advertise our services in such a way that we promote diversity and not limit it. We may be required, among other things, to change our marketing techniques to comply with these requirements.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we are required to operate our facilities in compliance with applicable fire and safety regulations, building codes and other land use regulations and food licensing or certification requirements as they may be adopted by governmental agencies and bodies from time to time. Like other healthcare facilities, our affiliated SNFs are subject to periodic surveys or inspections by governmental authorities to assess and assure compliance with regulatory requirements. Surveys occur on a regular (often annual or biannual) schedule, and special surveys may result from a specific complaint filed by a patient, a family member or one of our competitors. We may be required to make substantial capital expenditures to comply with these requirements.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operations are subject to environmental and occupational health and safety regulations, which could subject us to fines, penalties and increased operational costs.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a wide variety of federal, state and local environmental and occupational health and safety laws and regulations. Regulatory requirements faced by healthcare providers such as us include those relating to air emissions, wastewater discharges, air and water quality control, occupational health and safety (such as standards regarding blood-borne pathogens and ergonomics), management and disposal of low-level radioactive medical waste, biohazards and other wastes, management of explosive or combustible gases, such as oxygen, specific regulatory requirements applicable to asbestos, lead-based paints, polychlorinated biphenyls and mold, other occupational hazards associated with our workplaces, and providing notice to employees and members of the public about our use and storage of regulated or hazardous materials and wastes. Failure to comply with these requirements could subject us to fines, penalties and increased operational costs. Moreover, changes in existing requirements or more stringent enforcement of them, as well as discovery of currently unknown conditions at our owned or leased facilities, could result in additional cost and potential liabilities, including liability for conducting cleanup, and there can be no guarantee that such increased expenditures would not be significant.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to This Offering and Ownership of Our Common Stock </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The market price of our common stock may be volatile or may decline steeply or suddenly regardless of our operating performance, which could result in substantial losses for purchasers of our common stock in this offering, and we may not be able to meet investor or analyst expectations. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following this offering, the market price of our common stock may be highly volatile and fluctuate or decline significantly in response to numerous factors, many of which are beyond our control, including&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">variations between our actual operating results, or those of companies that are perceived to be similar to us, and the expectations of securities analysts, investors and the financial community&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any forward-looking financial or operating information we may provide to the public or securities analysts, any changes in this information or our failure to meet expectations based on this information&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actions of securities analysts who initiate or maintain coverage of us, changes in financial estimates by any securities analysts who follow our Company or our failure to meet these estimates or the expectations of investors&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">additional shares of our common stock being sold into the market by us or our existing stockholders, or the anticipation of such sales, including if existing stockholders sell shares into the market when applicable &#8220;lock-up&#8221; period ends&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">hedging activities by market participants&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements by us or our competitors of significant features, technical innovations in facilities, acquisitions, strategic partnerships, joint ventures or capital commitments&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in operating performance and stock market valuations of companies in our industry, including our competitors&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in third-party payor reimbursement policies&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an inability to obtain additional funding&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic, political, industry and market conditions, including rising inflation, high interest rates, capital market disruptions, and price and volume fluctuations in the overall stock market&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expiration of market stand-off or lock-up agreements&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lawsuits threatened or filed against us&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments in new legislation and pending lawsuits or regulatory actions, including interim or final rulings by judicial or regulatory bodies&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other events or factors, including those resulting from political conditions, election cycles, pandemics, war or incidents of terrorism, or responses to these events, many of which are outside of our control. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, extreme price and volume fluctuations in the stock markets have affected and continue to affect many healthcare companies&#8217; stock prices. Stock prices often fluctuate in ways unrelated or disproportionate to the companies&#8217; operating performance. In the past, stockholders have filed securities class action litigation following periods of market volatility. This risk is especially relevant for us because companies in the healthcare industry have experienced significant stock price volatility in recent years. If we were to become involved in securities litigation, it </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">could subject us to substantial costs, divert resources and the attention of management from our business and seriously harm our business. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, because of these fluctuations, comparing our operating results on a period-to-period basis may not be meaningful. You should not rely on our past results as an indication of our future performance. This variability and unpredictability could also result in our failure to meet the expectations of industry or financial analysts or investors for any period. If our revenues or operating results fall below the expectations of analysts or investors or below any forecasts we may provide to the market, or if the forecasts we provide to the market are below the expectations of analysts or investors, the price of our common stock could decline substantially. Such a stock price decline could occur even when we have met any previously publicly stated revenue or earnings forecasts that we may provide. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">An active trading market for our common stock may never develop or be sustained, and you may not be able to resell your shares at or above the initial public offering price. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to this offering, there has been no public market for our common stock. Although we have applied to list our common stock on the New York Stock Exchange under the symbol &#8220;PACS,&#8221; an active trading market for our common stock may never develop or be sustained following this offering. The initial public offering price for our common stock will be determined through negotiations between the underwriters and us, and may vary from the market price of our common stock following this offering. This initial public offering price may not be indicative of the market price of our common stock after this offering. We cannot assure you that the market price following this offering will equal or exceed the initial public offering price. In the absence of an active trading market for our common stock, you may not be able to sell your shares of our common stock when desired or at or above the initial public offering price. An inactive market may also impair our ability to raise capital by selling shares and may impair our ability to acquire other businesses or properties using our shares as consideration, which, in turn, could materially and adversely affect our business. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our founders, Jason Murray and Mark Hancock, will continue to hold a substantial portion of our outstanding common stock following this offering, and their interests may conflict, or appear to conflict, with our interests and the interests of other stockholders.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the completion of this offering, and without giving effect to any purchases that may be made otherwise in this offering, our founders, Jason Murray and Mark Hancock, will own approximately&#160;&#160;&#160;&#160;&#160;&#160;% of the voting power of our common stock (or&#160;&#160;&#160;&#160;&#160;% if the underwriters exercise their option to purchase additional shares from us in full). In addition, we will agree to nominate to our board of directors Messrs. Murray and Hancock in accordance with the Stockholders Agreement between us and the investors party thereto. Messrs. Murray and Hancock have each agreed to vote, or cause to vote, all of their outstanding shares of our common stock at any annual or special meeting of stockholders in which directors are elected, so as to cause the election of Messrs. Murray and Hancock. See the section titled &#8220;Certain Relationships and Related Party Transactions&#8212;Stockholders Agreements.&#8221;</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even when the parties to our Stockholders Agreement cease to own shares of our stock representing a majority of the total voting power, for so long as such parties continue to own a significant percentage of our stock, they will still be able to significantly influence or effectively control the composition of our board of directors and the approval of actions requiring stockholder approval through their voting power. Accordingly, for such period of time, the parties to our Stockholders Agreement will have significant influence with respect to our management, business plans and policies. For instance, for so long as Messrs. Murray and Hancock continue to own a significant percentage of our common stock, they may be able to cause or prevent a change of control of the Company or a change in the composition of our board of directors, and could preclude any unsolicited acquisition of the Company. The concentration of ownership could deprive us of what we perceive as an attractive business combination opportunity, or investors of an opportunity to receive a premium for their shares of common stock as part of a sale of the Company and ultimately may affect the market price of our common stock.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, our Amended and Restated Charter, which will be in effect following this offering, will provide that the doctrine of &#8220;corporate opportunity&#8221; will not apply with respect to certain parties to our Stockholders Agreements or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">their affiliates (other than us and our subsidiaries), and any of their respective principals, members, directors, partners, stockholders, officers, employees or other representatives (other than any such person who is also our employee or an employee of our subsidiaries), or any director or stockholder who is not employed by us or our subsidiaries. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future sales of shares of common stock by existing stockholders could cause the market price of our common stock to decline. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our existing stockholders sell, or indicate an intention to sell, substantial amounts of our common stock in the public market after the lock-up and legal restrictions on resale discussed in this prospectus lapse, the trading price of our common stock could decline. Upon consummation of this offering, based on the number of shares of our common stock outstanding on December 31, 2023, we will have outstanding a total of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock, assuming no exercise by the underwriters of their option to purchase additional shares of our common stock from us. Of these shares, only the shares of common stock sold in this offering will be freely tradable, without restriction, in the public market immediately after this offering unless purchased by our affiliates. The remaining shares are held by Messrs. Murray and Hancock and are subject to lock-up and market standoff agreements that restrict their ability to, among other things and subject to certain exceptions, sell or transfer their shares for a period of 180 days after the date of this prospectus subject to certain exceptions. However, Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Truist Securities, Inc. may, in their sole discretion, waive the contractual lock-up before the lock-up agreements expire. After the lock-up agreements expire, all shares outstanding as of December 31, 2023 (assuming the closing of this offering) will be eligible for sale in the public market, of which the shares are held by directors, executive officers and other affiliates and will be subject to volume limitations under Rule 144 of the Securities Act (Rule 144), and various vesting agreements. Sales of a substantial number of such shares upon expiration of the lock-up and market stand-off agreements, the perception that such sales may occur or early release of these agreements, could cause our market price to fall or make it more difficult for you to sell your common stock at a time and price that you deem appropriate. Messrs. Murray and Hancock are additionally entitled to rights with respect to the registration of all of their shares following this offering and if they were to exercise those rights they may be able to sell their shares outside of the volume limitations imposed by Rule 144. See the section titled &#8220;Description of Capital Stock&#8212;Registration Rights&#8221; for a description of these registration rights.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to file a registration statement on Form S-8 under the Securities Act covering the shares of common stock issuable or reserved for issuance under our 2024 Plan and our ESPP. That registration statement will become effective immediately on filing, and shares covered by that registration statement will be eligible for sale in the public markets, subject to Rule 144 limitations applicable to affiliates and the lock-up agreement described above. If these additional shares are sold, or if it is perceived that they will be sold in the public market, the trading price of our common stock could decline. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If you purchase our common stock in this offering, you will incur immediate and substantial dilution. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumed initial public offering price is substantially higher than the as adjusted net tangible book value (deficit) per share of our common stock of $ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share as of December 31, 2023. Investors purchasing common stock in this offering will pay a price per share that substantially exceeds the book value of our tangible assets after subtracting our liabilities. As a result, investors purchasing common stock in this offering will incur immediate dilution of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, based on the assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, which is the midpoint of the price range set forth on the cover page of this prospectus. This dilution is due to the substantially lower price paid by our investors who purchased shares of common stock prior to this offering as compared to the price offered to the public in this offering. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future issuances of shares of our common stock, or the perception that these sales may occur, could depress the market price of our common stock and result in dilution to existing holders of our common stock. Also, to the extent outstanding options, restricted stock units or other stock-based awards are issued or become vested, there will be further dilution. The amount of dilution could be substantial depending upon the size of the issuances or exercises. Furthermore, we may issue additional equity securities that could have rights senior to those of our common stock. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, purchasers of our common stock in this offering bear the risk that future issuances of debt or equity securities may reduce the value of our common stock and further dilute their ownership interest.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our estimates or judgments relating to our critical accounting policies are based on assumptions that change or prove to be incorrect, our operating results could fall below our publicly announced guidance or the expectations of securities analysts and investors, resulting in a decline in the market price of our common stock. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and the accompanying notes thereto. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets, liabilities, equity, revenue and expenses that are not readily apparent from other sources. It is possible that interpretation, industry practice and guidance involving estimates and assumptions may evolve or change over time. If our assumptions change or if actual circumstances differ from our assumptions, our operating results may be adversely affected and could fall below our publicly announced guidance or the expectations of securities analysts and investors, resulting in a decline in the market price of our common stock. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have broad discretion in how we may use the net proceeds from this offering, and we may not use them effectively. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management will have broad discretion in applying the net proceeds we receive from this offering, and accordingly, investors in this offering will need to rely upon the judgment of our management with respect to the use of proceeds with only limited information concerning management&#8217;s specific intentions. We currently intend to use the net proceeds of this offering, together with our existing cash and cash equivalents, to support the growth of our business, including to expand our commercial organization and increase our sales and marketing programs, fund expansions, improvements and upgrades at our existing facilities and the development and construction of new skilled nursing facilities, and for working capital and general corporate purposes. We may use a portion of our net proceeds to acquire and invest in SNFs or businesses engaged in activities that are similar or complementary to our business&#59; however, we currently have no agreements or commitments to complete any such transaction. We may also spend or invest these proceeds in a way with which our stockholders disagree. If our management fails to use these funds effectively, our business could be seriously harmed.  </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Amended and Restated Charter will provide that the doctrine of &#8220;corporate opportunity&#8221; will not apply with respect to Jason Murray and Mark Hancock and any director or stockholder who is not employed by us or our subsidiaries.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The doctrine of corporate opportunity generally provides that a corporate fiduciary may not develop an opportunity using corporate resources, acquire an interest adverse to that of the corporation or acquire property that is reasonably incident to the present or prospective business of the corporation or in which the corporation has a present or expectancy interest, unless that opportunity is first presented to the corporation and the corporation chooses not to pursue that opportunity. The doctrine of corporate opportunity is intended to preclude officers or directors or other fiduciaries from personally benefiting from opportunities that belong to the corporation. Pursuant to our Amended and Restated Charter, which will be in effect following this offering, we will renounce, to the fullest extent permitted by law and in accordance with Section 122(17) of the Delaware General Corporation Law, all interest and expectancy that we otherwise would be entitled to have in, and all rights to be offered an opportunity to participate in, any opportunity that may be presented to Jason Murray and Mark Hancock or their affiliates (other than us and our subsidiaries), and any of their respective employees or other representatives (other than any such person who is also our employee or an employee of our subsidiaries), or any director or stockholder who is not employed by Jason Murray and Mark Hancock or their affiliates and any director or stockholder who is not employed by us or our subsidiaries, therefore, have no duty to communicate or present corporate opportunities to us, and have the right to either hold any corporate opportunity for their (and their affiliates&#8217;) own account and benefit or to recommend, assign or otherwise transfer such corporate opportunity to persons other than us, including to any director or stockholder who is not employed by us or our subsidiaries. As a result, certain of our stockholders, directors and their respective affiliates will not be prohibited from operating or investing in competing businesses. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, therefore, may find ourselves in competition with certain of our stockholders, directors or their respective affiliates, and we may not have knowledge of, or be able to pursue, transactions that could potentially be beneficial to us. Accordingly, we may lose a corporate opportunity or suffer competitive harm, which could negatively impact our business, operating results and financial condition.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Upon the listing of our common stock on the New York Stock Exchange, we will be a &#8220;controlled company&#8221; within the meaning of the corporate governance standards of the New York Stock Exchange. As a result, we qualify for, and intend to rely on, exemptions from certain corporate governance standards. You will not have the same protections afforded to stockholders of companies that are subject to such requirements.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the completion of this offering, Jason Murray and Mark Hancock collectively will control a majority of the voting power of shares eligible to vote in the election of our directors. Because more than 50% of the voting power in the election of our directors is held by an individual, group, or another company, we are a &#8220;controlled company&#8221; within the meaning of the corporate governance standards of the&#160;New York Stock Exchange. As a controlled company, we may elect not to comply with certain corporate governance requirements, including the requirements that, within one year of the date of the listing of our common stock&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a majority of our board of directors consists of &#8220;independent directors,&#8221; as defined under the rules of such exchange&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our board of directors has a compensation committee that is composed entirely of independent directors with a written charter addressing the committee&#8217;s purpose and responsibilities&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our board of directors has a nominating and corporate governance committee that is composed entirely of independent directors with a written charter addressing the committee&#8217;s purpose and responsibilities&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there be an annual performance evaluation of the nominating and corporate governance and compensation committees.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following this offering and for so long as we remain a &#8220;controlled company,&#8221; we may rely on these exemptions. As a result of any such election, our board of directors may not have a majority of independent directors, our compensation committee may not consist entirely of independent directors and our directors may not be nominated or selected by independent directors. Accordingly, you will not have the same protections afforded to stockholders of companies that are subject to all of the corporate governance requirements of the&#160;New York Stock Exchange rules.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">After this offering, our principal stockholders and management will own a significant percentage of our stock and will be able to exercise significant influence over matters subject to stockholder approval. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, our executive officers, directors and 5% or greater stockholders beneficially owned 100% of the outstanding shares of capital stock, and, upon the closing of this offering, that same group will hold approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of our outstanding shares of common stock (assuming no exercise of the underwriters&#8217; option to purchase additional shares from us). Therefore, even after this offering, these stockholders will have the ability to influence us through this ownership position. The interests of these stockholders may not be the same as or may even conflict, or appear to conflict, with your interests. For example, these stockholders could attempt to delay or prevent a change in control of us, even if such change in control would benefit our other stockholders, which could deprive our stockholders of an opportunity to receive a premium for their common stock as part of a sale of us or our assets, and might affect the prevailing market price of our common stock due to investors&#8217; perceptions that conflicts of interest may exist or arise. In addition, these stockholders, acting together, will be able to significantly influence all matters requiring stockholder approval, including the election and removal of directors and any merger or other significant corporate transactions after completion of this offering. As a result, this concentration of ownership may not be in the best interests of our other stockholders.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Participation in this offering by our existing stockholders and their affiliated entities may reduce the public float for our common stock. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent certain of our existing stockholders and their affiliated entities participate in this offering, such purchases would reduce the non-affiliate public float of our shares, meaning the number of shares of our common stock that are not held by officers, directors and principal stockholders. A reduction in the public float could reduce the number of shares that are available to be traded at any given time, thereby adversely impacting the liquidity of our common stock and depressing the price at which you may be able to sell shares of common stock purchased in this offering. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delaware law and provisions in our Amended and Restated Charter and Amended and Restated Bylaws that will be in effect on the completion of this offering could make a merger, tender offer or proxy contest difficult, thereby depressing the trading price of our common stock. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Amended and Restated Charter and Amended and Restated Bylaws that will be in effect on the completion of this offering contain provisions that could depress the trading price of our common stock by acting to discourage, delay or prevent a change of control of our company or changes in our management that the stockholders of our company may deem advantageous. These provisions include the following&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishing a classified board of directors so that not all members of our board of directors are elected at one time&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">permitting our board of directors to establish the number of directors and fill any vacancies and newly-created directorships&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">providing that directors may only be removed for cause and only by the affirmative vote of the holders of at least a majority of the voting power of all then outstanding shares of our capital stock&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requiring the approval of holders of two-thirds of our outstanding common stock to amend some provisions in our Amended and Restated Charter and Amended and Restated Bylaws&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">authorizing the issuance of &#8220;blank check&#8221; preferred stock that our board of directors could use to implement a stockholder rights plan&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prohibiting stockholders from calling special meetings of stockholders&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prohibiting stockholder action by written consent, which has the effect of requiring all stockholder actions to be taken at a meeting of our stockholders&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">providing that the board of directors is expressly authorized to make, alter or repeal our Amended and Restated Bylaws&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restricting the forum for certain litigation involving us to Delaware or federal courts, as applicable&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishing advance notice requirements for nominations for election to our board of directors or for proposing matters that can be acted upon by stockholders at annual stockholder meetings. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any provision of our Amended and Restated Charter or Amended and Restated Bylaws that will be in effect on the completion of this offering or Delaware law that has the effect of delaying or deterring a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our common stock, and could also affect the price that some investors are willing to pay for our common stock. See the section titled &#8220;Description of Capital Stock&#8212;Anti-Takeover Effects of Provisions of the General Corporation Law of the State of Delaware and our Amended and Restated Charter and Amended and Restated Bylaws.&#8221; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The provisions of our Amended and Restated Charter requiring exclusive forum in the Court of Chancery of the State of Delaware and the federal district courts of the United States for certain types of lawsuits may have the effect of discouraging lawsuits against our directors and officers. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Amended and Restated Charter to be in effect upon the completion of this offering will provide that, unless we otherwise consent in writing, (A) (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of a fiduciary duty owed by any current or former director, officer, other employee or stockholder of us to the us or the our stockholders, (iii) any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law, our Amended and Restated Charter or our Amended and Restated Bylaws (as either may be amended or restated) or as to which the Delaware General Corporation Law confers exclusive jurisdiction on the Court of Chancery of the State of Delaware or (iv) any action asserting a claim governed by the internal affairs doctrine of the law of the State of Delaware shall, to the fullest extent permitted by law, be exclusively brought in the Court of Chancery of the State of Delaware or, if such court does not have subject matter jurisdiction thereof, the federal district court of the State of Delaware&#59; and (B) the federal district courts of the United States shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act&#59; however, there is uncertainty as to whether a court would enforce such provision, and investors cannot waive compliance with federal securities laws and the rules and regulations thereunder. Notwithstanding the foregoing, the exclusive forum provision shall not apply to claims seeking to enforce any liability or duty created by the Exchange Act or any other claim for which the federal courts of the United States have exclusive jurisdiction. The choice of forum provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees and may also result in increased costs for stockholders to bring any such claim, which may discourage such lawsuits against us and our directors, officers, and other employees, although our stockholders will not be deemed to have waived our compliance with federal securities laws and the rules and regulations thereunder. Alternatively, if a court were to find the choice of forum provision contained in our Amended and Restated Charter to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could have an adverse effect on our business, financial condition and results of operations. Any person or entity purchasing or otherwise acquiring or holding any interest in shares of our capital stock shall be deemed to have notice of and consented to the forum provisions in our Amended and Restated Charter (as may be amended or restated). </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-U.S. Holders who own more than 5% of our common stock may be subject to U.S. federal income tax on gain realized on the sale or other taxable disposition of such common stock.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the determination of whether we are a &#8220;U.S. real property holding corporation&#8221; (USRPHC) for U.S. federal income tax purposes depends on the fair market value of our &#8220;U.S. real property interests&#8221; (USRPIs) relative to the fair market value of our non-U.S. real property interests and our other business assets, and because we have significant interests in real property located in the U.S., we may currently be, or may become in the future, a USRPHC. There can be no assurance that we do not currently constitute, or will not become, a USRPHC. As a result, a &#8220;Non-U.S. Holder&#8221; (as defined below under &#8220;Material U.S. Federal Income Tax Consequences to Non-U.S. Holders&#8221;) may be subject to U.S. federal income tax on gain realized on a sale or other taxable disposition of our common stock if such Non-U.S. Holder has owned, actually or constructively, more than 5% of our common stock at any time during the shorter of the five-year period ending on the date of the sale or other taxable disposition or the Non-U.S. Holder&#8217;s holding period in such stock. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Being a Public Company </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will incur increased costs as a result of operating as a public company, and our management will be required to devote substantial time to new compliance initiatives and corporate governance practices. Additionally, if we fail to maintain proper and effective internal controls, our ability to produce accurate financial statements on a timely basis could be impaired. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we will incur significant legal, accounting, and other expenses that we did not incur as a private company. We will be subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act, the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dodd-Frank Wall Street Reform and Protection Act, as well as rules adopted, and to be adopted, by the Securities and Exchange Commission, or the SEC, and the New York Stock Exchange. Our management and other personnel will need to devote a substantial amount of time to these compliance initiatives. Moreover, we expect these rules and regulations to substantially increase our legal and financial compliance costs and to make some activities more time-consuming and costly, which will increase our operating expenses. For example, we expect these rules and regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance and we may be required to incur substantial costs to maintain sufficient coverage. We cannot accurately predict or estimate the amount or timing of additional costs we may incur to respond to these requirements. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees, or as executive officers. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as a public company we will be required to incur additional costs and obligations in order to comply with SEC rules that implement Section 404 of the Sarbanes-Oxley Act. Under these rules, beginning with our second annual report on Form 10-K after we become a public company, we will be required to make a formal assessment of the effectiveness of our internal control over financial reporting, and we will be required to include an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. To achieve compliance with Section 404 within the prescribed period, we will be engaging in a process to document and evaluate our internal control over financial reporting, which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants and adopt a detailed work plan to assess and document the adequacy of our internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are designed and operating effectively, and implement a continuous reporting and improvement process for internal control over financial reporting. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rules governing the standards that must be met for management to assess our internal control over financial reporting are complex and require significant documentation, testing, and possible remediation to meet the detailed standards under the rules. During the course of its testing, our management may identify material weaknesses which may not be remedied in time to meet the deadline imposed by the Sarbanes-Oxley Act. Our internal control over financial reporting will not prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system&#8217;s objectives will be met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud will be detected. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are not able to comply with the requirements of Section 404 of the Sarbanes-Oxley Act in a timely manner, or if we are unable to maintain proper and effective internal controls, we may not be able to produce timely and accurate financial statements. If that were to happen, the market price of our stock could decline and we could be subject to sanctions or investigations by the stock exchange on which our common stock is listed, the SEC or other regulatory authorities. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our management team has limited experience managing a public company. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most members of our management team have limited experience managing a publicly traded company, interacting with public company investors and complying with the increasingly complex laws pertaining to public companies. Our management team may not successfully or efficiently manage us as a public company that is subject to significant regulatory oversight and reporting obligations under the federal securities laws and the continuous scrutiny of securities analysts and investors. These new obligations and constituents require significant attention from our senior management and could divert their attention away from the day-to-day management of our business, which could have an adverse effect on our business, financial condition and results of operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the completion of this offering, we will become subject to the periodic reporting requirements of the Exchange Act. We must design our disclosure controls and procedures to reasonably assure that information we </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">must disclose in reports we file or submit under the Exchange Act is accumulated and communicated to management, and recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC. Any disclosure controls and procedures or internal controls and procedures, no matter how well-conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. For example, our directors or executive officers could inadvertently fail to disclose a new relationship or arrangement causing us to fail to make a required related party transaction disclosure. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements due to error or fraud may occur and not be detected. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could be subject to securities class action litigation. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, securities class action litigation has often been brought against companies following a decline in the market price of its securities. This risk is especially relevant for us because companies in the healthcare industry have experienced significant stock price volatility in recent years. If we face such litigation, it could result in substantial costs and a diversion of management&#8217;s attention and resources, which could harm our business. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our failure to meet the New York Stock Exchange&#8217;s continued listing requirements could result in a delisting of our common stock. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If, after listing, we fail to satisfy the continued listing requirements of the New York Stock Exchange, such as the corporate governance requirements or the minimum closing bid price requirement, the&#160;New York Stock Exchange may take steps to delist our common stock. Such a delisting would likely have a negative effect on the price of our common stock and would impair your ability to sell or purchase our common stock when you wish to do so. In the event of a delisting, we can provide no assurance that any action taken by us to restore compliance with listing requirements would allow our common stock to become listed again, stabilize the market price or improve the liquidity of our common stock, or prevent future non-compliance with the listing requirements of the&#160;New York Stock Exchange. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts either do not publish research about us or publish inaccurate or unfavorable research about us, our business or our market, or if they change their recommendations regarding our common stock adversely, the trading price or trading volume of our common stock could decline. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our common stock will be influenced in part by the research and reports that securities or industry analysts may publish about us, our business, our market or our competitors. If one or more analysts initiate research with an unfavorable rating or downgrade our common stock, provide a more favorable recommendation about our competitors or publish inaccurate or unfavorable research about our business, our common stock price would likely decline. If any analyst who may cover us were to cease coverage of us or fail to regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause the trading price or trading volume of our common stock to decline. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regardless of accuracy, unfavorable interpretations of our financial information and other public disclosures could have a negative impact on our stock price. If our financial performance fails to meet analyst estimates, for any of the reasons discussed above or otherwise, or one or more of the analysts who cover us downgrade our common stock or change their opinion of our common stock, our stock price would likely decline. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if our common stock is actively covered by analysts, we do not have any control over the analysts or the measures that analysts or investors may rely upon to forecast our future results. Overreliance by analysts or investors on any particular metric to forecast our future results may lead to forecasts that differ significantly from our own. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risks </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Global economic and financial market conditions, including severe market disruptions and the potential for a significant and prolonged global economic downturn, could impact our business operations in a number of ways, including, but not limited to, reduced demand in key customer end-markets.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global economy can be negatively impacted by a variety of factors such as the spread or fear of spread of contagious diseases, man-made or natural disasters, actual or threatened war, terrorist activity, political unrest, civil strife and other geopolitical uncertainty. Such adverse and uncertain economic conditions may impact the post-acute services industry and consumer demand for our services. Decreases in demand for our services without a corresponding decrease in our costs would put downward pressure on margins and would negatively impact our financial results. Prolonged unfavorable economic conditions or uncertainty may have an adverse effect on our sales and profitability.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the U.S. and global social, political, regulatory and economic conditions or in laws and policies governing foreign trade, manufacturing, development and investment could also adversely affect our business. If global economic conditions remain volatile for a prolonged period or experience further disruptions, it could have a material adverse effect on our business, financial condition and results of operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increased attention to, and evolving expectations for, environmental, social, and governance (ESG) initiatives could increase our costs, harm our reputation, or otherwise adversely impact our business.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Companies across industries are facing increasing scrutiny from a variety of stakeholders related to their ESG and sustainability practices. Expectations regarding voluntary ESG initiatives and disclosures may result in increased costs (including but not limited to increased costs related to compliance, stakeholder engagement, contracting and insurance), enhanced compliance or disclosure obligations, or other adverse effects on to our business, financial condition and results of operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we may at times engage in voluntary initiatives (such as voluntary disclosures, certifications, or goals, among others) to improve our ESG profile, such initiatives may be costly and may not have the desired effect. Moreover, we may not be able to successfully complete such initiatives due to factors that are within or outside of our control. Even if this is not the case, our actions may subsequently be determined to be insufficient by various stakeholders, and we may be subject to investor or regulator engagement on our ESG efforts, even if such initiatives are currently voluntary.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain market participants, including major institutional investors and capital providers, use third-party benchmarks and scores to assess companies&#8217; ESG profiles in making investment or voting decisions. Unfavorable ESG ratings could lead to increased negative investor sentiment towards us, which could negatively impact our share price as well as our access to and cost of capital. To the extent ESG matters negatively impact our reputation, it may also impede our ability to compete as effectively to attract and retain employees, which may adversely impact our operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we expect there will likely be increasing levels of regulation, disclosure-related and otherwise, with respect to ESG matters. For example, the SEC has published propose rules that would require companies to provide significantly expanded climate-related disclosures in their periodic reporting, which may require us to incur significant additional costs to comply, including the implementation of significant additional internal controls processes and procedures regarding matters that have not been subject to such controls in the past, and impose increased oversight obligations on our management and board of directors. These and other changes in stakeholder expectations will likely lead to increased costs as well as scrutiny that could heighten all of the risks identified in this risk factor. Additionally, our business partners may be subject to similar expectations, which may augment or create additional risks, including risks that may not be known to us.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may acquire or invest in companies, which may divert our management&#8217;s attention and result in additional dilution to our stockholders. We may be unable to integrate acquired businesses and technologies successfully or achieve the expected benefits of such acquisitions.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may evaluate and consider potential strategic transactions, including acquisitions of, or investments in, businesses, technologies, services, products, and other assets in the future. An acquisition, investment or business relationship may result in unforeseen operating difficulties and expenditures. In particular, we may encounter difficulties assimilating or integrating the businesses, technologies, products, personnel, or operations of the acquired companies. Key personnel of the acquired companies may choose not to work for us, their software may not be easily adapted to work with ours, or we may have difficulty retaining the customers of any acquired business due to changes in ownership, management, or otherwise. We may also experience difficulties integrating personnel of the acquired company into our business and culture. Acquisitions may also disrupt our business, divert our resources and require significant management attention that would otherwise be available for development of our existing business. The anticipated benefits of any acquisition, investment, or business relationship may not be realized or we may be exposed to unknown risks or liabilities.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Negotiating these transactions can be time-consuming, difficult, and expensive, and our ability to close these transactions may often be subject to approvals that are beyond our control. Consequently, these transactions, even if undertaken and announced, may not close. For one or more of those transactions, we may&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issue additional equity securities that would dilute our stockholders&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">use cash that we may need in the future to operate our business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incur debt on terms unfavorable to us or that we are unable to repay&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incur large charges or substantial liabilities&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">encounter difficulties retaining key employees of the acquired company or integrating diverse software codes or business cultures&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">become subject to adverse tax consequences, substantial depreciation, or deferred compensation charges.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to pay or maintain dividends and the failure to do so would adversely affect our stock price. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2023, 2022 and 2021, we paid $ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , $60.3 million, and $53.8 million, respectively, in cash dividends to holders of our common stock. We currently anticipate that we will retain future earnings for the development, operation and expansion of our business and do not anticipate declaring or paying any cash dividends for the foreseeable future. Any return to stockholders will therefore be limited to any appreciation in the value of their stock. Our ability to pay and maintain cash dividends is based on many factors, including our ability to make and finance acquisitions, our ability to negotiate favorable lease and other contractual terms, anticipated operating cost levels, the level of demand for occupancy at our facilities, the rates we charge and actual results that may vary substantially from estimates. Some of the factors are beyond our control and a change in any such factor could affect our ability to pay or maintain dividends. The Credit Facility restricts our ability to pay dividends to stockholders if we receive notice that we are in default under the agreement. The failure to pay or maintain dividends could adversely affect the market price of our common stock.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_682"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus contains forward-looking statements that involve substantial risks and uncertainties. All statements contained in this prospectus other than statements of historical facts, including, but not limited to, statements regarding our business strategy, plans, market growth and our objectives for future operations, are forward-looking statements. The words &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;contemplate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;forecast,&#8221; &#8220;predict,&#8221; &#8220;potential&#8221; or &#8220;continue&#8221; or the negative of these terms and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements contained in this prospectus include, but are not limited to, statements about&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our future financial performance, including our expectations regarding our revenue, operating expenses, and our ability to achieve and maintain future profitability&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the demand for our services in general&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability and the ability of local leaders and others to transform SNFs and other acquired facilities into higher acuity, high value-add short-term transitional care SNFs, including through the implementation of PACS Services&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding improvement in clinical quality, patient experience, and operating metrics over time as facilities mature over a transition period, and our ability to maintain standards in our Mature facilities&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully execute upon our strategy to deploy our decentralized, local operating model in acquired SNFs and in existing and new markets&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully execute upon our acquisition strategy, including with respect to SNFs, and our ability to successfully identify, acquire and integrate facilities, businesses and operations&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scalability of PACS Services and our operating model&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully compete with existing and new competitors generally and in specific existing and new geographical markets&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the size of our market and market trends, including with respect to SNFs, expected growth rates of the market and our ability to grow within and further penetrate our market&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract, train, and retain motivated, entrepreneurial individuals, including local leaders. administrators, clinicians, and other important employees and personnel&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the effects of existing and developing laws and regulations&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to comply with regulations applicable to our business&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to develop and protect our brand&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding, and management of, future growth&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain, protect and enhance our technology and intellectual property&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to implement, maintain and improve effective internal controls and remediate material weaknesses&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the sufficiency of our cash to meet our liquidity needs&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the increased expenses associated with being a public company&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our anticipated uses of the net proceeds from this offering. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We caution you that the foregoing list may not contain all of the forward-looking statements made in this prospectus.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should not rely upon forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this prospectus primarily on our current expectations, estimates, forecasts, and projections about future events and trends that we believe may affect our business, financial condition, results of operations, and prospects. Although we believe that we have a reasonable basis for each forward-looking statement contained in this prospectus, we cannot guarantee that the future results, levels of activity, performance, or events and circumstances reflected in the forward-looking statements will be achieved or occur at all. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties, and other factors described in the section titled &#8220;Risk Factors,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition&#8221; and elsewhere in this prospectus. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as predictions of future events. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this prospectus. The results, events, and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward-looking statements. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward-looking statements made in this prospectus relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this prospectus to reflect events or circumstances after the date of this prospectus or to reflect new information or the occurrence of unanticipated events, except as required by applicable law. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments we may make. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, statements that &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this prospectus, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and you are cautioned not to unduly rely upon these statements. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should read this prospectus and the documents that we reference in this prospectus and have filed with the SEC as exhibits to the registration statement of which this prospectus is a part with the understanding that our actual future results, performance, and events and circumstances may be materially different from what we expect. We qualify all of the forward-looking statements in this prospectus by these cautionary statements.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_692"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">USE OF PROCEEDS</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate that the net proceeds to us from the sale of shares of our common stock in this offering will be approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; million (or $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; million if the underwriters exercise their option to purchase additional shares of our common stock from us in full), based upon an assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share (which is the midpoint of the price range set forth on the cover page of this prospectus) and after deducting the underwriting discounts and commissions and estimated offering expenses payable by us.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each $1.00 increase or decrease in the assumed initial public offering price per share of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (which is the midpoint of the price range set forth on the cover page of this prospectus) would increase or decrease the net proceeds to us from this offering by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; million, assuming that the number of shares of common stock offered by us, as set forth on the cover page of this prospectus, remains the same, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. Similarly, each 1,000,000 share increase or decrease in the number of shares of common stock offered by us in this offering would increase or decrease the net proceeds to us from this offering by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; million, assuming that the assumed initial public offering price per share remains the same, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal purposes of this offering are to increase our capitalization and financial flexibility, create a public market for our common stock, and enable access to the public equity markets for us and our stockholders. We intend to use the net proceeds from this offering for general corporate purposes to support the growth of our business. As of the date of this prospectus, we cannot specify with certainty the specific allocations or all of the particular uses for the net proceeds to be received upon completion of this offering. We may use a portion of the net proceeds to acquire or invest in additional nursing facilities or other businesses and service offerings, although we do not have binding agreements or commitments for any material investments for which we would use the net proceeds of this offering at this time. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected use of net proceeds from this offering represents our intentions based upon our present plans and business conditions. We cannot predict with certainty all of the particular uses for the proceeds of this offering or the amounts that we will actually spend on the uses set forth above. Accordingly, our management will have broad discretion in applying the net proceeds of this offering. The timing and amount of our actual expenditures will be based on many factors, including cash flows from operations and the anticipated growth of our business. Pending their use, we intend to invest the net proceeds of this offering in one or more capital-preservation investments, which may include short- and intermediate-term investments, interest-bearing investments, investment-grade securities, U.S. government securities, certificates of deposit and money market funds.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_702"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DIVIDEND POLICY</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2023, 2022 and 2021 we paid $ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , $60.3 million and $53.8 million, respectively, in cash dividends to holders of our common stock. We have no current plans to pay dividends or other distributions on our common stock in the foreseeable future following this offering. Any decision to declare and pay dividends in the future will be made at the sole discretion of our board of directors and will depend on, among other things, our results of operations, cash requirements, financial condition, contractual restrictions and other factors that our board of directors may deem relevant, and subject to the restrictions contained in any future financing instruments and applicable law.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_712"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAPITALIZATION</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our cash, cash equivalents and capitalization as of December 31, 2023 as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">on an actual basis&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">on an as adjusted basis, giving effect to&#58; (i) the filing and effectiveness of the Amended and Restated Charted and Amended and Restated Bylaws and (ii) the issuance and sale by us of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock in this offering based on an assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share (which is the midpoint of the price range set forth on the cover page of this prospectus), after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information below is illustrative only. Our capitalization following the closing of this offering will be adjusted based on the actual initial public offering price and other terms of this offering determined at the pricing of this offering. You should read this table together with the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our audited consolidated financial statements and the related notes included elsewhere in this prospectus.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2023</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Actual</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Adjusted</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt (including current portion of long-term debt)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; (deficit) equity&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt;text-indent:-12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $0.001 per share&#59;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares authorized, &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares issued and outstanding, actual&#59; and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares authorized,&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares issued or outstanding, as adjusted</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total capitalization</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each $1.00 increase or decrease in the assumed initial public offering price per share of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (which is the midpoint of the price range set forth on the cover page of this prospectus) would increase or decrease, as applicable, each of our as adjusted cash and cash equivalents, additional paid-in capital, total stockholders&#8217; equity, and total capitalization by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. Similarly, each 1,000,000 share increase or decrease in the number of shares of common stock offered by us in this offering would increase or decrease, as applicable, each of our as adjusted cash and cash equivalents, additional paid-in capital, total stockholders&#8217; equity, and total capitalization by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, assuming that the assumed initial public offering price per share remains the same, and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of our common stock to be outstanding after this offering is based on&#160;20,000 shares of our common stock outstanding as of&#160;December 31, 2023, and excludes&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares of our common stock reserved for future issuance under our 2024 Plan, which will become effective in connection with this offering, including approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stock issuable upon the settlement of restricted stock units that we intend to grant to certain of our directors, executive officers and other employees in connection with this offering as described under &#8220;Compensation Discussion and Analysis&#8212;Equity Compensation,&#8221; as well as any annual automatic &#8220;evergreen&#8221; increases in the number of shares of our common stock reserved for future issuance thereunder pursuant to the terms of the 2024 Plan&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock reserved for future issuance under our ESPP, which will become effective in connection with this offering, as well as any annual automatic &#8220;evergreen&#8221; increases in the number of shares of our common stock reserved for future issuance thereunder pursuant to the terms of the ESPP.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_722"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DILUTION</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you invest in our common stock in this offering, your ownership interest will be immediately diluted to the extent of the difference between the assumed initial public offering price per share and the as adjusted net tangible book value per share of our common stock immediately after this offering. Dilution in the as adjusted net tangible book value per share to new investors represents the difference between the amount per share paid by purchasers of shares of our common stock in this offering and the as adjusted net tangible book value per share of our common stock immediately after completion of this offering.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, we had a net tangible book value of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, or $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share of common stock. Our historical net tangible book value represents our total tangible assets excluding deferred offering costs, less our total liabilities, divided by the total number of shares of our common stock outstanding as of December 31, 2023.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After giving effect to receipt of the net proceeds from our sale of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares of common stock at an assumed initial public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share (which is the midpoint of the price range set forth on the cover page of this prospectus), after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us, our as adjusted net tangible book value as of December 31, 2023 would have been approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; million, or $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share. This represents an immediate increase in net tangible book value of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share to our existing stockholders and an immediate dilution of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share to new investors participating in this offering.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates this dilution on a per share basis to new investors&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed initial public offering price per share</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net tangible book value per share as of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in net tangible book value per share attributable to new investors participating in this offering</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As adjusted net tangible book value per share after this offering</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div style="text-align:right"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilution per share to new investors in this offering</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each $1.00 increase or decrease in the assumed initial offering price per share of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(which is the midpoint of the price range set forth on the cover page of this prospectus) would increase or decrease, as applicable, our as adjusted net tangible book value after this offering by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, or $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, and would increase or decrease, as applicable, the dilution per share to new investors purchasing our common stock in this offering by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, assuming that the number of shares offered by us in this offering, as set forth on the cover page of this prospectus, remains the same, and after deducting estimated underwriting discounts and commissions, and estimated offering expenses payable by us. Similarly, each 1,000,000 share increase in the number of shares of common stock offered by us would increase the as adjusted net tangible book value after this offering by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share and decrease the dilution per share to new investors participating in this offering by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, and each 1,000,000 share decrease in the number of shares of common stock offered by us in this offering would decrease the as adjusted net tangible book value by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, and increase the dilution per share to new investors in this offering by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, assuming that the assumed initial public offering price per share of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;remains the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents, on a as adjusted basis as described above, the differences between the number of shares purchased from us, the total consideration paid and the average price per share paid to us by existing stockholders and by investors purchasing shares in this offering based on an assumed initial public offering price per share of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(which is the midpoint of the price range set forth on the cover page on this prospectus), before </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us (assuming no purchases of any shares of common stock in this offering by existing stockholders).</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares Purchased</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Consideration</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average price per Share</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Existing stockholders</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New investors</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each $1.00 increase or decrease in the assumed initial offering price per share of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (which is the midpoint of the price range set forth on the cover page of this prospectus) would increase or decrease the total consideration paid by new investors, total consideration paid by all stockholders, and average price per share paid by all stockholders by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , and $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share, respectively, assuming that the number of shares offered by us in this offering, as set forth on the cover page of this prospectus, remains the same, before deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. Each 1,000,000 share increase or decrease in the number of shares sold in this offering, as set forth on the cover page of this prospectus, would increase or decrease, as applicable, the total consideration paid by new investors, total consideration paid by all stockholders, and average price per share paid by all stockholders by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , and $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share, respectively, assuming that the assumed initial public offering price per share of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(which is the midpoint of the price range set forth on the cover page of this prospectus) remains the same, before deducting underwriting discounts and commissions and estimated offering expenses payable by us.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table above assumes no exercise by the underwriters of their option to purchase additional shares of our common stock from us in this offering. If the underwriters exercise their option to purchase &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; additional shares of our common stock in full, the as adjusted net tangible book value (deficit) per share after this offering would be $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share and the dilution to new investors in this offering would be $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share, and the number of shares of common stock held by new investors will increase to approximately &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, or approximately &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of the total number of shares of our common stock outstanding after this offering.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing discussion and tables (other than the historical net tangible book value (deficit) calculation) are based on 20,000 shares of our common stock outstanding as of December 31, 2023, and excludes&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock reserved for future issuance under our 2024 Plan, which will become effective in connection with this offering, including approximately &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock issuable upon the settlement of restricted stock units that we intend to grant to certain of our directors, executive officers and other employees in connection with this offering as described under &#8220;Compensation Discussion and Analysis&#8212;Equity Compensation,&#8221; as well as any annual automatic &#8220;evergreen&#8221; increases in the number of shares of our common stock reserved for future issuance thereunder pursuant to the terms of the 2024 Plan&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock reserved for future issuance under our ESPP, which will become effective in connection with this offering, as well as any annual automatic &#8220;evergreen&#8221; increases in the number of shares of our common stock reserved for future issuance thereunder pursuant to the terms of the ESPP.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dilution information discussed above is illustrative only and may change based on the actual initial public offering price and other terms of this offering. To the extent any options are granted and exercised in the future, there may be additional economic dilution to new investors. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may choose to raise additional capital due to market conditions or strategic considerations, even if we believe we have sufficient funds for our current or future operating plans. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the issuance of these securities could result in further dilution to our stockholders.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_1950"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following discussion and analysis of our financial condition and results of operations together with our audited consolidated financial statements and the related notes included elsewhere in this prospectus. Some of the information contained in this discussion and analysis or set forth elsewhere in this prospectus, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. You should read the sections titled &#8220;Risk Factors&#8221; and &#8220;Special Note Regarding Forward-Looking Statements&#8221; for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis. Our historical results are not necessarily indicative of the results to be expected in the future. </font></div><div id="i2baa8a1031f44c51b1664e00d256c582_1973"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities. Founded in 2013, we are one of the largest skilled nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. We also provide senior care, assisted living, and independent living options in some of our communities. Our significant historical growth has been primarily driven by our expertise in acquiring underperforming long-term custodial care skilled nursing facilities and transforming them into higher acuity, high value-add short-term transitional care skilled nursing facilities. We believe our success is driven in significant part by our decentralized, local operating model, through which we empower local leaders at each facility to operate their facility autonomously and deliver excellence in clinical quality and a superior experience for our patients. We provide our independently operated facilities with a comprehensive suite of technology, support, and back-office services that allow local leadership teams to focus more of their time and effort on providing quality care to patients. We believe our operating model delivers value to all of our healthcare stakeholders, including patients and families, referring providers, payors, and administrators and clinicians.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were founded in 2013 with two skilled nursing facilities located in San Diego and a mission to improve the delivery, leadership and quality of post-acute care. By implementing our operating model across our SNFs, we quickly expanded using a disciplined and balanced acquisition strategy. A significant amount of our early expansion was in California, where we were able to leverage our experience from our initial facilities as we expanded our footprint across the state by acquiring select SNFs that fit our acquisition strategy. Over time, we expanded into additional states, such as Texas, Missouri, South Carolina, and Nevada, among others. In 2021, we acquired the operating assets of Plum Healthcare Group, then one of the largest operators of SNFs in California, which significantly increased our number of SNF facilities and operational beds. Since 2021, we have remained disciplined but opportunistic in our acquisition strategy, having acquired or opened 12 facilities in 2022 and 58 in 2023. The graphic below provides an overview of our corporate history and sets forth our acquisitions per year for the periods indicated, as well as our number of facilities and operational beds as of the end of the periods indicated. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of Facilities Operated</font></div><div style="margin-bottom:12pt;text-align:center"><img alt="mda1a.jpg" src="mda1a.jpg" style="height:346px;margin-bottom:5pt;vertical-align:text-bottom;width:600px"></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We aim to create value by identifying and acquiring underperforming custodial care facilities and converting them into higher-value short-term transitional care facilities by investing in clinical teams and processes and upgrading technology, equipment, training, staffing, aesthetics, and other aspects of the business. The resources and guidance offered by PACS Services is key to rapid integration of new facilities and provides our local leadership teams with an effective technology infrastructure, support tools, and regional support teams that allow local leadership to focus on operational improvements. Our facilities generally undergo an up to three-year post-acquisition transition period. During this period, we seek to implement best practices designed to realize and sustain the facility&#8217;s full potential. These practices often result in significant improvements to clinical quality and other operational metrics, including skilled mix, occupancy rates and payor contracting. We believe the results of our acquisition strategy are demonstrated by our high average QM Star rating and occupancy rate for Mature facilities of 4.2&#160;and &#160;&#160;&#160;&#160;&#160;&#160;, respectively, as of December 31, 2023. As of December 31, 2023, the average QM Star rating and occupancy rate for New facilities was 3.9&#160;and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, respectively.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our portfolio of owned and leased properties is strategically located in nine states&#58; Arizona, California, Colorado, Kentucky, Missouri, Nevada, Ohio, South Carolina and Texas. We anticipate that available acquisition opportunities will enable us to further penetrate our reach into these nine states and to enter new states in the future. We believe our current markets are attractive and that the states in which we operate each has unique benefits, such as favorable reimbursement dynamics, high barriers to entry, or population growth of adults aged 65 and older, which is our primary patient demographic. We generally look for similar attributes in new markets that we enter. As of December 31, 2023 we leased 165 facilities, directly owned the real estate at 29 facilities, and owned partial interests in an additional 14&#160;facilities through joint ventures. The joint venture operations were formed to develop, own, and lease health care facilities to our operational subsidiaries, and our investment in these joint ventures is accounted for under the equity method because we do not have a controlling financial interest in such ventures. Each joint venture is governed by a managing member that makes significant decisions that impact the performance of the joint venture. We are not the managing member for any of the joint ventures in which we invest and operational and strategic decision making power is held by entities that we do not control. However, certain of our joint venture agreements provide for specified consent rights to the members regarding, among others, the ability of the joint venture to enter into a material contract, engage in new business outside the specified business purpose of the joint venture, enter into leases, incur capital expenses above specified thresholds, and file for bankruptcy or similar acts. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the respective agreements, some of the joint ventures hold options to purchase the related real estate property holdings. As we continue to grow, we intend to explore additional purchases of real-estate assets, through purchase options or right-of-first refusals in existing leases, as well as acquisitions and de novo construction of purpose-built facilities.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_1992"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Industry Trends</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in the post-acute care industry, which is an essential component of the healthcare delivery ecosystem, serving high need, medically fragile patients. The post-acute care industry has evolved to meet the growing demand for post-acute and custodial healthcare services generated by an aging population, increasing life expectancies and the trend toward shifting patient care to lower cost settings. The industry continues to evolve, driven by several trends, including the following&#58;</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SNFs are an Integral and Essential Part of the Post-Acute Care Continuum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SNFs play an essential role in post-acute patient care. SNFs provide higher-acuity skilled nursing care to patients that cannot be adequately treated in community-based care settings, such as assisted living or independent living facilities, and who are no longer appropriate candidates for hospital care. Despite the wide array of services and variety of needs addressed, SNFs are the lowest cost facility-based post-acute healthcare. As reimbursement and coverage continues to shift toward value-based models with greater emphasis on controlling costs, SNFs are integral to post-acute care and will continue to drive high-quality outcomes in low-cost settings.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Large, Fragmented Industry Comprised of Mostly Small and Independent Operators</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> According to the National Center for Health Statistics (NCHS) 2020 National Post-acute and Long-term Care Study</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the SNF industry in the United States encompasses approximately 15,000 facilities and serves approximately 1.3 million patients annually.The industry is highly fragmented, with the top 10 operators, each having greater than 100 facilities, representing approximately 11% of total number of SNFs in the United States, according to CMS data as of September 2022, approximately 5,000 smaller and independent operators of less than 100 facilities making up the remainder. According to this data, of the approximately 15,000 facilities, approximately 13,200 facilities have less than 100 beds, and approximately 74% and 26% of SNFs are located in urban and rural areas, respectively. In addition, approximately 72%, 23%, and 6% of SNFs are operated as for-profit, non-profit, and by the government, respectively, according to such data. We believe this fragmented landscape creates opportunities for larger providers with greater scale to serve patients better and meet regulatory requirements nation-wide by effectively addressing staffing, quality standards, and billing processes. In addition, due to the increasing demands from hospitals and insurance carriers to implement sophisticated and expensive reporting systems, we believe this fragmentation provides us with significant acquisition and consolidation opportunities.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Growing Demand Outpacing Supply of Skilled Nursing Facilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The demand for healthcare services in the United States has increased in recent years and is expected to continue growing, largely due to a rapidly aging population and an increasing prevalence of chronic conditions. While demand has increased for SNFs, the number of SNFs has declined in recent years from approximately 15,650 in 2017 to approximately 14,900 in 2023. We believe this is due to a variety of factors, including an inability of many facilities to comply with the industry&#8217;s stringent regulatory compliance obligations and with quality standards, rigorous staffing, and billing requirements, as well as a lack of technology and sophistication at small and independent operators. Furthermore, new operators to this highly regulated industry face multiple barriers to entry, including the requirements to obtain a Certificate of Need, complex licensure and regulatory compliance requirements, lack of operating experience, and significant capital requirements. As a result, the addition of new SNFs has not kept pace with the number of SNFs exiting the market, amplifying the need for skilled nursing to serve an aging population.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Favorable Reimbursement Environment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> According to CMS, approximately 72% of SNF revenue in 2022 was derived from government sources, including Medicaid and Medicare. Medicaid represents 51% of industry revenue, while Medicare represents approximately 21%. The remainder comprises managed care, private pay, and other payors. Medicare and Medicaid reimbursement has steadily increased over the past few years. Medicare reimbursement per patient day increased at a CAGR of approximately 3.6% from 2012 to 2021, while Medicaid </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reimbursement per patient day increased at a CAGR of approximately 1.9% from 2012 to 2021. The industry has experienced over 9 years of growth in reimbursement rates. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Environment.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SNF industry is highly regulated with stringent regulatory compliance obligations. In the ordinary course of business, providers are subject to federal, state and local laws and regulations relating to, among other things, billing and reimbursement, relationships with vendors, business relationships with physicians and other healthcare providers and facilities, as well as licensure, accreditation, enrollment, quality, adequacy of care, physical plant, life safety, personnel, staffing and operating requirements. Changes in law or new interpretations of existing laws and regulations may have a significant impact on revenue, costs and business operations of providers and other industry participants. In addition, governmental and other authorities periodically inspect the SNFs, senior living facilities and outpatient rehabilitation agencies to verify continued compliance with applicable regulations and standards and may impose citations and other regulatory penalties for regulatory deficiencies. Such regulatory penalties include but are not limited to civil monetary penalties, temporary payment bans, suspension or revocation of a state operating license and loss of certification as a provider in the Medicare or Medicaid program, which may be temporary or permanent in nature. This regulatory environment and related enforcement can have an adverse effect on providers and other industry participants. See the section titled &#8220;Business&#8212;Regulatory Matters.&#8221;</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_2010"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Skilled Services Metrics and Non-GAAP Financial Measures</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the following key skilled services metrics and non-GAAP financial measures to help us evaluate our business, identify trends that affect our financial performance, and make strategic decisions. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Key Skilled Services Metrics</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor the below key skilled services metrics across all of our facilities and by Mature facilities, Ramping facilities, and New facilities. Mature facilities are defined as facilities purchased more than 36 months prior to a respective measurement date. Ramping facilities are defined as facilities purchased within 18 to 36 months prior to a respective measurement date. New facilities are defined as facilities purchased less than 18 months prior to a respective measurement date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Skilled nursing services revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Skilled nursing services revenue reflects the portion of patient and resident service revenue generated from all patients in skilled nursing facilities, excluding revenue generated from our assisted and independent living services.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Skilled mix </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; We measure both revenue and nursing patient days by payor. Medicare and managed care patients, whom we refer to as high acuity patients, typically require a higher level of skilled nursing care. As a result, Medicare and managed care reimbursement rates are typically higher than those from other payors. In most states, Medicaid reimbursement rates are generally the lowest of all payor types. Changes in the payor mix can significantly affect our revenue and profitability. To monitor this performance, we evaluate two different measures of skilled mix&#58;  </font></div><div style="margin-bottom:12pt;padding-left:76.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt;text-decoration:underline">Skilled mix by revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Skilled mix by revenue represents the portion of routine revenue generated from treating high acuity Medicare and managed care patients. Routine revenue refers to skilled nursing services revenue generated by contracted daily rates charged for skilled nursing services. Services provided outside of routine contractual agreements are recorded separately as ancillary revenue, including Medicare Part B therapy services, and are not routine revenue. The inclusion of therapy and other ancillary treatments in the contracted daily rate varies by payor source and by contract. Revenue associated with calculating skilled mix is based on contractually agreed-upon amounts or rates, excluding the estimates of variable consideration under the revenue recognition standard, Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:9pt;padding-left:76.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.96pt;text-decoration:underline">Skilled mix by nursing patient days</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Skilled mix by nursing patient days represents the number of days our high acuity Medicare and managed care patients receive skilled nursing services at skilled nursing facilities as a percentage of the total number of days that patients from all payor sources receive skilled nursing services at skilled nursing facilities for any given period. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Occupancy </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; The total number of patients occupying a bed in a skilled nursing facility as a percentage of the beds in such facility that are available for occupancy during the period. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Number of facilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The total number of skilled nursing facilities that we operate. Excludes five and one assisted living facilities for the year ended December 31, 2023 and 2022, respectively. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Number of operational beds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The total number of operational beds associated with the skilled nursing facilities that we own.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the above key skilled services metrics by category for all facilities, Mature facilities, Ramping facilities and New facilities as of and for the years ended December&#160;31, 2023, 2022 and 2021&#58;</font></div><div style="margin-bottom:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:35.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.072%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Growth Rate for the year ended December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in thousands)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total facility results&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Skilled nursing services revenue</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,391,309&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,133,103&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">111.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Skilled mix by revenue</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">64.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">57.8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">6.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Skilled mix by nursing patient days</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">40.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">34.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">6.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Occupancy for skilled nursing services&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Available patient days</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,719,689</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,106,602</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">84.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Actual patient days</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,139,736</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,681,927</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">91.6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Occupancy rate (operational beds)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">89.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">86.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Number of facilities at period end</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">150</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">138</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">8.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Number of operational beds at period end</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">16,345</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">14,841</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">10.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:35.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.072%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Growth Rate for the year ended December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in thousands)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Mature facility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:700;line-height:100%;position:relative;top:-2.97pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"> results&#58;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Skilled nursing services revenue</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">951,936&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">653,871&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">45.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Skilled mix by revenue</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">66.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">59.6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">6.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Skilled mix by nursing patient days</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">43.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">36.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">6.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Occupancy for skilled nursing services&#58; </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Available patient days</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,175,718</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,637,371</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">32.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Actual patient days</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,995,321</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,441,566</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">38.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Occupancy rate (operational beds)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">91.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">88.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Number of facilities at period end</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">62</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">49</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">26.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Number of operational beds at period end</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">6,525</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,137</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">27.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Mature facilities represent facilities purchased more than 36 months before the date presented.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:35.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.072%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Growth Rate for the year ended December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in thousands)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Ramping facility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:700;line-height:100%;position:relative;top:-2.97pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%"> results&#58;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Skilled nursing services revenue </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">141,542&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">240,631&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(41.2)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Skilled mix by revenue </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">64.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">55.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">8.9&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Skilled mix by nursing patient days </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">38.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">31.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">6.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Occupancy for skilled nursing services&#58; </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Available patient days </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">365,702</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">765,547</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(52.2)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Actual patient days </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">330,306</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">652,272</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(49.4)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Occupancy rate (operational beds) </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">90.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">85.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">6.0&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Number of facilities at period end</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">17</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(76.5)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Number of operational beds at period end</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">453</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,822</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(75.1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Ramping facilities represent facilities purchased within 18-36 months of the date presented. </font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:35.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.072%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Growth Rate for the year ended December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Dollars in thousands)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">New facility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.52pt;font-weight:700;line-height:100%;position:relative;top:-2.97pt;vertical-align:baseline">(1) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">results&#58;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Skilled nursing services revenue </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,297,831</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">238,601</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">443.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Skilled mix by revenue </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">62.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">55.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">7.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Skilled mix by nursing patient days </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">39.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">33.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Occupancy for skilled nursing services&#58; </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Available patient days </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,178,269</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">703,684</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">351.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Actual patient days </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,814,109</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">588,089</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">378.5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Occupancy rate (operational beds) </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">88.5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">83.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Number of facilities at period end </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">84</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">72</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">16.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Number of operational beds at period end </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">9,367</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">7,882</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">18.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">New facilities represent facilities purchased less than 18 months from the date presented. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present additional detail regarding our skilled mix, including our percentage of nursing patient days and revenue by payor source for all facilities, Mature facilities, Ramping facilities and New facilities for the years ended December&#160;31, 2023, 2022 and 2021&#58;</font></div><div style="margin-bottom:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:12.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="69" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Year ended December 31,</font></td></tr><tr style="height:9pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Skilled mix by revenue</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Mature</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Ramping</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">New</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medicare</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51.5&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">45.7&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49.8&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43.6&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44.9&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36.7&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47.8&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43.3&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Managed care</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14.6</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.9</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14.5</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.8</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17.6</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.7</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16.3</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14.5</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Skilled mix</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">66.1</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">59.6</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">64.3</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">55.4</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">62.5</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">55.4</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">64.1</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">57.8</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medicaid</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29.0</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35.5</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30.8</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38.3</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31.8</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37.2</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30.6</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36.4</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Private and other</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.9</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.9</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.9</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.3</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.7</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.4</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.3</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.8</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Total</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:12.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="69" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Year ended December 31,</font></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Skilled mix by nursing patient days</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Mature</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Ramping</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">New</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</font></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medicare</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30.3&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25.5&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27.8&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23.0&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25.5&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19.5&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27.5&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23.6&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Managed care</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.8</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.7</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.6</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.6</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.9</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14.0</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.2</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.9</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Skilled mix</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">  </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">43.1</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">36.2</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">38.4</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">31.6</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">39.4</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">33.5</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">40.7</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">34.5</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medicaid</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49.4</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56.7</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53.6</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59.4</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52.1</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57.8</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51.2</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57.6</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Private and other</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.5</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.1</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.0</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.0</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.5</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.7</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.1</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.9</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Total</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Average daily rates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The routine revenue by payor source for a period at the skilled nursing facilities divided by actual patient days for that revenue source for that given period. These rates exclude additional state relief funding, which includes payments we recognized as part of The Families First Coronavirus Response Act (FFCRA). Revenue associated with calculating average daily rates is based on contractually agreed-upon amounts or rates, excluding the estimates of variable consideration under the revenue recognition standard, Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606. </font></div><div style="margin-bottom:12pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents average daily rates by payor source, excluding services that are not covered by the daily rate, for the years ended December&#160;31, 2023, 2022 and 2021&#58;</font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:13.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="69" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Year ended December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Mature</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Ramping</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">New</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medicare</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">802.83&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">795.90&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">773.15&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">695.43&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">817.51&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">765.33&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">808.35&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">766.53&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Managed care</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">544.92&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">575.73&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">590.76&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">501.86&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">588.94&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">540.78&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">572.60&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">551.72&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Total for skilled patient payors </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"> (1) </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">726.56&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">730.92&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">722.75&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">642.79&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">736.89&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">671.08&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">731.80&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">698.54&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medicaid</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">278.25&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">277.94&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">248.66&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">236.02&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">283.38&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">261.73&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">279.12&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">263.85&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Private and other</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">301.46&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">311.66&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">261.47&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">258.02&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">313.43&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">343.94&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">305.76&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">304.62&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Total </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">473.09&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">444.38&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">431.75&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">366.52&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">464.75&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">406.17&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">465.87&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">417.06&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents weighted average of revenue generated by Medicare and managed care payor sources. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents weighted average.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_2028"></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-GAAP Financial Measures</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our results provided throughout that are determined in accordance with GAAP, we also present the following non-GAAP financial measures&#58; EBITDA, Adjusted EBITDA and Adjusted EBITDAR (collectively, Non-GAAP Financial Measures). EBITDA and Adjusted EBITDA are performance measures. Adjusted EBITDAR is a valuation measure. These Non-GAAP Financial Measures have no standardized meaning defined by GAAP, and therefore have limitations as analytical tools, and they should not be considered in isolation, or as a substitute for analysis of our results as reported in accordance with GAAP. You should review the reconciliation of net income to the Non-GAAP Financial Measures in the table below, together with our audited consolidated financial statements and the related notes in their entirety, and should not rely on any single financial measure. Additionally, other companies may define these or similar Non-GAAP Financial Measures with the same or similar names differently, and because these Non-GAAP Financial Measures are not standardized, it may not be possible to compare these financial measures to those of other companies. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Measures</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use EBITDA and Adjusted EBITDA to facilitate internal comparisons of our historical operating performance on a more consistent basis, as well as for business planning and forecasting purposes. In addition, we believe the presentation of EBITDA and Adjusted EBITDA is useful to investors, analysts and other interested </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">parties in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our ongoing operating performance. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">EBITDA &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate EBITDA as net income, adjusted for net losses attributable to noncontrolling interest, before&#58; other expense, net&#59; provision for income taxes&#59; and depreciation and amortization.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted EBITDA &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate Adjusted EBITDA as EBITDA further adjusted for non-core business items, which for the reported periods includes, to the extent applicable, costs incurred to acquire operations that are not capitalizable, costs related to the integration of acquired companies, lease termination fees, losses incurred from debt restructuring, litigation, and certain one-time expenses that are not representative of our underlying operating performance. Costs related to acquisitions include costs related to our acquisition of SNF facilities and providers, including related costs such as legal fees, financial and tax due diligence, consulting and escrow fees. Costs associated with acquisition integration include legal settlements paid following acquisitions made in prior periods. Costs associated with litigation include specific matters assumed through acquisition, which were nonrecurring and outside the normal course of business. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Valuation Measure</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use Adjusted EBITDAR as a measure to determine the value of prospective acquisitions and to assess the enterprise value of our business without regard to differences in capital structures and leasing arrangements. In addition, we believe that Adjusted EBITDAR is also a commonly used measure by investors, analysts and other interested parties to compare the enterprise value of different companies in the healthcare industry without regard to differences in capital structures and leasing arrangements, particularly for companies with operating and finance leases. For example, finance lease expenditures are recorded in depreciation and interest and are therefore removed from Adjusted EBITDA, whereas operating lease expenditures are recorded in rent expense and are therefore retained in Adjusted EBITDA. Adjusted EBITDAR is a financial valuation measure that is not specified in GAAP, and is not displayed as a performance measure as it excludes rent expense, which is a normal and recurring cash operating expense, and is therefore presented only for the current period. While we believe that Adjusted EBITDAR provides useful insight regarding our underlying operations, excluding the impact of our operating leases, we must still incur cash operating expenses related to our operating leases and rent and such expenses are necessary to operate our leased operations. As a result, Adjusted EBITDAR may understate the extent of our cash operating expenses for the respective period relative to our actual cash needs to operate our leased operations and business. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted EBITDAR &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate Adjusted EBITDAR as Adjusted EBITDA less rent-cost of services.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents a reconciliation of EBITDA, Adjusted EBITDA and Adjusted EBITDAR to net income, the most directly comparable financial measure calculated in accordance with GAAP, on a consolidated basis for the periods presented&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,496&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,947&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,538&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,278&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,549&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,479&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,311&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,153&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EBITDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,894&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,857&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition related costs</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,216&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition - integration related costs</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease termination fees</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss resulting from debt restructuring</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation (1)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,516&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,073&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent - cost of services</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,003&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,122&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDAR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Litigation relates to specific legal settlements arising outside of the ordinary course of business.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_2046"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of Results of Operations</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Patient and Resident Service Revenue</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient and resident service revenue typically represents over 97% our total revenue. Patient and resident service revenue comprises skilled nursing services revenue, revenue generated from our senior assisted living services and revenue generated from certain ancillary services provided outside of routine contractual agreements. For the year ended December&#160;31, 2023, skilled nursing services revenue represented over&#160;        of patient and resident service revenue. For each of the years ended December&#160;31, 2022 and 2021, skilled nursing services revenue represented over 99% of patient and resident service revenue, respectively. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive patient and resident service revenue from services rendered, under short-term contracts, to patients for skilled and intermediate nursing, rehabilitation therapy, assisted living and hospice services. This revenue is reported at the amount that reflects the consideration to which we expect to be entitled in exchange for providing patient services. These amounts are due from patients, governmental programs, and other third-party payors, and include variable consideration for retroactive revenue adjustments due to settlement of audits, reviews, and investigations. Within our skilled nursing operations, we generate revenue from Medicaid, Medicare and other payors such as commercial insurance companies, health maintenance organizations, and preferred provider organizations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect patient and resident service revenue to continue to represent the vast majority of our total revenue and that such revenue will continue to increase to the extent we successfully execute on our acquisition strategy.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Additional Funding</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received funding from the U.S. Department of Health and Human Services (HHS) through the Provider Relief Fund (PRF) as we are the healthcare providers who diagnose, test, or care for individuals with cases of COVID-19 and have health care related expenses and lost revenues attributable to COVID-19. In 2023, this program ended and we do not expect to recognize any revenue based on funding through the PRF in the future.</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Revenue </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenue relates to ancillary revenue generating activities and primarily consists of revenue associated with arrangements in which we are a lessor of certain facilities. Other revenue typically represents an immaterial portion of our total revenue and we expect this to continue for the foreseeable future.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Services (exclusive of rent and depreciation and amortization shown separately)</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cost of services represents the costs of operating our operating subsidiaries, which primarily consist of payroll and related benefits, supplies, purchased services, and ancillary expenses such as the cost of pharmacy and therapy services provided to patients. Cost of services also includes the cost of general and professional liability insurance, rent expenses related to leasing our operational facilities (such as taxes, insurance, impounds, capital reserves or other charges payable under the applicable lease agreements), dietary services, contracted services and other general cost of services with respect to our operations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continue to execute on our acquisitions strategy and grow our business, we expect that our cost of services will continue to increase. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rent - Cost of Services</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent - cost of services consists solely of base minimum rent amounts payable under lease agreements to third-party real estate owners. Our operating subsidiaries lease and operate but do not own the underlying real estate and these amounts do not include taxes, insurance, impounds, capital reserves or other charges payable under the applicable lease agreements. As we continue to execute on our acquisitions strategy and expand our network of facilities, we expect that our rent - cost of services will continue to increase. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expense </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense consists primarily of payroll and related benefits and travel expenses for our PACS Services personnel, including training and other operational support. General and administrative expense also includes professional fees (including accounting and legal fees) and costs relating to our information systems. Historically, our general and administrative expense has not included any stock-based compensation. In connection with this offering, we are adopting the 2024 Plan and ESPP and we anticipate that going forward our general and administrative expense will include stock-based compensation. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect general and administrative expense to increase on an absolute dollar basis for the foreseeable future as we continue to increase investments to support our growth. Following this offering, we also expect that our costs will increase related to legal, audit, accounting, regulatory and tax-related services associated with maintaining compliance with exchange listing and SEC requirements, director and officer insurance costs, investor and public relations costs, and other expenses that we did not incur as a private company. We anticipate that general and administrative expense as a percentage of revenue will vary from period to period, but we expect to leverage these expenses over time as we grow our revenue.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and Amortization </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are recorded at their original historical cost. Depreciation is computed using the straight-line method over the estimated useful lives of the depreciable assets. The following is a summary of the depreciable lives of our depreciable assets&#58;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Buildings and improvements - minimum of 5 years to a maximum of 40 years, but generally 30 years</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Leasehold improvements - shorter of the lease term or the estimated useful life, generally 5 to 15 years</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Furniture and equipment - 3 to 15 years</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other (Expense) Income, net</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net consists primarily of interest expense related to our debt, as well as income from gains and losses from investments in partnerships, including joint ventures.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for Income Taxes </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes consists primarily of income taxes in certain jurisdictions in which we conduct business. </font></div><div id="i2baa8a1031f44c51b1664e00d256c582_2064"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Year Ended December&#160;31, 2023 Compared to the Year Ended December&#160;31, 2022</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient and resident service revenue</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,399,155&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional funding</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,482&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,421,994&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861,314&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent - cost of services</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,003&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,006&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,311&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,192,634&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,360&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,538)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,223&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total other expense, net</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,315)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,045&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56,549)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,496&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Patient and resident service revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Patient and resident service revenue increased by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million to $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, or&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;%, for the year ended December&#160;31, 2023, compared to the year ended December&#160;31, 2022. The increase was primarily attributable to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. For the year ended December&#160;31, 2022, skilled nursing services revenue represented more than&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of patient and resident service revenue.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Additional funding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Revenue generated by additional funding increased by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million to $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, or&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;%, for the year ended December&#160;31, 2023, compared to the year ended December&#160;31, 2022. The decrease was primarily attributable to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Other revenue increased by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million to $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, or&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;%, for the year ended December&#160;31, 2023, compared to the year ended December&#160;31, 2022. The increase was primarily attributable to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of services</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of services increased by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million to $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, or&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;%, for the year ended December&#160;31, 2023, compared to the year ended December&#160;31, 2022. The increase was primarily attributable to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rent - cost of services</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent - cost of services increased by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million to $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, or&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;%, for the year ended December&#160;31, 2023, compared to the year ended December&#160;31, 2022. The increase was primarily attributable to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and administrative expense</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense increased by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million to $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, or&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;%, for the year ended December&#160;31, 2023, compared to the year ended December&#160;31, 2022. The increase was primarily attributable to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and amortization</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization increased $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million to $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, or&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;%, for the year ended December&#160;31, 2023, compared to the year ended December&#160;31, 2022. The increase was primarily attributable to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other expense, net </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net increased by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million to $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million, or&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;%, for the year ended December&#160;31, 2023, compared to the year ended December&#160;31, 2022. The increase was primarily attributable to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for income taxes</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes totaled $ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million for the year ended December&#160;31, 2023, representing an effective tax rate of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;%, compared to a provision for income tax of $56.5 million and an effective tax rate of 27.3% for the year ended December&#160;31, 2022. The change of provision for income taxes in 2023 compared to 2022 was primarily due to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  .</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Year Ended December&#160;31, 2022 Compared to the Year Ended December&#160;31, 2021</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient and resident service revenue</font></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,399,155&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,135,909&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,263,246&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional funding</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,482&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,563&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,081)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.8)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,091&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(734)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,421,994&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166,563&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255,431&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.6&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861,314&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901,095&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960,219&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent - cost of services</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,003&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,122&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,881&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,006&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,834&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,172&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.9&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,311&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,153&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,158&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,192,634&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083,204&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,109,430&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.4&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</font></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,360&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,359&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,001&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.1&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,538)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,278)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,260)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,223&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,345&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:33pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total other expense, net</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,315)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,933)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,382)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1054.4&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</font></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,045&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,426&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,619&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.3&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56,549)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,479)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,070)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,496&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,947&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,549&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.9&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Patient and resident service revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Patient and resident service revenue increased by $1,263.2 million, or 111.2%, to $2,399.2 million for the year ended December&#160;31, 2022, compared to the year ended December&#160;31, 2021. For each of the years ended December&#160;31, 2022 and 2021, skilled nursing services revenue represented over 99% of patient and resident service revenue, respectively.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skilled nursing services revenue increased by $1,258.2 million, or 111.0%, to $2,391.3 million for the year ended December&#160;31, 2022, compared to the year ended December&#160;31, 2021, which increase was primarily driven by an increase in revenue from New facilities of $1,059.2 million resulting from the acquisitions. Skilled nursing services revenue also increased due to increases in skilled mix by revenue and skilled mix by nursing patient days across Mature, Ramping and New facilities due to the application of Emergency Waivers under the COVID-19 PHE to skilled nursing patients and resumption of elective procedures resulting in increased demand for skilled nursing services. In addition, skilled nursing services revenue was positively impacted by a higher occupancy rate across all facilities of 89.9% for the year ended December&#160;31, 2022, compared to 86.3% for the year ended December&#160;31, 2021, due to increased demand as a result of continued execution on our business model. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our skilled nursing services revenue was impacted by developments in our average daily rates and fluctuations in our payor sources. Our Medicare daily rates at Mature and Ramping facilities increased by 0.9% and 11.2%, respectively, compared to the year ended December&#160;31, 2021. This increase was primarily due to the 1.2% net market basket increase that became effective in October 2022, offset by the removal of the temporary sequestration suspension. In 2022, Medicare daily rates includes three months of sequestration suspension of 0%, three months of sequestration suspension of 1% and six months of sequestration suspension of 2% in comparison to what was in place for the entire year of 2021.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our average Medicaid rates increased 5.8% due to state reimbursement increases and our participation in supplemental Medicaid payment programs and quality improvement programs in various states. Medicaid rates exclude the amount of state relief revenue we recorded.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Additional funding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Additional funding revenue decreased by $7.1 million, or 24.8%, to $21.5 million for the year ended December&#160;31, 2022, compared to the year ended December&#160;31, 2021. The decrease was primarily attributable to a reduced amount of funding from the HHS.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Other revenue decreased by $0.7 million, or 35.1%, to $1.4 million for the year ended December&#160;31, 2022, compared to the year ended December&#160;31, 2021. The decrease was primarily attributable to a reduction of fees from an external management contract in 2021 related to a facility that we acquired in 2022. Following this acquisition, the facility generated patient and resident services revenue. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of services</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of services increased by $960.2 million, or 106.6%, to $1,861.3 million for the year ended December&#160;31, 2022, compared to the year ended December&#160;31, 2021. The increase was primarily driven by an increase of $612.7 million in salaries and wages. Of the salaries and wages increase, those attributable to New facilities accounted for 88% of the increase and those attributable to Ramping and Mature facilities accounted for the remaining 12%. Aside from labor costs, the increase in cost of services was due to increases of $120.5 million in contracted services, $91.4 million in administrative expenses for facilities, $40.7 million in nursing expenses, and $37.1 million in dietary expenses with the remainder spread out across various expense types. Of these non-labor costs, increases in New facilities accounted for 93% of the change with Ramping and Mature facilities accounting for the remaining 7%.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rent - cost of services </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent - cost of services increased $81.9 million, or 104.8%, to $160.0 million for the year ended December&#160;31, 2022, compared to the year ended December&#160;31, 2021. The increase was primarily attributable to the addition of New facilities, which accounted for approximately 98% of the increase, with the remainder attributable to annual escalators on Mature and Ramping facilities' rent.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and administrative expense </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense increased $52.2 million, or 53.9%, to $149.0 million for the year ended December&#160;31, 2022, compared to the year ended December&#160;31, 2021. This increase was primarily due to a $48.0 million increase in salaries and wages of which 92% was attributable to New facilities with 8% attributable to Ramping and Mature facilities. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and amortization</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization increased by $15.2 million, or 211.9%, to $22.3 million for the year ended December&#160;31, 2022, compared to the year ended December&#160;31, 2021. This increase was primarily attributable to a $10.5 million increase in expense from New facilities. Additionally, there was an increase in expense of $4.7 million from Mature and Ramping facilities.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other expense, net</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net increased by $20.4 million to $22.3 million for the year ended December&#160;31, 2022, compared to the year ended December&#160;31, 2021. Other expense, net primarily consists of interest expense related to our debt, which increased by $20.3 million, to $25.5 million for the year ended December&#160;31, 2022, compared to the year ended December&#160;31, 2021, due to an increase in lines of credit and long-term debt of $49.6 million during the year. Other expense, net also includes other income and expenses from gains and losses from investments in partnerships, including joint ventures, which decreased by $0.1 million, or 4%, to $3.2 million, for the year ended December&#160;31, 2022, compared to the year ended December&#160;31, 2021.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for income taxes</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes totaled $56.5 million for the year ended December&#160;31, 2022, representing an effective tax rate of 27.3%, compared to a provision for income tax of $33.5&#160;million and an effective tax rate of 41.0% for the year ended December&#160;31, 2021. The difference of the effective tax rate from the statutory rate is mainly due to the state tax, permanent difference, and other adjustments. The increase of provision for income taxes in 2022 compared to 2021 was primarily due to much higher pre-tax book income in 2022. The effective tax rate for the year ended December 31, 2022 was lower than that for the year ended December 31, 2021, which was primarily attributable to our transition from an S-Corporation to a C-Corporation during 2021 and the associated increase to the 2021 effective tax rate of 10.2% due to the recognition of prior period deferred tax liabilities. See Note 10 &#8220;Income Taxes&#8221; to our audited consolidated financial statements for more information.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_2082"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holding Company Status&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a holding company with no significant direct operating assets, employees or revenues. Our operating subsidiaries are operated by separate, independent entities, each of which has its own management, employees and assets. In addition, through a separate wholly-owned subsidiary we provide centralized accounting, payroll, human resources, information technology, legal, risk management and other consulting and centralized services to the other operating subsidiaries through contractual relationships with those subsidiaries. We also have a wholly-owned captive insurance subsidiary that provides some claims-made coverage to our operating subsidiaries for professional liability and general liability insurance.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_2099"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity &#38; Capital Resources</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary sources of liquidity have historically been derived from our cash flows from operations, mortgage loans (including both Housing and Urban Development (HUD)-insured and non-HUD mortgage loans), and credit facilities maintained with commercial banks. Our liquidity as of December&#160;31, 2023 is impacted by cash generated from strong operational performance that improved through a combination of long-term leases and real estate purchases and increased acquisitions. As of December&#160;31, 2022, we had cash and cash equivalents of $ $58.3 million, total assets of $2,461.9 million, total liabilities of $2,393.2 million and total equity of $68.7 million.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have primarily financed the majority of our acquisitions through mortgages on our properties, our credit facilities and cash generated from operations. Cash paid to fund acquisitions was $     million, $55.4 million and $79.7 million for the years ended December&#160;31, 2023, 2022, and 2021, respectively. Total capital expenditures for property and equipment were $       million, $22.9 million and $124.1 million for the years ended December&#160;31, 2023, 2022, and 2021, respectively. We currently have approximately $     million budgeted for renovation projects for 2024. We believe our current cash balances, our cash flow from operations and the amounts available for borrowing under our credit facilities will be sufficient to cover our operating needs for at least the next 12 months.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may, in the future, seek to raise additional capital to fund growth, capital renovations, operations and other business activities, but such additional capital may not be available on acceptable terms, on a timely basis, or at all.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents as of December&#160;31, 2023 consisted of cash and short-term investments with original maturities of three months or less at the time of purchase.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents selected data from our consolidated statement of cash flows for the periods presented&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by&#47;(used in)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,615&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,602&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,321)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218,600)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,350&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,048&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,644&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,050&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at beginning of period</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,562&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,512&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at end of period</font></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,206&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,562&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by operating activities is net income adjusted for certain non-cash items and changes in operating assets and liabilities</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities for the year ended December&#160;31, 2023 of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million increased by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million as compared with the same period in 2022.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities for the year ended December&#160;31, 2022 of $92.6 million increased by $35.0 million as compared with the same period in 2021. The increase to net cash provided by operating activities was primarily driven by the $124.9 million increase to net income (inclusive of adjustments for non-cash expenses) offset by changes in working capital. Changes in working capital were driven by growth of the business during the year and timing of collections of accounts receivable, including an increase in days sales outstanding, and of accrued wages and related liabilities. Days sales outstanding was 52.0 and 48.4 for the years ended December&#160;31, 2022 and 2021, respectively, growing primarily due to the increase of New facilities which typically have a longer collection period due to the distressed state of many of the facilities we acquire.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing cash flows consist primarily of capital expenditures, investment activities, proceeds from sale of property and equipment and cash used for acquisitions.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities for the year ended December&#160;31, 2023 of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million increased by $   million as compared with the same period in 2022.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities for the year ended December&#160;31, 2022 of $75.3 million decreased by $143.3 million as compared with the same period in 2021. This decrease was primarily attributable to a decrease in acquisitions in 2022 as compared to 2021, in which a large portfolio of facilities was acquired consisting of a cash outflow of $104.2 million. Additionally, in 2022 we did not make any additional investments in partnerships as compared to 2021 which had related cash outflows of $15.7 million.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing cash flows consist primarily of payment of lines of credit, distributions and repayment of short-term and long-term debt, borrowings on lines of credit and contributions from non-controlling interest.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities for the year ended December&#160;31, 2023 of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million increased by $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million as compared with the same period in 2022. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities for the year ended December&#160;31, 2022 of $12.3 million decreased by $169.7 million as compared with the same period in 2021. The decrease was primarily driven by a decrease of $306.4 million in borrowing on our lines-of-credit offset by a decrease of $233.0 million in payments on the lines-of-credit. Also contributing to the decrease in net cash provided by financing activities, we had a decrease of $73.6 million in borrowings of long-term debt and an increase of $19.5 million in payments on long-term debt. The high level of borrowings in 2021 was primarily related to the high acquisition activity in that year. Dividends also increased $6.5 million in 2022.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material cash requirements from known contractual and other obligations</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-term debt obligations outstanding as of the end of each fiscal year were as follows&#58; </font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lines of credit</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,820&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loan and promissory notes</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,232&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</font></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503,052&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant contractual obligations as of December&#160;31, 2023 were as follows, including the future periods in which payments are expected&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2026</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2027</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2028</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payments on long-term debt</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facilities </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We historically maintained several lines-of-credit with commercial banks. As of December&#160;31, 2022, the total commitment limit under such lines-of-credit amounted to $176.0 million and was secured by certain of our assets. The interest rates of such agreements range from the London Interbank Offered Rate (LIBOR) to LIBOR plus 3.5% or the Secured Overnight Financing Rate (SOFR) plus 3.15%. Each of these agreements was scheduled to mature on or prior to November 5, 2024. The balance outstanding on all such lines-of-credit was $146.8 million as of December&#160;31, 2022, resulting in available cash of $29.2&#160;million. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lines of credit referenced above contained certain financial and non-financial covenants and restrictions. Default by the applicable credit parties on any covenant or restriction thereunder could affect the applicable lender&#8217;s commitment to lend, and, if not waived or corrected, could have made the outstanding balances thereunder due on demand. We were in compliance with all such covenants and restrictions, or received applicable waivers, as of December 31, 2022. Deferred financing fees on these lines of credit were immaterial for 2022. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, and December&#160;31, 2021, we have letters of credit outstanding of $22.4 million and $22.4 million for each year, respectively.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;28, 2023, we entered into a working capital loan agreement (Working Capital Loan) in connection with the acquisition of various new facilities. The Working Capital Loan allowed us to borrow up to $17.5 million at an annual interest rate of 9%. On May&#160;8, 2023, we drew on the Working Capital Loan in the amount of $15.0 million. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2023, PACS Group, Inc., as holdings, PACS Holdings, LLC, as borrower, and certain of their subsidiaries entered into a credit agreement with Truist Bank (Truist) and a syndicate of lenders (2023 Credit Agreement) that extended credit in the form of a revolving credit facility thereunder (2023 Revolving Credit Facility), including letter of credit and swing line sub facilities, and a term loan facility (Truist Term Loan), together referred to as the 2023 Credit Facility. The 2023 Credit Agreement provided for&#58; (i) the 2023 Revolving Credit Facility with revolving commitments in an aggregate principal amount of $150.0 million, including a letter of credit sub facility in an amount representing that portion of the aggregate revolving commitments that may be used by the borrower for the issuance of letters of credit in an aggregate face amount not to exceed $30.0 million and a swingline loan sub facility in an aggregate principal amount at any time outstanding not to exceed $20.0 million and (ii) the Truist Term Loan in an aggregate principal amount of $275.0 million. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding borrowings under the 2023 Credit Facility accrued interest, at our option, equal to either&#58; (a) the Secured Overnight Financing Rate (SOFR) plus a margin ranging from 2.50% to 3.50% per annum&#59; or (b) the Base Rate (which was defined in a customary manner for credit facilities of this type) plus a margin ranging from 1.50% to 2.50% per annum. The applicable margin was based on the Total Leverage Ratio (which was defined as the ratio of (x) total indebtedness of PACS Group, Inc. and its subsidiaries less up to $50.0 million of unrestricted cash to (y) the consolidated EBITDA of PACS Group, Inc. and its subsidiaries). In addition, we agreed to pay a commitment fee on the unused portion of the 2023 Revolving Credit Facility, which ranged from 0.30% to 0.50% per annum, depending on the Total Leverage Ratio. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with executing the 2023 Credit Agreement, we wrote off deferred financing costs of $2.2 million and capitalized additional deferred financing costs of $9.7 million were capitalized during the year ended December 31, 2023. In addition, on the closing date of the 2023 Credit Agreement, we drew $75.0 million on the 2023 Revolving Credit Facility and borrowed the entirety of the $275.0 million Truist Term Loan. We used approximately $142.0 million of such proceeds to repay certain outstanding indebtedness on prior lines of credit and the Working Capital Loan.  </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 7, 2023, we amended and restated the 2023 Credit Facility (Amended and Restated 2023 Credit Facility). The Amended and Restated 2023 Credit Facility provides for revolving commitments in an aggregate principal amount of $600.0 million, which revolving commitments may also be utilized for (x) the issuance of letters of credit in an aggregate face amount not to exceed $50.0 million and&#47;or (y) the borrowing of swingline loans in aggregate principal amount not to exceed $20.0 million at any time outstanding. The maturity date of the Amended and Restated 2023 Credit Facility is December 7, 2028.  </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding borrowings under the Amended and Restated 2023 Credit Facility bear interest, at our option, based on SOFR (plus a 0.10% credit spread adjustment) or the Base Rate (which is defined consistent with the 2023 Credit Facility), in each case, plus an applicable margin ranging from 2.25% to 3.25% for SOFR borrowings and 1.25% to 2.25% for Base Rate borrowings based upon our Total Leverage Ratio (which is defined consistent with the 2023 Credit Facility) as determined with reference to our most recently delivered financial statements. In addition to interest paid on all outstanding revolving loans, we are required to pay (i) a commitment fee on the unused portion of the revolving commitments, which ranges from 0.25% to 0.45% per annum based upon our Total Leverage Ratio as determined with reference to our most recently delivered financial statements, (ii) a letter of credit fee in respect of each revolving lender&#8217;s participation in each outstanding letter of credit, which is based on the then applicable margin for SOFR loans, and (iii) other fees customary for credit facilities of this type.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended and Restated 2023 Credit Facility contains affirmative and negative covenants customary for credit facilities of this type as well as two financial covenants, a total leverage financial covenant and a fixed charge coverage ratio financial covenant. The leverage covenant requires that we maintain a Total Leverage Ratio of not greater than 3.00&#58;1.00 as of the end of each fiscal quarter (calculated for the four consecutive fiscal quarter period </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ending on the applicable date of determination), commencing with the fiscal quarter ending on December 31, 2023. The fixed charge coverage ratio financial covenant requires that we maintain a Fixed Charge Coverage Ratio (as defined in the Amended and Restated 2023 Credit Facility) of not less than 1.10&#58;1.00 as of the end of each fiscal quarter (calculated for the four consecutive fiscal quarter period ending on the applicable date of determination), commencing with the fiscal quarter ending on December 31, 2023.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the Amended and Restated 2023 Credit Facility, we borrowed $460.0 million of revolving loans, the proceeds of which were used to repay and refinance all term loans and revolving loans under the 2023 Credit Facility, to repay certain other outstanding indebtedness, and to pay transaction costs in connection with the Amended and Restated 2023 Credit Facility.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term debt</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During year ended December&#160;31, 2022, one of our subsidiaries entered into HUD-insured mortgage loans in the aggregate amount of $7.0 million. As a result, five of our subsidiaries had mortgage loans insured with HUD in the aggregate amount of $79.0 million as of December&#160;31, 2022, of which $1.5 million is classified as short-term and the remaining $77.5 million is classified as long-term. These subsidiaries are subject to HUD-mortgage oversight and periodic inspections. Some of the mortgage loans bear fixed interest rates in a range of 2.4% to 5.5% per annum or SOFR plus 4.25% and have various maturity dates through January&#160;1, 2055. In addition to the interest rate, we incur other fees for HUD placement, including but not limited to audit fees. Amounts borrowed under the mortgage loans may be prepaid, subject to prepayment fees based on the principal balance on the date of prepayment. The original terms for all the HUD-insured mortgage loans are 30 to 35 years.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the HUD-insured mortgage loans above, we have 23 other loans or promissory notes. The non-HUD-insured mortgage loans and notes bear interest rates in the range of 2.0% and 7.3% per annum with various maturity dates through August&#160;15, 2027. The notes are secured by equipment and guarantees by us and our stockholders. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating and finance leases</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease most of our skilled nursing and assisted living facilities, as well as office space and certain vehicles and equipment, under various non-cancelable operating lease agreements. These operating leases expire at various dates throughout 2049. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all operating leases for skilled nursing and assisted living facilities are on a &#8220;triple-net&#8221; basis, which require lessees to pay for all insurance, repairs, utilities, and real property taxes assessed on the leased property, and most of the leases are guaranteed by us and&#47;or our stockholders.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For five of the facility operating leases, we hold an option to purchase the real estate which can be exercised at varying times starting September&#160;9, 2021 through January&#160;31, 2035. At lease inception it was determined that the exercise of these purchase options was not reasonably assured.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At our option, the facility leases are generally renewable for additional terms ranging from 3 to 30 years. All facility leases provide for an additional percentage rent based upon specified rates per the terms of the agreements.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also lease certain skilled nursing and assisted living facilities under finance lease agreements. The economic substance of each lease is that we are financing the facilities through the lease. The lease terms of these finance leases allow for a purchase option during a specified window. We have determined that we are reasonably certain to exercise the purchase option at the end of each purchase option window. Therefore, we have calculated the lease term through the end of the purchase option window for each lease.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_2474"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inflation </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically derived a substantial portion of our revenue from the Medicare program. We also derive revenue from state Medicaid and similar reimbursement programs. Payments under these programs generally provide for reimbursement levels that are adjusted for inflation annually based upon the state&#8217;s fiscal year for the Medicaid programs and in each October for the Medicare program. These adjustments may not continue in the future, and even if received, such adjustments may not reflect the actual increase in our costs for providing healthcare services.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Labor, supply expenses and capital expenditures make up a substantial portion of our cost of services. Those expenses can be subject to increase in periods of rising inflation and when labor shortages occur in the marketplace. To date, we have generally been able to implement cost control measures or obtain increases in reimbursement sufficient to offset increases in these expenses. There can be no assurance that we will be able to anticipate fully or otherwise respond to any future inflationary pressures.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_2486"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may enter into off-balance sheet arrangements and transactions that can give rise to material off-balance sheet obligations. As of December&#160;31, 2023, our material off-balance sheet arrangements and transactions include&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  in letters of credit. We expect to enter into similar contractual arrangements in the future in order to support our business plans. There are no other transactions, arrangements or other relationships with unconsolidated entities or other persons that are reasonably likely to materially affect our liquidity or availability of our capital resources.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_2498"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of these consolidated financial statements and related disclosures requires us to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. We believe that the application of the following accounting policies, which are important to our financial condition and results of operations, require significant judgments and estimates on the part of management. See Note 2 &#8220;Summary of Significant Accounting Policies&#8221; to our audited consolidated financial statements for a summary of our significant accounting policies, including the accounting policies discussed below.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition- </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized from healthcare services is adjusted for estimates of variable consideration to arrive at the transaction price. We determine the transaction price based on contractually agreed-upon amounts or rates, adjusted for estimates of variable consideration. Variable consideration includes estimates of implicit price concessions so that the estimated transaction price is reflective of the amount to which we expect to be entitled in exchange for providing the healthcare services to customers. If actual amounts of consideration ultimately received differ from the estimates, we adjust these estimates, which would affect net service revenue in the period such variances become known.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accrued Risk Reserves-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are principally self-insured for risks related to professional and general liability. Accrued risk reserves include the accrual for risks associated with professional liability claims and include a liability for unpaid reported claims and estimates for incurred but unreported claims. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize a wholly owned captive insurance subsidiary to provide coverage to our various consolidated operating subsidiaries related to professional and general liability insurance. The related assets and liabilities of this consolidated subsidiary are included in the accompanying financial statements.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our policy is to accrue amounts using the information obtained from the actuarially determined estimated costs to settle open claims of insureds, as well as an estimate of the cost of insured claims that have been incurred but not </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reported. We develop information about the size of the ultimate claims based on historical experience, current industry information and actuarial analysis, and evaluate the estimates for claim loss exposure on a quarterly basis. We use actuarial valuations to estimate the liability based on historical experience and industry information.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_2118"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 2 &#8220;Summary of Significant Accounting Policies&#8221; to our audited consolidated financial statements for a description of recently adopted accounting pronouncements and recently issued accounting pronouncements not yet adopted as of the date of this prospectus.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_2135"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Qualitative and Quantitative Disclosure About Market Risk</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to risks associated with market changes in interest rates through our borrowing arrangements. As of December&#160;31, 2023, we had approximately &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;   of variable rate debt, none of which was subject to an interest rate hedge. In particular, our credit facility exposes us to variability in interest payments due to changes in SOFR interest rates. We manage our exposure to this market risk by monitoring available financing alternatives. Our mortgages and promissory notes require principal and interest payments through maturity pursuant to amortization schedules.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mortgages generally contain provisions that allow us to make repayments earlier than the stated maturity date. In some cases, we are not allowed to make early repayment prior to a cutoff date. Where prepayment is permitted, we are generally allowed to make prepayments only at a premium which is often designed to preserve a stated yield to the note holder. These prepayment rights may afford us opportunities to mitigate the risk of refinancing our debts at maturity at higher rates by refinancing prior to maturity.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents as of December&#160;31, 2023 consisted of cash and short-term investments with original maturities of three months or less at the time of purchase. Risks due to changing interest rates impact the return we realize related to our cash and short-term investment balances.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, we had outstanding indebtedness under mortgage loans insured with HUD and two promissory notes to third parties of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  &#160;  , all of which are at fixed interest rates.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above only incorporates those exposures that exist as of December&#160;31, 2023 and does not consider those exposures or positions which could arise after that date.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_914"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BUSINESS</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_2195"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Overview</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities. Founded in 2013, we are one of the largest skilled nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. We also provide senior care, assisted living, and independent living options in some of our communities. Our significant historical growth has been primarily driven by our expertise in acquiring underperforming long-term custodial care skilled nursing facilities and transforming them into higher acuity, high value-add short-term transitional care skilled nursing facilities. We believe our success is driven in significant part by our decentralized, local operating model, through which we empower local leaders at each facility to operate their facility autonomously and deliver excellence in clinical quality and a superior experience for our patients. We provide our independently operated facilities with a comprehensive suite of technology, support, and back-office services that allow local leadership teams to focus more of their time and effort on providing quality care to patients. We believe our operating model delivers value to all of our healthcare stakeholders, including patients and families, referring providers, payors, and administrators and clinicians.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after they have been discharged from the hospital. This ecosystem ranges from higher acuity, higher-cost settings, such as long-term acute care hospitals and inpatient rehabilitation facilities, to lower acuity, lower-cost settings, such as assisted living facilities, and home health. Skilled nursing facilities (SNFs) are positioned at the center of this ecosystem and play an essential role in providing cost efficient facility-based care to patients that have been discharged from hospitals but still require 24-hour in-patient services. SNFs can provide both long-term custodial care and higher value short-term transitional care. The SNF industry is large and growing, with the Centers for Medicare &#38; Medicaid Services (CMS) expecting total industry expenditures to increase from $193.6 billion in 2022 to $283.3 billion in 2031, representing a compound annual growth rate (CAGR) of 4.3%. Based on the number of facilities as reported by CMS, we are one of the largest SNF operators in the United States. We are primarily focused on providing higher value short-term transitional care and believe we are uniquely positioned to capitalize on the current underlying trends within the SNF industry and to capture a growing portion of the expected demand.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that healthcare is local and we operate through a decentralized model, recognizing that each patient, facility, and community is unique. To that end, we believe that our local leaders and employees understand the distinct needs and priorities of their patients, staff, and facilities and are best positioned to make clinical and operational decisions in order to optimize patient outcomes and experience. To facilitate this, each of our facilities operates independently, led by a facility administrator and his or her interdisciplinary team of medical directors, nurses, therapists, specialty consultants, and operators. To assist these local teams in achieving their best clinical and operating potential, we provide each facility with access to PACS Services. PACS Services is a comprehensive suite of offerings, including accounting, finance, human resources, payroll, accounts receivable and payable, legal, and risk management services, as well as a robust suite of technology tools. We operate in a highly regulated industry with stringent regulatory compliance obligations, which requires robust regulatory compliance operations. Failure to operate in compliance with applicable laws and regulations could require significant expenditures and result in regulatory deficiencies and other regulatory penalties. PACS Services functions to support our regulatory compliance obligations across our organization, including through controlled billing and cost reporting practices and legal, risk management, and compliance support. PACS Services also provides teams of regional professionals available as resources to each facility, including a regional vice president (RVP) and regional clinical and non-clinical directors and consultants. We developed PACS Services to be a resource to help reduce administrative burden so that local leadership teams can focus on making decisions that improve the care, well-being, and quality of life of their patients.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that talented local leadership is critical to the success of our model of independently operated, centrally supported facilities. At the facility level, administrators are effectively the chief executive officers, and together with other local licensed professionals, are ultimately responsible for the operations of their respective </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">facilities. We seek to recruit, train, and reward dynamic administrators for our facilities, and rely on them to work with their interdisciplinary teams to implement policies and procedures that are appropriate and effective and result in positive outcomes. We support the delivery of excellent care by building excellent teams. We believe our model attracts high caliber, entrepreneurial professionals who value having considerable autonomy, accountability, and aligned incentives. We provide these professionals with leadership and industry training, guidance, and operational support. Our model is intended to align local leaders&#8217; incentives with facility and organizational success, encouraging them to dedicate themselves to the long-term future of their facilities. To create such alignment, we have developed an administrator compensation structure that prioritizes quality of care and operational and financial performance. Our administrators understand that a well-performing facility is the result of providing quality care in an environment of healing and caring, and one that is appropriately staffed, supplied, and equipped to meet the needs of its patients. This dedicated focus by our administrators and their local teams on patient outcomes drives demand for our services and can ultimately result in higher patient census and profitability. We also seek to provide opportunities for upward career mobility, with many of our administrators being promoted from within our company to roles of increasing levels of responsibility. Our culture of meritocracy and pride of ownership has helped us retain experienced facility administrators as well as RVPs who had average industry experience of&#160;12.1&#160;years as of December 31, 2023. For the year ended December 31, 2023, we had a voluntary turnover rate of&#160;3.1%&#160;among our facility administrators. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excellence in clinical quality and experience for our patients is at the forefront of our mission. We believe our focus on quality is reflected in our CMS Quality Measures (QM) Star rating, occupancy rate, and skilled mix by nursing patient days (which refers to the number of days our Medicare and managed care patients receive skilled nursing services at SNFs as a percentage of the total number of days that patients from all payor sources receive skilled nursing services at SNFs for any given period). The QM Star rating is a number between 1 and 5 that is assigned to SNFs that participate in Medicare or Medicaid, and is based on an aggregate score across a range of quality reporting program requirements. As of December 31, 2023, 2022 and 2021 our average QM Star rating across our Mature facilities was&#160;4.2, 4.4 and 4.3&#160;Stars, respectively, compared to the industry average of 3.6, 3.7 and 3.7&#160;Stars, respectively. For the years ended December 31, 2023, 2022 and 2021 our average occupancy rate across our Mature facilities, which we define as facilities purchased more than 36 months prior to the measurement date, was&#160;<font id="ic735f08b7cf2469794e1a6169fa04444_211957"></font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 92%, and 88%, respectively, compared to the industry average of 76%, 74% and 71%, respectively. For the year ended December 31, 2023, our skilled mix by nursing patient days was &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically grown primarily through our disciplined and balanced acquisition strategy. We aim to create value by identifying and acquiring underperforming custodial care facilities and converting them into higher-value short-term transitional care facilities by investing in clinical teams and processes and upgrading technology, equipment, training, staffing, aesthetics, and other aspects of the business. The resources and guidance offered by PACS Services is key to rapid integration of new facilities and provides our local leadership teams with an effective technology infrastructure, support tools, and regional support teams that allow local leadership to focus on operational improvements. Our facilities generally undergo an up to three-year post-acquisition transition period. During this period, we seek to implement best practices designed to realize and sustain the facility&#8217;s full potential. These practices often result in significant improvements to clinical quality and other operational metrics, including skilled mix, occupancy rates and payor contracting. We believe the results of our acquisition strategy are demonstrated by our high average QM Star rating and occupancy rate for Mature facilities of 4.2&#160;and &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , respectively, as of December 31, 2023. As of December 31, 2023, the average QM Star rating and occupancy rate for New facilities, which we define as facilities purchased less than 18 months prior to the measurement date, was 3.9&#160;and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, respectively.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our portfolio of owned and leased properties is strategically located in nine states&#58; Arizona, California, Colorado, Kentucky, Missouri, Nevada, Ohio, South Carolina and Texas. We anticipate that available acquisition opportunities will enable us to further penetrate our reach into these nine states and to enter new states in the future. We believe our current markets are attractive and that the states in which we operate each has unique benefits, such as favorable reimbursement dynamics, high barriers to entry, or population growth of adults aged 65 and older, which is our primary patient demographic. We generally look for similar attributes in new markets that we enter. As of December 31, 2023 we leased&#160;165&#160;facilities, directly owned the real estate at 29&#160;facilities, and owned partial interests in an additional&#160;14&#160;facilities through joint ventures managed by third parties. As we continue to grow, we </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intend to explore additional purchases of real-estate assets, through purchase options or right-of-first refusals in existing leases, as well as acquisitions and de novo construction of purpose-built facilities.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2023, we generated total revenue of $ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, representing a CAGR of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; % over the last five years. A substantial portion of our revenue is generated from payments from third-party payors, including Medicare and Medicaid, which represent our largest sources of revenue and accounted for &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% and &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; % of our routine revenue for the year ended December 31, 2023, respectively. For the year ended December 31, 2022, we generated total revenue of $2.4 billion, and Medicare and Medicaid accounted for 47.6% and 30.2% of our total revenue, respectively. For the year ended December 31, 2023, we generated net income of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , total operating expense of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; and Adjusted EBITDA of $  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , representing a CAGR of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;%, &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; %, respectively, over the last five years. For the year ended December 31, 2022, our total operating expenses were $2,192.6 million and we generated net income of $150.5 million and Adjusted EBITDA of $255.5 million, respectively. As of December 31, 2023, we had total long-term liabilities of $ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. Adjusted EBITDA is a non-GAAP financial measure. See the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Conditions and Results of Operations&#8212;Key Skilled Services Metrics and Non-GAAP Financial Measures&#8212;Non-GAAP Financial Measures&#8221; for a reconciliation of Adjusted EBITDA to the most directly comparable GAAP financial measure.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_2207"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Operating Model</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Decentralized Operations</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our decentralized model is informed by our beliefs that &#8220;healthcare is local&#8221; and that each patient, facility and community is unique. Our administrators have autonomy in the decision-making process because they know what is best for their community and their markets. Our over 200 post-acute facilities are independently operated by autonomous local teams with robust administrative and consulting support from our PACS Services. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of our facilities is led by an experienced and highly qualified local facility administrator, who serves in effect as a &#8220;local CEO,&#8221; alongside an interdisciplinary team of medical directors, clinicians, specialty consultants, and operators. In addition to a full clinical team of certified nursing assistants (CNAs), licensed practical nurses (LPNs), registered nurses (RNs), directors of nursing (DONs), and clinical directors, each facility has a local team of non-clinical staff including supervisors, admissions professionals, marketing professionals, and other business support personnel who have the common goal of providing excellent care and superior experiences for patients. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide PACS Services to each of our facilities, which includes support through a regional team of seasoned, highly qualified, cross-functional professionals, and led by an RVP. The team is also includes regional clinical support personnel (such as directors of therapy, quality assurance, medical records, and clinical services personnel) as well as non-clinical personnel such as regional directors of recruitment and accounts receivable and payable, reimbursement, and risk and compliance personnel. As of December 31, 2023, we had&#160;14&#160;RVPs and regional teams who each cover an average of&#160;14.9&#160;facilities within a region and have an intimate understanding of the intricacies and challenges of the post-acute industry. We place the utmost importance on clinical quality, and as a result, many employees that provide PACS Services are clinicians by trade.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Technology and Services</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology focus delivers real-time data access to caregivers and administrators, allowing delivery of the best care at the right time. We have invested into internally developed and third-party technologies that comprise part of PACS Services. This robust suite of technologies helps support facility administrators, clinicians, and local teams by providing them with valuable tools to enable them to reduce the time and effort they spend on administrative tasks so that they can better focus on providing quality care and driving efficient business operations. PACS Services includes access to an industry-leading, third-party Electronic Health Record system, and a singular Enterprise Resource Program. In addition, we have internally developed an operational dashboard that is custom-built to provide invaluable tools and real-time data insights to our local teams in order to enhance resource management and improve the delivery of care. This app-based, mobile technology integrates facility-level detail on </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">admissions, occupancy, revenue, staffing, collections, and other key operational data points. Our technology platform enables local leaders and regional teams to continually review and monitor this data, which allows them to be agile in assessing the ongoing needs of their facility and to more easily identify and address the unique needs and priorities.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With this readily-available, real-time data, our local leaders are able to more easily assess what works well in their facilities and can appropriately manage their operations and share best practices with their colleagues within the company. This data also facilitates greater risk management and compliance efforts, as financial and clinical information can be analyzed, which we believe helps promote accountability across the company. Across the company, we use insights from our data management tools to benchmark performance, manage expenses, monitor risk, and manage compliance. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe PACS Services provides technology systems and support infrastructure that can enable seamless integration of new facilities and help to reduce risk when we acquire new facilities. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical and Operational Leadership</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe we are an employer-of-choice in the SNF industry and have attracted highly qualified local leadership and clinicians. Our facility-forward model helps attract and retain motivated professionals whom we provide with extensive training, professional guidance by seasoned experts, and access to best practices. We offer challenging and fulfilling opportunities for clinicians to gain meaningful experience treating higher acuity patients. Through work-education programs, we also offer many of our clinicians the opportunity to improve or enhance their clinical licenses with sponsored certification programs. We believe we are at the forefront of enabling operators and clinicians to operate in their highest value capacity and at the best of their professional capabilities. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Administrator-in-Training program, geared towards recent college graduates, and our PACS Professional Program for experienced nursing home administrators, both provide valuable, intensive training and mentorship to help aspiring PACS administrators build important skills, such as operational systems management, administrative effectiveness, and leadership and people development. Our placement process assesses skill sets, qualifications, and career interests in order to pair leaders with the facilities and teams that will be a good fit.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our frontline CNAs, LPNs, and RNs are also encouraged to participate in our internal continuing education programs, as well as outside programs, to help them continue to develop their skills and to meet any mandated continuing education requirements. We also offer our clinicians and other personnel educational assistance to enable them to sharpen their skills and enhance their capabilities. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disciplined Acquisition Playbook</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an established track record of successful acquisitions. Our significant historical growth has been primarily driven by implementing our expertise in acquiring underperforming long-term custodial care SNFs and converting them into higher acuity, high value-add short-term transitional care SNFs. In pursuing each acquisition opportunity, we employ a disciplined evaluation process to identify facilities that meet our acquisition criteria and strategic priorities. We believe our framework and focused approach for acquisitions has contributed to our overall success. Our approach involves&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Sourcing and evaluation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have developed specific acquisition criteria to drive efficient sourcing and growth, and we continually monitor our pipeline of suitable acquisition targets. We believe we have a reputation as an acquiror-of-choice, which has led to regular inbound opportunities from small operators, larger platforms, and industry partners, such as landlords, brokers, and REITs. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Integration and execution.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Prior to and following closing of an acquisition, we perform a full facility evaluation focused on operational, clinical, financial, and administrative functions. Through this evaluation, we develop a detailed action plan with goals for IT integration and implementation of best practices led by facility administrators. We believe that administrators can create immediate additional value through </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">technology integrations and then drive continued growth over time with improvements to clinical quality, operations, and financial performance. Our facilities generally undergo an up to three-year post-acquisition transition period. During this period, our integration efforts and implementation of best practices often result in significant improvements to clinical quality and other operational metrics. We believe the results of our strategy are demonstrated by our high average QM Star rating and occupancy rate for Mature facilities of 4.2&#160;and  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, respectively, as of December 31, 2023. By comparison, the average QM Star rating and occupancy rate for New facilities was 3.9&#160;and&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, respectively, as of December 31, 2023. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Diversified Portfolio of Properties</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a diverse portfolio of facilities that are located in selected attractive markets. A majority of our facilities are leased, with our remaining facilities either wholly-owned or partially-owned through joint ventures managed by third parties. Real-estate ownership is a key component of our growth strategy as it can provide balance sheet support as an inflationary hedge, provide capital flexibility as a source of asset collateral, reduce the burden of leases and restrictive agreements, and allow us the opportunity to create additional value in improving distressed assets.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our leased and owned facilities&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Leased Properties.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of December 31, 2023, we had 165 leased facilities. The majority of these leased facilities are in California, with the remainder in Arizona, Colorado, Kentucky, Missouri, Nevada, Ohio, South Carolina, and Texas. We leverage our financial and operational condition to negotiate favorable lease terms, including low annual rent escalators, long expiration dates, and purchase options. As of December 31, 2023, our weighted average annual lease escalator was&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;%, our average monthly lease expense per bed was $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per bed, our average remaining lease term across our portfolio was approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;years, and we had&#160;14 total purchase options and 3 right of first refusals that we may exercise in future years. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Owned Properties.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have historically purchased the real-estate assets for certain of the post-acute care facilities we operate. Many of our owned properties were acquired with limited cash outlay while in a distressed state, or through the exercise of a purchase option that was originally negotiated while in a distressed state. We seek to create value in our properties by purchasing these distressed facilities and making improvements under our operations and ownership. As of December 31, 2023 we owned&#160;29 post-acute care facilities, and through joint ventures we operated&#160;14 post-acute care facilities. The majority of our owned real-estate properties are located in California, South Carolina, Texas, and Kentucky. We have also explored facility ownership through de-novo, or new-build, facilities where we construct facilities and own them. Since 2013, we have opened or are in the process of opening 7 de-novo facilities.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify each of our facilities into three distinct categories based on the amount of time that has passed since acquisition&#58; Mature, Ramping and New. Mature facilities are defined as facilities purchased more than 36 months prior to a respective measurement date. Ramping facilities are defined as facilities purchased within 18 to 36 months prior to a respective measurement date. New facilities are defined as facilities purchased less than 18 months prior to a respective measurement date. As of December 31, 2023, we operated&#160;65&#160;Mature facilities, 77&#160;Ramping facilities, and&#160;66 New facilities. For the year ended December 31, 2023, our Mature, Ramping, and New facilities generated skilled nursing services revenue of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, and $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, respectively. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our success in improving our acquired properties is reflected in the average QM Star rating, occupancy rate, and skilled mix by revenue for each of our Mature, Ramping and New facilities, depicted in the table below for the year ended December 31, 2023&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2023</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Mature facilities</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ramping facilities </font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">New facilities</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average QM Star rating</font></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Occupancy rate (operational beds)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled mix by revenue</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, our facilities had an average QM Star rating of 4.1 Stars compared to the industry average of 3.6 Stars, and an average occupancy rate of         % compared to the industry average occupancy rate of 76%. See the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Key Skilled Services Metrics and Non-GAAP Financial Measures.&#8221;</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the success of our strategy is further exemplified by our historical ability establish and maintain a QM Star rating for our Mature facilities that is higher than the industry average, The graphic below sets forth our QM Star rating over time for our Mature facilities, as well as the industry average QM Star rating, for the periods indicated</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QM Star Ratings Over Time for PACS Mature Facilities vs. Industry Average</font></div><div style="margin-bottom:12pt;text-align:center"><img alt="business1a.jpg" src="business1a.jpg" style="height:177px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Source&#58; CMS SNF Provider Information (Aug. 2023)&#59; PACS data for facilities with CMS certification and QM Star rating.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Execution of our strategy has also increased our number of facilities with QM Star ratings of 4 or 5 Stars over time. The graphic below sets forth our number of facilities by QM Star rating from 2015 through 2023. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QM Star Ratings Over Time for PACS Facilities</font></div><div style="margin-bottom:12pt;text-align:center"><img alt="business3a.jpg" src="business3a.jpg" style="height:138px;margin-bottom:5pt;vertical-align:text-bottom;width:600px"></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_2219"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Value Proposition</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our operating model creates meaningful value for patients and their families, our referring providers, our payors, and our administrators and clinicians. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Value Proposition for Patients and Families</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Coordinated care.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We empower team members at every level through skillful training, shared resources, and a collaborative spirit. We help deliver coordinated care before, during, and after a patient&#8217;s stay with us. Prior to admission, our administrators or other facility leaders meet with patients and their families, as well as hospital discharge planners, to plan for the patient&#8217;s discharge and enable a seamless transition to our facility. During a stay with us, our local facility team coordinates closely with physicians to deliver high-touch, high-quality care for patients. As care nears completion, we meet with our patients, their families, home health agencies and downstream care providers to plan for and ensure a smooth transition. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Outstanding patient experience.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our goal is to provide each patient with superior care and an outstanding experience. When patients arrive at our facilities they are greeted by a warm, inviting, and modern environment. We often upgrade facility infrastructure shortly after acquisition and perform periodic refreshes, to ensure our facilities are comfortable and well-equipped to serve patients across a wide range of acuities with a primary focus on high acuity patients. High acuity patients generally require higher levels of medical care or monitoring due to conditions or complications that cannot be easily managed, and often need more nursing resources and attention to maintain their quality of life. We believe our investment in modern equipment and technology allows our facility care teams to identify and respond to patient needs and provide them high quality care in a timely manner. Moreover, our clinicians are highly trained, have significant experience, and are able to leverage bespoke care plans to help ensure that patients receive care tailored to their particular needs. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Value Proposition for Referring Providers </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Strategic and seamless transitions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our administrators and their interdisciplinary teams seek to become a preferred partner by developing a deep understanding of local referring providers&#8217; and their patients&#8217; needs. Administrators often visit with patients and their families prior to discharge to plan for and map out a smooth admission to our facility. Once a plan is set, the facility team endeavors to quickly and seamlessly transition new patients to the facility with a focus on ensuring continuity of care in the transition. We believe that hospitals and other referral sources consider our facilities to be attractive discharge options because we are able to care for a wide variety of patient needs, and are often able to accept admissions on short notice, including on nights and weekends. Our flexibility helps hospitals maintain adequate bed availability to meet their other patients' needs.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Trusted partner with quality care.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our ability to care for higher acuity patients allows referring providers to have confidence that we will be able to adequately care for their patients and assist them in their recovery. Our facilities seek to work with patients&#8217; doctors to create personalized care plans to help ensure that patients stay on track in their recovery and to reduce the likelihood of their readmission to the hospital. Our facility teams also seek to coordinate closely with a patient&#8217;s home health agency or other post-SNF caregivers to try to ensure the patient&#8217;s transition home or to their next care setting is successful. This close coordination allows us, where warranted, to directly readmit patients back to our facility who would have otherwise been readmitted to an acute care hospital in the event they have a change of condition after leaving our facility.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Value Proposition for Payors</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Higher value site of care.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We believe we provide high acuity care in a cost-effective setting and are able to quickly transition patients from the acute care setting, reducing length of stay and delivering more overall value for payors. Moreover, we believe we provide payors with a high-quality alternative to higher cost </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">post-acute sites of care. For example, according to MedPAC, SNFs are the lowest cost facility-based post-acute healthcare, costing an average of $550 per covered day compared to $1,850 and $1,753 per covered day for inpatient rehabilitation facilities and long-term acute care hospitals, respectively.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Robust culture of compliance.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We focus on instilling a unified, cohesive culture of innovation and compliance that we believe provides consistency in our results and confidence in our facilities as an attractive care option for patients. Our rigorous approach to billing integrity, our independent internal compliance function, and our regular facility billing audits are intended to provide a foundation of trust and collaboration that makes us a natural choice for payors.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Value Proposition for Administrators and Clinicians</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Autonomy and aligned compensation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Each facility administrator is, in effect, the local &#8220;CEO&#8221; and dedicated leader of their facility. Alongside their local interdisciplinary team, they are empowered to make real-time decisions locally around all aspects of their business and to manage their individual facility in a way that they believe is best suited to address their local market and its needs. We have designed a transparent incentive model for our administrators that is intended to align their compensation with the quality of care and operational and financial performance of their facility. We provide them the tools and the autonomy to optimize the performance of their facility, and we reward them for success in their efforts. We believe that a well-performing facility is the result of providing quality care in an environment of healing and caring and one that is appropriately staffed, supplied, and equipped to meet the needs of its patients. This dedicated focus by our administrators and their local teams on patient outcomes drives demand for our services and can ultimately result in higher patient census and profitability. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Robust technology enabled operating infrastructure.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We developed PACS Services to reduce the managerial and operational burden on our administrators, allowing them to focus on leading their facilities and spending more time with patients and staff. PACS Services includes a robust suite of technology tools that provide detailed real-time data and trends that local clinicians and leadership teams can use to monitor and improve operational performance. PACS Services also includes regional support teams that leverage their deep tenure and experience across markets to provide higher-level support to local leaders on complex issues, including billing and cost reporting practices and regulatory compliance obligations. The regional teams are connected to and support the facilities within their designated region, which enables them to identify best practices and trends within the region, communicate those across their region, and provide facility-level support as needed. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Highly entrepreneurial career development.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> By providing our administrators with autonomy in the operation of their facility, we believe we create a highly entrepreneurial environment that encourages and rewards leaders to optimize operational performance. We empower our clinicians to do the same and provide top performers the opportunity to progress via training for higher skill licenses and certifications. People are provided the opportunity to advance to become an administrator through our Administrator-in-Training program, and to join a regional leadership team. For example, in the year ended December 31, 2023, we promoted 26 of our administrators from within our organization after participating in our Administrator-in-Training program, and 12 of our RVPs were previously successful administrators with us. </font></div><div id="i2baa8a1031f44c51b1664e00d256c582_2233"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Competitive Strengths</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our success is driven by the following competitive strengths&#58; </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Superior Overall Quality</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excellence in clinical quality and experience for our patients is at the forefront of our mission and is reflected in our above-industry average QM Star rating and occupancy rate. Our facilities employ skilled administrators and clinicians and equip them with purpose-built technology and support so they can operate at the top of their professional capacity and deliver high-quality care for patients. We continuously invest in our people, processes, and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">facilities to promote an excellent patient experience. We believe we deliver superior overall quality that has contributed to our reputation as a provider-of-choice in our communities, driving greater referral volumes from referring providers who value our high standards. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Decentralized Market-Driven Operating Model</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our decentralized model emphasizes local operational autonomy. We believe that placing decision-making power at the local level with teams who understand the needs of their patients and their communities facilitates responsiveness and adaptability to evolving patient needs and facility and community factors. We believe the empowerment of local leadership promotes improved quality care for patients, greater referral volumes and higher occupancy rates. Our operating model is highly transferable to new markets, and enable us to quickly integrate and enhance new facilities. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transparent and Meritocratic Leadership Culture</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have built a transparent, competitive, and collegial culture that promotes individual growth both personally and professionally and prioritizes a deep commitment to our patients, families, and team members. We promote transparency in performance, which we believe encourages collaboration and healthy competition among local leadership that in turn drives best practices. We believe this meritocratic culture, supported by highly seasoned industry veterans, helps optimize clinical and financial outcomes at facilities and instills accountability throughout the organization. This leadership mindset has empowered us to develop a deep bench of leaders capable of supporting our existing and future facilities.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employer-of-Choice with Directly Aligned Incentive Model</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we are an employer-of-choice in the post-acute care industry, which enables us to attract and retain highly motivated, entrepreneurial individuals who value operational independence and financial opportunity. This has allowed us to attract enterprising individuals from diverse backgrounds who may not have otherwise considered careers in skilled nursing. Our unique compensation model is designed to align local individual incentives with the long-term clinical quality and operational performance of the facility, which we believe fosters a shared ownership mentality. We believe this directly aligned incentive model has played a critical role in successfully attracting, incentivizing, and retaining our industry veterans. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Robust Suite of Technology-Enabled Services</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology focus delivers real-time data access to caregivers and administrators, facilitating delivery of the right care at the right time. Our technology tools enable our local leadership teams to focus on their first priority, providing the highest quality care possible to patients. We believe our suite of technologies helps drive decision-making and enhances operating efficiencies that can improve clinical quality, operational metrics, and the financial performance of our facilities. While other facility administrators may spend considerable time on paperwork and low-value activities, we strive to reduce the administrative burden on our facility administrators so they can walk the halls, personally meet patients, and provide a bespoke, concierge-level customer service experience. We equip our clinicians with industry-leading technology, including point-of-care and digital charting technologies, which streamlines charting and paperwork, so they can spend more time with patients and focus on providing high quality care. We believe our technology and internally developed dashboards help to facilitate better patient care, risk management, regulatory compliance, staffing, and resource allocation. We have designed our technology to be easily integrated into new facilities and allow us to scale quickly and efficiently.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Differentiated, Multi-faceted, and Disciplined Acquisition Playbook</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the past 9 years, we have demonstrated the effectiveness of our disciplined, multi-faceted playbook of acquiring and improving underperforming facilities, having successfully acquired and integrated over 195 facilities to date. We believe we have established a reputation as an acquiror-of-choice, which has led to several inbound opportunities, and has helped us build an extensive opportunity pipeline. Our balanced approach to evaluation </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">allows us to selectively pursue opportunities that meet our strategic priorities and criteria and grow in a responsible manner. Through our investment into facilities and our integration process, we are able to transition new underperforming facilities to higher-value short-term transitional care facilities. We believe our success is evidenced by our robust QM Star ratings, occupancy rates, and profitability at our Mature facilities.  </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our High-Quality Facilities </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to providing a high-quality experience for all of our patients, which is why we invest in capital improvements and ongoing maintenance to all of our facilities, regardless of whether we lease or own. Our investment into facilities is differentiated from traditional industry operators who we believe are often hesitant to make physical plant investments into facilities and who often seek to extract value through cost-cutting or other limitations on facility resources. Our renovations are intended to improve the look and feel of facilities in order to provide an excellent experience. Our investments into medical beds, vitals monitors, physical therapy equipment, and other improvements allows us to provide services to higher acuity patients. We believe our high-quality facilities lead to sustained referral volumes, more admissions, and high skilled mix at our facilities, ultimately leading to higher occupancy rates and revenue per patient day. We also believe our investment into leased facilities makes us a preferred tenant with our landlords and provides us leverage in negotiating favorable lease terms. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Size and Scale</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our market density in key regions offers strategic advantages, such as brand recognition with referring providers, including hospitals and health systems, and consistency and continuity of referrals of patients. For example, our ability to accommodate a high volume of patients within our markets allows us to accept referrals without turning patients away to competitors, and can also further our reputation as a reliable, go-to provider of care for referring providers. We also believe our size and scale has provided us with the ability to negotiate favorable contracts with managed care and other payor sources, the ability to navigate stringent regulatory compliance obligations and withstand potential reimbursement and regulatory industry dynamics, and the ability to leverage real estate value for liquidity and growth. </font></div><div id="i2baa8a1031f44c51b1664e00d256c582_2305"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Industry Overview and Market Opportunity</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Post-Acute Care Continuum is Essential to the Healthcare Ecosystem</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in the post-acute care industry, which is an essential component of the healthcare delivery ecosystem, serving high need, medically fragile patients. Post-acute care encompasses multiple care settings outside of acute care hospitals that are differentiated by the acuity level of patients and the services they require. While services may overlap across each distinct post-acute offering, post-acute rehab or SNFs provide the most comprehensive array of services. Upstream care providers, such as acute care hospitals, generally discharge patients to post-acute facilities where patients can receive key services at lower costs. For example, according to MedPAC, SNFs cost an average of $550 per covered day compared to $2,914 for short-term acute care hospitals.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Post-Acute Care Continuum</font></div><div style="margin-bottom:12pt;text-align:center"><img alt="business4a.jpg" src="business4a.jpg" style="height:586px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SNFs are an Integral and Essential Part of the Post-Acute Care Continuum</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SNFs play an essential role in post-acute patient care. SNFs provide higher-acuity skilled nursing care to patients that cannot be adequately treated in community-based care settings, such as assisted living or independent living facilities, and who are no longer appropriate candidates for hospital care. Patients referred to a SNF are typically recovering from surgery or non-critical conditions, such as strokes, joint replacements, and acute infections, and are admitted to a SNF within 30 days of being discharged from a hospital where they spent at least three days as an inpatient. In many instances, patients are treated at SNFs prior to receiving home health nursing care and therapy services. The majority of SNF patients are aged 65 years or older. Despite the wide array of services and variety of needs addressed, MedPAC reports that SNFs are the lowest cost facility-based post-acute healthcare, costing on average $550 per covered day compared to $1,850 and $1,753 per covered day for inpatient rehabilitation facilities and long-term acute care hospitals, respectively. According to CMS MedPAC data, SNFs accounted for approximately 44% of the total post-acute care continuum spend. According to CMS Inpatient Hospital discharge data, in 2022, approximately 22% of Medicare patients over 65 years old were discharged to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SNFs, representing more than any other facility type, including inpatient rehabilitation facilities and long-term acute care hospitals (approximately 6%), and more than home health nursing care (21%) or hospice (5%). As reimbursement and coverage continues to shift toward value-based models with greater emphasis on controlling costs, SNFs are integral to post-acute care and will continue to drive high-quality outcomes in low-cost settings. Furthermore, during the COVID-19 pandemic, SNFs were widely utilized to treat medically fragile patients, reinforcing the importance of SNFs to the healthcare ecosystem.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The skilled nursing industry can be classified into two main sub verticals&#58; A) long-term custodial care and B) short-term transitional care. Long-term custodial care predominantly focuses on lower acuity, Medicaid-eligible patients and provides institutional, custodial care services, including nonskilled, personal care services such as assistance with bathing, dressing, or eating. Short-term transitional care predominantly treats higher acuity, Medicare-eligible patients and primarily provides short-term inpatient-level skilled nursing care such as rehabilitation, physical therapy services, and intravenous injections.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Large, Fragmented Industry Comprised of Mostly Small and Independent Operators</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to the National Center for Health Statistics (NCHS) 2020 National Post-acute and Long-term Care Study</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the SNF industry in the United States encompasses approximately 15,000 facilities and serves approximately 1.3 million patients annually.The industry is highly fragmented, with the top 10 operators, each having greater than 100 facilities, representing approximately 11% of total number of SNFs in the United States, according to CMS data as of September 2022, approximately 5,000 smaller and independent operators of less than 100 facilities making up the remainder. According to such data, of the approximately 15,000 facilities, approximately 13,200 facilities have less than 100 beds, and approximately 74% and 27% of SNFs are located in urban and rural areas, respectively. In addition, approximately 72%, 23%, and 6% of SNFs are operated as for-profit, non-profit, and by the government, respectively, according to such data. We believe this fragmented landscape creates opportunities for larger providers with greater scale to serve patients better and meet regulatory requirements nation-wide by effectively addressing staffing, quality standards, and billing processes. Moreover, many small and independent operators face pressure due to billing requirements, regulations, competition on quality of care and facilities, staffing shortages and competition, and the cessation of COVID-related provider relief funding, which has led them to pursue sales of their facilities or businesses. This provides additional opportunity for well-managed, high-quality operators to grow through acquisitions. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Growing Demand Outpacing Supply of Skilled Nursing Facilities</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The demand for healthcare services in the United States has increased in recent years and is expected to continue growing, largely due to a rapidly aging population and an increasing prevalence of chronic conditions. According to the U.S. Census Bureau, the U.S. population aged 65 and older is expected to nearly double from 2020 to 2060 and reach 95 million in 2060, which exceeds the expected increase in the general population during that same period, and comprise one fifth of the total U.S. population in 2030. Moreover, according to the U.S. Census Bureau, the U.S. population aged 85 and older is expected to nearly triple from 2020 to 2060 and reach 19 million in 2060. Additionally, according to an article published in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Frontiers in Public Health</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2022, the percentage of people in the United States aged 50 and older with at least one chronic condition is estimated to increase by 99.5% from 2020 to 2050.  According to CMS data as of September 2022, approximately 82% of SNF patients were 65 years of age or older.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As demand has increased for SNFs, the number of SNFs has declined in recent years from approximately 15,650 in 2017 to approximately 14,900 in 2023. We believe this is due to a variety of factors, including an inability of many facilities to comply with quality standards, rigorous staffing, and billing requirements, and a lack of technology and sophistication at small and independent operators. Furthermore, new operators face multiple barriers to entry, including the requirements to obtain a Certificate of Need, complex licensure requirements, lack of operating experience, and significant capital requirements. As a result, the addition of new SNFs has not kept pace with the number of SNFs exiting the market, amplifying the need for skilled nursing to serve an aging population. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Favorable Reimbursement Environment</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to CMS, approximately 72% of SNF revenue in 2022 was derived from government sources, including Medicaid and Medicare. Medicaid represents 51% of industry revenue, while Medicare represents approximately 21%. The remainder comprises managed care, private pay, and other payors. Medicare and Medicaid reimbursement has steadily increased over the past few years. Medicare reimbursement per patient day increased at a CAGR of approximately 3.6% from 2012 to 2021, while Medicaid reimbursement per patient day increased at a CAGR of approximately 1.9% from 2012 to 2021. The industry has experienced over 9 years of growth in reimbursement rates. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following charts depict the increase in Medicaid and Medicare Fee for Service reimbursement per patient day from 2015 through 2021 as reported by CMS.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicaid and Medicare Reimbursement Per Patient Day</font></div><div style="margin-bottom:12pt;text-align:center"><img alt="business5a.jpg" src="business5a.jpg" style="height:144px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Environment</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SNF industry is highly regulated with stringent regulatory compliance obligations. In the ordinary course of business, providers are subject to federal, state and local laws and regulations relating to, among other things, billing and reimbursement, relationships with vendors, business relationships with physicians and other healthcare providers and facilities, as well as licensure, accreditation, enrollment, quality, adequacy of care, physical plant, life safety, personnel, staffing and operating requirements. Changes in law or new interpretations of existing laws and regulations may have a significant impact on revenue, costs and business operations of providers and other industry participants. In addition, governmental and other authorities periodically inspect the SNFs, senior living facilities and outpatient rehabilitation agencies to verify continued compliance with applicable regulations and standards and may impose citations and other regulatory penalties for regulatory deficiencies. Such regulatory penalties include but are not limited to civil monetary penalties, temporary payment bans, suspension or revocation of a state operating license and loss of certification as a provider in the Medicare or Medicaid program, which may be temporary or permanent in nature. This regulatory environment and related enforcement can have an adverse effect on providers and other industry participants. See the section titled &#8220;Business&#8212;Regulatory Matters.&#8221; </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Market Opportunity</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the decline in the number of SNFs, the industry is large and growing, with CMS expecting total industry expenditures to increase from $193.6 billion in 2022 to $283.3 billion in 2031, representing a CAGR of 4.3%. Based on the number of facilities as reported by CMS, we are one of the largest SNF operators in the United States and believe our scale and other competitive strengths uniquely position us to capitalize on the current underlying trends within the SNF industry and capture a growing portion of this expected growth.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Growth Strategy</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have built a multi-faceted growth strategy with multiple organic and inorganic levers to help drive our growth and capitalize on the favorable industry dynamics. To continue our growth, we intend to&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Expand our presence in existing and new markets.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have a robust pipeline of potential single-facility tuck-in acquisitions, larger multi-facility portfolio acquisitions and select new facility builds across existing and new markets. We have historically completed an average of approximately 20 acquisitions and one de-novo, or new-build, facility per year, but have the flexibility to increase or decrease this cadence from period to period in line with our business priorities and as strategic opportunities arise. We plan to continue to strategically pursue opportunities within our pipeline to supplement our organic growth and have entered into contracts to acquire up to 10 facilities that we expect to close in the first quarter of 2024. While we expect to continue to execute on this strategy, we do not have binding agreements or commitments for any material investments at this time.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Leverage operational upside within our existing footprint.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our portfolio has a healthy foundation for strong embedded organic growth. We are focused on driving higher occupancy and increasing skilled mix in an effort to fill unused capacity with higher acuity patients, which can improve our revenue per patient day and our profitability, which in turn drive growth. Historically, we have found that it takes up to 3 years for a New facility to scale to performance similar to that of a Mature facility. As of December 31, 2023, we had 66 New and&#160;77&#160;Ramping facilities, which we believe provides us some degree of near-term visibility into expected organic growth within our footprint.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Continue to grow our pipeline of leaders.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our rapid growth in size and scale can be attributed to our deep bench of talented leaders. Our administrators in training provide us with leadership resources that we can use to quickly staff new facilities with qualified operators. Similarly, our RVPs enable us to scale within regions. We intend to invest heavily in training existing leaders and expanding our bench of new administrators and RVPs to support our future growth.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Extract embedded value from real estate ownership.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We plan to continue to evaluate our real estate purchase options in an effort to reduce our rent burden and grow the underlying earnings of our business. We have executed 17 purchase options since 2013 and had 14 additional options available to us as of December 31, 2023. We intend to continue to selectively exercise purchase options and continue structuring additional purchase options to provide an additional lever to grow net margins and enhance stockholder value. Moreover, we believe that our real estate ownership provides balance sheet support as an inflationary hedge, provides capital flexibility as a source of asset collateral, reduces the burden of leases and restrictive agreements, and allows us the opportunity to create additional value in improving distressed assets. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Ancillary opportunities.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have identified and continue to evaluate multiple investment opportunities that have the potential to improve our post-acute patient experience by augmenting the services we provide. We may capitalize on these investment opportunities that are ancillary to our core business, such as pharmacy services, laboratory services, transportation, and imaging, which have the potential to be additional sources of revenue and operating income over time. We refer to these efforts to build a strategic mix of investments in ancillary business lines as &#8220;PACS Ventures.&#8221; We continue to evaluate opportunities to in-source, acquire, and commercialize these ancillary opportunities. Additionally, we may choose to monetize our PACS Services by offering it to third-party SNF operators in the future. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Expand into other post-acute sites of care.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We believe that our proven operational playbook and focus on delivering high-quality care have the potential to be utilized in additional post-acute sites of care, including home health and hospice as well as within broader senior living communities. As of December 31, 2023, we had&#160;one&#160;independent living facility and&#160;four assisted living facilities which provide a foundation for further expansion.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_2288"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital Resources</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Culture and Values</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leading culture of collegiality and committed focus on quality is driven from the top with entrepreneurial, passionate leaders who are determined to deliver a superior experience for patients and staff. Our culture of transparency across our regions and facilities fosters an environment where best-practices are shared among regions which promotes healthy competitiveness and constant improvement across our facilities. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our culture is centered on the following core values&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Love. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize that love is the foundation for providing care to the vulnerable. We support our clients as they build a culture of loving care within and beyond their communities.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Excellence. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We look for and act on opportunities to improve every day.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Trust. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We act with integrity and expect the same of others.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Accountability. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek responsibility for our actions, attitudes, and mistakes.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Mutual respect. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We treat others the way they want to be treated.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Fun. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We create and instill fun and enjoyment in everything we do.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Employees</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, we had&#160;32,433 employees working across&#160;208&#160;post-acute care facilities in 9 states and at our corporate headquarters in Farmington, Utah. Of our 32,433 employees, 19,321 are clinicians, including approximately&#160;2,244 RNs including DONs, approximately&#160;5,355&#160;LPNs, and approximately 11,722 CNAs. Approximately 13,112 of our employees work in non-clinical functions and administrative &#47; support functions, including&#160;14 RVPs, and&#160;150 facility administrators, 143 clinical and compliance support, 72 information technology support, and approximately 12,733 additional administrative and support staff.  We also employ a dedicated team specifically focused on ensuring smooth functioning and support for our point-of-care including the clinical and compliance support, information technology support above.  Additionally, approximately 3,478 of our employees were represented by unions under collective bargaining agreements as of December 31, 2023.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior management team boasts extensive experience, totaling over 10.9 years with us and 17.3 years within the SNF industry as of December 31, 2023. As of December 31, 2023, our RVPs had an average of&#160;7.2&#160;years of experience, our administrators an average of 2.4 years and our Directors of Nursing an average of&#160;2.9 years.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_2277"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The post-acute care industry is highly competitive and fragmented and we compete with numerous local and regional providers, in addition to large national providers that have achieved geographic diversity and economies of scale. We expect that the industry will become increasingly competitive in the future. Our independently operated facilities also compete with inpatient rehabilitation facilities and long-term acute care hospitals. Increasingly, we are competing with home health and community-based providers who have developed programs designed to provide services to seniors outside a facility-based setting, potentially decreasing the time they need the higher level of care provided in a SNF. Competitiveness may vary significantly from location to location, depending upon factors such as the number of competing facilities, availability of services, expertise of staff, and the physical appearance and amenities of each location. We believe that the primary competitive factors in the post-acute care industry are&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ability to attract and to retain qualified management and clinicians&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reputation and achievements of quality healthcare outcomes&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">attractiveness and location of facilities&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ability to charge competitive prices&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expertise and commitment of the management team and employees&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">community value, including amenities and ancillary services.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to compete effectively in each market by establishing a reputation within the local community as a preferred provider of post-acute care services This means that the facility administrators are generally free to discern and address the unique needs and priorities of referring providers, patients, payors and other stakeholders in the local community or market, and then create a superior service offering and reputation for that particular community or market that is calculated to encourage prospective patients and referral sources to choose or recommend the facility.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increased competition could limit our ability to attract and retain patients, qualified management and caregivers, maintain or increase rates or to expand our business. Some of our competitors have greater financial and other resources than we have, may have greater brand recognition and may be more established in their respective communities than we are. Competing companies may also offer lower costs, newer facilities or different programs or services than we offer, and may therefore attract individuals who are currently patients of our facilities, potential patients of our facilities, or who are otherwise receiving our healthcare services. Other competitors may have lower expenses or other competitive advantages than us and, therefore, provide services at lower prices than we offer.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_2266"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Matters</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthcare </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare is an area of extensive and frequent regulatory change. Changes in the law or new interpretations of existing laws may have a significant impact on revenue, costs and business operations. Our independent operating facilities that provide healthcare services are subject to federal, state and local laws relating to, among other things, licensure, accreditation, enrollment, quality, adequacy of care, physical plant, life safety, personnel, staffing and operating requirements. In addition, these facilities are subject to federal and state laws that govern billing and reimbursement, relationships with vendors, business relationships with physicians and other healthcare providers and facilities, and workplace protection for healthcare staff. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Governmental and other authorities periodically inspect the SNFs, senior living facilities and outpatient rehabilitation agencies to verify continued compliance with applicable regulations and standards. The operations must pass these inspections to remain licensed under state laws and to comply with Medicare and Medicaid provider agreements. The operations can only participate in these third-party payment programs if inspections by regulatory authorities reveal that the operations are in substantial compliance with applicable state and federal requirements. In the ordinary course of business, federal or state regulatory authorities may issue notices to the operations alleging deficiencies in certain regulatory practices. These statements of deficiency may require corrective action to regain and maintain compliance. In some cases, federal or state regulators may impose other remedies including imposition of civil monetary penalties, temporary payment bans, loss of certification as a provider in the Medicare or Medicaid program, or suspension or revocation of a state operating license. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulatory environment surrounding the healthcare industry subjects providers to significant scrutiny. In the ordinary course of business, providers are subject to inquiries, investigations and audits by federal and state agencies related to compliance with participation and payment rules under government payment programs. These inquiries may originate from the United States Department of Health and Human Services (HHS) Office of the Inspector General (OIG), state Medicaid agencies, state Attorney Generals, local and state ombudsman offices and CMS Recovery Audit Contractors, among other agencies. In response to the inquiries, investigations and audits, federal and state agencies continue to impose citations for regulatory deficiencies and other regulatory penalties, including </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">demands for refund of overpayments, expanded civil monetary penalties that extend over long periods of time and date back to incidents prior to surveyor visits, Medicare and Medicaid payment bans and terminations from the Medicare and Medicaid programs, which may be temporary or permanent in nature. We vigorously contest each such regulatory outcome when appropriate&#59; however, there are significant legal and other expenses involved that consume our financial and personnel resources. Expansion of enforcement activity could have an adverse effect on our business, financial condition or results of operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Coronavirus</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In an effort to decrease the spread of COVID-19, federal, state and local regulators have implemented new regulations and requirements on our subsidiaries.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Testing requirements - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 23, 2022, CMS issued an interim final rule (IFR) regarding COVID-19 testing of staff, stating that individuals who show symptoms of COVID-19, regardless of vaccination status, should be tested for COVID-19 as soon as possible. Additionally, this IFR called for testing of residents and staff and investigation of an outbreak when there is a single positive COVID-19 case among residents or staff of the long term care (LTC) facility. We have implemented procedures for testing for COVID-19 that are intended to comply with federal and state mandates.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal and state COVID-19 vaccination requirements - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS developed an IFR requiring all workers within Medicare and Medicaid-participating nursing homes to be vaccinated against COVID-19 as a condition of participation in the Medicare and Medicaid programs. In addition, OSHA introduced an emergency temporary standard (ETS) requiring employers with more than 100 employees to mandate that its employees be fully vaccinated against COVID-19 or submit to weekly testing for the virus. Both CMS&#8217;s IFR and OSHA&#8217;s ETS for vaccination were challenged in court and halted from enforcement in certain states, but the United States Supreme Court allowed CMS to enforce its vaccine mandate nationwide. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the IFR mandating vaccinations for health facility workers, several states where our facilities are located have issued vaccine mandates that apply to facility staff. These vaccine mandates are largely aligned with CMS's requirements. For example, California issued an order requiring adult care facilities and direct care workers to be vaccinated as well, and for all affected workers to be fully vaccinated by November 30, 2021. The order was expanded to allow workers who had completed their primary vaccination series and contracted COVID-19 since becoming fully vaccinated to defer the receipt of a vaccine booster dose by up to 90 days after infection with COVID-19&#59; otherwise, booster vaccine doses were required to be completed by March 1, 2022. On October 23, 2022, CMS issued further guidance unifying its recommendations for all facilities under its oversight, including SNFs and LTC facilities, reaffirming CMS's activities to verify vaccination of all SNF and LTC facility staff, and where necessary, to pursue corrective action for facilities found deficient in this requirement.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reporting requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In accordance with CMS reporting guidance, SNFs are required to report to the CDC National Health Safety Network certain information related to COVID-19 cases on a weekly basis. Facilities are also required to provide residents and staff with vaccine education and offer vaccines, when available, to residents and staff. The IFR published on August 23, 2021 requires facilities to develop policies and procedures to ensure the availability of the COVID-19 vaccine to residents and staff and to educate them concerning the benefits, risks and potential side effects associated with the vaccine. CMS may initiate enforcement activities and assess civil monetary penalties for not meeting any of these COVID-19 related reporting requirements under this IFR and reaffirmed its intent to seek corrective action against SNFs and LTC facilities that do not satisfy these requirements. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare and Medicaid Reimbursement and Requirements</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2023, Medicare and Medicaid accounted for approximately &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% and &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of our skilled nursing services revenue, being our&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;largest payors, respectively. The federal government and state governments continue to focus on efforts to curb spending on healthcare programs such as Medicare and Medicaid. The Medicare program and state Medicaid programs and their reimbursement rates and rules are subject to frequent change. These include statutory and regulatory changes, rate adjustments (including </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">retroactive adjustments), administrative or executive orders and government funding restrictions, all of which may materially adversely affect the rates at which Medicare and state Medicaid programs reimburse us for our services. Budget pressures often lead the federal government to reduce or place limits on reimbursement rates under Medicare and Medicaid. We cannot predict the extent to which such proposals will be adopted or, if adopted and implemented, what effect, if any, such proposals and legislation will have on us. Historically, adjustments to reimbursement under Medicare and Medicaid programs have had a significant effect on our revenue.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicaid - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March of 2020, the FFCRA provided a 6.2% increase to the FMAP during the PHE. In addition to this funding increase, the FFCRA imposed conditions restricting the disenrollment and standards for re-enrolling Medicaid beneficiaries to promote continuous care of beneficiaries during the PHE. The bipartisan omnibus spending plan passed by Congress and signed into law by the President on December 29, 2022, amended these Medicaid enrollment protections and increased FMAP funding provided in the FFCRA. The FMAP increase CMS provides to states was subject to reduction reductions in 2023 as noted below&#58; for the second quarter, April through June 2023, this increase was reduced to 5.0%&#59; in the third quarter, from July through September, the FMAP increase was reduced to 2.5%, and in October through December, the FMAP increase will be reduced to 1.5%. The ultimate amount of funding from each state will vary substantially based on that states&#8217; policies.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS&#8217;s provision of these increased FMAP funds to states is conditioned upon states reporting to CMS certain Medicaid-related information, including data pertaining to Medicaid renewals, termination of Medicaid coverage, beneficiary customer service information, and other eligibility and renewal information that may be identified in regulations or by the HHS Secretary. States that do not report required data to CMS beginning in July of 2023 will be penalized 0.25% percentage points, up to a total of 1.0%, for each quarter the state does not report data to CMS. The omnibus spending plan also grants CMS authority to impose fines, penalties, and other sanctions upon states that do not comply with this law&#8217;s requirements for increased FMAP payments. These requirements and budgetary pressures can lead state governments to reduce or limit Medicaid spending.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the omnibus spending bill adopted in December of 2022, states began disenrolling Medicaid beneficiaries on April 1, 2023. During the PHE, funding was provided for continuous Medicaid enrollment, and the unwinding of the continuous enrollment period reduces CMS&#8217;s contribution to state-administered Medicaid programs. CMS guidance permits states up to 14 months to initiate and process traditional Medicaid renewals, including the eligibility and enrollment process. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare Annual Payment Rule and Updates - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Balanced Budget Act of 1997 required the implementation of a per diem prospective payment system (PPS) for SNFs covering all costs related to the provision of services to Medicare Part A beneficiaries. The SNF PPS payment rates are adjusted for case mix and geographic variation in wages and cover all costs of furnishing covered SNF services (routine, ancillary, and capital-related costs). CMS is required to calculate an annual Medicare market-basket update to the payment rates. On July 31, 2023, CMS issued a final rule for Fiscal Year (FY) 2024 that updates Medicare payment rates for skilled nursing facilities under the SNF PPS. For FY 2024, SNF PPS rates under Medicare Part A will increase by 4.0%. This estimate reflects a 6.4% net market basket update to the payment rates, which is based on a 3.0% SNF market basket increase plus a 3.6% market basket forecast error adjustment and less a 0.2% productivity adjustment and less a 2.3% adjustment as a result of the second phase of the recalibrated parity adjustment under the Patient Driven Payment Model (PDPM). </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sequestration of Medicare Rates - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Budget Control Act of 2011 requires a mandatory, across the board reduction in federal spending, called a sequestration. Medicare FFS claims with dates of service or dates of discharge on or after April 1, 2013 incur a 2.0% reduction in Medicare payments. Due to subsequent legislative amendments to the statute, the sequestrations will remain in effect through 2032, with the exception of a temporary suspension from May 1, 2020 through March 31, 2022. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patient-Driven Payment Model (PDPM) - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PDPM, a case-mix classification model used in the SNF PPS for classifying SNF patients in a stay covered under Medicare Part A, became effective October 1, 2019. PDPM classifies patients into payment groups based on the patient&#8217;s condition (clinically relevant factors) and resulting care needs, rather than on the volume of services provided, to determine Medicare reimbursement. PDPM utilizes five case-mix adjusted payment components&#58; physical therapy, occupational therapy, speech language pathology, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nursing and social services and non-therapy ancillary services. It also uses a sixth non-case mix component to cover utilization of SNFs&#8217; resources that do not vary depending on resident characteristics.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skilled Nursing Facility Value-Based Purchasing (SNF-VBP) Program - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All SNFs that receive reimbursement under the SNF PPS are also subject to the SNF Value Based Purchasing (VBP) Program. The SNF-VBP Program awards SNFs with incentive payments based on the quality of care they provide to Medicare beneficiaries. For the FY2024 Program year, performance in the SNF VBP Program is based on a single measure of all-cause hospital readmissions. Beginning in the FY 2026 program year, the measures will be expanded to include (1) Skilled Nursing Facility Healthcare Associated Infections Requiring Hospitalization (SNF HAI), and (2) Total Nursing Hours per Resident Day Staffing (Total Nurse Staffing), and beginning in the FY 2027 program year, the measures will be further expanded to include Discharge to Community&#8212;Post-Acute Care Measure for Skilled Nursing Facilities (DTC PAC SNF).</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skilled Nursing Facility &#8211; Quality Reporting Program (SNF QRP) - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT Act) created data reporting requirements for certain Post-Acute-Care (PAC) providers. The IMPACT Act requires that each SNF submit its quality data and standardized patient assessment data elements in connection with the Quality Reporting Program (QRP). If a SNF does not submit required quality data, the SNF&#8217;s payment rates are reduced by 2.0% for each such fiscal year. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare Part B Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">- </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our revenue is paid by the Medicare Part B program under a fee schedule. Medicare Part B provides reimbursement for certain physician services, limited drug coverage, and other outpatient services outside of a Medicare Part A covered patient stay. Although certain therapy services were historically subject to a payment cap, the Bipartisan Budget Act of 2018 (BBA) repealed those caps while retaining and adding additional limitations to ensure appropriate therapy services. The BBA also establishes coding modifier requirements and retains the targeted medical review process established under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) at a threshold amount of $3,000. The Current Year (CY) 2024 Physician Fee Schedule (PFS) Final Rule reduced the conversion factor (i.e., the number by which CMS determine all current procedural terminology code payments) by 3.4% from the CY 2023 conversion factor. This changed lowered the overall payment rate under the PFS by 1.25% in CY 2024 compared to CY 2023. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Programs of All-Inclusive Care for the Elderly</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Programs of All-Inclusive Care for the Elderly (PACE) provides medical and social services to elderly individuals who qualify for nursing home care but, at the time of enrollment, can still live safely in the community. CMS conducts a comprehensive annual review of the PACE organization's operation of the PACE program during a 3-year trial period to assure compliance with all significant requirements. For example, each PACE organization must establish an interdisciplinary team that, among other responsibilities, comprehensively assesses the individual needs of each participant and assigns each participant to an interdisciplinary team. On April 12, 2023, CMS published updates to the PACE program, including to the determination of a contract year and the types of contracted services.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal Healthcare Reform</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patient Protection and Affordable Care Act - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, there have been, and we expect there will continue to be, a number of legislative and regulatory changes to the U.S. healthcare system, many of which are intended to contain or reduce healthcare costs. For example, the Affordable Care Act (ACA) affects how healthcare services are covered, delivered and reimbursed, and it expanded health insurance coverage through a combination of public program expansion and private sector health insurance reforms. Several of the reforms are very significant and could ultimately change the nature of our services, the methods of payment for our services and the underlying regulatory environment. These reforms include modifications to the conditions of qualification for payment, bundling of payments to cover both acute and post-acute care and the imposition of enrollment limitations on new providers. Since its enactment, there have been judicial, executive and Congressional challenges to certain aspects of the ACA and, on June 17, 2021, the U.S. Supreme Court dismissed the most recent judicial challenge to the ACA brought by several states without specifically ruling on the constitutionality of the ACA.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August of 2022, Congress passed and the Biden Administration signed into law the Inflation Reduction Act of 2022 (IRA), which continued and expanded certain provisions of the ACA. Among other things, the IRA extended premium subsidies paid by the federal government, which were scheduled to expire at the end of 2022, until the end of 2024, resulting in subsidies being available to offset or reduce the costs of private health insurance policies for older persons on fixed incomes or with limited savings. This may aid older patients in obtaining or keeping their health insurance in order to pay for long-term care services. Other healthcare-related provisions of the IRA include phased-in provisions for Medicare to negotiate the prices of certain prescription drugs, limiting the out-of-pocket cost of prescribed drugs to Medicare Part D recipients to $2,000 per year (in addition to a monthly cap on out-of-pocket prescription drug expenses) and limiting the monthly cost of insulin to $35.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Five-Star Quality Reporting Metrics - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS created the Five-Star Quality Rating System, which assigns each a nursing home a rating between one and five stars, as a resource to assist consumers with comparing nursing homes. Each nursing home receives an overall rating, as well as separate ratings for health inspections, staffing and quality measures. In part due to the competitive nature of the system, achieving a four- or five-star ranking can be challenging. The results of the Five-Star Quality Rating System are published on CMS&#8217;s public website, Care Compare. CMS also displays a consumer alert icon next to nursing homes that have been cited for incidents of abuse, neglect, or exploitation, which is updated monthly with CMS&#8217;s refresh of survey inspection results on that website. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed and Enacted Federal and State Legislation - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Congress has introduced various bills intended to improve quality of care and oversight in nursing homes. For example, on August 10, 2021, the Nursing Home Improvement and Accountability Act of 2021 was introduced in the U.S. Senate and proposed to reduce SNF payments for inaccurate submission of certain data, provide federal funding to carry out SNF data validation and ensure accuracy of cost report information, and mandate staffing requirements for SNFs. Although this bill was not approved by Congress, similar proposed legislation may be introduced in the future. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to proposed legislation at the federal level, state legislatures have introduced and enacted legislation to address quality of care and oversight in nursing homes. For example, California enacted the Skilled Nursing Facility Ownership and Management Reform Act of 2022, which took effect on July 1, 2023, increases the oversight authority of the California Department of Public Health and changes several provisions regarding SNF licensing. We expect for states to continue to introduce and pass legislation that increases the regulation of SNFs. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quality of Care initiatives - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Biden Administration has published several fact sheets related to the quality of care in nursing homes. On October 21, 2022, the Biden Administration published a fact sheet calling for improvements to the quality of care in nursing homes, and on September 1, 2023, the Biden Administration published another fact sheet regarding initiatives to improve resident safety in nursing homes, such as minimum staffing requirements. Additionally, on September 1, 2023, CMS issued a proposed rule that would create minimum staffing standards for skilled nursing facilities and nursing facilities and requirements for states to report the percent of Medicaid payments spent on compensation to direct care workers and support staff at each nursing facility and each intermediate care facility for individuals with intellectual disabilities. We anticipate there will be continued administrative, regulatory, and legislative efforts at the federal and state level to monitor and regulate LTC facilities.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare and Medicaid Enrollment and Participation Requirements</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare providers, including SNFs and other LTC facilities, must comply with certain requirements in order to participate in the Medicare and Medicaid Programs. Examples include requirements related to resident rights, admission, transfer and discharge, resident assessments, care planning, availability of certain services, administration and governance, emergency preparedness, quality assurance and performance improvement programs, infection control, compliance and ethics programs, physical environment, and training requirements. Compliance with these requirements can be burdensome and costly. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One such requirement of participation in the Medicare and Medicaid programs involves limitations around the use of pre-dispute, binding arbitration agreements by LTC facilities. CMS has issued guidance and direction around arbitration, to include&#58; the facility must not require signing of an arbitration agreement as a condition of admission </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or a requirement to continue to receive care at the facility, and the agreement must expressly contain language to this effect&#59; the facility must inform the resident or the resident's representative of the right not to sign the agreement&#59; the facility must confirm that the agreement is explained in a manner that can be understood and that the resident or their representative acknowledges their understanding of the agreement&#59; the agreement must provide for the right to rescind the agreement within 30 calendar days of signing&#59; and the agreement may not contain language that prohibits or discourages communications with federal, state, or local officials, including federal and state surveyors, other federal or state health department employees, and representatives of the Office of the State Long-Term Care Ombudsperson. Congress has routinely introduced, but not passed, legislation addressing the issue of arbitration agreements used by LTC facilities. While legislative action is possible in the future, federal regulations and state&#47;federal laws remain our primary source of authority over the use of pre-dispute binding arbitration agreements.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The requirements of participation serve as the basis for survey activities for the purpose of determining whether a facility meets the requirements for participation in Medicare and Medicaid. CMS has updated its guidance for surveyors and state agencies in order to, among other things, enhance responses to resident complaints and reported incidents. The guidance focuses on the following topics&#58; (1) resident abuse and neglect (including reporting of abuse)&#59; (2) admission, transfer and discharge&#59; (3) mental health and substance abuse disorders&#59; (4) nurse staffing and reporting of payroll to evaluate staffing sufficiency&#59; (5) residents&#8217; rights (including visitation)&#59; (6) potential inaccurate diagnoses or assessments&#59; (7) prescription and use of pharmaceuticals, including psychotropics and drugs that act like psychotropics&#59; (8) infection prevention and control&#59; (9) arbitration of disputes between facilities and residents&#59; (10) psychosocial outcomes and related severity&#59; and (11) the timeliness and completion of state investigations to improve consistency in the application of standards among various states. In 2022, CMS published the survey resources CMS and state surveyors would be using to evaluate LTC facilities' compliance with vaccination and reporting requirements. These updates provided more information for state surveyors to utilize when evaluating LTC facilities&#8217; compliance with the Medicare Requirements of Participation, as well as included guidance for facilities on operationalizing compliance with these requirements based on how surveyors would measure and evaluate facility performance. CMS has also made significant software enhancement, including those used to measure and evaluate LTC facility compliance with the Medicare Requirements of Participation.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensure and Certification</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our facilities and healthcare professionals are subject to various federal, state, and local licensure and certification requirements in connection with our provision of healthcare services. Certain states in which we operate have certificate of need or similar programs regulating the establishment or expansion of healthcare facilities. The initial and continued licensure of our facilities and certification to participate in government healthcare programs depends upon many factors including various state licensure regulations relating to quality of care, environment of care, equipment, services, minimum staffing requirements, staff training, personnel, and the existence of adequate policies, procedures, and controls. In addition to facility licensure requirements, states also impose licensing requirements on the healthcare professionals who provide services at our facilities. States may impose restrictions on, or revoke, licenses of healthcare providers for, among other things, improper clinical conduct and delegation of such services, patient mistreatment, ethical violations and substance abuse, or aiding and abetting the unlicensed practice of medicine. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal, state, and local agencies survey our facilities on a regular basis to determine whether the facilities are in compliance with regulatory operating and health standards and conditions for participating in government healthcare programs. Unannounced surveys or inspections generally occur at least annually and may also follow a government agency's receipt of a complaint about a facility. Facilities must pass these inspections to maintain licensure under state law, to obtain or maintain certification under the Medicare and Medicaid programs, to continue participation in the Veterans Administration program at some facilities, and to comply with provider contracts with managed care clients at many facilities. From time to time, our facilities, like others in the healthcare industry, may receive notices from federal and state regulatory agencies of an alleged failure to substantially comply with applicable standards, rules or regulations. These notices may require corrective action, may impose civil monetary penalties for noncompliance, and may threaten or impose other operating restrictions on SNFs such as admission holds, provisional skilled nursing license, or increased staffing requirements. If our independent operating subsidiaries fail to comply with these directives or otherwise fail to comply substantially with licensure and certification laws, rules </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and regulations, the facility could lose its certification as a Medicare or Medicaid provider, or lose its license permitting operation in the State. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, CMS has increased its focus on facilities with a history of serious or sustained quality of care problems through the special focus facility (SFF) initiative. SFFs receive heightened scrutiny and more frequent regulatory surveys. Failure to improve the quality of care can result in fines and termination from participation in Medicare and Medicaid. A facility &#8220;graduates&#8221; from the program once it demonstrates significant improvements in quality of care that are continued over a defined period of time. On October 21, 2022, CMS issued a Memorandum identifying the changes it intends to make in connection with the oversight of those facilities that fall under the SFF Program. These proposed measures included increased penalties for SFFs that fail to improve their performance upon further inspection by CMS, increasing the standards SFFs must meet to graduate from the SFF program, maintaining heightened oversight of any SFF for a period of three years after it graduates and increasing the technical assistance CMS provides to SFFs. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS has undertaken several initiatives to increase or intensify Medicaid and Medicare survey and enforcement activities, including federal oversight of state actions. CMS is taking steps to focus more survey and enforcement efforts on facilities with findings of substandard care or repeat violations of Medicaid and Medicare standards and to identify multi-facility providers with patterns of noncompliance. CMS is also increasing its oversight of state survey agencies and requiring state agencies to use enforcement sanctions and remedies more promptly when substandard care or repeat violations are identified, to investigate complaints more promptly, and to survey facilities more consistently. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Civil and Criminal Fraud and Abuse Laws and Enforcement</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. healthcare industry is heavily regulated by federal, state and local governments. We are subject to federal and state laws that regulate our relationships with physicians and other healthcare providers, the manner in which our facilities provide and bill for services and collect reimbursement from governmental programs and private payors, our marketing activities, and other aspects of our operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal Anti-Kickback statute (AKS) prohibits, among other things, knowingly and willfully offering, paying, soliciting or receiving remuneration, directly or indirectly, in cash or kind, to induce or reward either the referral of an individual for, or the purchase, order or recommendation of, any good or service, for which payment may be made under federal and state healthcare programs such as Medicare and Medicaid. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. The AKS includes statutory exceptions and regulatory safe harbors that protect certain arrangements. Failure to meet the requirements of the safe harbor, however, does not render an arrangement illegal. Rather, the government may evaluate such arrangements on a case-by-case basis, taking into account all facts and circumstances, including the parties&#8217; intent and the arrangement&#8217;s potential for abuse, and may be subject to greater scrutiny by enforcement agencies.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Stark Law prohibits a physician from referring a Medicare or Medicaid patient for a &#8220;designated health service&#8221; to an entity with which the physician or an immediate family member has a financial relationship, unless an exception applies. Designated health services include inpatient and outpatient hospital services, physical therapy, occupational therapy, speech language pathology services, durable medical equipment, prosthetics, orthotics and supplies, diagnostic imaging, and enteral and parenteral feeding and supplies and home health services. Under the Stark Law, a &#8220;financial relationship&#8221; is defined as an ownership or investment interest or a compensation arrangement. If such a financial relationship exists and does not meet a Stark Law exception, the entity is prohibited from submitting or claiming payment under the Medicare or Medicaid programs or from collecting from the patient or other payor.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal False Claims Act (FCA) prohibits a person from knowingly presenting, or caused to be presented, a false or fraudulent request for payment from the federal government, or from making a false statement or using a false record to have a claim approved. The FCA further provides that a lawsuit thereunder may be initiated in the name of the government by an individual referred to as a &#8220;whistleblower.&#8221; Moreover, the government may assert </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that a claim including items and services resulting from a violation of the AKS or the Stark Law constitutes a false or fraudulent claim for purposes of the civil FCA. Penalties for a violation of the FCA include fines for each false claim, plus up to three times the amount of damages caused by each false claim.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the Civil Monetary Penalties Statute authorizes the imposition of civil monetary penalties, assessments and exclusion against an individual or entity based on a variety of prohibited conduct, including, but not limited to offering remuneration to a federal healthcare program beneficiary that the individual or entity knows or should know is likely to influence the beneficiary to order or receive healthcare items or services from a particular provider.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many states have also adopted or may adopt similar anti-kickback, self-referral, false claim, and fraud and abuse laws as described above. The scope of these laws and the interpretations of them vary by jurisdiction and are enforced by local courts and regulatory authorities, each with broad discretion. Some state fraud and abuse laws apply to items or services reimbursed by any third-party payor, including commercial insurers, and to funds paid out of pocket by a patient. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violation of any of these laws or any other governmental regulations that apply may result in significant penalties, including, without limitation, administrative civil and criminal penalties, damages, fines, additional reporting requirements and compliance oversight obligations, contractual damages, the curtailment or restructuring of operations, exclusion from participation in governmental healthcare programs and&#47; or imprisonment. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, providers are subject to inquiries, investigations and audits by federal and state agencies related to compliance with participation and payment rules under government payment programs, as well commercial payors. These inquiries may originate from the United States Department of Health and Human Services (HHS) Office of the Inspector General (OIG), state Medicaid agencies, state Attorney Generals, local and state ombudsman offices and CMS Recovery Audit Contractors, among other agencies and commercial payors. In response to the inquiries, investigations and audits, federal and state agencies and other payors may impose citations for regulatory deficiencies and other regulatory penalties, including demands for refund of overpayments, civil monetary penalties, payment bans and terminations from the Medicare and Medicaid programs, which may be temporary or permanent in nature. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, there has been increased regulatory scrutiny into post-hospital SNF care. For example, in November 2019, the OIG released a report of its investigation into overpayments to hospitals that did not comply with Medicare&#8217;s post-acute-care transfer policy. Hospitals violating this policy transferred patients to certain post-acute-care settings, such as SNFs, but claimed the higher reimbursements associated with discharges to homes. A similar OIG audit report, released in February 2019, focused on improper payments for SNF services when the Medicare three-day inpatient hospital stay requirement was not met. In 2021, the OIG released the result of an audit finding that Medicare overpaid millions of dollars of chronic care management (CCM) services. The OIG's 2021 report found that in calendar years 2017 and 2018, Medicare overpaid millions of dollars in CCM claims. In 2022, the OIG released an audit revealing that CMS had not collected $226 million, or 45%, of identified overpayments within that period, potentially affecting SNFs. These investigatory actions by OIG demonstrate its increased scrutiny into post-hospital SNF care provided to beneficiaries and may encourage additional oversight or stricter compliance standards.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On numerous occasions, CMS has indicated its intent to vigilantly monitor overall payments to SNFs, paying particular attention to facilities that have high reimbursements for ultra-high therapy, therapy resource utilization groups with higher activities of daily living scores and long average lengths of stay. The OIG recognizes that there is a strong financial incentive for facilities to bill for higher levels of therapies, even when not needed by patients. We cannot predict the extent to which the OIG's recommendations to CMS will be implemented and, what effect, if any, such proposals would have on us. We expect for regulators to continue to focus on post-hospital SNF care, which may result in additional oversight or stricter compliance standards.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_2255"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Facilities</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PACS Services. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our PACS Services&#8217; main office is located in Farmington, Utah. The property consists of approximately 35,000 square feet of usable office space. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Facilities. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, we operated&#160;208&#160;post-acute care facilities in Arizona, California, Colorado, Kentucky, Missouri, Nevada, Ohio, South Carolina and Texas, with the operational capacity to serve approximately&#160;23,760 patients with 23,070 skilled nursing beds and 690 assisted living beds. Of these post-acute care facilities, we leased&#160;165&#160;facilities and directly owned the real estate at&#160;29&#160;post-acute care facilities. In addition, we have entered into contracts to acquire up to 10 facilities that we expect to close in the first quarter of 2024, including seven facilities representing 1,084 skilled nursing beds in California and three facilities representing 250 skilled nursing beds and 174 assisted living beds in Missouri. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides summary information regarding the location of our post-acute care facilities and operational beds by property type as of December 31, 2023&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.194%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.321%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leased</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Owned</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Facilities</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beds&#47;Units</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Facilities</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beds&#47;Units</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Facilities</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beds&#47;Units</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,524&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,206&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,730&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,210&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,452&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kentucky</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Missouri</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ohio</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,719&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="i2baa8a1031f44c51b1664e00d256c582_2244"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various legal proceedings, claims, and governmental inspections, audits, and investigations that arise in the ordinary course of our business. Although the results of these legal proceedings, claims, and investigations cannot be predicted with certainty, we do not believe that the final outcome of any matters that we are currently involved in are reasonably likely to have a material adverse effect on our business, financial condition or results of operations. Regardless of final outcomes, however, any such proceedings, claims, and investigations may nonetheless impose a significant burden on management and employees and be costly to defend, with unfavorable preliminary or interim rulings. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_929"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors and Executive Officers</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information regarding our directors and executive officers as of the date hereof. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.420%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Age</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 5.5pt;text-align:center;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Position</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Executive Officers</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jason Murray</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, Co-Founder, Chief Executive Officer and Chairman</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Hancock</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, Co-Founder and Executive Vice Chairman</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joshua Jergensen</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Operating Officer</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derick Apt</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Mitchell</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Legal Officer and Secretary</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter (P.J.) Sanford</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President, Providence Administrative Consulting Services, Inc.</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michelle Lewis</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Accounting Officer</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Non-Employee Directors</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jacqueline Millard</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taylor Leavitt</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Member of the Nominating and Corporate Governance Committee.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Member of the Audit Committee.</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Member of the Compensation Committee.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Officers</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jason Murray</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Chief Executive Officer and a member of our board of directors since January 2013 and has served as Chairman since January 2024. Mr. Murray co-founded our company and has worked in the post-acute sector for 23 years. Prior to our founding, Mr. Murray was an Operations Officer for Intermountain Healthcare, Inc. a non-profit healthcare system, from June 2011 to January 2013 where he was the interim Chief Executive Officer of Park City Medical Center from June 2012 to October 2012. From February 2009 to June 2011, Mr. Murray served as a nursing home administrator at a facility affiliated with Plum Healthcare Group, a skilled nursing facility operator. Mr. Murray received a B.A. in Healthcare Administration and a Master of Healthcare Administration from Weber State University. We believe Mr. Murray is qualified to serve on our board of directors because of his business acumen, executive leadership and extensive knowledge of our business.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mark Hancock </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as our Executive Vice Chairman since January 2024 and a member of our board of directors since January 2013 and previously served as our Chief Financial Officer and Secretary from January 2013 to January 2024. Mr. Hancock is also a co-founder of our company. Prior to our founding, Mr. Hancock was Vice President of Finance and Treasurer of Farm Credit Mid-America, a financial services provider, from 2010 to 2013 and served as a nursing home administrator at a facility affiliated with Plum Healthcare Group, a skilled nursing facility operator, from 2009 to 2010. From 2007 to 2009, Mr. Hancock was the Director of Corporate Finance for Steel Technologies Inc., a publicly traded steel processor, and served as the Assistant Controller for Ford Motor Company, a publicly traded multinational automobile manufacturer, from 2000 to 2007. Mr. Hancock received a B.S. in Civil Engineering and a Master of Business Administration with a focus in Finance from Brigham Young University. We believe Mr. Hancock is qualified to serve on our board of directors because of his extensive leadership experience, financial expertise and strong understanding of our business.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Joshua Jergensen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our President and Chief Operating Officer since January 2023. Prior to that, Mr. Jergensen served as our Executive Vice President of Operations from July 2014 to January 2023. From October 2009 to July 2014, Mr. Jergensen was a nursing home administrator at Balboa Nursing and Rehabilitation Center, one of our affiliated skilled nursing facilities. Mr. Jergensen received a B.S. in Business Management with an </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">emphasis in Finance from Brigham Young University and a Master of Healthcare Administration from the University of Southern California.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derick Apt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Chief Financial Officer since January 2024 and previously served as our Executive Vice President, Chief Investment Officer and Treasurer from January 2023 to January 2024. Prior to that, Mr. Apt served as our Executive Vice President of Corporate Finance and Treasurer since joining our company in April 2018. From February 2015 to April 2018, Mr. Apt was Manager of Treasury and Finance for Vivint, Inc., a smart home platform company. Mr. Apt received a B.S. in Biological Engineering from the University of Missouri and a Master of Business Administration from the George Washington University School of Business.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">John Mitchell </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as our Chief Legal Officer since January 2023. Prior to that, Mr. Mitchell served as our Executive Vice President and General Counsel since joining our company in January 2017. From April 2016 to November 2016, Mr. Mitchell served as Vice President, Legal at HCP, a publicly traded REIT. Prior to that, Mr. Mitchell was Senior Vice President of Legal Affairs and Chief Compliance Officer of Skilled Healthcare Group, Inc., a publicly traded provider of post-acute healthcare services, from January 2011 to May 2015. Mr. Mitchell received a B.A. in History and a J.D. from Brigham Young University.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Peter (P.J.) Sanford</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as President of Providence Administrative Consulting Services, Inc., which provides PACS Services, since January 2024. Prior to that, Mr. Sanford served as our Chief Administrative Officer from January 2023 to December 2023 and as our Executive Vice President of Operations and Finance from October 2015 to January 2023. From December 2012 to October 2015, Mr. Sanford served as a nursing home administrator at Paradise Valley Health Care Center, one of our affiliated skilled nursing facilities. Mr. Sanford received a B.A. in English with a minor in Business from Brigham Young University and received a Master of Business Administration from the University of Michigan.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Michelle Lewis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Chief Accounting Officer since January 2023. Prior to that, Ms. Lewis served in various roles of increasing responsibility, including as our Controller, since joining our company in July 2018. Prior to that, Ms. Lewis owned and operated Michelle Lewis Accounting Services, PLLC, a certified public accounting firm, and also provided controller functions at a privately held healthcare organization, from January 2008 to May 2015. Ms. Lewis received a B.S. in Business Administration from the California State University, East Bay.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Employee Directors</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jacqueline Millard</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as a member of our board of directors since July 2023. Since January 2021, Ms. Millard has owned and operated a private investment advisory firm. Previously, Ms. Millard was the Vice President and Chief Investment Officer of Intermountain Healthcare, Inc., a non-profit healthcare system, from June 1993 to January 2021. Ms. Millard received a B.S. in Finance from Weber State University and a Master of Business Administration from Westminster College. We believe Ms. Millard is qualified to serve on our board of directors because of her extensive financial and leadership experience.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Taylor Leavitt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as a member of our board of directors since July 2023. Mr. Leavitt owns and has served as the Chief Executive Officer and Managing Partner of Leavitt Equity Partners, a healthcare-focused private equity firm, since August 2014. Mr. Leavitt currently serves on the board of directors of several private entities that provide healthcare services. Previously, Mr. Leavitt was a co-founder and Partner of Leavitt Partners, a healthcare strategy consulting firm, from June 2009 to December 2020. Mr. Leavitt received a B.S. in Finance and Economics from Utah State University and a Master of Business Administration from the UCLA Anderson School of Management. We believe Mr. Leavitt is qualified to serve on our board of directors because of his strong business acumen and extensive experience in finance and investing.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Family Relationships</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no family relationships among any of our directors or executive officers. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Composition</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors currently consists of four&#160;directors. Our Amended and Restated Charter and Amended and Restated Bylaws will provide that our board of directors will be divided into three classes, as nearly equal in number as possible, with the directors in each class serving for a three-year term, and one class being elected each year by our stockholders. Pursuant to the stockholders agreement, Each of Messrs. Murray and Hancock will also agree to vote, or cause to vote, all of their outstanding shares of our common stock at any annual or special meeting of stockholders in which directors are elected, so as to cause the election of Messrs. Murray and Hancock. See the section titled &#8220;Certain Relationships and Related Party Transactions&#8212;Stockholders Agreement.&#8221;  </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When considering whether directors have the experience, qualifications, attributes, or skills, taken as a whole, to enable our board of directors to satisfy its oversight responsibilities effectively in light of our business and structure, the board of directors focuses primarily on each person&#8217;s background and experience as reflected in the information discussed in each of the directors&#8217; individual biographies set forth above. We believe that our directors provide an appropriate mix of experience and skills relevant to the size and nature of our business.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Classified Board of Directors </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Amended and Restated Charter will provide that, upon the completion of this offering, our board of directors will be divided into three classes with staggered three-year terms. Upon expiration of the term of a class of directors, directors for that class will be elected for three-year terms at the annual meeting of stockholders in the year in which that term expires. As a result, only one class of directors will be elected at each annual meeting of our stockholders, with the other classes continuing for the remainder of their respective three-year terms. Each director&#8217;s term will continue until the election and qualification of his or her successor, or his or her earlier death, resignation or removal for cause. Our directors will be divided among the three classes as follows&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Class I directors, whose initial term will expire at our first annual meeting of stockholders following this offering, will consist of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, and, &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Class II directors, whose initial term will expire at our second annual meeting of stockholders following this offering, will consist of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, and, &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Class III directors, whose initial term will expire at our third annual meeting of stockholders following this offering, will consist of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, and, &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Amended and Restated Charter and Amended and Restated Bylaws will provide that only our board of directors may fill vacancies on our board. We expect that any additional directorships resulting from an increase in the number of directors will be distributed among the three classes so that, as nearly as possible, each class will consist of one-third of the total number of directors. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classification of our board of directors may have the effect of delaying or preventing changes in our control or management. See the section titled &#8220;Description of Capital Stock&#8212;Anti-Takeover Effects of Provisions of our Amended and Restated Charter and Amended and Restated Bylaws&#8212;Amended and Restated Charter and Amended and Restated Bylaw Provisions&#8221; for additional information. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Independence and Controlled Company Exception</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will be a &#8220;controlled company&#8221; under the rules of the New York Stock Exchange. As a result, we qualify for exemptions from, and may elect not to comply with, certain corporate governance requirements under the rules, including the requirements that within one year of the completion of this offering we have a board that is composed of majority of &#8220;independent directors,&#8221; as defined under the rules, and a compensation committee and a nominating and corporate governance committee that are composed entirely of independent directors. Even though we will be a controlled company, we are required to comply with the rules of the SEC and the New York Stock Exchange relating to the membership, qualifications and operations of the audit committee, as discussed below.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rules of the New York Stock Exchange define a &#8220;controlled company&#8221; as a company of which more than 50% of the voting power for the election of directors is held by an individual, a group or another company. After the closing of this offering the Founders, as described in &#8220;Certain Relationships and Related Party Transactions&#8212;Stockholders Agreements&#8221; will beneficially own approximately  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; % of the combined voting power of our common stock (or&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; % if the underwriters exercise their option to purchase additional shares of our common stock from us in full). Accordingly, we will qualify as a &#8220;controlled company&#8221; and will be able to rely on the controlled company exemption from the director independence requirements of the New York Stock Exchange relating to the board of directors, compensation committee and nominating and corporate governance committee. See the section titled &#8220;Risk Factors&#8212;Upon the listing of our common stock on the New York Stock Exchange, we will be a &#8220;controlled company&#8221; within the meaning of the corporate governance standards of the New York Stock Exchange. As a result, we will qualify for, and intend to rely on, exemptions from certain corporate governance standards. You will not have the same protections afforded to stockholders of companies that are subject to such requirements.&#8221; If we cease to be a controlled company and our common stock continues to be listed on the New York Stock Exchange, we will be required to comply with these requirements by the date our status as a controlled company changes or within specified transition periods applicable to certain provisions, as the case may be.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the consummation of this offering, our board of directors undertook a review of the independence of our directors and considered whether any director has a material relationship with us that could compromise that director&#8217;s ability to exercise independent judgment in carrying out that director&#8217;s responsibilities. Our board of directors has affirmatively determined that Jacqueline Millard, Taylor Leavitt and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;are each an &#8220;independent director,&#8221; as defined under the Exchange Act and the rules of the New York Stock Exchange.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Oversight</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors is responsible for overseeing our risk management process. Our board of directors focuses on our general risk management strategy, the most significant risks facing us, and oversees the implementation of risk mitigation strategies by management. Our board of directors is also apprised of particular risk management matters in connection with its general oversight and approval of corporate matters and significant transactions. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Committees</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors has established an audit committee, a compensation committee, and nominating and corporate governance committee, each of which has the composition and the responsibilities described below. In addition, from time to time, special committees may be established under the direction of our board of directors when necessary to address specific issues.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the audit committee, the compensation committee, and nominating and corporate governance committee operates under a written charter that was approved by our board of directors in connection with our initial public offering. A current copy of each of the audit committee, compensation committee, and nominating and corporate governance committee charters are available on our corporate website at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.pacs.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The reference to our website address in this prospectus does not include or incorporate by reference the information on our website into this prospectus. We have included our website address in this prospectus solely as an inactive textual reference.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors directs the management of our business and affairs, as provided by Delaware law, and conducts its business through meetings of the board of directors and standing committees. We will have a standing audit committee, compensation committee, and nominating and corporate governance committee. In addition, from time to time, special committees may be established under the direction of the board of directors when necessary to address specific issues. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit committee will be responsible for, among other things&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">appointing, compensating, retaining, evaluating, terminating, and overseeing our independent registered public accounting firm&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">discussing with our independent registered public accounting firm their independence from management&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing with our independent registered public accounting firm the scope and results of their audit&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approving all audit and permissible non-audit services to be performed by our independent registered public accounting firm&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">overseeing the financial reporting process and discussing with management and our independent registered public accounting firm the interim and annual financial statements that we file with the SEC&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and monitoring our accounting principles, accounting policies, financial and accounting controls, and compliance with legal and regulatory requirements&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing our policies on risk assessment and risk strategy and management, including risk policies and risk mitigation strategies by management&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing related party transactions&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishing procedures for the confidential anonymous submission of concerns regarding questionable accounting, internal controls, or auditing matters.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the consummation of this offering, our audit committee will consist of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; ,&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;, with&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; serving as chair. Rule&#160;10A-3 of the Exchange Act and the New York Stock Exchange rules require that our audit committee have at least one independent member upon the listing of our common stock, have a majority of independent members within 90&#160;days of the date of this prospectus and be composed entirely of independent members within one year of the date of this prospectus. Our board of directors has affirmatively determined that &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; each meet the definition of &#8220;independent director&#8221; for purposes of serving on the audit committee under Rule&#160;10A-3 and the New York Stock Exchange rules. Each member of our audit committee meets the financial literacy requirements of the New York Stock Exchange listing standards. In addition, our board of directors has determined that &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; will qualify as an &#8220;audit committee financial expert,&#8221; as such term is defined in Item&#160;407(d)(5) of Regulation&#160;S-K. Our board of directors will adopt a new written charter for the audit committee, which will be available on our website at www.pacs.com substantially concurrently with the consummation of this offering. The information on, or that can be accessed through, our website is deemed not to be incorporated in this prospectus or to be part of this prospectus.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Committee</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our compensation committee will be responsible for, among other things&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and approving, or recommending that our board of directors approve, the compensation of our Chief Executive Officer, Executive Vice Chairman and other executive officers&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">appointing and overseeing any compensation consultants&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and approving or making recommendations to our board of directors regarding our incentive compensation and equity-based plans&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and making recommendations to our board of directors with respect to director compensation&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and discussing annually with management our &#8220;Compensation Discussion and Analysis&#8221; disclosure if and to the extent then required by SEC rules&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">preparing the compensation committee report if and to the extent then required by SEC rules. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the consummation of this offering, our compensation committee will consist of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; ,&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, with &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; serving as chair. Our board has determined that &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;are &#8220;non-employee directors&#8221; as defined in Section&#160;16b-3 of the Exchange Act. Our board of directors will adopt a new written charter for the compensation committee, which will be available on our website at www.pacs.com substantially concurrently with the consummation of this offering. The information on, or that can be accessed through, our website is deemed not to be incorporated in this prospectus or to be part of this prospectus. The composition of our compensation committee meets the New York Stock Exchange requirements for independence under the current listing standards and SEC rules and regulations, including the exemptions available to controlled companies.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nominating and Corporate Governance Committee</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our nominating and corporate governance committee will be responsible for, among other things&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">identifying individuals qualified to become members of our board of directors, consistent with criteria approved by our board of directors&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and making recommendations to our board with respect to management succession planning&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">evaluating the overall effectiveness of our board of directors and its committees&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing developments in corporate governance compliance and developing and recommending to our board of directors a set of corporate governance guidelines and principles.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the consummation of this offering, our nominating and corporate governance committee will consist of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,&#160;and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;, with &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; serving as chair. Our board of directors will adopt a new written charter for the nominating and corporate governance committee, which will be available on our website at www.pacs.com substantially concurrently with the consummation of this offering. The information on, or that can be accessed through, our website is deemed not to be incorporated in this prospectus or to be part of this prospectus. The composition of our nominating and corporate governance committee meets the New York Stock Exchange requirements for independence under the current listing standards and SEC rules and regulations, including the exemptions available to controlled companies.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee Interlocks and Insider Participation</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the members of the compensation committee is currently, or has been at any time, one of our executive officers or employees. None of our executive officers serves as a member of the board of directors or compensation committee (or other committee performing equivalent functions) of any entity that has one or more executive officers serving on our board of directors or compensation committee. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Diversity</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our nominating and corporate governance committee will be responsible for reviewing with the board of directors, on an annual basis, the appropriate characteristics, skills and experience required for the board of directors as a whole and its individual members. Although our board of directors does not have a formal written diversity policy with respect to the evaluation of director candidates, in its evaluation of director candidates, our nominating and corporate governance committee will consider factors including, without limitation, issues of character, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">integrity, judgment, potential conflicts of interest, other commitments, and diversity, and with respect to diversity, such factors as gender, race, ethnicity, experience, and area of expertise, as well as other individual qualities and attributes that contribute to the total diversity of viewpoints and experience represented on the board of directors.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code of Ethics and Code of Conduct</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the completion of this offering, we intend to adopt a written code of business conduct and ethics that applies to our directors, officers, and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. We intend to post a copy of the code on our website, www.pacs.com. In addition, we intend to post on our website all disclosures that are required by law or the New York Stock Exchange listing standards concerning any amendments to, or waivers from, any provision of the code. The information on, or that can be accessed through, our website is deemed not to be incorporated in this prospectus or to be part of this prospectus.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_1059"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPENSATION DISCUSSION AND ANALYSIS</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This section provides an overview and analysis of the compensation awarded to or earned by our &#8220;named executive officers,&#8221; including the elements of our compensation program for our named executive officers, material compensation decisions made under that program for fiscal 2023 and the material factors considered in making those decisions. Where relevant, the discussion below also reflects certain contemplated changes to our compensation programs that we intend to implement following the effectiveness of the registration statement of which this prospectus forms a part. Our named executive officers for 2023 (and their current positions) are&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Jason Murray, Director, Co-Founder, Chief Executive Officer and Chairman&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mark Hancock, Director, Co-Founder and Executive Vice Chairman&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Josh Jergensen, President and Chief Operating Officer&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Peter (P.J.) Sanford, President of Providence Administrative Consulting Services, Inc.&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Derick Apt, EVP, Chief Financial Officer. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2024, Mark Hancock resigned as our Chief Financial Officer and Secretary and was appointed as our Executive Vice Chairman. In connection with Mr. Hancock&#8217;s resignation, Derick Apt, our EVP, Chief Investment Officer and Treasurer, was appointed as our Chief Financial Officer.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This discussion may contain forward-looking statements that are based on our current plans, considerations, expectations and determinations regarding future compensation programs. Actual compensation programs that we adopt following the completion of this offering may differ materially from the currently planned programs summarized in this discussion.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Compensation Philosophy and Objectives </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that for us to be successful we must hire and retain people who can continue to develop our strategy and innovate our services. To achieve these objectives, our executive compensation program has been designed to motivate, reward, attract and retain high caliber management and to align compensation with our short- and long-term business objectives, business strategy and financial performance. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our compensation programs for our named executive officers are built to support the following objectives&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">attract the top talent in our leadership positions and motivate our executives to deliver the highest level of individual and team impact and results&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reward high levels of performance with commensurate levels of compensation.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Determination of Compensation</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors is responsible for overseeing all aspects of our executive compensation programs, including executive salaries, performance-based incentives and any executive perquisites for our named executive officers. Our board of directors has the authority to engage its own advisors to assist in carrying out its responsibilities. For fiscal 2023, in preparation for this offering, we engaged Pearl Meyer, an outside compensation advisor, for purposes of setting executive or director compensation.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to 2023, Messrs. Murray and Hancock were the sole members of our board of directors at the time our 2023 compensation program was established. No other executive officer participated directly in the final deliberations or determinations regarding his own compensation package. We expect that our board of directors or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">its compensation committee will review and establish our executive compensation programs following the closing of this offering.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Elements of Our Executive Compensation Program</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary elements of our named executive officers&#8217; compensation and the main objectives of each are&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Base Salary.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Base salary attracts and retains talented executives, recognizes individual roles and responsibilities and provides stable income&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Performance-Based Bonuses&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Performance-based bonuses promote short-term performance objectives and reward executives for their contributions toward achieving those objectives&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Other Benefits and Perquisites&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In addition, our named executive officers are eligible to participate in our health and welfare programs and our retirement programs. We also provide certain perquisites, which aid in attracting and retaining executive talent. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of these elements of compensation is described further below.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Base Salaries</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The base salary of each named executive officer is an important part of the officer&#8217;s total compensation package, and is intended to reflect the officer&#8217;s respective position, duties and responsibilities. Base salaries provide our named executive officers with a reasonable degree of financial certainty and stability. For fiscal year 2023, the base salaries of our named executive offers were $3,000,000 for each of Messrs. Murray and Hancock and $200,000 for each of Messrs. Jergensen, Sanford and Apt. Our named executive officers&#8217; base salaries were not increased from fiscal year 2022. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 31, 2023, we terminated the consulting and strategic advisory services agreement between us and Helios Consulting, LLC (Helios), an entity jointly owned and operated by Messrs. Murray and Hancock (the Helios Consulting Agreement), pursuant to which we paid Helios consulting fees for services provided by Messrs. Murray and Hancock. In connection with the termination of the Helios Consulting Agreement, and the reduction in payments made to Messrs. Murray and Hancock, the base salaries for each of Messrs. Murray and Hancock were increased to $5,000,000, effective as of January 1, 2024. See the section titled &#8220;Related Party Agreement in Effect Prior to this Offering&#8212;Helios Consulting Agreement&#8221; below for additional information about the Helios Consulting Agreement.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in connection with Mr. Apt&#8217;s appointment as our Chief Financial Officer, his base salary was increased to $400,000, effective January 1, 2024.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the consummation of this offering, the base salaries for each of Messrs. Murray, Hancock, Jergensen, Sanford and Apt will be $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;and $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, respectively, in each case.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2023 Bonuses</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to base salaries, certain named executive officers are eligible to receive performance-based cash bonuses, which are designed to provide appropriate incentives to our executives to increase our operating subsidiaries&#8217; net income, and to reward our executives for achievements towards this goal. The performance-based bonus each named executive officer is eligible to receive is equal to a percentage of the monthly net income of our operating subsidiaries.  </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2023, Messrs. Jergensen, Sanford and Apt were each eligible to receive a performance-based bonus equal to 3.0%, 2.0% and 0.75% of the monthly net income of our operating subsidiaries, respectively. For Messrs. Jergensen and Sanford, 0.25% of each earned monthly bonus will be earned and paid only if we achieve certain clinical criteria </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the year.  The final monthly bonuses earned in 2023 will be determined and paid in the first quarter of 2024. Accordingly, the aggregate bonus compensation for our executive officers for 2023 has not yet been determined as of the date of filing of this prospectus.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2023, Mr. Apt also was eligible to receive performance-based bonus(es) based on the net operating income (NOI) of our acquisitions. Specifically, he was eligible to receive bonus(es) equal to 3.0% of the applicable entity&#8217;s NOI in the first year after the acquisition, 2.0% of the applicable entity&#8217;s NOI in the second year after the acquisition and 1.0% of the applicable entity&#8217;s NOI for each year thereafter. Bonuses are payable on the closing anniversary of the applicable acquisition. For 2023, Mr. Apt&#8217;s aggregate performance-based bonus under this program was $2,938,342. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the consummation of this offering, the target annual bonuses for each of Messrs. Murray, Hancock, Jergensen, Sanford and Apt will be &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; %, &#160;&#160;&#160;&#160;&#160;&#160;%, &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;%, &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; % and &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of annual base salary, respectively.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Compensation</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have not granted equity awards to our employees and executives, including our named executive officers. However, we view equity-based compensation as a critical component of our balanced total compensation program going forward as a public company. Equity-based compensation creates an ownership culture among our employees that provides an incentive to contribute to the continued growth and development of our business and aligns interest of executives with those of our stockholders.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, we intend to adopt a 2024 Incentive Award Plan, referred to below as the 2024 Plan, in order to facilitate the grant of cash and equity incentives to directors, employees (including our named executive officers), and consultants of our Company and certain of its affiliates and to enable our Company and certain of its affiliates to obtain and retain the services of these individuals, which is essential to our long-term success. We expect that the 2024 Plan will be effective on the day prior to the date the registration statement relating to this prospectus becomes effective. See the section titled &#8220;Equity Incentive Award Plans&#8212;2024 Incentive Award Plan&#8221; below for additional information about the 2024 Plan.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IPO Equity Awards</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors intends to approve the grant of restricted stock unit awards pursuant to the 2024 Plan to certain of our employees, including our named executive officers, which grants will become effective in connection with the completion of this offering. The terms of these awards, including the aggregate dollar-denominated value of the awards and the vesting schedule, have not yet been determined.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Compensation Plan </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently maintain the Providence Administrative Consulting Services, Inc. Nonqualified Deferred Compensation Plan (Deferred Compensation Plan), as may be amended from time to time, for certain of our employees, including our named executive officers. Participating employees may defer up to 100% of their bonus compensation per plan year.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Deferred Compensation Plan provides our employees an opportunity to elect to defer a portion of their bonus compensation and to provide a deferred compensation vehicle to which we may credit discretionary contributions and matching contributions pursuant to the terms of the plan. Discretionary and matching contributions, if any, are 100% vested after participants complete three years and five years of service as our full-time employee, respectively. We have not historically made any matching or discretionary contributions under the Deferred Compensation Plan. Participants have an opportunity to earn returns (positive or negative) based on investment options as determined by us. Typically, participants elect a level of risk tolerance for their deferred compensation at the beginning of each fiscal year and the plan administrator invests and manages the asset mix accordingly. In the event of a &#8220;separation from service&#8221; (as defined in the Deferred Compensation Plan and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determined pursuant to Section 409A of the Code), a participant will be paid his or her account balance in two annual installments. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2023, Messrs. Jergensen, Sanford and Apt were the only named executive officers to participate in our Deferred Compensation Plan and each elected to defer up to $180,000, $120,000, and $200,000, respectively, of their aggregate 2023 bonus compensation. The &#8220;Executive Contributions in Last FY&#8221; column of the Non-Qualified Deferred Compensation for 2023 table below shows the actual amounts deferred pursuant to the Deferred Compensation Plan for Messrs. Jergensen, Sanford and Apt in 2023.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Benefits and Perquisites</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of our full-time employees are eligible to participate in our health and welfare plans, including medical, dental and vision benefits, medical and dependent care flexible spending accounts, short-term and long-term disability insurance, and life and accidental death and disability insurance. Our named executive officers are eligible to participate in health and welfare plans on the same basis as other similarly-situated executive officers.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Benefits.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain of our named executive officers participate in a 401(k) retirement savings plan. The Internal Revenue Code allows eligible employees to defer a portion of their compensation, within prescribed limits, on a pre-tax basis through contributions to the 401(k) plan. In 2023, we matched a portion of the contributions to the 401(k) plan on behalf of eligible employees. The discretionary employer match for 2023 was 25% of the participant&#8217;s contribution to the plan up to a max of 4% of their eligible compensation. We believe that providing a vehicle for tax-deferred retirement savings though our 401(k) plan adds to the overall desirability of our executive compensation package and further incentivizes our employees, including our named executive officers, in accordance with our compensation policies. In addition, we maintain a non-qualified deferred compensation plan for the benefit of certain officers and employees who qualify for participation in the plan, including our named executive officers. See the section titled &#8220;&#8212;Compensation Discussion and Analysis&#8212;Deferred Compensation Plan&#8221; for a description of the Deferred Compensation Plan.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clawback Policy</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this offering, we intend to adopt a compensation recovery policy that is compliant with the listing rules of the national securities exchange or association on which our securities are listed, as required by the Dodd-Frank Act.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting for Share-Based Compensation</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we historically have not issued any stock-based compensation awards and currently do not have any outstanding stock-based compensation awards, in connection with this offering, we intend to issue stock-based compensation awards and follow Financial Accounting Standard Board Accounting Standards Codification Topic 718, Compensation &#8212; Stock Compensation (ASC Topic 718). ASC Topic 718 requires companies to measure the compensation expense for all share-based awards made to employees and directors, including stock options and RSUs, based on the grant-date fair value of these awards.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_2417"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE COMPENSATION TABLES</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Summary Compensation Table</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table contains information about the compensation earned by each of our named executive officers during our most recently completed fiscal year ended 2023. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.861%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name and Principal Position</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Salary ($)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Equity Incentive Plan Compensation ($)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in Pension Value and Nonqualified Deferred Compensation Earnings ($) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">All Other Compensation ($)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total ($)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jason Murray</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000,000&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,056,976&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,056,976&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Co-Founder, Chief Executive Officer and Chairman</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Hancock</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000,000&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,056,976&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,056,976&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Co-Founder, Executive Vice Chairman and former Chief Financial Officer and Secretary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Josh Jergensen</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,808&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,208&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,016&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Operating Officer</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PJ Sanford</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,917&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,299&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,216&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;President of Providence Administrative Consulting Services, Inc. and former Chief Administrative Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derick Apt</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938,342 (3)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,314&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,722&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,209,378&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer and former Chief Investment Officer and Treasurer</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents the above-market earnings on deferred compensation that is not tax-qualified, which is calculated as the excess of the earnings credited on deferred amounts under our Deferred Compensation Plan that were deemed invested in the investment vehicles under such plan over the amount that would have been earned had the deferred amounts been credited with a return equal to 120% of the applicable federal rate in effect for 2023. For more information, see &#8220;Nonqualified Deferred Compensation for 2023&#8221; table below.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reported in this column represent our contributions towards our named executive officers&#8217; medical insurance premiums ($31,208 for Messrs. Murray, Hancock, Jergensen, and Sanford and $35,021 for Mr. Apt), life insurance premiums ($25,770 for Messrs. Murray and Hancock), life and disability insurance premiums ($1,091 for Mr. Sanford and $10,778 for Mr. Apt) and for Mr. Apt $1,923 for our 401(k) match. In addition, $1,999,998 represents amounts paid by us to each of Messrs. Murray and Hancock pursuant to the Helios Consulting Agreement, which was terminated effective December 31, 2023, as further described in detail under &#8220;Certain Relationships and Related Party Transactions.&#8221; </font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reflect cumulative payouts made pursuant to our performance-based bonus programs maintained in 2023, including amounts that were earned but deferred pursuant to our Nonqualified Deferred Compensation Plan, as described below. Aggregate bonus amounts for 2023, other than Mr. Apt&#8217;s annual cash bonus opportunity related to the NOI of our acquisitions, are not calculable as of the date of this prospectus. It is anticipated that the aggregate 2023 bonus amounts will be determined in the first quarter of 2024, at which time we will disclose the amounts of such bonuses. Please see the description of such awards under &#8220;Elements of Our Executive Officer Compensation program&#8212;2023 Bonuses&#8221; above.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Grants of Plan-Based Awards in 2023</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information relating to grants of plan-based awards made to our named executive officers during fiscal 2023. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr style="height:20pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Possible Payouts Under Non-Equity Incentive Plan Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Threshold ($)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Target ($)</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum ($)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jason Murray</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Hancock</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Josh Jergensen</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PJ Sanford</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derick Apt</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">______________</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts shown in these columns represent each named executive officer&#8217;s annual cash bonus opportunity under our 2023 performance-based bonus program and Mr. Apt&#8217;s annual cash bonus opportunity related to the NOI of our acquisitions. There are no threshold, target or maximum payouts under these bonus programs given the final payments in respect of such awards are based on a percentage of net income and NOI, as applicable. For additional detail on these awards, please see the description of such awards under &#8220;Elements of Our Executive Officer Compensation program&#8212;2023 Bonuses&#8221; above. The amounts earned by our named executive officers under our bonus programs are reflected in the Summary Compensation Table above.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employment Arrangements with Our Executive Officers </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 18, 2023, we entered into an employment offer letter with Mr. Apt in connection with his appointment as our Chief Financial Officer, effective January 1, 2024 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Apt Offer Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).The Apt Offer Letter provides for an annual base salary of $400,000 and an annual cash bonus opportunity expected to equal between 5x &#8211; 10x his annual base salary, which amount will be approved by our compensation committee.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have any other existing employment arrangements with our executive officers.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding Equity Awards at Year-End </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our named executive officer did not hold any unvested equity awards as of December 31, 2023. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Option Exercises and Stock Vested in 2023</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of our named executive officers exercised any stock options or vested in any stock awards during 2023.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Qualified Deferred Compensation for 2023</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information regarding our Deferred Compensation Plan that provides for the deferral of bonus compensation for certain of our employees, including our named executive officers, on a basis that is not tax-qualified, as described further under &#8220;Compensation Discussion and Analysis&#8212;Deferred Compensation Plan&#8221; above.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Executive Contributions in Last FY ($)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Registrant Contributions in Last FY ($)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Earnings in Last FY ($)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Withdrawals &#47; Distributions ($)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Balance at Last FYE ($)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jason Murray</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Hancock</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Josh Jergensen</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,667&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,197&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614,285&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PJ Sanford</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,806&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,576&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derick Apt</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183,333&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,303&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298,156&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents amounts the named executive officer elected to defer in 2023, which are deferred from bonus compensation earned in 2023 and therefore reported in the appropriate column in the Summary Compensation Table.</font></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Represents net amounts credited to the named executive officers&#8217; accounts as a result of performance of the investment vehicle in which their accounts were deemed invested. These amounts include above-market earnings, which are reported in the appropriate column in the Summary Compensation Table.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Potential Payments Upon Termination or Change in Control</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to our initial public offering, we maintained a long-term incentive compensation program (the &#8220;LTIP&#8221;) that was intended to provide cash payments to certain of our executives, including Messrs. Jergensen, Sanford and Apt, in connection with a &#8220;qualifying sale&#8221; of our Company.  A &#8220;qualifying sale&#8221; included a sale, whether through merger, consolidation, combination, the sale of all or substantially all of the Company&#8217;s assets, or otherwise, of the Company to a third party such that the then-current shareholders of the Company, as measured immediately prior to the closing of the transaction, sold at least 50% of the Company. Any cash payments that could have become payable pursuant to the LTIP would have been based on the participant&#8217;s individual participation percentage multiplied by the total net cash proceeds that we received in the qualifying sale.  Because any potential payments under the LTIP to the participating executives in connection with a qualifying sale presumed to occur on December 31, 2023 would have been based on the total net cash proceeds received in the qualifying sale, such amounts are not quantifiable.  We expect to terminate the LTIP in connection with this offering. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as described above with respect to our LTIP, upon a termination of employment or a change in control, our named executive officers would not be entitled to any payments or benefits other than those required by applicable law. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Incentive Award Plans</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal features of our 2024 Plan and ESPP are summarized below. These summaries are qualified in their entirety by reference to the actual text of the applicable plan, each of which is or will be filed as an exhibit to the registration statement of which this prospectus is a part. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2024 Incentive Award Plan </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this offering, we intend to adopt the 2024 Plan, under which we may grant cash and equity incentive awards to eligible service providers in order to attract, motivate and retain the talent for which we compete, subject to stockholder approval. The material terms of the 2024 Plan are summarized below.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eligibility and Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our employees, consultants and directors and employees and consultants of our subsidiaries will be eligible to receive awards under the 2024 Plan. Following the completion of this offering, the 2024 Plan will be administered by our board of directors with respect to awards to non-employee directors and by our compensation committee with respect to other participants, each of which may delegate its duties and responsibilities to one or more committees of its directors and&#47;or officers (referred to collectively as the plan administrator), subject to the limitations imposed under the 2024 Plan, Section 16 of the Exchange Act, and&#47;or stock exchange rules and other applicable laws. The plan administrator will have the authority to take all actions and make all determinations under the 2024 Plan, to interpret the 2024 Plan and award agreements and to adopt, amend and repeal rules for the administration of the 2024 Plan as it deems advisable. The plan administrator will also have the authority to determine which eligible service providers receive awards, grant awards, and set the terms and conditions of all awards under the 2024 Plan, including any vesting and vesting acceleration provisions, subject to the conditions and limitations in the 2024 Plan.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Limitation on Awards and Shares Available</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The initial aggregate number of shares of our common stock that will be available for issuance under the 2024 Plan will be equal to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of the number of shares of our common stock outstanding as of immediately following the completion of this offering. In addition, the number of shares of our common stock available for issuance under the 2024 Plan will be subject to an annual increase on the first day of each calendar year beginning on and including January 1, 2025 and ending on and including January 1, 2034, equal </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the lesser of (A) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of the aggregate number of shares of our common stock outstanding on the final day of the immediately preceding calendar year and (B) such smaller number of shares as is determined by our board of directors. The maximum number of shares that may be issued pursuant to the exercise of incentive stock options (ISOs) granted under the 2024 Plan, will be &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;. Any shares issued pursuant to the 2024 Plan may consist, in whole or in part, of authorized and unissued common stock, treasury common stock or common stock purchased on the open market.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an award under the 2024 Plan expires, lapses or is terminated, exchanged for, or settled in cash, any shares subject to such award (or portion thereof) may, to the extent of such expiration, lapse, termination, or cash settlement, be used again for new grants under the 2024 Plan. Prior to the tenth anniversary of the effective date of the 2024 Plan, shares tendered or withheld to satisfy the exercise price or tax withholding obligation for any award will not reduce the shares available for grant under the 2024 Plan. Further, the payment of dividend equivalents in cash in conjunction with any awards under the 2024 Plan will not reduce the shares available for grant under the 2024 Plan. However, the following shares may not be used again for grant under the 2024 Plan&#58; (i) shares subject to stock appreciation rights (SARs) that are not issued in connection with the stock settlement of the SAR on exercise, and (ii) shares purchased on the open market with the cash proceeds from the exercise of options.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards granted under the 2024 Plan upon the assumption of, or in substitution for, awards authorized or outstanding under a qualifying equity plan maintained by an entity with which we enter into a merger or similar corporate transaction will not reduce the shares available for grant under the 2024 Plan but will count against the maximum number of shares that may be issued upon the exercise of ISOs.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Plan provides that the sum of any cash compensation and the aggregate grant date fair value (determined as of the date of the grant under Financial Accounting Standards Board Accounting Standards Codification Topic 718, or any successor thereto) of all awards granted to a non-employee director as compensation for services as a non-employee director during any fiscal year, or director limit, may not exceed an amount equal to $ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(increased to $ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;in the calendar year of a non-employee director&#8217;s initial service as a non-employee director or any calendar year during which a non- employee director serves as lead independent director), which limits shall not apply to the compensation for any non-employee director who serves in any capacity in addition to that of a non-employee director for which he or she receives additional compensation or any compensation paid prior to the calendar year following the calendar year in which the 2024 Plan becomes effective.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The 2024 Plan provides for the grant of stock options, including ISOs and nonqualified stock options (NSOs), SARs, restricted stock, dividend equivalents, restricted stock units (RSUs), and other stock or cash based awards. Certain awards under the 2024 Plan may constitute or provide for payment of &#8220;nonqualified deferred compensation&#8221; under Section 409A of the Code, which may impose additional requirements on the terms and conditions of such awards. All awards under the 2024 Plan will be evidenced by award agreements, which will detail the terms and conditions of awards, including any applicable vesting and payment terms and post-termination exercise limitations. Awards other than cash awards generally will be settled in shares of our common stock, but the applicable award agreement may provide for cash settlement of any award. A brief description of each award type follows.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Stock Options and SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Stock options provide for the purchase of shares of our common stock in the future at an exercise price set on the grant date. ISOs, in contrast to NSOs, may provide tax deferral beyond exercise and favorable capital gains tax treatment to their holders if certain holding period and other requirements of the Code are satisfied. SARs entitle their holder, upon exercise, to receive from us an amount equal to the appreciation of the shares subject to the award between the grant date and the exercise date. Unless otherwise determined by our board, the exercise price of a stock option or SAR may not be less than 100% of the fair market value of the underlying share on the grant date (or 110% in the case of ISOs granted to certain significant stockholders), except with respect to certain substitute awards granted in connection with a corporate transaction. The term of a stock option or SAR may not be longer than ten years (or five years in the case of ISOs granted to certain significant stockholders). Conditions applicable to stock options and&#47;or SARs may be based on continuing service, the attainment of performance goals and&#47;or such other conditions as the plan administrator may determine.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Restricted Stock and RSUs.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Restricted stock is an award of nontransferable shares of our common stock that are subject to certain vesting conditions and other restrictions. RSUs are contractual promises to deliver shares of our common stock in the future, which may also remain forfeitable unless and until specified conditions are met and may be accompanied by the right to receive the equivalent value of dividends paid on shares of our common stock prior to the delivery of the underlying shares (i.e., dividend equivalent rights). The plan administrator may provide that the delivery of the shares underlying RSUs will be deferred on a mandatory basis or at the election of the participant. The terms and conditions applicable to RSUs will be determined by the plan administrator, subject to the conditions and limitations contained in the 2024 Plan. Conditions applicable to restricted stock and RSUs may be based on continuing service, the attainment of performance goals and&#47;or such other conditions as the plan administrator may determine.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Other Stock or Cash Based Awards.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other stock or cash based awards are awards of cash, fully vested shares of our common stock and other awards valued wholly or partially by referring to, or otherwise based on, shares of our common stock. Other stock or cash based awards may be granted to participants and may also be available as a payment form in the settlement of other awards, as standalone payments and as payment in lieu of compensation to which a participant is otherwise entitled.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Dividend Equivalents.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Dividend equivalents represent the right to receive the equivalent value of dividends paid on shares of our common stock and may be granted alone or in tandem with awards other than stock options or SARs. Dividend equivalents are credited as of the dividend record dates during the period between the date an award is granted and the date such award vests, is exercised, is distributed, or expires, as determined by the plan administrator. Dividend equivalents payable with respect to an award prior to the vesting of such award instead will be paid out to the participant only to the extent that the vesting conditions are subsequently satisfied and the award vests.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The plan administrator has broad discretion to act under the 2024 Plan, as well as make adjustments to the terms and conditions of existing and future awards, to prevent the dilution or enlargement of intended benefits and facilitate necessary or desirable changes in the event of certain transactions and events affecting our common stock, such as stock dividends, stock splits, mergers, acquisitions, consolidations and other corporate transactions. In addition, in the event of certain non-reciprocal transactions with our stockholders known as &#8220;equity restructurings,&#8221; the plan administrator will make equitable adjustments to the 2024 Plan and outstanding awards. In the event of a change in control (as defined in the 2024 Plan), to the extent that the surviving entity declines to continue, convert, assume, or replace outstanding awards, then all such awards will become fully vested and exercisable in connection with the transaction. Upon or in anticipation of a change in control, the plan administrator may cause any outstanding awards to terminate at a specified time in the future and give the participant the right to exercise such awards during a period of time determined by the plan administrator in its sole discretion. Individual award agreements may provide for additional accelerated vesting and payment provisions.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Repricing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our board of directors may, without approval of the stockholders, reduce the exercise price of any stock option or SAR, or cancel any stock option or SAR in exchange for cash, other awards or stock options or SARs with an exercise price per share that is less than the exercise price per share of the original stock options or SARs.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plan Amendment and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our board of directors may amend or terminate the 2024 Plan at any time&#59; however, no amendment, other than an amendment that increases the number of shares available under the 2024 Plan, may materially and adversely affect an award outstanding under the 2024 Plan without the consent of the affected participant, and stockholder approval will be obtained for any amendment to the extent necessary to comply with applicable laws. The 2024 Plan will remain in effect until terminated by the plan administrator in accordance with the 2024 Plan. No awards may be granted under the 2024 Plan after its termination.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Participants, Claw-back Provisions, Transferability and Participant Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The plan administrator may modify award terms, establish subplans and&#47;or adjust other terms and conditions of awards, subject to the share limits described above, in order to facilitate grants of awards subject to the laws and&#47;or stock exchange rules of countries outside of the United States. All awards will be subject to any Company clawback policy as set forth in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such clawback policy or the applicable award agreement. Awards under the 2024 Plan are generally non-transferrable, except by will or the laws of descent and distribution, or, subject to the plan administrator&#8217;s consent, pursuant to a domestic relations order, and are generally exercisable only by the participant. With regard to tax withholding, exercise price and purchase price obligations arising in connection with awards under the 2024 Plan, the plan administrator may, in its discretion, accept cash or check, shares of our common stock that meet specified conditions, a &#8220;market sell order&#8221; or such other consideration as it deems suitable.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2024 Employee Stock Purchase Plan </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this offering, we intend to adopt the 2024 Employee Stock Purchase Plan (ESPP), subject to stockholder approval. The material terms of which, as it is currently contemplated, are summarized below. Our board of directors is still in the process of developing, approving, and implementing the ESPP and, accordingly, this summary is subject to change. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP is comprised of two distinct components in order to provide increased flexibility to grant options to purchase shares under the ESPP to U.S. and to non-U.S. employees. Specifically, the ESPP authorizes (1) the grant of options to U.S. employees that are intended to qualify for favorable U.S. federal tax treatment under Section 423 of the Code, (Section 423 Component), and (2) the grant of options that are not intended to be tax-qualified under Section 423 of the Code to facilitate participation for employees located outside of the U.S. who do not benefit from favorable U.S. federal tax treatment and to provide flexibility to comply with non-U.S. law and other considerations (Non-Section 423 Component). Where permitted under local law and custom, we expect that the Non-Section 423 Component will generally be operated and administered on terms and conditions similar to the Section 423 Component. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shares available for awards&#59; administration.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A total of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock will initially be reserved for issuance under the ESPP. In addition, we expect that the number of shares available for issuance under the ESPP will be annually increased on January 1 of each calendar year beginning in 2025 and ending in and including 2034, by an amount equal to the lesser of (A) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;% of the shares outstanding on the final day of the immediately preceding calendar year and (B) such smaller number of shares as is determined by our board of directors, provided that no more than &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock may be issued under the Section 423 Component. Our board of directors or a committee designated by our board of directors will have authority to interpret the terms of the ESPP and determine eligibility of participants. We expect that the compensation committee will be the administrator of the ESPP (referred to as the plan administrator below). </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eligibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The plan administrator may designate certain of our subsidiaries as participating &#8220;designated subsidiaries&#8221; in the ESPP and may change these designations from time to time. Employees of our Company and our designated subsidiaries are eligible to participate in the ESPP if they meet the eligibility requirements under the ESPP established from time to time by the plan administrator. However, an employee may not be granted rights to purchase stock under the ESPP if such employee, immediately after the grant, would own (directly or through attribution) stock possessing 5% or more of the total combined voting power or value of all classes of our common or other class of stock.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Participation in an Offering.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock will be offered under the ESPP during offering periods. The length of the offering periods under the ESPP will be determined by the plan administrator and may be up to twenty-seven months long. Employee payroll deductions will be used to purchase shares on each purchase date during an offering period. The number of purchase periods within, and purchase dates during, each offering period will be established by the plan administrator. Offering periods under the ESPP will commence when determined by the plan administrator. The plan administrator may, in its discretion, modify the terms of future offering periods. In non-U.S. jurisdictions where participation in the ESPP through payroll deductions is prohibited, the plan administrator may provide that an eligible employee may elect to participate through contributions to the participant&#8217;s account under the ESPP in a form acceptable to the plan administrator in lieu of or in addition to payroll deductions.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that the ESPP will permit participants to purchase common stock through payroll deductions of up to a specified percentage of their eligible compensation. The plan administrator will establish a maximum number of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares that may be purchased by a participant during any offering period. In addition, no employee will be permitted to accrue the right to purchase stock under the Section 423 Component at a rate in excess of $25,000 worth of shares during any calendar year during which such a purchase right is outstanding (based on the fair market value per share of our common stock as of the first day of the offering period).</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the first trading day of each offering period, each participant automatically will be granted an option to purchase shares of our common stock. The option will be exercised on the applicable purchase dates(s) during the offering period, to the extent of the payroll deductions accumulated during the applicable purchase period. We expect the purchase price of the shares, in the absence of a contrary determination by the plan administrator, will be 85% of the lower of the fair market value of our common stock on the first trading day of the offering period or on the applicable purchase date, which will be the final trading day of the applicable purchase period. Participants may voluntarily end their participation in the ESPP at any time during a specified period prior to the end of the applicable offering period and will be paid their accrued payroll deductions that have not yet been used to purchase shares of common stock. Participation ends automatically upon a participant&#8217;s termination of employment.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A participant may not transfer rights granted under the ESPP other than by will, the laws of descent and distribution or as otherwise provided in the ESPP.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain transactions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of certain transactions or events affecting our common stock, such as any stock dividend or other distribution, change in control, reorganization, merger, consolidation, or other corporate transaction, the plan administrator will make equitable adjustments to the ESPP and outstanding rights. In addition, in the event of the foregoing transactions or events, or certain significant transactions, including a change in control, the plan administrator may provide for (i) either the replacement of outstanding rights with other rights or property or termination of outstanding rights in exchange for cash, (ii) the assumption or substitution of outstanding rights by the successor or survivor corporation or parent or subsidiary thereof, (iii) the adjustment in the number and type of shares of stock subject to outstanding rights, (iv) the use of participants&#8217; accumulated payroll deductions to purchase stock on a new purchase date prior to the next scheduled purchase date and termination of any rights under ongoing offering periods, or (v) the termination of all outstanding rights. Under the ESPP, a change in control has the same definition as given to such term in the 2024 Plan.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plan amendment&#59; Termination.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The plan administrator may amend, suspend, or terminate the ESPP at any time. However, stockholder approval of any amendment to the ESPP must be obtained for any amendment which increases the aggregate number or changes the type of shares that may be sold pursuant to rights under the ESPP, changes the corporations or classes of corporations whose employees are eligible to participate in the ESPP, or changes the ESPP in any manner that would cause the ESPP to no longer be an employee stock purchase plan within the meaning of Section 423(b) of the Code.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_2432"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DIRECTOR COMPENSATION</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information for the year ended December 31, 2023 regarding the compensation awarded to, earned by or paid to our non-employee directors who served on our board of directors during 2023. Ms. Millard and Mr. Leavitt joined our board of directors on July 1, 2023&#59; prior to that time, our board of directors consisted only of Messrs. Murray and Hancock. Messrs. Murray and Hancock do not receive any additional compensation for their board service and therefore are not included in the Director Compensation table below. All compensation paid to Messrs. Murray and Hancock is reported above in the &#8220;2023 Summary Compensation Table.&#8221;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fees Earned or Paid in Cash ($)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total ($)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jacque Millard</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,000</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taylor Leavitt</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,000</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,000</font></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reflect fees paid to each of Mses. Millard and Leavitt pursuant to an initial board retainer fee of $125,000 in connection with their appointment to our board of directors, as well as quarterly fees of $62,500. Our non-employee directors were not granted any equity awards in 2023 nor do they hold any outstanding equity awards as of December 31, 2023. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Post-IPO Director Compensation Program</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this offering, we intend to approve and implement a compensation program, or the Director Compensation Program, which will become effective upon the closing of this offering. The Director Compensation Program is expected to provide for annual retainer fees and equity awards for our non-employee directors, who we refer to as eligible directors. The details of this program have not yet been determined, but compensation under the program will be subject to the annual limits on non-employee director compensation set forth in the 2024 Plan, as described under &#8220;Equity Incentive Award Plans&#8212;2024 Incentive Award Plan&#8221; above.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_979"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the equity and other compensation and other arrangements discussed in the section titled &#8220;Compensation Discussion and Analysis,&#8221; the following is a description of each transaction since January 1, 2021 and each currently proposed transaction which&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we have been or are to be a participant&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the amount involved exceeded or will exceed $120,000&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any of our directors, executive officers or, to our knowledge, beneficial owners of more than 5% of our capital stock or any member of the immediate family of any of the foregoing persons had or will have a direct or indirect material interest.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Related Party Agreement in Effect Prior to this Offering</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Helios Consulting Agreement </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2021, we entered into a Consulting and Strategic Advisory Services Agreement with Helios Consulting, LLC (Helios), a limited liability company owned and operated by Jason Murray, our Co-Founder, Chief Executive Officer, Chairman and a member of our board of directors, and Mark Hancock, our Executive Vice Chairman and a member of our board of directors (Helios Consulting Agreement), pursuant to which we paid Helios consulting fees for services provided by Messrs. Murray and Hancock. The Helios Consulting Agreement provided for a cash consulting fee of approximately $4 million annually, paid in monthly installments, for consulting and strategic advisory services provided to us by Helios. For the years ended December 31, 2023, 2022 and 2021, we paid approximately $4.0 million, $4.0 million, and $2.3 million (inclusive of approximately $150,000 paid to a subsidiary of Helios), respectively. On December 31, 2023, we terminated the Helios Consulting Agreement. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subscription Agreements</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 24, 2023, we entered into subscription agreements with Messrs. Murray and Hancock, pursuant to which Messrs. Murray and Hancock each purchased 10,000 shares of our common stock for a purchase price of $100,000, or $10.00 per share, in a private placement concurrent with our incorporation in the State of Delaware and in anticipation of effecting our reorganization on June 30, 2023. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stockholders Agreement</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this offering, we intend to enter into a new stockholders agreement, or the Stockholders Agreement, with Messrs. Murray and Hancock. Subject to certain limitations and exceptions, the Stockholders Agreement will grant each of Messrs. Murray and Hancock certain board designation rights for so long as they each beneficially own at least 5% of the aggregate number of shares of common stock outstanding immediately following this offering. Following completion of this offering, we expect that Messrs. Murray and Hancock will have the right to designate &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; and&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;directors, respectively. In addition, Messrs. Murray and Hancock will agree to elect a certain number of directors who are not affiliated with any party to the Stockholders Agreement and who satisfy the independence requirements applicable to audit committee members established pursuant to Rule 10A-3 under the Exchange Act.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each ofMessrs. Murray and Hancock will also agree to vote, or cause to vote, all of their outstanding shares of our common stock at any annual or special meeting of stockholders in which directors are elected, so as to cause the election of the their respective designees, in each case to the extent that each or any of Messrs. Murray and Hancock have exercised their right to designate individuals for election to the board of directors.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director and Officer Indemnification and Insurance</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the consummation of this offering, we intend to enter into separate indemnification agreements with each of our directors and executive officers. We have also purchased directors&#8217; and officers&#8217; liability insurance. See the section titled &#8220;Description of Capital Stock&#8212;Limitations on Liability and Indemnification of Officers and Directors.&#8221; </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Policies and Procedures for Related Party Transactions</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the completion of this offering, our board of directors will adopt a written related party transaction policy, to be effective upon the completion of this offering, setting forth the policies and procedures for the review and approval or ratification of related party transactions. This policy will cover, with certain exceptions set forth in Item 404 of Regulation S-K under the Securities Act, any transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships in which we were or are to be a participant, where the amount involved exceeds $120,000 and a related party had or will have a direct or indirect material interest, including without limitation purchases of goods or services by or from the related party or entities in which the related party has a material interest, indebtedness, guarantees of indebtedness and employment by us of a related party. In reviewing and approving any such transactions, our audit committee will be tasked to consider all relevant facts and circumstances, including but not limited to whether the transaction is on terms comparable to those that could be obtained in an arm&#8217;s length transaction with an unrelated third-party and the extent of the related party&#8217;s interest in the transaction. All of the transactions described in this section occurred prior to the adoption of this policy.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_993"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRINCIPAL STOCKHOLDERS</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information with respect to the beneficial ownership of our common stock as of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2024, and as adjusted to reflect the sale of common stock offered by us in this offering, assuming no exercise of the underwriters&#8217; option to purchase additional shares, by&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each of our directors&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each of our named executive officers&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">all of our directors and executive officers as a group&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each person or group of affiliated persons known by us to beneficially own more than 5% of our outstanding shares of common stock.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares beneficially owned by each stockholder is determined under rules issued by the SEC. Under these rules, a person is deemed to be a &#8220;beneficial&#8221; owner of a security if that person has or shares voting power or investment power, which includes the power to dispose of or to direct the disposition of such security. Except as indicated in the footnotes below, we believe, based on the information furnished to us, that the individuals and entities named in the table below have sole voting and investment power with respect to all shares beneficially owned by them, subject to any applicable community property laws.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have based percentage ownership of our common stock before this offering on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares of our common stock outstanding as of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , 2024. The percentage ownership of our common stock after this offering also assumes the foregoing and the issuance and sale of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares of common stock by us in this offering, and assumes no exercise of the underwriters&#8217; option to purchase &#160;&#160;&#160;&#160;&#160;&#160; additional shares from us.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the stockholders listed has sole voting and investment power with respect to the shares beneficially owned by the stockholder unless noted otherwise, subject to community property laws where applicable. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated, the address of each beneficial owners in the table below is c&#47;o PACS Group, Inc., 262 N. University Ave., Farmington, Utah 84025.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beneficial Ownership Before the Offering</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beneficial Ownership After the Offering</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of Beneficial Owner</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Shares</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Shares</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Named Executive Officers and Directors&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jason Murray</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Hancock</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter (P.J.) Sanford</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Josh Jergensen</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derick Apt</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jacqueline Millard</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taylor Leavitt</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Executive Officers and Directors as a Group (9 individuals)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212; &#160;&#160;&#160;&#160;None</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14pt">Less than 1%.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_1428"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF CAPITAL STOCK</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary describes our capital stock and the material provisions of our Amended and Restated Charter and our Amended and Restated Bylaws. The following is a summary and is qualified by reference to the Amended and Restated Charter and the Amended and Restated Bylaws that will be in effect immediately prior to the completion of this offering. Copies of these documents will be filed with the SEC as exhibits to our registration statement, of which this prospectus forms a part.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the completion of this offering, our authorized capital stock will consist of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares of common stock, par value $0.001 per share, and &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares of preferred stock, par value $0.001 per share, the rights and preferences of which the board of directors may establish from time to time. As of December 31, 2023, there were 20,000 shares of our common stock outstanding held by two stockholders of record, and no shares of our preferred stock outstanding.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividend Rights</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of shares of our common stock are entitled to receive dividends when, as and if declared by our board of directors out of funds legally available therefor, subject to any statutory or contractual restrictions on the payment of dividends and to any restrictions on the payment of dividends imposed by the terms of any outstanding stock. Under Delaware law, we can only pay dividends either out of &#8220;surplus&#8221; or out of the current or the immediately preceding year&#8217;s net profits. Surplus is defined as the excess, if any, at any given time, of the total assets of a corporation over its total liabilities and statutory capital. The value of a corporation&#8217;s assets can be measured in a number of ways and may not necessarily equal their book value.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the section titled &#8220;Dividend Policy&#8221; for additional information.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of stockholders. The holders of our common stock vote together as a single class, unless otherwise required by law. The holders of our common stock do not have cumulative voting rights in the election of directors.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Amended and Restated Bylaws will provide for a classified board of directors consisting of three classes of approximately equal size, each serving staggered three-year terms. If the number of directors is changed, any increase or decrease shall be apportioned among the classes by the board of directors so as to maintain the number of directors in each class as nearly equal as possible, and any additional director of any class elected to fill a vacancy resulting from an increase in such class shall hold office for a term that shall coincide with the remaining term of that class. In no case will a decrease in the number of directors shorten the term of any incumbent director.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">No Preemptive or Similar Rights</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is not entitled to preemptive rights, and is not subject to conversion, redemption, or sinking fund provisions.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Right to Receive Liquidation Distributions</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we become subject to a liquidation, dissolution, or winding-up, the assets legally available for distribution to our stockholders would be distributable ratably among the holders of our common stock and any participating preferred stock outstanding at that time, subject to prior satisfaction of all outstanding debt and liabilities and the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">preferential rights of and the payment of liquidation preferences, if any, on any outstanding shares of preferred stock.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fully Paid and Non-Assessable</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All shares of our common stock that will be outstanding upon the completion of this offering will be fully paid and non-assessable.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Preferred Stock</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No shares of preferred stock will be issued or outstanding immediately after the offering contemplated by this prospectus. Our Amended and Restated Charter authorizes our board of directors to establish one or more series of preferred stock. Unless required by law or any stock exchange, the authorized shares of preferred stock will be available for issuance without further action by the holders of our common stock. Our board of directors is able to determine, without stockholder approval and with respect to any series of preferred stock, the powers (including voting powers), preferences and relative, participating, optional, or other special rights, and the qualifications, limitations, or restrictions thereof, including, without limitation&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the designation of the series&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of shares of the series, which our board of directors may, except where otherwise provided in the preferred stock designation, increase (but not above the total number of authorized shares of the class) or decrease (but not below the number of shares then outstanding)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether dividends, if any, will be cumulative or non-cumulative and the dividend rate of the series&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the dates at which dividends, if any, will be payable&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the redemption or repurchase rights and price or prices, if any, for shares of the series&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the terms and amounts of any sinking fund provided for the purchase or redemption of shares of the series&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the amounts payable on shares of the series in the event of any voluntary or involuntary liquidation, dissolution, or winding-up of our affairs&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether the shares of the series will be convertible into shares of any other class or series, or any other security, of us or any other entity, and, if so, the specification of the other class or series or other security, the conversion price or prices, or rate or rates, any rate adjustments, the date or dates as of which the shares will be convertible and all other terms and conditions upon which the conversion may be made&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on the issuance of shares of the same series or of any other class or series&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the voting rights, if any, of the holders of the series.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We could issue a series of preferred stock that could, depending on the terms of the series, impede or discourage an acquisition attempt or other transaction that some, or a majority, of the holders of our common stock might believe to be in their best interests or in which the holders of our common stock might receive a premium over the market price of the shares of our common stock. Additionally, the issuance of preferred stock may adversely affect the rights of holders of our common stock by restricting dividends on the common stock, diluting the voting power of the common stock or subordinating the liquidation rights of the common stock. As a result of these or other factors, the issuance of preferred stock could have an adverse impact on the market price of our common stock. We have no current plan for the issuance of any shares of preferred stock.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registration Rights</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this offering, we, Jason Murray and Mark Hancock will enter into the Stockholders Agreement, pursuant to which Messrs. Murray and Hancock will have registration rights. Registration of these shares under the Securities Act would result in these shares becoming fully tradable without restriction under the Securities Act immediately upon the effectiveness of the registration, except for shares purchased by affiliates. Shares covered by a registration statement will be eligible for sale in the public market upon the expiration or release from the terms of the lock-up agreement. Under the Stockholders Agreement, we will generally be required to pay all expenses (other than underwriting discounts and commissions and certain other expenses) related to any registration, whether or not such registration becomes effective or this offering is consummated. The Stockholders Agreement also contains customary indemnification and procedural terms.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Demand Registration Rights</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the completion of this offering, Messrs. Murray and Hancock will hold an aggregate of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock, which together represents &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; % of our outstanding shares of common stock after this offering, and will be entitled to certain demand registration rights. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing demand registration rights are subject to a number of exceptions and limitations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Piggyback Registration Rights</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that we propose to register any of our securities under the Securities Act, either for our own account or for the account of other stockholders, Messrs. Murray and Hancock will be entitled to certain &#8220;piggyback&#8221; registration rights, entitling them to notice of the registration and allowing them to include their registrable securities in such registration. These rights will apply whenever we propose to file a registration statement under the Securities Act other than with respect to (1) a registration related to the sale of securities to employees pursuant to a stock option, stock purchase or similar plan or (2) a registration relating to a corporate reorganization or other transaction covered by Rule 145 promulgated under the Securities Act.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Takeover Effects of Provisions of the General Corporation Law of the State of Delaware and our Amended and Restated Charter and Amended and Restated Bylaws</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain provisions of the General Corporation Law of the State of Delaware (DGCL) and our Amended and Restated Charter and our Amended and Restated Bylaws that will become effective immediately prior to the completion of this offering contain provisions that could make the following transactions more difficult&#58; e.g., acquisition of us by means of a tender offer&#59; acquisition of us by means of a proxy contest or otherwise&#59; or removal of our incumbent officers and directors. It is possible that these provisions could make it more difficult to accomplish or could deter transactions that stockholders may otherwise consider to be in their best interest or in our best interests, including transactions that might result in a premium over the market price for our shares.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions, summarized below, are expected to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our board of directors. We believe that the benefits of increased protection of our potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us outweigh the disadvantages of discouraging these proposals because negotiation of these proposals could result in an improvement of their terms.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delaware Anti-Takeover Statute</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to Section 203 of the DGCL, which prohibits persons deemed &#8220;interested stockholders&#8221; from engaging in a &#8220;business combination&#8221; with a publicly held Delaware corporation for three years following the date these persons become interested stockholders unless the business combination is, or the transaction in which the person became an interested stockholder was, approved in a prescribed manner or another prescribed exception </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applies. Generally, an &#8220;interested stockholder&#8221; is a person who, together with affiliates and associates, owns, or within three years prior to the determination of interested stockholder status did own, 15% or more of a corporation&#8217;s voting stock. Generally, a &#8220;business combination&#8221; includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. The existence of this provision may have an anti-takeover effect with respect to transactions not approved in advance by the board of directors, such as discouraging takeover attempts that might result in a premium over the market price of our common stock.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Undesignated Preferred Stock</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ability to authorize undesignated preferred stock will make it possible for our board of directors to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to effect a change in control of our company. These and other provisions may have the effect of deterring hostile takeovers or delaying changes in control or management of our company.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Special Stockholder Meetings</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Amended and Restated Charter will provide that a special meeting of stockholders may be called at any time by our board of directors, but such special meetings may not be called by the stockholders or any other person or persons.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Requirements for Advance Notification of Stockholder Nominations and Proposals</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Amended and Restated Bylaws will establish advance notice procedures with respect to stockholder proposals and the nomination of candidates for election as directors, other than nominations made by or at the direction of the board of directors or a committee of the board of directors.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Elimination of Stockholder Action by Written Consent</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Amended and Restated Charter will eliminate the right of stockholders to act by written consent without a meeting.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Classified Board&#59; Election and Removal of Directors&#59; Filling Vacancies</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective upon the completion of this offering, our board of directors will be divided into three classes, divided as nearly as equal in number as possible. The directors in each class will serve for a three-year term, one class being elected each year by our stockholders, with staggered three-year terms. Only one class of directors will be elected at each annual meeting of our stockholders, with the other classes continuing for the remainder of their respective three-year terms. Our Amended and Restated Charter will provide for the removal of any of our directors only for cause and requires a stockholder vote by the holders of at least a 66 2&#47;3% of the voting power of the then outstanding voting stock. See the section titled &#8220;Management&#8212;Classified Board of Directors&#8221; for more information on the classified board. Furthermore, any vacancy on our board of directors, however occurring, including a vacancy resulting from an increase in the size of the board, may only be filled by a resolution of the board of directors unless the board of directors determines that such vacancies shall be filled by the stockholders. This system of electing and removing directors and filling vacancies may tend to discourage a third-party from making a tender offer or otherwise attempting to obtain control of us because it generally makes it more difficult for stockholders to replace a majority of the directors.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Choice of Forum</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Amended and Restated Charter will provide that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware will be the exclusive forum for the following types of actions or proceedings under Delaware statutory or common law&#58; any derivative action or proceeding brought on our behalf&#59; any action asserting a claim of breach of fiduciary duty owed by any of our directors, officers or stockholders to us or to our stockholders&#59; any action asserting a claim against us arising pursuant to the DGCL, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our Amended and Restated Charter or our Amended and Restated Bylaws (as either may be amended from time to time)&#59; or any action asserting a claim against us that is governed by the internal affairs doctrine. As a result, any action brought by any of our stockholders with regard to any of these matters will need to be filed in the Court of Chancery of the State of Delaware and cannot be filed in any other jurisdiction&#59; provided that, if and only if the Court of Chancery of the State of Delaware dismisses any such action for lack of subject matter jurisdiction, such action may be brought in another state or federal court sitting in the State of Delaware.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Amended and Restated Charter will also provide that the federal district courts of the United States of America will be the exclusive forum for the resolution of any complaint asserting a cause or causes of action under the Securities Act, including all causes of action asserted against any defendant to such complaint. The choice of forum provisions will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any action the subject matter of which is within the scope described above is filed in a court other than a court located within the State of Delaware, or a foreign action, in the name of any stockholder, such stockholder shall be deemed to have consented to the personal jurisdiction of the state and federal courts located within the State of Delaware in connection with any action brought in any such court to enforce the applicable provisions of our Amended and Restated Charter and having service of process made upon such stockholder in any such action by service upon such stockholder&#8217;s counsel in the foreign action as agent for such stockholder. Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. As a result, both state and federal courts have jurisdiction to entertain such Securities Act claims. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our Amended and Restated Charter will contain the choice of forum provision described above. Our decision to adopt a such a provision follows a decision by the Supreme Court of the State of Delaware holding that such provisions are facially valid under the DGCL&#59; however, there is uncertainty as to whether a federal court or state court would enforce such a provision, and investors cannot waive compliance with federal securities laws and the rules and regulations thereunder.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, although our Amended and Restated Charter will contain the choice of forum provision described above, it is possible that a court could find that such a provision is inapplicable for a particular claim or action or that such provision is unenforceable.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This choice of forum provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or any of our directors, officers, other employees or stockholders, which may discourage lawsuits with respect to such claims and may result in increased costs for stockholders to bring a claim, although our stockholders will not be deemed to have waived our compliance with federal securities laws and the rules and regulations thereunder.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amendment of Charter Provisions</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amendment of any of the above provisions in our Amended and Restated Charter, except for the provision making it possible for our board of directors to issue undesignated preferred stock, would require approval by a stockholder vote by the holders of at least a 66 2&#47;3% of the voting power of the then outstanding voting stock.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provisions of the DGCL, our Amended and Restated Charter, and our Amended and Restated Bylaws could have the effect of discouraging others from attempting hostile takeovers and, as a consequence, they may also inhibit temporary fluctuations in the market price of our common stock that often result from actual or rumored hostile takeover attempts. These provisions may also have the effect of preventing changes in our management. It is possible that these provisions could make it more difficult to accomplish transactions that stockholders may otherwise deem to be in their best interests.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Limitations on Liability and Indemnification of Officers and Directors</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DGCL authorizes corporations to limit or eliminate the personal liability of directors and officers to corporations and their stockholders for monetary damages for breaches of directors&#8217; or officers&#8217; fiduciary duties, subject to certain exceptions. Our Amended and Restated Charter includes a provision that eliminates the personal liability of directors for monetary damages to the corporation or its stockholders for any breach of fiduciary duty as a director, except to the extent such exemption from liability or limitation thereof is not permitted under the DGCL. The effect of these provisions is to eliminate the rights of us and our stockholders, through stockholders&#8217; derivative suits on our behalf, to recover monetary damages from a director for breach of fiduciary duty as a director, including breaches resulting from grossly negligent behavior. However, exculpation does not apply to any breaches of the director&#8217;s duty of loyalty, any acts or omissions not in good faith or that involve intentional misconduct or knowing violation of law, any authorization of dividends or stock redemptions or repurchases paid or made in violation of the DGCL, or for any transaction from which the director derived an improper personal benefit.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Amended and Restated Bylaws generally provide that we must indemnify and advance expenses to our directors and officers to the fullest extent authorized by the DGCL. We also are expressly authorized to carry directors&#8217; and officers&#8217; liability insurance providing indemnification for our directors, officers, and certain employees for some liabilities. We believe that these indemnification and advancement provisions and insurance are useful to attract and retain qualified directors and executive officers.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The limitation of liability, indemnification, and advancement provisions in our Amended and Restated Charter and Amended and Restated Bylaws may discourage stockholders from bringing a lawsuit against directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against directors and officers, even though such an action, if successful, might otherwise benefit us and our stockholders. In addition, your investment may be adversely affected to the extent we pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is currently no pending material litigation or proceeding involving any of our directors, officers, or employees for which indemnification is sought.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnification Agreements</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to enter into an indemnification agreement with each of our directors and executive officers as described in &#8220;Certain Relationships and Related Party Transactions&#8212;Director and Officer Indemnification and Insurance.&#8221; Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors or executive officers, we have been informed that in the opinion of the SEC such indemnification is against public policy and is therefore unenforceable.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Exchange Listing</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have applied to have our common stock listed on the New York Stock Exchange under the symbol &#8220;PACS.&#8221; If our listing application is not approved, we will not proceed with this offering.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transfer Agent and Registrar</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer agent and registrar for our common stock is &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; . The transfer agent and registrar&#8217;s address is &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  , and its telephone number is &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; . </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_1454"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHARES ELIGIBLE FOR FUTURE SALE</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to this offering, there has been no public market for our common stock, and a liquid trading market for our common stock may not develop or be sustained after this offering. Future sales of our common stock in the public market after the completion of this offering, or the perception that those sales may occur, could adversely affect the prevailing market price for our common stock from time to time or impair our ability to raise equity capital in the future. As described below, only a limited number of shares of our common stock will be available for sale in the public market for a period of several months after the completion of this offering due to contractual and legal restrictions on resale described below. Future sales of our common stock in the public market either before or after restrictions lapse, or the perception that those sales may occur, could adversely affect the prevailing market price of our common stock at such time and our ability to raise equity capital at a time and price we deem appropriate.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of Restricted Shares</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the number of shares of our common stock outstanding as of&#160;December 31, 2023, upon the completion of this offering and assuming no exercise of the underwriters&#8217; option to purchase additional shares of common stock, we will have outstanding an aggregate of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares of common stock. Of these shares, all of the shares of common stock to be sold in this offering will be freely tradable in the public market without restriction or further registration under the Securities Act, unless the shares are held by any of our &#8220;affiliates&#8221; as such term is defined in Rule 144, or subject to lock-up agreements. All remaining shares of common stock held by existing stockholders immediately prior to the completion of this offering will be &#8220;restricted securities,&#8221; as such term is defined in Rule 144. These restricted securities were issued and sold by us in private transactions and are eligible for public sale only if registered under the Securities Act or if they qualify for an exemption from registration under the Securities Act, including the exemptions provided by Rule 144 which rule is summarized below.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the lock-up agreements referred to below and the provisions of Rule 144, based on the number of shares of our common stock outstanding (calculated as of&#160;December 31, 2023, on the basis of the assumptions described above), the shares of our common stock (excluding the shares sold in this offering) that will be available for sale in the public market are as follows&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate&#160;Number&#160;of&#160;Shares</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First&#160;Date&#160;Available&#160;For&#160;Sale&#160;Into&#160;Public&#160;Market</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">181 days after the date of this prospectus, upon expiration of the lock-up agreements referred to below, subject in some cases to applicable volume, manner of sale and other limitations under Rule 144.</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may issue shares of common stock from time to time as consideration for future acquisitions, investments or other corporate purposes. In the event that any such acquisition, investment or other transaction is significant, the number of shares of common stock that we may issue may in turn be significant. We may also grant registration rights covering those shares of common stock issued in connection with any such acquisition and investment.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the shares of common stock reserved for future issuance under our 2024 Plan will become eligible for sale in the public market to the extent permitted by the provisions of various vesting schedules, the lock-up agreements, a registration statement under the Securities Act or an exemption from registration, including Rule 144.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rule 144</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Rule 144, as currently in effect, once we have been subject to the public company reporting requirements of the Exchange Act for at least 90 days, and we are current in our Exchange Act reporting at the time of sale, a person (or persons whose shares are required to be aggregated) who is not deemed to have been one of our &#8220;affiliates&#8221; for purposes of Rule 144 at any time during the 90 days preceding a sale and who has beneficially owned restricted securities within the meaning of Rule 144 for at least six months, including the holding period of any prior owner other than one of our &#8220;affiliates,&#8221; is entitled to sell those shares in the public market (subject to the lock-up agreement referred to below, if applicable) without complying with the manner of sale, volume limitations or notice </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provisions of Rule 144, but subject to compliance with the public information requirements of Rule 144. If such a person has beneficially owned the shares proposed to be sold for at least one year, including the holding period of any prior owner other than &#8220;affiliates,&#8221; then such person is entitled to sell such shares in the public market without complying with any of the requirements of Rule 144 (subject to the lock-up agreement referred to below, if applicable).</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, under Rule 144, as currently in effect, once we have been subject to the public company reporting requirements of the Exchange Act for at least 90 days, our &#8220;affiliates,&#8221; as defined in Rule 144, who have beneficially owned the shares proposed to be sold for at least six months, are entitled to sell in the public market, upon expiration of any applicable lock-up agreements and within any three-month period, a number of those shares of our common stock that does not exceed the greater of&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">1% of the number of shares of our common stock then outstanding, which will equal approximately&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock immediately upon the completion of this offering (calculated as of December 31, 2023 on the basis of the assumptions described above)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the average weekly trading volume of our common stock on the New York Stock Exchange during the four calendar weeks preceding the filing of a notice on Form 144 with respect to such sale.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such sales under Rule 144 by our &#8220;affiliates&#8221; or persons selling shares on behalf of our &#8220;affiliates&#8221; are also subject to certain manner of sale provisions, notice requirements and requirements related to the availability of current public information about us. Notwithstanding the availability of Rule 144, the holders of substantially all of our restricted securities have entered into lock-up agreements as referenced above and their restricted securities will become eligible for sale (subject to the above limitations under Rule 144) upon the expiration of the restrictions set forth in those agreements.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lock-Up Agreements</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our officers, directors, and holders of substantially all of our common stock have agreed with the underwriters, subject to certain exceptions, not to dispose of or hedge any of our or their common stock or securities convertible into or exchangeable for shares of common stock during the period from the date of this prospectus continuing through the date 180 days after the date of this prospectus, except with the prior written consent of Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Truist Securities, Inc. This agreement does not apply to any existing employee benefit plans. These agreements are described in the section titled &#8220;Underwriting.&#8221;</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our employees, including our executive officers, and&#47;or directors, may enter into written trading plans that are intended to comply with Rule 10b5-1 under the Exchange Act. Sales under these trading plans would not be permitted until the expiration of the lock-up agreements relating to the offering described above.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the lock-up periods set forth in the agreements described above, and assuming that the representatives of the underwriters do not release any parties from these agreements and that there is no extension of the lock-up period, all of the shares of our common stock that are restricted securities or are held by our affiliates as of the date of this prospectus will be eligible for sale in the public market in compliance with Rule 144.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registration Rights</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the completion of this offering, the holders of up to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock will be entitled to rights with respect to the registration of their shares under the Securities Act, subject to the lock-up agreements described under &#8220;&#8212;Lock-Up Agreements&#8221; above. Registration of these shares under the Securities Act would result in the shares becoming freely tradable without restriction under the Securities Act, except for shares purchased by affiliates, immediately upon the effectiveness of the registration statement of which this prospectus is a part. Any sales of securities by these stockholders could have a material adverse effect on the trading price of our common stock. The requisite percentage of these stockholders will waive all such stockholders&#8217; rights to notice of this </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">offering and to include their shares of registrable securities in this offering. See the section titled &#8220;Description of Capital Stock&#8212;Registration Rights.&#8221;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Incentive Plans</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to file with the SEC a registration statement on Form S-8 under the Securities Act covering the shares of common stock issuable or reserved for issuance under our 2024 Plan and our ESPP. Such registration statement is expected to be filed and become effective as soon as practicable after the completion of this offering. Accordingly, shares registered under such registration statement will be available for sale in the open market following its effective date, subject to Rule 144 volume limitations and the lock-up agreements described above, if applicable.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_1463"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion is a summary of the material U.S. federal income tax consequences to Non-U.S. Holders (as defined below) of the purchase, ownership and disposition of our common stock issued pursuant to this offering, but does not purport to be a complete analysis of all potential tax effects. The effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local or non-U.S. tax laws are not discussed. This discussion is based on the U.S. Internal Revenue Code of 1986, as amended (Code), Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the U.S. Internal Revenue Service (IRS), in each case in effect as of the date hereof.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect a Non-U.S. Holder. We have not sought and will not seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a contrary position to that discussed below regarding the tax consequences of the purchase, ownership and disposition of our common stock.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This discussion is limited to Non-U.S. Holders that hold our common stock as a &#8220;capital asset&#8221; within the meaning of Section 1221 of the Code (generally, property held for investment). This discussion does not address all U.S. federal income tax consequences relevant to a Non-U.S. Holder&#8217;s particular circumstances, including the impact of the Medicare contribution tax on net investment income and the alternative minimum tax. In addition, it does not address consequences relevant to Non-U.S. Holders subject to special rules, including, without limitation&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. expatriates and former citizens or long-term residents of the United States&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">persons holding our common stock as part of a hedge, straddle or other risk reduction strategy or as part of a conversion transaction or other integrated investment&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">banks, insurance companies and other financial institutions&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">brokers, dealers or traders in securities&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;controlled foreign corporations,&#8221; &#8220;passive foreign investment companies&#8221; and corporations that accumulate earnings to avoid U.S. federal income tax&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and investors therein)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">tax-exempt organizations or governmental organizations&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">persons deemed to sell our common stock under the constructive sale provisions of the Code&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">persons who hold or receive our common stock pursuant to the exercise of any employee stock option or otherwise as compensation&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">persons that own or have owned (directly, indirectly or constructively) more than 5% of our common stock&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">tax-qualified retirement plans&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;qualified foreign pension funds&#8221; as defined in Section 897(l)(2) of the Code and entities all of the interests of which are held by qualified foreign pension funds.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an entity treated as a partnership for U.S. federal income tax purposes holds our common stock, the tax treatment of a partner in the partnership will depend on the status of the partner, the activities of the partnership and certain determinations made at the partner level. Accordingly, partnerships holding our common stock and the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">partners in such partnerships should consult their tax advisors regarding the U.S. federal income tax consequences to them.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THIS DISCUSSION IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT TAX ADVICE. INVESTORS SHOULD CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF OUR COMMON STOCK ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL OR NON-U.S. TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition of a Non-U.S. Holder</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this discussion, a &#8220;Non-U.S. Holder&#8221; is any beneficial owner of our common stock that is neither a &#8220;U.S. person&#8221; nor an entity treated as a partnership for U.S. federal income tax purposes. A U.S. person is any person that, for U.S. federal income tax purposes, is or is treated as any of the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an individual who is a citizen or resident of the United States&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a corporation created or organized under the laws of the United States, any state thereof or the District of Columbia&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an estate, the income of which is subject to U.S. federal income tax regardless of its source&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a trust that (i) is subject to the primary supervision of a U.S. court and all substantial decisions of which are subject to the control of one or more &#8220;United States persons&#8221; (within the meaning of Section 7701(a)(30) of the Code) or (ii) has a valid election in effect to be treated as a United States person for U.S. federal income tax purposes.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distributions</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in the section titled &#8220;Dividend Policy,&#8221; we have no current plans to pay dividends or other distributions on our common stock in the foreseeable future following this offering. However, if we do make distributions of cash or property on our common stock, such distributions will constitute dividends for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Amounts not treated as dividends for U.S. federal income tax purposes will constitute a return of capital and first be applied against and reduce a Non-U.S. Holder&#8217;s adjusted tax basis in its common stock, but not below zero. Any excess will be treated as capital gain and will be treated as described below under the subsection titled &#8220;&#8212;Sale or Other Taxable Disposition.&#8221;</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the discussion below regarding effectively connected income, dividends paid to a Non-U.S. Holder will be subject to U.S. federal withholding tax at a rate of 30% of the gross amount of the dividends (or such lower rate specified by an applicable income tax treaty, provided the Non-U.S. Holder furnishes a valid IRS Form W-8BEN or W-8BEN-E (or other applicable documentation) certifying qualification for the lower treaty rate). A Non-U.S. Holder that does not timely furnish the required documentation, but that qualifies for a reduced treaty rate, may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. Non-U.S. Holders should consult their tax advisors regarding their entitlement to benefits under any applicable tax treaties.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If dividends paid to a Non-U.S. Holder are effectively connected with the Non-U.S. Holder&#8217;s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, the Non-U.S. Holder maintains a permanent establishment in the United States to which such dividends are attributable), the Non-U.S. Holder will be exempt from the U.S. federal withholding tax described above. To claim the exemption, the Non-U.S. Holder must furnish to the applicable withholding agent a valid IRS Form W-8ECI, certifying that the dividends are </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">effectively connected with the Non-U.S. Holder&#8217;s conduct of a trade or business within the United States. Any such effectively connected dividends will be subject to U.S. federal income tax on a net income basis at the regular rates applicable to U.S. persons. A Non-U.S. Holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on such effectively connected dividends, as adjusted for certain items. Non-U.S. Holders should consult their tax advisors regarding any applicable tax treaties that may provide for different rules.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale or Other Taxable Disposition</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Non-U.S. Holder will not be subject to U.S. federal income tax on any gain realized upon the sale or other taxable disposition of our common stock unless&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the gain is effectively connected with the Non-U.S. Holder&#8217;s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, the Non-U.S. Holder maintains a permanent establishment in the United States to which such gain is attributable)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Non-U.S. Holder is a nonresident alien individual present in the United States for 183 days or more during the taxable year of the disposition and certain other requirements are met&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our common stock constitutes a U.S. real property interest (USRPI), by reason of our status as a U.S. real property holding corporation (USRPHC), for U.S. federal income tax purposes.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain described in the first bullet point above generally will be subject to U.S. federal income tax on a net income basis at the regular rates applicable to U.S. persons. A Non-U.S. Holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on such effectively connected gain, as adjusted for certain items.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Non-U.S. Holder described in the second bullet point above will be subject to U.S. federal income tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on gain realized upon the sale or other taxable disposition of our common stock, which may be offset by certain U.S.-source capital losses of the Non-U.S. Holder (even though the individual is not considered a resident of the United States), provided the Non-U.S. Holder has timely filed U.S. federal income tax returns with respect to such losses.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the third bullet point above, because the determination of whether we are a USRPHC depends on the fair market value of our USRPIs relative to the fair market value of our non-U.S. real property interests and our other business assets, and because we have significant interests in real property located in the United States, there can be no assurance that we currently are not a USRPHC or will not become one in the future. Even if we are or were to become a USRPHC, gain arising from the sale or other taxable disposition of our common stock by a Non-U.S. Holder will not be subject to U.S. federal income tax if our common stock is &#8220;regularly traded,&#8221; as defined by applicable Treasury Regulations, on an established securities market, and such Non-U.S. Holder owned, actually and constructively, 5% or less of our common stock throughout the shorter of the five-year period ending on the date of the sale or other taxable disposition or the Non-U.S. Holder&#8217;s holding period.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-U.S. Holders should consult their tax advisors regarding any applicable tax treaties that may provide for different rules.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information Reporting and Backup Withholding</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments of dividends on our common stock will not be subject to backup withholding, provided the Non-U.S. Holder certifies its non-U.S. status, such as by furnishing a valid IRS Form W-8BEN, W-8BEN-E or W-8ECI, or otherwise establishes an exemption. However, information returns are required to be filed with the IRS in connection with any distributions on our common stock paid to the Non-U.S. Holder, regardless of whether such distributions constitute dividends or whether any tax was actually withheld. In addition, proceeds of the sale or other taxable disposition of our common stock within the United States or conducted through certain U.S.-related brokers </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">generally will not be subject to backup withholding or information reporting if the applicable withholding agent receives the certification described above or the Non-U.S. Holder otherwise establishes an exemption. Proceeds of a disposition of our common stock conducted through a non-U.S. office of a non-U.S. broker that does not have certain enumerated relationships with the United States generally will not be subject to backup withholding or information reporting.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Copies of information returns that are filed with the IRS may also be made available under the provisions of an applicable treaty or agreement to the tax authorities of the country in which the Non-U.S. Holder resides or is established.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or a credit against a Non-U.S. Holder&#8217;s U.S. federal income tax liability, provided the required information is timely furnished to the IRS.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional Withholding Tax on Payments Made to Foreign Accounts</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Withholding taxes may be imposed under Sections 1471 to 1474 of the Code (such Sections commonly referred to as the Foreign Account Tax Compliance Act (FATCA)) on certain types of payments made to non-U.S. financial institutions and certain other non-U.S. entities. Specifically, a 30% withholding tax may be imposed on dividends on, or (subject to the proposed Treasury Regulations discussed below) gross proceeds from the sale or other disposition of, our common stock paid to a &#8220;foreign financial institution&#8221; or a &#8220;non-financial foreign entity&#8221; (each as defined in the Code), unless (i) the foreign financial institution undertakes certain diligence and reporting obligations, (ii) the non-financial foreign entity either certifies it does not have any &#8220;substantial United States owners&#8221; (as defined in the Code) or furnishes identifying information regarding each substantial United States owner or (iii) the foreign financial institution or non-financial foreign entity otherwise qualifies for an exemption from these rules. If the payee is a foreign financial institution and is subject to the diligence and reporting requirements in (i) above, it must enter into an agreement with the U.S. Department of the Treasury requiring, among other things, that it undertake to identify accounts held by certain &#8220;specified United States persons&#8221; or &#8220;United States owned foreign entities&#8221; (each as defined in the Code), annually report certain information about such accounts, and withhold 30% on certain payments to non-compliant foreign financial institutions and certain other account holders. Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United States governing FATCA may be subject to different rules.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under applicable Treasury Regulations and administrative guidance, withholding under FATCA generally applies to payments of dividends on our common stock. While withholding under FATCA would have applied also to payments of gross proceeds from the sale or other disposition of our common stock beginning on January 1, 2019, proposed Treasury Regulations eliminate FATCA withholding on payments of gross proceeds entirely. Taxpayers generally may rely on these proposed Treasury Regulations until final Treasury Regulations are issued.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prospective investors should consult their tax advisors regarding the potential application of withholding under FATCA to their investment in our common stock.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_1071"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNDERWRITING</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Truist Securities, Inc. are acting as joint book-running managers of this offering and as representatives of the underwriters named below. Subject to the terms and conditions stated in the underwriting agreement, which will be filed as an exhibit to the registration statement of which this prospectus is a part, each underwriter named below has severally agreed to purchase, and we have agreed to sell to that underwriter, the number of shares of common stock set forth opposite the underwriter&#8217;s name in the following table&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Underwriter</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Citigroup Global Markets Inc.</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J.P. Morgan Securities LLC</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Truist Securities, Inc.</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriting agreement provides that the obligations of the underwriters to purchase the shares of our common stock included in this offering are subject to approval of legal matters by counsel and to other conditions. The underwriters are obligated to purchase all of the shares of our common stock (other than those covered by the over-allotment option described below) if they purchase any of the shares.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of our common stock sold by the underwriters to the public will initially be offered at the initial public offering price set forth on the cover of this prospectus. Any shares of our common stock sold by the underwriters to securities dealers may be sold at a discount from the initial public offering price not to exceed $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share. After the initial public offering of the shares of our common stock, if all of the shares of our common stock are not sold at the initial public offering price, the underwriters may change the offering price and the other selling terms. The representatives have advised us that the underwriters do not intend to make sales to discretionary accounts.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the underwriters sell more shares of our common stock than the total number set forth in the table above, we have granted to the underwriters an option, exercisable for 30 days from the date of this prospectus, to purchase up to an additional&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock at the initial public offering price less the underwriting discounts and commissions. The underwriters may exercise the option solely for the purpose of covering over-allotments, if any, in connection with this offering. To the extent the option is exercised, each underwriter must purchase a number of additional shares of our common stock approximately proportionate to that underwriter&#8217;s initial purchase commitment set forth in the table above. Any shares of our common stock issued or sold under the option will be issued and sold on the same terms and conditions as the other shares of our common stock that are the subject of this offering.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, our directors, executive officers and all of our stockholders have agreed that, subject to specified limited exceptions, for a period of 180 days from the date of this prospectus, we and they will not, without the prior written consent of the representatives, offer, sell, contract to sell, pledge or otherwise dispose of, including the filing of a registration statement in respect of, or hedge any shares of our common stock or any securities convertible into, or exercisable or exchangeable for, our common stock.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The representatives, in their sole discretion, may release any of the securities subject to these lock-up agreements at any time, which, in the case of our directors and executive officers, shall be with notice. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to this offering, there has been no public market for our common stock. Consequently, the initial public offering price for the shares of our common stock will be determined by negotiations among us and the representatives. Among the factors considered in determining the initial public offering price will be our results of operations, our current financial condition, our future prospects, our markets, the economic conditions in and future prospects for the industry in which we compete, our management, and currently prevailing general conditions in the equity securities markets, including current market valuations of publicly traded companies considered comparable to our company. We cannot assure you, however, that the price at which the shares of our common stock will sell in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the public market after this offering will not be lower than the initial public offering price or that an active trading market in our shares of common stock will develop and continue after this offering.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have applied to have our common stock listed on the New York Stock Exchange under the symbol &#8220;PACS.&#8221;</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the per share and total public offering price, underwriting discounts and commissions that we are to pay to the underwriters and proceeds to us, before expenses, in connection with this offering. These amounts are shown assuming both no exercise and full exercise of the underwriters&#8217; over-allotment option.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Per share</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">No exercise</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Full exercise</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public offering price</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwriting discounts and commissions paid by us</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds to us, before expenses</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate that expenses payable by us in connection with this offering, exclusive of underwriting discounts and commissions, will be approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million. We have also agreed to reimburse the underwriters for certain of their expenses in an amount up to $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this offering, the underwriters may purchase and sell shares of our common stock in the open market. Purchases and sales in the open market may include short sales, purchases to cover short positions, which may include purchases pursuant to the underwriters&#8217; over-allotment option, and stabilizing purchases. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Short sales involve secondary market sales by the underwriters of a greater number of shares of our common stock than they are required to purchase in this offering.</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">&#8220;Covered&#8221; short sales are sales of shares of our common stock in an amount up to the number of shares of our common stock represented by the underwriters&#8217; over-allotment option. </font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">&#8220;Naked&#8221; short sales are sales of shares of our common stock in an amount in excess of the number of shares of our common stock represented by the underwriters&#8217; over-allotment option. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Covering transactions involve purchases of shares, either pursuant to the underwriters&#8217; over-allotment option or in the open market.</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">To close a naked short position, the underwriters must purchase shares of our common stock in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the shares of our common stock in the open market after pricing that could adversely affect investors who purchase in this offering.</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">To close a covered short position, the underwriters must purchase shares of our common stock in the open market or exercise their over-allotment option. In determining the source of shares of our common stock to close the covered short position, the underwriters will consider, among other things, the price of shares of our common stock available for purchase in the open market as compared to the price at which they may purchase shares of our common stock through their over-allotment option.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Stabilizing transactions involve bids to purchase shares of our common stock on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, as long as the stabilizing bids do not exceed a specified maximum. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases to cover short positions and stabilizing purchases, as well as other purchases by the underwriters for their own accounts, may have the effect of preventing or retarding a decline in the market price of the shares. They may also cause the price of the shares of our common stock to be higher than the price that would otherwise exist in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">151</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the open market in the absence of these transactions. The underwriters may conduct these transactions on&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, in the over-the-counter market or otherwise. The underwriters are not required to engage in any of these transactions and, if they do commence any, they may discontinue them at any time. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A prospectus in electronic format may be made available on websites maintained by one or more of the underwriters or their respective affiliates. The representatives may agree with us to allocate a number of shares of our common stock to underwriters for sale to their online brokerage account holders. Any such allocation for online distributions will be made by the underwriters on the same basis as other allocations. Other than the prospectus in electronic format, the information on the underwriters&#8217; or their respective affiliates&#8217; websites and any information contained in any other website maintained by any of the underwriters or their respective affiliates is not part of this prospectus, has not been approved and&#47;or endorsed by us or the underwriters and should not be relied upon by investors in this offering.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conflicts of Interest</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters are full service financial institutions engaged in various activities, which may include securities trading, commercial and investment banking, financial advisory, investment management, principal investment, hedging, financing and brokerage activities. The underwriters and their respective affiliates have in the past performed commercial banking, investment banking and advisory services for us from time to time for which they have received customary fees and reimbursement of expenses and may, from time to time, engage in transactions with and perform services for us in the ordinary course of their business for which they may receive customary fees and reimbursement of expenses. In the ordinary course of their various business activities, the underwriters and their respective affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (which may include bank loans and&#47;or credit default swaps) for their own account and for the accounts of their customers and may at any time hold long and short positions in such securities and instruments. Such investments and securities activities may involve securities and&#47;or instruments of ours or our affiliates. In addition, an affiliate of Truist Securities, Inc. is, among others, a lender and the administrative agent for the lenders under our Amended and Restated 2023 Credit Facility. See the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Conditions and Results of Operations&#8212;Liquidity &#38; Capital Resources&#8212;Credit Facilities&#8221; for additional information regarding the Amended and Restated 2023 Credit Facility. Certain of the underwriters or their affiliates that have a lending relationship with us routinely hedge their credit exposure to us consistent with their customary risk management policies. A typical such hedging strategy would include these underwriters or their affiliates hedging such exposure by entering into transactions which consist of either the purchase of credit default swaps or the creation of short positions in our securities. The underwriters and their affiliates may also make investment recommendations and&#47;or publish or express independent research views in respect of such securities or financial instruments and may hold, or recommend to clients that they acquire, long and&#47;or short positions in such securities and instruments.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act, or to contribute to payments the underwriters may be required to make because of any of those liabilities.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notice to Prospective Investors in the European Economic Area</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In relation to each Member State of the European Economic Area (each a Relevant State), no shares of common stock have been offered or will be offered pursuant to this offering to the public in that Relevant State prior to the publication of a prospectus in relation to the shares of our common stock which has been approved by the competent authority in that Relevant State or, where appropriate, approved in another Relevant State and notified to the competent authority in that Relevant State, all in accordance with the Prospectus Regulation, except that offers of shares of common stock may be made to the public in that Relevant State at any time under the following exemptions under the Prospectus Regulation&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">to any legal entity which is a qualified investor as defined under the Prospectus Regulation&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus Regulation), subject to obtaining the prior consent of the representatives for any such offer&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">in any other circumstances falling within Article 1(4) of the Prospectus Regulation,</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provided that no such offer of shares of common stock shall require the Company or any underwriter to publish a prospectus pursuant to Article 3 of the Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each person in a Relevant State who initially acquires any shares of common stock or to whom any offer is made will be deemed to have represented, acknowledged and agreed to and with the Company and the underwriters that it is a qualified investor within the meaning of the Prospectus Regulation.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the case of any shares of common stock being offered to a financial intermediary as that term is used in Article 5(1) of the Prospectus Regulation, each such financial intermediary will be deemed to have represented, acknowledged and agreed that the shares of our common stock acquired by it in the offer have not been acquired on a non-discretionary basis on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise to an offer to the public other than their offer or resale in a Relevant State to qualified investors, in circumstances in which the prior consent of the representatives has been obtained to each such proposed offer or resale.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, the underwriters and their respective affiliates will rely upon the truth and accuracy of the foregoing representations, acknowledgments and agreements.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to any shares of common stock in any Relevant State means the communication in any form and by any means of sufficient information on the terms of the offer and any shares of common stock to be offered so as to enable an investor to decide to purchase or subscribe for any shares of common stock, and the expression &#8220;Prospectus Regulation&#8221; means Regulation (EU) 2017&#47;1129.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above selling restriction is in addition to any other selling restrictions set out below.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notice to Prospective Investors in the United Kingdom</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In relation to the United Kingdom (UK), no shares of common stock have been offered or will be offered pursuant to this offering to the public in the UK prior to the publication of a prospectus in relation to the shares of our common stock which has been approved by the Financial Conduct Authority in the UK in accordance with the UK Prospectus Regulation and the FSMA, except that offers of shares of common stock may be made to the public in the UK at any time under the following exemptions under the UK Prospectus Regulation and the FSMA&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">to any legal entity which is a qualified investor as defined under the UK Prospectus Regulation&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">to fewer than 150 natural or legal persons (other than qualified investors as defined under the UK Prospectus Regulation), subject to obtaining the prior consent of the representatives for any such offer&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">at any time in other circumstances falling within section 86 of the FSMA,</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provided that no such offer of shares of common stock shall require the Company or any underwriter to publish a prospectus pursuant to Section 85 of the FSMA or Article 3 of the UK Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the UK Prospectus Regulation.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each person in the UK who initially acquires any shares of common stock or to whom any offer is made will be deemed to have represented, acknowledged and agreed to and with the Company and the underwriters that it is a qualified investor within the meaning of the UK Prospectus Regulation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the case of any shares of common stock being offered to a financial intermediary as that term is used in Article 5(1) of the UK Prospectus Regulation, each such financial intermediary will be deemed to have represented, acknowledged and agreed that the shares of our common stock acquired by it in the offer have not been acquired on a non-discretionary basis on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise to an offer to the public other than their offer or resale in the UK to qualified investors, in circumstances in which the prior consent of the representatives has been obtained to each such proposed offer or resale.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, the underwriters and their respective affiliates will rely upon the truth and accuracy of the foregoing representations, acknowledgements and agreements.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to any shares of common stock in the UK means the communication in any form and by any means of sufficient information on the terms of the offer and any shares of common stock to be offered so as to enable an investor to decide to purchase or subscribe for any shares of common stock, and the expression &#8220;UK Prospectus Regulation&#8221; means Regulation (EU) 2017&#47;1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, and the expression &#8220;FSMA&#8221; means the Financial Services and Markets Act 2000.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This document is for distribution only to persons who (i) have professional experience in matters relating to investments and who qualify as investment professionals within the meaning of Article 19(5) of the FSMA Order 2005 (as amended, Financial Promotion Order), (ii) are persons falling within Article 49(2)(a) to (d) (&#8220;high net worth companies, unincorporated associations etc.&#8221;) of the Financial Promotion Order, (iii) are outside the UK, or (iv) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the FSMA) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as relevant persons). This document is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this document relates is available only to relevant persons and will be engaged in only with relevant persons.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notice to Prospective Investors in France </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither this prospectus nor any other offering material relating to the shares of our common stock described in this prospectus has been submitted to the clearance procedures of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Autorit&#233; des March&#233;s Financiers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or of the competent authority of another member state of the European Economic Area and notified to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Autorit&#233; des March&#233;s Financiers.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The shares of our common stock have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in France. Neither this prospectus nor any other offering material relating to the shares of our common stock has been or will be&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">released, issued, distributed or caused to be released, issued or distributed to the public in France&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">used in connection with any offer for subscription or sale of the shares of our common stock to the public in France. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such offers, sales and distributions will be made in France only&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">to qualified investors (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">investisseurs qualifi&#233;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and&#47;or to a restricted circle of investors (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cercle restreint d&#8217;investisseurs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), in each case investing for their own account, all as defined in, and in accordance with articles L.411-2, D.411-1, D.411-2, D.734-1, D.744-1, D.754-1 and D.764-1 of the French Code </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">mon&#233;taire et financier</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">to investment services providers authorized to engage in portfolio management on behalf of third parties&#59; or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">in a transaction that, in accordance with article L.411-2-II-1&#176;-or-2&#176;-or 3&#176; of the French Code </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">mon&#233;taire et financier</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and article 211-2 of the General Regulations (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R&#232;glement G&#233;n&#233;ral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Autorit&#233; des March&#233;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financiers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, does not constitute a public offer (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">appel public &#224; l&#8217;&#233;pargne</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of our common stock may be resold directly or indirectly, only in compliance with articles L.411-1, L.411-2, L.412-1 and L.621-8 through L.621-8-3 of the French </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Code mon&#233;taire et financier</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notice to Prospective Investors in Hong Kong</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of our common stock have not been offered or sold and will not be offered or sold in Hong Kong, by means of any document, other than (a) to &#8220;professional investors&#8221; as defined in the Securities and Futures Ordinance (Cap. 571) of Hong Kong and any rules made under that Ordinance&#59; or (b) in other circumstances which do not result in the document being a &#8220;prospectus&#8221; as defined in the Companies Ordinance (Cap. 32) of Hong Kong or which do not constitute an offer to the public within the meaning of that Ordinance. No advertisement, invitation or document relating to the shares of our common stock has been or may be issued or has been or may be in the possession of any person for the purposes of issue, whether in Hong Kong or elsewhere, which is directed at, or the contents of which are likely to be accessed or read by, the public of Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to the shares of our common stock which are or are intended to be disposed of only to persons outside Hong Kong or only to &#8220;professional investors&#8221; as defined in the Securities and Futures Ordinance and any rules made under that Ordinance.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notice to Prospective Investors in Japan</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of our common stock have not been and will not be registered under the Financial Instruments and Exchange Law of Japan (Law No. 25 of 1948, as amended) and, accordingly, will not be offered or sold, directly or indirectly, in Japan, or for the benefit of any Japanese Person or to others for re-offering or resale, directly or indirectly, in Japan or to any Japanese Person, except in compliance with all applicable laws, regulations and ministerial guidelines promulgated by relevant Japanese governmental or regulatory authorities in effect at the relevant time. For the purposes of this paragraph, &#8220;Japanese Person&#8221; shall mean any person resident in Japan, including any corporation or other entity organized under the laws of Japan.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notice to Prospective Investors in Singapore</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, the shares of our common stock were not offered or sold or caused to be made the subject of an invitation for subscription or purchase and will not be offered or sold or caused to be made the subject of an invitation for subscription or purchase, and this prospectus or any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the shares of our common stock, has not been circulated or distributed, nor will it be circulated or distributed, whether directly or indirectly, to any person in Singapore other than (i) to an institutional investor (as defined in Section 4A of the Securities and Futures Act (Chapter 289) of Singapore, as modified or amended from time to time (SFA)) pursuant to Section 274 of the SFA, (ii) to a relevant person (as defined in Section 275(2) of the SFA) pursuant to Section 275(1) of the SFA, or any person pursuant to Section 275(1A) of the SFA, and in accordance with the conditions specified in Section 275 of the SFA, or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where the shares of our common stock are subscribed or purchased under Section 275 of the SFA by a relevant person which is&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">a corporation (which is not an accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor,</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">155</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities or securities-based derivatives contracts (each term as defined in Section 2(1) of the SFA) of that corporation or the beneficiaries&#8217; rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the shares of our common stock pursuant to an offer made under Section 275 of the SFA except&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">to an institutional investor or to a relevant person, or to any person arising from an offer referred to in Section 275(1A) or Section 276(4)(i)(B) of the SFA&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">where no consideration is or will be given for the transfer&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">where the transfer is by operation of law&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">as specified in Section 276(7) of the SFA.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notice to Prospective Investors in Canada</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of our common stock may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prospectus Exemptions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or subsection 73.3(1) of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Ontario), and are permitted clients, as defined in National Instrument 31-103 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Registration Requirements, Exemptions and Ongoing Registrant Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any resale of the shares of our common stock must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&#8217;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#8217;s province or territory for particulars of these rights or consult with a legal advisor.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to section 3A.3 (or, in the case of securities issued or guaranteed by the government of a non-Canadian jurisdiction, section 3A.4) of National Instrument 33-105 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Underwriting Conflicts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (NI 33-105), the underwriters are not required to comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notice to Prospective Investors in Australia</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No placement document, prospectus, product disclosure statement or other disclosure document has been lodged with the Australian Securities and Investments Commission (ASIC) in relation to this offering. This prospectus does not constitute a prospectus, product disclosure statement or other disclosure document under the Corporations Act 2001 (Corporations Act), and does not purport to include the information required for a prospectus, product disclosure statement or other disclosure document under the Corporations Act.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any offer in Australia of the shares of our common stock may only be made to persons (Exempt Investors) who are &#8220;sophisticated investors&#8221; (within the meaning of section 708(8) of the Corporations Act), &#8220;professional investors&#8221; (within the meaning of section 708(11) of the Corporations Act) or otherwise pursuant to one or more exemptions contained in section 708 of the Corporations Act so that it is lawful to offer the shares of our common stock without disclosure to investors under Chapter 6D of the Corporations Act.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of our common stock applied for by Exempt Investors in Australia must not be offered for sale in Australia in the period of 12 months after the date of allotment under this offering, except in circumstances where disclosure to investors under Chapter 6D of the Corporations Act would not be required pursuant to an exemption under section 708 of the Corporations Act or otherwise or where the offer is pursuant to a disclosure document </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which complies with Chapter 6D of the Corporations Act. Any person acquiring shares of our common stock must observe such Australian on-sale restrictions.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus contains general information only and does not take account of the investment objectives, financial situation or particular needs of any particular person. It does not contain any securities recommendations or financial product advice. Before making an investment decision, investors need to consider whether the information in this prospectus is appropriate to their needs, objectives and circumstances, and, if necessary, seek expert advice on those matters.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notice to Prospective Investors in Chile</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of our common stock are not registered in the Securities Registry (Registro de Valores) or subject to the control of the Chilean Securities and Exchange Commission (Superintendencia de Valores y Seguros de Chile). This prospectus and other offering materials relating to the offer of the shares of our common stock do not constitute a public offer of, or an invitation to subscribe for or purchase, the shares of our common stock in the Republic of Chile, other than to individually identified purchasers pursuant to a private offering within the meaning of Article 4 of the Chilean Securities Market Act (Ley de Mercado de Valores) (an offer that is not &#8220;addressed to the public at large or to a certain sector or specific group of the public&#8221;).</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notice to Prospective Investors in Switzerland</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of our common stock may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (SIX) or on any other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering or marketing material relating to the shares of our common stock or this offering may be publicly distributed or otherwise made publicly available in Switzerland.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither this document nor any other offering or marketing material relating to this offering, the Company, or the shares of our common stock have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of shares of our common stock will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA (FINMA), and the offer of shares of our common stock has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes (CISA). The investor protection afforded to acquirers of interests in collective investment schemes under the CISA does not extend to acquirers of shares of our common stock.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notice to Prospective Investors in the Dubai International Financial Centre</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus relates to an Exempt Offer in accordance with the Offered Securities Rules of the Dubai Financial Services Authority (DFSA). This prospectus is intended for distribution only to persons of a type specified in the Offered Securities Rules of the DFSA. It must not be delivered to, or relied on by, any other person. The DFSA has no responsibility for reviewing or verifying any documents in connection with Exempt Offers. The DFSA has not approved this prospectus nor taken steps to verify the information set forth herein and has no responsibility for the prospectus. The shares of our common stock to which this prospectus relates may be illiquid and&#47;or subject to restrictions on their resale. Prospective purchasers of the shares of our common stock offered should conduct their own due diligence on the shares of our common stock. If you do not understand the contents of this prospectus you should consult an authorized financial advisor.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notice to Prospective Investors in the United Arab Emirates</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of our common stock have not been, and are not being, publicly offered, sold, promoted or advertised in the United Arab Emirates (including the Dubai International Financial Centre) other than in compliance with the laws of the United Arab Emirates (and the Dubai International Financial Centre) governing the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">157</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issue, offering and sale of securities. Further, this prospectus does not constitute a public offer of securities in the United Arab Emirates (including the Dubai International Financial Centre) and is not intended to be a public offer. This prospectus has not been approved by or filed with the Central Bank of the United Arab Emirates, the Securities and Commodities Authority or the Dubai Financial Services Authority.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notice to Prospective Investors in Qatar</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shares of our common stock described in this prospectus have not been, and will not be, offered, sold or delivered, at any time, directly or indirectly in the State of Qatar in a manner that would constitute a public offering. This prospectus has not been, and will not be, registered with or approved by the Qatar Financial Markets Authority or Qatar Central Bank and may not be publicly distributed. This prospectus is intended for the original recipient only and must not be provided to any other person. It is not for general circulation in the State of Qatar and may not be reproduced or used for any other purpose.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">158</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_1083"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LEGAL MATTERS</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The validity of the shares of our common stock offered hereby will be passed upon for us by Latham &#38; Watkins LLP, Costa Mesa, California. Goodwin Procter LLP, New York, New York, is acting as counsel for the underwriters in connection with certain legal matters related to this offering.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_1095"></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXPERTS</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ernst &#38; Young LLP, independent registered public accounting firm, has audited our combined&#47;consolidated financial statements at December 31, 2022, and for each of the two years in the period ended December 31, 2022, as set forth in their report. We&#8217;ve included our financial statements in the prospectus and elsewhere in the registration statement in reliance on Ernst &#38; Young LLP&#8217;s report, given on their authority as experts in accounting and auditing.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_1107"></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WHERE YOU CAN FIND MORE INFORMATION</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the shares of common stock offered hereby. This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth in the registration statement or the exhibits filed therewith. For further information about us and the shares of our common stock offered hereby, reference is made to the registration statement and the exhibits filed therewith. Statements contained in this prospectus regarding the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and in each instance, we refer you to the copy of such contract or other document filed as an exhibit to the registration statement. The SEC maintains a website that contains reports, proxy and information statements and other information regarding registrants that file electronically with the SEC. The address of the website is </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.sec.gov</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this offering, we will become subject to the information and reporting requirements of the Exchange Act and, in accordance with this law, will file periodic reports, proxy and information statements and other information with the SEC upon the completion of this offering. These periodic reports, proxy and information statements and other information will be available for inspection at the website of the SEC referred to above. We also maintain a website at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.pacs.com.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Upon the completion of this offering, you may access these materials free of charge as soon as reasonably practicable after they are filed electronically with, or furnished to, the SEC. The inclusion of our website address in this prospectus is an inactive textual reference only. The information contained on, or that can be accessed through, our website is not incorporated by reference into, and is not a part of, this prospectus or the registration statement of which this prospectus forms a part. Investors should not rely on any such information in deciding whether to purchase our common stock.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO THE AUDITED FINANCIAL STATEMENTS</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PAGE</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">REPORT O</a><a href="#i2baa8a1031f44c51b1664e00d256c582_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F</a><a href="#i2baa8a1031f44c51b1664e00d256c582_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> INDEPENDENT REGISTERED </a><a href="#i2baa8a1031f44c51b1664e00d256c582_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PUBLIC ACCOUNTING FIRM</a></font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-</a><a href="#i2baa8a1031f44c51b1664e00d256c582_7" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2</a></font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">CONSOLIDATED FINANCIAL STATEMENTS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-</a><a href="#i2baa8a1031f44c51b1664e00d256c582_10" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">4</a></font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_13" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">CONSOLIDATED BALANCE SHEET</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_13" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-</a><a href="#i2baa8a1031f44c51b1664e00d256c582_13" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">4</a></font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_16" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">CONSOLIDATED STATEMENTS OF INCOME</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_16" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-</a><a href="#i2baa8a1031f44c51b1664e00d256c582_16" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">5</a></font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_19" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">CONSOLIDATED STATEMENTS OF S</a><a href="#i2baa8a1031f44c51b1664e00d256c582_19" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">TOCK</a><a href="#i2baa8a1031f44c51b1664e00d256c582_19" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">H</a><a href="#i2baa8a1031f44c51b1664e00d256c582_19" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">OLDERS' EQUITY&#47;(DEFICIT)</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_19" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-</a><a href="#i2baa8a1031f44c51b1664e00d256c582_19" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">6</a></font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">CONSOLIDATED STATEMENTS OF CASH FLOWS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-</a><a href="#i2baa8a1031f44c51b1664e00d256c582_22" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">7</a></font></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_25" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#i2baa8a1031f44c51b1664e00d256c582_25" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-</a><a href="#i2baa8a1031f44c51b1664e00d256c582_25" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">8</a></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of PACS Group, Inc.  </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying combined&#47;consolidated balance sheet of PACS Group, Inc. and subsidiaries (the Company) as of December 31, 2022, the related combined&#47;consolidated statements of income, stockholders' equity&#47;(deficit) and cash flows for each of the two years in the period ended December 31, 2022, and the related notes (collectively referred to as the &#8220;combined&#47;consolidated financial statements&#8221;). In our opinion, the combined&#47;consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2022, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2022, in conformity with U.S. generally accepted accounting principles.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matter</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that&#58; (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.085%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.074%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Professional liability claims reserve</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At December 31, 2022, the Company&#8217;s professional liability claims reserve was $138.1 million. As further described in Note 14 to the consolidated financial statements, the professional liability claims reserve includes an estimate of the Company&#8217;s liability for professional claims that have been reported as well as claims that have been incurred but not reported. The Company utilizes an external actuary to assist management in estimating the exposure for claims obligations, both asserted and unasserted.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Auditing the professional liability claims reserve is complex and highly judgmental due to the significant estimation required in determining the claims reserve, particularly the assumptions regarding the ultimate claim loss exposure. The Company develops information relating to the ultimate size of the claims based on historical experience and current industry information which is used in the actuarial analysis.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">To test the professional liability claims reserves, our audit procedures included, obtaining an understanding of the factors considered and assumptions made by management and its external actuary in developing the estimate of the general and professional liability reserves, including the sources of data relevant to these factors and assumptions. We tested underlying claims data, including the completeness and accuracy of open and settled cases handled by legal firms. We reviewed the Company&#8217;s insurance contracts to understand the policy terms and verified that the policy terms were incorporated within the actuary report. We also involved our actuaries to assist in evaluating the methodologies and key assumptions used by the Company in developing the estimate. We compared the Company&#8217;s professional liability claims reserve to an independent range calculated by our actuaries.</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ernst &#38; Young LLP</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2022.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Salt Lake City, Utah</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February xx, 2024</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing report is in the form that will be signed upon issuance of the December 31, 2023 financial statement which will reflect the completion of the reorganization transaction described in Note 1 to the financial statements.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst and Young, LLP</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Salt Lake City, Utah</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 8, 2023</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_10"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="text-align:center"><font><br></font></div><div id="i2baa8a1031f44c51b1664e00d256c582_13"></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PACS GROUP, INC. AND SUBSIDIARIES</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONSOLIDATED BALANCE SHEET</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands, except for share values)</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">ASSETS</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Assets&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,269&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,924&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,200&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,770&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current Assets</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511,163&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430,565&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345,044&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Escrow funds</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,217&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other indefinite-lived assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,491&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,411&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,461,891&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">LIABILITIES AND EQUITY</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Liabilities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,576&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll and benefits</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,360&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current operating lease liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,171&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current maturities of long term debt</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,363&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of accrued self-insurance liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,233&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,159&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current Liabilities</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,862&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-Term Liabilities&#58;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,304,780&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued benefits, less current portion</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,287&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lines of credit</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,820&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, less current maturities, net of deferred financing fees</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,521&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued self-insurance liabilities, less current portion</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,894&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,076&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Long-Term Liabilities</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909,378&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393,240&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 14)</font></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock - 100,000 shares authorized, $0.001 par value, 20,000 shares issued and outstanding</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,645&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' equity</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,646&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling interest in subsidiary</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,005&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Equity</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,651&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Liabilities and Equity</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,461,891&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-4</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_16"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PACS GROUP, INC. AND SUBSIDIARIES</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONSOLIDATED STATEMENTS OF INCOME</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands, except for share and per share values)</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient and resident service revenue</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,399,155&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,135,909&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional funding</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,482&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,563&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,091&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,421,994&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166,563&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Expenses</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,861,314&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901,095&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent - cost of services</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,003&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,122&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,006&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,834&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,311&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,153&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Operating Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,192,634&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083,204&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income </font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,360&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,359&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (Expense) Income</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,538)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,278)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,223&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,345&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Other Expense, net</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,315)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,933)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,045&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,426&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56,549)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,479)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Income</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,496&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,947&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income per share</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,525&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average shares outstanding</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements. </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-5</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_19"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PACS GROUP, INC. AND SUBSIDIARIES</font></td></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY&#47;(DEFICIT)</font></td></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands, except for share values)</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Retained Earnings (Accumulated Deficit) </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Non-Controlling Interest  </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Total Stockholders' Equity (Deficit) </font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance January 1, 2021</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,864)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,759&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,104)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends on Common Stock ($1,683 per share)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,654)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,654)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income </font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,947&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,947&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance December 31, 2021</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000&#160;</font></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,571)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,759&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,811)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contributions</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,246&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,246&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends on Common Stock ($3,014 per share)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60,280)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60,280)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Income </font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,496&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,496&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance December 31, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,645&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,005&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,651&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;padding-right:-13.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-6</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_22"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PACS GROUP, INC. AND SUBSIDIARIES</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONSOLIDATED STATEMENT OF CASH FLOWS</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,496&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,947&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,311&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,153&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing fees</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on disposition of property and equipment</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,974)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on investment in partnership</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,921)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,834&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncash lease expense</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,464&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114,416)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,903)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,185)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,371)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,967&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,341)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,193&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Escrow funds</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,526)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,112)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,091)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,808&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,778&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll and benefits</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,564)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,825&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued self-insurance liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,636&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,633&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,390)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,294)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,168)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET CASH PROVIDED BY OPERATING ACTIVITIES</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,615&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,602&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in partnership</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,714)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-operating distributions from investment in partnership</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,905&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of facilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,374)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,676)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property and equipment</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,862)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124,087)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of property and equipment</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET CASH USED IN INVESTING ACTIVITIES</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,321)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218,600)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowing on lines-of-credit, net of deferred financing fees</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,528&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460,923&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on lines-of-credit</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119,149)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(352,120)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends on common stock</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60,280)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,797)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contributions from non-controlling interest</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,246&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings of long-term debt </font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,906&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,474&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on long-term debt</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,901)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,432)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET CASH PROVIDED BY FINANCING ACTIVITIES</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,350&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,048&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PACS GROUP, INC. AND SUBSIDIARIES</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONSOLIDATED STATEMENT OF CASH FLOWS (CONTINUED)</font></div></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(dollars in thousands)</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash </font></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,644&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,050&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash - beginning of year</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,562&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,512&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash - end of year</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,206&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,562&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental disclosures of cash flow information</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,911&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,943&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,554&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,110&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-cash financing and investing activity</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued capital expenditures</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,799&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired for notes payable</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,200&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,800&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements. </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-7</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_25"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </font></div><div id="i2baa8a1031f44c51b1664e00d256c582_28"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:33.69pt">ORGANIZATION AND NATURE OF BUSINESS</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Providence Group, Inc. (PGI), a California corporation, was incorporated on December&#160;17, 2012. PGI is a holding company which consolidates various operating and other subsidiaries. PGI&#8217;s applicable operating subsidiaries operate various skilled nursing facilities (SNF) and assisted living facilities (ALF). PGI also owns other subsidiaries that are engaged in the acquisition, ownership, and leasing of health care-related properties. As of December&#160;31, 2022 PGI subsidiaries operated 151 health care facilities in the states of California, Nevada, Kentucky, Texas, Missouri, South Carolina and Ohio. PGI subsidiaries collectively owned approximately 16,330 skilled nursing beds, 180 assisted living beds, and 270 subacute beds as of that date. As of December&#160;31, 2022, PGI subsidiaries operated 130 facilities under long-term lease arrangements and had options to purchase 7 of those facilities.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PGI also owns subsidiaries that own real estate and related improvements that are leased to applicable affiliated SNF operating entities and one non-affiliated ALF operating entity. The Company&#8217;s real estate portfolio includes 22 properties which are operated and managed by applicable PGI subsidiaries. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Providence Administrative Consulting Services, Inc. (PACS), a California corporation, is a subsidiary of PGI and provides administrative support services, on a consulting basis, to other subsidiaries of PGI. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Starting in January 2022, PGI formed a wholly-owned captive insurance subsidiary, Welsch Insurance Ltd. (Welsch). Welsch provides coverage to various consolidated operating subsidiaries related to Professional Liability and General Liability (PLGL) insurance.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, PGI acquired 100% of the outstanding membership units of Bay Bridge Capital Partners, LLC and as a result acquired the operating assets of the company formerly known as Plum Healthcare Group (Plum). The transaction added the operations of 58 stand-alone skilled nursing, assisted living, and subacute facilities, and eight real estate purchases. See Note 15 for additional detail.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reorganization</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;30, 2023, PGI and its consolidated subsidiaries reorganized (the Reorganization) to facilitate their entrance into a new credit agreement, dated June 30, 2023 (the New Credit Agreement), between certain lenders party thereto, Truist Bank, as administrative agent, PACS Group, Inc. (PACS Group), and PACS Holdings, LLC (PACS Holdings) as borrower thereunder. PACS Group and its wholly owned subsidiary PACS Holdings were created on March&#160;24, 2023, and April&#160;10, 2023, respectively, in anticipation of the Reorganization. The equity interests of certain other direct or indirect wholly-owned subsidiaries of PGI at the time of the Reorganization were also contributed to other new direct or indirect wholly-owned subsidiaries of PACS Group to facilitate the New Credit Agreement. PACS Group and its consolidated subsidiaries subsequent to the Reorganization are collectively referred to herein as the Company. The New Credit Agreement is described in Note 8.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Reorganization was effected by the two then-existing stockholders of PGI (which at the time was the direct or indirect parent company of all consolidated entities comprising the Company), contributing their respective shares in PGI to newly-formed PACS Holdings, in exchange for a proportionate interest of shares in newly-formed PACS Group (via issuance of shares of PACS Group), and thus became the sole stockholders of PACS Group. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Reorganization, (i) for most practical purposes PACS Group in effect became the successor to the historical consolidated business of PGI, and (ii) both of the two stockholders of PGI immediately prior to the Reorganization became the sole stockholders of PACS Group, and maintained their respective pro rata ownership percentage in PACS Group that they held in PGI immediately prior to the Reorganization (which was and remained 50&#47;50).</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Reorganization was accounted for as an equity reorganization between entities under common control. The Reorganization combined entities that historically have not been presented together resulting in financial statements that are effectively considered to be those of a different reporting entity. The contribution of shares of PGI and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receipt of shares of PACS Group will be accounted on a retrospective basis. Accordingly, all share and per share amounts in these consolidated financial statements and related notes have been retrospectively restated, where applicable, for all periods herein, to give effect to the current shares outstanding of PACS Group. </font></div><div id="i2baa8a1031f44c51b1664e00d256c582_31"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:33.69pt">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP). The consolidated financial statements include the accounts of PACS Group, and its consolidated subsidiaries, or the Company as defined above. All intercompany transactions and balances have been eliminated in consolidation. The Company presents noncontrolling interests within the equity section of its consolidated balance sheet and the amount of consolidated income that is attributable to the Company and the noncontrolling interest in its consolidated statements of income. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The most significant estimates in the Company&#8217;s financial statements relate to revenue, acquired property, right-of-use assets, lease liabilities, impairment of long-lived assets, and general and professional liabilities included in accrued self-insurance liabilities. Actual results could differ from estimated amounts.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash, Cash and Cash Equivalents</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of cash and short-term investments with original maturities of three months or less at the time of purchase and therefore approximate fair value. The Company considers highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. The Company maintains its cash and short-term investment balances in several high-credit quality financial institutions.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in restricted cash as of December&#160;31, 2022 are funds held for workers&#8217; compensation (WC) and PLGL claims. Funds held in restricted cash are contractually obligated to be segregated from the Company&#8217;s other cash accounts and is legally restricted for the use of funding WC and PLGL claims. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any point in time the Company has funds in operating accounts and restricted cash accounts that are with&#160;third-party financial institutions. While management monitors the cash balances in operating accounts, these cash and restricted cash balances could be impacted if the underlying financial institutions fail or could be subject to other adverse conditions in the financial markets.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the consolidated balance sheet to total cash, cash equivalents, and restricted cash on the consolidated statement of cash flows as of December 31, 2022 and 2021&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,269&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,962&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in prepaid expenses and other current assets)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,847&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,700&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,090&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,900&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,206&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,562&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash in Excess of FDIC Limits</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently has bank deposits with financial institutions in the U.S. that exceed FDIC insurance limits. FDIC insurance provides protection for bank deposits up to $250,000. The Company has not experienced any losses in such amounts.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Subsidiary Deposits and Investments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's captive insurance subsidiary cash and cash equivalents, deposits and investments are designated to support long-term insurance subsidiary liabilities and have been classified as short-term and long-term assets based on the timing of expected future payments of the Company's captive insurance liabilities. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patient and Resident Service Revenue</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient and resident service revenue is derived from services rendered, under short-term contracts, to patients for skilled and intermediate nursing, rehabilitation therapy, and assisted living services. Patient and resident service revenue is reported at the amount that reflects the consideration to which the Company expects to be entitled in exchange for providing patient services. These amounts are due from patients, governmental programs, and other&#160;third-party payors, and include variable consideration for retroactive revenue adjustments due to settlement of audits, reviews, and investigations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue as its performance obligations are completed. Routine services are treated as a single performance obligation satisfied over time as services are rendered. These routine services represent a bundle of services that are&#160;not&#160;capable of being distinct. The performance obligations are satisfied over time as the patient simultaneously receives and consumes the benefits of the healthcare services provided. Additionally, there&#160;may&#160;be ancillary services which are&#160;not&#160;included in the daily rates for routine services, but instead are treated as separate performance obligations satisfied at a point in time when those services are rendered.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Doubtful Accounts </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable consist primarily of amounts due from Medicare and Medicaid, managed care health plans and private payor sources, net of estimates for variable consideration. At December&#160;31, 2022, the allowance for doubtful accounts was immaterial to the consolidated financial statements.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the transaction price based on established billing rates reduced by contractual adjustments provided to&#160;third-party payors. Contractual adjustments are based&#160;on contractual agreements and historical experience. The Company considers the patient's ability and intent to pay the amount of consideration upon admission and records an implicit price concession based on historical patient collection experience. The allowance for implicit price concession is routinely evaluated and any subsequent changes are recorded as an adjustment to patient and resident service revenue in the consolidated statements of income. The implicit price concession recorded as a reduction to patient and resident service revenue was $33,927 and $13,733 for the years ended December 31, 2022 and 2021, respectively.&#160;As of&#160;December&#160;31, 2022,&#160;the Company has recorded estimated implicit price concessions as a reduction to accounts receivable of $33,988.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Government Grants</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the absence of specific guidance to account for government grants under U.S. GAAP, the Company has concluded to account for government grants in accordance with International Accounting Standard (IAS)&#160;20,&#160;Accounting for Government Grants and Disclosure of Government Assistance, and as such, the company recognizes grant income on a systematic basis in line with the recognition of specific expenses and lost revenues for which the grants are intended to compensate. Additional funding presented on the consolidated statements of income is associated with government grants received through the Coronavirus Aid, Relief, and Economic Security Act (CARES Act). See Note 3 for more details.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, Net</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at historical cost less accumulated depreciation and amortization. Repair and maintenance charges which do not increase the useful lives of the assets are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful life of the property and equipment. The following is a summary of the depreciable lives of the Company&#8217;s depreciable assets&#58; </font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Buildings and improvements - minimum of 5 years to a maximum of 40 years, but generally 30 years</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements - shorter of the lease term or the estimated useful life, generally 5 to 15 years</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and equipment - 3 to 15 years</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Leasehold improvements are amortized over the lesser of the estimated useful life of the improvement or the term of the lease. Upon sale or retirement, the cost and the related accumulated depreciation and amortization are eliminated from the respective accounts and the resulting gain or loss included in current income.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PACS Group subsidiaries lease skilled nursing facilities, assisted living facilities, and commercial office space. The Company determines if an arrangement is a lease (for accounting purposes) at the inception of each lease. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Real estate leases are generally classified as operating leases and therefore the Company records rent expense on a straight-line basis over the term of the lease. The lease term used for straight-line rent expense is calculated from the date the Company is given control of the leased premises through the end of the lease term. Renewals are not assumed in the determination of the lease term unless they are deemed to be reasonably assured at the inception of the lease. The lease term used for this evaluation also provides the basis for establishing depreciable lives for buildings subject to lease and leasehold improvements. The Company has made an accounting policy election to keep leases with an initial term of 12 months or less off of the balance sheet and recognize those lease payments in the consolidated statements of income on a straight-line basis over the lease term. The Company has also elected the practical expedient to not separate lease and non-lease components for all of its leases as the non-lease components are not significant to the overall lease costs.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s real estate leases generally have initial lease terms of ten years or more and typically include one or more options to renew, with renewal terms that generally extend the lease term for an additional three to twenty years. Exercise of renewal options is generally subject to the satisfaction of certain conditions which vary by contract and generally follow payment terms that are consistent with those in place during the initial term.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for acquisitions using the acquisition method of accounting in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC)&#160;805,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 805). Acquisitions are accounted for as purchases and are included in the consolidated financial statements from their respective acquisition dates. Assets acquired and liabilities assumed, if any, are measured at fair value on the acquisition date. Goodwill generated from acquisitions is recognized for the excess of the purchase price over tangible and identifiable intangible assets. In determining the fair value of identifiable assets, the Company uses various valuation techniques. These valuation methods require management to make estimates and assumptions surrounding projected revenues and costs, future growth, and discount rates.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Indefinite-Lived Intangible Assets</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price of acquired businesses over the estimated fair value assigned to the individual assets acquired and liabilities assumed. The Company assesses goodwill for impairment at least annually on October 1st. The Company will perform an impairment assessment at other times if facts and circumstances indicate that it is more likely than not that the fair value of a reporting unit that has goodwill is less than its carrying value.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When assessing goodwill for impairment the Company may elect to first perform a qualitative assessment to determine if the quantitative impairment test is necessary. If the Company does not perform a qualitative assessment, or if the qualitative assessment indicates it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the Company performs a quantitative test. the Company recognizes an impairment charge for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value&#59; however, the loss recognized would not exceed the total amount of goodwill allocated to the reporting unit.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s indefinite-lived intangible assets primarily consists of licenses. The Company reviews indefinite-lived intangible assets for impairment on an annual basis or more frequently if events or changes in circumstances indicate that the carrying amount of the intangible asset&#160;may&#160;not&#160;be recoverable.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may elect to first perform a qualitative assessment to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying value. If the Company does not perform the qualitative assessment, or if the qualitative assessment indicates it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying amount, the Company calculates the estimated fair value of the indefinite-lived intangible asset. If the estimated fair value of the indefinite-lived intangible asset is lower than their carrying amount, an impairment loss is recognized for the difference.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments consist principally of cash and cash equivalents, accounts receivable, insurance subsidiary deposits, accounts payable and borrowings. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value measurements are based on a three-tier hierarchy that prioritizes the inputs used to measure fair value. The three-tiers include&#58; Level 1&#58; observable inputs such as quoted market prices in active markets&#59; Level 2&#58; inputs other than quoted market prices included in Level 1 that are directly or indirectly observable for the asset or liability and Level 3&#58; unobservable inputs for which little or no market data exists, thereby requiring management to develop their own estimates and assumptions.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC Topic 360, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant, and Equipment </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 360), long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Recoverability of these assets is determined based upon expected undiscounted future net cash flows from the operating subsidiaries to which the assets relate, utilizing management&#8217;s best estimate, appropriate assumptions, and projections at the time. If the expected future cash flow from the use of the asset and its eventual disposition is less than the carrying amount of the asset, an impairment loss is recognized and measured using the fair value of the related assets. The Company did not identify any indicators of impairment of its long-lived assets during the years ended December 31, 2022 and 2021.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Risk Reserves</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is principally self-insured for risks related to PLGL claims. Additionally, the Company is partially self-insured for risks related to WC policies. Accrued risk reserves primarily represent the accrual for risks associated with WC and PLGL claims. The accrued risk reserves include a liability for unpaid reported claims and estimates for incurred but unreported claims. The Company&#8217;s policy with respect to a significant portion of its WC program assumed as part of the Plum acquisitions (this acquisition is discussed further in Note 15), and its PLGL claims is to use an actuary to assist management in estimating the Company&#8217;s exposure for claims obligation (for both asserted and unasserted claims). The Company&#8217;s retrospective-rated premium WC policy is subject to an annual assessment of the policy premium in relation to the payroll and losses incurred for the policy period. The Company recognizes the WC retrospective policy adjustment as the amount of settlement is determined.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Joint Ventures</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in joint ventures, in which the Company exercises significant influence over operating and financial policies, are accounted for using the equity method of accounting. Under this method, the investment is carried at cost and is adjusted to recognize the investor&#8217;s share of earnings or losses of the investee after the date of acquisition and is adjusted for impairment whenever it is determined that a decline in the fair value below the cost basis is other than temporary. The fair value of the investment then becomes the new cost basis of the investment, and it is not adjusted for subsequent recoveries in fair value. The Company evaluates its investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December&#160;31, 2022 and 2021. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Noncontrolling Interest</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is the majority-owner in a subsidiary which was formed to develop land, a building, and other assets to be leased to a facility operated by the Company upon completion. The noncontrolling interest in subsidiary is initially recognized at estimated fair value on the contribution date and is presented within total equity in the Company&#8217;s consolidated balance sheet since these interests are not redeemable. Upon completion of construction, operations will begin and the amount of net income attributable to the Company will be recorded on the consolidated statements of income. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are expensed as incurred. For the years ended December 31, 2022 and 2021, advertising expenses included in the Company&#8217;s consolidated statements of income were $5,414 and $4,870, respectively.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes ASC Topic&#160;740,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxe</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s (ASC 740), which requires an asset and liability approach for financial accounting and reporting for income taxes. Under this guidance, deferred tax assets and liabilities are determined based upon differences between financial reporting and tax basis of assets and liabilities and are measured using the enacted tax laws that will be in effect when the differences are expected to reverse. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. See Note 10&#160;for further discussion of the Company&#8217;s accounting for income taxes.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 740, tax positions are evaluated for recognition using a more&#8211;likely&#8211;than&#8211;not threshold, and those tax positions requiring recognition are measured at the largest amount of tax benefit that is greater than&#160;50&#160;percent likely of being realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. Liabilities for income tax matters include amounts for income taxes, applicable penalties, and interest thereon and are the result of the potential alternative interpretations of tax laws and the judgmental nature of the timing of recognition of taxable income.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes deferred tax assets (DTAs) to the extent that it believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, carryback potential if permitted under the tax law, and results of recent operations. If the Company determines that it would be able to realize the DTAs in the future in excess of their net recorded amount, it would make an adjustment to the DTA valuation allowance, which would reduce the provision for income taxes.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risks</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s credit risks primarily relate to cash and cash equivalents, restricted cash, and accounts receivable. Cash and cash equivalents are primarily held in bank accounts and overnight investments. The Company holds amounts of cash in excess of the FDIC insured limits. Restricted cash is primarily invested in commercial </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">paper and certificates of deposit with financial institutions and other interest-bearing accounts. Accounts receivable consist primarily of amounts due from patients (funded through Medicare, Medicaid, other contractual programs and through private payors) and from other health care companies for management, accounting and other services. The collectability of account receivable balances is dependent on the availability of funds from certain programs that rely on governmental funding, primarily Medicare and Medicaid. The Company&#8217;s receivables from Medicare and Medicaid programs accounted for 32% and 21% of total accounts receivable, respectively, at December&#160;31, 2022.  These receivables represent the only significant concentration of credit risk for the Company. The Company does not believe there are significant credit risks associated with these governmental programs. The Company performs continual credit evaluations of the Company&#8217;s clients and maintains appropriate allowances for doubtful accounts on any accounts receivable proving uncollectible, and continually monitors and adjusts these allowances as necessary. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operating subsidiaries, excluding two subsidiaries that exclusively operate assisted living facilities, have all of their skilled nursing beds designated for care of patients under federal Medicare and&#47;or state Medicaid programs. Approximately 73% of skilled nursing beds are located in California. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have any components of other comprehensive income recorded within its consolidated financial statements and, therefore, does not separately present a statement of comprehensive income in its consolidated financial statements.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Presentation</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s chief operating decision maker, the Chief Operating Officer, reviews the consolidated results of operations when making decisions about allocating resources and assessing the performance of the Company as a whole and, hence, the Company has only one reportable segment. The Company does not distinguish between markets or regions for the purpose of allocating resources.  </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the FASB issued ASU 2021-10, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832)&#58; Disclosures by Business Entities about Government Assistance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which created Topic 832, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 832). ASC 832 requires business entities to disclose information about certain government assistance they receive. The Company adopted this standard on January 1, 2022 and determined there was no material impact on the Company's financial statements.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_34"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:33.69pt">REVENUE AND ACCOUNTS RECEIVABLE</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patient and Resident Service Revenue</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s patient and resident service revenue is derived primarily from the Company&#8217;s applicable subsidiaries providing healthcare services to their respective patients and residents. Revenue is recognized when services are provided to the patients at the amount that reflects the consideration to which the Company expects to be entitled. These amounts are due from residents, third-party payors (including health insurers and government payors), and others and includes variable consideration for retroactive revenue adjustments due to settlement of audits and other reviews by the payor. Generally, the licensed healthcare provider entity providing the applicable services bills the applicable payors monthly. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare services in skilled patient contracts include routine services in exchange for a contractual agreed-upon amount or rate. Revenue is recognized as the performance obligations are satisfied.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance obligations are determined based on the nature of the services provided by the applicable licensed healthcare provider entity. Revenue for performance obligations satisfied over time is recognized based on actual charges incurred in relation to total expected (or actual) charges. The Company believes that this method provides a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">faithful depiction of the transfer of services over the term of the performance obligation based on the inputs needed to satisfy the obligation. Generally, performance obligations satisfied over time relate to residents receiving services in the facility and, when applicable, residents receiving services in their homes (independent care or assisted living). The Company measures the performance obligation from admission into the facility, or the commencement of the service, to the point when the applicable licensed healthcare provider entity is no longer required to provide services to that resident, which is generally at the time that the resident discharges from the applicable facility or passes away.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized from healthcare services is adjusted for estimates of variable consideration to arrive at the transaction price. The Company determines the transaction price based on contractually agreed-upon amounts or rates, adjusted for estimates of variable consideration. Variable consideration includes estimates of implicit price concessions so that the estimated transaction price is reflective of the amount to which the Company expects to be entitled in exchange for providing the healthcare services to customers. Variable consideration is estimated using the expected value method based on the Company&#8217;s historical reimbursement experience. The amount of variable consideration constrains the transaction price, such that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. Historically the Company has not had material differences between its estimated transaction price and actual collections from payors.  If actual amounts of consideration ultimately received differ from the Company&#8217;s estimates, it adjusts these estimates, which would affect net service revenue in the period such variances become known. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreements with third-party payors typically provide for payments at amounts less than established charges. A summary of the payment arrangements with major third-party payors is as follows&#58; </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicaid&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Payments for skilled nursing facility services rendered to Medicaid (including Medi-Cal, which is the name of the state Medicaid program in California) program beneficiaries are based on an annually established daily reimbursement rate for eligible stays. The rate is adjusted annually. The final settlement is determined after submission of an annual cost report and audits thereof by Medicaid. Revenue from the Medicaid program amounted to approximately 30% and 35% of the Company&#8217;s consolidated net patient and resident revenue for the years ended December 31, 2022 and 2021, respectively.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicare&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Payments for skilled nursing facility services rendered to Medicare program beneficiaries are based on prospectively determined daily rates which vary according to a patient diagnostic classification system. The applicable licensed healthcare provider entity is paid for certain reimbursable services at the approved rate with final settlement determined after submission of the annual cost report and audit thereof by the designated Medicare fiscal intermediary. Revenue from the Medicare program amounted to approximately 48% and 44% of the Company&#8217;s consolidated net patient and resident revenue for the years ended December 31, 2022 and 2021, respectively.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Managed Care, Private and Other&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Payments for services rendered to private payors and other primary payors included in the table below are based on established rates or on agreements with certain commercial insurance companies, health maintenance organizations, and preferred provider organizations, which provide for various discounts from the established rates. Revenue from these sources collectively amounted to approximately 22% and 21% of the Company&#8217;s consolidated net patient and resident revenue for the years ended December 31, 2022 and 2021, respectively.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s contracts are short term in nature with a duration of one year or less. The Company has minimal unsatisfied performance obligations at the end of the reporting period as patients are typically under&#160;no&#160;obligation to remain admitted in the Company&#8217;s facilities or under the Company&#8217;s care. As the period between the time of service and time of payment is typically&#160;one&#160;year or less, the Company did&#160;not&#160;adjust for the effects of a significant financing component.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the Company&#8217;s consolidated balance sheets are contract balances, comprising of billed accounts receivable and unbilled receivables, which are the result of the timing of revenue recognition, billings and cash collections, as well as contract liabilities, which primarily represent payments the Company receives in advance of services provided. The Company has no material contract liabilities and contract assets as of December&#160;31, 2022. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laws and regulations concerning government programs, including Medicare and Medicaid, are complex and subject to varying interpretation. As a result of audits and other reviews by governmental agencies or payor sources, health care providers from time to time receive requests for information and notices regarding billing audits and potential noncompliance with applicable laws and regulations, which, in some instances, can ultimately result in substantial monetary recoupments or other remedies being imposed on the healthcare provider. Compliance with such laws and regulations may also be subject to future government review and interpretation, as well as significant regulatory action, including fines, penalties, and potential exclusion from the related programs. The Company believes that it is in compliance with all applicable laws and regulations. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contracts the applicable consolidated entity has with commercial payors also provide for retrospective audit and review of claims. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Settlements with third-party payors for retroactive adjustments due to audits or other reviews are considered variable consideration and are included in the determination of the estimated transaction price for providing resident services. These settlements are estimated based on the terms of the payment agreement with the payor, correspondence from the payor, and the Company&#8217;s historical settlement activity, including an assessment to ensure that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the retroactive adjustment is subsequently resolved. Estimated settlements are adjusted in future periods as adjustments become known (that is, new information becomes available), or as years are settled or are no longer subject to such audits or other reviews. These amounts continue to be immaterial. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disaggregates revenue from contracts with its patients by payors. The Company determines that disaggregating revenue into these categories achieves the disclosure objectives to depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. The composition of patient and resident service revenue by primary payors for the years ended December 31, are as follows&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142,863&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.6&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,311&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723,896&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399,141&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416,089&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,541&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,307&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,916&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total patient and resident service revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,399,155&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,135,909&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Additional Funding and CARES Act</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through the CARES Act, the Company received $14,962 and $5,654 in funding from the U.S. Department of Health and Human Services (HHS) through the Provider Relief Fund (PRF) during the years ended December 31, 2022 and 2021, respectively.&#160;These funds were provided to healthcare providers who diagnose, test, or care for individuals with cases of COVID-19 and have health care related expenses and lost revenues attributable to COVID-19. The Company recorded these funds as deferred revenue upon receipt and revenue is recognized only to the extent that health-care related expenses or lost revenues have been incurred and are not reimbursed from other funding sources. For the year ended December 31, 2022, the deferred revenue balance related to the HHS funds was $0.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CARES Act also provided for refundable payroll tax credits known as the Employee Retention Tax Credit (ERTC), which allows qualified employers to receive a credit of 70% of the employee qualified wages and related payroll costs paid after December 31, 2020 through September 30, 2021, up to a maximum credit of $7 per employee, per quarter, for a maximum of $21 per employee in 2021. The Company has treated these credits under the accrual basis of accounting in conformity with U.S. GAAP. The Company has interpreted the condition of partial suspension through governmental orders during all quarters of 2020 and the first three quarters of 2021, as defined by the CARES Act and to incur qualified payroll and related costs during the applicable quarters. The Company claimed a total of $32,428 under the ERTC, $18,656 related to 2021 qualified wages and $13,772 related to 2020 </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">qualified wages. The Company utilized outside consultants to calculate the qualified wages and the ERTC amounts, and to prepare and submit the applications. Subsequently, due to uncertainty related to meeting the necessary qualifications, the Company recorded a reserve against the entire amount claimed. The Company has also recorded $17,119 in other liabilities to reflect the cash already received related to these credits which may need to be returned and potential penalties. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, under the CARES Act, employers could elect to defer the deposit and payment of the employers share of Social Security taxes through the end of 2020. One half of the deferral was required to be repaid on or before December&#160;31, 2021 with the remaining half due on or before December 31, 2022.&#160;The deferral of social security tax payments in the amount of $7,793 was recorded as a liability at December&#160;31, 2021. The Company paid $7,793 during the year ended December 31, 2022 and there are no remaining short-term or long-term balances as of December&#160;31, 2022.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_37"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:33.69pt">ESCROW FUNDS</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain subsidiaries of PGI have obtained Department of Housing and Urban Development (HUD)-insured mortgages on properties that they lease to affiliated operating subsidiaries of PGI, while various other subsidiaries of PGI lease properties from unrelated third-party landlords that have obtained HUD-insured mortgages on the applicable properties. Under the terms of the HUD-insured mortgages, borrowers and&#47;or their tenants are required to make certain deposits into escrow funds to be used for payment of property insurance, mortgage insurance premiums, and taxes. The deposits are generally maintained in an interest-bearing account with a federally insured financial institution.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, some HUD-insured mortgages require a reserve for replacement account and a non-critical repair reserve. Under the terms of the HUD-insured mortgages and the related regulatory agreements required by HUD, the tenants are required to make regular monthly deposits into a reserve for replacement account to assure the availability of funds to replace building components, furniture and equipment over time. All disbursements from this account require prior written approval by HUD and the mortgage lender. The non-critical repair reserve is used to cover estimated repairs on the properties typically within 12 months of closing on the HUD loans. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, a majority-owned subsidiary of PGI obtained a construction loan from an unaffiliated third-party lender that the subsidiary expects will be refinanced through a HUD-insured mortgage at a future date. At December&#160;31, 2022, this subsidiary has escrows related to debt service reserves, working capital escrows, and various other construction related escrows, in accordance with the terms of the loan agreement. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These reserve and escrow accounts are maintained under the control of the mortgage lender for the benefit of the applicable tenant and are generally held in an interest-bearing account with a federally insured financial institution.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-17</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_40"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:33.69pt">PROPERTY AND EQUIPMENT</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following at December 31&#58; </font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,520&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,238&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures, and other </font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,842&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in process</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,813&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,357&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,960&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470,730&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58; accumulated depreciation and amortization</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,165)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property and equipment, net</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430,565&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated its long-lived assets and did not record an impairment charge for the years ended December 31, 2022, and 2021. Depreciation expense amounted to $21,081 and $6,962 for the years ended December 31, 2022, and 2021, respectively, for property and equipment. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 15 for information on expansions during the years ended December 31, 2022 and 2021.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_43"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:33.69pt">GOODWILL AND OTHER INDEFINITE-LIVED INTANGIBLE ASSETS</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill consisted of the following&#58;  </font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Goodwill</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of January 1, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,882&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,495&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period adjustment - Plum</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,844&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,221&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no prior period accumulated goodwill impairment losses nor any goodwill impairment losses for the years ended December 31, 2022, and 2021.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the year ended December 31, 2022, the Company's indefinite-lived intangible assets consisted of the following&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,270&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total other indefinite-lived intangible assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,270&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no prior period accumulated indefinite-lived intangible asset impairment losses nor any indefinite-lived intangible asset impairment losses for the years ended December 31, 2022, and 2021.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_46"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:33.69pt">INVESTMENT IN PARTNERSHIP</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the years ended December&#160;31, 2022 and 2021, the Company invested $12,018 and $15,269, respectively, in multiple equity investments. These joint venture operations were formed to develop, own, and lease health care </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">facilities to operational subsidiaries of the Company. Some of the joint ventures hold options to purchase the related real estate property holdings. Each of the joint ventures is governed by a managing member who makes the significant decisions that impact the economic performance of the joint venture. The Company is not the managing member of any of the joint ventures in which it is invested. All of the investments are individually immaterial with the Company&#8217;s largest equity investment of $11,665 in a joint venture representing an ownership of 27%. All investments are included in other assets in the Company&#8217;s consolidated balance sheet. The Company accounts for its share in its equity method investments in the other income (expense), net line item in the Company&#8217;s consolidated statements of income. (Loss) income from the investments in partnerships was $(346) and $232 for the years ended December 31, 2022 and 2021 respectively.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_49"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:33.69pt">CREDIT FACILITIES</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains several lines-of-credit with commercial banks. At December&#160;31, 2022, the total commitment limit amounted to $176,000 and was secured by Company assets. These agreements bear interest at rates ranging from LIBOR to LIBOR plus 3.5% and SOFR plus 3.15%. The agreements mature through November&#160;5, 2024. The balance outstanding on all applicable lines was $146,820 at December&#160;31, 2022, resulting in available cash of $29,180. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The line-of-credit agreements above contain certain financial and non-financial covenants and restrictions. Default by the applicable credit parties on any covenant or restriction could affect the lender&#8217;s commitment to lend, and, if not waived or corrected, could make the outstanding balances due on demand. The Company was in compliance with all such covenants and restrictions, or received applicable waivers, as of December&#160;31, 2022. Deferred financing fees on the lines-of-credit were immaterial for 2022.  </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, and 2021 ended the Company has letters of credit outstanding of $22,370 and $22,370 for each year, respectively.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2022, on February&#160;28, 2023, the Company entered into a working capital loan agreement (the Working Capital Loan) in connection with the acquisition of various new facilities. The Working Capital Loan allowed the Company to borrow up to $17,500 at an annual interest rate of 9%.  On May&#160;8, 2023, the Company drew on the Working Capital Loan in the amount of $15,000.  </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also subsequent to December&#160;31, 2022, on June 30, 2023, the Company and certain of its subsidiaries entered into a credit agreement with Truist Bank (Truist) and a syndicate of lenders (the 2023 Credit Agreement), that extended credit in the form of the revolving credit facility thereunder, (the 2023 Revolving Credit Facility), including letter of credit and swing line sub facilities and a term loan facility (Truist Term Loan), together referred to as the 2023 Credit Facility. The 2023 Credit Agreement provided for&#58; (i) 2023 Revolving Credit Facility with revolving commitments in an aggregate principal amount of $150,000, including a letter of credit sub facility in an amount representing that portion of the aggregate revolving commitments that may be used by the borrower for the issuance of letters of credit in an aggregate face amount not to exceed $30,000 and a swingline loan sub facility in an aggregate principal amount at any time outstanding not to exceed $20,000 and (ii) the Truist Term Loan in an aggregate principal amount of $275,000. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding borrowings under the 2023 Credit Facility accrued interest at either&#58; (a) the Secured Overnight Financing Rate (SOFR) (plus a 0.10% credit spread adjustment) plus a margin ranging from 2.50% to 3.50% per annum&#59; or (b) Base Rate (which was defined in a customary manner for credit facilities of this type) plus a margin ranging from 1.50% to 2.50% per annum. The applicable margin was based on the Company&#8217;s debt to income ratio as calculated in accordance with the terms of the 2023 Credit Agreement. In addition, the Company agreed to pay a commitment fee on the unused portion of the 2023 Revolving Credit Facility, which ranged from 0.30% to 0.50% per annum, depending on the same debt to income ratio. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with executing the 2023 Credit Agreement, deferred financing costs of $2,220 were written off and additional deferred financing costs of $9,662 were capitalized during the year ended December 31, 2023. In addition, on the closing date of the 2023 Credit Agreement, the Company drew $75,000 on the 2023 Revolving </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit Facility and borrowed the entirety of the $275,000 Truist Term Loan. See Note 9 for more details. The Company used approximately $142,000 of the net proceeds to repay certain outstanding indebtedness on prior lines of credit and the Working Capital Loan. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 7, 2023, the Company amended and restated the 2023 Credit Facility (Amended and Restated 2023 Credit Facility). The Amended and Restated 2023 Credit Facility provided for an increase of the 2023 Revolving Credit Facility to an aggregate principal amount of $600,000, which revolving commitments may also be utilized for (x) the issuance of letters of credit in an aggregate face amount not to exceed $50,000 and&#47;or (y) the borrowing of swingline loans in aggregate principal amount not to exceed $20,000 at any time outstanding. The maturity date of the Amended and Restated 2023 Credit Facility is December 7, 2028.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding borrowings under the Amended and Restated 2023 Credit Facility bear interest at the option of the Company based on&#58; (a) SOFR (plus a 0.10% credit spread adjustment) plus a margin ranging from 2.25% to 3.25% per annum&#59; or (b) the Base Rate (which is defined consistent with the 2023 Credit Facility) plus the applicable margin ranging from 1.25% to 2.25% per annum. The applicable margin is based on the Company&#8217;s debt to income ratio as calculated consistent with the 2023 Credit Facility. In addition, the Company will pay a commitment fee on the unused portion of the commitments, which ranges from 0.25% to 0.45% per annum, depending on the same debt to income ratio. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended and Restated 2023 Credit Facility contains affirmative and negative covenants customary for credit facilities of this type as well as two financial covenants the calculations for which are specifically defined in the Amended and Restated 2023 Credit Facility. Under the Amended and Restated 2023 Credit Facility, the Company must maintain a debt-to-income ratio of not greater than 3.00&#58;1.00. The Amended and Restated 2023 Credit Facility also requires that the Company maintain a minimum interest&#47;rent coverage ratio of not less than 1.10&#58;1.00. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the Amended and Restated 2023 Credit Facility, the Company borrowed $460,000 of revolving loans, the proceeds of which were used to repay and refinance all term loans and revolving loans under the 2023 Credit Facility, to repay certain other outstanding indebtedness, and to pay transaction costs in connection with the Amended and Restated 2023 Credit Facility.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_52"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:33.69pt">LONG-TERM DEBT</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During year ended December 31, 2022, one of the Company's subsidiaries entered into Department of Housing and Urban Development (HUD)-insured mortgage loans in the aggregate amount of $7,027. As a result, five of the Company's subsidiaries had mortgage loans insured with HUD in the aggregate amount of $79,031 as of December&#160;31, 2022, of which $1,509 is classified as short-term and the remaining $77,522 is classified as long-term. These subsidiaries are subject to HUD-mortgage oversight and periodic inspections. Some of the mortgage loans bear fixed interest rates in a range of 2.4% to 5.5% per annum or SOFR plus 4.25% and have various maturity dates through January&#160;1, 2055. In addition to the interest rate, the Company incurs other fees for HUD placement, including but not limited to audit fees. Amounts borrowed under the mortgage loans may be prepaid, subject to prepayment fees based on the principal balance on the date of prepayment. The original terms for all the HUD-insured mortgage loans are 30 to 35 years. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the HUD-insured mortgage loans above, the Company has 23 other mortgage loans or promissory notes. The non-HUD insured mortgage loans and notes bear interest rates in the range of 2.0% and 7.3% per annum with various maturity dates through August&#160;15, 2027. The notes are secured by equipment and guarantees by the Company and its stockholders. As of December&#160;31, 2022, the Company&#8217;s operating subsidiaries had $277,201 of debt principal outstanding under the mortgage loans and promissory notes, of which $59,854 is classified as short-term and the remaining $217,347 is classified as long-term.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was in compliance with all applicable loan covenants with respect to the foregoing as of December&#160;31, 2022. The loans above are guaranteed by the Company and&#47;or stockholders of PGI. Additionally, various loans are secured by real property with a carrying value amounting to $323,439 at December&#160;31, 2022.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following at December 31&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HUD-insured mortgage loans</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,031&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other mortgage loans and promissory notes</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277,201&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58; current maturities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,363)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58; deferred financing fees, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,348)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291,521&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt maturities, excluding deferred financing fees, for the next five years and in the aggregate are as follows as of December&#160;31, 2022&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,363&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,947&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,298&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,834&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,598&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,192&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356,232&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred financing fees of $4,734 incurred in conjunction with debt financing are being amortized over the life of the respective loans. Total amortization related to deferred financing fees is included in interest expense and amounted to $978 and $462 for the years ended December 31, 2022 and 2021, resulting in total accumulated amortization of $1,386 and $408 for the respective years then ended. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 8, subsequent to December&#160;31, 2022, the Company borrowed under the Truist Term Loan in connection with the execution of the 2023 Credit Agreement. Under the Truist Term Loan, the Company borrowed $275,000. The Truist Term Loan has a maturity date of June&#160;30, 2028. Upon closing of the Truist Term Loan, the Company paid off certain other mortgage loans and promissory notes in the aggregate amount of $224,802. </font></div><div id="i2baa8a1031f44c51b1664e00d256c582_55"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.69pt">PROVISION FOR INCOME TAXES</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January&#160;1, 2021, the Company elected &#8220;C&#8221; corporation status with the Internal Revenue Service.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial reporting purposes, income before income taxes includes the following components&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,045&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,426&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes on continuing operations for the years ended December 31, 2022 and 2021, respectively, is summarized as follows&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,044&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,438&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,932&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,551&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current provision</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,976&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,989&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,345&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,700&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,210)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred provision</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,573&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,490&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total income tax provision</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,549&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,479&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the federal statutory rate to the effective tax rate for the years ended December 31, 2022 and 2021, respectively, is comprised as follows&#58; </font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense at statutory rate</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes &#8211; net of federal benefit</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of prior year deferred tax liability</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible transaction costs</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Adjustments</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total effective tax rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.0&#160;</font></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s deferred tax assets and liabilities as of December&#160;31, 2022 are summarized as follows&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets (liabilities)</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,113&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,919&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,473&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375,669&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred tax assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407,063&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash to accrual method change</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,082)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets and intangibles</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,269)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,579)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in partnership</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,252)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(364,055)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred tax liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415,237)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net deferred tax liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,174)</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to U.S.&#160;federal income tax, as well as income tax in certain states in which it operates. The Company&#8217;s federal returns for tax years 2019 and forward are subject to examination, and state returns for tax years 2018 and forward are subject to examination. The Company is not, to its knowledge under examination by any federal or state income tax authority. The Company&#8217;s balance of net deferred tax liabilities is included within other liabilities on the consolidated balance sheet.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company did not have any unrecognized tax benefits. The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense. The Company does not anticipate the uncertain tax position to change materially within the next 12 months.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 29, 2020, the state of California enacted Assembly Bill No. 85 (AB 85) suspending California Net Operating Loss (NOL) utilization and imposing a cap on the amount of business incentive tax credits companies can utilize, effective for tax years 2020, 2021 and 2022. There was no material impact from the provisions of AB 85 for the years ended December 31, 2022 and 2021. On February 9, 2022, Senate Bill No. 113 was enacted that removed the limitations on the use of NOLs and the cap on the business incentive tax credits that were suspended in accordance with AB 85 effective for tax year 2022. The Inflation Reduction Act 2022 (IRA) which incorporates a Corporate Alternative Minimum Tax (CAMT) was signed on August 16, 2022. The changes will be effective for the tax years beginning after December 31, 2022. The new tax will require companies to compute two separate calculations for federal income tax purposes and pay the greater of the new minimum tax or their regular tax liability. The IRA is not expected to have a material impact for the Company.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_58"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.69pt">LEASES</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases most of its skilled nursing and assisted living facilities, as well as its office space and certain vehicles and equipment, under various non-cancelable operating lease agreements. These operating leases expire at various dates throughout 2049. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all operating leases for skilled nursing and assisted living facilities are on a &#8220;triple-net&#8221; basis, which require lessees to pay for all insurance, repairs, utilities, and real property taxes assessed on the leased property, and most of the leases are guaranteed by PACS Group and&#47;or its stockholders. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For five of the facility operating leases, the Company holds an option to purchase the real estate which can be exercised at varying times starting September&#160;9, 2021 through January&#160;31, 2035. At lease inception it was determined that the exercise of these purchase options was not reasonably assured.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The facility leases are generally renewable at the Company&#8217;s option for additional terms ranging from 3 to 30 years. All facility leases provide for an additional percentage rent based upon specified rates per the terms of the agreements. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the Company acquired facility leases and various leases for laptops, copiers, and vehicles as part of the acquisition further described in Note 15. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Real estate lease payments are deemed to constitute the right to use the underlying facilities and operate as a skilled nursing facility as permitted by the accompanying license. As the license is deemed to be inseparable from the related real estate in determining value, the payments related to these components have been combined into a single lease obligation representing the right to use the facilities and to operate under the terms of the accompanying license, respectively. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Finance Leases</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain skilled nursing and assisted living facilities under finance lease agreements. The economic substance of each lease is that the Company is financing the facilities through the lease. The lease terms of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">these finance leases allow for a purchase option during a specified window. The Company has determined that it is reasonably certain to exercise the purchase option at the end of each purchase option window. Therefore the Company has calculated the lease term through the end of the purchase option window for each lease. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, such leases are recorded in the Company&#8217;s consolidated financial statements as assets and liabilities. The leased facilities were acquired as part of the Plum business combination during the year ended December&#160;31, 2021 and are included in property and equipment with a cost of $34,960. Finance lease liabilities are included in other accrued expenses.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.241%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent - cost of services </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,003&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,122&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,252&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,337&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease expense</font></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,797&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,046&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease expense</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,230&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financing lease expense</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,776&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease expense</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183,573&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,324&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Rent - cost of services includes other variable lease costs such as Consumer Price Index (CPI) increases and other rent adjustments of $964 and $242 for the years ended December&#160;31, 2022 and 2021, respectively. </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Variable lease costs, including property taxes and insurance, are classified in Cost of services in the Company&#8217;s Consolidated Statements of Income. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense is included in Rent - cost of services and General and administrative expense as indicated above. For finance lease expense, the amortization of right-of-use assets is included in depreciation and amortization while the interest component is included in interest expense. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes supplemental cash flow information related to leases&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash paid for amounts included in the measurement of operating lease liabilities</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,683&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,717&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash paid for amounts included in the measurement of finance lease liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash paid for amounts included in the measurement of finance lease liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,088&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets obtained in exchange for lease liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,843&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916,823&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease right-of-use assets obtained in exchange for lease liabilities</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,960&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information relating to the lease term and discount rate is as follows&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average remaining lease term (years)</font></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average discount rate</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing leases</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the discount rate used to measure the right-of-use asset and lease liability, the Company uses rates implicit in the lease, or if not readily available, the Company will use its incremental borrowing rate. The Company&#8217;s incremental borrowing rate is based on an estimated secured rate comprised of a risk-free rate plus a credit spread as secured by its assets. Determining a credit spread as secured by the Company&#8217;s assets may require significant judgment.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2022 were as follows&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,275&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,397&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,672&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,257&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,257&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,715&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,715&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,250&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,250&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,891&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,891&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,191,137&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,191,137&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,275&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928,647&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,966,922&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less&#58; present value discount </font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(380)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(540,696)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(541,076)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of lease liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,895&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,387,951&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425,846&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to its lessee activity, the Company generates an immaterial amount of revenue from arrangements where it is a lessor of certain facilities. Revenue from those arrangements is included in other revenue on the consolidated statements of income. </font></div><div id="i2baa8a1031f44c51b1664e00d256c582_61"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.69pt">RETIREMENT PLANS</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has two 401(k) defined contribution plans for the benefit of all eligible union and non-union employees. Employees over the age of 21 may begin elective deferrals and become eligible for matching contributions after two months of service. Employer discretionary matching contributions may be up to 25% of the employee&#8217;s elective deferrals that do not exceed 4% of the employee&#8217;s compensation. Employees vest in matching contributions over five years in accordance with the vesting schedule set out in the plan documents. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the acquisition of Bay Bridge Capital Partners, LLC (see Note 15), the Company acquired another 401(k) defined contribution plan for the benefit of all eligible employees. Eligible employees may enter the plan immediately upon being hired. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employees are eligible to receive discretionary matching contributions up to 25% of the employee&#8217;s elective deferrals that do not exceed $1,060 per participant after completing six months of service. Employees vest in matching contributions over five years in accordance with the vesting schedule set out in the plan document.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 19, 2019, the Company adopted a non-qualified deferred compensation plan. The deferred compensation plan allows certain employees to receive supplemental retirement income payments through the deferral of base salary and bonus compensation. Eligible employees may elect to defer receipt of no less than twenty thousand dollars of base salary and bonus compensation for any plan year. Additionally, the Company may elect to make a discretionary matching contribution on behalf of the participant. Participants become fully vested in discretionary matching contributions after five years of continued employment from the date of the applicable matching contribution. Payment of vested balances will occur at future dates, as defined by the plan documents. Deferred compensation plan balances are recorded in other long-term liabilities on the consolidated balance sheet and amounted to $2,047 and $1,140 at December&#160;31, 2022 and December&#160;31, 2021, respectively. </font></div><div id="i2baa8a1031f44c51b1664e00d256c582_64"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.69pt">RELATED PARTY TRANSACTIONS</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2021, the Company entered into a Consulting and Strategic Advisory Services Agreement with Helios Consulting, LLC (Helios), a limited liability company owned by Jason Murray, the Company&#8217;s Chief Executive Officer and a member of its board of directors, and Mark Hancock, the Company&#8217;s Chief Financial Officer, Secretary and a member of its board of directors, (Helios Consulting Agreement) which automatically renews for successive one-year terms. The Helios Consulting Agreement provides for a cash consulting fee of approximately $4,000 annually, paid in monthly installments, for consulting and strategic advisory services provided to the Company by Helios. For the years ended December&#160;31, 2022 and 2021, the Company paid approximately $4,000, and $2,333 (inclusive of approximately $150 paid to a subsidiary of Helios), respectively. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2023 Related Party Transactions </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On March 24, 2023, the Company entered into subscription agreements with Mr. Murray and Mr. Hancock, pursuant to which Mr. Murray and Mr. Hancock each purchased 10,000 shares of the Company&#8217;s common stock for a purchase price of $100, or $10.00 per share, in a private placement concurrent with our incorporation in the State of Delaware and in anticipation of effecting our reorganization on June 30, 2023. </font></div><div id="i2baa8a1031f44c51b1664e00d256c582_67"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.69pt">COMMITMENTS AND CONTINGENCIES</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Matters</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laws and regulations governing Medicare and Medicaid programs are complex and subject to review and interpretation. Compliance with such laws and regulations is evaluated regularly, the results of which can be subject to future governmental review and interpretation, and can include significant regulatory action including fines, penalties, and exclusion from certain governmental programs. Included in these laws and regulations is monitoring performed by the Office of Civil Rights which covers the Health Insurance Portability and Accountability Act of 1996, the terms of which require healthcare providers (among other things) to safeguard the privacy and security of certain patient protected health information. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The skilled nursing business involves a significant risk of liability given the age and health of the patients and residents served by the Company&#8217;s independent operating subsidiaries. The Company, and others in the industry are subject to an increasing number of claims and lawsuits, including professional liability claims, alleging that services provided have resulted in personal injury, elder abuse, wrongful death or other related claims. In addition, the Company, its independent operating subsidiaries, and others in the industry are subject to claims and lawsuits in connection with COVID-19 and a facility&#8217;s preparation for and&#47;or response to COVID-19. The defense of these lawsuits may result on significant legal costs, regardless of the outcome, and can result in large settlement amounts or damage awards. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare litigation (including class action litigation) is common and is filed based upon a wide variety of claims and theories. The Company and other companies in its industry are routinely subjected to varying types of claims and suits, including class-actions. Class-action suits have the potential to result in large jury verdicts and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">settlements, and may result in significant legal costs. The Company expects the plaintiffs&#8217; bar to continue to be aggressive in their pursuit of claims. The Company has been subjected to, and is currently involved in, litigation alleging violations of state and federal wage and hour laws as resulting from the alleged failure to pay wages, to timely provide and authorize meal and rest breaks, and related causes of action. While there can be no assurance, based on the Company&#8217;s evaluation of information currently available, management does not believe that the ultimate resolution of these actions will have a material adverse effect on the Company&#8217;s business, cash flows, financial condition, or results of operations.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been, and continues to be, subject to claims and legal actions that arise in the normal course of business, including potential claims filed by residents and responsible parties related to patient care and treatment (professional negligence claims), as well as employment related claims filed by current or former employees. While there can be no assurance, based on the Company&#8217;s evaluation of information currently available, management does not believe the results of such litigation and investigations would have a material adverse effect on the results of operations, financial position or cash flows of the Company, taken as a whole. However, the Company&#8217;s assessment may evolve based upon further developments in the proceedings at issue. The results of legal proceedings are inherently uncertain, and material adverse outcomes are possible.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Claims</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchased a PLGL claims made insurance policy to cover applicable claims through an unrelated insurer. The PLGL policy is a claims-made high deductible self-insured policy whereby the Company is responsible for the first layer of coverage, generally ranging from $250 to $350 per claim, with the unrelated insurer covering up to $10,000 in aggregate claims paid per policy year.  The Company uses its wholly-owned captive insurance company for the purpose of insuring certain portions of its risk retained under its PLGL programs. Accordingly, the Company is in essence self-insured for claims that are less than the policy deductible amounts, claims not covered by such policies, and claims that exceed the policy limits. It is the Company&#8217;s policy to use an actuary to assist management in recording the expense and related liability for PLGL claims, both asserted and unasserted, on an undiscounted basis. Included in the accompanying consolidated balance sheet are self-insurance liabilities amounting to $138,127 as of December&#160;31, 2022, which includes $42,549 of estimated obligations that will be covered by the unrelated insurer. As of December&#160;31, 2022, the Company recorded an asset for the estimated obligations that will be covered by the unrelated insurer amounting to $7,233 and $35,316 within other receivables and other assets, respectively, as the claims related to the Company's general and professional liability and the anticipated insurance recoveries are recorded on a gross rather than net basis in accordance with U.S. GAAP.  </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Plum acquisition in 2021 (refer to Note 15), the Company assumed Plum&#8217;s workers&#8217; compensation plan. Plum purchased an occurrence-based high deductible self-insured workers&#8217; compensation policy whereby the Company is responsible for the first layer of coverage, generally ranging from $250 to $500 per claim. The estimated obligation recorded at December&#160;31, 2022 was $17,062. The Plum facilities were transferred onto the Company&#8217;s retrospective-rated premium workers&#8217; compensation policy as of the acquisition date.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnities&#160;</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into certain types of contracts that contingently require it to indemnify parties against third-party claims. These contracts primarily include (i) certain real estate leases, under which the Company may be required to indemnify property owners or prior facility operators for post-transfer environmental or other liabilities and other claims arising from the Company use of the applicable premises, (ii) operations transfer agreements, in which the Company agrees to indemnify past operators of facilities against certain liabilities arising from the transfer of the operation and&#47;or the operation thereof after the transfer to the Company's independent operating subsidiary, (iii) certain lending agreements, under which the Company may be required to indemnify the lender against various claims and liabilities, and (iv) certain agreements with the Company officers, directors and others, under which the Company may be required to indemnify such persons for liabilities arising out of the nature of their relationship to the Company. The terms of such obligations vary by contract and, in most instances, do not expressly state or include a specific or maximum dollar amount. Generally, amounts under these contracts cannot be reasonably estimated until a specific claim is asserted. Consequently, because no claims have been asserted, no </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">liabilities have been recorded for these obligations on the consolidated balance sheet for any of the periods presented.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_70"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.69pt">OPERATION EXPANSIONS</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FASB ASC Topic 805, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 805) defines the definition of a business to assist entities with evaluating when a set of transferred assets and activities is deemed to be a business. Determining whether a transferred set constitutes a business is important because the accounting for a business combination differs from that of an asset acquisition. The definition of a business also affects the accounting for dispositions. When substantially all of the fair value of assets acquired is concentrated in a single asset, or a group of similar assets, the assets acquired would not represent a business and business combination accounting would not be required.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2022 Expansions</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, the Company&#8217;s consolidated operations and real estate portfolio grew through a combination of long-term leases and real estate purchases. The Company acquired operations at nine stand-alone skilled nursing, assisted living, and subacute facilities and four real estate purchases. Of the four real estate purchases, two of the properties were acquired in conjunction with the operations of the associated facility. For the other two acquired properties, the Company previously operated the respective facilities and has now acquired the real estate associated with those operations. These new operations added approximately 1,180 operational skilled nursing beds. The purpose of any such expansion, may include, without limitation, to expand the scope of the Company's operations, add additional team members with important skill sets, and&#47;or realize synergies. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate purchase price for these expansions during the year ended December 31, 2022 was $55,374. The fair value of assets for the entities where real estate was acquired were concentrated in property and equipment and other assets, amounting to $46,500 and $378, respectively. As such, these transactions were classified as asset acquisitions. The remaining aggregate purchase price for transactions during the year ended December 31, 2022 was concentrated in goodwill in the amount of $8,496 and as such, the transactions were classified as a business combination. The Company expects 100% of the goodwill to be deductible for income tax purposes. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the new operations made through long-term leases, the Company did not acquire any material assets or assume any liabilities other than the tenant's post-assumption rights and obligations under the long-term lease. The Company entered into separate agreements with the applicable prior operators as part of each transaction.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Expansions</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plum Healthcare Group Acquisition</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;5, 2021, the Company completed the acquisition of all of the equity interest of 58 stand-alone skilled nursing, assisted living, and subacute facilities and eight real estate entities from Bay Bridge Capital Partners, LLC d&#47;b&#47;a Plum Healthcare Group (Plum) for $121,000, consisting of cash of $104,200 and notes due to prior owner of $16,800, in order to grow and expand its footprint. The acquisition added approximately 6,380 operational skilled nursing beds, 40 assisted living beds, and 190 subacute beds.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below represents the purchase price allocation to total identifiable assets acquired and net liabilities assumed using the acquisition method, based on their respective fair values as of November&#160;5, 2021.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,957&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,555&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid and other </font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,076&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,483&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,072&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612,522&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,781&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other indefinite-lived assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,345&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current operating lease liabilities assumed</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,324)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities assumed</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134,886)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities assumed</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(576,848)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt and finance lease liabilities assumed</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,095)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities assumed</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,638)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total purchase price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,000&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indefinite-lived intangible assets acquired include the certificates of need and licenses. Fair value of the indefinite-lived intangible assets was determined using a cost approach. The cost approach uses the replacement or reproduction cost as an indicator of fair value. The cost approach utilized assumptions for the current replacement costs of similar assets which for these indefinite-lived intangible assets included assumptions regarding estimated fees on a per unit basis in the applicable jurisdictions. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value of property and equipment was determined using a combination of an income and cost approach. The income approach utilized significant assumptions including management&#8217;s best estimates of the expected future cash flows and the estimated useful life of the asset group. The cost approach utilized assumptions for the current replacement costs of similar assets adjusted for estimated depreciation and deterioration of the existing property and equipment and economic obsolescence. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value of the right-of-use assets was determined under a market approach. The market approach utilized significant assumptions based on estimated market rent assessments for the acquired lease contracts. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill is primarily attributed to the workforce acquired. The Company expects 100% of the goodwill to be deductible for income tax purposes. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, the Company recorded a measurement period adjustment primarily related to the finalization of professional liability loss reserves, which increased the amount of goodwill and other liabilities assumed in the Plum acquisition by $18,844. At the time of the adjustment, the measurement period was still open as the Company was gathering further information about facts and circumstances that existed as of the acquisition date related to the legal matters that gave rise to the professional liability loss reserve adjustment. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other 2021 Expansions</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company invested in two joint ventures during the year ended December 31, 2021. Information related to joint venture activity is disclosed in Note 7.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company sold one real estate entity, resulting in a gain on sale of approximately $3,100. In conjunction with the sale, the Company entered into a note receivable agreement with the buyer in the principal amount of $5,000 with monthly interest payments accruing at 6% percent. Annual principal payments are due on </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">each anniversary date, with the remaining principal due and payable on the maturity date of June&#160;1, 2024. At December&#160;31, 2022, the outstanding balance of the note was $4,250 which is included in Other Assets.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, the Company&#8217;s consolidated operations grew through a combination of long-term leases and real estate purchases, with the addition of 17 stand-alone skilled nursing facilities and five real estate purchases. These new operations added approximately 1,780 operational skilled nursing beds. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate purchase price for these acquisitions during the year ended December 31, 2021 was $118,324. The fair value of assets for the real estate entities were concentrated in property and equipment amounting to $116,423. As such, these transactions were classified as asset acquisitions. The remaining aggregate purchase price for transactions during the year ended December 31, 2021 was concentrated in goodwill in the amount of $1,901 and as such, the transactions were classified as a business combination. The Company expects 100% of the goodwill to be deductible for tax purposes. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the new operations acquired for the stand-alone skilled nursing facilities, the Company did not acquire any material assets or assume any liabilities other than the tenant's post-assumption rights and obligations under the long-term lease. The Company entered into agreements with the applicable prior operators as part of each transaction.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s expansion strategy has been focused on identifying both opportunistic and strategic acquisitions within its target markets that offer strong opportunities for return. The operations added by the Company are frequently underperforming financially and can have regulatory and clinical challenges to overcome. Financial information, especially with underperforming operations, is often inadequate, inaccurate or unavailable. Consequently, the Company believes that prior operating results are not a meaningful representation of the Company&#8217;s current operating results or indicative of the integration potential of its newly acquired operating subsidiaries. The assets added during the year ended December&#160;31, 2022 and 2021 and through the issuance of the financial statements were not material operations to the Company individually or in the aggregate. Accordingly, pro forma financial information is not presented. The additions have been included in the December&#160;31, 2022 consolidated balance sheet of the Company, and the operating results have been included in the consolidated statements of income of the Company since the date the Company gained effective control.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2023 Expansions</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2022, the Company&#8217;s operations and real estate portfolio grew through a combination of long-term leases and real estate purchases, with the addition of 57 stand-alone facilities and five real estate purchases. Of the five real estate purchases, three of the properties were acquired in conjunction with the operations of the associated facilities. For the two acquired property, the Company previously operated the facility and now has acquired the real estate associated with the operations. These new operations added approximately 6,624 skilled nursing beds and 484 assisted living beds operated by the Company's affiliated operating subsidiaries. The aggregate purchase price for these acquisitions was $88,791. </font></div><div id="i2baa8a1031f44c51b1664e00d256c582_1262"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.69pt">OTHER ACCRUED EXPENSES</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued expenses consisted of the following at December 31&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</font></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,895&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts due to former Plum shareholders</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,586&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,678&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,159&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-30</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_1873"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PACS GROUP, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands, except for share and per share values)</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.69pt">EARNINGS PER SHARE</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share is calculated by dividing net income attributable to the common stockholders by the weighted-average shares of Common Stock outstanding for the period. The computation of diluted net income per share is similar to the computation of basic net income per share, except that the denominator is increased to include the number of additional shares of common stock that would have been outstanding if the dilutive potential shares of common stock had been issued. As the Company did not have any potentially dilutive securities, basic and diluted EPS are the same.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of the Company&#8217;s basic and diluted net income attributable per share to common stockholders for the years ended December 31, 2022 and 2021&#58;</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands, except per share amounts)</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic EPS&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,496&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,947&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted weighted average common stock outstanding  </font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income per share&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,525&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income per share calculations and potentially dilutive security amounts for all periods prior to the Reorganization have been retrospectively adjusted to the equivalent number of shares outstanding immediately after the Reorganization to effect the reorganization in accordance with ASC Topic 250, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Changes and Error Corrections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Reorganization resulted in the Common Shares outstanding being converted from 600 shares of PGI to 20,000 shares of PACS Group (a 1 to 33.33 conversion ratio).</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_73"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.69pt">SUBSEQUENT EVENTS</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, following trial in Sacramento County (CA) Superior Court, the jury rendered a verdict in a case entitled Rios et al. v. Daisy Holdings, LLC dba Pine Creek Care Center, et al. The plaintiffs alleged, among other things, that Mr. Rios suffered elder abuse while at Pine Creek Care Center. The defendants, which included multiple affiliates of Plum which later became indirect subsidiaries of the Company as a result of the Plum Healthcare Group acquisition (see Note 15) in November 2021, denied the allegations. The jury verdict was for approximately $5.9 million in compensatory damages and $25.0 million in punitive damages. The court also awarded plaintiff counsel approximately $4.6 million in attorney fees. The litigation was originally filed in November 2018, and the events giving rise to the litigation occurred in 2017. The defendants appealed the judgment, and during the appeals process the case was settled on confidential terms, including as to the settlement amount. Contemporaneously with the Rios settlement, the Company also settled four other cases that it had inherited in connection with the Plum Healthcare Group acquisition. As a result of the aggregate settlement amount, including the Rios matter, the Company recognized an incremental $7.3 million in operating expenses in the 2023 statement of income.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-31</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_1306"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-indent:18pt"><font><br></font></div></div><div style="margin-bottom:120pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:30pt;font-weight:700;line-height:120%">PACS GROUP, INC.</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Shares</font></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:21.314%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><img alt="companylogo1a.jpg" src="companylogo1a.jpg" style="height:58px;margin-bottom:5pt;vertical-align:text-bottom;width:259px"></div><div style="margin-bottom:6pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">COMMON STOCK</font></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:21.314%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Citigroup</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">J.P. Morgan</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Truist Securities</font></div></td></tr></table></div><div style="margin-bottom:72pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:21.314%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Through and including&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2024 (the 25th day after the date of this prospectus), all dealers effecting transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This delivery requirement is in addition to the dealers&#8217; obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-indent:18pt"><font><br></font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_1473"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION NOT REQUIRED IN PROSPECTUS</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_1652"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13.&#160;&#160;&#160;&#160;Other expenses of issuance and distribution.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table indicates the expenses to be incurred in connection with the offering described in this registration statement, other than the underwriting discounts and commissions, all of which will be paid by us. All amounts are estimated except the Securities and Exchange Commission registration fee, the Financial Industry Regulatory Authority, Inc. (FINRA) filing fee and the New York Stock Exchange listing fee.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities and Exchange Commission registration fee</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FINRA filing fee</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Initial New York Stock Exchange listing fee</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accountants&#8217; fees and expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal fees and expenses</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blue Sky fees and expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer Agent&#8217;s fees and expenses</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Printing and engraving expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miscellaneous</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenses</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</font></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14pt">To be filed by amendment.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_1489"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14.&#160;&#160;&#160;&#160;Indemnification of directors and officers.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 102 of the General Corporation Law of the State of Delaware (DGCL) permits a corporation to eliminate the personal liability of directors or officers of a corporation to the corporation or its stockholders for monetary damages for a breach of fiduciary duty as a director or officer, except where the director or officer breached his or her duty of loyalty, failed to act in good faith, engaged in intentional misconduct or knowingly violated a law, obtained an improper personal benefit, and in the case of a director, authorized the payment of a dividend or approved a stock repurchase in violation of Delaware corporate law, and in the case of an officer, a breach of fiduciary duty in any action by or in the right of the corporation. Our Amended and Restated Charter will provide that no director or officer of PACS Group, Inc. shall be personally liable to it or its stockholders for monetary damages for any breach of fiduciary duty as a director or officer, notwithstanding any provision of law imposing such liability, except to the extent that the DGCL prohibits the elimination or limitation of liability of directors or officers for breaches of fiduciary duty.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 145 of the DGCL provides that a corporation has the power to indemnify a director, officer, employee, or agent of the corporation, or a person serving at the request of the corporation for another corporation, partnership, joint venture, trust, or other enterprise in related capacities against expenses (including attorneys&#8217; fees), judgments, fines, and amounts paid in settlement actually and reasonably incurred by the person in connection with an action, suit, or proceeding to which he or she was or is a party or is threatened to be made a party to any threatened, pending, or completed action, suit, or proceeding, whether civil, criminal, administrative, or investigative, by reason of such position, if such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, in any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful, except that, in the case of actions brought by or in the right of the corporation, no indemnification shall be made with respect to any claim, issue, or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines that, despite the adjudication of liability but in view of all of the circumstances </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon consummation of this offering, our Amended and Restated Charter and Amended and Restated Bylaws will provide indemnification for our directors and officers to the fullest extent permitted by the DGCL. We will indemnify each person who was or is a party or threatened to be made a party to any threatened, pending, or completed action, suit or proceeding (other than an action by or in the right of us) by reason of the fact that he or she is or was, or has agreed to become, a director, or officer, or is or was serving, or has agreed to serve, at our request as a director, officer, partner, employee, or trustee of, or in a similar capacity with, another corporation, partnership, joint venture, trust, or other enterprise (all such persons being referred to as an &#8220;Indemnitee&#8221;), or by reason of any action alleged to have been taken or omitted in such capacity, against all expenses (including attorneys&#8217; fees), judgments, fines, and amounts paid in settlement actually and reasonably incurred in connection with such action, suit, or proceeding and any appeal therefrom, if such Indemnitee acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, our best interests, and, with respect to any criminal action or proceeding, he or she had no reasonable cause to believe his or her conduct was unlawful. Our Amended and Restated Charter and Amended and Restated Bylaws will provide that we will indemnify any Indemnitee who was or is a party to an action or suit by or in the right of us to procure a judgment in our favor by reason of the fact that the Indemnitee is or was, or has agreed to become, a director or officer, or is or was serving, or has agreed to serve, at our request as a director, officer, partner, employee, or trustee of, or in a similar capacity with, another corporation, partnership, joint venture, trust, or other enterprise, or by reason of any action alleged to have been taken or omitted in such capacity, against all expenses (including attorneys&#8217; fees) and, to the extent permitted by law, amounts paid in settlement actually and reasonably incurred in connection with such action, suit, or proceeding, and any appeal therefrom, if the Indemnitee acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, our best interests, except that no indemnification shall be made with respect to any claim, issue, or matter as to which such person shall have been adjudged to be liable to us, unless a court determines that, despite such adjudication but in view of all of the circumstances, he or she is entitled to indemnification of such expenses. Notwithstanding the foregoing, to the extent that any Indemnitee has been successful, on the merits or otherwise, he or she will be indemnified by us against all expenses (including attorneys&#8217; fees) actually and reasonably incurred in connection therewith. Expenses must be advanced to an Indemnitee under certain circumstances.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the consummation of this offering, we intend to enter into separate indemnification agreements with each of our directors and executive officers. Each indemnification agreement will provide, among other things, for indemnification to the fullest extent permitted by law and our Amended and Restated Charter and Amended and Restated Bylaws against any and all expenses, judgments, fines, penalties, and amounts paid in settlement of any claim. The indemnification agreements will provide for the advancement or payment of all expenses to the indemnitee and for the reimbursement to us if it is found that such indemnitee is not entitled to such indemnification under applicable law and our Amended and Restated Charter and Amended and Restated Bylaws.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a general liability insurance policy that covers certain liabilities of directors and officers of our corporation arising out of claims based on acts or omissions in their capacities as directors or officers.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In any underwriting agreement we enter into in connection with the sale of common stock being registered hereby, the underwriters will agree to indemnify, under certain conditions, us, our directors, our officers, and persons who control us within the meaning of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) against certain liabilities arising in connection with such offering.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_1508"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 15.&#160;&#160;&#160;&#160;Recent sales of unregistered securities.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Set forth below is information regarding all unregistered securities sold by us since January 1, 2020. Also included is the consideration received by us for such shares and information relating to the section of the Securities Act, or rule of the Securities and Exchange Commission, under which exemption from registration was claimed.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Issuances</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On March 24, 2023, and in connection with our incorporation in the State of Delaware, we issued and sold an aggregate of 20,000 shares of our common stock to Jason Murray and Mark Hancock for an aggregate purchase price of $200,000, or $10.00 per share.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated, the issuances of the above were deemed to be exempt from registration under the Securities Act in reliance upon Section 4(a)(2) of the Securities Act or Regulation D promulgated thereunder, or Rule 701 promulgated under the Securities Act, as transactions by an issuer not involving any public offering or pursuant to benefit plans and contracts relating to compensation as provided under Rule 701. Individuals who purchased securities as described above represented their intentions to acquire the securities for investment purposes only and not with a view to, or for sale in connection with, any distribution thereof.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the foregoing transactions involved any underwriters, underwriting discounts or commissions or any public offering. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-3</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_1523"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="-sec-extract:summary;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="-sec-extract:summary;margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16.&#160;&#160;&#160;&#160;Exhibits and financial statement schedules.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.91pt">Exhibits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents are filed as exhibits to this registration statement.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.766%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description of Exhibit</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Underwriting Agreement</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1*</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of Incorporation of PACS Group, Inc., as currently in effect</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2*</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Amended and Restated Certificate of Incorporation of PACS Group, Inc., to be in effect upon the consummation of this offering</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3*</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bylaws of PACS Group, Inc., as currently in effect</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4*</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Amended and Restated Bylaws of PACS Group, Inc., to be in effect upon the consummation of this offering</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1*</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Certificate of Common Stock</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2*</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Stockholders Agreement </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Opinion of Latham &#38; Watkins LLP</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Credit Agreement, dated as of December 7, 2023, by and among PACS Group, Inc., PACS Holdings, LLC, Truist Bank and the lenders party thereto</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2#*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Indemnification Agreement between PACS Group, Inc. and its directors and officers</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3#*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PACS Group, Inc. Non-Employee Director Compensation Program</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4#*</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PACS Group, Inc. 2024 Incentive Award Plan</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5#*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Stock Option Agreement under PACS Group, Inc. 2024 Incentive Award Plan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6#*</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Restricted Stock Unit Agreement under PACS Group, Inc. 2024 Incentive Award Plan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7#*</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Restricted Stock Unit Agreement (Executive IPO Awards) under PACS Group, Inc. 2024 Incentive Award Plan</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8#*</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PACS Group, Inc. 2024 Employee Stock Purchase Plan</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9#*</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Providence Administrative Consulting Services, Inc. Nonqualified Deferred Compensation Plan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10#*</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Offer Letter, dated as of December 18, 2023, by and between PACS Group, Inc. and Derick Apt</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">List of subsidiaries of PACS Group, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of Latham &#38; Watkins LLP (included in Exhibit 5.1)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of Ernst &#38; Young LLP, independent registered public accounting firm</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Power of Attorney</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.1*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registration Fee Table</font></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">#</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14pt">Indicates management contract or compensatory plan.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#94;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.25pt">Portions of the exhibit have been omitted as permitted under Item 601(b)(10) of Regulation S-K.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14pt">To be filed by amendment.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Financial Statement Schedules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Schedules not listed above have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements or notes thereto.</font></div><div id="i2baa8a1031f44c51b1664e00d256c582_1538"></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 17.&#160;&#160;&#160;&#160;Undertakings.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned registrant hereby undertakes to provide to the underwriters, at the closing specified in the underwriting agreement, certificates in such denominations and registered in such names as required by the underwriter to permit prompt delivery to each purchaser.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insofar as indemnification for liabilities arising under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned hereby undertakes that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-5</font></div></div></div><div id="i2baa8a1031f44c51b1664e00d256c582_1598"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIAL TREATMENT REQUESTED BY PACS GROUP, INC. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 17 C.F.R. SECTION 200.83</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement on Form S-1 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Farmington, State of Utah, on this &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; day of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2024.</font></div><div style="margin-bottom:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:33.012%"><tr><td style="width:1.0%"></td><td style="width:14.919%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.881%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PACS GROUP, INC.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jason Murray</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div id="i2baa8a1031f44c51b1664e00d256c582_1583"></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES AND POWER OF ATTORNEY</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, the undersigned officers and directors of PACS Group, Inc., hereby severally constitute and appoint Jason Murray and Mark Hancock, and each of them singly (with full power to each of them to act alone), our true and lawful attorneys-in-fact and agents, with full power of substitution and re-substitution in each of them for him or her and in his or her name, place and stead, and in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement (or any other registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act of 1933, as amended), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as full to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement on Form S-1 has been signed by the following persons in the capacities held on the dates indicated.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.624%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Signature</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</font></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, Co-Founder, Chairman and Chief Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Executive Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jason Murray</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Financial Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derick Apt</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Accounting Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Accounting Officer)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michelle Lewis</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director, Co-Founder and Executive Vice Chairman</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Hancock</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jacqueline Millard</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taylor Leavitt</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-6</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>business1a.jpg
<TEXT>
begin 644 business1a.jpg
M_]C_X  02D9)1@ ! 0( .P [  #_X0^ 17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     P   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   "=!   %
M )T$   4    1TE-4" R+C$P+C(R   R,#(T.C Q.C(S(#$R.C,S.C4R  $
M : #  $    !          @   $$  $      0   0$$  $   !(     @$#
M  ,    , 0   P$#  $    &    !@$#  $    &    %0$#  $    #
M 0($  $    2 0   @($  $   !E#@        @ "  ( /_8_^  $$I&248
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M^G:+<M<68E61EV'<^>,Y_I6U10 W!_O'\J=110 4444 %%%% !1110 4444
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M !( '0 K86-S<$U31E0                                  /;6  $
M    TRUL8VUS
M               -9&5S8P   2    ! 8W!R=    6     V=W1P=    9@
M   48VAA9    :P    L<EA96@   =@    48EA96@   >P    49UA96@
M @     4<E120P   A0    @9U120P   A0    @8E120P   A0    @8VAR
M;0   C0    D9&UN9    E@    D9&UD9    GP    D;6QU8P         !
M    #&5N55,    D    ' !' $D 30!0 "  8@!U &D ; !T "T :0!N "
M<P!2 $< 0FUL=6,          0    QE;E53    &@   !P 4 !U &( ; !I
M &, ( !$ &\ ;0!A &D ;@  6%E:(        /;6  $     TRUS9C,R
M   !#$(   7>___S)0  !Y,  /V0___[H?___:(   /<  # ;EA96B
M  !OH   ./4   .06%E:(        "2?   /A   ML1865H@        8I<
M +>'   8V7!A<F$       ,    "9F8  /*G   -60  $]    I;8VAR;0
M     P    "CUP  5'P  $S-  "9F@  )F<   ]<;6QU8P         !
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M[[?MH_)Y'CKC;\-=  J<Z_%Z(V&S;KQJ4W+"7A'/9<?=D%>K/ZE'VH<ED@
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M[]%/GQ5K<>-RGUT^@        #K<?3VOZZD[8
M      $>]DQY":WD #P]?!<\Y*UZ           ,9RJ=23-KC[GDD=8R
M       (\;)CR'UO(      &G)NS^^.-N^;T@+X         'B7E<#F9/:ID
M^/H
M                     <YC^_91Z
M
M
M
M                                      /$\CU//8]_0
M           <7[YR?GHXOVGE?*@
M                  ."JIJ2F(JXB%EJZY*/S&BN<N!G
M      ?)[Y2).PUVL%,:*OV889V':K$R@                      _ \_7
MOK>>QZ                          !6M*1VA\BS<;"2T>\G'COD6+((V0
M                      AMFX=?$C@6ZP\K 60P<;JIMWAY;R
M            (,9^%L>W<^OQ#O,Q+4HF3][T
M  8_51'K)L9#35I*]9W#9O20QL@                     #U/-27K7'^^;
MCLWM47;6Y+-X                     #&ZJ:@)F)EOAY4T<',KTDL"R6,D
M?T
M                  'RO-3WK6N[MO75VW@-RBR&+D/H>@
M        :*G[&$9]        &28M4B-;R  !\CR&F=B2YP\K0]^QC==,N</+
M         $8]HQX?;MB        <C:]M#Y/)?3X  'J>>Q[^'@>P_0
M                                #K-?4&O0"Z3'@       2OTS+[6?
MR3LP  Q^JFNZ2CY.XN3MVQ=KZD<"SR+DP        !3%VV)I [W"@
M9+AU]QSXGVSF[?H  K:DX[-Z*]\XU^M*4CKB866YGRH        #'K].H96V
M       !^&Y8B[S=KT  ::O6>1\]VC:N1BRL>2.-D??YZ             !U
MG?I_7H"])P        )6Z9E]J_Y*V4  :ZNVZ\I' SBW5GUNYOW'O[?LW@
M      !3%VV)I [W"@       9+AU]QSXGVSF[?H 'B1KRL:..38L6C<^O*1
MP+&XV0         $".@8767^J=;_ 'P       /74[2OR-L\S=.R@ /PA]F8
M>C,BS,##RZ\9*/L@C)'<=B\             !UG?I_7H"])P        )6Z9
ME]J_Y*V4  ?AAM='+^>^1S--7Z         "F+ML32!WN%        R7#K[C
MGQ/MG-V_0 /P@'(8&;T5\]35L^S=VS:N@        "!/0,+K+_5&N>0
M  /7Z[2?R/LTS=.R@ /4\@SGX>E[]B3&+DQ6R\626+DS2PLP
M #K._3^O0%Z3@        2MTS+[5_P E;*              !3%VV)I [W"@
M       9+AU]QSXGVSF[?H              @3T#"ZR_U1KGD       #U^N
MTG\C[-,W3LH  8371YGT^,1N4;2LW?<]              ZSOT_KT!>DX
M     $D>>9]U_P L["]       #EBP0\@     4Q=MB:0.]PH       &38-
MSMZ?%.U\Q;]        R,]X     ($] PNLO]4:YY        ]?KM)_(^S3-
MT[*                   '6=^G]>@+TG         WSR^2G'\SSP
M&4%ZA[      4Q=MB:0.]PH       &:Z[?LO^-]I\*@       \"ZPVD
M  "!/0,+K+_5&N>0       /75YV OCG:9 ZWD        2"-M@
M ZSOT_KT!>DX        &^>7R4X_F>>        R@O4/8     "F+ML32!WN
M%        S77;]E/QOM/C4       '@78&TP     0)Z!A=9?ZHUSR
M !ZJ_+0?BG;,@BKH       %EQ-(          '6=^G]>@+TG         WS
MR^2G'\SSP       &4%ZA[      4Q=MB:0.]PH       &:Z[?LI^-]I\:@
M       \"[ VF     "!/0,+K+_5&N>0       /57Y:#\4[9D$5=
M LN)I           ZSOT_KT!>DX        &^>7R4X_F>>        R@O4/8
M     "F+ML32!WN%        S77;]E/QOM/C4       '@78&TP     0)Z!
MA=9?ZHUSR       !ZJ_+0?BG;,@BKH       %EQ-(          '6=^G]>
M@+TG         WSR^2G'\SSP       &4%ZA[      4Q=MB:0.]PH
M &:Z[?LI^-]I\:@       \"[ VF     "!/0,+K+_5&N>0       /57Y:#
M\4[9D$5=        LN)I           ZSOT_KT!>DX        &^>7R4X_F>
M>        R@O4/8     "F+ML32!WN%        S77;]E/QOM/C4       '
M@78&TP     0)Z!A=9?ZHUSR       !ZJ_+0?BG;,@BKH       %EQ-(
M        '6=^G]>@+TG         WSR^2G'\SSP       &4%ZA[      4Q
M=MB:0.]PH       &:Z[?LI^-]I\:@       \"[ VF     "!/0,+K+_5&N
M>0       /57Y:#\4[9D$5=        LN)I           ZSOT_KT!>DX
M     &^>7R4X_F>>        R@O4/8     "F+ML32!WN%        S77;]E
M/QOM/C4       '@78&TP     0)Z!A=9?ZHUSR       !ZJ_+0?BG;,@BK
MH       %EQ-(          '6=^G]>@+TG         WSR^2G'\SSP
M &4%ZA[      4Q=MB:0.]PH       &:Z[?LI^-]I\:@       \"[ VF
M   "!/0,+K+_ %1KGD       #U5^6@_%.V9!%70       ++B:0
M  .L[]/Z] 7I.        !OGE\E./YGG@       ,H+U#V      IB[;$T@=
M[A0       ,UUV_93\;[3XU       !X%V!M,     $">@8767^J-<\@
M   >JORT'XIVS((JZ       !9<32          !UG?I_7H"])P        -
M\\ODIQ_,\\       !E!>H>P     %,7;8FD#O<*       !FNNW[*?C?:?&
MH       / NP-I@     @3T#"ZR_U1KGD       #U5^6@_%.V9!%70
M  ++B:0      !\GM/QU>  "ACZ A8;;UA@       ;AY_G2XX+,
M9 6Z'F     "K7J\=4SV.*        RJ$O3Q^7]A\??       !XEJYL(
M  $.MSQ:$_HB#_?        ]=?E@7RGLG-QU8       $\"4X  .0IJ]_GH
M  ]7OGI]\  'P5/1Z        ]ARM        #\/$      ^3U\E0
M#].7H?H       !X      'I]<?4        ')TO=X        \3\  ![Z??
M8]
M                                    &(5T:1OV=E6KG#U><%53GUNY
MZ7FT+5T                    #%:J-$Y-G:-FYP%7GQ>^9115I^]:E%BY/
M(^>@                   #X/?(NY>-OS&OZIO6LHHJ_# KMO?6-D9/34
M                       -)W[$&\_#]GCGZ:I)8V1&S*Q\?JHM.B90
M                #2]^S!S/P?49!37*3$R8HY>)E]%>_,>_(_&R0
M            !@-RW!60PM:7+>;6ZI/8V5&'*QLTMUY135.' S0
M               !&_)QH$2&#G]NY];W ;EN;V!FQ_R<>QV,D0
M          ([Y./7W(X&R+5SS."J\D3BWX-R&%;]#2V=V[@
M       U_<MU%S,5O_&OXE71E=->96Z^+J\>+&8V0
M      &,U4XG71F%%?R>^<)5YSE/OV>>Y!34                    !C55
M.)5T9C17\/OG%^^>XXCWS/K=?+>5                    #B?:<!N49O17
MC]5/F]\7GQ>LYMU\AYZ
M
M
M
M
M/PQVJGGJ??F]?7X]9CE=.445XW51DU-?'^^<AY[Q_OG(>>@     #X??/M\]
M_08W53DE-0   ''>^<CYZ
M                  */N[0\9MJQKP^#3%?F'@[VQ[V)5TRCQ,G0.38RBBKZ
M/&G;]JSZ*DJ@YF)MAB)2I:7BI]1^?YF@LBQ+["R^(J\P.Y;^KSW9UJYN&S>
MP@K:)$&-2&!NFS>PVNG)Z*H9YN'/^/S_ '>-,W[.*UTYG;K]IM>S=\3-**Z=
M)J)MEAY3W&OKMO2]ZU.? S>3\]
M                     ZO'U9KD)]\PNT'\H['#F Q+&(V0K8DX[8ENYE5%
M5@T=GZ6OV8E9F)8/&R$&,_"CAE8V_P#'O\I35\/OFP[5S@JZ<3KISBW7'O)L
M;_QK]C$;( :N*2R99FTC'\-7Y[Z??(QBJC(_*_+QJJ]:R^BJ1^-D8Q[Y%S,Q
M9XQ^=H;(L18RL:9N%EP?S\/?./>^[SVQR,D.6\J
M                                  A[NF)KV2MS!TK+QC%IR:BK[O/=
M?7;?,4^QFRL>6>'E1?R\::N#F:ONVL;JIY^FK4=ZULFW<PFNCC_:<RHN9M17
MJF[:V9:N;@LW@.&(^&>GKO6?7Z\_&&W*,;JIR6FKYS#JZ-U6+V#7*-NV;L&L
M_"L<C)#2&19WICW]+7[/!54QCRL;5UVU/^/S]\8]\
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M$4:(BC1$4:(BC1$4:(BC1$4:(BC1$4:(BC1$4:(BC1$4:(BC0T46B]BQ;_\
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M;'"MCA6QPK8X5L<*V.%;'"MC@61P+(X%D<"R.!9' LC@61P+(X%D<"R.!9'
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M0X/_V@ ( 0,! 3\!]$FYQYE[1H"3L&\8^W_O?!G9INA<;%ONTAAY+[86GXC
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MP*  B98+[.C!H=D:$,2;B'>L*;:1*-/N)46G+$!5*5@/3$O,):<7>%?O]#B
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M3#+1M<<2D[Z&-=E>V1^O\1KLKVR/U_B-=E>V1^O\1KLKVR/U_B-=E>V1^O\
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M;T_I#S5SX?/T(PS^"S_QH^7JGI+SG^@>A=&?C'W3Z@Z5\EKWC\O0I7SAKO\
MXC^WI_2'FKGP^?H1AG\%G_C1\O5/27G/] ]"Z,_&/NGU!TKY+7O'Y>A2OG#7
M?_$?V]/Z0\U<^'S]",,_@L_\:/EZIZ2\Y_H'H71GXQ]T^H.E?):]X_+T*5\X
M:[_XC^WI_2'FKGP^?H1AG\%G_C1\O5/27G/] ]"Z,_&/NGU!TKY+7O'Y>A2O
MG#7?_$?V]/Z0\U<^'S]",,_@L_\ &CY>J>DO.?Z!Z%T9^,?=/J#I7R6O>/R]
M"E?.&N_^(_MZ?TAYJY\/GZ$89_!9_P"-'R]1$@;S%Z<8O3C%Z<8O3C%Z<8O3
MC$\TXZ_<VDJ%M*QJS_9F-6?[,QJS_9F-6?[,QJS_ &9C5G^S,:L_V9C5G^S,
M:L_V9C5G^S,:L_V9C5G^S,:L_P!F8U9_LS&K/]F8U9_LS&K/]F8D&UM.U<3:
M*$5B].,7IQB].,7IQB].,7IQB].,7IQB].,7IQB].,7IQB].,7IQB].,7IQB
M].,7IQB].,7IQB].,7IQB].,7IQB].,7IQB].,7IQB].,7IQB].,=()4ZEL-
MBZA-:=T:L_V9C5G^S,:L_P!F8U9_LS&K/]F8U9_LS&K/]F8U9_LS&K/]F8U9
M_LS&K/\ 9F-6?[,QJS_9F-6?[,QJS_9F-6?[,QJS_9F)=AY#R%*00D':8O3C
M%Z<8O3C%Z<8O3C%Z<8O3C%Z<8O3C%Z<8O3C%Z<8O3C%Z<8O3C%Z<8O3C%Z<8
MO3C%Z<8O3C%Z<8O3C%Z<8O3C%Z<8O3C%Z<8O3C%Z<8O3C$Y]Y+K0C:HTV#OC
M5G^S,:L_V9C5G^S,:L_V9C5G^S,:L_V9C5G^S,:L_P!F8U9_LS&K/]F8U9_L
MS&K/]F8U9_LS&K/]F8U9_LS&K/\ 9F-6?[,QJS_9F&E --I)VI0D'O B].,7
MIQB].,7IQB].,7IQB].,7IQB].,7IQB].,7IQB].,7IQB].,7IQB].,7IQB]
M.,7IQB].,7IQB].,7IQ@&N[_  2 =\6C"+1A%HPBT81:,(M&$6IPBU. BU.
MBU. BU. BU. BU. BU. BU. BU. BU. BU. BU. BU. BU. BU. BU. BU.
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MD)0E/DI [HM36Z@KCZL4A*O* /?&A:R)Y04I4*$5$)0A'DI [H+39-2A)/=
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M<4LE6T;]D(9"5ERIJK?_ .&+4WE5-N/VG4)6FBA40RRTDU2BA[S_ #ZX_\0
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M^1>M9P_=HBWJU+M34BM140L)!/$- ^Z*38RBT^S3=<M/-SKS"FP\)5AU:6T
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M649A?Y.DDQ,K+;; 7G=&^] XH9>??F J^X#3Q 1-J2I]93__ (_5;3F26%@
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MS[G-+.ESW>Z.K^[N,(E\H47[ZA).',X"^,AK1"*8D*HJ(6S5JJT&^\_']IW
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M21ACQFU5*08$>7)=S#,P;''1YFU"7"I=PA";80C<!\'.4*M(JE]U3Q@,.BW
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MU](LJ;A/FA^M?@R\IH2N%@4JAC>T0IL:\QVGQ0=4V0ZI*?,LA15]"B/3F<7
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M/[]FZ)N^1V_;_2=KZ'[UWX!_GR/X<[%T?PV;";[QT3OO1\_OV;HF[Y';]O\
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MJLIJ3 0M?&(0 )IM0"*/(@(\TH=J,LZ7QF&V6F#;CUX99IUHZ'(+:\()]V"
M6( J!OJ#7.24SUFRES;G:8^EB+T4_P#9@1,H,RS?$T/DN*RM\A(#^P?*6*V^
M.BV[MRW'7B<$OPIEAE--JQMD71-1Q:9>(L:PB\$*,@J_3&A9=5]5$.)KB(H'
M#R>,;%A%5[:K6HX+Q,3P;%SQPF6XV?&[JWAT'CS <+8!LQIM5V;CA;A-8AU1
M@@49OP/]E5],MR:- :LXXHKMUMA[K -7'2:F@4K5I0CF8,TSW#,+T9W$ A 0
MF:F1DJ^.,AKWX.LB0T&NJEPD=OX*DM95YP?I&#! -:% ^ENPUG MP9!=L&"<
M+""51C )**OL+33M)?'A,D0B\.,"%GEX(05'$"D5@#R)>KO4'7!3HUY]#P*M
M$T:HN4LZTP-K2F^-28H ^JZ3(2>0&H0.GF(>S "/#**=6%,HEA!C$;FUAAWD
M7]IGN@6(15/5C!&TWQTH7"==X$L91YOTS%NSGPP%K.8">6WJ+:J!'A(+#@3Q
M142@ KH1G6W:'PJ&GW;G]76 ^S08ZKE;:Q'83SG_ !G8D# ^EI >UR\22=9>
M?&FS!C8_6M*AQB)N%5+?%5J&"L&1H7-$TX%*XHNH)=G 03K6_?/"[,(@0'_X
M;9\F* JPXMXGY0G(C5]F>*WUR RWP(',2XAH&$>$@M5OS['!_<;G7*70YOE$
M+0)9( ZWJO&-(2B;X&_@,_#&SY3*=1>Y]OAX7?R1GC]OWRPAJ.NKYY!F" 2Q
M!$TCD3S^.-]VVK1R_M<;A ?="']?S6_\_';YL,=(-#&+MQF9<H>81M<E :RJ
M)N/J2F %M:U49NY' \K9A>XZ6LDE7RP!YBZ6#:_5.B.7H2HGBCU[L&A,)DE)
M[.:S=<S,MWJD6+)-L1<&;- NF&DYGH(B3PRXS@GYS1$92D^R:*4\O6B5X0J8
M$=G7H5*T^Y$+;%S4#PKJWPJ4R]$)L/5:JN@*YXBN?2+\S0,>9B $*_0>'EK=
MREH[HFZKA=U!9M4T @*$:I3,XCWU^$>J#S7Z!P19LY7^Z1 6J=="RHNJN4;E
MN]QUB<8Y!;.8ND9=S3M?)2KT<LN7N+/CE'C4#/0&OY" /VANQ'92E61]HP**
M6/ 55_F4M#8E;NB^'F&2!EC@J'4VS!;X@BT%&=4\FH)\:90G,KKR\(_C=Y@J
M2P<1P&/F>#!6'Q*6F ;50<^++JA6H8^_3*X908B8(^02^##BY,-#F,#*IH,6
M>F^"MCB!SK0-M16\X?-"W"JI )8,BUQ"-OS0&P^CG^8XN^='X,Q9FT1_BHER
MFF+RS 6A "[25J[>;H*>"+T2DV8WITY!RU=94X'E#H4 MISB&0I<C@6O *G4
MVXHVB',;X@'&&[@-:&AX61%A#.2J=0/N@T$PKJR7B71*"[PE#5UU\FI3TI@9
MI5S9A;-@I-'*UTJ'TUWP4 -AA(X4DRE1<;5_2.KF.U$H9IFC?%L<BRMCM7)#
M:[<E&EJIIF55.P/#[\.F*@?M^3_@-OT=NZ9W+I^//@>R&+50.RXK:I^_#@0X
MC*4#Q0M_#(47B%3@Q4FI$[ZZ5'YE+H1E"U,C1>HKFKPDCFP$(='  1/A(ZQ4
MK&&>UN7BEWMN)DEG%H,4*45L 6+4\_/$/<E K,[;YN,8>,C@4R9KQ50SF,@\
M!LI@;G"0)QY-N!.<Q^MF'S-.V 2HAW-5?T7?BLRH8\0S'@ R1CH0Y !0:!U^
M5/YASP]9J(QLF>46$V%2W]=Q'[Q3?548J=>2 /-%M[+T $H><P!^A/E5\\KF
MI3Q0@@'$034PQ-3*JJ.'7>(%Y*%2Q3H4S&J:M X:N?W)F#<=!NW%!70AE9N*
M4 =W%<5K=[:U>X.ZL_\ 8MS4N :)R+*7T.D3)9##P,'JN;W+'!*>]\F R,)J
M*#,;YF5>!R7P+=\Q-$[M-I7O)B SUX$/*W"$8G"B-+75C,V0;F4W47Q_0OH_
MYRLP;U((*P#IA1"^ * $8E72-D"72!,SAFC(N*?WS@RGJ(Q 4SR8@L 7!Y5!
MH)4.%T",KZ:@ )N7(5&1B:8TI W5MR8L>NGB*X6;LYG!4E#!67BS?6'>S,Z'
MH*5*BBF_M.8;9A9E[!SW\0+0.% <X^T*\2A(P!M \H$0N618$Y$49;'N"J,M
M"^B5"%=ZZR_A=:F17+@%%,QY923,S$BZR!N.=M!5+C1X/^&#&ZOU?5@?8_4'
MMHBC%"F.DO',BK=T+^WUA__:  P# 0 "  ,    0          ''@,.5'LP!
MX    -  <4H "['&XZ*  #K :0     !P &8 &X  PP
M          FYAC5C#I[P)%#\#D9I7%*0!MHQN?W$4 /B$Y,&/PM!2(SPPII>
M(G% '(QC*]                    ?$(NQK&_8^O3(J#(4_A\-?%A[_ *Z!
M\:AARWZ K!Q= 5SP&47+AT!(#V?HE2D                    (%/VI8P1)
M%U]0_10@/+6[,Q!U^@RC5. 5HDVH;Y:ER1:S-4=X-TM%!&34#]]P
M                                " !(           !!
M!P      +^          %4
M                                         0
M
M
M
M                                                   ('
M                , P
M          !'20                     !05@
M (0P                          !(G@                     !_?H
M                     %#F                           Z-@
M               !VP@                     !ON@
M
M!T;.                       "DDDDDDDDJ  !Q70         $DDDDDDD
MDK@  /!H                                       %_P#_ /\ _P#_
M /\ ^   $/P                  "P  -4F         *;;;;;;;;?@  %F
M@              ,        ,  !$ZP         (        "P  ) P
M     ,?_ /\ _P#_ /\ _H   Y-               P        P  $5,
M       @        +  $=N          6        4  '370
M  P        P               @        +               6
M 4   2Y8              P        &               @        EDDD
MDDDDD@      6        4                    P        P
M       @        +DDDDDDDD@      6        ?DDDDDDDDD
M  P        P               @        /               6
M I        $           P        P               @        /
M            6        I        $           P        P
M       @        /               6        I        $
M  P        P               @        /               6
M I        $           P        P               @        /
M            6        I        $           P        P
M       @        /               6        I        $
M  P        P               @        /               6
M I        $           P        P               @        /
M            6        I        $           P        P
M       @        /               6        I        $
M  P        P               @        /               6
M I        $       #)))"222222221)))))))))))))))2222222220)))
M))))))))))))X22222222N))))))))-)))    !)))"22222222A))))))))
MI))))))R222222221))))))))-))))))"222222221))))))))))))X
M
M                             %ZD%                     #AT6
M                    FFUP                         #20C
M               /F;X                    %#\@@
M         #R!6                      ?X9H                    !
M'<4X                         &Z(,                     &8OO8
M                   '9HL@
M
M
M
M
M     $3!]G %       H P
M                        #)GF$8O/QZ"7 $$=@X^B65VYV
M                                            "W8\=#P=6U_&   =
M6;Y-UL2#K
M    %]"QN2AZ0G@W $D49E7VN8B*<
M                                            #  #H
M                _\0 +A$!  $"!0(& P$! 0$! 0$  1$ (3%!46'PP>%Q
M@9&AT?% 4+$0(#!@<("0_]H " $# 0$_$/Q!0A8)%5&:UX AF5A$+TJQ*+=
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MF9!HVOG5TU&1K@C<CV:60*&);!C09MI-,[TD EF7Q)BVF%*!!"R801PRUZ(
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M^,4'@8:%<Z1>U8?!_%<UHKDM%<+?_/"?-H,5M'O'IH4D$! #+<?+!GPH%V3
M%0A4LRAK<QUIR&"4Q2PPO;7PBA],!XM*@*ZX$JZYQ65R0 ! BQ>RWQO5K6-
M XP84&YI"M'Z$P$ D@,O"B18&&$8=&,&L#X/\K@-'_)<7EC0&Z1F-$D[7O\
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MZ5:8!V9HN_P\O\(EG-4AMRL8MY_PD9$)Q4172U.$#AI8'/6A-P"EQF"1EK2
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MC[:C[:C[:C[:C[:C[:C[:C[:C[:C[:C[:C[:C[:C[:C[:@9.B&DQCB!_V")
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M@^6>AXTOM@HV.0S&6?A;*'OT0A4F+B+&7:FC+$@9#CA$<M:C@88/B<?7[O\
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M7WW:OONU??=J^^[5]]VK[[M7WW:OONU??=J^^[5]]VK[[M7WW:F-SB,>Q0:
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M23TKZ'6;44D$0Y1QIY4'%!-]PY!31>Q072C@]@ ?4K=3B)_G(-*! !8 @/\
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M=GXXU+"LV!\0QG.>M0::N(E=_'_LDI+&&+DQSSRIRK"QLQ:Y:D+1+.LS>BL
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MI!38;XQAO2RQV=800H8%";%*P&3@$B=TE$<P6M4H$.D>O:QG(PD3%0>#G+9
M77*PL;4:I(V;@*>U/3JEF%"][+8\Z?.'B%%I(7DN_-*O HS$';-E[E%V$DL
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M.J7K!$66:P1 L$L11Y:GF84H WE@Q1)X,D6J"[).O)EIRMH$Q]=0JN5^E;'
M])+'B8 L,F0>.RRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRR
MRRRRRRRRRRRRRRR=,"4P#,8%2AO/]99994BR"?,@B@W$N4'@0"L8BH(6DO%L
M?4RRRRRRRRRRRRRRRRRRRRRRRRDR $I 4)@0VO4P52'_ !-ZK[B86D J?KB(
MJ HDJ*,GU$LLLLLLLLLLLLLLLLLLLLLLJYO:0:DPP"U47_.)++++++++++++
M* ;=DT@F,(6$N2T6<8Q(0F(7NL7M3.JJ4RL7M ;!]-++++++++++++++++++
M++*L#8H.VM,F2PL9D W$F3)0Y+ ("   %@  L?\ @^3)DR9,F3)DR9,F3)DR
M9,F3)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR9,F3
M)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR9,F3)DR9
M,F3)DR9,F3)DR9,F3)]1DR9,F3)DR9,F3)DR9,F3)DR9,F3(HM)=F EX0!*K
M &G_ -[@N!>A/B$NP&8%C73C^0Q$<*0/1UQ_M1(R@%IRQ-.AV+&0Q,60<9Z9
M_AZYD@4G)?J'K%0-L 3D3C;2<;9OX:@7% '+3<21%Q)AMK)S(2(5WC=IB&UQ
MT@EA<&.M!J!BA$EF=>?U$>(HF1.OC!DJ\(B%DOYY;8Z-%Z!4;Q,IHBTXS/E4
M;5PADGK01,& $3-G1M[4!,P)5B&(+VC:WF^'$2&B#.#>UF+^6TR-& 9& 8P'
MG?I:U3N#(2OV_P"XIZM0G)L.<WB]K&IB+%D@G:QK+)^)\/8D.BX6U_*,_HG<
M<@8R\4980'Y4G5H9[-<0QI </_:2%-E/1CQ<."-A@]*3I(W*2=OQMI0E)2,R
M=9SE=?3%.Y %QB+7Q-WTAHEA*,0\.E,*4RE,BE;3:=3VH$P)%$I,X?-[S<64
MNME(O;T[BH4;4,JN9GAV_?ARCL,4NFK[%$Y &26Q9W.(G3>2H$ &<PNF?U24
MD0!OBF[60LI$GI!K#_XXB$0,B9&EP!+)";=_EIQ :6V0;L7/*,6HMD@-I"Z=
M=2"B62H&DK>E%4(%4-B<>(*CX)/ ,UPV?HEJU:M6K5JU:M6K5JU:M6H=@ 5<
M27!L0O[H@%5@"ZK4E 4&W$;27Q.TT=$J$IX:%+H_.FM(&\T?.GTJ&R.(<2%4
MQ!&OT7MRY<N7+ERY<N7+ERY<N5IOE+@;(""4)UKW0"DHXDM_>%P+_$+@FH=G
MT?\ 41(!B2:MHOSFNQ/S78GYKL3\UV)^:[$_-=B?FNQ/S78GYKL3\UV)^:[$
M_-=B?FNQ/S78GYKL3\UV)^:[$_-#"Q-JD\J_WC D$G<1V=J9B+,HD- '+A T
MYJ6RBPC:^^#:[O-#9* "<KMYT(4D2LLI-]2_;;Z7NF_ZKE?D,H65N7'.+K6>
M,.BLQ&<SS11 D"B#UYXHKGDHO!B$U]I-Z2(A) T)M])+O09CI8+L&:0SV7-=
MI?FNTOS7:7YKM+\UVE^:[2_-=I?FNTOS7:7YKM+\UVE^:[2_-=I?FNTOS7:7
MYKM+\T(P7.[-*NB[+LF/[S*V0H#S6@@W4!.'F@5 NK ;K43J$@4&"9!^V:=.
M1")"/UV/NN^B]]_?+!9A)I(/L]-ZE($#M,VF^9Q:_6A$K=DNY8AO=R[F+T3"
M!,B0B<3G&DTRF21P.-O#J7*_FH8," )F5B9/U4$( 36LT0!I>^N]( *F!#F8
MZT<- 1YAO>^OK>?I=8"8P&&0(^E(EWWU:R5N2MR5N2MR5N2MR5N2MR5N2MR5
MN2MR5N2MR5N2MHYNGM T0!AP #T_O*VI B&RIWU@2A\T)BRT++:\-"&DN3I^
ML\-ZD\*#""D>G9FL/E@@G>.[1U?K<?==]%[[_!D8.$1*(IU6.4;O5J4@["OU
MO?S\0I<K^"Y"P(&CRZMZD$,2PAHWVMQ3BS) @*8G)F^G2G$066>#OV^F^9/5
M^_T/NJ[#L_V(DG$D]-:@WA! !%S4M-(!)9DA+%[6PNAOFC<&+)DB%V,;?;>I
M^T L&]B-3.GVJ0 P)"%,XS>;_78^Z[Z+WW^I]+E?^9/5^_T/NJ[#L_W4F6S*
M)ZGGW>CR\E*89FWGC:IY$KC!M4 F,0*Q:QQ;%*JJRK*N5W?KL?==]$:MN+"2
M(-Z)U9YQXC2'MC6N)!.)="FD@+B,B*".R7\ ^9/5^_T/NJ[#L^$X^Z[Z+N6_
MQ*DT<8<I1[+P#YD]7[_0B'N"D'+(Y6]!E8Y\)Q]UWT7<M_B=+)[+P#YD]7[_
M $/8<-=XW^$X^Z[Z+N6_Q.ED]EX!\R>K]_H>PX:[QO\ "<?==]%W+?XG2R>R
M\ ^9/5^_T/8<-=XW^$X^Z[Z+N6_Q.ED]EX!\R>K]_H>PX:[QO\)Q]UWT7<M_
MB=+)[+P#YD]7[_0]APUWC?X3C[KOHNY;_$Z63V7@'S)ZOW^A[#AKO&_PG'W7
M?1=RW^)TLGLO /F3U?O]#V'#7>-_A./NN^B[EO\ $Z63V7@'S)ZOW^A[#AKO
M&_PG'W7?1=RW^)TLGLO /F3U?O\ 0]APUWC?X3C[KOHNY;_$Z63V7@'S)ZOW
M^A[#AKO&_P "FIH78BT]6NP/W78'[KL#]UV!^Z[ _==@?N@&2F)"R(6V9OC,
M?0NW;MV[=NW;MV[=NW;MV[(&^2=6  #K7=%=T5W17=%=T5W17=%=T5W17=%=
MT5W17=%=T5W17=%=T5N/R1[[\NP/W78'[KL#]UV!^Z[ _==@?NNP/W78'[KL
M#]UV!^Z[ _==@?NNP/W0/#&*Z((1#+!IGZ)V[=NW;MV[=NW;MV[=NW9* JB!
M0 KJVHI,4-E=T5W17=%=T5W17=%=T5W17=%=T5W17=%=T5W17=%=T5W16[Y$
M/YKL#]UV!^Z[ _==@?NNP/W78'[KL#]UV!^Z[ _==@?NNP/W78'[HIQ 4@A!
ML$6&*97??7^ANW;MV[=NW;MV[=NW;MV!B)+C-^FD.%R24-85((-=T5W17=%=
MT5W17=%=T5W17=%=T5W17=%=T5W17=%=T5W17*\D?SW;>NP/W78'[KL#]UV!
M^Z[ _==@?NG88<Q;7I_AN"3IZ_>OGJ^>KYZOGJ^>J;]U&0H9N+W"URJ7*I<J
MERJ7*I<JERJ7*I<JERJ7*I<JERJ7*I<JERJ7*I*)!D ?8-?-;U\]7SU?/5\]
M7SU?/5\]7SU?/5\]7SU?/5\]7SU?/5\]7S5?/5\]7SU?/5\]7SU?/5\]7SU?
M/5\]7SU?/5/+$YLI]#7*I<JERJ7*I<JERJ7*I<JERJ7*I<JERJ7*I<JERJ7*
MI<JEEU"&!MY4^6KYZOGJ^>KYZOGJ^>KYZOGJ^>KYZOGJ^>KYZOGJ^>KYZOGJ
M^>KYZOGJ^>KYZOGJ^>KYZOGJ^>KYZOGJ^>H$ ,-GV1*Y5+E4N52Y5+E4N52Y
M5+E4N52Y5+E4N52Y5+E4N52Y5+E4N525D'>?U7SU?/5\]7SU?/5\]7SU?/5\
M]7SU?/5\]7SU?/5\]7SU?/5\]7SU?/5\]7SU?/5\]2*4KNY_\_?)A&W+L4P@
MB<B.F7TYIW(C)8.K^*#6PF']?FG!"X$@4T#GO), Q7@+#$D7:E0B!4,]&'PQ
MXF,'YIZ74$O4=X:4ZT38'*Z\9H\V,;B]^M.!2(M!.QN\9H$D<N@TBK,BP,2L
MO[_]V,-0B.1+/A9IJ !E6I1F"6*!$K&;0Z=8H2N2$QE$[ UJ'!Q2F6SW[5/7
M<@P'Q3Y9P#(]^=1VI@H;)M-*&SA\5 <729#AZW\BAO00=ED$(6)R?JA5+)1P
MDV'2R'-),)+2+K$KR'GS5QXM$A1RQG_F] *)1@@BQSOO4/Y@""T(1YQT\,+(
M@@MPC%]+>OF3+MN.RI]FG<6H#8<!=[-KAQ4&R2TBTQT]#H4//$GR)COVA"AP
MUA09$<<Z/-3*0H%CVBQ&+?LBB0(&%,(R^OA:) Y 3?1.:7*070&ZV_VIE)=9
M%DP)9O\ ,,31BSPREQTC7RNU"*. ARMMV9^P%*Y %J(WO)$''E1:XF,!& B5
MM.O6B"H*R)F4\YWSXJ--D%NV8G=*1E="" 2K;K9UUO0!J\=" Z+]MBUZ&Z)@
M(O5P.8Q)-"F]RD2PLN4OIKJ$H""VB5KP1D"_<%>__!X85:"B[8RA*:??TFJ2
MB P+KSW:*,M"\4N"X]-)]ZE)&"S.,L1GN] 1868!)83KOZ1R& %%*)@!T'\N
MM,QQDL&&)+I,[:-BB9"Y89F7,\^%Y)%=V-7KM0J*!@(@DRN9+&6Q0@@QN,,<
M3KUTJ-4B@77A"S$Q?&:-*PMV+BC@+'FX*20%261L!>X,-]/.B0,:JC([QLYF
M[%)*B)01A,NZW\5<5IS))ZU,);1$E".?6N:5*/M2(H&)3%#@"P(!Y5$6[$EC
MI2:D<)D.AX8DK#E44L1;2(EAG]OJU)ZLHQ-YO2 P.)*'E1 XL" =*>%A09$=
MS9KYM4V*RDOKX7- &HP_Q;F9-]YWHT/-$?NUJ**("M6=2$]*<,F@H.2$AIPZ
MX5R__AL,2,1,B;9VI$81'9(?1I6$68":1%$A+(Y'9H%0"K@!7T*@![I?PD$K
M"H/X^V QZ^7\7UHV,?YY"2%V"?Z-[RQI_B3"!840WU_W4J.)0TT%N$M)08UC
MS]*T:VN@T9:84%A-Z-7L&>A)KN^=Z&+C9&)TP>AKM5@@4,+AY_\ =J!T4AP@
MU(:$;5!3#,21@ZP]#6FD0H !&I(-./\ E3O%4JQE:;EVY,\Z-20F(6%TAC\K
ME'%)(HDER#0AR1%D2@9GT^XR);V_-%8@3+HKM]9WG%J)62* KB?UYVJ, @K$
M'$YQ1,4RWHD!Y>O"TE0@D VQZW:OH6VF)WNS^SI4+ZI<@0.?7BAZ!)A=$DN*
M!P(3=(Z_W@H@Q(,,,/E-,K PCSY+!?;WA,,,WIC:8B=?O8?GH;=XOY8;T!,5
MD2::]2^(YUG<H--<3^:ULM0"M^]J7)36R^K?V:=8U(N6)N3;3?\ =2IQPLW8
M>G&#>[4RPZ!.LXB4/>FD% HL,H!,MY<33("@09!%O?BD)R1Y:XOBF=!!"X%[
MYDO-KWS-(5!.HZ.KU]:+$A/B0YZ4L2>,(SK]Z!:MRU,DS!Z<,-2JC)),,;?[
MC]D=3[_QK<"B(&4+7;;]VPG(!$D"AP3Y4!:0LEU"[%Y[&H*X#NE(&=X[UAAL
MB,R!!8]_)<-CTR8NB+Q>>: TCA8L)B9+\3YUD)J(O 25;0QI;V*3X7A&(VMV
M8I H(3['UF';-#N  TM+Q>[QG,7FE4NTGDA;0\]ZEV(N;2R3&\X\NBOROXAI
M.LWUQ-:](KF-&_DT[F0)"Y1TTMF@A(%QM,_JIA1!(8&Y,Z7-ZX*":%SC6+SY
M9:/50C,\V9C0_P 'F-*+$=T/M18P @IT=ZAG2+*<R7O$/;Q"(G,+UY&(6^8.
MVB0J$$"6Q_WSOY)$B2@E_(QQ^*'-Q+1*98Y_[%2?7D9R*3&<^?-J&(L)@E$*
M%IMZ:TV)!!-M\<;:ZTZ<L/8EI,G_ #RIH[+P;!_R,WJ?98D,2R\P7\N*:4!4
MD78CK,.GV;,8:+*B1SO?/X$ONSV!1(8F]II3K*D:C)ISY;4NR;6B"<SD="DP
M(N"&'F7/Y_W"\*\TV(@G V-*B[[WK"B>Y@;0T%K5;$0;@ /Q1^HR D^=JS54
MNQP<49L&!,=.^::PC)R\KU+3<A(DWB#;T:AEWS*EBA4!!;9'1GBF2E%3JN6H
M8DDS+/?<5+*8WV&FG>E) 2EG7CS&:NL#$OL_7RTJ -T#6;=]I%5(($ QIZN:
M/L&$ESQ;2T>]!42I@_\ .](H< ( !BQ![4*QX&79&WK;2AC$& @..G]RA%5S
MH.I::'NXFY)5MY]*"X0(Y#BWYH@R*3$GC;OK1BCQ"QR6_/G5^(B$D[WFF:)!
MLX+%L>E*-1#A)D-%M;6@PY!GRG!Y6J:?)D"_6VQJ/M<80 &,6Q[6I!PO+%W5
MT?>+:TB&4KYLT9 :46\T%SK0PR9+E6[R)E#?F:L1-35.?0IK'%LF"9"7T.RC
M/[4,+HG?C)>U+9P@"XO$NL6C3VC_ ,78]PN61,FL3[_V#+:RD:(X1*ER"$AM
M'!XQ_\0 +A ! 0 " 0,"! 8# 0$! 0   1$ (3%!4?!0P4!AT?$0('&!H;$P
M8)%PX8"0_]H " $!  $_$/A&BT9W)J2*Y,@8L_O.EL;=FJ",<@+K@'5IJ&+Z
M5*D(\SU+V;Z(HI7A6"DE38PJ(;6_@YOEO7#RJKQ8Q VZ-9!C"PNP0G.I#MX)
M@Q$ B<?=YF:G=\0+D3!^1 G5Y,(7)74*^!I<'(%800LT8Y<#E-D6<,# .'=&
MZ($Q23-8L=CBM$$>"LR  !L& 7^ABR S0HX-<_BZ*0$Q22Z+7N=,W@W $8PC
M09&/;_"J6T+II"\/5(& A;:W(GP)";AO"NM"HZFP2.P =_EG!$FP=4D"%$)@
MZRY='KQX1!1R[H [^KZ(K$"ZP*,0V"(.H-FW<)BINC$U/A0CN7\DE92(BO(F
MFS#)AI7!>+#,06VI6X*/SMTE&903(**65L79D>PF(A,N.41#A $@%ADJH'"
MC^XCA[NF1ZJNUX7>/_\ ^)]=P.0+QCB+JDF@'J  *N3%2[%OK,#E#181D!9P
MH-Q:H 2"H"%D<>5=P$V7)6Z"G(A"*FM.Y^8@J9OCK1 D*'75PET%T8=\P X-
M()4BBC=,X$45_ -7O ;*4$6!U=&]8D-,1O\ *IP=5UA.42<T8PM"H7_*%Q"Y
MK&QU0QVN5R8>951"(Z $7\C7OTEQ)J)YFOYO[^5HA%95A^GY6WA.A2@+%E>!
MKK"?\CZ(B95YC^9U+H3C"#E  J@8_P":M/'QZ*0"O8&</69(BNVH/K"8G).I
MA)'1+K*-B_A?:,T2E' WFR=.,_1!/EDL&CHO-*2 '^@=I*? HR"4&JP3#2S
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MA$_*\7W>@(L'F^_X,O\ SS^CT ALGX+L^!_D?[/7")^5XON] 18/-]_P9?\
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M]U@>>MB;&\8B#XXT0T[A+D'CLI@Q%":?TP]24-)A 4*MZY5GDQPO*JNHE-1
M.A!5+= *:Z7CJ@SRI@+SM=%WMRS3AC"35@ HAO4KXK'H=0<W>Z[6N!600*A.
M6A00_1Q)A,R(&I$UO"EGHX02.AX/;IAC$-0"C10J'5<DDJ:57H$B6)IPBK:B
MDYH,'2*.+ 'L>.D*0!9BP&B"]NH/M!6MQR@$. ;XC>A.;@ZR2$-LH7B O.&;
M;*A3VV@!.Q_XP,D[%B!DLUM_/\R\L88TQNF@.2.\4HO&"IXT)&=)G''J_P#_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>business3a.jpg
<TEXT>
begin 644 business3a.jpg
M_]C_X  02D9)1@ ! 0( .P [  #_X0TH17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     P   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   "=!   %
M )T$   4    1TE-4" R+C$P+C(R   R,#(T.C Q.C(S(#$R.C,U.C Q  $
M : #  $    !          @   $$  $      0   0$$  $    [     @$#
M  ,    , 0   P$#  $    &    !@$#  $    &    %0$#  $    #
M 0($  $    2 0   @($  $    .#         @ "  ( /_8_^  $$I&248
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M<5]?GY_>>4ZMC^V;['3[1)_Z$:]'^#2@MK60#Q!U_P"VE<A<^&&ENI9%UG1
MKN6&;],X)KH/"5FFAF[\[6]+'G;,>3?Q]MW7)'K7#2C%U+-V1S0J<D^<]J2*
MU-NY<D2_PJ!P?T^M>;_%]0/#-E@ ?Z8.@_V'I_\ :EK_ -!RS_\ !A%_\76%
MXJBBUK3H;>'6]-+)*'/G7\>,8([,?6NJI2I*#:FFS:>+YXN-MSS.OH<>*<*!
M]C[?\]?_ *U>+_\ "*2?]!K0_P#P/2O2/MFE=M3T_'_7]#_\52P7L?>]KY'.
MJDH?"=#_ ,)3_P!.?_D7_P"M7A'B"7S_ !)JDVW;YEY*V,YQER:]5^V:7_T$
MM/\ _ Z'_P"*K@=1\-FZU.[N(M9T4)+,[J&OTS@DD9JL9[#E7L@=6<_B9R]7
M[._@M8=CV,<S;LEGP?PZ?UJA17 G835R6XF2:0,D2Q@*!A>Y]:BHHI /A=8Y
MD=TWJIR5]?:M&;5;:6)T738$+*5# #(/KTK+HIIM"L%%%%(9=L[V"VA9)+..
M9BV=SXX'ITJ&[G2XFWQP)"H&-JU!13OT%;J%.1@LBL5W $$CUIM6;1V1)F4X
M(7(/I3BKNPRX=5MBK*-,@ (P#@9'Z?2LJNZL%5TD5U##S9N"/]L_XU7T+F"^
M0@8-T3TYZ>O6M.1O=F:DM3C:N65Y#:JWF6B3DGC?C _2NH11_P (ZS8&Y+7<
MI]#MJI8NP\/0XP"L<I! P<[O6B-+5Z[(?-=&!>74=SLV6T<.W.=@'S9_"JM=
MEKP T>5@!N^49QSC-7KUR]CHJD+@6-N.% /4=Q4N&HXN\7+L>?UK_P!L6@QC
M2K?@8YQ_\36IXI15LP0H!\\#/MAJU-1<MJ;-P"6[ #HB^E)+WK(:2E2]IYK\
M;_Y' 45T/BI562U"J!E6/'X5SU2U9V!.ZN6[&[BM"YEM4GW8P'QQ^8-)>74=
MR5\NV2$ D_+CG@<< >A_.JM%%W:P6UN%%%%(9JIJMHJ;3I<+=.3C/_H-9CL'
MD9@H4$DX':FT4V[B22"K5C=16LC-+:I/D<!^WZ&JM%(;5R[>WT-U&%BLHH#N
MSE<>G3H*I444-W!*Q__9_^$.H6AT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"\ /#]X<&%C:V5T(&)E9VEN/2+ON[\B(&ED/2)7-4TP37!#96AI2'IR95-Z
M3E1C>FMC.60B/SX@/'@Z>&UP;65T82!X;6QN<SIX/2)A9&]B93IN<SIM971A
M+R(@>#IX;7!T:STB6$U0($-O<F4@-"XT+C M17AI=C(B/B \<F1F.E)$1B!X
M;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y
M;G1A>"UN<R,B/B \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(B!X;6QN
M<SII<'1C17AT/2)H='1P.B\O:7!T8RYO<F<O<W1D+TEP=&,T>&UP17AT+S(P
M,#@M,#(M,CDO(B!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+VUM+R(@>&UL;G,Z<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"]S5'EP92]297-O=7)C945V96YT(R(@>&UL;G,Z<&QU<STB:'1T
M<#HO+VYS+G5S97!L=7,N;W)G+VQD9B]X;7 O,2XP+R(@>&UL;G,Z1TE-4#TB
M:'1T<#HO+W=W=RYG:6UP+F]R9R]X;7 O(B!X;6QN<SID8STB:'1T<#HO+W!U
M<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B('AM;&YS.GAM<#TB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87 O,2XP+R(@>&UP34TZ1&]C=6UE;G1)1#TB9VEM<#ID
M;V-I9#IG:6UP.F$Q.6(V9CDT+3AD-#8M-&)E-BUA,#$P+3=A9&(V8F4U,C$Q
M8R(@>&UP34TZ26YS=&%N8V5)1#TB>&UP+FEI9#IE8C0V8C!E."UC-C,R+30W
M83<M83)C82TY-SDR83)C.6$V8SDB('AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)
M1#TB>&UP+F1I9#HP-S<T,C@W,RUC,S$S+30V,C4M83-A."TW-S<X-V8X-S8R
M,3(B($=)35 Z05!)/2(R+C B($=)35 Z4&QA=&9O<FT](E=I;F1O=W,B($=)
M35 Z5&EM95-T86UP/2(Q-S V,#,T.3 T,C X.3DX(B!'24U0.E9E<G-I;VX]
M(C(N,3 N,C(B(&1C.D9O<FUA=#TB:6UA9V4O:G!E9R(@>&UP.D-R96%T;W)4
M;V]L/2)'24U0(#(N,3 B/B \:7!T8T5X=#I,;V-A=&EO;D-R96%T960^(#QR
M9&8Z0F%G+SX@/"]I<'1C17AT.DQO8V%T:6]N0W)E871E9#X@/&EP=&-%>'0Z
M3&]C871I;VY3:&]W;CX@/')D9CI"86<O/B \+VEP=&-%>'0Z3&]C871I;VY3
M:&]W;CX@/&EP=&-%>'0Z07)T=V]R:T]R3V)J96-T/B \<F1F.D)A9R\^(#PO
M:7!T8T5X=#I!<G1W;W)K3W)/8FIE8W0^(#QI<'1C17AT.E)E9VES=')Y260^
M(#QR9&8Z0F%G+SX@/"]I<'1C17AT.E)E9VES=')Y260^(#QX;7!-33I(:7-T
M;W)Y/B \<F1F.E-E<3X@/')D9CIL:2!S=$5V=#IA8W1I;VX](G-A=F5D(B!S
M=$5V=#IC:&%N9V5D/2(O(B!S=$5V=#II;G-T86YC94E$/2)X;7 N:6ED.F$V
M8C-E9C8Y+6(W,# M-&4S,"TX-#4R+6$S96-A.39A8V$W92(@<W1%=G0Z<V]F
M='=A<F5!9V5N=#TB1VEM<" R+C$P("A7:6YD;W=S*2(@<W1%=G0Z=VAE;CTB
M,C R-"TP,2TR,U0Q,CHS-3HP-"(O/B \+W)D9CI397$^(#PO>&UP34TZ2&ES
M=&]R>3X@/'!L=7,Z26UA9V53=7!P;&EE<CX@/')D9CI397$O/B \+W!L=7,Z
M26UA9V53=7!P;&EE<CX@/'!L=7,Z26UA9V5#<F5A=&]R/B \<F1F.E-E<2\^
M(#PO<&QU<SI);6%G94-R96%T;W(^(#QP;'5S.D-O<'ER:6=H=$]W;F5R/B \
M<F1F.E-E<2\^(#PO<&QU<SI#;W!Y<FEG:'1/=VYE<CX@/'!L=7,Z3&EC96YS
M;W(^(#QR9&8Z4V5Q+SX@/"]P;'5S.DQI8V5N<V]R/B \+W)D9CI$97-C<FEP
M=&EO;CX@/"]R9&8Z4D1&/B \+W@Z>&UP;65T83X@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" \/WAP86-K970@96YD/2)W(C\^_^("L$E#0U]04D]&24Q%  $!
M   "H&QC;7,$,   ;6YT<E)'0B!865H@!^@  0 7 !( '0 K86-S<$U31E0
M                                 /;6  $     TRUL8VUS
M                                                       -9&5S
M8P   2    ! 8W!R=    6     V=W1P=    9@    48VAA9    :P    L
M<EA96@   =@    48EA96@   >P    49UA96@   @     4<E120P   A0
M   @9U120P   A0    @8E120P   A0    @8VAR;0   C0    D9&UN9
M E@    D9&UD9    GP    D;6QU8P         !    #&5N55,    D
M' !' $D 30!0 "  8@!U &D ; !T "T :0!N "  <P!2 $< 0FUL=6,
M     0    QE;E53    &@   !P 4 !U &( ; !I &, ( !$ &\ ;0!A &D
M;@  6%E:(        /;6  $     TRUS9C,R       !#$(   7>___S)0
M!Y,  /V0___[H?___:(   /<  # ;EA96B        !OH   ./4   .06%E:
M(        "2?   /A   ML1865H@        8I<  +>'   8V7!A<F$
M  ,    "9F8  /*G   -60  $]    I;8VAR;0       P    "CUP  5'P
M $S-  "9F@  )F<   ]<;6QU8P         !    #&5N55,    (    ' !'
M $D 30!0;6QU8P         !    #&5N55,    (    ' !S %( 1P!"_]L
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M$ ,0   !W^
M     XE2;]GI*I C6R=FZ
M                  ,0K'Q5V-*]_2H
M                          %2M-[W7[7>K  #(+FKV+=-\A
M                                             :YN8^OJ::;Z&  &
M97=!NR[O\V@                                                !
MX.AK''Y4RB,NWI4  #7-S'U]333?0P  S*[H-V7=_FT
M                         !U-:85*/MI7/HR^@    ^)2IE^U'%R%L\>]
M*D)@  :YN8^OJ::;Z&  &97=!NR[O\V@
M              ,4K2#;MN,)QN5CWLBI4         :YN8^OJ::;Z&%@=AY3
MV,L2MFM]A\F97=!NR[O\V@
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MFF^A@ !F5W0;LN[_ #:
M TC<)^E.*6MV.PEB>FESY:7Q=;=_.6P[I?D@ #4=QOWU!F#Z4)YV'EV+6=W%
M^+VPL'L/*=L/8?"( &N;F/KZFFF^A@ !F5W0;LN[_-H
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M15<A+5N<GPF    ,#E&M5ZW+5N4[V[@   TC<)^E.*6MV  +K;OYRV'=+\D
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M!*V%I/2E%^;N19;4\G;[0\& !KZZCU",,S<"1\34]K"Q$>=O1+6#H[]<SYF
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MZ/TV'9L0 !??SS,V>>39X &DCW[5UXZ>T  +,\G>W2^#;, #5YZEKZ-=UA@
M#.,*6_#P#= ?#*/ %'/3,3I<F@  FCG+ME>-O@ 53Z_&P'8P  &;X$[9\=D@
M 5VZJS"O06@ !VME=[SO+  BS<78%Z&\  .1;GBL7LK= !$V9375U-H  #8M
MRUV6,.H Z>;7!VV-XH  %N>>O3_J)@ :O.QL]!=  "SFGE<;0W  *(=78C;-
MB  )4P)WDY:\ !4GH+5?=Q;  '?VJ[&>,R![#[8R  P:4?JHYU<Z5RFE0
M,'E'Z:5[$ZJM,SC(   #$)1]!VU*XO*,D0F   !T-:=/6GO/69E&7D   '7J
M8S*GM/499&OU*@  #B85*/PGW'>TKW5*@   8/*/(]IVE*][2H   &$2C]!\
MQY,WC(   #%*T^2M/2?09I&0   '@K!>LX9)]RDE0G/=JX   !6*]:P^L<NI
M+&I4N)CW@   (-N6XMG'W$PVYR["8   $;SA ]R&)RCWM*W!Q[WW*@  #%:Q
MJM?M=O2O@FFW.5(3   'SE4+]G$94[J-9BA.:;<P   *P7K4=2C*T)_<6 M7
M    *RWK6"RCE\9?46;LW0   (7N0BB<,3E&283M%9N@   #UG(\G@Y    '
MK.1Y/!R    . .0/(   !Q/!Y!R    /!Q/)X.8   !X.!Y!R/(   !ZSR#D
M>0   #UG(X@]@   !P!X.1R
M                                              -4_7VKQ\K7/82K
MM=M_-6DVVKDNPG17O,.=^)R,DA6N]VWE-)2K"4LVYZ]/7<6Q7D][,8UKM=MR
M5">;QK)D;T#[7J<;P.-DVW.!KMN082D&,I LYU6-1[IV?0?/>>1K%$X]S1.5
MNYFT9                                          0-GQE/">^E<)E
M'%94E"W/+Z5BO;6O.LEE<985*/0RI)\)99&4/]%;[;02[^-<*E'YJTD"$\DI
M+%<C/ZBUK>XBPR5/EK2183[^-W!,;JODS>.[:E<8K3K*TEVW/M%0
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M=&;5Z@NT(PKUNS4-AK@N&#EJSIVT['7,2L9K095^S=YP2X=7!"2C%F;"W)<
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MUQ'[/FU^UQ._WTK^LH;9>AT]C4]^&T_06-G>OV*WF_R].OJZ(_5:[7L<N_\
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M.DDY@O2!+6O)5,875/3 JU/7$(\UCPZV&+#BQ8:BM*5'ZF8AGIRX#R6!KO\
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M*@*9Z='4PH&V)._HMB%*UT6!!T=2Q"M*VQ"M*Z+ @Z+ @UH:TR/=ZD5 :;5
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MS^+90K:J (H:99VPYZ3IT;EB*YZ"-T:;81PZ:UWR<L[:F.'04C/0#;1_VO\
M_\0 6A$  0(# P(-#P<*!00!!0   0(#  01!1(A,4$3%18@(E%487&3H='2
M!A 4,#(S-%5B<X&2E++3%T)24Y&S\ <C5F!C@Z*QP>$U0W6TPE!T@J- )'*
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M#3*W%71H(JJZDT%1CKI21E)]:VYMD/(0B^E)4M-%7@FNP4G,8U.6)N!'&O\
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M.T!]@I -"",HQ$.34PZDH<=4I)R@TS8[4)6I-:$X@C*<A@*N[X.!!R&-$-<
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M\9EAIQ^0X#C+J*C#;FYLR[457#4R$\C\9Y%4'$0AY%42$@<$7&S$D43;<$3
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M/@QWLQZ(.;'>S'H@YL=[,>B#FQWLQZ(.;'>S'H@YL=[,>B#FQ (&&@+W1QA
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MVWS;:T]NN#(HHY4(LX$2*F*:49J1!=F1WSE4J6_M$F"3,@FFC-U1;/++;ZX
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M)\5T5,>'J=Z=,>'J=Z=,>'J=Z=,>'J=Z=,>'J=Z=,>'J=Z=, TW6Z>;CA"
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M$N?5*JL6._&@A47XYMP6Y+6@\L=(T2,1.G'ZQK22D.Z:DF>YFI%"]LJXL9^
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M;1^U_P#_V@ , P$  @ #    $
M                    !9
M                    &8
M                  (VVV0
M                  P  ,
M           !&:   &  !@
M    !2@    'K0   P  ,
M    -H          &!G1@
M          222P  P->,
M  )MMM      "  &  !@
M !          0  P  ,
M (!&     #P"  &  !@
M! /     !4 0 !/_ /\ 8                                    "^
M   @!H       (  (  #                              'M     0P
M  $         !  ! 3(8                              4H
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M-MXMMMQMM_;;:MMNMMMQMMMMMNMD  'W     ;$    6Z@    4F    ,F\
M   54     VP    $F@   #5T    1B@    !P    !DD    %^L   #TV@
M  *A     %J    "44    3L     ""           ""     "      "
M "0      0     0"    "
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MT=]?:.^OM'?7VCOI=%0#A6''.F77H]_9KT>_LUZ/?V:]'O[->CW]F@ 7%PG
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M[4K1ZM$  K, "P(=MFS9LV;-.8((0:$ ,!>%G:=]HJE!>P!8 -!VSAPX<.'
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M+!3>?'IM(9]"&C^FB-*1CXC;+/)K2ZB><XB0LS2]Q1H.!PC 32*)F6-4!-[
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M,L55UWY578ZY?.$G'MA<"*V"!J.85@=J7,4(.08$$H>$P,P81&;4I^5N$W[
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DZ?3^\>Q7,\-3/#RGS%H6OD^#,=G3L#$B"P*I$LH51+0_JO_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>business4a.jpg
<TEXT>
begin 644 business4a.jpg
M_]C_X  02D9)1@ ! 0( [ #L  #_X3R.17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     P   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8    C+@  ,@
M ",N   R    1TE-4" R+C$P+C(X   R,#(S.C$Q.C(S(# Q.C$R.C R  $
M : #  $    !          D _@ $  $    !      $$  $      0   0$$
M  $   #P     @$#  ,    8 0   P$#  $    &    !@$#  $    &
M%0$#  $    #     0($  $    > 0   @($  $   !G.P        @ "  (
M /_8_^  $$I&248  0$   $  0  _]L 0P (!@8'!@4(!P<'"0D("@P4#0P+
M"PP9$A,/%!T:'QX=&AP<("0N)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R
M_]L 0P$)"0D,"PP8#0T8,B$<(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R_\  $0@ \ $  P$B  (1 0,1 ?_$
M !\   $% 0$! 0$!           ! @,$!08'" D*"__$ +40  (! P,"! ,%
M!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()
M"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T
M=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%
MQL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$!
M 0$! 0$        ! @,$!08'" D*"__$ +41  (! @0$ P0'!00$  $"=P !
M @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:
M)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#
MA(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3
MU-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ ]KUS7+;0
M[,RRG=*W$40/+G^@]37%:-XUNX-3D;4G,MM.V6P/]5[J/3V_'KUO^)DTR^AU
M6>.-WO+4HIF$I91\X!7&?E(R>"/IGG'(:= EQJ=I#*,QR3(C#.,@L :QFY<Q
M]%EV'PT\-*4E=]?ST/7KJ<-I,]Q!("#"SHZ'_9R"#7EUIJWB6_9EM;J]F*#+
M;"3CZUW=BMK%H>IVUI"\*0>;&49V<9 .2I;M].,YKA_#MS(+._MR(VB C<*\
M:-AC(BY^8$9PQ'/'-%2]T1ED8*G4E%)ZJUUW)_,\8_WM1_6H;J_\5647FW,]
M_%'G&YL@9J\DNZ15,<&"R _N;;N[J?X?11_^HBJU_=R?\([. L2^:]N'*11J
M2"A<CY .-P'O6;]3T8.\DG".ZZ#(-0\1W-J9XM3E('\/F$'J /;DG@9R<&G)
M>>)3-#&^IR1^<VU6,NX#/ SMSP20,UE6QM#9[)KN:.0-NVKG:1D?D1C/3GBI
M9/L&;=A?SN^]?,)W<#/)!Q4W.ATHW:Y%_P" E\7?B=P&2_E9&7<K>>HW+Z\D
M'N/SKI?"GBT:@%L=0<"Z'"2'@2?_ %ZXT?V<R1E[Z96Y4JFXJ@QVR.G;%9*L
M58,I((.01VIJ;B[F=3 T\33<)1L^C2M_PY[Q17'^$O%?V\+87S?Z4!\DG_/0
M?XUT=\]^A4V<<;@(S,KG&XC&%'U&ZNJ,E)71\EB,//#U'3J+4NT50:YOE#A;
M0,0?E(; .,>OU_0TEO=7S/MFM-J[P P/4'/..U,P-"BLHWNIHBYL%=B!G:V,
M>IQ[?7D=.E*+S4OWI-BI592J?-@E?[V/Z=\>] &I15!)[]X"6MTBE);"9W8
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M6(\VU..XF%34BVU97,\KJPC2G&4^5MKSV.TM+6:-+6(6"PPJH615D4@?,PR
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M%S'+ MD(<(O.\R;CUX^[M(Z'.16C10!3L$OHXRM[(DA[.IYZ#V'N<^]7***
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M  C;TP3CGL >YJ*&#62L!DO8&<!O-V# /=<#'X'VZ<U $@U.\$2N=-E.8]Q
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MHHY00,_?S@<9YX/M0!HT55CO[>56:-BX7&2%/?H/UJ(:S9-&DBRDHREMVPX
M!P2?3F@"_15"SUBSOHH)86<K.S(A*$9*YS^JG\J?+JEK#@.[9,AC "DY89S_
M .@G\J +E%41JUJ9%C!?>SE%&T\D=?PY!_&A-6M9)+A%+$VY57^4]3T ]>U
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M-1=S]V:T]/\ @@>PZ)K=KKEBMQ;MAAQ)&3RA]*NW$CQ!"D)E)< @'D#UKAO
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MRVL-12$1%C0*H 4< "N<\;?\@F#_ *[C_P!!:NEJIJ$2RVP#6\<^UP=LD>\
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M))P.3TK/"TH33YD85YRBURGJG_"\+C_H Q?^!)_^)H_X7A<?] &+_P "3_\
M$USUUX4LO[-T^&!E-S.T8CGC60FX+;MP 8CC[A!VC ]<KG)\1&PTW7HAIUHD
M9MFW$%6\N0;MT9&6)(*;<G.#V]3O&E1D[*)FYU4KMG<_\+NN@Q7_ (1]-PSD
M?:3D8Z_PTG_"\+C_ * ,?_@2?_B:Y^VOM?>SGD@T[2YEA:19Y'7:P(Y9CN8=
MRQXXZ]L5'>OXB<36LFFZ?^_S&'4C(Z#@ELKV'/K4^SI7^%?>/GGW_ Z3_A=U
MU_T (_\ P)/_ ,37H?A/Q=8>+--^T6I\N=,">W8Y:,_U'H:\5M[+Q!81- -,
MT\O'M)$CJS$$;,YWXQ\F/K^-53XCU/0KO3IK=([>\@+RLZON$JN5RK#T^0GK
MU;/6E*A"6D%KZCC5E'67Y'TI17/>$?%MCXLTL7%N1'<)@3VY/S1M_4'L:OZG
M#!-+%YE[]FD$4A3D#^Z=V3S\N!T]>>*X9)Q=F=2::NC2HK'8QL'":O&%.6&&
MW;<'@Y+'IAL^^.F.7VUN8FDD_M021QL'89X08R0>>F#GGVZTAFK16)%M=?.7
M7$9&56'/'4'/WNAR/SQ38[8Q0KG7 3NW;R< JIY ^;&!R#0!NT5EF%H@A;5=
MJM)YBEVZH.2HYY&,\U'^Y=YB^KHR/N*C<!L'?!![ ?UH V**R;B)BL.-66%&
MC54;=S(>N>3SGCIS[U&\6+A\:V5#(6";L[<8!;KTR&]AD^@P ;5%9(>*)YT.
MK(6DC81@MGR\#)/7L"N>G;UIDD)VR.VM"-00F0V C9!QRW7'&#ZYH V:*RIP
MLDTKKJZQ!B-JAQ\A49/?TY/YU%)#N$"0ZTD7ER%Y #GS%.6*G+9'!'/7 H V
MJ*R D6&;^U8S&03C?QZ9SNSUXJ.UVVL4/F:VLHRR!^,$E=P[X&!@^GYT ;=%
M91B1$5?[03S'F))+$[P.-H^;/!(_K45L C1,-7CF5I<L2X!9<MM4<G/( ]P#
M0!M45DFW6&.-'U0*B#/7:3MX;G/T'MSZU&!)]BC-QJ<2!IV9)A(1N7:>.>,]
M\=!B@#:HK.@,L>H;)+R)UC@PZEB&)^7YL=,=>?>KZ.DB*Z,K(PRK*<@CU% '
M->(]3@N]$U*UC67?$5^8H=C .H.&Z'GC'7@UQ.E+_P 3BQ_Z^(__ $(5UFK0
M"*S\0$&<^8T+'S&) ^?&%!X XSQZY/6N8TM?^)O9?]=T_P#0A770=J;$STK6
MO^0#J/\ U[2?^@FOF?PU!/<ZR(;4I]H>"9(PQ !)C8=3TZY_"O>[6!TTOQ&B
M(?+?SC$BQ(H^8NW&P?-DG/<_-DG)('SY;0:M872SVT-Y!/&3M=$967MUJL)\
M,D<V(WBST:_T348]#D,DB1R:58R0E,CY<VT6_!'7E7'_  *N%U[4I]1LM(>Y
MVO,+9RTN/F?]ZXY]?NYSW))/)IKWWB62/RWN=5:/!7:SR$8QC&/IQ5%K+4'5
M%:VNF"#:H,;?*,DX'XDG\:Z:<>7=HQG*^R)[.6V_LV^::ZECO<HUO@M\QS\V
M<<9Z<GTK<=O#LDL:'6=0B@4E@ '.-Q(XR.RX'OM/KQS7]GWO_/G<?]^F_P *
MVCJ6H-9M!)HYE;RA&CR1NWEX4+E >%Z \#K^&'-)[,46^J!ETDPSF#5[PNJ%
MU5G*@\9P<@9).%XSZ],@<\SN^-S,V!@9.<"KU[!>7=TTPTV2$$*-D<) & !Z
M=\9^M>@?#WX>27DL>IZI$5C4YCB8?J??^7\E*I&G&[8U"4W9%OX6^#[^WO4U
MJ=Y(!M(6,$C<#_>'?Z?UKU/4!9M-"MRCL[!E0 D YP"#SCTZU<BB2")8XU"H
MHP *AN)IXIHA'!YD;9WL#RO3M^=>94FYRYF=T(*"LC&AN=$-C;301NT$*X@&
M6! W8Z$YZJ!S4\+:=:AF5I\28C*#)"DJ7QQT(&6S_M>].M-3U*XMDDDTUHI&
MDD5D)^X%8KGWR!N&.N<#UJ0W&HQ0W4RV"&38KQQ*0"[\@@MGT5>>V?:H**?V
M;0VB"FV8(D(&YF(*H"6'S9^ISFCSM+%C JP3Q'RC+$H)RO&[KG&>_P#]>M!;
MG42"39J&$6\+N^\^,[<]N>,TR2_U!91&FGESY.\'=@,W=<]NH//TH K2G2!<
M164ZRO+:P.59L\1Y"L<]^<#_ .M21?V5#$JPQRQX0HA!8E0"!QGODK^?UJ\+
MF_,3$VBA]N5PW&1C@]QG/IV/M2)=Z@S19L=H;)?<P^4#D=^IZ>U %.-]+AL+
M>U*3M%%!Y<>[).S&,9!]!^E1P#2%:Z@M[25196Z2%58JN&W$ #/7"#GW'-:4
M4U^;KRY+=?++M^\ST4$[?Q(_SVJ(7NHR%L6.T!0R,3][..,=01R.?8^U %,V
M^C2S^88'::)PV6D8_,<,".>3P"#VQVI]M?:7Y05('412X50"<-SC\\G^N*L_
M:]4,<K?845E4% 6SN8GD<=,>O/K4K7-]NB"67RO&&=BP^1CVQW[_ *4 9WE:
M-9%K&.&0E1C;O<\$ D!B>P*]^ 13(;;1X9H+HV\OF&W;RPW/E1+C<.O^T/4F
MM1I[\6Q86ZM+YH  XRGKUXJ/[7J?EHWV!,DD,-_W??W^GM0!2SHB@S_9V ^S
MA2Y!XCZ =?I^=7&%BHDBD649'VC&X]%4#*D'MQ^8]:/M>J9C)LE4,K%@&W;3
MG Y[^OX^W-^!FEACEDB\N4J-RGDJ>XS0!C3MHTDL<$ENSM;(9%4<A58X/?!Y
MXJ0PZ3:W@E$+&X1L[LDD$CJ<GT-;5% &*8M-6&,2K*6LU506?##/1N#U/.3Z
MTR0:0EA);-')Y"2$["['YBN[CG/0Y_\ U5N%0V,@'!R,TM &3 ^GWUW=1+')
MYDL8$C98;E*X&"#QP3[UIQ1)!$L4:[4484>@I]% ''7ZVD>E:W%;Q1Q2"5&F
M2-BPW&0X.2H.2 #C) [>IYW3%_XFMG_UW3_T(5TFI!Q:^( ^W!DB9")0V5W8
MY'4<AASZ<=..>TW_ )"EI_UW3_T(5T4G[K$=983R16VM;;1;5K;>D+"21]R+
MNVG#H H] I9?0US!UF^)R94)/_3)/\*Z"P""W\3E%(!EE()).[A@2.2,;@PX
M Z$<D&N?T^TBN [NP)0C]WG'4@ ^_) [>Y%332L[C%&JZB4+AAL!P6\E< _E
M2?VQ??\ /5/^_2?X5<\[^-)+?[*ORL?FR,]L;?Z$>N:JWUK D7GQL$)( 3^]
MD Y [<$'\>W2K2780W^V+[_GJG_?I/\ "C^V+[_GJG_?I/\ "HHK6&1V!N40
M#NW_ .NAK6%?+)ND97&3CJO(Z_G^E.T>P$O]L7W_ #U3_OTG^%=9X>UV.^C%
MM*%CN%'  P''J/>N2%C %+&\B/3 4C/3WJL2;>=6BEY7#*Z\$<9_.DX1DM /
M5:*P= U]-006]P0MRH_!_<>]:5]J,=@R"2.5PRLY*(3M5<9)QTZYY]/PKG::
M=F,N453DU.VBW!V*E>HQSVST],C\Q1#J4$W W*=VP[AT.<=?KC\Z0%RBL^UU
M>VNTB*;P9 2 1TQC/\Q3XM4MYFA5 Y,K,HR.A4'/ZJ10!=HK.?6[-&A7<S//
M&\D2A?O!0"WL.".OK4DNIV\+S+)O'E8W?+ZX_P 0* +M%4_[3M?+\S<VW.,[
M3Z _^S#\_K3+C5[:U,@EW QLJN ,X+#(_3)_"@"_15,:G;F0)\^[+#[O0@9/
MZ5';:Q;W+%560'>4&1U(_P ]Z -"BLP:[9FPAO 7\F9B$)7DX;&<?KCKBEAU
MJVFOIK10_F1C=TX('7]2/SH TJ*HC5K46ZS.613!YYR.BXS_ $IO]LVGF*FY
M@S1^8 5Y*XSG\J -"BJ:ZG;/MVECN4L/E/0!3_[,OY_6B+4[:8J$9B6&5!4C
M(SC^?% %RBJ<.J6EPJ-')E'!*MC@@9[_ ('\J8NKVK'"EBV]H\8Q\R_>'X4
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M "T "F%C<W!-4T94                                  #VU@ !
M -,M;&-M<P
M            #61E<V,   $@    0&-P<G0   %@    -G=T<'0   &8
M%&-H860   &L    +')865H   '8    %&)865H   'L    %&=865H   (
M    %')44D,   (4    (&=44D,   (4    (&)44D,   (4    (&-H<FT
M  (T    )&1M;F0   )8    )&1M9&0   )\    )&UL=6,          0
M  QE;E53    )    !P 1P!) $T 4  @ &( =0!I &P =  M &D ;@ @ ',
M4@!' $)M;'5C          $    ,96Y54P   !H    < %  =0!B &P :0!C
M "  1 !O &T 80!I &X  %A96B        #VU@ !     -,M<V8S,@
M 0Q"   %WO__\R4   >3  #]D/__^Z'___VB   #W   P&Y865H@
M;Z   #CU   #D%A96B         DGP  #X0  +;$6%E:(        &*7  "W
MAP  &-EP87)A       #     F9F  #RIP  #5D  !/0   *6V-H<FT
M  ,     H]<  %1\  !,S0  F9H  "9G   /7&UL=6,          0    QE
M;E53    "    !P 1P!) $T 4&UL=6,          0    QE;E53    "
M !P <P!2 $< 0O_; $, $@P-$ T+$A .$!03$A4;+!T;&!@;-B<I("Q .41#
M/SD^/4=09E='2V%-/3Y9>5IA:6UR<W)%57V&?&^%9G!R;O_; $,!$Q04&Q<;
M-!T=-&Y)/DEN;FYN;FYN;FYN;FYN;FYN;FYN;FYN;FYN;FYN;FYN;FYN;FYN
M;FYN;FYN;FYN;FYN;O_" !$(#ED/10,!$0 "$0$#$0'_Q  :  $  P$! 0
M            ! 4& P(!_\0 &0$! 0$! 0$               $" P0%_]H
M# ,!  (0 Q    &\
M
M
M
M                             !QF_+4B\@
M
M
M
M                                       !RFZO/M^18[\DF\@
M    !'G6-.H                                             '=SD
MZXCZ
M
M
M      <INKS[/,T/MEEKR2+R          @9],//H
M                           $[7EEZX?3Z
M
M
M                                      <INKS[/,T /MEEKR2+R
M      $#/IAY]
M$S7EEZX>CZ?0
M
M
M           <INKS[/*@ #Z66O)(O(        "!GTP\^@
M                                 3->67KAZ/0
M
M
M                                         !RFZO/L^*   !9:\DB\
M@       ! SZ8>?0
M   !,UY96N'L^GT
M
M
M            '*;J\^SXH    %EKR2+R        @9],//H
M                                   $O7EEZX>SZ?0
M
M
M                                           <INKS[/B@     66O
M)(O(       0,^F'GT
M       2]>67KA[/I]
M
M
M             !RFZO/L^*      !9:\DB\@      (&?3#SZ
M                                      !+UY9>N'L^GT
M
M
M                                            '*;J\^SXH
M%EKR2+R      $#/IAY]                         'VR=KS=&1"SZ.,Z
M6&O+7Y]0    $G7&/GK\4?;++7D'IGRUQFX6?2          )>O++UP]GT^@
M
M
M                                                     Y3=9GV>
M5         LM>21>0     $#/IAY]                         $G7'I,
MPIZ/5EEKQU>/;9[\5?GU^F>4Z#[9U8YS?E?5S]/23]>6!GU<IL >KFQOEK,^
MP#W<^F>4Z#W<_4\J/:>5\KU8Y3?Q0   )>O++UP]GT^@
M
M
M                                    Y3=9GV>5         'U+'7ED
M7D     (&?3#SZ    !]L[,             #X<IOXH    ZZQ87RQ,]^#IX
MFA:]/#QSU6?,V([V.O)&G:1>4#/IF:X>I.+<F\86?3'G4 >KFQOEK,^P2-<I
M+CR;[,5N?7:]/#RSTX.DZ^:).\F\>,Z>5]I7Y]0    EZ\LO7#V?3Z
M
M
M                                             #E-UF?9Y4
M    ?4L=>61>0    $#/IAY]    'VRRUY)%Y              1,]H&?5\4
M    =+F1>/>\_,M=GUVF_%5X]OVRRODCNOF6-.W;7.0Y>K(F._)NRWXZ['K[
M:Y^V>4Z<IOU<V-\M9GV"SWXX^>ORV5>%?CU6._+58]ONYG7S5V?7.WYH^.O&
M]+/7BK,>T    "7KRS-</1]/H
M
M
M               .4W69]GE0          !]2QUY9%Y    "!GTP\^@   >K
M++7C[WG\/,U\            /I[N1%SVK\^KXH   EZX<,].;8LM^.!CU6&_
M)68]OVRRODX.GB:C3MVUSDN7VR'COS;LM^.NQZ^VN?MGE.G*;]7-C?+69]@L
M]^*)GT?%^L\9UL=^.LQ[?=S-OFK\^N=OS1L=N5W9Z\=9CV     "9KRR]</1
M]/H
M
M                                                    .4W69]?E
M0           !]+'7ED7D   ! SZ8>?0  !]LL]>/O>?P@9]4:=@
M    )=\\[7G$7/:NSZP  !VUSG7S19V])WO.LQ[+/?BK,>W[997R0)Z9^O-#
MSWEZX0\^B5KC#QWYMV._)QSTB3N /5S8WRUF?8)>N'1CA.LS7GK,>RRWXZS'
MM]W,V^:OSZYV_-&QVY7=GKQUF/8     !,UY96N'L^GT
M
M
M                                '*;K,^ORH             ^ECKRR
M+R   $#/IAY]   $K7"QUY1!SZ(L[@             3;YY>N I.?T0   /=
MSVO/Y+PG3XO6XY3:NK'*;]W/:\^4WSF^EQXFOB^K/;'*= !]LZ,\IL#M>?MG
MA.GEKK<<IO[9[9YS?2Y\2_%ZW'*;      $O7EF:X>CZ?0
M
M
M                                 <INLSZ_*@             #Z6.O
M+(O(  "!GTP\^@  "5KA8Z\H                %)S^B
M                !,UY9>N'H^GT
M
M
M              '*;K,^ORH               ^ECKRR+R  $#/IAY]   $K
M7&?KR_3Z@^+\            /I]0>5%-S^@
M       )FO+*UP]GT^@
M
M
M    $2=O*@  (A3T        "7>/JY   ^DN\/H ! SZ8>?0  !]L]IZ9M-^
M+Z5>/9X;            [7G8Z\G.:K<^SXO.:
M          EZ\LO7#V?3Z
M
M
M          #X4V/>        +77BZW(      @9],//H    ]W-OOP?2HQ[N
M<V           !WO*TWX^<U4Y]WR4    "5KC\B-.P    '6XYS?P   'NYE
MWAZ2/.L>=0              )>O++UP]GT^@       K8\4/9.3HH      A
MQWLZJ!'CS9*4     #X#Z       >3T         ? ?0#Y%2=;+)0
M  !Y/17%B     #R>@      "N+$              'B(EDY0(T+)*@
M     "-'VSU+RLEJ  /)Z             /)Z              !7Q.L]*
M ! B'5TGU0                   /A38]X        M=>+K<@     "!GTP
M\^@   #W<V^_!]*C'NYS?U+'?D]) SZ>4Z=KSG:\WE:['K^+/UY>MQ&G:)GO
M]2QWY/20<^GC.G6\Y^O-Y6NQZ_B][RM-^/G-5.?=\E    "K/7C)68]H
M%EOQUV/7\4  #W<V.O) SZ?+4[7FC9[1YU               EZ\LO7#V?3Z
M       9"6VN?2\HJ[-:>U      K)9>LR)0*O-X[S=2@     9W-NMYD2@
M    "KS?F\VLH        &;S;_>>LH%9FUV\W42E          J\WYO-K+2%
MV     0<V#O-Y*      $9&M<              "/FT6\:6: A0U)LH
M      ILWIO,S-CZEC*  ,J:H             RTNHN?J@             9
M7-TV\=)H   >8R-:%)Z@                   #X4V/>        +77BZW(
M      @9],//H    ]W-OOP?2HQ[N<W]LM]>'W<U>/9PG61>5GOQ^)JHQ[OB
MVF_%WO.'GO SZOJ6^_#[N:S'LCSKWO*TWX_$U49]WR7O>5IOQ\YJIS[ODH
M  [ZY=IS^Z<,]>$Z=;SFZ\_Q>.>GBZ^R1IVF[\_+.Y^_+$QWC.T_7E^+XFH.
M?2!,WY_.=19V'JSZGI)NO-\7[%;GUV6_)Z9B9[]=8]S/VR!CU>&@
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MF[EI)9>L3<;S>\Z>7.2VVLR\W-FAU*W&HN\V\><ZJ]YT$M5F^=XO)H
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M6=S9F\S)?AX2<H          JR(1R&<20:<DE/GW        "TOCZW($<D
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M/.O>\K3?C\351GW?)>]Y6F_'SFJG/N^2@
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MW-9CV1YU[WE:;\?B:J,^[Y+WO*TWX^<U4Y]WR4
M               "7KRR]</9]/H
M                 /.;E=YUDH
M                         %868
M                /AE"$="6=R ;('PI\^X        6E\?6Y%*0BO-84)>$
MT  $#/IAY]    'NYM]^#Z5&/=SFQ*UQ^I'G7Q->[F1>7E8V>PD7E[N>4WQG
M02M<?J1YU\37NYD7E\6+GL.]Y6F_'SFJG/N^2@
M               2->67KAT/9]
M                !\B+9+4
M
M            9PFD<B$TO ?"GS[@       !:WQ]+D>#/G8G&:-B>P  0,^F
M'GT    >[FWWX/I48]W.;            [WE:;\?.:J<^[Y*      !]L])X
MFAZL^IXF@     !UN.4V   .EQSFP              .FO-WUY^IU.AZ
M
M
M                                    !0G4^G<F'4 'PI\^X
M 6M\?2Y CD,ZG<D   $#/IAY]    'NYM]^#Z5&/=SFP  ).N/5@   #A.G"
M=0  .]Y6F_'SFJG/N^2@      =M<Y+C SZA(URZS$*>@      3->>'GT6.
M_)78]8 "K/7BK,>T              >]>;IKS]#J=3V>CZ
M
M
M                          0CP517'@[EF7X/A3Y]P        M;X^ER(
M1E3V<BZ+\   @9],//H    ]W-OOP?2HQ[N<V  )>N%AKR@   #X5N/7'G8
M =[RM-^/G-5.?=\E       [:YR7&!GU"1KEUF(4]$K7#LQ'G6/.O:\Y-X^6
MH>>_;7/JQT9X3I&G:5KASF['7DA9],=UEWS^TC3KP=;/7BK,>T
M   #WKS=->?T=#J=#V>@  !%%5Z    5\OO69LH       BRQM9GYM5J7,H
M   I8M]3W*           !3RVFL])0*(O0                 1HD6?5
M    %$7H         .,>K.B@                  #G&>)&I>R@   ?(I=2
M[EHB]*(O3A'2SVH
M     '@]$8AG@N0?"GS[@       !:WQ]+D9\ZEV1#*FM)   (&?3#SZ
M/=S;[\'TJ,>[G-@ 2]>>?KS?3C-\VP  .K'6X\K7X]4:=@ .]Y6F_'SFJG/N
M^2@      =M<[&^3FV/3,?/;G==6(4]%AKRQ,]YVO-6X]G?7+Q-=M<_N9"GI
MLM^.#CU3]^2LQ[;/?CK,>R9KS\9TYMV>O'59]MGKQ5F/:             />
MO-TUY_1T.AU/1Z/H   C(UK@   "/'VSNH       @9L#>+S.HEDU0   !E<
MW3;QTF@           ,QFZ#>>\H&1-<                 #)RZNY^J
M   ,B:X         &;S;K>)4T                   *W-A;S?2_0   #Y$
M*R<N1-<0">9G-OMYD2@
M         9 \DPF$XE@^%/GW        "UOCZ7(HR,:0^F1- 3@  0,^F'GT
M    >[FWWX/I48]W.; $O7"?KR_2/.M;GU_)0  /=S9:\?:X\K78]<>=0!WO
M*TWX^<U4Y]WR4      #MKG*<:_/J$C7+K,>M9BX[\FY&N728^6RKQXS<//H
MD[X\<=.+I,WY^>=R]>>LQ[;/?CK,>SI<2[P^G>\JC/OL]>*LQ[0
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M0RY$UQG"YES"3-2?G7?69\L>6LUF[E
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MER)KHR-:XS.;?;SXQJEWG2RT>;*WBRF@
M                   !R.H(A4&B!\*C/M        %I?)TN?A'.I7'@LCL
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M=SFP!/UY>UYCK<?3E-_  #TG2Y^'*;$>=H6?0 .]Y6F_'SFJG/N^2@
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M-=&1K7&9S;[>9$M-F\-1<Z":
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M4TF-97>=9+D371D:UQG<WYO.BCG-8Y-7K,N:@YL#>;V4
M                               12&6Q') !\*C/M        %I?)!N:
M V(!Y,::@F   @9],//H   'VRPUY95X@ <)TKL^OQ- 773YWTJL>WC.@ $B
M\;/?D\35/CW@=;SL=>7K< #X0\^B%GT?%
M     'O7FZ:\_HZ'0Z'L]'T      '(^1RLEJ!QCA4H]G@'T^'L^'@\QQL[+
M]ES6LZJ4 >(BU*/A[.9U.<1J[IV4>(BU)3HO(Z'TYGH]$0])W7P>SR=#A'.S
MJOS-SV\ZB41H\5+/H(T+.J^SZ <3L#D=0<8X5+/1S/1Z.1T/IR.H.,<*E'L
M BQ\LEJ.1T/H .<1[)B^(BU(3JH ^$0Z)V7R= #B=@<(Y5+/IX![/)\.,?+.
MB\LVFWC230 \Q$J8A8A[22HXG8'$[ XG8'(Z@ \1%J2G1?)$.R=%^'T'L'.(
MU2$ZJ /)\/9RB/4I/*^ST1XYU+/IR.IQ.QQ.QXB+4Q/DN7LU2CR>3H
M                                         #(%F7AC2[+<'PJ,^T
M      6FO(9QI=%V?3D8XU1,  ! SZ8>?0   )VO--UYQ'G3A.O5B3KC](\Z
M5F/:!==/G?2JQ[>,Z3]>;I><>=HF>\B\;/?D\35/CWCZEKOQ=;CR1<]_+7>\
MN]YBOSZHF>X                               'O7FZ:\_HZ'0Z'L]'T
M               '.,Q4HC1<ZEC*               !RC,U*(Q=V3Y0
M                                   (\N;LF$0O[)DH
M                    $.7/I<ZEG*
M                   ,6; Z$ SQL ?"HS[0       !::\G1FL,X?3N1R0:
MT^@  @9],//H   ]66^_G^B#GTPL^@"1>-EOR?2KQ[.$ZBZZ?.^E5CV\9TM-
M^+O><//>!GU2+QL]^3Q-4^/>)6N%CKR^5J\>SE.@%CKR2M<><U48]X     '
M2X[N<5VG:\W1D0L^CRU/UY?J?3RL?/6)._NYL]>.KQ[?*CW<S=>;T@@Y]/.;
ML=>2NSZQ]LGWS5\]4Z^:#GT@        >]>;IKS^CV=3H>ST?0
M      ?#D=#T                 ?#D=#T
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M 3=^?U,^)J'/0+3?B@9]7*;Z7%A?+5SVVNO#58]P^V6=\=7GVRM</$UPG4
M     #WKS=->?T=#H=#V>CZ
M
M
M         >2D*\]%^3 ?"HS[0       !::\G1D      0,^F'GT   2M<+'
M7E^'"=0 .KG[LYS7-L2+R'&=/*]KS])SFN;?IGM<?#A.HZN?NSG-<VP!]3M>
M?TI.?T0    !ZLGWRUV?7UUBPOEB9[\'3Q- =M<Y+C SZ@JTUXJS/LL]>.KQ
M[>FL3GFK<^P *MM>"%/2/J2G&KS[?5S/OFKL^L       >]>;IKS^CH=#H>S
MT?0
M
M                                                  #P<22#X5$]
MH        M+Y.C(      @9],//H   E:X6.O*                !2<_H@
M    #MKG(<H.?2.ES(O'O>?F6NSZQVUSDN,#/J'?7.8\\.=YFO/#SZ?-LMYZ
M_/K "K?7@A3T#Z27&KS[1:;\57CV@      >]>;IKS^SV=3H>CT?0
M
M
M                                      ",02,1B,<"8:T'PJ)[
M    !:7R]&89&.I8 \GH   @9],//H   ZW$B\0        !\/H      (6?
M2     .VN<AR@Y],O7#AGIS;%EOQP,>KPUVUSDN,#/J%AOR<YOROI.K%?/5:
M:\=5CV@6&_) QZ[3?AJL>X?;+.^.KS[1:;\57CV@     #WKS=->?V>SH=3T
M>CZ
M
M                                                 #.E269)*PM"
MX/8/A43V        "TOEZ,YXIR06!+*<T)-  ! SZ8>?0             /%
MSZ7[*           !ZLL+Y:W/K[:YSKYHL[>D[WG68]@[:YR7&!GU?;+/7CJ
M\>T"UWX:S'LE;X]9B/.O?7+QG4)Z;77AJL>X?;+.^.KS[?5S/OFKL^L
M#WKS=->?T=#H=#V>CZ
M
M
M     03.GHT)2%F6H!\*B>P        6E\O1GR4)%/9#/!KSN  "!GTP\^@
M                          6._)7X]7Q?=SVO/Y+PG3XH^V>V><W]L])X
MF@/=S\E\KUN.MQSFN,Z#K>?*= KJQRFY6N'F:CSJ     />O-TUY_1T.IT/1
MZ/H
M
M                                                  !\*@HSR7I<
M@'PJ)[        !:7R]&0.9T    ! SZ8>?0
M   .MQV<XD[@            !4^^6!GU     #WKS>]>?V=#H=3T>CZ
M
M
M                                            #F4A3EL:$'PJ)[
M      !:7R]&17%*: S98E\   0,^F'GT
M                      >]>;WKS^SH=#H>ST?0
M
M
M                              ".59> ^%1/8        +2^7HR,\2B
M<R.:DD@  @9],//H
M    'O7FZ:\_HZ'4]GL]'T
M
M
M               'PJ)[        !:7R]&11G$JS4E*7).  ! SZ8>?0
M                                           ![UYO>O/[.AT.A[/1
M]
M
M                                                   !!)I]  /A
M4SV        "SOEZ,CD9H[%N98V1T  ! SZ8>?0
M                          />O-[UY_9T.AT/9Z/H
M
M
M                                 !',Z1"_)Y[*0OP?"IGL
M%G?+T9 YD<Z',F   $#/IAY]
M           'O7FZ:\_HZ'4]GL]'T
M
M
M                    J2@!S/1W-@#X5,]@        L[Y>C(A&6/AH",:
M   @9],//H                                              'O7F
MZ:\_HZ'0Z'L]'T
M
M
M      KR:<B(2"6#X5,]@        L[Y>C(SYW.).* TY)  !&G6+GMY/)\!
M\                                           !ZO/IKA].AT.A[/1
M]
M
M                                                     !6'0ZD
MMCV#X5,]@        L[Y>C(IB">RU*$T),  !\/)S.1X/A\
M                              !]/IZ.AT/1Z/H
M
M
M                                   !C31F</)/-*#X5,]8
ML[YNC(\F8*\$\U)]   /)X/!Y/@
M           /IZ/9Z/1]
M
M
M             !C31F8-@9,V0/A4SU@       "SOFZ,@1SP?24    ?#X>3
MX#X                                           ?0#T?3Z?0
M
M
M                                                #.E26Q,*@UH/
MA4SU@       "SOFZ,BF,^?223"_.@  .:_#X ?
M                       #J@^GT
M
M
M                        ^$4E%(32>#X5,]8        L[YNC(H3H3"(0
MR^.X  *[77R                                              =4F
M9Y_0?0
M
M
M02B/9=$HZ ^%2]8        LWFX,T1U(YI#N    5NNOP
M                               '5F5G'H^GT
M
M
M                                   QQ;E661&-*#X5+U@       "S
M>;RS2D,B'DD$LT)U  !6ZZ_
M          #HS*SCV?3Z
M
M
M             #&FM,P:@R1L0?"I>L        6;S=&0/A%(9$+L[@  K==?
M@                                               .C,G..A]/H
M
M
M                                                  !2%,"0=S2@
M^%2]8        LWFZ,BD*HF$PF$L^@  K==?@
M                        !T9DYQ[/1]
M
M
M                           *T@'8N#V#X53U@       "R>;HR(9F260
MSB>R_+<  K==?@
M  .B2<\_9Z/H
M
M
M   !2E>2B833N#X53U@       "R>;HR* DEL>#*%T9XVH !6ZZ_
M                                         #HDG//V>CZ
M
M
M                                          #%EH1R&=S6@^%4]0
M      LGGZ,BH*4NSH9PU)EC:'T %;KK\                         !V
M9XM         *DYR /"\;0         !T23GG[/1]
M
M
M                               ((*8OB2#F= ?"J>H        63S]&
M1\*,JCF61V(!K0 "MUU^          'H])]/AX7X            "?GG UT
M        5UD^I)SF+K?D\*          !T23GG[/1]
M
M
M                               !1%(?#H6)-)I*!\*IZ@       !9/
M/&9H2\.!+)1](YU/8 !6ZZ_         #T29CK,E^'U"\+J/=?
M  3\\X&N@'VI6<?3R1;N3,?3V<ECW4F8]GPYKPN@!ZJ7C$+6QZ)4P.2\+J7,
M>DXM=$^@\+T9XM<+H    =$DYY^ST?0
M
M
M                    >2(0R&0SJ:P'PJGJ        %D\YFL/90G ]DHTQ
MV  !6ZZ_         =$FYY\KJ-=>%'T]I*SCZ0];\*          !/SS@:Z
M2&41[J0S\EZLQ[KG;.QSB:W(SF)K?=GW$6Z 'JI>,0M;$N8X77-9LYQ+TFYY
MP==/J3,X@ZZ2YCDURU9N.<'70    #HDG//V>CZ
M
M
M                            "C.I,)1\/0/A5/4        +)Y_+,,F'
M8Y$,AEN=@  5NNOP        ]I-SSCW<>Z^G:9]ISNN*_25,=9(.NGD
M     $_/.!KH!*F.-US7JG23VD6[\D[/.-K72(UU[3O(3I)PNN%UZJ7C$+6Q
M.G/PH$>[EYYP==/22LYAZW*F.-USMG8YP==     !T23GG[/1]
M ,K+YL LK+J4      4>;8;S,E K9>6LV\H     &7-0  #C$:R>H
MR\NGN?J@    #Y%95H       5<6=GU0       !\BLLM% %%FU^IH[)4H
M       %46I2YLS>9TH    %9+8ZSZE      $'-A[S=9M59:KG\VXWF1*
M      !GLVZWGYF\K)LN7K4   SDM]K/64               "NEXZS;R@
M            4N;,WGGG7/6;7-K++1<_FW&\R)0           ,Z5 /1,+$N
M053U        "R>>.SDSX=B83"83CZ  "MUU^        $R8^$2['5)F>?&Z
M[3,#77R";GGXMBW8          GYYPM= .K/J(UU)F/#79F+=^2=GG#UTEYQ
M#UN1,?5BW0 ]5+QB%K8ES'%KEJRLXC7<W/.#KIZ25G,/6Y4QQNN=L['.#KH
M    !T23GG[/1]          !D)=;K/J7S&471ZS)E^'P]GPY'8   \'H^GP
MYD#-X[S=2CB=#T#X<CJ?0 <CJ?#Z<3J?2KS>&\W<H\'DZ@^'TXG4^@\'DZ@Y
M'4   Y@Z  \9N7WG5R_ >#H?#D=3Z <3T= 9*767)?IR/9Z.1T/H/AR.P .9
M]/9QS<[O.HE ^&4EU.L^Y?AR.I]!\.9U /A].)U/H!Q/9[!D37'@^GH'$ZGT
M'P\GPZ RF;J-X]S7@\G4     \GP^QE=362YK-O-X]S74^@ ^'TXG4'([
M&9S;[>:_&O6\VTO(ZGP^'@Z@RV;H]Y[2_#D=@   #D>ST#X<CJ?0#F?3V<CV
M>CX?3D=#Z5>;QWFZE'(]GH'P^@^'T 'D\'4 Y@Z ^'TXG4^@\GDILV;O$Z:^
M'C-SN\ZB7F>SZ>3F=@ <SZ>P>3F=@     9,T)V*(C'(MBY*IZ@       !9
M//T9\D0SAT.1P->20  5NNOP       'TL,\H.NGA>J=).TS!UTGYY1KOG;X
M7JDO.(&NGP          E3'H'E8NM2<X]GA8UU(9X-?"3,QKKJG:9^'Q8UT
M/M=\YCW0^DJ8^G)>%U)F8UU].TSPNNS/-KS4C.8]T      .B2<\_9Z/H
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M+/:@   "L,V>CP6Y%)A?%4]0        LGGY,U1,*,O"R    *W77X
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M6NGA0                                     ![25GG[/1]
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M=V.B3<\^=UTF8&NOD$[//E=1KH          ?:GXYQKKA=    !4K.(MV
M/I+F /A$NP              .B2<\_9Z/H
M                                                *'-G;Q830
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MT
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M(NM_#O,QKJ5,Q;OP         #HDC//H>CZ
M
M
M                   #@9 V!#.1;@%5?2        +&>?H@      K==?@
M !9YY0-=/*SL\X6M^%   ]$B8[3/T^'T^+'NN%U\     /I]/(    /1/SSX
M6^T\RQ=[FXQ!UL"7,1[OP3IS@ZZ3L<X.NEAGERNAUF8&NOP$Z<X5Z?  >T[2
M>DZ20M[EXS"UN5,>X\U[3BU'N@         /:2L\_9Z/H
M
M
M                           !'/9Y,@;8  %5?2        +&>?H@
M  K==?@  !9YY0-=/*SL\X6M^%    'H^I\7R      =DEYYCG;"O0   "2S
M\CC=";GG!UTFYYP==/M=LYZ)'N_%3\<X&^D['.#KI.SS@ZZ#JG)0)4QS:XVB
M5,<VI$Q$UORL[/.%O<K&8>MR9CPUQM]I\7R          #VDK//V>CZ
M       #E'FSNH        $0E@       '..=DA0
M          !&CO9Z4            #A$*K!.B@#Q'&SM+RLD*
M (T=K/:@             "(2P       "/'2SHH           C1VL]J
M                    !G2H.QR+XF$L]@%5?2        +&>?H@      K=
M=?@  !9YY0-=/*S\\N=O"ZYM>0    >T[S/L  \$:[DS'L '29CW?"ZG9YPM
M;\*   J=GG"O3X"0S\CTGH^G!K[9WS/-=)(&NDZ<^+7RNLGP^$6[ ^DR<_BC
MX1+N;.?AKZG22%OI*QB'K?HF9Y\[>DD/73R           >TDYY]#T?0
M       "LS8^\W<H        ^1D]36R@       0,V!O%]- 0,WAO-M*
M                        !2RVFL]I0  !REH]9T,H       &3EM+FU/:
M@"/+7ZS+QJKWG0R@           #.9MQO$N:              &2EUES]4
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MQGGZ(      *W77X   3L\XFM_%G9YPM;\+Z.TSVF?I UT  $R8^$2[
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M^2U6I?YUGM9OI84L76-%G6+J[2<4<U9ZSVS:*M4GI0
M!57T        "QG#H@      K==?@  !]/AZ)^>4:[\T!ZB3,1KOS0 $K.8N
MM<6@     )^><76^2SL\XEUXN@
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MOR@    .DD36^+0     $_/.+K?)9V><2Z\70
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M&[#>)\UG\WSO-A$.:D:Q.QNAWC2YUD=37RBKS8^\>L;[;S:2C+RVJ0=9T,T
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MXVWBWFJ+-F;Q8S6;S;K>,UG>FUG[FYE;O6+.: RLMUK,G-S1H]2IQJPWB?-
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M+2YL+>=3FY/4ULJ,F7NI(S<R:;4[R@                  "JOH
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M=* !4%N<(ICU98KRLF9L2R7+$U+&6OBMJ?9YEM2H+<'B*<X58V6,L>*>S0*
M(<<[+!:Z.UDM:Z)>IVE@QUU),M9$"I26Z_0"!'>R0L./MDM:V*^NZ7)Z6'%5
M7M+@[+PBG.EG5;9"B-FT&\RLW[9<G1:@MP<XICG5JDQ:^)-G:6G(U6%EE+&C
ME9.7C$2RP6+%?4F6HUG4R\(ISY5JDM?$4QXLEK.L[2@<(IQ9<G26E.56:15M
MXJK+91RBG.=6B35                    JKZ        !8SAT0      5N
MNOP   L\\H&NGE9^>436_*@    2\XC:UQ:      GYYQ=;Y+.SSB77BZ
M   $N8YKXM$J8AWIU9ZR?#RO"ZESGX7W$+6YTY^%^'Q>5O:3S7;.8FNDF8\G
MM.#:S['"Z             'R83/HZ'0Z'0^GT
M                                     &3EU6L^I0          !'BI
M7MK%Q-              #C$74L)0                     !&S:/>-+-
M         "%FTN\W<M9+UUBZF@
M!57T        "QG#H@      K==?@  !9YY0-=/"S<\_0     /20];XM
M   3\\XNM\EG9YQ+KQ=      "7,#RH[3,+729GG!UT$Z<XMW*SB-K?D\+.S
MS@ZZ*G8YQ=;[2<+>\D76NDGPZI[DY6_8X70            'R83/HZ'0Z'L]
M'T
M   KXGV?5           $6(5ELOT
M      'B(EDY0           ($0ZDI9*
M       !57T        "QG#H@      K==?@  !9YY0-=.:@     "=GG'UK
MBT     !/SSBZWR6=GG$NO%T      )<QPNN:B9.<6])F><'7039SB7IZ3M,
M]9(6NDN<X5Z"=GG%UOM)PM[R1M:FYY\FOA[3E;]CA=            #Y,)GT
M=#H=#V>CZ
M
M                                                       "JOH
M       %C.'1      !6ZZ_   "SSRBW?B@     !*SGE;RM      EYQ'NO
M%LK.85UXN@     !+F.%US43)SBWI*F.+7FI6<1=;D3,:[E3G%O29.?!I7J.
M-O:3A;*SF-K4G.8FMR)CZ<K?L<+H           #Y,)GT>SJ=#V>CZ
M
M
M                                         55]         L9PZ(
M    *W77X   39S^QZ3Z>%             '1/*^2'K?E0     !T3ROD'5.
M:CO,CA=?#JG23G;R6=GG%UOZ<E^GM.=O:3FO1GW'&WT>#ZO@           '
MR83/HZ'0Z'L]'T      @Q,L^J/H    .<1K)J@   #C'&SM+QLF*
M          *XL4@RR[/:@     ?(J3K99*               !#CO9U4  #Q
M$6R:H         \GH   X1SLZR\K):@   "N+$            $"(=72?5
M          \1#LGKY/1'CS9*4    1X^625                $2.MG9?)Z
M                   *N^@        6$X=$      %;KK\    ),SZ2)=@
M           "?GG'NN%T              !.SS@ZZ                  ?
M)A,^CH=#H>ST?0     #E%%J:*7.YMUO,B4    <)86LVDH    @9M?O%AC=
M?O%_-                 #)2ZRYJY;#4ZR@     5F;7;S=1*4
M      #/YMEO,Z4   9R-!9[4        19:G6=!*  !6YL7>;/-CZEC*
M ,E+K+GZH           \QD:T*3U            '.*S4MY<J:I(<OC4GR@
M  "IS?.\7$T                *Z)&IRQJ#O-Y*                  !5
MWT        "PG#H@      K==?@   !)F9$QX4             =$B7?"Z
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MSUF8^M             ?8DS,:ZX70
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M>;'-S!JM2FQJ=O''&XN\W&=9S6=-+6R^]9M)0               !5WN
M    +"<>B      "MUU^    $J8^D2[             ^D[//A=1[H
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M%5C<[>/F-P]YN\W*$BRP+,]*                *N]P       !83CT0
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M',D)V4>,W+[SJY?D9&M>9.75:SZES6;>;Q58W.WCYC</>;N7F<(K%YZQI)H
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M_(DU&UC0S5/%GJ=90              *N]P       !83CT0      5NNOP
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M)%N@!ZJ7C$+6QV9E9SSM])X6+K<['.!KH![3RL[/.!KH!/SS@:Z"=.<&]
M    /DPF?1T.I[/9Z/H         /$9^S1J!'BG.NLW<T*7-[;S:2@
M  <8ISSJ:"4                    0,VFWFVEJHM=2RE
M          S<:*STH%'FRMXLIH                       ")FT&LVZUTL
M[6;:4
M          "KUW        %AGCT0      5NNOP   $F9DS CW46[
M     ^DR8ZS/PC7<>Z      ^U,QB%K?5.LD6Z 'JI>,0M;$V<XMZ>!4_'.#
MKI+F.#7*WT3<\X.ND[/.!KH!/SS@:Z"=GG!UT      'R83/L]G4Z'H]'T
M        $2)-GI1SB#5B?0<8^V=5         \17U8IZ4
M     ")$:I22E                        \1PLE* .$>K.J@
M              "-$2I"3%
M                            %7KN        +#/'H@      K==?@
M                        )LQ"N^B2LX^4.#?&W[4G.8MU]J3G$6[ [L^%
M\++F/H(UUS67,1+L"7,1+OU4G.(EV     !\F$SZ.AT.A[/1]
M
M
M                                         !5Z[@       "PSQZ(
M     *W77X                           #LREXV@            "0SR
M7PH     ^3"9]'0ZGL]GH^@
M
M
M               %7KN        +#/'H@      K==?@
M           %=9.2@            #JG)0    !\F$S[/9U.AZ/1]
M
M
M                                              !5Z[@       "P
MSQZ(      *W77X
M   #Y,)GT=#H=#V>CZ
M
M
M            5>NP        L,\NB      "MUU^
M                            'R83/HZ'4]GL]'T
M
M
M                                     %7KL        +#/+H@
M K==?@                                               /DPF?9[
M.IT/1Z/H
M
M
M  !5Z[        "PSRZ(      *W77X
M                  ?)A,^CH=#H>ST?0
M
M
M                            5>NP        L,\NB      "MUU^
M                                           ^3"9]'0ZGL]GH^@
M
M
M                                                     %9KL
M     +#/+V@      KM=?(
M       !\F$S[/9U.AZ/1]
M
M
M                  !6:[        "PSR]H      /)X.1R/!\
M                                   /IZ/9T.A[/I]
M
M
M                                            *S78        6&>7
MM      !\/)S/!Y/@
M!]/1Z/9[/I]
M
M
M        !6:[        "PSR]H      /A\/)Y/@
M                        !]/1Z/I]
M
M
M                              *S78        6&>7M       /A\!\
M                                            /I]!]
M
M
M                                               !6:Z@       "
MPSS]H      /)\!\
M!]/0/H
M
M
M     *S74        6&>?M      !E>LY4
M                   !;X6V+]/H
M
M
M                          !6:Z@       "PSS]H      ,GVG@
M                                         %MA;8OT^GT
M
M
M                                                 K-=0
M!89Y^T      &3[3P
M    6N%MB^CZ?0
M
M
M           5F^H        L,<_:      #)]IX
M                          !:86V+[/I]
M
M
M                                 *S?4        6&.?M      !D^T
M\                                                %IA;8OL^GT
M
M
M                                                       %9OJ
M       +#'/V@      R?:>
M            6F%MB^SZ?0
M
M
M                 "LWU        %ACG[0      9/M/
M                                  !:86V+[/I]
M
M
M                                       !6;Z@       "?CGT0
M   9/M/                             !VCE7P       'L^QSH
M    "TPML7V?3Z
M
M
M         5>^H        L,<^B      #)]IX        /9[@?#Q7D
M            T/.46]<[      !:YD)K[9[EAZ@   'JRZY:H^D     M,+;
M%]GT^@
M
M
MJ]]0       !88Y]$      &3[3P       ?2?E;8LF!\(=4_21:
M         &AYRBWJ2GN)>; TAZEIEUC[+4[<[+/*1E'MKMS1\D9JJZY]YL74
ML\I&;7Z1-2PRZ'?-JMI;-ORU1=$34     M,+;%]GT^@
M
M
M                                     %7OJ        +#'/H@
M R?:>       "ZPL\6)4+4^'HL<WK&>ZR)0                &AYRBWJVS
MGE-5W2:#E<WUFHY,WTO2YM>6JWIF1G5;N7V%/;9,US7:YZXVUC[G5;TE]S4F
M[H,2DU6LVG+=)VQ><=T'7(     %IA;8OL^GT           '$^ ]G0
M  YGH] '@'L      XG8           '$[          '@'L      XG8  '
M$[        'D\GLYG4           'PYG4  '$[
M   XG8                    \GP]@            'PYG4
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MU-:E/:CQ&5JY3A-0M9U$N0EF7-@1LZY;S-S:BM.G10      *OIT
M%ASQT0      9/M/   !WB]YWM  'LX5G.LGY3\V=E5ZD#3S6EY7F?  ?*C5
M0])Y                !HN5SO6                   "TPML7V?3Z
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MV5]SN6[3P2HTO*U>G*P >RUQ:'I*_0                6.5=H
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MC(FGS<[O.IE%+F]-XMIH<9<Q98)*EH]37RY$UQ\C&U=@$U):@      5?3H
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M;-RZZ+69,HK<VOWC135?FY_>=A+D37 RLM[K,R7.RVVLS90      *KIT
M     %CSQT0      9/M/   !<86V+&H #M'HX5\  /1(B/7D 'H[QG>DAZ
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M9<<M4W23\VOU  /I/S:_4O>=HND          L\+?%]GT^@
M                                KY>VLRI0,YFW&\2YH   <ROEAZSH
M)0                                         !PS<_O&GF@!#BAK4)
MZ4                        "'FU.\Z*4
M               573H        +'&.D@      R?:>    :'G1GND
M  'LT_&U>Y4[        "2EERU2=8)\DK&J;I/1(B/7DT&)2:UU2-7P]$B.9
MQJTS.4URU(U?#K'*M%RN=ZSK'JR[Y:H>DYU(CZ1J[I=\M4/2?3E0DQS.5>CZ
M=XXG.@     +/"WQ?9]/H
M        *Z)>IVE   $66JN;LZ*
M         /$5VI:2@"@BQU)TH                         XQ$LL5
M                                    %5TZ        "QQSZ0
M,GVG@   &AYT9[I!<85^D>A*B7E5;#V6N%9IRH667,@Z>S3\;5[E3L
M  )*6W+53TGTLLHJP]R[Y6#N3LVAVO<YYS7&R1FT?6:#DK])T5EO>YGXU7[D
M_%SW5H>3.]9HN5H.V;SCNLZ8N>>J'HMLR.O1$L+>;GGJAZ+OFSO6:#FAVRI(
M%OS6;;GJOU+'+/=+SL      L\+;%]GH^@
M
M
M                      JNG0        6..?2      !D^T\    T/.C/=
M)Z-9QM'TE;H+G"PS<SUG@DQI>5SW20M!H^5Y50])[-/QM7N5.P        DI
M=\M0M2?E76U726^9ZSJ/J2XBK.9H]:YV:+E<]UG>.L3HXR_-9XS4'<M\R)-6
MV6=ZS1<K0=LWG'=%VQ>\=T'7/>.A)B9BT/;-[QW0=<Z+E:;KFQYZI>D]&@Y6
MKZ9[XU5=)<9D%J+J      "SPM\7V?3Z
M
M
M                    573H        +''/I       R?:>    :'G1GND%
MWS5NT:A,REQ4[?#V7'-5;<:%IARJ!I[-/QM7N5.P        DI9<M4G6=#1<
MKG>BTF><U&U/<<+;G.:'6O-FBY6DZYN^6JW;HGW-^:S'FH>Y;9D::M<L[UFB
MY6@[9O..Z+MB]X[H.N='S5UO#4M>=H>V;WCN@ZYT7*T_7,_GJFZ3Z:'E:OIG
MKG=9O-QF06HNH      !9X6^+[/I]                     *Z)>IVE
M   ^11GO4NI0                   !&CE9.4    "IBUL^J    *F+6SZH
M "*BK<J"W        *Z)>IVE              %06X  *V)NIUE BQXU.V;&
MLDRQM2PEY'4   Y'4JHL[/2@              0X^V>Y>%D]>1U*N+&SVH
M               \Q666J@(J++=0               !5=.@        L<<^
MD      #)]IX   !H>=&>Z0        >S3\;].=    0[*;H\@  $E++EJDZ
MP6$DWGNKZXN.6JK<M<J;5N)FAUKS9HN5I^N;;EJJZ2TPC+YUF7C5;N6N+G^C
M0<V=ZS1<K0=LWG'=#VSI>-I.DNN=I=R;$G-S_::7C:+:YPSW6:'FJ]67)REX
M[SUSNLWFXS(+474       %GA;8OL]'T                    %?$NSJH
M    $#-JMYOI>P                    *[-A[S>R@    5<6=GU0   !DI
M=9<_5  1DM36RU1:@       &=S;;>9DH              R)K@  9S-N-XE
MS0$:/%GC.J_>+G.HUD^7)UK   <LW.;SJ):R+&STH              %-F]-
MYG9O"R7G68WG52UL3[/:@                #S%=99J BJJU
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M*EDVQG7+6;&6/+"UFRSJGUFZS:2H\6%D8O5I!$*K.RUEY11'BI9.LF2@
M      5778        L>>.D      #)]IX   !H>=&>Z3T:SC:/I*W076$_-
MS/6>"3&EY7/])!T&CY7G5!TGLT_&U>Y4[   "5&CY7.]9$H
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M7'2Z/69>;DC7:F<QJVWF;FY9;C6;.4          "IZ[        %ESQT@
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MQWFZEA9M7O-[C69WG4YN2U-=+\C)ZFMER)K@97-TV\92:UX*;-[;S9R@
M      5/78        LN>.D      #)]IX   !H>=&>Z0        >S3\;5[
ME3MI.5BV4O0+/"VQ<SVG>-'RN=ZR)0
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M*W5@ZEOEVS?)2])<\[4],W7+=/UQ-QJ2SWSJ!N1UAZEEE$7AJ
M  2<K'G?1T.AU/9Z/H                      *_-IM9GK7&@LER@
M                     (RI.LY2M30R@
M                          5N;4ZS.6N-%9)E
M         I,V1O-G*        *+-Y;SWS:^S4'M0         !\*KKL
M   67/'2      !D^T\    T/.C/=(        /9I^-J]RIVTO*Q;*3H%IA;
M8N8[3O&CY7.]9$H         :7FYJ.!2])9Y5FG5+OENIZXL.>J7I)T<%N^:
MAZYNN6ZGKBQY[B;QVQN#TQ;\M476:'FSW0            !)RL>=]'0Z'0]G
ML^@                       XQPJ2G10
M /A$/:25
M   X1QJ4>P                             >#Z>@        "-'BI9]
M          !4]=@       "RYXZ0      ,GVG@   &AYT9[I .L28^@   $
M>N% >S3\;5[E3MHN5C:E-L++*UQ<WUG>-'RN=ZR)0         TG)F^M(!;Y
M=\WQ9US:_IGUG5;N :+E:'KFZY;J>N+'GN)O';&ZOIG0<U5M-Q:?I
M     !)RL>=]'0Z'0Z'H^@
M
M
M       'PJNNP       !9<\=(      &3[3P   #0\Z,]T@%WS6F:    (5
M9WK /9I^-J]RIV]GP\@^GN.=2HT?*YWK(E         #2<F;ZT@]6:+AK-]I
M+2VY;I^N+/EJCZRUS(S5MA0]<W7+=3UQ8\]P]XE8U4])826O/5!MPU
M      ).5CSOHZ'0Z'L]GT
M
M
M        'PJ>NP       !9\\=(      &3[3P   #0\Z,]T@'H[1H.=YE'T
MEMBRXSW26.5KBYGK.5> #V:?C:O<J=O9] !\/!*C1\KG>LB4         +;"
MIV %KEVS>%>BIW++*7F\*J=RUPK-RQQJ#O,O&H6Y<856KXN=!QUG.T
M      DY6/.^CH=#H>SV?0         4\L[694H   Y2T^LWLH SIHC.FB*"
M6\UGQF^+)*@ "'$G4C9U%UFVE
M
M                                             ^%3VV        +/
MECI       R?:>    :'G1G^D^  T_*\3/=9=\[-C+]9:X7&+D^T^  ]FGXV
MKW*_31<[[@ >3.=9T-'RN=ZR)0                   '4M,(ZUVX
M     ).5CSOHZ'0Z'0]'T          SV;:;S-E   '#-S^\:>: $8DF1-<1
MHD64V==]YLY0 !E\W1[SZS?%G90
M
M                                              /A4]M        "
MSY9Z0      ,GVG@   &AYV7E'H "3$.L]UEWSLV,OUEKA<XL6@ !*BGW*O:
MUPN,6IW/I:XM3N5&TB-'RN=ZR)0                   'LEYL'4
M    $G*QYWT=#H=#V>SZ      (RQS+/4E9U2V>B79>RY[-XZS\7PFF/LN</
MM<2^L[XUE]9D+S+BRSERQJ3(FN,U+?69F/5FD*27G7(M+)>=9E)^LVN-PMYN
MY:"6-9Y+FRPS<O7N.-6%EY*
M
M                                     !\*GMH        6?+/2
M  !D^T\    T/.R<H>@ $[*)6>ZR[YV;&7ZRUPN<6!I\ !])V51N5.TJ-+RN
M:ZP:7E<[TD+25&CY7.]9$H                                2<K'G?
M1T.AT/9[/H      $8NMBGJ7(UK$]KFLVZWBIQN7O%M-46;*WGOF^-2?+7YM
M=O-UC68WG6Q\ER=:U,DNN,B:XRN;I=XJL;[[S-S:_4MI>>;E]YUDN7S='O,3
M&H.\3\;JMXTDUXC)UK8QU;%/LN0LV"@
M
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M>O41]36RY?-T>\Q,:@[QWQOYO%Q-#+9NBUG,UK91D37
M
M                                                          'P
MJ>V@       !9\L](      &3[3P   7.%CBB'H !.R\D/25'2(.G>),5^@
M'TG9<*CU[)V4'3Z3<H5<ZZ$S*'I2[D>@          +;*OMGS/*:X;S><=0]
MP2\J?=YZS?\ '470<RFZ2[YVDZ0          "3E8\[Z.AT.A[/9]
M C(UKCS&2LUQ]6MB792YU:;S-EILWIO,7&I6\6LU69L#>;O&LWO&KFOD9*M:
MF277&1-<97-TN\56-]]Y^8U#WG02\,W,;QKIK+YNBWF+C4'>)N-U^\:&:^1D
M36696M;*,B:X
M
M                           ^%3VT        +/EGI       R?:>   #
M7\;R.-               ?23%'TE;H          /9<\[1]):YG*:X;S9<M4
MG6"9)/YZK.N;3EJCZP 64G+.H6X         !)RL>=]'0Z'0]GL^@
M",C6N!49M;K/>7CJ::*'.K/>9LM-F]-Y]8U3ZS,7E'G4O\:RVI,3E+::EK+D
M37&1-<9;-TN\5^-TVLW:TA..9$37+GLWCO-OC4'>+W.LVOJYXRV6I;9N3U-;
M*,B:XILW[O-Q*
M
M                          /A4]M        "SY9Z0      ,GVG@   U
M_&U6U-N               =(U'*TG25N@          GR>\ZK=RUS.4UPWF[
MY:K]3Z38J=7GK-[RU7Z@B6Q=3LEMRW1]<@        "3E8\[[/9T.I[/1]
M         /!Y.H   .8.A\/H/ /8   !Q.I\.9V/A]/AR.P .1Z/8
M
M
M          !\*GMH        6?+/2      !D^T\   &OXV!I6Z@    '.HM
M?21$:A,R]      'LO.=I.DK=          !:YD>:A;EKF<IKAO-ORU5])8Y
M1I:OI)"7/+53T@XG*OM:'C<[U@        $G*QYWT=#H=#H>CZ
M
M
M                                         ?"H[:        %IRST@
M      9/M/   !K.-]@     Y&9[3O&AY7,=9[--ROT       S_ $D#0
M       6>9SFH&Y:YG*:X;S9<M4G6?31\U)J_-9M.6J/K !ZLON.L_U@
M    DY6/.^SV=3H>ST?0
M
M
M           ?"H[:        %IRST@      9/M/   !)R]@     \5&KZ28
MC4)4?8       BUYH          24G\]4_26N9RFN&\V'/5-T@DI<\M4O7-I
MRU1]8 ):2^>JGI        ).5CSOL]G0ZGL]'T
M
M
M                              ^%1WT        +3CGI       R?:>
M                                7W-0]       %SA5ZO*P       2
M<K'G?1T.AT.AZ/H
M
M
M       /A4=]        "TXYZ0      ,GVG@
M         $J1-1=0     #T6&+6[@       DY6/.^SV=3H>ST?0
M
M
M                                            #X5'?0        M.
M.>D      #)]IX
M  !)RL>=]GLZ'4]GH^@
M
M
M            ^%1WT        +3CGI       R?:>
M                             "3E8\[Z.AT.AT/1]
M
M
M                                       /A4=Z        +3C.D
M   #)]IX                                               !)RL>
M=]GLZG0]GH^@
M
M
M      ^%1WH        M.,Z0      ,GVG@
M                      DY6/.^SV=#J>ST?0
M
M
M                                #X5'>@       "TXSI       R?:
M>                                               2<K'G?1T.AT.
MAZ/H
M
M                                                           /
MA4=Z        +3C.D      #*=IS
M              ).5ESOH]G4Z'L]'T
M
M
M                          ^%/WH        M>,Z0      (U<CF<SR?
M                                           #M'H]G0Z'L]'T
M
M
M                                                    'PI^]
M     %KQG2      !\/!X.9Y/@
M         !]/I[/9[/1]
M
M
M                 /A3]Z        +7C.D      #X?#R>3X?
M                                  #Z?3T?3T?0
M
M
M                                         ?"G]%        %KPG2
M      /A\/@!\                                           /H!]
M/I]
M
M
M /A3^B@       "TX3K       K^T^ 'P
M                 [92N=^GT
M
M
M                        ^%/Z*        +3A.L      "C]6?E
M                                        3^-F<K]!]
M
M
M                                               /A3^B@
M"TX3K       H_5GY0
M    F\;,Y7T?3Z                 18B4/I*24H      YQ&LFJ BNJQ
M                   !RCA9,4        "N+$      '&(-=TFJ (42;.B@
M"#$NSVH                 'F(-E@H              'P'T    KBQ*^)U
MGI0 (<=K.R@                  (KJL0     5Q8@   $6/5DA0.<1K)4L
M2R7+#LGKY/0  !Y/1"B39T4         #X4_HH        M.$ZP      */U
M9^4                                              !,XV9ROL^GT
M                %)FQ=YG2_"JB[U+*4     #A+"UFTE 1DM36R@
M              "#FUN\:":         I"[      (\N;LN2OED:Q=S0CRY)
M-5K,N: &:S;S>),T                 !XEJM9N)0              ,WFW
M^\]90   ,B:XIXM=3W* !09MAO,^4                  !&2U-;*     ,
ME+K+GZH   I<WMO-I*!PEA:S,QJAWC19U6:EO+E35(4 !&5K5%7$W4[R@
M      ?"F]%        %KPG6      !1^K/R@
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M7MEM+4Q#KJER0YK.6:!/LLRRM6X!"CW9WEISC5HDU0    !\*;T4
M6O"=8      %'ZL_*
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M'K-!C5EO,W-S9HM21*    !\*;T        !:\'6      !1^K/R@
M                                        !,XV7ROL]'T
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M:     ^%-Z         M>#K       H_5GY0
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M      !1^K/R@
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M@        +7@ZP      */U9^4
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MP      */U9^4
M   )G&S.5]GT^@                                         RN;IM
MXZ30                                                    &4EM
M;GS+7:FIEB2^M9DR@                             1Y>>LS)0
M                                   /A3>D        +7SNL      "
MC]6?E                                                   3.-F
M<KZ/1]                                         (L2;/J@
M                                              >(@5]2>OH
M
M          ^%-Z0        M?.ZP      */U9^4
M                               )G&S.5]GT^@
M
M
M                                  ^%-Z0        M?.ZP      */
MU9^4                                                   !,XV9
MROL^GT
M
M                                                          ^%
M+Z0        MO.ZP      */U9^4   /L=(]RCG9XKY0
M                             F<;,Y7T>CZ                    9
MV-#9]4       #G&9)>I?R@         <XCV2Y<]J:*4    #G$>R8H
M %!+>:S[E     STM_<^E          SIH@           "!+SUF5G5=K-U*
M    *&6YUGK*           !GY;[6?4H%/+5V:*R5*        *.6UUGO*
M      *Z5K-AFPK)R@ "HEF:S+E          IY9NLRY0
M     !\*7T@       !;>=U@      4?JS\H  #W%AQO7%6!+QW(':>*
M  'N/<(\Z>*^                                    $SC9G*^SZ?0
M                  1B2        "OS8&\7\T          *S-X;S=2QB2
M    5F;PWFZE       RN;IMXZ30    &3EU6L^I0         ,B:X
M      J\WCO-QF\J[@    R^;H=Y[R@           9274:Q[F@,G+J=9]R@
M        9K-O-XDS0        Y0L\9U0[QIIH  4&;8;S/E          S^;
M9;S.E                     'PI?2        %MYW6      !1^K/R@  )
M_&]LH'6>-!TRL.-B]$+K     !]B7SLOF]2_!9&VA]9XH
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MT>-2]XMIK,YMUO$R:J,WSO%S-             #X4OI        "V\[K
M   H_5GY0  ^EGY[WQ8^YQV'?#OBQ>DK^\^     [867'4#M(VYTBPX7W$'J
MG<D/JB=(   /I.XWKEXJ#V>+)_&P.T G<D+I9O)#ZR7SL+K   !.XV#V@$GF
M]2Q.L$KFY:O+4     $_C8':         "9QLOE>A]/H        !#BB.-6M
MEKC60UF<HYEU978U:;S-EY2YO6;W&JG>-%-9*767.177@$/-S6LRU',O[(N=
M4Z?;+NK&4"NS8>\S\:K-YT,HS^;8;Q2XWIMXZ30'R,MJ:J49S-M]XXYW56?2
M+&FUF-C?#>;G-R>II<:RFLS5',O+*K&KC>)<U1YLK>/F-\-YNI:>6I3I9>5.
ME J,WUO%;-2\V9O--&I7*YNFWCI-9W-MMYSDNO!"S:K>=%*!DY=5K/J7-YMW
MO'G.J2AQBVUFSSK,:FAQJDWG22XR6;8/)867$H&4-6"@S9^\9S.YM@\EA9!Q
MKQK/M?ATLM\:J-YT<O+-S>\ZF4#*YNDWGM+79L;>9^-4^\Z#-H2!4M+\SV=7
M^\2)H#+YNAWGO+G\VRWG[FTU#A%SJ?<:C[S=RT&;/WBPFN>;F]YN<:SNLRU'
M(N8J]9TTT,O+I=8]S0&3EU=S5YUSWBYFJ'-F[Q8S0R!IXH-9T\U"S:O>=#+5
MYO'>+J: S6;>;Q)FJ'-G;Q3XWH-YD2^<W)[SJLVA(-3$ORFSJRWF9+%S:3>)
MV-MXGXW0[QIIJ!+3V?2-&@UFOQNPWGOFT)%JPLOX^J/D49%KT1+-A+D37 R<
MNJN<DNO!1YL[>9TH%5+6V?2'&LU*3&K3>9LN0ED7/U?),LO)0
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M&^&\W.;D]359UE-9ULOTJXG646=7&\2YJCS96\?,;X;S:YL"RT6'FT.\:J:
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M6+&BUFIQNTWF;+#ES]DLB&DLD2@            #X4OJ@        MO/>N0
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MPM;WD_CJM[YDX>\WOE7=GFRQX(/6^-0      2^-F\KZ/1]
M                   /D9C4U$H
M                               Y1FSW7@T%DF4
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M_'5;WS)P]YOFSOBQ]RQXVH]#QJ       3.-F<KZ/1]
M
M
M                              /A2>J        "W\]ZY      "C]6?
ME  >XMO-KT>2N[SCJ>:ZY6?GU[.5D?;OE6]Y]B3BR^5^G#<\5WPK/1/%=\69
MS=,AXJ+T1ND^     [X=\WP1ND\U(Q8^YTCU+]DX[=\7AN=L7AN=LI&+RJ-T
M@E\R7QI'W .N7FO%#OAST\U+Y7S7FH^Y(Q8^X)7-TEC[<=21B\-SMB\-SW'J
M7Y9[R]+*YJ[L\V       "9QLSE?9]/H
M
M
M                  /A2>J        "W\]ZY      "C]6?E  ?3MAZEE\W
MJ(W0)7-STB[>-29RO;+G7N/A"ZO&I-XWMF_2J]&>==LV1AUR^G*N.T?<\T
M                           ).$KE?&GV6N[Y        $OC9O*^CT?0
M                           #X<CJ?0
M
M                                                #X4GJ@
M  M_/>N0      H_5GY0   ]1+YV1@(VT7I/-"QX7ME%Z..G+4\T/L2N=F\U
M=VDKG9&'';E7RNF7?+Q4#M..@                             ]1]/%
M        "=Y[*Q?9]/H                    (6;6[S?R@     #+9OO6=
M#764              #+2Z?6?4H       'G-S&\ZF7(FN,G+J[GZH
M         %+FR=YL90 (F;4[SH90
M                                                    !\*3U0
M      6_GO7(      4?JS\H  #Z2.=E8=<AY(^T3K/%3.5E<U7Z)YH "=RO
M?#Q77*O[3CM\ .F5AQON*OT3Q0
M     ]XLWSWJ=#V?0    #D?3BDI?$1:DIT4?"(=4[J.<1JDIT7B=@>3R=#E
M$>I1[/!\(Y)/)[/)SCS9*4?"(=D+V .496M0>P<"6>(BU(3JOD\G*%DE8D=+
M.Z@#R13HDA1\(I[20HXGF/5A>P(\<ZEGTYGH]'@'LXQPJ4>P <3L9$UQDI=9
M<\E]Q%J4GM1RB/4H]@CQSJ6?3X13ZDI0 .<1JDIT7R>3@23T#F?0#A'VR2OD
M\'0YG4'$['$^1\KV=0<ST>@
M                                         ?"D]4        %OY[UR
M      %'ZL_*  'J)_&R<6/N<-OATRDX?9:_O.6I:>>\-H/6>: D8MCPO'<Z
MXM=WG#<  ]P+/SWAM [0  ?29RH A=8   ![CKF\[/J_4\KYL'J/2\=0
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M>=1*C(ZFNER,=ZF%8FM/JY2-19[4
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M[FVF\=,;IMYT<H
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MW/WB?-
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MFVQJIWF^QK*[SK98N;F]YU\N1-< 90^FI3ZO".E>P
M                                                          ?"
MC]>0       !<>;77(      4?JS\H ?2V\UB=$/K !])G*SN5@]9%Z2=QLG
M%^Q#ZSEH/I*YN^+RU*_M.&P   ]Q9^>U_><=  /19^?55Z,@?2QX4?3CITRA
M=7/4'7*7SUPWGWFD\6]\R)TO23WF]\OA\!$ZNF9+YWX5W=XL$KF]2P^L[X<=
MOATRL^%J/3+;SVI]$E\W3.N^94^B6WFM3Z8 !:^>U7H@     ]8=?/KT=#H=
M#H>CZ?0     4TL_694OB* Y5]30'9:26'9]2_.DN?.==$OSHO*7/:SI8^KR
MC/GFNB: A37G6;*6++!UF?G5=K-U+XEH]9OY:^6IL[I7+L  9TT152R-9FR^
M8H#C7I+\YS4'6;B6!+RUFTEJY>VLSI0*66#9]+FR=+42UU@N++"7.FB!GI;_
M %F+FTE"=9<RQXSQZJ43;)6;GQ71- >E'F*#4T,N=-$9V70W.?FK^Y]+1RVN
ML^LW/GFNB: CRT5?239?2U<M79]+.RTE \1GSG71+\Y35?K-S* *J7OK+.N&
MLVLL:6NUF=C53O.BEHY8-DNSY+H#.FB */-^;Q>S0HI;+69<H
M
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M7;QH)H   #F9V6^UF1*
M                                      /A1^O(        N/->N:
M    */U9^4 /I;>:PNJ+T@  $GG;#BJ_1/<MEPL+K(?6? 6'&_8@=I8\;\*[
MO/@  /<6?GM?WG'0 #Z3.5A=8!]+#C?ASKS4;I)W&^XC;<=SOB\]3[+]3Q;]
M27RL3K/4O#<G<;[CCI#ZR;R=<WQ4'M/@/I9>>UGHGTF\;VR\U"ZN6I-Y6%U@
M]Q,Y6!VD[C8/: #IE+YZ@=L@   #UAU\^O9[.AU/9Z/0
M
M
M                               /A1^O(        N/->N:      */U
M9^4 /I;>:PNJ+T@  %EPOFHO26?GUQU.V;7]I&Z06'&_8K^\[8MCQ5?><]
M![BS\]K^\XZ                    3>2/N\M0       "=QL3J\6    >L
M.OGUZ.AT.AT/1]/H
M
M
M   /A1^O(        N/->N:      */U9^4 /I:^:QNB/N  #S5EPL7H\5.X
MJOT2RX6/M#ZR1BV/"BN[SG99\+7]IPV  '3*RX6O[SCH
M   !].F;RU        .V7'0   #UAU\^O9Z.IT.AZ/I]
M
M
M                                /A1^O(        N/->N:      */
MU9^4 /I9^>]LT  "-N=<H?5YJRX6!VD[C8?60NLE\[/XT5_:<=2TX6#U2^;W
MD !]7Z57HSRT                                  ]8=?/KV>SV=3H>
MCT
M
M                                                   ?"C]>0
M    !<>:]<T      4?JS\H #['T   ^EGY[#ZH^Y)Q>.IVS>&IST^G?%^Q'
MZ3WE:<+7]GP^@  ^''<^                                  ]8=?/K
MT>SH=3H>CZ?0       #S7*P
M                                  =LWZ        "-N>*
M
M ]Q)Q0       /A1^O(        N/->N:      */U9^4     !ZBT\]A]47
MI    !TRM.%K^R/N                                     #UAU\^O
M1[.IT/9[/I]        !PW(/4
M                                   +'A>D        "%UG.@
M
M   /<3N5        ^%'Z\@       "X\UZYH      H_5GY0     'J+3SV%
MU1ND    'N+3SV!V1]P                                    #UAU\
M^O9[/9U.AZ/I]         .&Y!Z@
M                                     !8\+T@        0NLYT
M
M     ![B=RH       'PH_7D        7'FO7-      %'ZL_*      ]1:>
M>_3Q0    ';-K>\C[@                                    ]8=O/K
MZ=#H=#H>CZ?0         <-R#U
M                                    "QX7I         A=9SH
M
M    #W$[E0       /A1^O(        N/->N:      */U9^4      .^+T@
M     ?"/N>:                                    ]8=O/KT>SJ=#V
M>SZ          #AN0>H
M                             6/"](        $+K.=
M                                                         >XG
M<J       !\*/UY        %QYKUS0     !1^K/R@
M                               /6'7SZ]GLZ'4]GH]           '#
M<@]0
M              L>%Z0        (76<Z
M                                          ]Q.Y4       #X4?KR
M        +CS7KF@     "C]6?E
M               #UAU\^O1T.AT.AZ/I]           .&Y!Z@
M        /H !\           !]/L>:                   'J/A\H
M         6/"](        $+K.=    #I'3+S7+3X>X\U\        .D>X '
MDY:          >HZP /AQT        'T]QSH#U \T       .D<Z  ]QTR5Q
MT^           'N)W*@       ?"C]>0       !<>:]<T      4?JS\H
M                                              #UAU\^O9Z.QT/9
M[/H           !PW(/4      "67#5;W@          ZY2N;Z>\WGJ%@=H
M         /I,Y/4ORSU+!ZSS0    $GFC=    '?#U+SU.V+$ZP  EAPU7]X
M .F4SF\U]CQ;#ZP             "QX7I         A=9SH   #OETS>.IZC
MMFPNLDX<K>>H     )G-#Z ![CW'2/4O'4\USH         #T=,O4=<WAN?#
MEH        /IURXZ3.5A]9TCX>*       $SFB='P [9=L7AN?21BP^D\T
M        /<3N5        ^%'Z\@       "X\UZYH      H_5GY0
M                                         ]8=?/KT=#V=CV>CT
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M'V'3+Y4OE8W2>:^'BNL=</-1]OITR]Q].&WD]QVR^QQVYU,YHG1\ )W*P>L
MZ0.==LNF7RH^WP[9>XY:>:[X#AIYH   #W$[E0       /A1^O(        N
M/->N:      */U9^4
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MMBQND[9>I8^Y/XV)TGC27R1>@2N=A=8   ![B=RH       'PH_7D
M 7'FO7-      %'ZL_*
M      'K#KY]>ST=3H=#V?0             <-R#U       EEPU6]X!]2PX
M:KN\$OFYUURXZ<=I7-XKI'*N.W7*1BP^L^P/-#W),Y:@=H)7,6/N>HF<[!ZY
MG\=5W>"RX*WN]23^.J[O.DDGGJ%U@  L^%K.\  Z9DC&H?6>I)O+4+KF?QU$
MZSG0^63^.J_M+'@KNX2<$O22-MSTD8>I>6IWQ8G2>X\5TB9RM=WS8<-5_> =
MLN^+"ZP #W'P$C#ZO#697/4'M.N9)YZA]8)_%7]GR@     !8\+T@
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M'3+Z?25SO.P?+>&LR<:A=9WPDXO*P"+T?*      %CPO2        !"ZSG0
M  $SFA] $G#G;TDY6\]3ME]7U)SMY:@G<K"ZR7RL/K!-Y(75[CW'PY:#ME[E
MC;@E\W'3S0 [XL7I/<=\6+TG6/>;'W.^7Q>.H  ![B3BP^D'6.F;&W.V77-X
M;@[XL3I)O*PNL$WE876?3U'7+KFQ.LD\[$Z2;RL+K.^7Q?<G.WEJ"=RL/K)/
M.Q.D$WE8?63>5C;GC29R0>J9S1.CX 3N5@]8!UR]R_+/>;QW/IUQ8W22^5A]
M9[B3SL;I!]/%?    >XG<J       !\*/U9        %QY[US0     !1^K/
MR@                                             !ZPZ^?7H]G0Z'
M0]GT^@             '#<@]0      )9<-5W> ?"QX('9YJ?Q1.B1APVY:2
M>;Y0]YL3K)7-[EA=8 ![DF<M0.T$C#WFQ.LZ1WYV-TS-Y:@=H+'@KN[ZD_CJ
MO[3I))YZA=9[CQ0 DX=,V'UGPE<WJ6/TS+Y:@=IVRD\[#ZR1SL3K.DDOEJ#V
MS/XZK^TL.*%U>*F<G+3I'BV/N2^;XO+4[XO+4Z9L3K.N9,Y:KN^;#AJO[P 3
M^*/MPV^Q/Y(G1)PC;<M)?,7AK,G&H76>Y)O+5?VGTF<D+J       L>%Z0
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M]60       !<>>]<T      4?JS\H
M              #UAV\^O1Z.IT.AZ/I]              !PW(/4      !/
MX@!#ZO42N;X<M(W1)PY5ST[X?*XZ2N;IEXKTL+K  /4DC%B] $OF]Y")U>;)
M7+43K!-Y(75]27RU#ZSW)WQ8O1/XH/5\H 2>;OD.51>KX3.3W'+3[$3JE\WO
M(1>CGI.XN>KPW)?(.>D7H^DSD^QYKEIXTZX1]IO)\KQ7N(75,Y6'U@ ]1+YO
M<%C;G#;KE*YO->*+PWGMBQN@2,.^ C;<=@      +'A>D        "%UG.@
M  !TCIE\KCI\/<>:^'H1YKW'7+Q7+0=(YT/<=,N&P 'T^QYH#I'3+Q7+3Z>H
M\5]/<<Z]'V/%>H'FI7.Q>D  ^GJ/%#Z>H\4.V7V.6WO+EIURY:#KERT]'7!7
M'0>XYUTCW'*AYKW'7+Q7+3Z>XYT.N7+3I'3+GH/%>XYT ![CKE\KCI\!WR1R
MV]Y<M.D<Z'T[9(Y;>0   #W$[E0       /A1^K(        N//>N:
M*7U9^'P                                             ^YO;SWT>
MSV=3H>CZ?0              #AN0>H              =<OASTZY>XC[
M        "1A'V                                       %CPO2
M     !"ZSG0                           'N/%
M                       >XG<J       !\*/U9        %QY[US0
M !Y/!R.1Y/@                                           !]/1[.
MAT/1]/H               .&Y!Z@
M                                     !8\+T@        0NLYT
M
M     ![B=RH       'PH_5D        7'GO7-      'P\'@\'D^
M                                     'T]'L]GH]
M   X;D'J
M                  %CPO2        !"ZSG0
M                                              'N)W*@       ?
M"C]60       !<>>]<T      ?#X>3R?
M                 ?3Z>CZ?3Z                #AN0>H
M                                                          6/
M"](        $+K.=
M                          >XG<J       !\*/U9        %QY[US0
M     /@/@/@                                           !]!]/H
M                 .6I&V
M                                $SG?4        #G7RP
M                                                           #
M[+T@       #X4?JR        +CSWKF@
M
M
M
M                         ?"C]60       !<>>]<T
M
M
M
M                                      #X4?JR        +CSWKF@
M
M
M                                 #B? ?3J?0
M                <CJ            <8X5-
M  !\*/U9        %QY[US0
M                                    !"BB/E?"?9>R@      1XY63
M5     %46I6R\]9MI0       !&EIM9T4H@RTM@O+)DO&,^>:L[+64  ")+6
MZS>R@     9R6^UGK*       *HM2MEYZS;2@    (RR_-9U,?5
M       &3S>^L^E^$,T]DF4                >8HK+]0
M ,W+HM9]2@          >8R-6EEY*                          /A1^K
M(        N//>N:
M                            !QERUFH3NOPSN;8;Q9S7PYG4',^GL \'
M@[ I\WUO-M*.8.@/A\/A[ ,B:U*O.N>\6LU]/8!Q/9[!\/AX.H !6RT:=M9U
M$U\C)UJD\RYG4U<N:S;G>9>;EC2:G:4 ?#D<,VKWG0RCB>CH    9;-T>\]I
M?AR.P .9]/8!R.@/ID36I5YUSWBUFOI[  /AR.I].>;E]YU<OT
M       R>;I]YZRBHS>&\7TUXBOKJDY1$/D<:L$]+%C[7!+!8L1:FIW40HX5
M.3LHBQ%J:G=>$?:AG5)JP\W.[SIH[2P#Y5@GI0!QB#4A)B_(BV2U$,F$0^0L
MF*/,<+.,OFRP7Z1#Q'NSY++LBKTB%4].<L6K!/:^8@'FIR=5BQ]K@G19@.,+
M.RBOS:+>='$I84<:G)U4<(A5+22L0E@BQ)L2UY\J>GM0
M/A1^K(        N//>N:
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M<T
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M0N6S=)O-!C73>;.)2^P                #X4?JR        +CSWKF@
M
M         4V;YWB[FO$1*BRQ-9M\:J=YT4M9FT>LR5 T-E1G4.SJ0HU6I6XU
MZWGOC6>UF4H%]9G<:TV\=)H 9$UR56=<]XN9J%FU>\W>;GA72/&LZ7.LGJ:V
M49$UP !QS<[O&HFHN;2;QI9H97-TN\Y677@H\V3O-=C474EV,:MMYFRQ<VHW
MF\S<Z*ZQPU-3+29O?>*S.]#K/:4#+9NCWG+9U)N2B?9TQJ/O-W+#S:G>96-?
M=XMYH9,UAD37)59USWBYFH6;5[SH90,GFZG>/<UQS<YO.FQK+[SJY0
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MA1^K(        N//>N:
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M[*               /A1^K(        N//>N:
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M%*0ZEV7<L.*6NR=Y;?4X9M)7PL[+.6JEDZS,E               'PH_5D
M      7'GO7-
M
M        'R,L:BSTH       C2PM9MI8V;0[SIY0
M           $9&M<                          <,W/[QIYH
M  #A%*MCK%A-                              ?"C]60       !<>>]
M<T
M                                                         #S&
M5JWLM90       /D9\XU]+VR3*                                *@
MMP                         #Q%=J6DH           %7+RUFYE
M                        'PH_5D        7'GO7-
M
M
M
M                                      ^%'ZL@       "X\]ZYH
M
M
M
M                                                   'PH_5D
M     7'GO7-
M                                               'F(]DI8A+  !$
MB59]4            "OCU9.4             1"6
M   #Q%21J[I;G1:R)]G10    !R.H   !R.H           /$5VI:2@   54
M6=GI0(,==3SF_+/4OC4FR\CJ   <CJ5!;@
M       ^%'ZL@       "X\]ZYH
M                                           J,V3O,Z4
M    9J727/U0  !QS<[O.HS<_9H%  &4S=1O'N:            $#-I-YNXG
MJ             ,E+K+GZH                      &:S9F\SY84M9K.JE
MS6;>;Q)F@    !DS6    \9N8WG52@          #AFY_>-/-    97-TV\=
M)H"%'6R#G7G>)^=>+.^=9S>=1*  (.;7;Q?S546H
M             /A1^K(        N//>N:
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M-HCQ5K98R@                 ?"C]60       !<>>]<T
M
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MRYN6_P!9DYN870:S)E                 'PH_5D        7'GO7-
M
M         ILVNUFT+$ZK09MAO,^6/$:HT56IKY<]FV>\<<;Y;Q<S0&2EU=SZ
M7F>S)&N0N6S=)O.=QKIK-B6"^C)2ZRYSN=6V\39KQ+E-9M<:][Q;37'-SN\Z
M?-R>IK9>)&B,4IK]9R^-ZC>/<T(F;3;QI)H<CH18CU7QTUFXQO.[QJ9J'FY_
M>;>44TNEUB3-  5F;'WF5C4'>+^:&8S;W6<W6NE'(^YN8WG5RC(FLC)%A98$
MY:O-K=YLI11&HBCUG330R4NLN?JBES>F\6TT,A&L,KJ:V49$UP
M       !&BO*BM8F>SJ\WB3-4.;.WBHQN_WF1+XS<KO.AQJHWG1RC(FN !G<
MV'K-@6YTSK,;SJI>451&J)%UJ6.;EK-5+EJU8  */-D[Q9S6<S>6L]5^1&UG
M38WGMXU$U\C):FNE@Q7UP(5FRERLNHUGU+49OG>/&-RMXYXWYWCWC?/>+/&\
M[O.HEXQ5$>H4:'66-U^\7\UD359N8WG5RBHS?F\<<;G;Q8351FMXMYH><W)[
MSKI0! BOKB0[-C+DY=5K/S&L=J6((L6^LVTT                 /A1^K(
M       N//>N:
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MR.IJY?I'CK9V4                 ?"B]60       !<^>]<T
M
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MW4V4N3EU6L^I<_FMYF9M-6GLCYU'UFVE                'PHO5D
M  7/GO7-
M                      YQ3'.K"RQEBQ3U>)5R\*L+..;;6?5H,V9O%G-
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MT*(,<:GIU7C%39>*                /A1>K(        N?/>N:
M
M            *V*:M2GI0                             ! ED:SWE
M                                                         $&*
M0N-2QE$:/5G=0                                     (T>K.Z@
M            #X47JR        +GSWKF@
M                                                    "HB;9*4
M
M                              #G'&R4H
M                                   ^%%ZL@       "Y\]ZYH
M
M
M
M                                                'PHO5D
M  7/GO7-
M
M
M
M  ^%%ZL@       "Y\]ZYH
M                                            'B6HUFZE ^12ZEW+
M1%Z                "NCKJ3)0*2+JRHFK/6:S.K/6>LH   X2P-9MI0
M      *.+RPH       'F.5G=0                  *;-JM3063I0
M       .4M#K.CE       '.(-EDH        %#+::STS8UD]<N:@     J\
MUO-I*     !7YL?>;B4"/FT^\Z"4  9>-/9]4                   #X47
MJR        +GSWKF@
M                                       ?(A63E \YN5WG62P">
M             "CS96\64T!!B;9FLZOMYH<:OMYD2@  ")FT^\Z.4
M  " 3P        4^;ZWFVE                  'PS&;H-YD2CB=#T <SZ>
MP  #X<CJ?0?#D=3Z <3YFY[>=1* /AR.I]!\/)\.@ (6;5[SH9?A\/A[/!X.
MI]/A].1[/0/)S.I].9[*S-X;S=R\CJ#P>3J#X?3B=3Z>0>CX>#Z>P#B=0?0"
MLS8^\V\OT]GP\'0'(]GT^F2EUESR7L                   #X47JR
M   +GSWKF@
M                       5<L.SD$T)RFJ>R$:&R-G5;8+JSMG57K-Y*,[%
MZ4FIH):26%9WB)J:R7.&C*"/1#J19H98\4%#L65D^4"@CT0ZD6:&7G&?/%=4
MOR%-0;(QY-#9VS<\>*])H2FSJ5O$S.J*M E#-7^LYO&K[>:'&K[>>F;GSQ79
M+\^RY\XUTAJ:.4"#+36?"RLMI8<4E"QLMI::6/9&L[RZ,%-+/UFFS=%9#FJ6
MSX6EEI+5RU=GTNK)LM-+!L%W9,E'R,H+-)4'.JVP75DZ4
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MZYH
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MKJ,]J:F7Q&6K5QDK-<O"(FI9R@4^;ZWF9C5!O.HE\1E*UJ>E
M    R^;HMYJ,:D;Q:S7&7,ZSH\:H=YT\OF*NSUG7'>;J6%FU>\SL:K]YO8YR
M]K*+.K#>+&:@YM7O$W&^.\7<U$S:+>=1*!F\VVWB=-0LVGWBYQNCWC437#-S
MN\ZF4"%FU>\Z&7*YN@WB5-5<6=GQ<SFWV\5N-]-XN)JHS?F\>L;A[S>QQE[V
M4&=7&\1\;X;S=2Y$U4N6UG6RC-YMMO%1C=OO$Z:S^;8[Q'QMO'?&ZS>-'-1,
MVFWBQQN+O%[-<,W,[SK90*S-@[QH9J%FU6\W.-4>\7&-U&\:2:\1D;-BN1EU
M.L]9<MFZ/>>TH                  ^%%ZL@       "Y\]ZYH
M
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M>]<T
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MY[R@                 #X47JR        +GSWKF@
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M9*!7YL?>;B6+FU6\V^-4^\Z"6HEKK.R038+EXT]GU<[FWF\]I0
M       !\*+U9        %SY[US0
M                                         *7-Z[S)ED)T7R>3H#X1
M3TDE0.9Z/1\.9U/A$)"?%ZG$['(Z'TYGLKXFV%H\VQWB?- <CH?3F>SZ<XC5
M*3VO@'L\GDZ'.(U=T[+X/IZ.9]/)U.1T.9T/ISB-4E.BCQ$6I1\.@ (T>*EG
MT$>.=2CT<ST>@>3R= <3L"-'FI8/A%/J2E'PB'I)2@ 0R0GM8IZ22H
M                                                         B2Q
M=9M98>;3;QI9H    <9:S6;F7C&:U-7*                     /A1>K(
M       N?/>N:
M                          !39O7>;24              "GS:_6>TO+4
MTT?5
M                                                    'F,^<J^I
M?$A0    *"6/8+RR7*                     /A1>K(        N?/>N:
M
M                             !X/)U
M
M                                                       !\*+U
M9        %SY[US0
M
M
M
M         /A1>K(        N?/>N:
M
M
M           !%B19Z4          "+$FSZH         Y1\L[*     !XCE9
M(4       1XZ6=%                             'PHO3D        7/
MGO64
M                 "ES>^\V<H                  A9M;O-_+2%V
M    5,MEK,3&H6\7DT    !72R-9DR@   "+FY769"CR7EEE* ,H:L
M  SF;=;Q18W?;S(E                           %'+;ZS6XU)WF=*
M     .$M/K-_+12W6L^Y0   !XEH-9T4H   JLWGO%S-      0<VMWC030
M S)ID*   *'-G;Q830                             ^%%Z<@
M"Y\]ZR@
M                    4F;(WFSE\Q$KNG9>1T/IR.A].)V/)$.Z=E^',Y1W
ML]J!XB+71)*CX1#JG=>9Z/1X!]/!]C*5JCX=@>#Z>@>3R<8]62%'DBGTEGDR
M\M_K$F:\G0^$4]I(4<3['"I8,Y+9:S92\HCU)3HH  BYM%O&GFAPERVL["7D
M<XZV>%[G$^QPJ6<HY5+!\(I\)9].(CY9Z7H9K-OMY]2]@> >P
M      <HK#S5@DI?A6QPJQ22M<6(*XL2!$FL[+*UFRE]I)5%=5B 5Y]B)5DD
MA?A6Q'J2EDM1FU>\Z&.,LZSZM9'&K))"Q(5 .R6BUN;1[SHHZRUE>TM#VH%5
MFQ]YZ2]DLU$:*ZOI:)U7G%6++4B9U6[QH)J#'6R2HBQF*T"6*P8A5+2P4 4.
M;(WGG+W2S408A5+2P7G$:R-+YLM%K(]66B_2+%?7=+-0
M  !\*+TY        %SY[UE
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MZK>;N6HEEZQ/QO*ZSH2!-1-9O8J)JTUB1G>>N;Y:^7[K%Y-
M      ?"B].0       !<^>]90
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M>:K\VOWC0353F_-XY8WQWF;+\BFU-?*                  !\*+TY
M   %SY[UE
M                       I,V1O-?C5MO,V5&0K7F4++-D[S31)SJVWBHQO
MEK/=1TLM,:S^\:>: $.6@LDGN/&I)QKWO%M- 46;,WBQFJC-^;Q*QNMWC09U
MD=-='&7.ZS8XU]WBVF@(.; WF]E&0-3&;.U2HK-36RY?-T>\Q,:@[Q)QNIUF
M8H%X96S6RC(FN,]FVN\S):V*PBUHK)LH $7-HMXT\T /&;E]YU<HR)KC(FN/
M.;E=YUDL?-HMXT6=9DZ62RI-@N3EU6L^I<UFWF\46-WV\]<W+ZEQC7#>+J:
M                'B,K5HDLSTUK;G)+KT+PCV97370,@:],QG6@WFGQJPWF
M?+2YO3>:J-6H RAJP4>;)WF!C7K>9\L"69K,K&J7>=)+E<W2ZSDET(/A*2KS
MJ5O%E-56;SWBSQO.[SJ)?!"BN(NIJY0*K-\[Q;S7C-RV\Z+.L[<VQ)ES^IH<
M:J-YT<HB'C-I-YEXUUWBYF@!D37)F<ZO=XDS7C-RV\ZR4"AS9V\6$U49K>(&
M-WN\29KQFY;>='C5'O&EFH&;7[Q?S53F_-XX8VWF;*/J6"@
M     ?"B].0       !<^>]90
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M=9O&CFHV;EMYV4N3EU6L^I<UFWF\46-WV\R)<WFQ]336=I0
M   !'S<UO.IEARYFS9V4&-3-YL,W-&DU,OFZ2SC-9S6=I&8SK0;S48UWWFVE
MY2Y-+C6;J: &1S;C>9V;FS3ZF7SK1:STS<RMQK,S&L_O.EES.;I=XSN-V>\S
MLW.+>:S QJ5O%E-56;SWBTQO+[SI\W,5I$2YNS6J!59M3O.EEJ<W[O$C&Z_>
M=!+4RU6LZS-RE:-/$U1ZS=XU6[Q?9UE#2:DF4#)2Z2YA9U#WF]EI\W[O%Y-
M4.;.WBPFJC-;Q]QN'O-[+3YOW>+/&Z/>-+-0,VOWB_FJG-^;Q)QNDWG1Q!SJ
MMWG32@                  ?"B].0       !<^>]90
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M*
M                                     /!19MEO$Z: $'-K=XT$T
M                              /!39LG>+.:
M        YQ6D#4TLH &2EUES]4
M                             ?"B].0       !<^>]90
M
M                        !1R_-9O90 (T1-2TE
M              %/+'UF_E^@                           'B*BK5.J@
M 5Q8@
M        'PHO3D        7/GO64
M
M
M
M                     #X47IR        +GSWK*
M
M
M
M                                  !\*+TY        %SY[UE
M
M            \Q!LL%   'F(5D]0           (,2K.B@? <XX63%
M    $:%DE0 !%B+9:*!PB%9:*   !&C[9ZEY62U    '"/%DI0.4<+)B@
M                       0I?&LV$H                  %+%OJ,WG9W4
M   <HK-2XE          %/+::STE      BDH^$<DE$7H
M       /A1>G(        N?/>LH
M                                            'B6JUFXE   '+-S>
M\ZF4           #-YMWO$F: S>;?[S&QJMWC030          J,UO%O-  "
MES:/4UMDF44&;5;SM)0   *;-Z;S,S8^I8R@   ")+RUFPE A9M7O.AE
M                       J\WCO-U*                  !!B;939UWWF
MSE   '#-S^\:>:          &8S=!O/>4     #(FN*[-A[S>RP">
M               #X47IR        +GSWK*
M                                                !"CC4(O4@RUU
M24N%^1666JU1XB-5NE?+QLNC[G69WF?F^++@[RU%6X*@MRJ$<]2QS:@^5;I)
M6/%0++@[KRBF/MD6:OM8DS0C1F"SUF?C=3O/?-\V7)UEJJX1-U.^;4BRX.ZU
M,6MGU:R)]GN6F.-33ND3.N&\^<WI9='I0*7-A:DNYO)KY&9J,; \13'*K5)B
M_(ICC267K,W-X63UKXKJD)<'F6H(]24N%CQRLG+5Q"KO'#4T,H
M          JY:RSR3K+N6CE^60SK9HX\2YX\U]B9J74H$:**O).LNI:V6IL%
MM992T,OU(53K/&;#JULMLW.GPCU:I!EX5?V2,ZI=9OI49VM$9Z!&J=9>2Y^6
MZLS$>K+=?%EO+\C/V:%0.&;F=9D+X+JR=+5RUEGDG67<M;+56?"VLLI:R6JL
M^ES9.E@RTMGLCQIM3O*/D9\Y430G26B6-9Z2_(4UGK+JR%C7#6=%51+HS/P(
MM3++Z7A&?%=RPLZYU1V";9=2@              ?"B].0       !<^>]90
M
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M9L/>;W-R-:XR.;H]XES62EU&LY[&KK>9DN:S;#>86-6>\3YJE+E/J@
M       #X47IR        +GSWK*
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M-A[S>YN1K7&1EUMS]7,9N@WG+RZ]"U.;]WF3G6>3U99U<2@
M ?"B].0       !<^>]90
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MWF]S<C6N,E+K+GZN8S=!O.;SK2ZSVEHLV1O/7-G6<I<VM_K,R4
M    ?"B].0       !<^>]90
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MN;Y:J67K%5C=UO/O-SY<:G3&HN\S\:H]YO)::7KK.AEI(N-3W*
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M7&G2HFI>LV$H             ^%%Z<@       "Y\]ZR@
M                                                          18
M]62%$2*^NR6B_(@V6"UQ8GR(%E@O.(UDN6%9PE^66IZ6/%;4I"V!7Q/L^KSB
MK/-6:=UYQ5GRK-.R^8JSY9)64G10(L5]6D<;)B^8A63Y:ZRQ4<HJS[9:'1><
M51UL[2R[/"\(XU'E[:Q,SI9)7C'*R6H$6/5DA8$2[.BUI9'F*PXU8I*45L1Z
MFG5/4O*R6L2*^I26*\8JZZ)-E\V=)?%DI8<0*G'U)BUL6%GI0
M       .<1JDI\7V>#H?3F>CT<XCU)![ !PCE4L^@BPLE*.1T/IQ.P.)V.)V
M/AS.I\/!T/,1*E)X7L<3L#D=#F= 1"2GM<O+I-9Z2@#X>#E"R2HYQ&J2GQ?9
MZ(D*E'T$2%2P"-"SJOL^@'B(M=D[J/)$.R=U'&.5DM8D=K/B]CB=@<CH0(F6
M?%ILV;O%C-1XY5+/1S/1Z             !\*+TY        %SY[UE
M
M                                           %%F^=YF2TQI;.\H
M
M         'B7,I+U+Z4                           5.;6ZSVEXV:8]*
M                !\*+TY        %SY[UE
M
M                          @1RJ<G90
M                                              .1U
M                 !X/!V                  /A1>G(        N?/>LH
M
M
M
M                                                     'PHO3D
M       7/GO64
M
M
M
M      #X47IR        +GSWK*
M
M
M ,EFM9^K\)=FAE^@%'FS=XGS0       B9M3O-IC57O.AE       %/F]-YM
M)0  !G,VXWB7-           #SFY7>=9*!QB#9:+DY=5K/J4          9.
M75:SZE                   'PHO3D        7/GO64
M
M
M                    9+-U.\=)H9;-N]XDS0YIU7T? 1SJG58AW3JHXQPJ
M0G5?!\(Y)/)'S:O>;V7Z>P<3L <3Y"SNO&.-2CT<SZ?#Z1CLG58A(3HN<S;;
M>4LI/:^ >SR>3V<SE'>SY+&J0G51XB+4A.JCR13O&8U-9*!69L#>;^7+2Z>Y
MCK*3VO,' EGB(M2$ZKY/)T/AX.A\(AW3XO8R<NGN8ZRD]J
M    /A1>G(        N?/>LH
M
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M"C].0       !<>>]90
M
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MUF<V]WB3-                  ?"C].0       !<>>]90
M
M
M                     !DLW4;QUF@!F<V^WB1-4.;.WCAC;>+>:HLV9O%C
M-9O-NMXA9W662SA%EJ?<:C[S=RQ,VGWFVQJKWG0RT&;/WFDEU2?5 R)K4^RX
MPM* L+(N-=-YY8UUWFUES^;9;S.ES&;H-YH\:N]YD2P,VNWB5C?G>+B:K\V!
MO%QC>?WC3S0KHK"'6ALJ\:\ZSV4=;/>->=XN9I&5LU2@0,VOWB_FLG+JM9]2
MYO-N]XJ<;L-XGS67S=!O,B7SFY3>;S&H>\WLL3-I]YL,:B[S>RC)FL,G+JM9
M]2YO-N]XDS0                 'PH_3D        7'GUU@
M
M
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MYO,ZS>LZB(TUF-9V<N3EU6L^I<WFW>\29H                 #X4?IR
M     +CSWK*
M
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ME                  ^%'Z<@       "X\]ZR@
M
M
M                             ?#A&>LU*@
M              <9:76;^6-+0:SJ90                    /A1^C(
M    N.%ZR@
M
M
M<9<[9>63)0                                    !3RP;/:79(4
M                 #X4?HR        +CAKK
M
M
M
M                              'PH_1D        7'#76
M
M
M
M                                           /A1^C(        N.%
MZR@
M
M                                     "MCM9,4"!'NR8H   $")MD6
M7O9U4          #Y%74Y.Z@5D2[)"@  #Y%?98K7%B           >(A66"
M@ "!$RSVH       \GH                     'PH_1D        7'#76
M
M
M                                  !D)>FLZN4?(QRV6L:":    RV;
MI-Y@YU+UF1*          !XS<9J6USH)H1\W(:FCLM)0  !YS<KO.LEI"[
M         *C-I-33V2Y0 ,QFZ#>>\H      $/-K=YOI0
M     !\*/T9        %QPO64
M
M
M9&7NF@U.\L#-I=23<Z":C14'JRX.R\8ICW9 FM-K,/-E6=I:@BU8V6,L>*DY
MU8V6,M='BHJ7JU$1:L++*4  >,W*;SZEU:?5I,V#J6MEI+6Q7U*2W7Z08K*F
M14:FLEIRX.,4YYJW22L"*VOI;I)6J.,2-2PS:8Y5:I,4 #*2W"0=9T,T.,4Y
MZLA36BUFNEN 0([6?):H\U963Y:R/=5I,LMI<_FQ-9T![EJ3G5C98R^(ICQ9
M,64DA:F(E3[+.4             #X4?HR        +CAKK
M
M
M                      R,MRG/6;F:SLLQ(NLWN=96M&GF6@LU:Y26^UEF
MY<V&I28U9;S QKUO-K+G)=!K.?S;ZSI+ES6:E#C7G>;6(.=-YMY:"6TUFPE
M \9N5WF=C5CO$Z:S!+ED:S[QJKWG02U6;YWBUSO-7.E*W.JS>-9-9$UQE);W
M6>F;G;--+G-31RQLVDWG52XS-O=YFQ0S5KK,O-S9I-3O*!%S:+>=-FY(U=GM
M<K+>:S[S<L:W4H<:N]XE365ETUSF%T2?9<O6O3-YUVWFXESDM_K,;&H&\Z"7
M,Q?6=)<N:S4SV-6&\S,W,+?:Q&QOGO-S+12V&L64T             /A2>C(
M        M^%ZR@
M
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MS9V\?<;K]XOYKC%>1RJ-;J9:77@H\V7O%+C<S>?<O"&LZ.:
M'PI/1D        6_"]90
M
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MFJ'-G;Q]QNOWB]SK)U=I+,[G6DWG+2ZY/JT.;-WBEQN\WGK+Y/22E
M      'PI/1D        6_#76
M
M
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M;1&AUGCC<+>;B6FEL-8L\[IM9NY0           !\*3T9        %OPUU@
M
M
M                                  5T6%GR6!98KQCC9,7E%6*M$ZKX
MBK/MG>6;9%E[V=5K8C58I*6'$"I2=9>UG&7O9U45T1:F)/7Q%#9H5 ^17V6*
M\(XV35BQZLD+#B!7=+-?I'BMJ8GE; KBQ/$59YLM3HM7'&K!(ZV17%B#S%8<
M:L4E*!!CK9)4"''RR7+5'VR1++L]KQB/9.408A5,3[+*LBRR[/:Q(ZV=9:@F
M6)8%2DZR]K/BQX\V0,ZLMXG35?$2I:6"^8SUFC4            ?"D]&0
M    !;\-=8
M
M
M    'B(-EBH                                      &;S96\]<VHK
M4I[4 #Y%=99*            /A2>C(        M^&NL
M
M
M
M                  ?"OCS4].B@               #X4GHR        +?A
MKK
M
M
M                                                        'PI/
M1D        6_#76
M
M
M
M         /A2>C(        M^&NL
M
M
M          0)>>LV<H                   '*6FUF^E  &=-$
M                                    #X4GHR        +?AKK
M
M
M                                     %7F\=YNI0
M     /D<+)"@ #(FN
M  !\*3T9        %OPUU@
M
M                                                         4LL
M*SS$C4T,N>S?FL\5\IJ#G+G#W7.+#4NI0(4M%9Z)%F@EIY:ZP6-EQ+G)?MD>
M.^I]S8I8:EYFY8Z$>K!(RQR^LL):26#8+>RRES$<R;J2\ZJ+/I8V66=46LZ.
M6AEC6>(FZE[+D37 '&7.6>SP6UEG+3RU]GR.VI?YN<U-/*,W+H-9JLZK[/A9
MV6\N:CR>]23G4.SP6]EG*                             !\*3T9
M    %OPUU@
M
M                                            !%)5V#(2ZZYS>=6F
M\6,UG<VSWBMQNQWBPFJ/-];S=2@9272ZSVEI8L#.ZFKE&5ETFLY[&KG>)\UC
MY=3K/;-R5:Z,96P3QG65WG7RP\VJWFXQJAWG42^8R=:U,?-:O6>N;DJUB>EH
MBVES^L:7.JBRY7Y&0LV"Y$UP!PS<QO.MCY+DZUJ4JW8,C+J]8S>-WV\^\ZSN
MLZ#&L[O.JE^1E%TVLYO&KW>)LUD(U%G26!99*
M      !\*3T9        %OPUU@
M
M
M 4TL&SZ0C8IG,ZO-XDS5#FSMXI<;TF\]I:[-C;S=2A&0K7@$'-K-YT,HS^;8
M;Q3XWH=Y[RY*767/U<B:Z,C6N.>;F=YU4L3-I]YL,:H]9DJ.1IK,M+KCCFYS
M>=3*!PS<_O&GFJ26'9Z(5FRER)K@#AFT>\Z.497-TN\5N=U]GTA1K]9@XW$W
MCIC?7>.F-P-XOYH9W-M=YHL:TV\=)JMEI4^67-6DH
M          'PI/1D        6_#76
M
M
M    (^;G-YU4J,<NPUG.8U>;Q)FJ'-G;Q6XW:;Q.FJ?-\[S=2@9*-59[6DEF
M)2:FJE&6S=!O-!C6AWGO+DI=9<_5R)KHR-:XYYN9WG52Q,VGWFVQJGWC2S0I
MXM[,DNN/,9.S7*,]%R4&LW6-TN\Z>7S&/LV2Y$UP!PS<WO.KE^1DJT\9G4UD
MJ,@NLUCWG65L]2Z>R/G5#O.HE&4ETFLYS&M-O'O.JBRX7E&3LV*@
M                     ?"E]&0       !;<-=8
M
M
M               \1E2=7,AQJ=9H,;O-XDS5#FSMXD9UG*E$6+'4NI0*Z6FL
M[QYU-++0YL?64O?4OY<QFZ'>>TN2EUES]7)&MC(UKCGFYG>=5+$S:?>='+G)
M?-SYEDZE]+D37 ILV!K/N61J6V-9_>-%G66J><R$:U,HNN .&;E-9FG.6TU+
M/-RI,L\+$C2ZS)FL_F^=XT4T,_+RN?DLG4O9<KFZ;>.DUG<WQK/V7MJ7TN5S
M='O/>4                            ?"E[P        6W&]8
M
M
M                           'PY'4'T   ^',Z@  \G@Z@','0
M  Y@Z   \'PZ  ^'(['P^@ '#-S^\:2:'L'PY'4'T%!FV6\39H#F#H  #D?3
MH                              #X4O>        "VXWK
M
M
M                                                           X
MRT>LZ*4   #-9K>=+*                                     /A2]X
M        +;C>L
M
M
M
M       ?"E[P        6W&]8
M
M
M
M                   ^%+W@        MN-ZP
M
M
M
M                              !\*7O        !;<;U@
M
M
M
M                                          #X4O>        "VXWK
M
M
M
M                                                      'PI>\
M       %MQO6
M
M
M
M      /A2]X        +;C>L
M
M
M
M                  ?"E[P        6W&]8
M
M
M
M                              ^%+W@        MN-ZP
M
M
M
M                                         !\*;O        !:\;U@
M
M
M
M                                                     #X4W>
M      "UXWK
M
M
M
M     'PIN\        %KQO6
M
M
M
M                 /A3=X        +7C>L
M
M
M
M                             ?"F[P        6O&]8
M
M
M
M                                         ^%-W@        M>-ZP
M
M
M
M                                                    !\*;O
M     !:\;U@
M
M
M
M    #X4W:        "UY7K
M
M
M
M                'PINT        %KRO6
M
M
M
M                            /A3=H        +7E>L      #A9&L
M                                           D2]Y?H
M
M
M                                               !\*;M
M!:\KU@      4_3%;O
M    'J6\Y;E37T^@
M
M
M             'PINT        %KRO6      !3],5N\
M                              #U+=\MRIKT?0
M
M
M                                       ?"F[0        6O*]8
M   %/TQ6[P                                              !ZEN
M>6Y<UZ/0
M
M
M    !\*?M        !:<KU@      4_3%;O
M                       ]2W/+<N:]GT
M
M
M                              'PI^T        %IRO6      !3],5N
M\                                                >I;GEN7->CT
M
M
M                                                        ?"G[
M0        6G*]8      %/TQ6[P
M               /LMURW+FO1Z
M
M
M                     !\*?M        !:<KU@      4_3%;O
M                                         'J6YY;ES7L^@
M
M
M                                               'PI^T
M%IRO6      !3],5N\                      #T2\;A;P    !+SJ)K(
M'T^2K   /I(SJ-K($K.HNL@=9?LO'60![EZ2\-9    ]2W/+<N:]'H
M
M
M                                                'PI^T
M %IRO6      !3],5N\                      "QSJRY[HNF..L@   "?
MC4#>0 +KGNGW/-R  !Z+KCUH^W(#0\>N>[<@.\OV6/K( ZR]98NL@   #[+=
M<MRYKT>@            0X\T/9*/H      (\=;/:@<H^6=E
M \1RLD*                 !YCA9)4"/'2SHH                   B$L
M                  $2)5GU0      (T=[/2@ 1"6 >8X625         A1
MSLL5  ^1%LEJ  (D2K(TLFSZH  '"/5B7S9W4 "/'6SVH      $,F
M               'PI^T        %KRO2      !3],5N\
M        "^Y=*W>)6-U/7GZ+7GOW+#U(.\6N-])8Z5W3%ISW5],6N-])8Z0]
MYON6X&E9TYVO/?26'J0=XDRV//?+4[XU1]N0&AX]<]VY 29?LLF6LWDEGC<+
M69&=<M9E9U(S>-573'>+/&_!X2KZ8'J6YY;ES7L^@           &/EL;GZO
M*(NIJX]*     !42S=9E2@5>;QWFZE             BRPM9MY0 (4L36;B4
M              <9:O6;J7,FF*'-G;Q830                   R)KD*
M               !E)=1K'N:     'B6@UG12TLMIK/:4 #/F@*/-LMXZ9W5
MZS=2@       "/FYG6;PLE  YYN9WG52@ "@EO;G,9UH]Y[2@  4F;(WGMG7
M'6;.4 "HEFZS*E      %7F^MXLIH                    #X4_:
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M.(%3CPE@H'R,O6I!#B!4I+%0 *V(]3CTDI0             !\*?M
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M[H+F]6JEXZSJ)0(>;5;QH9J%FT>\WLM7+)UBWF@*C-B;S:RT$MEK-U*
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M;G=YU$H%3F^-XN9K/9OK>94OB6LUC5S0&5S=+O'6:J\WCO-U*
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M.AEK,V-O&AFJF+6RISJ+O-I+0RV.LW.;4V6Z@            #X5':
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M/2TT7%GQ:^(]?)?6L7&=4]ERH             ^%1V@        M.5Z0
M  *?IBMW@        "QQNUYZH^N(NI.Q;GGNDZXAZSVE[2B/9-SJUYZI.N(F
MI)S;SGNNUFKZ8                                   ]2W'+<R:]'T^
M@
M S6;>;Q)F@
M                  ($4AI=3K*         *_-JMYNI:J61K%Q- "FS9>\3
MIH   46;[WF=+0Q?ZDN4              ?"H[0        6G*](      %/
MTQ6[P       /<LW.I$O-)$LS.@*S>*[>;GGN7G7.SZ>Y:_>?43LZ @ZS3=<
M?$    'I4>;!]5'RP   >I?-@          ]2^;           !ZEN>6Y<UZ
M/0
M  (,2[/:@
M                 5<=K)R@         "OB)4E+)0 /D0++!0  !YBL.-3T
MF*              !\*CK        !:<[T@      4_3%;O       'J6]Y;
M[2Q=21+\*?ICT<;/)>\NGPJ.F.%GTDRW//<6RKZ8ZR\K.-?$     LL:AUQU
MD6>-<E@[P   +[ETH>O,          7W+I0]<$    L,ZC'#60     /4MSR
MW+FO9]
M
M                                                       /A4=8
M        +3G>D      "GZ8K=X       M.>['.J'ISX:GN71<NE9O-;O'U;
MOEOO+G^O/Q8/J_"3FWW+='UQ$UD      7'/=/TR06>-<EC:SUEDR\$A[SZ)
M^-<UL<VAZ\^LL[.N*0MR1'665FPM2+K/HGXU\6!K/JSOG4B7F0=Y^I/QKXL_
M-H>N.D3LZ\$#>>L=99,O!(N\WO+I%*KKS      'J6XY;F37H^GT
M
M
M                                        ^%1U@        M.=Z0
M    *?IBMW@      =)='QZ4_3$#>96=<K+'&I6=9_MSL,6VY[H>O./J 7_'
MI$U*OIBZY=.T9_M@@     ^EMSZ5'3F!9XUR7Y<V//I4].=MC=/O-IFP:]V6
M7/I0=N-YRZ5.\S(YR^M3OC51TQ=\]T^\V^;76?;)N-UW3G=<NM+TQ99M?4Q.
M,O+6;KEUS??C>\NE5O/<ZXU'WBQY]*GISML;I]YL\V#43>       /4MSRW+
MFO1Z      $457H   !\(Y)*(O0 5<LO69,H        %$7H        /D4N
MI=R@            1X[V19KCK-C*               (4OC69.=0-9MI0
M (I**F)^IWE                                ^$<DE/%M9Z4 4TM?9
MIK/<H      $"7[K,Z4"/+"UFUE    HB]       !REK=9MY0 !1%Z<H6=5
M   %$7H                !\*CK        !:<[T@      4_3%;O
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MKQ9)4               5>;QWFVS>%DM0   !XS<QO.JEB1WLZ*
M                      ! S:_>+^:A9L'>;N4!&0K6'L       %/F^MYM
MI0(6;5[SH90   ,B:Y"@      1\VBWC2S0  R)KC/9MKO,R4   0">
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M!+\KI9H8^J!G#1E!'HAU(LT,H J):^SR65EO*          /A4=8
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M5'3%IC4W&L[VY^+              )>;X6/K(
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MB9M!O.GE]1C[-BH          ^%1U@        M.=Z0      *?IBMW@
M 3,ZNN6\YVY^+ .TNCX]<YVY3\:M<;S/;ESL ON72/94], "3G5YSWY(.LV>
M-YSMRY6                                       "9C=OSWT/1]
M$8U;"Y]2^-31RY26PN?,M<7VL^\;S^LZ$SJZX&6S=)O-)C5EO-5C5QO$N:H\
MV5O$O.LU4LBQ*U-#+EI=/<^E S,LBYY2PM382Y7-TV\=)JMEI[FP6L-'9%QJ
MKUF>M::5,]-2;E+QU-%C65WG62Y$UP,G+JM9J<:K]9Z2PC3ZSRSN%K-Y*!RC
M,58I#EG:DO&J'6;189&LULN9S>^\3<;B[S9XU1[QI9KSFY7>=9+FY5SY6(FQ
M6JE^:S;2@4.;.WBPFLWFW6\2IK*2ZC6*[&ZK69ZUAI;/&=9^YL%K8L]2?C5/
MO.@S<N6%D*6VU(>-<MYDYM>3-9O<ZQ]7UE?C5QO''.Z:YL%K31V0\:Y[Q<S4
M'-K=XT$T!G,VXWB7-9;-TF\]9<B:XR<ME<\Y:XT.LP<;E;Q9355F\]X[XW4;
MS8RPHY:FIS<R=;.<L;4U\N>S?FL]985FI,WG5YO$F:RF;J-X]S61-<9[-^:S
MUEA6:DS>=7F\29JAS9V\=<;SFLZ&ILN6ETNL])0C(UKBNEIKFP6M-'9'QJ'O
M%[- "OEI+FQ6M-#9"QKUO,_-S5617Q)U-!FYA95SXE\:FDER)KD+D37(7,YO
M;>=!* ,_F^=YD9M>3M9N,ZR]6)"CWK.DSK)EA9P6/9K)<B:XHLV/K-I+2V62
MUT7^I+E R)KC*YNFWCI-9S-N-XES0X2YBRV(L5];!/2@         ?"HZP
M      6G.](      %/TQ6[P     +7GN5+0=>8 D9NAY=<QVY=#1\>N:[<N
M=@^KH^/2KWBOWD #K+><NG>49_KSCZR
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ME3TP )6=7_+IE^W+H:/CUSG;ERL'N71\>E+UQ#UD  7_ "Z1;+#.JC>(.\@
M     >BUY[]RU/3'.P 7//<.H6\"5+/Y[INO,
M#OC4_GT]G8ZGL]'T               $*6ALED0T=DB6&3
M   9_-Y:REZ:FAEX1ZLZJ          !YC+DFH\6FI:RQH[6>U
M                          '.,Q4HC1<ZEC*            !1RV>LR90
M                  !FY?.LZ:4
M#X5/6        "SYWI       I^F*W>     !I>/6IWB!O( EYU?<NF7[<O9
MH^/2@ZXCZR.DNBX]*+KB-K(  O\ ETBV<+(NISL       G9O7.^.L=L[K.G
M, :'ETY%'UYBXY[DYUGNW(>Y?AYL*.D<Z]'V/%@^K[CG1/J^H^'P^6?51\L
M          '?&IW/I[/9V.A[/0                /)S.I]
M      !S!T              .)[/8
M       !\.1T/0             .9T                    .1T/H
M                            !\*GK        !9\[T@      4_3%;O
M    'V74<>N?Z\XVL@"5G5_RZ9?MR]&BY=*3IB+K(Z2Z+CTHNN(VL@ "_P"7
M2+95=,        ="]X]>5E3O/'60!?\ +ISLI]SS<W'+IV*#KSML:]372*[4
M[V2\:Y6=I>-=XJM3SK-MSW'L[2TG3%[SU\7E9XEJNO.RSKC+#W@
M #OC4[GT]GLZ'4]GH^@
M
M
M   'PJ>L        %GSO2      !3],5N\     =9=)QZYOMRY6 "1FZ+EUS
M';E\-'RZ4W3$2R5+&LT?'I3]<0M9  %_RZ1;*KI@       "UQKKG726GZ\T
MO'60+_ETKMX]9USUGU-6.;2=>=YQZU/3'U+/GTA],>,V!TQH./3/]L3([8W(
M2KU..LVN-1EM,V@Z8^67_'I0=L7O+='TQ\L          '?&IW/IZ.AT.AT/
M1]
M          !\.1V
M                                              !!*DOCL  ?"IZP
M        6?.](      %/TQ6[P    !(S;_ETSG;GSL '672<>N<[<N9H>72
MHZ8\E_RZ9SMRN^72#K-9TP  +_ETBV573        Z%UQZT/;E98U9XW1[S&
MW@"_Y=*+KSN>73Q94[S>\]TW3G<\NM?O \G6N,L/>+[ETH>O.9+VQN4E-J>-
M9LLZYRV&;0]>8M<:Y+WS:CKS          '?&IW/IZ/9U.A[/9]
M  !79L;>;J4 #Y&4U-7FY34UDH         'R,KJ:N4 "#FUN\:":     &2
MEUES]4        90U8               !2%V   9.7O<Z,]*   !0YMCO-7
MC5KO,/&NF\V&;666ZY2757/U0        *7-D[S,S:[4MI<KFZ;>.DT
M                              ! S86\7.=55EPH            YYN<
MWG3R@(R6IK90            .1G2 7)='L ^%3U@        L^=Z0      *
M?IBMW@    "3G5]RWG.W/G8 /<NCX]*3KB-9H>72HZ8ZRW//=/TQ(S?I2]<?
M$  O^72+95=,       #Z:#CTJ.F9$6>-U>I7=.8%_RZ4'7G=<]^9:?KSO\
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M9F=0]9Z2S\Z\E?K/8\G*R7G436>DON7AK,W.NV;#U.&LR\ZB:R!?<NE#UP0
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MG72Y2\M2_P ZS>LZJ7Y&3K42YK6=3FY8G61I8VIKI:3-C;S(S8>IIX^J
M     !'*,X$<Y FFJ!4]8        +/G>D      "GZ8K=X     Z2WG+IU/
M<O*SO+S3S766DZ<XFIHN72DZ8M,:]R]8INN+SETSW7E'U  +_ETBV573
M                     Z%SRZ0-2#O          [XU.Y]/1[.IT/9[/H
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MUWB?-          0RH)9))0,B:<EE3U@        L^=Z0      *?IBMW@
M   "TY[F9M9TS>\ND:RIZ8ON73,]N7TT?'I0]<7?/=9O-OSU3=,6_/=3TS7[
MP !?\ND6RJZ8                         ]R^+         !WQJ=SZ>CH
M>SJ>ST>@      0HJB%5S9QQJ1O-I*,C+H4J-9TDT!6YL7>;3-SE2#O$+4U&
M;D]369N3U-;+5YO#>(N=WNLR)0,=+96 3;/&-<]XN9J#FUN\7.-Y_>-/-?(R
M>IH,:JMYT4H$'-K=XT$UQS<[O-OC5'K,Y0)\5>LZ2:&5EU-S]45V;1ZS.4"Z
MLS&=:K6?4N:S;S>/F-TN\R,:E[Q8S61-<9.75:SZS<A6O!7YM?O'K&YV\6$U
M49K>.^-P=XOIJIS?.\7$U19LS>*C&^NL]%$BSIC4?>;N6'FU.\Z*7(FN  !\
MC*:FLEJI:JR4G*6?K,7&['>)\T!G\VRWFKQJVWF%C73>9>-4N\Z27)2ZRYQL
MMI0%A9,S:DKSQ9J3VHYRYO6>V=6B56IRS=+939U*WCKC=7O.AERN;IMXZ36=
MS;;>9DH^1D]36R\<W.[SJ)86;5[Q,QNIUF8H%X96S6R\<W.[SJ)86;5[Q*QO
MYO%Q-#+9NCWG+RZX$+-JMXZ8W/WB?- 93-T^\=)H"@S8VLRB%+H=9JL;L-XG
MS62S9FL^E$JRUE S.;?;S(ES^;9;S&QIO%O-5^;!WB=C<'>+;&Z'>---<(J2
MO)>IHI0*S-Y;Q<32,A6JS<WO.IE@YM7O.BE&?S;'>.>-Q]XBYW>ZSTQK,[S;
M8UPWF[E&4--FY+6;-0+.R9*         *DAG TYZ(1T(Y./14]8        +
M/G>D      "GZ8K=X      N>?3U'.RPQKTM#UYW?+=+UQQLT?'KG^O.^Y;H
M>N+;&HUDG-Y52]>8 %_RZ1;*KI@
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MK/[SJ)8V;F]YUN;DJU"=EH);;69,H         C&7(Y])1X+<N@?"JZ0
M    66+T@"K+0    %/TQ6[P     !>\NG&R3G7#4E9M?K,R6-9%U+OENBZX
MO.6\]VYV&-2I8]DS.L[VY_$ %_RZ1;*KI@             =I9.;QJ-J$
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M:S[7TE^>IJDUF_E%;+4V"ULLY12RR-9LI?$M'K-_+42UUG=!H5AQ1T)EEY*
M        !\.)6$LB$<NSN#X572        "RQ>D03/D8T!,/A7%Z  "GZ8K=
MX      T/'K&U+#%I.N).;.SKX<[(EEGC474[RYSKSF2W/+</4FYN=[<^5@
MO^72+95=,             6.=2L:A:S*E\2U77F                 !WQJ
M=SZ>CH>SJ>ST>@                    #D9J-/9[4
M                             ?(I++Q0
M                  !S,[+?:S(E                       K,V/O-W*
M                      !B#3E<3"820 ?"JZ0        66+T@5)G3L< 6
M1IP  4_3%;O      %_RZ=\WS5!UY^BUY['"SA9.SH1[*OICM+?<NGPX64_3
M'.P 66-\+(FL@           #T7_ !ZY[MS(+'&Z[>;'%D32*KIB1$G.O4M;
MTQ:8TEKMYCZR           .^-3N?3T=#H=#H>CZ
M #,RV>LV<H                                               ^'T
M                                           &>EDZS<2@
M              "'+RUFQE                        @'0HR&<3V:4L0?
M"JZ0        66+T@""3CD124=0  4_3%;O      'J7T?#Q8    !ZE\T0
M               =XL^?6EZ\@!Z++GNKZ8GYOO.US[SJLZ8NN>JC<\:S>\>E
M!VP0          =\:G<^GHZ'0Z'L]GT
M
M
M                 ',YD@XD,DDD'PJND        %EB]( S1<$0B%\=0  4
M_3%;O                               '4N./6B[<@)$O"K7GKI+[(M?
M+GBL/>-'QZ1=!TBDZ8\V          =\:G<^GL]G0ZGL]'T
M
M
M                                  @F4.I+)A;'<'PJND        %E
MB]('@QQJ#)DTD&C  !3],5N\                               "^Y=*
MG>8^L]I;KETJNO.9SW4=>=CG7K.OESQ6'O%_RZ4?3'BRTY[J^F2
M#OC4[GT]'0Z'0Z'H^@                                 X1[LZ*
M           !&CO9Z4 "(2P      >(KZEI(4          #E'RSLH
M      'F(]DI0.$>K.J@   1XZ6=%            '&%G90
M                                          .!#(!5FE+$'PJND
M     %EB]('DR!9D T9GS5   I^F*W>
M  !UEMN>_1\*G>?&LW/+ISL\',\:SR6-K,B6SY[$/4@;P         .^-3N?
M3T=#H=#V>SZ                        #Q+0:SHI0       *+-F[Q830
M              %++::SVE  SYH       4&;\WFWB2H         &:ETES!
MFO&LV4H    %+FSMYF2@     #E+4:S>2YDTR4>=2MXLIH   #/YMEO,Z4
M         9S-T&\0L[:S82@
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MR6JCM99J(40:EI8+SB-9'EYU:ISERY>:S+SI9)6%$&NB6A[4
M                                        ""90]$LY%P7(!4](
M    ++%Z0 /(*DLSJ  "GZ8K=X
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MUOM8X8VWB5C=)O-Y+72^=9OY0
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MWG5RY3-U&\5>-MXMIJ-$:H,OC6-)-
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M&\5>-MXZXW4:S:GV:KM8TDT
M               !7%":@C&9-<2 "IZ0        67.] >#&FR/9 *0U0  *
M?IBMW@                                               =\:G<^G
MHZ'0Z'0]'T            $?-SN\Z2(>=5N\7F-YK>=-+52P]9U&;BETNL]L
MW.5JTS.=3-YMLW.%_J56-==YM9<_+9:QYQOGO%S-<LW+[SJ)>H(>;1;SII:^
M7.ZSM8R*ZX&5S=-O%'C<G>;#-S"WVL6$T/,9.M,GF7.ZFHSK*7.G*Z:K-8UD
MUCLV]WF7FYNM2E#G4K>;.7/2VNL<,;];Q;30ILVFUG65VES6;>;QG,ZT-GN7
M,UK4R2ZXRLMUK,G-S1H]2CQJ\WB3-4.;.WBPF@,YFW.\?,;H-YT<0YJJUG49
MN1K7  K,VEWG316YURWB;C=7O.BEJ\VEWG8RY.71:S$QKGO$_.\]<Z0C35+K
M.IS<GJ:V49$UQGLV9O/C.N.LW4M'FS-XM)H"OS<WJ:RYK\;I-YV,<LZS^\:>
M:R4NDN:S.I6\64U5YO'>;J4#.9L[>9N;F%T.L\\:J]YT,M9FQMXL\;K=XT$U
M5YO'>;J6DS9&\?,;K]YOY:K-Y;Q;8W1[QI9KSFY7>=9+E<V^WB)C;>..-^]Y
MMI:*7GK&EFH,=;)*@
M       "M*DU ,X2BY *GI        !9<[T ,N1BQ()--"  "GZ8K=X
M                                          [XU.Y]/1[.IT/9[/H
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M1TU),M7$&I"7!XEA662_(JK+9:^6OUFTS5DB6E/-69%2W6OCK9+4
M                                           >3('LF%<: LP"IZ0
M       67.] #P4I#)!>G0  %/TQ6[P
M                 .^-3N?3V>SH=3V>CZ                  !&1K7  R
M^;H=Y[R@                     9$UP                         *S
M-C[S=R@
M                                             <BG(Q-+D %3T@
M      LN=Z$<S1>E@5QV)8  !6;Q6[S\!\
M                  !US9O/IZ.AT.AT/1]                   !7%B "
M!$VSTH                     %<6(                         .$>+
M)2@
M                                         #F12,324 572
M "QYWH9@\&D.Q1%*:LF   ^'DY'(\'D
M               'H]'0Z'L]'T
M
M
M                  SQ%(QR!)-"3P"JZ0        6/.]#(%X68!G3P:4
M'P^',\'D^                                             ^GH]GL
M]'T
M
M                                                       &&))?
M'LS!M@ "JZ0        6/.]#-'DTQ]!3E::H   ^'D\GP^
M                               ^GH^GH^@
M
M
M                               $$SYY+LSQM@ "JZ0        6/.]"
M,9,ZEB"I+@O0   ?#X ?
M   #Z ?0?0
M
M
M   #X511'(U)/ !5=(        +'G>@.)2D,$\O#Z  #A7P ^
M                                  [Q]/H
M
M
M                                  !X*4I32ED 56X        +'%Z
M      K-/E                                              =(FY
M>@?0
M
M                                                           #
M@>22 56P        L<.@      *S3Y0
M                 ]Q,R]GT^@
M
M
M                       %5L        +'#H 0B:    "LT^4
M                                     ![B7E[/1]
M
M
M                                      !\.)')X  !5;        "Q
MPZ$$IBO-02SD0"X  !6:?*
M         'N)>7L]'T
M
M
M          HRJ/I=DPKB060!5;        "QPZ H2E/I\/9,-2  "LV^
M                                            'N)670]'T
M
M
M                                            'DH"L/IQ!HRV *K8
M        6.'0 JBT(A%)I)  !6;?
M                 >XE9=#T?0
M
M
M                 >2.2CB<"8?0"KV        %AAT *<GG,CEH?0  5FWP
M                                                 ]Q*RZ'H^@
M
M
M                                                '@S1IRC.Q;@
MJ]P        6&+T!Y,6:HRI]+@O0  5FWP
M                       'N)670]'T
M
M
M                      %:4Q;&?/1HRP *O8        6&'0',RA=%$:<H
M#5   K-O@                                                 ![
MB5ET/1]
M
M                                                         *TK
MS@2CH?2Z *O8        6&'0 RA"+P^$8TP  *S;X           #I'@^4
M                                   /<2LNAZ/H
M
M
M                                 /!D3D:LS1>EF 5>P        L,.
M@!X(I,,Z7!+  !6;?           >XEQTCX1-.-
M                #W$K+H>CZ
M
M
M              #X>3T4!?GT J]@       !88= "M*8EEB3CZ  "LV^
M      ^DC*3'*HU=8DQSJ+7.@
M /<2LNAZ/H
M
M                                                          /)
MFRO+\\ER "KV        %AAT!Y,8797G8[EZ  "LV^         '6)>0BZ<:
M ]1*CO$>HU>:                                    'N)670]'T
M
M
M                                             K2F)Y]*LORP *O8
M        6&'0'@QYKC-%^4!J@  5FWP        ]1*CM$>HU?*^G:.9XH=8E
M9>B)IQH                                    >XE9=#T?0
M
M
M                                       5Q3EJ<3P>RZ *O8
M  6&'0 S1"!T+ O@  5FWP       ^G>)67.HM<Z'6)>7H$>HVGP^G?*5'.H
ME>*                                    ]Q*RZ'H^@
M
M
M                                  'PR9%.QR-82@"KV        %AA
MT ()&(9)+D^@  K-O@      /<2XZ1&J/I\/428[QQJ-70E9>2+IRH=(EY>B
M+IQKX                                   #W$K+H>CZ
M
M
M                                   ".<#D<2P)0 *O8        6&'
M0 Q1++PG    K-O@     /I)RD1QJ-7BAVB7E\(FG*@/428D1PJ+7FOIWB5E
MSJ)7B@                                  !ZB7E[/9]
M
M
M                                   (IDR87A.  *O8        6&'0
M YE04Q*+XF   K-O@    !VB7E\(FG*ATB5'2(M1]   /<2XZ1%KAI\/42H[
MQ&J-I\    /I\ /I\         !]/@!]/@    /I\ /I\        /<2LNAZ
M/H
M
M                                               !X*@IB2:(D %7
ML        +##H 9LYG(AEH:4  %9M\    /<2HZQ&J/I\/42(D1QJ-7B@
M!WB5EY(NG*AUB7D(VG&O@  !/P@; 3\(&P        '221+#T'63K+%T
M])+Q8>Y)S8ND[*#H        /<2LNAZ/H
M
M
M                 !$,V>3F#1ED 5>P        L,.@!E2"6Y<G8]   K-O
M@  !])&4F.51:\4.\2LOA$TY4     !ZB3$B.%1:\U])&4F.=1*\4  )^$#8
M"?A V])WS?-<*]2>UZ1RKZG26/7RNLG27E7.@.DDB6'H.TG26+IUDZ2\JYU]
M3O+]CC7RR7B\-25FP])41[/<O"O-       #U$O+V>SZ
M
M
M                            #B9PB%X6QZ !5[        "PPZ  AE(1
M"_+,  %9M\   +##Z1-.-#I$N/41=.-?#W'H'@\T  /<>CX>#Y7N)D>XBZ1Z
M'J)4=XK]/%  6&9S4#I%?N3\6)IT3U+SLD9L729F1K?MGJ7E9WEC5*DBV^*'
M229F\Z'I.:\K.\L:I4D6V3)PM^)*S8>Y+Q8FY,Q86T_,C+\L[9L/8
M#W$K+H>CZ      #*R^; +*RZE      %'FV&\S)0*V7EK-O*     !ES4)G
M<ZO-Y[2@  #+RZ>YB2^]23*   !ES4        $:/&I,E $&)&ISQJKWF^E
M            H\VPWF9* !XB!99*       !3RR-9F9L&RR6NEFZSTE
MA1UU)$H  'R,QJ:B4"'+7ZS:XU2[S=8U2[SH90   ,[FWF\]I0         ,
MS+I-9]2@             !&7K4               '#-I=YT,H
M      $ SYS-.3 "KV        %AAT ,F<3B>BV-   "LV^   $S+I%?MZB3
M'>.-1:\UTB5'2/@!'J/I\!UB5E[/@!'J/H.T2LO-1*YUVB9E7Z>:  GXD+5
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MY.H.9T/A].)U/H/AS.I\/H .1].@!S!T!\/A\/8 !R.H.8.@!R/9Z .)T/0
M!X/!U/I\/IR/9Z .)XS:/>-+-                0C*GP['<O2< 5>P
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MA0*N+.SXN9S;[>*W&^F\7$U49OS>/N-^=XN9J#FU&\:6:
M ^&6(![+LNP 5>P        L,.@/ABR]/I2EL78  *S;X    ?3[%CE6[?"3
MEVB#M\  !])&7*N=   2,I$0-OA-RYD;3Z?       >CX?     >H\T
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M*:JLWGO'+&YN\6,URS<_O&EF@               *XHS1$8SYI2> 5>P
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ML=#J>SZ                                     #AFY_>-/-
M
M        "JEEZS*EH\WOO%K-
M        <"F.!8%N "KV        %AAT  !&/A*  !6;?     >HL<JW;X3<
MO!%T ^Q)@=3P0].D3LH]#G7&@/<6&5=IYJ;ES(V@       $G*-H/J2<V+H/
M2=\V-H      )69&M^4                 /F7J.AU.I[/0
M                         .4M/K-[*
M                                                (T4-#M9?QZ4
M                                            59,) !5[
M"PPZ   IB&:4  %9M\    !ZBQRK=OA)RZD'0#I$_+A0XUQKU$F/I[/A!T [
MQ)R@;?";ES(V@       ])WS8V@^I-Q8.P]I)S8>@]1YH#Z#X?0>H\U\/4GF
MT?0? ?1'R@            !\R^Q[.AU.A[/H
M
M
M                  !EBU+0 J]@       !88=",=ST 4Q#-*  "LV^
M ]18Y5NWP]Q890-.=#I$W*OV^   [QWB#H!.R\$303<N9&T       $B3FO.
MA]2=BQ-![3K+$U)N;S.A#KNGJ7T<!9*S8]=B'4N2';*D+[(M>T[2_#P1M
M         !\R^QZ.AU.A[/I]
M
M
M    !6$P[@&6+4M "KV        %AAT,J0242R81CD:4  %9M\    !ZBQRK
M=O@)V0@Z#I$W*'H/!YKZ=('6.A!T'6)V5?IXH3<N9&T       $O*)H!]2PQ
M>%#ZGU>5GV6/IUDZR^D\+QKX=$]2Q].\GV7JD6V5E"V])]EF1%H2\J_10
M        ^9?8]GLZG0]'H^@       ',]'H   'PYG4 '$['$['(Z'T    '
MD\G0       'PYG4XG8       'D\G0   '$[           XG8        '
M./%G=0.9Z/0
M                                      !B#R=283"L+LM "KV
M   %AAT.1#(9#(9S+0TH  *S;X    #U%CE6[? =8FY1-.%>XG9?#T<*B:=(
MGY>0<:B:?2=ASJ)H!-RYD;0       DO-B: ?4FXL'8>TDYOBSQ+QT]I(S8N
MIVCM'A>=GJ6/IWD^R]4C6R(AZ$]2SLHV@'"@          !\R^QZ.AT.A[/1
M]        !GLVTWF;*   .&;G]XT\T ,R:8R)KC.RWVLP\Z:S82@ "DS;;>8
M^-0]YN90      !SS<SO.JES)I@      5&;.WF/C4/>;V4   9DTP
M  !!EYZS92YDTP    !$EBZS:R@ 0I:W6;^4"CS96\64T
M
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MM?,<+.4OBRP6!'VR>HYQ KLDU1&B)4I)2@
M                                                   >#X= "KV
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M]8L,[H+FW6GB]U)LH
M                                CU\   !$T        $G+T   "1'T
M  K-O@    /46.5;M\  )$2LHU1M.L=H \D;3W$W+X0M/-  3<N9&T
M           [2>I8^@                ^9?8]'0Z'0]GH^@     1CJV)X
MER-SHU%/+:ZQ7XW8[Q835+F]=YL<WG7,KI>6LW>-9[>-1-#)2ZO6<G+KC(FN
M,KFZ7>*K&^^\V,O$\D2*?4ULN7S='O,3&H.\2L;C[Q>30R4NIN<G6PE&1-<
M5.;SWBZFN6;FMYU4N1-<9+-U&\],W'5I 5,MCK%5C>AWCO-<(]V9_.KK>.&-
MP]YN\W*6:U<WFW6\RI0,B:XR,NLUGU+E\W1;SVE",C6N!FLVZWGU+](\4"ZG
M6:W&O6\VV;D:TN;F]YOY112Z'6*'&[_>),UGLVTWGCC7#>;;.LI9<).)"_0
M"CS>^\6LU59O/>(V-VF\3IKG+EM9TV-9S>=5+!S:K>='+5YO'>/N-Q]YLY?D
M9[4TN-9W6;@G+V/H
M                               .1!V^                $W+O   K
M-O@    /46.5;M\  !UB;EPJ+I\ !UB9ESJ'I\  !-RYD;0
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MQ+FOD9+4T^-9_>-/-0LVKWG0RU>;QWCSC<?>9DH^I;K$BM*TO-2SE
M
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MJ\L
M                   <B#M\              )N7>   !6;?     >HL<JW
M;X   #U$V$0].\2(B:<*    FY<R-H
M   /F7V/1T.AT/9Z/H       BBJ]!'BD/%6-EK+5RS-9D2U\OO6>V;1'VK
MX66N;4U'CY9>G=:(O2B+TI8M]3AG5#9>)52^*G61Y;XK):K6;[-C:EG+6RU=
MGM+L[RTEEXHHB] !5RUMDM/I=+1%Z4<7=GU>$49XJPLMI?,49'J=9<2U\M-9
M=G.RRE&/EUFL])0!1%Z49>(6FEM=9Z2A&0J?'*KFR9+3RPK)"=);'4^9M!5[
M96RWI#BFKX6UEA+32VNL]):N69K/K-SQ<:D?.H%GM+P[J !71VU)<L*/&I/E
MIHAUW2\/DM7J7$L>6%K-K+#EYZS82U4M=9[2[.\M&1J[)>'1<_%_9]4
M
M          <B#M\             )N7>    *S;X    #U%CE7Z>*    ^DW
M+K'P@Z<Z    $_#A4?0                                #YE]CT=#J
M>SV>CZ                                                >2/%1J
M:&4      (R]:@
M
M   '(@[?            ";EW@    5FWP     G9>")H    /I)RXUSH
M=8FY0-/%                                #YE]CV>SJ=#T>CZ
M
M
M                                           #D0=O@          !
M-R[P    !6;?     #I$[+E7&O@  !\.5 >X]@   Z1(B/470
M                     ?,OL>SV=3H>SZ?0
M
M
M                         <B#M\          )N7>     !6;?      >
MXD1T@   ?*A:? 2<NT   #Y4>N-                                #
MYE]CV=#H=#V?3Z
M
M
M    #D0=O@        !-R[P     !6;?
M                       ?,OL>SV=3H>SZ?0
M
M
M                             <B#M\        )N7>      !6;?
M                                              #YE]CV>SJ=#V?3
MZ
M
M                                                     #D0=O@
M     !-R[P      !6;?
M          ?,OL>SH=#H>SZ?0
M
M
M                  <B#M\      )N7>       !6;?
M                                 #YE]CV>SJ=#V?3Z
M
M
M                                          #D0=O@    !-R[P
M    !6;?                                                 ?,O
ML>SV=3H>SZ?0
M
M
M       <B#M\    )N7>        !6;?
M                    #YE]CV=#H=#V?3Z
M
M
M                               #D0=O@  !-R[P        !6;?
M                                            ?,OL>SV=3H>SZ?0
M
M
M                                                        <B#M
M\  )N7>         !6;?
M       #YE]CV>SJ=#V?3Z
M
M
M                    #D0=O@!-R[P         !6;?
M                               ?,OL>SH=#H>SZ?0
M
M
M                                             <B#M\)N7>
M    !7Z>3X#X                                            !'V/
M1T.AT/9]/H
M
M
M          .1YKO           'PYG,Y'@^
M                   'T]'LZ'L]GT^@
M
M
M                                             ^'DYG@\@
M                                     'H]GL]'T^@
M
M
M
M \GD^'P^                                            'T^GH^GT
M^@
M
M
M                 ^'P ^
M     ^@ ^GT
M
M
M                            'P
M               ^@
M
M
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M .1K9_K(P^2)G>?KJ9S?@6/O_DBV?ZQ,/DB9WG\%3.;Z]C[_ -H*8C/XHSD
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M+NTQ-H\5;8LEV6%8XD4"+;IG/_*C#M2Q&F^YL\JJEAC'E,##+C&%M;Q=QJR
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MH>/IO"WXVG=Z8WA]<T&-]D1NZX5?R.+U0Y8DRJW]1C9DLL9ION=V:/DO5UE
M;*K/U",?9*QE-'1!ZH<N)94;^HQLQK+1UD]%=WR5]O-1[U3QKZ9YT7>F!:A&
MS%M,--G+OC:;W,F.:'(.N8WV1'\UN:GDY<K2))O$$'J'R2D[#(C:+M:9E%PE
M0R_)0P"#$=CC_P!KA;\D?;=K=3$6C1DZA&T0RTU2X4O4O=1\;-0\BMX^7/)'
MVW*_5A-DZ^3J,;3++34*A*^-NM($J\0PS4)F*]<G'E[R4]GX+HR-A5Z9ERH<
MO^2JV-0C9U@[$TZ_2CC=3(-3>Y1/4/DQ3.33I_CXEY67:TGB+9)PM0^0@RTU
M80L-2]NG=C-0\?3<,8,6*969&H'M/5LY1\GX-1&>=-V5KF(:MBV5F!J'R?=)
M@TJT\V1Y7"QY/ /*P^W2\GC85UEB3*K/U&-C-EIE=717;3*FKO["=^9QJF".
MGSO7U+VZ?V,LIZRP-E5GZC&SGG8*G7Z(\=0\?3?LT.HL9.LZ-0'9EEEC&+E3
M GF"[6DI1<)4'J'RK()["]M3R<'RL7Y6:B,]55V0#&AU%SO&55]-&7"D$46F
M;O\ ('O%$5K9.=D.7+/QE^R_&]9!<K^,Q$PP>1E2>:M\5C[_ $(C?%JV^(UP
M6$/+/PM[GPI]^%]N(!S2(0/Q,5_@D1QB,V_"A01)J!F#62/P&E;,](G!&!C"
M 3P1@8(8*! 0X3$3 K <<SI+19!^=)<X<PM=..:S\! )QZ1.<@\H@(9]\A8#
M.$ GGI$X"@7Q(1./2)P%B'"5 4\"6!9$1$9-5)8%=09,1,"L!F8@H$!#@YO1
M6BP#\Z2\;,+31C>SP*NH\BJF,B-N)UU'@(4$DL"F/E''I+WX2H)G@:09D5$Q
MD1 QA )Y P,82P*8C:,E0%/ U S/2)P1$(^$JZCP:R1XRL"G[?"8"R(JIB<(
M8*/2)P%@OX9C?)JIG 0L,(8*!6 ?!TE[\#2MF143&1$1&$ G@C QA#!0("&/
M="12X7CTEY:* KZ?&[_@(8*/2)R(VB8B8FJF<"NH./27OPE2YGATE[\(4 S\
M! )QZ1.  A&3$3$U$S@)6O"$3@0$,(!/!&!C@0"<>D3@*!?PD,% @(<#6+,]
M(G! 0@E@4Q$#&&A9Y%5(\84N)SI+WSI+WPA@H](G/MDSRPH>O:X$,% K 9_R
M"R?4?3K&)8Z=W4;$L_&7[&!U%D,B56Y'+$Q,8Q@J RYSIQM6^*Q]_H)#B38'
M.OD.B>+ YH^%O<P%C,=$,:$#P3[\+[<0#EC)G;)?&0_ 9!<7!M_@41\$1_2&
M$&! VJR-0/&.;9FI7Z,?T+0ABY%M5GZ@>&UMF:E?HC_B+U=94=6J?Z@>$3;1
M5D= /\#M&2TLLM;%)'2#_)&1RM6<,#+:88JM/+8_%7[,MU>MA#(R)D&>I=A$
M1S71+CB-H^*Q]_CB-\CY<''\^*CY9^_!L;%\#>YBO;EC@GWX7VX(C]V3.T,+
MF+BH]^!QS1]4!YB=,1P%,1G\49R 6,7R8&W/_%FR\D0C/XL=R[8$<Q<@X4;3
MP$9*82,9_%DJ H,)"<(!Z?"/NT!@,F.HO\.(^&/Z;I+R!@?Z7HKR(B/\4F-\
MZ*\B(C_!?OD+ 9_R74$[&EYIP=1Q][J!5'GL?BK]G!B@9!:>$Y^G8&GA&",!
M'QV/O\:/?A>TIWGX%3N./^_P-[F*]N6."??A?;@CVX^=H^!<[''V^LJ.1<SO
M*(_?8*=\B=IG8U\%=RQ[>-<<@_Y[ _/@$=,#.3G *1D]C7A]KA'W=V\06Q.'
ME/\ !B.,1FW^J,Q!0ZADU71@4W%E>O"!_%7[/K6/O\=?WY/SCHCG1'.B.=$<
MZ(X(P/ @@LZ(YT1XRL9GHCD1MP(8+.B."N!GAT1SHC@C QA!!9T1SHCG1'.B
M.=(8^O$;R[Y+Q9<I$$,B4%DC,? KN6/;Q[:M_F7\B\"-S?/\?PS&X= LZ!9T
M2W=V\&=B?&X?@1'P1'^JLF(Y%A4E^*OV?6L??XZ_O_KU=RQ]N G(Y#\AHSC%
M1,<%=RQ[>"AYC;!%'1/%1(BT>4U=RQ[/AF=@ZY9URSKECNWP+YI^O$?#'^J#
M7K3A:@&%J)85UTX3F%PJ>3^*OV8-I,Y<L$N*CR?'#FC?X['W^-9\D^HSU&>H
MSU&>HSU&>HSU&>HSU&>HSU&>HSU&>HSU&>HSU&>HSU&39VSU&>HSU&>HSU&>
MHSU&>HSU&>HSU&>HSU&>H^JKN6/MB0$H,>4^")W _?BNY8]O! ["3YWZY8+Y
MYGCN$?*3CG7QA0\F'VN$?=W;X%\D_6B.,1FW^J6I=V/G(T&%$:=EE4);04!J
M@1'\9?LR^GE+%.-.#J!X.H+G++(:^G.]7XK'W_,(8*(^4?DQ.TN^:\4?(1!#
M(E$Y")PBA8<%=RQ[<B-Y.>1?$)YUE'*26;8:8+.@6 GEQS.!]KA'W=V\&-R?
M.P?5B/@C_5.Q6A^-0:938-.(M [+_DZ=V/QE^S)B"B\@0BO6Z\%1=&$I@8(D
M<I#II^*Q]_[A4\ZYC:<$I'.N62XIS[\8G:2,BX1.V24S\$%,9,[\!80YURPF
M$7'J%,<984QB!W)Q<Q_4B/AC_528WAU""PP)9$4E.G,&%_C+]G'F'G^E8^_]
MPLN0G#^=/\2_J1'&(S;_ %8,!9#J$QDQ,33LLZGXJ_9PNNE2J9;6K+^@N;+I
MFM=GF^.Q]_\ (XCX(_U;:@'0%0E6?Q5^SAJ7<T]<=.^?,^K6Z\N7*F5BYZ_Q
M6/O_ )%$?#'^N2_9PU(<JVQ2HBYBIKZ=>_,38I>+\5C[_P"0Q'&(S;_5J;:H
M.)WC\A?LX-7#094:$UZ9D5LB"N,29+'D7\5C[_Y!$?!'^K+PEBXMO##+G--U
M4 +EGC)V6FZPF?BK]G$V"&>J3AQ#THK GZ%C[_X_$?#'^K5BEU3,>0Y HX<T
M[5XYK'XJ_9PM/Z*YF2F8F,$N73*EN8GX['W_ ,>B.,1FW^KK*:V$(\H$A1Y-
M!,XFNM/XR_9PU+N:<L>GJ7OK!#*3U=%M8N>O\3ER>=$LZ99R3G+.<LYRSG+.
M<LYRSG+.<LYRSG+.<LYRSG+.<LYRSG+.<LYRSG+.<LYRSG+.<LYRSG+.<LYR
MSG+.<LYRSG+.<LYRSG+.<LYRSG+.<LYRSG+.<LYRSG+.<LYRSG+.<LYRSG+.
M<LYRSG+.<LYRSG+.<LYRSG+.<LYRSG+.<LYRSG+.<LYRSG+.<LYRSG+.<LYR
MSG+.<LYRSG+.<LYRSG+.<LYRSG+.<LYRSG+.<LYRSG+.<LYRSD1PVS;(C-O]
M7;=KHY3;+4OL B!U$=Q*#'\5?LX:D&XU+/1R\P635*!J6FPUU2-JWT)R<VS;
M-LVS;-LVS;-LVS;-LVS;-LVS;-LVS;-LVS;-LVS;-LVS;-LVS;-LVS;-LVS;
M-LVS;-LVS;-LVS;-LVS;-LVS;-LVS;-LVS;-LVS;-LVS;-LVS;-LVS;-LVS;
M-LVS;-LVS;-LVS;-LVS;-LVS;-LVS;-LV_U?<7.ZJGH+<SJMZ9\E!O(W\5?L
MX$,$-BJ2IX5JTN+Z6V;9MFV;9MFV;9MFV;9MFV;9MFV;9MFV;9MFV;9MFV;9
MMFV;9MFV;9MFV;9MFV;9MFV;9MFV;9MFV;9MFV;9MFV;9MFV;9MFV;9MFV;9
MMFV;9MFV;9MFV;9MFV;9MFV;9MFV;9MFV;9MFV;9MFV;9MFV;9MFW^L!?M?;
M; UACF+DB%([_P"*OV<>NJ)Z2&Y%9(_Y-M_K'?1(GFGIYF7+/)E0>:S^*OV<
M-0;(QP&RX<'4&1BRYU_%)C&=0<Z@YSCG..<XYSCG..<XYSCG..<XYSCG..<X
MYSCG..<XYSCG..<XYSCG..<XYSCG..<XYSCG..<XYSCG..<XYSCG..<XYSCG
M..<XYSCG..<XYSCG..<XYSCG..<XYSCG..<XYSCG..<XYSCG..<XYSCG..<X
MYSCG..<XYSCG..<XYSCG..<XYSCG..<XYSCG..<XYSCG..<XYSCG..<XYSCG
M..<XYSCG..<XYSCG..<XYSCG..<XYSC_ *R>E3O$;1>2;'5:_0'\5?LX:D/S
MH) E%426%IPX5!L8B)%/Q3]_\= ]O]8K-F$05MQ8BPWK6+/0(#@Q_%7[+12-
M<;KAP[D-75L2@EN6SZ4_?_'A+;-_]8'ESN50'E7&UO4%%,T&\C?Q5^QJ^JLM
M.+"J.')&1X"Y@8-]L8HN=?Q3]_\ 'Q+;(_U?;'(Y3(: ^:>W(CO_ (J_9QF-
M\*LDL+3PG"T]D8D9%/Q3]_\ (!+;-_\ 5Z_7F<!A+F#F&.M,=%!7.W\5?LX:
ME]AL-#!OMC!U ,&TDLB8GXY^_P#D(EMD?ZO-I+9DZ<>+T^,$8 ?Q5^SA9Z4+
M@):ST+L-1KX"1!-2WU)^&?O_ )$);9'^KEJY('%U^#J)8-]4X#EL_&7[.&I3
M^[3MNCA#!B4="P=-3 &96SX9^_\ D8EMD3_JVSN1IY<I47#A+,,J>3^*OV<-
M05S+2XDD%]<X=Y409RPU'"ZQSSLC[?!/W_M.G\OQ.EG2SI9TL)?+'XPEMD?Z
ML/M"@QN)++@1#4.AR^'3#F_%7[.+Z'S)3 SEF<KTR(M2G*JI:[X9^_XNV<A9
MTRSD+-OR_P#^?XG4+(,MSG8>H624S^0);9'^J^H+,CVVX 9!(7V1@Z@$XNPI
MD_BK]ESY5DV&P=JQ*,'4%S@V4EF^_!B%LD1$(^&?O^'$;Y"\^49S1G-&;QFT
M3A+R8V_)_P#Y_!"XC-UX2XX+&)& B,_9.&&W %Y^S.G$XP8CX8^[/9PB-YY!
M'/V3AKVX<D<D",841SRN,_9&2$3 AMD<DXP-OIB6V1/^J\C!851)86G#A4&Q
MA(:&5/*_%7[&!# ] ,%>2;H)+ X04C@VW#BBYU?%/W_"$=\B-L)F24S\$'."
M>^2,3A#M^1__ #XJCYMGYXJ?FV/W*]ISN63\UA&Y-G:,5/[G?#'W9[."H^1S
MN6+G<9C:8]D_/!]S)V'$_9D_NP_9],2VR/\ 5<[QK<.H!.#9261.^<L;_BK]
MC6=)8WDS@M6? E@>%226%IV*'D5\4_?\$8WF/E!GQA>=+"#;B!X4;Q,;3^-_
M_/BG&>_%^]V*]L_?/_YK][N >]V <0/4'&%$\(^[/9P7[.K&=4<ZL84[E_\
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M3SV==\:@',_X-2]VGKV5EX.9&G'^YRNL%>M".%EB^C0\C"\K-2]U'QM1/]U
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MN^&OY+;JUS&HQBG Z,GY8=]8S&HQBG Z,F8B#OK'/U'%7%LG@ZVM4_J,;V'
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M^H"%3J,8NZLYX.LK3GZC&*NK9/!K@5$ZC&!? IB8F,8P5B6H#BKH'-GR8^W
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ML_H%^HY^HXT^HR"_XRSY&?J.?J.6;'7G3YWKZEW)81+T\Q%F3'-#4F@PO-'
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MXU ,6A$(QR1<*4"B.)#!P>GA.#IXX "L<91 IC3HQ2 5GH@Y\]$OGX3$%!T
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MD!X2D"GTZ\].O/3KSTZ\A"XG+)\Y_P"'5WY'XC:3#;'V^"S4-K@CE##"#%E
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M6QBZ!3(# #EBE#)])8C$T=LK5#4[B0P8G1;$TE,5C:3#=PLU#:U8\JS"#%E
MHGTMC$T/G]LM))RZB"0.,7#0.BT9]-9+$TA#%4VJ<_L55PQQ4FA(T6E*4BD>
M&HC$-H+Y4_!8KB^)I.&?2/+*]2$SCD"X2HM&?2/+*].%3EJJ;F)"5JX6D=<*
MM64GP]$SK8Y0N$J+1GTCRFO5%/"Q3%L^D>.#2:4H0*8RQ2AD^DL#@T6E*4BD
M>-E'7#T3L0,BFQ4%V>C>.#1:4I0*8XV_&J*AQE3<$A184J6*AF-X;0+>*]G$
MT=I;2.6QOM;JRV1J/@K*I<JI7)'"Q3%L^D>.#2:4H0*8P*3!=P;28;LM(ZX>
MC=BP_@;0G?TMG%4)W$8&.,QO'Z>S>/E#U]52:)BW#C<*],U.X#29#L<@7"5%
MHSZ-Y97J"KX"B"AM HF*]G$T8&3I'U8^Q4F2[@U0M$Z#(GTMB<11@9_H@]GU
MC]_QQ.TURYU,/D'U8YZL<]6.>K'/5CGJQSU8YZL<]6.>K'/5CGJQSU8YZL<]
M6.>K'/5CGJQR+<8,[C;9,1^%7C=QBD,YZV<U;)KJ9#5RL_AJJ DE[OCI@)E:
M&!=Q6L/38Y017'W6U@*?OC:_23\/WQM?I)Q:P]-^+7L?Y!<(^2LKHJXZCWZG
MC?0,Q7#[80O3U[G_ (L_L4/)^";28@YFU9&.4?[.WXVG=[_) ]GUC]_T*G9M
M]G\(?<OMW?PZW?O=OA3.8;?C]N",EGIFY(R,Y3['(1GZ9N3&W"(F<],V<))A
MPH>ZU$S8].W)B8G.F<QC_%PEF,*61S:&348$'"$,G)KMC@I9'-H9-1@09TSF
M.$5VSA+,. C)3(D,Q7;.$L@^M7L?Y)8J]<U!TU_0L*ZRAT\MP"%C_BQCS@BG
MT6? 5 Y.O6A']JT.HNO5Z!_Y('L^L?O^A4[-OL\ IQLY?3+@A/4EU6!'@(\Q
M14CD8'(?!%;J"]'3X#[E]N[^'6[]L",/3MST[<K5^G-QD$2E]0S,*P>M/>)"
MTLQD#I]ACQ1@7?W6UP2HCFG]E97K3Q%CJY;7 -H>YI@G(NEN0A95,;2KQ,?X
MH>^[V$/)>6&2I;6RV:RH6LKL[JN<Q75QRH>2\L,E2VMELJ\3%+%"RNSNFS#<
MM)Z<T^^V05/K2W AL*,>0_JUWY'^LX>SZQ^_Z%3LV^SD<+ONX4L=VR]^5N_'
MVM][A5[%SMX/N7V[OX=;OO=T1]=BG"V+)N'A0C'US:ST3,K(-1WH_EI]@YW/
M"\2)VG^5V14;.(K2L[_NH>ZY.[\H3EN-GJ\3'^*'ON]@?==[&0;"B*S9P*9;
MW.P/NN]C%>)7C=]XOV9$[39_=7I]^_/[LH?:SW_K5['^LX>SZQ^_Z%3LV^SP
M"V.SF=0N"'=.76H(. %RE%L>1I\Y\*]F "P_J<!]R^W=_#K=^]V\ Y67[7J,
M) Z$_*PYJV^J;D6'EC3,II]@O=D^(D.HQK!KA-QDY68;'W_=0]UN-GY0CYVY
MW>KQ,?XH>^[V!]UWL8(C725T\Z[#*YV!]UWL8KQ*T[/OQ^W(^<V/VUJ??O>_
M*'VL^1]>O8_K[%KH&H^HOZLSM#-0G>O<-K?ZI[>BNM9Z_P!1MWIMCYQ])M[I
ML^,+W.S/7?R_@V+70-1]1?YWKOY?BL6^@:CZB^-AW0"M8Z\/9TEUK/7ES.DJ
MM:ZY83!&?CZ@\^.N])HSS#^?9?T(KNZX/;T5UK/7G)8,'C[G18!<P?TA3RBF
M[U6_ N]SL_M ]GUC]_T*G9M]G\(?<OMD$%G2C.E&=*,Z49THSI1G2C.E&=$<
M=5C:8VGXZW?O=OA4;R';5SC79TF/3#Q]*W="H0#V=5E/L%[LGQ*Q\CK29:,5
MFXA0HR_E#W6$P[(J-W_;624\Q*\3'^*'ON]B/NP.LIJI01Q#T^F;NFOTLM?.
MO'W8'64],IQ7B1.TC(V4E49$UZO*5QW-E/OWO?E#[6?(_ KOR/ZU]6'FH.FO
MZMZ=JU%0L,5 ,_U5_P ;3?J-I0QD?*/I6O)C[?$CR<]%'4_!U'O5/&_.GROB
MU'OU?&XO3UPKHZ$7?&TWWN7U5UZT(+%3,VOB;\E4O*QU.&L&.4?S]2]FG=ER
M^JNO6A$G[*GSM8ZG#F /*'](4;BFG"F? %* 9_:![/K'[_H5.S;[/ *D;/7T
MRX5T]275M@X /,458Y&AR'PKU^<;".GP'W+[;7=//61GK(SUD9ZR,]9&>LC/
M61GK(Q=GG/\ ^6>_\<3(R3#/X.NS@MQKSUC,8XV< >P(X==G)@66!$W&3G.7
M.QQL@&$O(<<'ZQF&9'.0]D#A/80X;F'& XPPV$S%N->>L9AL)F>H9R8#C##8
M3,A[('!*0F+C,.PP^ '(2;"9. TUX121?@U['UE7#)S;QR5.P;I<X4B5YI3Z
MMXY7M"[@10 LOE,^JL1B+W-..>*1*\TI]8\<KVQ;A[\B+I&WA9N$MJY*5OL"
MB)NN*8N.":]@7QC[9K?9NS!5K;3;;LFEB#EB;=DTF=WE7-Q\XJ^6\3O$_*'7
M_GZNQ@7N9=2R;CX3]FVC:"7DG*CR='K#]0Z\7-4LL:QK14)WF%/JWCE>Y#)R
MW9-+&W>0/6/RM=YRL7>2?6/RK;ZL\6ER*1=DL.\PIBZZ)KV(>./L"B)NN*8N
MN&46!?&/N&MPSN.6K1I:DN=5NP299=D5!==S;_)U_P"?JK&*OSN)047_ !M-
MX6+@KGU;RP+S!E31<.6+(HR;CRE=Y@RZ\4&/S%]QBW1\X88K%E\YGU=B,KW(
M9.6+0IR;CBSU;QRO<ZA9:\F/MQL6X5/JWEB;WS1Y.>L9ULLVX3/J[!8-YHRA
MPN'+%L4YZQY2-YHRAXN'"MG%A]TN:I98QC6BD3O-*1NN";C1:=3QB*!%M^=_
M56(Q%[FG+392H;L]#UKMULW0R^4SZJQBK_S^!]D4Y-UQ3%UPS7LB[A9MFIUB
MY(S7MM)O&Q:%.>L>4JO%$_>SC&"H3OL*?5V!RO<ALYJ/?BWTD>KL8F]O.6VD
ME=1Y.B[XVF^^P<K34LFX[=DTD)R)UK1N:PQ6)WSF?56,7?*)$H,;=DP-3)4=
M2P3YL6V*<$[A:M&EKKO)'K'XF_.^3.T-OSOZNQ&#>W54L&XN+#%8LOG,^KL1
ME>Y#)Q]@405UQ3%QXS7M"[A:M&EKKO)'K'XF_.^&< ++YS,6WCEIXO5IW9LL
ME2:E@GS;LFHUG*SJ63<=FV:G++F69P LOE,^JL1B;^\Y;>28];LB;CIQ=\XD
M#@Q*8&&7RF?56,5?^?P%;.+#[I<U2RQC&,%0G?84^KL#E>Y#9PSA8LO&4^KL
M!AW?X:K9<JTV4JJ/)\8\Y6FI9-QG.P5[;&NQ-TB8R\R2IV#=BKC#=GK#]0Z]
M\_6/C*USJ%C&"H#O,*8N/'#O?Q56RY7]2'L^L?O^A4[-OLY'"[[N%+'=L_?E
M;OQ]K?>X5>Q<[6#[E]N[]&MW_P#Y:[_^&5['U9]ZJJP %@O'G+WH0*1(8*+*
MO3N2?45J#-SIUX$,MUI%E>2Z#"FP]*12)#!195T&UV=5-H.E86?461<HI'KV
M2GE']UFPM0J$P%@G$UK ES#<\FI6'IPH!+4>]4\;4NY1KP4;9?5"SH%O7U!F
MP4:\3&7J\#&G=WC?\;3?OCN]7J@"P4 399+GUZXI&8@HMHZ+*C>JG4>_11$C
M,1,6 Z;Z:!%9!!CVK'&SXZ5]5H+%<64BQ5$MK)ER ,%9>M8K%BQ8/SK6(G>+
MGDA[,U#OUO'U+WT40S.@O?4&[11KQ,9=KQ(:>W8[_C:;EIG2343UF0,##T"X
M4'*'E/*(Q-FPM8K%R1<)C($'LM^2/MOLYG5:\+"8B8L5B!RI*5>G:QXA 00P
M4,CI/RUY,?;@\^FFLKKN@8&+=>&!6\C/^U@['8B(B+"8:NI7:ICV=)-=77<(
MP$.2+A&2KOCYQ8\BM6 5BH *VSJ/KH%(& F+U=)M3QM0;N=.O AEZO 90;SJ
MU#QZB>LWTZMK_P"VOIT!PM5)(ZXD">!ER ,%8>M8K%BQ8+!*N]9<X7O)IUQZ
M<)7!\&%R+4$V'B A%A N!?=RVR6OKUQ2,Q$Q<3T65F=5.H]^C7B8R\B%S19S
MIU'L:;[;OC:;[[OC:;W,3Y.V7@:R:B(6O-04(SI\[H=VJ/DY=\I?;U#R*5<>
M3;+JH4VF7-6U%FT4:\<N7J\!FF^_C?9S.JUX6$Q$Q8K$#@*81^ZR]2A4)@+!
M:$UWJ/J+U#R*5<>3;+JH4VF7-6U!FYTZ\"N8B8N(Z+-.[-[QM-]Q^RGY.7_)
M1V;[>9M.O !EZO 9I[>8-2]M)$-*(B,U!(Q&FE^S4)F$:= <+522.N) GC8\
MBM6 5BH *VR6OKUQ2,Q$Q<3T65F=5.H,YFTT0M<Q$Q;3T6:?X^H=C3?MESQM
M.[K.W2\F?M$;DNLL!%8KBOY./[]:N*@(8.&CTGC.XWF<[JM>% 0P46D]%FG^
M/_4A[/K'[_H5.S;[/ +?R<SJ%P0WIRZSS#P$N4HM_L87.?!%CD%[^IP'W+[=
MW@"C/# @XP,EA(,8RMW_ /Y:[_\ AM69E<?35Y.,G98'R'Z]N>O;CWD_-/[%
MKYV1^0\'?)-*-[/#4H_;IW9U!>Z].9N&H,Y5:<O8;<[5E-E1^O;GKVXYLN*G
M\ZUSR5_)>:CWJGC:EW*7C9J7MT[L:AY%;Y5\M?.MIW=XW_&TW[XSR<+VUOG9
MX:C'\.F_;4>_4\;+ODJ[6-\KC9\?3_(PO;4\F[.U9+92?KVYZ]N-9+CJ_.O<
M\D/9FH=^MX^I>^CXV7_)KQLC"^8U?E9O^-IN:E[=.C^+A;C:R^?^%IW?X7?)
M#V6_)'VG^ZS\#K*TY.HSGK'GA\W/'VM>3'VX:AV--XJC:WG_ &LM5"YQ<U6!
MJ!8IX.C4>QIL?+A>C_DU_FA_DQ]L3^ZSPU*/Y*GC69WL1>9$>O;C;9M#3N[J
M'CZ;P<N&K-+4$%QHXN^,Y$[QPN>-IT?S<-1C^2CXU[R4=GC>\;38_DX'&UR?
MM!;'Z]N>O;CK!/C3>WJ/?KQLC+WC:;W-1[&F^V[XVF^^[XVF]S$^5AF*Q+4(
MR;[)QQM.-.[+>U1\G+OE+[>H>16\?-2]U'QKWDH^2,N>-IOOXG^ZSQM_*MI\
M?S\-2C]U#QM0\BMX^:E[J/C6?G9'Y#FHQ_%IW9O>-ION/V4_*R_Y*.R[YV.%
MN-ZVG]_4O;IW8S4/'TW'+AJS2U!!<:.+OC.1.\<7^3'VG[06Q^O;GKVXZP3X
MTWMO^=F/MFI1_'I_CZAV--^V7/&T[NL[=+R9^U?R>%?R<9Y/"[Y*^W[K/#4O
M9I_C_P!2OV?6/W_0J=FWV?PA]R^W=X5QCIW8CDX4QB38,2!_(ZW?_P#EKO\
M^&)5S9&1]-/DX<<P5YY+'(.<@XQB52L@(;D<ME1<R\LV.A@,]2BJ7)9X:D7S
MT^-D&/.%8NC:N'U+*@Z:[(\U>E,18Y!SD'#:A9A,2-SR0[>:CWJGC:EW*?C9
MJ7MT[L:B.S:1\U?+I\M?3N[QO^-IOWP_*R?G"IZ5CAJ)?LTT?X]1[]3QLN^2
MKM8WRN-GQ]/\C"]M3R;8\U>C,=?D'.0<-R ,=I&YY*^WE^=[%;Q]2]]'QLU
M=GU"YJ^.+D53CFLW_&TW-1'=6FE^W@^>I8:&]>D7+8X62Y[ >RWY(^UT<EF)
MWC+-GH%U]ZR0E[AK*'(B(Q\\SX^UKR8^W"^.]?32_=DSM")WM9_VIG: LJ,R
M 3QE%90B978OCO7TTOW<+9<]A4<JG^3P[5CAJ);MJ>-;CELKY#7R#C)6H5,4
M>:AX^F_;&.!6+8+1.NH\MU83&G%,APM#S5Z!<K^&H%N^I'+6O>2GL\;8\U;3
MRV=PDN:U@_QOY1SD'&&I6*,#C4>_5+FKYJ!;(TT<U'L:;[;OC:;[[OC:;W,3
MY67F23Z],( 0$<U*?EIW9;VJ/DY=\I?;U#R*_CYJ7NH^-J [.J'SU\OGRHTW
MW\71R68G>,LV>@1%ZBI1+EL<-1+=M*-JVH>17\?-2]U'QK@\ME1<ZLU(OV:=
MV;WC:;[C]E/RLO\ DH[-F.2R!<P9=+EKZ='\NI>W3NQFH>/IN,<"L6P6B==1
MY;JPF-.*9#B_R> _QOY1SD'&&I6*,#BT/+967.&:D7RT_P ?4/'TWA>G:MIW
M=9VZ7DS]JWD\*_DXSRN%WR5]MT=.R,\PYJ1_/3_'_J5^SZQ^_P"A4[-OL\ J
MAL]?3+A63#)=6& G[XL>8XJAR.#D9PKUQ(+*(#@/N7V[O"L6Z[I?MX4RV-I<
MJS^9UN__ /+7?_$74YP]#.>AG/0SC0Z9_1*KRJB-Y=6E0+'G-Z.C&&L@_HU*
MYLC(R/II\GA=KR)HO<HE?7$?OM.6$+7=1U!K6I3DWU;&1VG*#IKN5Y T7MA.
M^$0(G:: P 9?#D=2#J6.%E$I8J_&S+X1"UG9;$<L7/)#MYJ/>J>-J7<I^-FI
M>W3NQ83UE@QE5GZC&S298S3N[QO^-IOWP_*X7J\P5>[R"5]<1_):<I<*7J/?
MJ>-EWR5=K&^5QL^/I_D87MJ>3EA)5V*OQLR^.R5%8;$;1J"IAE>[R S4(V8)
M1E;Q]2]]'QLMHZRT/*N?KE;6+,ORE7Z0W_&TW&!# _DJN&^N8?>YAI5Y(LMU
MY6:K\Q#;I,@QD"#V6_)'VWJ\EE:YTH*^N(_?;>2HZ"R*NZ+R9AUWF@P)9+G=
M=KR8^W HYA8!U7!?"8?;EV(C:SG_ &L:!5G!?"8;?'EIIEC2&"$P.JT+X3#K
M_P"VI7EAX_R>%ZO.]>[R"R^$0?-.5/&NU^I%:U*,]<K:P\K!5$=%>H>/IOVR
MXGJJK6)1/KE99L]?*:94KC822&*OCLV^.R$E89'RB]Y*>S\#U%7:N^.S[O/
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M4"XX'346115&",!'!B@;"U KC,1,%246115&",!&'6491\HQB%MD1@!8A;9
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M:IQM9;9546HR&#B:*IP*:APP$P6A:IQE13)36!)'64PHC:&5UL(1@1QB0;@
M*Q:\%3LMXQ43&7MAK:;'PLJJ9D4%8 "N,F-X*DHL&BJ,B(&,976PA&!'&)!N
M  K'&5EMR**HDDK(%K%4& L%:05P;56V4U021UU,*(Y8QE93,] K%J!7!B@;
MBUBJ,8L6"M(*X,KK9GH%8NNM?PS541<3J*//0*Q:@5'!E9;<&BJ)U&($=/\
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M(Q$#=\E?;S4>]4\;K+W-*V8= )S]R'#.X_\ :RPOJ)H'RNM%UK(#R!J,?Q4
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M1M&.J@XEA"P,!8):>.1IT8I(*C/1+ZG!]<'XE(I'@U(-B=.C!T\(P1@(XNK
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M!1':SQ,!8):>.#IX1DI#I)JBDV!# 35!)9,;PJF"CQJ@;$Z=&)J J8I@+.+
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M+'8H>1\6I>^EXWXNI=REXW]^OM_6G[_&D?FP^6).9SYY\\ADQ@%S8Z/JQ&^
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M?-\WS?-^"_LW(G;.K\N?Y]7Y$6_$6;83-^ >Z.VSWP>=3.IG4SJ9U,ZF2?\
M@T1O\$1FWXI%RQU1SJCG5'.J.=4<ZHYU1SJCG5'.J.=4<ZHYU1SJCG5'.J.=
M4<ZHYU1SJCG5'.J.=4<ZHYU1SJCG5'.J.=4<ZHYU1SJCG5'.J.=4<ZHYU1SJ
MCG5'.J.=4<ZHYU1SJCG5'.J.=4<ZHYU1SJCG5'.J.=4<ZHYU1SJCG5'.J.=4
M<ZHYU1SJCG5'.J.=4<ZHYU1SJCG5'.J.=4<ZHYU1SJCG5'.J.=4<ZHYU1SJC
MG5'.J.=4<ZHYU1SJCG5'.J.=4<ZHYU1SJCG5'.J.=4<ZHYU1SJCG5'.J.=4<
MZHYU1SJCG5'.J.=4<ZHYU1SJCG5'.J.=4<ZHYU1SJCG5'.J.=4<ZHYU1SJCG
M5'.J.=4<ZHYU1SJCG5'.J.=4<ZHYU1SJCG5'.J.=4<ZHYU1SJCG5'.J.1.\?
MA&<P74+.H6=0LZA9U"SJ%G4+.H6=0LZA9U"SJ%G4+.H6=0LZA9U"SJ%G4+.H
M6=0LZA9U"SJ%G4+.H6=0LZA9U"SJ%G4+.H6=0LZA9U"SJ%G4+.H6=0LZA9U"
MSJ%G4+.H6=0LZA9U"SJ%G4+.H6=0LZA9U"SJ%G4+.H6=0LZA9U"SJ%G4+.H6
M=0LZA9U"SJ%G4+.H6=0LZA9U"SJ%G4+.H6=0LZA9U"SJ%G4+.H6=0LZA9U"S
MJ%G4+.H6=0LZA9U"SJ%G4+.H6=0LZA9U"SJ%G4+.H6=0LZA9U"SJ%G4+.H6=
M0LZA9U"SJ%G4+.H6=0LZA9U"SJ%G4+.H6=0LZA9U"SJ%G4+.H6=0LZA9U"SJ
M%G4+.H6=0LZA9U"SJ%G4+.H6=0LZA9U"SJ%G4+.H6=0L$YDOZ17;^M/W^K&+
M^S?IA[A[;?=_AD1\,?C.]G_AP>S\)GO_ /#0]_\ 2*[?UI^_U8Q?V;],/</L
M;[O\+B-^,9MFWX[O9_X<'L_"9[__  T/?_2*[?UI^_U8Q?V(-\Z>=/.GG3SI
MYT\Z>=/.GG3R%Y]A;[O\*B-_@C\EWL_\.#V?A,]__AH>_P#I%=OZT_?ZPLVS
MK9ULZV=;.MG6SK9ULZV=;.MG6R6_*9WG_"8C?X8_)=[/_#@]GX3/?_X:'O\
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M[_Z17;^M,3OM.;?XW$<=LB,V_HW>S\X.7#Y=\7M$M*"_+"8&/\0#V?A,]_\
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MF2M6(CEC^^MBTQ0KI+_SBTZ4"ZT;HI)Z2^#URU:5"D/\->N6K2H4A_:J[?\
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M._"8B<B(CB1B."8E\'57GW^'4/'TW",1P3$N$Y C'&6!&1,3QL>3_P#.JO\
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MU#Q].#=F7(WK:=WK/CZ?Y%L^2OIZ^9N$,&,1RORSY"@Y%Y=C:RGYI_N5=O\
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M=2^]#QLU'M:;V[OC:;W+-;KD <S*]3HL:/0L 7.&7CYWH#IIX7?&690*]/\
ME8J$F*5B3PB@1(F6FQI\;.HRL:#IAEA766Y?28JCE[QM-]TSM#WG8,-/^3J1
M+BE9F9Q;)4Q=1CL90(1INE;6AU%V$= E4NJM[.@A*3M'^GCC%G68AG55\-KQ
MJ'D\',A2T#SO/V*9*R"DTQIHE,?]K.?DL+K,LXZE*P39)0KI&W+%24CI[9G)
MG:&M.RT=/^3:$B-)T@W+,[6Q4VV5>H2WZAY%;Q[_ )".Q;#I6$GU%9J#-V5%
M]-'](PBL/"FH8.FHHC=#\ON^=6G!"51,PP2K/6?46GR>#?)R_P"2L8*M=4"B
MJUE,195S5J#.5V7&=-&G+W/C8^5FK4@X.JHH*#JO6?4#4&SO5J"0>E3.6T=
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MMUNEE*2E/%YR]ZZ:A@Z:BB=T.CYQ=.3L+IJ$6TUD-3G6]Q<BJRO4.]*G+=6
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M5.GI@IR\F"7I_D-[5'R>"/)PO*S4>[3\;4>UIQ!RY8I]5B0Z:^+/*R[Y--,
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M4!3P-0,STB<$1".!K$\BJF)D!D1 0R8B8%8#PF(F)J)G 4"^)5DE@UU!DQO
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M(TY?P6BY["S4"^LK+Q+-6FE\M1[&FC\\O1_QM-[C^Q4'FL<*_DV"Y$40YK'
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MZ7_G3ZC2=6I\A?V%I4N54KDC^R*DDL:GFKE1=&$I@<!,ARB9&G\5?LXE33/
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M_?\ QX2Y<B=_]>@]G$;:2^G/W_Q\2VR)_P!7G,Z2DVP<7Y(>S+8GTQO.C/\
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MQ-M;?R ]G$P%D-T_#6:Y3;8K$60=\<_?Z8KF<@=L(XC"/?C S."&V3.V$SZ
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M/'JKX?;.JOCRAOFI>^EXW"6 .00E\$L <B8+&^5\)&(X)B7P28CD-7/P3,1
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M,&IM::MCK"4\HFQEIGZ>>&MM4JKNLOC<LR$KJM=!:>R(6UE=@SS#J6"UA+]
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M/Q1.V0WY$6_T%%AQN/!7M=PW^OO/U.:?J\T_!S3_ $,3MD3]6QY I7R]%60
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M)T]L1.&<+!-QC&V#):JEJ6GEN!E%#R.$_9?[G<+3.H^KXVI90\?-1[&F^W4
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M;9MFV;9MFV;9MFV;9MFV;9MFV;9MFV;9MFV;9MFV;9MFV;?_ /)A_\0 ,!$
M @$$ 0,$ @,! 0 " P$!  $0 B Q01$#(3 2$T!08( R87!1(B.@0I# T$/_
MV@ ( 0,! 3\!_?RBCU'4Z?IQ^\]%'J$N.RCJ=/T]U\?I]/U'L4GL4GL4GL4G
ML4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4G
ML4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4G
ML4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4G
ML4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4GL4G
ML4GL4GL4GL4GL4GL4GL4GL4GL4E?2]/=?KA11ZA+CLK.IT_3W7QNAC\?ZG3X
M[K];J*/4)<=E=U.GZ>Z^+T,?D'4Z?'=?K911ZA+CLO!U.GZ>Z^)T,?D/4Z?'
M=?K511ZA+CLO%U.GZ>Z^'T,?D74Z?'=?K111ZA+CMY.IT_3W7PNAC\CZG3X[
MK]9J*/4)<=EYNIT_3W7P>AC\DZG3X[K]9**/4)<8^!U.GZ?@=#'Y+U.GQW7Z
MQ44>H2X^%U.GZ?/T,?:U=9Z/_D/7724=3U0ZGZ^/)U.IZ>UC/_D.>H>JIG_R
M'3]7/?X_4Z?'=?K!11ZA+CXG4Z?I\W0Q]IUG_P"3HT[AKD7--4/^8ZDLGN4R
MWP>Y2)IXAU)9'4ED]=)U'S5V%72^UM6#I?RL=263W*9]2P.NE'*?<33P/J4H
M52>!O@]RGQ]3I\=U^KU%'J$N/C=3I^GR]#'C;X/<1[B/<1[B/<1[B/<1[B/<
M1[B/<1[B/<1[B/<1[B/<1[B/<1[B/<1[B/<1[B/<1[B/<1[B/<7DKI]2*:G0
M+K(52>)K_D4])U=V5]'A<HZ-6BI^E<G?J,]A%5+Z;**O4N3KY%2^IW%T?^E=
M/I?!3TDN]M6#I?RGJ5^E%'3=7=CZ"T4U.A\.&^*N1=%ON*GTT,I;PA=#_I4G
M0Q)]7NRKH]NQT:N_'CZG3X[K]7**/4)<?(ZG3]/DZ&/$WP5U^KYW3ZGD=*JR
M/H?\'TJD4=1KLXJ_G#.E_(Z[['17_F.HN:3H,Z^3I_QCK?R$5=54O@]ZDIK5
M6(JP=+^4]5_^A=6E'O4G4J53Y10^:3_\XJ_BSH_RCKZ.G_&.G_/R=3I\=U^K
M5%'J$N/E=3I^GQ]#'A;X.I7ZI]+/2STL]+/2STL]+/2STL]+/2STL]+/2STL
M]+/2STL]+/2STL]+/2STL]+/2STN>G7P9\/5K=+[%#]2YGK+_P!%.!_SGI?R
M.O@Z/\8ZG\3H9.ODH_BHZW\A%7253Y/9I*:%3B*L'2_E/5_D>W0>U2>BA"22
M['__ $BK^+.CF.OHZ?\ %1T_Y^7J=/CNOU8HH]0EQ\SJ=/T^+H8\#?!7U/5/
M3Z?&3A'".$<(X1PCA'".$<(X1PCA'".$<(X1PCA'".$<(X1PCA'".$=3I[4T
M=3CP]2CU(IJ=![R'UUHII=;A_P YZ7\BNGU+@IJ=#/=I*Z_7V1TZ?2CKY*/X
MJ.LO_13U>>UM6#I?RGJT<]T=/J\=F/JTG?J5"7!__P!(J_BSHYCKZ.G_ !4=
M/^?FZG3X[K]5J*/4)<?.ZG3]/AZ&/!UOXSTZ5EGJ/4>H]1ZCU'J/4>H]1ZCU
M'J/4>H]1ZCU'J/4>H]1ZCU'J/4>H]1ZCJ4;7D=*>3V:1=*F?13SS*HI6(=*J
MR>S24T*G$.A59%VAI/(NG2KE12L6/ITL]FD22Q'HIYYE4*G$54JK(EQ"HI3Y
M\_4Z?'=?JI11ZA+CZ"NCT^#H8\'7_C^2]3I\=U^J5%'J$N/HJZ/3?T,>#K?Q
M.&<.>&<,X9PSAG#.&<,X9PSAG#.&<,X9PSAG#.&<,X9PSAG#.&<,XGAG#_ ^
MIT^.Z_5%=7C1[W]'O?T>]_1[W]'O?T>]_1[W]'O?U\.KJ\/@][^CWOZ/>_H]
M[^CWOZ/>_H][^CWOZ'=T,>!KD]**J5Q--*X/2CTH]*/2CTH]*/2CTH]*/2CT
MH]*/2CTH]*/2CTH]*/2CTH]*/2CTH]*/2CJ4KB*<BI1Z5^"=3I\=U^M=?\O/
MT,>*K#'%'\5\KJ8BC(L>3J=3T]D=/J>K/DJK5/BJJ5.1]?\ X>\RGJJKZ#J=
M/CNO\ ?;YK[?Z;7_ "\_0QXJL,<4?Q4U=1\GN,H?*CJ/A'N,IZCYFNMIGN,Z
M57,U=1\GN,Z;Y45OA'N,IZCYGJ8BC(L>1?\ NL7_ (K\G6_D+P5/TKD2?48N
MG2CTHZG3]/='2J]2^@ZG3X[KX;%+7Q$;\Z\^C?Q5BQ?(T;BKOY$;^!7\]#^=
MHWX:\?,8L?.8L>%#?W]?\O/T,>*K#'%'\5#*LN.EB.KB*<J>IF.C-67'2Q'5
MQ%.4*.IB*,BQX^J^*3HK9UELZ=7-,5U^E'_NL?3KI[G3ZG/9G5?%)T7RHZS:
M?8X=5!4FGPRCIU)\E57I7)S76>U6BCJ-/BJSKO1T5VYEKGL*E4X*ZO2A>NL]
MJHIZCI?#AU-5G_JON=)/CN5]5XI/:K9S7TRFKU+GXO4Z?'=?"8L2Q>)>%&_/
MA"-^==[%W\3NPI7S'V\"Q9CX-?E?;X2R/SKSK!OPOO\ &5C[0^YCYS%CPX\*
M^WK_ )>?H8\56&.*/XJ&59<=+$=7$4Y4]3,=&:LN.EB.KB*<H4=3$49%CQ]9
M\O@H7"X*US2=&KA\1U7S44KA<0NEWY.M_$Z.(Z^2C^*.M_(1UGWX*/2J3U+_
M *=;CGE'3?-,]?)TOXVUT>HI7I7!ZDCJ-.KL+!5_(P=1\4G1XYY9ZE_TK=+I
M.@^_'QNIT^.Z^"Q8EL0[,V:-QH1H5NQ3F%X&(4I#<OM%4M"-&RG-^Q#<OM#F
MKM#%BW<-RT(=JR.6H<L1HW%>X;EJ'+%&Q9'.Y15VA]D.*NPBK,U0[%8S,-"C
M,JY6.S1NW^H8C4LS%2$/M+0C5FQ&Q6;BOR(;FJ'VFI%(YJABP*<^!B&YJAWJ
MQRQ7+(X?:6(U*G/V5?\ +S]#'BJPQQ1_%3Z$>BG_ ()<0UR>BG_AZ%/I1Z*?
M^"I2GT(]%/\ P2XAKD]%/_#T*>IB*,BQXF^%R).MGLU'LU#3H92^5R5_SLZW
M\3HXCKY*/XHZW\A'6_D+H\[/8_L]C^RBGTKB>NMG1?;B:GPN2CJ>KL=2OTX%
M376+H?\ 2NGTO@6!_P XZW\2CI^L]C^SV/[*.EZ7S\?J=/CNO@.YBBH4(8A]
MHJC0ABQ"-FK&(XO8A2K5BU8-&RG(X4HV:LJ[B*IKABQ9HV(W.A#%8LCEBM1H
MW%>Q6H8HT(1N&KV+N5%0NX^\5[FH15*-V52Q8'9L=C-"A9'9HW&XU.A&A2H9
M3A%7>S8Q8C1L1NUQ7N'8_%4+([%D<U14+!JQV,6+W#%#%.[&+$:-CL8LC$53
MHV:%&I0_L:_Y>?H8\56&.*/XKY74Q%&18\76?;@Z*[<SUJ>W)T:M'6I[\G3K
M30ZDLB_]UG57_DZ-279C:1U*O4RC^*.M_(IK3.M3LZ74[<,Y*^HV^Q3SQWFI
M<K@3?38NI2QU)'4ZGJ[(Z5'I1UOY%#30ZDLE3]3Y%@?\XJ7*X**O0^XGR=3J
M<+A'2Y?=_(ZG3X[KSL6+6+$5"A&X93@W&A#%"-FO#NQB$;A&[$-RQ8-&RG(X
M4HV:-V(JFN&+%FC8ASH0Q8L61RRD;EB-&XKV(=K%B-"$;\.BG)LT4X-Q7-0B
MJS=E<L6"H5C%9HW"R.S1N-QH4:$:%*AE."JUBQ&C8C=B'%>X8O"AN:]BR564
MY'"*HJ%@UX&+$H;FJ&+$,5[%B-&QBL61B*IT;-"C0OM*_P"7GZ&/%5ACBC^*
ME]9IGO5%%7*BNKTH]ZH75;<U=5IGO5'3K=4OJM,]ZHHJ]2BNKA'O5"ZS;GJ8
MBC(L>*KI^I\B7"XEKE<%/2]+Y&N1]'_A[+*:53B*NC_P71>RKI<KA%*X7!70
MJA='A\\Q5T?^'LLHZ2IMJH561]#_ (>RRGI*F*J%4>RQ='_I5TN<%*X7![7_
M *YFOIJH]EBZ/_3'R>IT^.Z\S%BUBQX%"C0K=B&K%9NQB$;EJ6Q=AJQ&C93D
M<*4;$-2^\537#,*S1N&I;ABQ8LV/N+L-6(T;BO<-2V(8L1H0H3&KU"%"BN:A
M6-BLKEBQXT-2[-&XW&A1H1H4J&4X,RV*W8C9JQQ5X'VL4X*L0^\MB[#48'#,
M(0UXFRD=B&+'B<MBN61QF6Q&A0OM:_Y>?H8\56&.*/XJ&59<=+$=7$4Y4]3,
M=&:LN.EB.KB*<H4=3$49%C\-ZG3X[K[9=O@+MYGWE]_B+(_*^_S7WE]_$^_W
M+\56.?A/O+_**_Y>?H8\56&.*/XJ&59<=+$=7$4Y4]3,=&:LN.EB.KB*<H4=
M3$49%C\.ZO3X[K\J61_G3[_GM?\ +S]#'BJPQQ1_%2^BF>RBFGTQ53ZCV4+H
MI2^DF>RBGIJF7T4SV44T^F*J?4>RA=%*>IB*,BQ^'=7J<]E^L5?\O/T,>*K#
M'%'\5\KJ8BC(L? ;X%4GB6^,BJ3QY_73SQX56G]!U.II?K'7_+S]#'BJPQQ1
M_%>"OJ<'O'O'O'O'O'O'O'O'O%'4]7@ZF(HR+'P.I_$Z&9ZW\3H;\[Z3]7,5
M5-U\7]/^?S^IU-+]9*_Y>?H8\56&.*/XJ_J=3CLO)1U/5?U,11D6/@=3^)T,
MSUOXG0W%762P>\RCJJJ*ZU2>\Q=;_IDZE?I'UNQ[E91U?5V</J_^N"NKTKD]
M7?DHZCJ? VED?7_X>\RCJ*J.G_/YW4ZFEYZNWBU\/8O*OEJRKM]O5V_"T.*N
MT5=O\%K_ )>?H8\56&.*/XJ[J=32FFAL]IGM,]IGM,]IGM,]IE5#4)\'3ZG-
MW4Q%&18^!U/XE-3IP>[4>[4/J5/LSH;.M5PN#I4<]V<'5H]/='3J]2*N]?<2
M1U.GS@Z=+I7#.OHZ-&XZM/I?8I?*Y'_.*OYQU54\%%"I0TF?QKCI_P _F]3J
M:7P*_F(WY6+'RF*RO?TM0L?!KW\9?4HWYJ]P^\,7^!5_R\_0QXJL,<4?Q5O4
MZG':>G1ZA+CP54\E='IA/@Z=?J[6]3$49%CX'4_B=#,]7^)T-G7R4?Q4=;^)
MT,'4Z7/='-5(NL]E-2JP=?1T_P",=?!TOXC_ )Q5_.*JU2/K/1ZNHSOZN\=/
M^?S.IU-+X-7BU"\-5Z-B'XV+LO"I5E7C5E?BT*W'G</XU>[]"\#L7AJFKXFA
M0KUF=^)#BO<5=IT:E?GU?\O/T,>*K#'%'\5;U<PA=5'O(]Y'O(]Y'O(751[R
M/>1[R*NHG/1S;U,11D6/@=3^)T,SUOXG0V==;.D^:8ZS[<'17_D75Y?$=2A<
M<G0R=?1T:NW$=:KE\%"XI'_.*OYQU.]0J4L0WS5S'3_G\OJ=32^%5+0ABE&C
M8I1L4H=FK-BR,1NS5K%#%9HV(<*5_P '%3EB*I8K*A14(8K-2YJ%@8I4H;EB
M'=4+!J4.U1H5E>XJ["E&IT;%*'<A2BKM%610Q0^T+([-7*-"-3JS=B-PYJBK
MM+*2J*]Q7N&(0XT+\]K_ )>?H8\56&.*/XJWJY^!T<V]3$49%CX'4_B=%-/O
M/57-)T4USR-<K@]-5#['NU%/3JJ?+,'4Z??E'NU(;KK.G1Z4=?0J'QZD<]1]
MBCI<=W#I?KCJ=-\\HZ?KY[G5Z;RA=6I=CFNLJH=+BBE^KY74ZFE\.N="*K-F
MC8C<(V:-S78Q0C8LCNT*QBQ&A6[$;C1N:Q6TY'8K*]RRG!7N4;-"E0RG!5FS
M<H<Z$,6+:A8-"FO?DKV(JE&S1N$;-"A9&*=PC5CBO<U"BO<+([5X$:-P['8C
M=K$56+)5%>XKW#%%0NY5^?5_R\_0QXJL,<4?Q5O4H;9[;/;<JAL]MGML]MGM
ML]MCI:GVV>VSI4\.WJ8BC(L?/Z^CI?Q^FZG4TOB5RQ%5NC8C<(V(W"*K-"A&
MQ9';LT*QBQ&A#%&C8C<[A%0AV)E4L5E>Y93@JG1LT*5#*<%0KD.Q#%BVH6#0
MH158Q1JVO<53HV:-PC9HW"'<C1N7VBO<U"BO<+([-"LJ[3H1J="O1L0YJ$56
M4E45[BO<,4:*<F_SZO\ EY^ACQ588X];/=93U5L3YOZ?\;NK_&*;6TBKK?\
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MPX5CAB'#APA^!^!6*%<OHM"C5JE1JS<:$*59HW"-B-Q3D8AJ:K:]QH4:E?\
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M,T(T8AHYAH5G A&(I-B-B-PAV5'(XYAJ-&S1B&CF&HT?U#0C1N$;%F4NXW'
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M:C4H9HW-45E.1^"J*]PLC[V;LU9L61RQ"-B':Q8&*-"$;N17N="&*=_K34+
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MISSV/,YC/G4*=B%Z/T]<]CYZ%P?AIQ&BG^_4V.'S>)UXG@44:BGN.-]S<O\
MPU^DIL6+%BQ8L6+%BTOBO30Y0Q2AC4(8APH>(>.+Q%7MI>E2.*6,I[CEFQX'
MD4,T.7]RGALQ&#0\"&:X;,1N$/[0AY-SLT,4.7]Q#*5*8^Q2I0\\*<(<4L93
MW'+-FH0XI&+N.-C^\LI4IC$/C2,V8A_<7%QL?#Z>HI[CE_<V:C9J,0^PM\4,
M?VEE/>*<(<4C&+N,8N&S$;A#A9&;-1LQ&#7!Y-#%VFC44]QPBO#%%&HHA#R,
M4;'_ (8_27H/BO30Y0XR6+Q<L8A1V&X>(N,3+&)?M)>G1.RHIX:-CP/)J&:-
MFIHX(<,T/ N6Q\$59C95QT,U&QXAE(^->!2AYX?3U-)442S1L<+8XI'DIQPU
M+-3L8BK/&D8LCFC7@?#Z>AX*99HV/$,T;'%6!#G0AF^%/:*-31-$58%P0_ S
M8\0N"X/)KC3DJP4\*L"BC440AYBEC[%*_P -?I(N7X7+ERY?A<N/BO@E\.EZ
ME$HJ*..QX'DU#-#-0RGAL<,T/ N.C8YT(JS&RH0XV:&:C9J&(>!<&BF4//#Z
M>II'DHG9HV.%L<4CR4=A\F*4,15GC2,V.&4\*1QL?#Z>HH<[-&QPS1LU#%OB
MAFS4KO%&IHFB*L"X;'.BGO*R,V.$/F\FABFC0RERBO#%%&HHA#S&RK!K_#7Y
MK%O ^2\%BWP=_ADO56"]X7:,%X2&;'@>34,U"<6V4\&)Q@T/ AB<6AB<)#$5
M9C948G!H9J4XQW%&)2C'!YX?3U-(\Q>$AFQPMCBD>8O"0^"[2NT(JSQ1EC$X
MMQ7:<&N'T]1@O"0S8X9J$XQW%OCN&A.<11J:)HBK N#$X2&+M..PS8X8G%N+
MR:&)Q:XF/)B5V*L"BC440LF8<.&:_P *?BMY7R7EM^")?%58%\+5@7XJS7X*
MRGM_AS\*FY<OX7%BPX7AN7+R_P "2^(8G%O@V)Q;\39>+?@K_P 0?C?!2^+A
M0X7%<UZ"'%CL6A':>PX7*QV+2Y0X?J)?KZ_ O H?%PH<+BH?JX4(<N4/@A#G
M$H<52LCA>FE^OS\"FQ8L6+<+%IL6X6X6+<+%BQ8MYT.$6+<4/@X<(?)EBPD.
M$/T4OU_?@7R"'PN7&I0Y0RTH?)ERY<<U>@E^P#\-RY<N7+ERY<N7+ERY<N7+
MERY<N7+ERY<N7+ERY<N7\J'"7-#E%RXF.'PM%4K(YJ\Z7[ OYA#A%BQ8<H<O
MAF$RQ8L-Q5*R.$/S)?L$_F<KA<OY[E_$O,E^P;^90_>?E2_81_DB7["O\C2_
M89_D27[#O\A2_8A_D"7[$O\ 'TOV*98L6+%BQ8L6+%BQ8L6+%BQ8L6+%BQ8L
M6+%BQ8L6+%BQ8L6+%BQ8L6+%BQ8L6+%BQ8L6+%BQ8L6+%BQ8L6+%BQ8L6+%B
MQ8L6+%BQ8L6+%BQ8L6+?_P!T>Q8L6+%BQ8L6+%BQ8L6+%BQ8L6+%BQ8L6+%B
MQ8L6+%BQ8L6+%BQ8L6+%BQ8L6+%BQ8L6+%BQ8L6+%BQ8L6+%BQ8L6+%BQ8L6
M+%BQ8L6+%BQ8M_\ O(+^K<N7+E_VRN7]U^K8M%OVQORO[3XWB\,O%XO*\5XO
MP1>;POVBM\ ^#%#$,7!0Q>%BAP^+%^TUR_NO@Q2ABAPI0RPN3+%BW%0Q?%+T
M]CX;->:C7@UZ-/G7H+OZJXYA^LN\;'Y7GSLU"[PA^HAYX4<T59^"V:^ V,V:
MA0A_BK%QMR7KO@Q0Q#%#X,7A8H;XJ&+XJD>90_3V:]5Y->_5@7H4C]-X%QI'
MGU_IZ\](\^B\%,+8_40\FS7A15GX+9KX#8Y>!?D;]BQ8L6BT6AS:;%A<K<+1
M:+3:'-OB*1YE#*3^Q1:$X0XV:-C&6C)J$HO#$H3'PHU%):$QF(9DM&8I+0G-
MH7>*!E/>:>XS):,\,1HV9=Q9&Q*$QC$HO&Q=Q=C9F$RT)S:$XV9BXS$:G8NX
MNSBT)PS/:'.S,)C&)1>-B[B-CA*+Q4:L6MQPXM"[\-CA8&,I[#T:,2MF>\)C
MX(R[Q<M&8HU-$(KEE$4X+1F$59BT)^!*+S:$X9F$RUW"8S9F$QFS4)1>&)QD
MQQM"[QF+F8I+0G-H_L9LT8C0MCS%H3C9F+C&6A/\)?R%RXOGJ>2'%(YT/[FH
MI[C-C%D<;-&S4,0_!1J$.$,>30RE2AB'"&(?>%VBB$,8ABE#S-6!1L<;'#-<
M&**1FS4;'"*LE(XV:-FH9H>!<:1B'#-#%QV.&:X,4?3U&QFQPQ8*A15@44CR
M;,\F:&/!H9H>C0\%,+8XV/@MCBD>8HU%&IHA#R;-11%,H8BK(AQLURV:X(?V
MAB'DU&S4;&;-0S1LT;-0RGO&!X%VXT2BKN*4,0X0RGN.$,V:'@4+8RGN.-FC
M9J'DT;_"7+%\?;\ I'GBBK,4:EBQ%+*OL*-C$59AFC?!>&C4(JS"R,>30^+$
M59A9'RHA_<T;&/BYJP*-CA<%P8HI&;'&QPAY*<<-&S4,T/ N-(RD>8>!#-<=
MCABQP8H^GJ-C%P14+$58%%(\^&@V58L4]S8QZ-#P4PMCS&Q\%L>8I'F/IZBC
M4T0AY-FHHBB=C$59*>&N6Q\$59BK AY-1L>(V,V.*L"-FC?!9E<64\&:G8Q%
M6862H^GJ=C-FAX%"V5%$LT;-0]&OPU_F%(\\459A#C9J-C[L<;&;']XV:-FH
M<ZAFN%&H15F%D8\FAE+E#$59A9&(<(91-)2H8I0YJP*-CC8^&S4,44C-CC8X
M0\B'PV:AFAX%QI&(?WAFAFN.^&C9J&*/IZC8S<N*A8BK HI'F'"'P63-0RGL
M4J'HT/!3"V/,;'P6QYBD>8^GJ*-33"'DV:BB*9I0Q%61#^_A>34,T;']X9H>
M34;'B-C-FH9HV:-FH8HR/["8^%/8<(K%*0Q%6861E/8<+[C-FAX%"V/)3V'&
MS1LU#T:AQL>/Q%_D](\\4/,WXL4['%XP:X6F\6XT:A#S+'PO&(0\RXO&(IG9
MKA<L8XIQL<WBT,O-,+L+NS8XV.$/,7BT;-0S0Q,UPI'%XM#-<=F(M-XP*%V$
M;'%XM#FK I7=Q?FQ1LU#-0H0XV/@AQ2/,4:C$6%F$/(X91%)<M**LQ>+0RGG
M:;Q:&:C<[&;,1:-FN%H8H8N-XQ&"Y:4/,N+EH9LT,3-"'%^&S4,U%XM#-?-W
M+^!BXWY+V5ZURQ;_ #O8_P *H\M/;OZVQ_.LPK?A-BWO+C<OQOQN7XL4L47+
MS<O-_P#+]C_"J>WP>_SI>C?VW#%#+%A#%#X,M&.#Y,MQMP?[16Y6]NY<7)BA
MQN;E^+YW+RH<7+B_<!BE\;C%#C<.;\&*6(?%0Q?H'G_&+E_+<N7+ER_"Y<N7
MA2O"^#$,N7%-Y?"_*Q<O++\%PO\ +O)KTW@I])FN.OG$/PL7I4]^;-#->VLC
M]^CTMC]G95^5VFY?Q6+%BQ8MPL6+%H4K\G>37IO!3Z3T:XZA=_,^WJOBN_E7
M?P/GGPOQ4]O"S7%=X7?T%WX+)5GROMZ5''^^*[^#8_9V5?EUO"Q>=2OQAB4Z
M&:AX%N$I7<>>&N&^#-RF.7@4T]XR8A,</M+']N&N&S44X,0N\IC$.-C-RC^X
M3'F'VE\%WE,9L_L7"DM:,F(3&(<4Q28A,8MCR;/[$;X,?:<F(3&;/[C9J-CX
M4=XWP>!FAFAX%#*8IP8C)B$Q\MC'#&:%F4,?VX9X;/[EC+3D8E.82E9X5&97
M>*<#A=Y3&;&9FXQYX:&)2H2E.%WX5<$I7<8E&#0\3H7>4_Q>Y<N7+Q<N7+ER
M\+SJ5^&OQL3X,U#P+8Q<'DU#->#7@>"F:-#*>T[-<6+(X9KALU%&N;$.-C-F
MHV.%L?%R\%,[-&Q\:1YBF=FC'&@<;'@6QY-CY:*A#*)V:-FH8N\4KC1KEH9H
M9H>!0RF*-0RGM.S7)FC95HT;&+(XV/0LCAX*>&QQLT;EB-FII[%0IHX5&IH&
M4:AX*9V:-C*!PS0\FH9HV/$/ A\:BB=E4L7@0\%,/ N#_$K\;%BQ8L6+%BQ8
MM"\ZE?CK-0\"V,4Y'DU#-<,SLUPN.7@IFC0RGOQ7>=C%D<,UPV:CZ>I7>4,0
MXV,V:C8X0Q=YV.:L"G9HV/C2.*>_@3&43L>!;'DV.,SLT5"&4R\FC8Y78J-<
M:-1F7DT,T,T/ H>"F/IZAX*>_B93W*>[*NXL%$+(XV/0AP\%/#8XV:%D?#9K
MA4*:.%1J:1E&HJP*=FC8RB6:'DU#-&QXAX$/B^Y1.RJ6*<C^Q:'@0\%,58%^
M3,7G4KSL4OT%X5\8Q0S0Q1D6XI<T]AY-0S7!#G1LS+EX*9HU"[2AE/8<(8_O
MPUPV:CZ>H92Y0S9F6;-1L<(93V'"'PI[2D,V/C2.%V,RQ=I2&4F82&+8\FQP
MASH>!0NTI#-CEP^-&H0YT,T,T/ G&2F/IZE=I0^:[,I[0C4+(XV/7#)A<-CC
M9H?WG,,3FGM%+E<*A2NT4:FGM*0S8S!F7]AY-0S0Q.5"<I#%VE%7"ES3V-FH
MR(>"F:7*0_R)B\ZE>=BEB]%<F+Y1XL+POP/OXEVFGMYWX*>W+?'?A?J+MY:1
MYXOF^&O$\%/*GMQ?>'X*>T4]O"L>1^^N%1KC3V]>K O%L?D788NWX]<N7+ER
MY<N7+EX7G4KSL4L4VG)8Q#BPH7!EBPAB_P ?I'GV]>^S5OCZA8]E\-?X&O.I
M7G98L6A<'-Y<N%"X7$,7^/KM^AB\ZE>=BEBX.;2Y<*%-BPAB_9RY<N7+ERY<
MN7+ERY>;ERY<N7+ERY<N7+S>%YV*6(9>,\&(9<N*%S0Q?LU;YFQ;A8M#BW&T
MVBWYDN_SS^,7?_0F+WE\ _FV+LH0\^-^1FAFOA:)?F>37P>Q^&GMV'Z;->!F
MHUXZ/:>!+W'-&9UX]FO@]PS7XFXN7+ERY<N7+ERY<N7+ERY<N7+ERY<N7+RO
MQO8YR^#E\'Y&:&:X,7A0X7?U*9</F\<'XGVEPX?A?CV.%S9KB_-GPLUY:/&X
M?!>'*X/(N;\[Q#[33V\VS7F7?Q/@N\4]^.XSW_%'%BQ8L6+%BQ8L6+%BQ8L6
M+%BQ8L6+%BQ8M"_&Z)0\C-1LT;G!H9H8E&#1N=FAFAFA_<4,UPI5Y3&8[F3)
M@8E#%W&)1@R,2FEW'V*5*A;'DWP8_MP7#9H;$I3&(JS&RHV?WP8H7W-10-B4
MT]XI[RF,V5"4/ IU#P4\-\7]IP+N,U+&:X[X:'HT,U+-F(0Q&(3'DV/M+'F:
MG<48$,2FGOP>!1N<LQP>>']PARQ*&+N,45"BB-FA_;@X<LV:X4J\TL8H8HIP
M.%WE,<U8%-$4F(3'DV.-#P*=?AS%[R]>Y<N7+S?E<O-^%_CF4RAYBEQ3W&;'
M#P(9HV:\&AFAFHI8Q=QR\<7"["AFN&^%(^-8IHA;'DV.-FC8X>!<-FABQ.QB
M*LQLJ-CQQH*NPL% S0^"[%>Q=N#-QJ&)\OIZX;'#$;'-&AE^#-0I0X9H>C0R
M_!%6>%$H>>+'DU&QP\"'P78>9JP*-CBD>88AY-1LU&QRS7!FH>!11J-FC8_
MS9J7@7@44:AX%VX/$U8%-$4CS"V/)L8S0Q/\3O\ '*%PL6BQ;@N-BTODQ?%L
MHE#S&RL6(V.&(9HV:Y[-#-#-1LJP4]N#P+DD)C&+$KN;-<&:X5"FB%L>38XV
M:-CABX;-#%.QB*LPBHV/CLJT:%DJ_P"AC-<*A<=C^PA^"C7#8X8L&QS1KCH9
MKBAPS0]&N.A%6>%$H>13L8\FHV:BK AFN=6!1L<(>88AY-1L>(V.6+$KN,U#
MP**-1LT;'P7>=C-FI>!<'FTU8%%&H>"GOSJP*&412/,+8\FQC-?BR]E^FY7B
M8O!:'S7QE/8<(S#A_:-\/Z&:&)S@0YT,T,U#,CXKM*0S)@8AH3E=AB<9%V&)
MRD/N)RLPMCR;'&S0Q./[%PV:A.4AFYP5&Q\7#R;%D8Q.4H7:4AFQC$QH3A]S
M4/ N&^#^PQ.,F!_?AH?)_?AH>C0_OQQ*0RB4/(AR\#R:AB<H8G*7"K HV.,<
M/Z'DU&QXC8^"<KL,U#P**8V:']^#^Q3VX,V:X+M-/8>349%%&I7:4ARREQDI
MBD>86QY-C&:&A.'W-0A_A+%+%[2EB]%>1B\#YOXS8^5$['YGW\%(_@5V\5HJ
M->?^_"NWMZX;'KUWYEV\UHJP+XI>TNT+MYEVA=OQY>R_34KRKP/F_C&4]^6I
MV/UL+XM_>;']?)4_?CL?R3+_ .9VFWO6])>%BXL7%\W^Y3FTKE;@Q1;B^:_<
MM>ZQ?_Z'U?CS7[U-?O4U^]37[U-?O4U^]37[@W]._K-?KJ_@KER_P]93CSU%
M.!X*5;QIW?D:_71_ .HOPN)_"UE.!NQU=CJ%5>.KN=7V.IB=X=1U'5#=Q56&
M)WAU'4*J\-V=AU'4)W&[0G?R-?KF_?;BQTG2=):$_A*RG!64J*NT/(E8M<79
MCP4J*D4X*RG \%!4^Q2HJ0G=%>1(M<IR(6?,U^N3]YPE/5+0OA*RG!64XCZD
M?_4O,=1U,=]E."LIP/!05BN79W925YA"R(6?.U[=/I['PV:\U/-FO1I];9KS
M4:Y,I])FA^A3W\3P+?!BQ%'R-':WJ/U%W'D9KROSU8%\V_>J$**H450O@ZRG
M!64XCZD/,KNRK!2HK*<%93@>"@K*<0W83N5YA"R(6?0:]JD>90_3>37F7?GD
MUZ*[^MLUYEW\R[^-FO1I[>*K M\,FHH^17?T]C]1#[OPYX['YZL"])=_B7[U
M0H;FY2QPO@ZA8*BG$5J'DLT=V)6&KG='4SI*1JYW'@IBS1U,LW%2[PA+O#I*
M;^@U[-(\RAB+",RF,V.-C-C/Z+3H8EP8E+X40BT)C,=C4+O*<(M"8S<TN*!E
M+FE#8E>5WYK)_<)C-\-&S4;-&QQ3WBC49E,92,2E126M"8^#^Q:=%0L#P?U%
M^PN\KO&93+693WFT7&,2C^A;X8-126M"<9E,9LS%3$IT/!GM.1E/>&4]N"[R
MN\+O*<(_L12QQ3W&?3U&93'V$IR,2G7#<-B4KOP9F<C$I4(PQFAB4YA8+6BG
MO&QE3NY3'+-0C44]RK@H7>4^#$I44X+6C,IC^"?KMERY<N7+PLQTC4=(D.;E
MRY<N*KX1_P#7Q+7L4XY(>8I[CAFABBE1L8AYC9HW+P(9?G1"'F-C&:'@7;@Q
M#S&QF^-$;&,T/@AYY+(X9HV:AFAE/>*>XS?&C44<&4\:8I'F$//!#AY-%0L#
MP*&*45%'&B$.&(V:AX%O@S44CA%62D<Z-FN+$/ II'D0QFN"[<'@7;@Q#C8Q
MBCZ>AE/!Y-32-"?/8QFI0\RS4T<:8I'D9HV:FD91-$;&/P4#["78I[CP+L58
M%- \"G8^=,4:FGM.QX^"?KU1TG2=)TG2-"S-7!PJ3I.DZ3I.F*?@^GO?XIKU
MZ1YXHJS%&I9J*>Q5]C4;&(JS#-&_!?C1"*LQL8S0\<D59C8^"8RB&:%D8_&L
MCS#-&S4,U"[%8NW%,91H93P92,2FB*1YA;'D4(0\PS14+ \"A\64:XT0A\-C
MQ%6!;X,U%$H>2GCLU-H8AX-32/(S13W'S15R0X8NYL?VCZ>AX*>&_#GAL9LU
M*'F6:F@;$IHBD>1FC?%E$T1L?"X^&RLT+L59-%6!30/ IV:EB4,ICZ>H>!=_
MAGZ[%RJ%S<+BXI_#FO6I'GBBK,(?>=1LV.-C-F9UP<.6:X40BK,;&,U%+E#$
M59C8Q#A#*)I93VAB<I#Y+)F7]C9J&:AC'"'"&4:BGL.$BHI&:AE.8I'F%L>>
M&S,Z*A8'@4,3E#%V'"0RC4;,SH?WG(M\&:BB4/(A]^&S4;-1D0\"FGM*?879
M<:9I15W*7*&(<T]BE3]/44]II15]Q32,4,7#8QB<TK@Q0Q=AFH93F$/(S0Q3
M3%$T1L9N=FN#AFS+&58%-$4N4ARS4/N*/IZFGMP?P3]>J+LNR[+LNYNR[+LN
MR[+LO%R[+LNR[+POP]KU5V'Q0\^!BX/@S7FI[0ARQ^!#E\J>T[->#'<UP61Y
MXZAFH93W\%/;FNW%=H78<OFS0X8O+@7A>!<'&BGMP?/7%B'CGL?H/G3V]5^!
MFO NTK,:YT]II[<'W\#%#%#%-/;RT]HI[?$OV&(Z3I.DZ3I.DZ3I.DZ3I.DZ
M3I.DZ3I.DZ8I7J=SN=R[0G?E4Q8\%6"GA4^\7[PGWCJ[\^KO%3[^LU^09[#X
M+(_$S7XN\"Y4KY5FOR5^Q5DISZC*?4IS+P4YFZFL6#J7"Z+J*L%&"ZF\;BY>
MPLEXN747L+)<O-T7X71?S-?DK_(GR7^./V*LE.9ZA.6["JX=0I;$Y93ZE.2Z
M+H=12MQWJ.D:L)W*Q*YTB[.&[LZ1TE+*L"[]CI/^8KS&X62UQ9$K%3T=)TE+
M[EKBR)6*\Q4SI'24L>!?8Z1JPG=>9K]:'[%62G/"F:A2\13B7DIEE/J+N=(U
M8IM%6"EV.H;NB@K%B*O^H[(ZD.HH*L%$58*,%>8W"R(68L71U"R(68KS%.9P
MQX*(K*<>=K]9W[%62G,](E+5Q4\.D4M"4LI]2G,OL)W*RE7.E%D*Q6+$5?\
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M:A*'B*<?%]*]EOUE@L:BQ<S&Q]XN.+1>'B+%YHU'T]0BO<LS%^&^XS49B\/
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MCZF1%/\ T,^GD^I@H:1UHJJ31],KS-2M5P^H?3P?4IV?3JT?4*,'U"G$5?\
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MVT57V+J*W9%#N8'6W@_]E-?WAU_8M6*MK/&CNX^H45:GH4?_ $5TV*:KJ/\
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MD<8E(<:^6JS_ (Z^_!=IV/S/OS7A>)7;DQ#\;[P_#CN:]1=O.O"^_"GM^%/
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M**L%&(JS#P4%8L15@H*LS64OL4Y]=NWP#-<G@I'@I]9X*>3->6CU*-?!4]_
MH?BV,V,V,8HH]78X6(15G\*9H8O;JP+@RGY=^>CR.%Q<4PRDJBDJ*>=13Z35
MF*I#J+%-7"K,5B[N'F&K,50ZK%.2K!1B*LP\%!4KE+L714[B5D59XTX]9NWQ
M#P4CP4^ZS7EH^6HYO!3YMCEFO99J$59_#&+X!E/R[\]'D<=1U'4=1U'5%,,I
M*HI*A<ZBGT^@Z8Z>_!TWAJXE:.F>@Z(:N)6ATRE:'2= E:'3?AE^LW;TV)1>
M&)1<S"[SD9H8E.4/!2/!2,4TKC:$QFS,7&,_J'@IA=YR,SVXKO.87>+V%GBN
M\YBDM"8UHI<T]QGT]126L*+0F,V9[PF,>C/:+EKN$QC$H3&/)GBN\/ N&!=Y
MM"8QB47&;&;&;'@Q&BB;0G&97?@ACQ#R,T;&8E']PF.7@T6M&>*4Y'@T6M&>
M*4YBG!:QHI<T]Q\+0F,S*8S9GN+(V6A,?!#S&QFS,7&/1HQ*[SG@\F8O#P?U
M&A=Y7<8N\,I15@4)1<IC,IW^2?GH\C+%HM-HI4,I*I>(7*HI^4ZBE;]5NWJ,
M3X;-305"E=AFN#$/!2/!3"[#&:X4CC9HV:AFABAX*1BE=AFH8ABFGL5BFG@Q
M33V'DI'F$/)L8Q1]/44CS%$[-&QQLT/1J-FHV,61PQ8'DU#-11S>"GCLT;'P
MV,V,V/ S4413.S1OF\FAY'H9L9L8S4(JS"'+P4P\"AFAFII*BF'@4,T/)J:6
M/)1H<;&,UP0\\%VE#-CA#AFN"'F-C-FH9H>C14**>W-Y-0\%(\"ABE#%V&,T
M58$,U#*1X*>T['\B_/1YJRDJA#EPAE,+$4\JBGY2WJMV]B\;'-)4+'!FAEH8
MAX*1X*8V:%W'PIX:-FH9H8H>"D9K@S4/ MCXU&IIX/BRD>86QY&+!L<?3U%(
MXHEFC8XV:'HU&S4;&(?!Y-0S44<W@IFT;-&Q\-C-C-CP,U% RGOX+CEE/<7=
ME9HI[C-C&:A%68V52\%,/ MPS1OC44P\"W#-&S4HJR?3U+^YHV/[<*2K/#):
M6;'%/@0\QL9LU#T:'HT5"XYX/)J&4#P*&:G8QFA=QE6!&S4T%6/EGYZ/-44E
M4Z&4CX4X*BDJR4\JBG\(;MZS%#$.64]AE+FD>31LU#$/!2/!3#$^Q3VXH?WX
M;-0S0Q0\%(Q.&4]AFH>!;&*4,I<T\&*5%(\PMCS%/8I4_3U%(XI[#EFQQLT/
M1J-FHV,V9G0\FH9J*-<W@IA%69T;,J=&QFQFQX&:BB*>PY8APA\*>Q3VBG N
MRC8QFH15F-E4O!3#P+<,T,4H93#P+<,T,4TJ/IZX4E/'8_O&RK!3*&;'+[]Y
MUP0X0S9J'HT/1H8HIFC@\G]0_L(>!0Q.4AC$^Q3VBK ABAE,4N4/Y%^>CS5%
M(RD9259*2J*L0BHI*A<JBGW;G4CJ7Q#=OA]<:1X$/ I637BV:AFABAE/)FH8
MO$O%2.$.-FIH[6BD?/8XV:&:C9J-CYZAFH780\%.>#P+BS7+8X9N'&BGMXL<
M=FIU&QCC0AYERQ0Q0S7)BABAFN=';ALUXL3L9L?EV,V:AFAFAQKP/)K@\"\6
MH>!<:?[^7?GH\S*7%)4)V&[E.2J'5<450W>%QJ*?<J=A*YTH=)2_AF[?*4H?
MY!3V[_C2[L?R#R:_#GYZ/,U%A#1TG2*D:.DZ14PRQ8Z1<6A*WN9?!TPZK%V=
M3$[C=CJ['4XZB[$[^RW;Y1?YVOD]?AS\]'GM\E3GDJ>\58*"K!2HK8E:'V?L
M-V_7%^>C\!6>%[0ZB[+,H*L%&(>2U1:HLQ>LW;]<GYZ/P&I"=XP98\%.8JP4
M%6"C$59$[PZO6;M^:+O_ +^_/1^!.D[EFQ*T=+1>HZ?N4IIE6"E6AJY9H[BI
M]5NWS3%OTMC^ 0^5/;S[]BGN.->5^=BBC,;'XMC]E=QY-FO\,?GH_)6[?$KO
MZ#[0Q>)=_!L?F7?QOMYEW\#^W@?-=_078SYV8\S[33VC8]>+8_91E_X<_/1^
M2-V]]B4Z&:AX%N%B4X4IC,S<9N7]Q<&)33WBG!B*7&3$OA2IT,458%%.#$)C
M,F(3&;G8X61BV/)3WABCZ>H7>4QBW*8^+&Q*,&86!\'F<&4,2ABBGN8-FAB4
M8,CP*:>\L?=RARS4(U%!4**>\;X/ADQ+&6G(S,_W+']N-1F&*$89LT/AK_!W
MYZ/R-NWP#$^#-0\"W%$K(Q#S&S10.&:-FH>!>"G44:E%62C4['P7;@Q15@44
M3L93PT;-0S0RGM"V/(NW'Z>AX*9V:%L<;'P0S8\30,HXO)J'@IXTQ2,V:-FI
MH&4S]/4;&,OSH&6[%/<9H>!11J-CC9KA1J=C-RQ#-1LU&QZ%D<,14**L"BD>
M39KCK_!WYZ/R)NWPS-0\"W%$K(Q#S&S11+-&S4/ N#$IHU%&I15DHU.Q\UW&
M**L"BB=C*-<=FII'FQJ%L>>"CZ>BK IV:%L>8V/@AFQXF@91Q>34,I&)0\%,
M4C-FC?%X*9HU&Q\+CX;*LFBGL/\ Z&/ HHU&QQLUPHU.QBR/@S4;-1L>A#X5
M"Q%6!12/)LU%H9K_  =^>C\A;M\$Q0S0Q1D6XIFE0C,)#,&9?V-FHJP+@Q1D
MIS%&I15DP9A#EE+FGL/ G&113B4AQF6;-3LRQPME12YI4?3U%/:4ABV/,;'P
M0QB<KM%'%YG)H9J,E,4QLT,3E=AX*9HU&QF'.Q\'#R;%W8QX%%$;'&S7!=C,
M(8_O.89J-FHV/7#)HJ%B*L"A#R;-&^"Q_@[\]'Y W;XMXL**.*'GU4,I[<'W
M]%=HHUYGQ?*GMX'X'S7;B\FO NTKPKM-/;@^_@8N+X+X!R^XI1OBQ?X._/1^
M/MV^/HXHJS\=1KY5Y-?[$_/2RZ+HNBZ+HNBZ+HNBZ+HNBZ+HNBZ+HNBZ+HNB
MZ+HNBZ+HNBZ+HNBZ+HNBZ+HNBZ+HNBZ+HNBZ+HNBZ+HNBZ+HNBZ+HNBZ+HNB
MZ+HNBZ+HNBZ+HNBZ+HNBZ+HNBZ+HNBZ+HNBZ+HNBZ+HNBZ+HNBZ+HNBZ+HNA
MU?(+M\HNWZ,/]Z7^]+_>E_O2_/8L6+%BQ8L6+%BQ8L6+%BQ8L6+%BQ8L6+%B
MQ8L6+%BQ8L6+%BQ8L6+%BQ8L6+%BQ8L6+%BQ8L6+%BQ8L6+%BQ8L6+%BQ8L6
M+%BQ8L6+%BQ8L6+?KZ_WI?[TO]Z7^]+_ 'I?[TO]Z7__ #]7_>B\W_>2\6BT
M7_>FT7_=Z\6X7YW_ ':OXK\+1?\ =B\6X7BT6\-_W4O%N%_!:+\+1?\ =&_A
MMX;1?A:+_N=>+<+Q;R6\-_"^#]5<%XUP?[*WBW"_I6B_"WB?!S<OPN7B_"Y?
MBN"FY>;EY7!ER_[*6Y6X7+^&Y?E?A;P,N7+\+%A#X(L+@Q<;ERXN#$,MP7!E
MBPOA%Z>Q\-FO-1"'GPT^6C7LL9KW-CYKTMCC4O/E?@93P9H8AB\2'GUJ1Y^
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MKJ5?NJ//X-?U%1_QHZE7[RCS^"7]1T?\9NI5^^H\_@5_4E'_ !DZE7\!1Y_
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M_$*>)BB]')B<'1U-K:G4JK_8Q;TD7D-O)%/"P17\0I/'44HY,@=R](I!T_\
M1M.KYDHQE@([$-#L0T+TLBGAX(K^(4\7%%5D593PL%S*_B$_#\7.F8]/)SDS
M9O=BK<^Y<\3/G9S?(V:_ZE6Y]R[XF#YV)0E3 C&+QIBQ)3>/,NSE@GCA:H^&
MZ<Q/Q'5LE%2PK9SER-FO^I5N?<NSPE9=AC(JG/L;5?\ 8Y2Y67/#SYE=LVF_
M]CDUFO(O:UIH?A5IH1<]XN^'B^95.?8VF_\ 8Y2Y?(HJ+6',NRS$ZQQ*RX%%
MZ(QDCEU1CO+.RYX;HN95[.I>X<T7)[W,[D[)DM!R,_4WD4RZ"DN)>93/H;R.
M7_&7D-O)%%EP1C)(<);K0O)>?8Y_^C>B<O\ V56?$F2NYLO2PU*O+FBY/%K+
MR3\7"Z4C0:E3%DAW55(5Y-)%R&?%EYOU,))G_4)KB0(^#X53.)^UBEQXE[CP
M&Z]V;R*?84EQ%H0+\J4J.[3 NRS/][+GA]V7LES954D7?$QC_P L["AX>ZC.
M)R?%"DN)'4EJ,<8;TBLFEJ5?JAQEO(J\B[&M.",6D=/LR.OD[CC#.1632U,?
M5%);R)Z':R[#=_Z5;42]PZ%[G*R>IAN_8P:91[O%?.X_X6@.<N&5E_\ 5$<.
M>),47D4I@.[AR-K)9V79+ ZQ97F8<'5":XDF7OVDM"))K/(K+*-C_<LB%DOJ
MLD*7ZG9AD\2&@UP6 EQXV;.4COY)"E^IV89/$AH*'!"F]YV>T6:S'X?<6HW+
M*-E[BB:'0E>SX6)QHF76ZD"]+F?_ &!1=W9,1V(:'8AH*'!"F]Z5GM%FLQP?
M#(45^H?B/M9[19K,>GD9&YRLO*22KA9J\"[&S9R>)&7$CH>T:QX&0I_N%S6!
M4^IV3ULU9=B49^&L$\&.7$VLLV41=DL#Z68"?B95Q,!Q]"\Y=O)#4>I)K,VL
MEG9=DL#K%B?/Y$R&A&'<O\96.+(^A)F/#&RC%._ET.Y.R9+0T8XSR?$V9)B<
MN!=CD*/(3XRLETQ''FA1YLE/M9+IB+R7>2%S>-CYK$I^XF*O#&R:Z$?),EI9
M(BK'*^\;,6D5@ZX$-"!*7%NR+ZD]1/DQQGZFS),3D78Y"T('<G9_N2ER0D]7
M;>7ZA=,#L+KC9%\T1(ZDM1C;_2K)G8I^YDI]K'%D-?)W'+E9(>A/0[$O0<G^
MFQQ>3*<I63U(Q5DB&GSJ/^%H"ULEH1)CTL6I.UZ$-"/B=B[^TC#N+G+$EH1(
MZD];8ZV2^JR1'2Q:$-#']UL-3OY)$=+%H0T)D=+)Z$1:D[)$M!Q>3-G:1A*2
MZ'XD:Z%Z.1 NQQ,<LG;,1V(:'8AH3U**M/I./_B795H_[3%/(CH1LGH/3R56
M$D8Q:ZHWJZEV:NLEH)PS./\ XG'_ ,17TW3H8\R.A&Q\UB.',:XRP)>)VLGJ
M/0AY.X_9?\./_B<?_$O23KH0KR'+PN/ _5$VJ2,,'R\D-1ZBU)VO0AI\B9#0
M6A"U?4,GIY.Y.R9+0HROARIT9NOL;U>C+R&)JE'U.'J</44I4H0.]CT%Y)$-
M+):$"8]+):$?),EI9(CI9<\//F87V;5$7:UP(:$#O8M2>I1Y'X<NS-U]C.O1
MEY"T('<G9_N3T.UL!ZG8AI9 1'4EJ,G9/0[$!ZVQU\G<G9/0>A/0['<G:_KL
MGK:]"&ALQE3H;OB>A"L9TK\WC_A: X\G9+K@5Y(F2TL?3$E'G;)K0BN2)1YE
M'QP-79+0B5Y,E#G8Y/@0ULE]5DB.EBT(:$M:BDN-D8+@=_)(CI8M"&@^I%V2
MZX%>2%J3ULD2T*RKV&UA0VDF7X8$UP('<]K'N>SEVLF([$-#L0T'U(NR](I%
M,A+L7>*LEUP'IY'&CJK-J"'%9"KQB)O@[;LJO0O1R(Z$+='4262(QLGJ4%7@
M[7&*32*\<QQ?ZK7&CP+W<N)/O9NT?-$*<_)#4>H^F)*/.V36A%<E\B9#0C/L
M>S>:RL;X\!=,243')X6.3R0DIRHV=R4>=ESBR6@G%+$=[>5B?ZJD^0I\RYQC
M97]7 HTJ(JOTC@^.5CYO!"\BGS%'C&QKC(O<(DQZ62T(^29+2R1'2Q7N+QM;
M61#0@=[%J3U(W4L3'>5D7^HEJ+0@=R=G^XUS$WP>)596891(IZG8AI9 1'4E
MJ,G9/0[#IFL1QEE*Q_N>1#7R=R=D]!Z$]#L2B;63P=EYB?6R>MKT(:?.H_X6
M@>UAED8PQU*4T2*<7F3):64959<&;<:Z%V"NB\2:PX6U7ZL27B=K):$2C*K+
M@S;ACT+D51$-;)?59(CI8M"&A6.\BGV92*2%*><COY)$=+%H0T,-Y9%*:IFY
MCJ9=D4XO,6I/6R1+0<3+5&,&74J+D;6\R!W*/)FF3%+U)B.Q#0[$-##>612F
MJ9N/U,M$C'>>8XL_^Q,88ZC?Z8CT\GM(K4NR5Y&S J^[*+@>T@M479*\C9AC
MU*^K%%9(CH0MCXG85>&-L];/:06J+LE>1L1IU9?GN_\ 2A>CN\&;<:]44@KO
M4ORW5][*K+@S;AZ%(1IU/:26"R\E5P8U2J95K/@567!FW&NA=@KHO$FL.'R-
MN,)-:$=!QEDRL*M<T4K]BKKJRBSXNR_X7=%W'NBF+*O>8XOB5QU11/[$O$\6
MM:8(E>BUAQ'%E575'_\ !65=6**'&16-7U12OV*NNK*+N[+WA8K_ (4KZHO^
M)6@G*$DM/)=D5C75%*_8K*NK+L2:2JQWHM8<59+0BW"26GDE'F<8LE?=234)
M-:"TL<O#58LIGJ4_3Z$;M9<Q*2::YD+L6]"DDUCQL5U-X\"5Z+6I=955U1__
M  5E75BC$5V+>'!$$U1CBLS"L6;>=2MR5+W*R]#>_P"E,5J7<>R+WB^EE8PD
M\."()\K(78MZ"4E1D;J;QX$KR:QXC455D[T6M;)I<BLHM8<59>\+T*+VA?\
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M_N4EL_/(_P"%H'<<F<__ $8SQ+U<.:+LMY$9]BG[79*7-BZ8#?(5>=1R9_\
M8&,\2\GAS126\B>A*[FU0K@M1WMYVN7'@9ZLWV5K6(X2X#D\D4]$;4\>A>3J
MN9=EO(@+6R.I+4D2T$[U*"AS="]>KV'3@ZH4EQLHOTX$8VR'"'ZC\26/0O1=
M47)Y\!R? IZ(VIEZ+O4/9O)EVM!PK4C._P!<ADRK+L<N"-N7H7H.\CV<WH[+
MRS+_ (DJ5*PE>Z"C^ECCE42K44[]*]"O'(;;U9OLST8I>:>@K6V174>A59T+
MV"KS)7\V?[V.7*1[2<J5+T97J$HKMT+_ (DJ5+R=Y#\-\,BI19<$;4_0K"5>
M@H_IE9)]1S_Z5G2B.Q#0[$-!TXXHC+G8H?M(KB\?DNKHC%7F8*Z^AUB[/9KN
M7_$XY(I=H8/+)BES(_5;+ZK&1B\G$C<5*BE)8CBOTY%W]UCYO <^7DGJ>T\7
M&O I=IH=4*2XB\-=R_XF->!N(5,F*O# GXE-HI-84'<5*DB.A[-9+,O>+QX&
M[30P>C%)<2!1O9B;OW$X[K*/])*;6U0499#N*E2G6ANUU&_#5&BE'=?D6I=6
M12[74O\ AY<4>S?#(E+D8OJV;@W!48ES*FN2-I7F5\-4D7>$B1+0NPWO^%^>
M[_THK5?5:$HK*HI1CBNI2.](O2W3<+\-T]G+-9>2!B]E&X*[NLQX8%([TB]+
M=-POPW3V<LUD3T+D?U&TKS+\,N0O!3V<S&-1..ZRCX#EQX&+U9N5+_A<.![*
M7;YW'_"T#N1CW+W&5CB^)'6A)#CS1)GBRY$H]Q]<"4^Q"/<;E**;ZGYD?4<?
M:0QZD>N!/0CY:3&HF,XKN2BI59+0IS9*?:QQ?$K&M2 M;(ZDM21+2R/U61\3
ML7?VCER*O5^20Y?MLHQ=)#C+)EZ-3&20]JNA#6R1#09,?7 <IM*F53\R/J?F
M0]1N#P3P*D5UM?U61T(#IPQ'553-ZFHKR4BD51>:>A6+HS?9OLRD]2KQDQZ$
M%UM_WL:_N*#(+K9/0[#3R9>C4QDD;Z[$:?NLGJ172SL0T.Q#04_VDH=QM\#'
MBZOY->E=74SJ;,&]1RYB)=96UE%/4P(_5;+ZK&0T(:$;'3@ZH4EQ%#]I%<<_
M))?W6P9HS:2*7EV,%)BV:4.Y/0>EDB.A>ESQ,I&4B-U.JYDER9 [V+4GJ3T(
MV-\'BF;:4C&L=2J=?(M24NMC7-$+*N[$XOL;,/4AJ3*\E;505="1*[FT)^)B
MJXF&7EE]5FB(:627-$/) [V1U):FB(:627-$">AVLD3TLCJ2U((:DG5O@92-
MV1!KG\[C_A:!W%H0M7U6:,C'GB*OZA)\Z$8<B*(Z"DI(WT;Z(ROK!D]#MY?[
MGD<68R2)2O-M$M"&I+7R0%K9'4EJ2):61^JR4>8D^. H<QS_ '>21.U_4.3X
M%%71&+2*RG70AK9(AH,F+4=)4H;Z-]&^A+DB&MLOJLCH0LK'99LTD<8LQWEG
MYIZ"\KT(6_[V?[V,AK9/0[#D\D4C71&-$;<_07U63U%9V(:'8AH.+XBKSHRG
M[B4^WR5R? ZLVY/L;M=2=.8A])6J^Z5*Q=41^JV7U6,AH0T(V1GV&G^@QXNK
M\K?]UL$:L]FLD*4W2O XO4@HI([D]!Z62(Z"4LJXF3]3)^IQ]1W.) [V+4GJ
M3T(V4=#*[H;$KPN7%>1:DEUL;(:CEQX&>K9M2;&U!=R&I,?56W;V)(VLD>T@
MM3V<NWEE]5FJ(:6-]"&OD@*R.I+4U1#2QOH0U)Z':R1.R.I+4@RLLZF3]3)^
MHFJ^OSN/^%H'<4UP/9R[6/\ <\A/A'&R,^9!=*"7(KSQ%7B[%-?I/9R[6-\>
M!1RJN)/0[>6.AAG7&SV:SXCT'3-8CC+*5CYO(KP1!CAQ5BC'])+4D2TLC]5M
M5QQ%3045P\DC')V5X\!/@L1:D^=C_<\B&MC(:#)DDLS:R=EZ612#S>5D-;9?
M59'0B*7ANG,<9O:L2_54F^!63HBD9)OR3T%Y7H0M_P![/][&0ULGH=ACKG3"
MQMY\".MD]16=B&AV(:67OW$.B(QY?)9I<A.61521@[TBK$>T63%&;HT5<T;.
MB(QY#Z,K>2Z,V7>ET%6QD-" HRDDT51*/,G'G@2GV\L]11FZ215R1@L\D*/(
MG7G45&J\C:DB]PX#U)Z%9.BH;,DR1'0O+*12;I(JYHV=U9"O9L@=[%J3U):$
M7+(:C),ZQ95215R6AJZ^1:F.Z\RJFCV?ANO-C\1]BO)C4L*F:'#PW5OB0U&G
MQ-#"2T9FG+D5>2Q9(EH4>1AV8I>ODGJ*DU5BFLXER>[S*WX^I[/P\>;/:/MY
M("LCJ2U%-9Q+D]WF5OQ]3V?AX\V>T?8GH=K)$[(ZDM3#-8HVMUYE5-#4'61>
MX1^=Q_PM&XJT*35'4HROA8KD4_$*SPZLNQLHL^!%SC1*R+@JM#EXBIRLQ*^%
MBN13\0K*NLBB[LDEFT7IQHO+3CP-E/\ U*;7_!WW60FX867O"]"BOE9U761=
MB.+,%7JBFWW,-KQ&24U3$E&.9)SC3"QN"JGR%>4[O6R]R+W[?+(DJT:6!17J
M="LZKK(I$<9<2L<>J*;?H7O'?8K&&">%E^&/-&$9C45B2OJE;+WAX/D42GV-
MI2[E7C*R,G'"O.URNX7N=B<<T449K049K-8E?#VD4_$*^)AU9=B.,55E9QHJ
M>248YL4I1HO*R,I1PUMO7<+U<[+UW"]7.V,I1P76R26;16<:*@XO)E88KH4V
M_0O>.Q^SCL\#$E*,<'UMK"-50BGFD7H1JJ$4\TK&_P!N(N4<?D]Z#NLWHE9N
M\7E*[V%%NM"C54?ARIT9C*)7.7.S'!\S"42OB.]T+]^G:R_?IV%'DBC[,WHD
M8OA9)1YD8\O+/4K!W68RB89\[,<^9A*)MS]#V<=D>U5,H?AR5.I*\UCR'._2
MO02Y%)*J-B7J8RB5>U*R.U2A=K6R[6F(U>K6ROAR6C&Y-9<#'/F;,T;4UV-G
MU\EVM,2Y)UQK4PDBOB.O2RC/PY4Z,QE$KO2+\9TQKE9M>ILS7<VYKL78H<*T
MJ-WJUZ64R:XE?:57*GDO1=)$97HX.RL'=9O1*S=[IY5M4IT+E:V)7J#5ZM;*
MP=UF]$K-WNECCS+U^O:QPK0>U6O2Q*M!J]6ME=V1A*)MR]"[%47SN/\ D/>0
MH0=4LQ<WCY9$M/Z%HVCV<'7F7GG+YTY/)&Q5LOO)8^:>O^%8_P"0[T%4O>+Z
M>9Q6;&Y-8\OZ%4H*N!7Q<%R^=N+XF_AH78K#S.3<JO\ PK'^=,?YTQ_P\WR%
M%*57[EOD74I5^*NR3["DN/DQ*H<GDAJ*>'/X=.5<>0W&O?SJ]7'D4I+R7I%*
M2]TG*N/(O1KW+TLAW4\.?N[TJ]AW4\.?D<GDAJ*>'/YQ>C3/B2O4PY?*'%*-
M$)\T5DZ(K'+W,I+@B[)1I\/=BHT(R?%>^4:UD^%F))0X6*-(TK3^@H_X>:YB
MFY+#W,M"/Q78AIY'&NRN!#0D2T^'CJ2U\\"I%VQARQ%K[J&H]1Q1*K3K[NZG
M0E5IU\DR6GSA:D_E%Z5:E"!W]S/06GP[T(:>^7UV/4G9>QKG_04?\++9K44V
ML7P,8J@GS*+:D81B4\2-.J*H;Y"A<I7K9<N4ZU*>&J]3&,2\L*9E/#C7JS:B
MNQ>B2T$WD?AQ[LVX+L5B[%"YFZ9VN%S)TSL<+E>Y=@JL491SY%9&S!=S:@NQ
MLY\K*R9LP7<VX+L5@[+TF;$/4_$CZ"E%U5"&EMZE1SI0C#V?3,D3E)T5#8CZ
MFW!=B]&RZXTZU/PXJG4:<:4-KT-F"[FU!=BL78X7*TZVW;E>XI<T5>1^'&O5
MF,47XJKY#=*4(ZDG+F;,5W/Q(^A6.7D@2?[9$H=[:\*U/]K+TG1&Q'U,8Q,,
M'RLJ\C\.->K-J*[$''F/4<Z5'LTI93>D81B4\2-.J*HK)T1L1]3=B4\2-.ME
MZE26S2EE(*\S=B3X2Y$M/E=V&,BJO=BK<Q0\3CQLI"5%04?#SXLJ_:&WM(JA
MRED4AAH7MLNRWDR?DJ_0I#TB5=\N^+ZV78XR-ER[&TY=R[+"5CC&5$7?!]2K
M?B(N^+ZEWP,BLG-:ER>?.S;GLE/"32Z&TYK4;\3-?<_#JE_:8RE_L5XK,DUR
M%&4JJV,7+"O*RCGLWB[X.163\1"AXO'C9*,9417C=%[6O=%/"K30C-.DN. X
M^(ZOA9448RP;Y>2>A>?(V*T_M-IR_P!CE)<++L,9%5>[%6YBAXG'C9=CC(JK
M_8VG+N7982LNQQD;+EV-J]_L4RERLYR? V7+_4VZT_N+RY$-/)3PL$5_$*3Q
MZ,4HV4\+U*_B%)X]&7HD?95[(K^JHEXE;NA)3K<KR'[*O6B*^+G44;V%ZQQO
M[-XN^#D5;\1"CXO'C9>D4CATB5=_N8;,ZC<W7$KQX(V:_P"I5WQ0\3CQ^9Q_
MPM VMV)NT,,W@BLMU%%!>@Y^&J-<#V;[$M"-CH;2O2ZC:BDUR+D?U&ZF^;'.
M*HUR)1Z$M!16;,JOF94ES,='9'ZK9?59(]IXN-2_%4'7A@*D5J4NK43NNG$;
M? U-VKYLW:/FC3.RBR6"-I5D8Q2ZH<7P(:6TDJH:BJ(@[D:TY$A1,(+N.<%1
MKD./-68&VKS)-99G5F$4^K,J/FCJA-<2>MKT(:"\-=Q3\15KDBC@C#=>1+4C
MJ8[JS**$2_!4YDH\O) FGQ9CP=+'S>!*?8_VLNK)8%9JLBC@C9?5,4N8O#7<
MO^(JUR11P13@\AZC)C:S>"-K=69101[2"IS0X/AD**3NH4IJLGS-Q>@G')BZ
M8'<F46<B]/=12Y&FA?ANLEI\KK/)O$PLDEP=G8OO>=B:_41%#N7WO2L4X\<R
M?D?3 2X\;/PHX%Z>:11\<64BJ(H\446J(RYC%+]4K)17!BY\1IY,C]5E.HHQ
M))\B,>92*HB3Y$ET)Z$;8?59/426?&R27 3)$="!W'%\3'@\;*<98$I]O)/0
M42D51%V1]+LK/)O$PLDEP=DKW,5S(:>3%.^L"4N1M:LHBDE5&'Z65-678E)*
MJ'$AI;.G(V^UBI120TY5%%?J/:2X96/]RR+O"5B^NQZD[(_59/47-YV22R(O
MH7>$1?N>=E8Y2'J+0BHY\;&XR45\SC_A: ];(KH7;E>Y^7]S\O[D-26A&Q?5
M9+0A9/0>A+072V1%]"/U6R^JR1'2SVD%7F43PY,VX>AL,D7KM3\O[GY?W+]*
M$7T(:VI\T0T\DB&A(EI9/05D-;)$GTM3YH@3UM>A#0GJ)6)]26I'4EK8R?D@
M2U+W[B+%!<",3_8;%)XT=3\O[GY?W%LTIU&NI/42LB^H]1DR"-7Y*R=$859L
MP^XKW [G<F170C9,EI\KNK:D841^K_@U+,1V(:60$2(:6/4GY%]7DD2TMCH1
M&0TLGK:OKLC]5DM"-D]!Z$]"-L/JLE]5LB.A(CH0.]BG^X7-8%W]I&)&YQ,U
MZ&:]!M_M'I;,CH75M2,*(_5_P:EF(OPWC*4>IG>U+KV9#U*^'GH<?_$X_P#B
M7I)MZ"YW2%JT(:6T97P]I&<HFVE(K$CH4\.M-#C_ .)Q_P#$@[KSL7UV/4G9
M'ZK)ZVLAH2^JV.H]3E)9&Z]4;U=2GB*G7YG'_"T!ZV1?0QBFS\M&XA7+E26A
M&R/U62T(V3T'H2T%UMD17)$?JMD_[K)$=+*7U4VHHV)-']T1OI4NS5<#\M'Y
M:*-03*1R(UX.U+DB&GDD0T)$M+)Z"LAK9(DN:MIR1 GJ*QD-"7J)\U9&/-DM
M2.I+6R1/R0):E?VXDHO4J^=;/]AHBIY5Q-Q'Y:-I16I^'2G0F1?-6174>HR9
M!E.3L<GP*1K4<>$1/Q*UY&$$02.YW)D7T%TLF2T^52DN0E(V8I62?41V(:60
M$5YHCTPL4>;)^1])":XV*,:/F-M8M&/'"VB_3@00R&ED];5]=D?JLEH1LGH/
M0EH1L;? AK8_JMD1T)$="!WL?-8DT\J5*O5V;44]3\N/H?EQ]"?TBKQPM=.+
M)-<$)2-F*5DGU$*-'G2S&*[#2>ZQ^I1_JM<77 U0J\':Z<,"&EMZ5:#HJ4,5
M4<XJZT-="$NQ=XQL;>2%%*578OKL>I.R/U63UM9#0EUQ%)61AW'J76G437$V
MHIE(Y,A7YE'_  M >ME%FLC%8<4;Y<\+CQ/:/)9$M"-D?JLEH1LGH/0EH5CF
ML3;=UE/#QD7GNJQZU1M.ZRGA8OF4EG9(CI97@\4;;NR-ZNA]1=X9'_&;6RS9
M=YG5YB2X%]9,N^+@^9LN\R_+B0T\CT(INCR)$M+)Z"LAK8T^)ID;3NLV-IG_
M %E"]PD*/B8-&QM,O2_5B0T+\<T79*L3"K/:2RR):D=26MDB?D@2U*,DNPY\
M[/\ :R^MUEWQ<'S-ZNAEHA1]3VD<UF7/$RYE;U2]P'J,F./'@.JU1OESP\N+
M'.6;)=<17G=?4WJZ'M&L,AZG<F89K(::PXHK?+L%LHEI9*-U8,3YKY.X\SJC
M&#J7/"C2I=EF1?0[$-+("*<5D9:IF$,=1^++(GY+\-XNM51LPQZEZ67%E"_#
M=_X4FJ]2D(TZEZ>[_P!L9#2R>MJ^NR/U62T(V3T'I9_QFU"K+D51$5RE8_JM
MD1T)$=!-<&-4JA3YV2B.?/RST'=S6)3Q(UZEV*NH]I/LAQYG5&,'4N>%&E2[
M+,B^A?CNO[%)QKU-B'J7I;O%V7H[O_"DXUZE(1IU+TMW_MGM(+5%V2O(IX<:
M=17LWB0TM<7Q.3_Z8P+J5$7I9L<6<G_TVH8EU*BY%^>?"QZU(P<:5)4'15J-
MTIB1^JR>MK(:&&\LBGV92,4A3\3.0]3VD,^)=:O(P@?_ & HK@)1DU@5DZNO
MS"/^%E>KAR+L:][=I8\T8>)]C:;D40US%).559>K*M:V4%).558XOB7HM]QK
MF557J5B[IM2;*15%9MHP\3[%=Y]2^VZV.3<JLI922JC9FT8S?H;"LI-5-F;1
MM3;*05+*/(V6XFU)R%6JIA@**X>3:SYGYGV+DAN+>/.QI\2]%RK8I)RJK:35
M39FT;4FRD5164DJHV9M%9.\)MM4Y"BN!=E))E:=T<60BL,1OJ)2KAR&HU[V7
M99#NMX\_(KU<.12->]EYMUZ"BLE9>K+.ME'BC9;B8^)]C96/.VJV7T,9_84,
MDN1=C7N799#NMX\[-I8\T?F?8J]I];*31AXGV-IN1<R70=UO'F795[#NMX\[
M*O!\T?F?8<5QS8W%O'G8Y-RQ$N7RC:BF;ALI(VHIZE$J(K*$7JBBLVHIZE(J
MBLVHIFX4<53D;,4M/+M13-PPMQ@C""MK*$6]#"RKA&NEM;D:Z65N1KI;50BG
MI91XFS%+164DJFX4BDBMQ5TLK<C72VKA%O2RKA%O2W<*15%92.@HKAY<39BE
MHC:@C9@K=J*9N&RDC:BGJ42HK,8(P@O)C!&$%Y-J"-F"-J*>J,/)223-PV8I
M6TDJFX;,4K=N-2L8XV5<"D%0K<C72RKA&NEM90BWH8%R46)T33,(I=B,35V;
M4$;A2*I9M13U12*2T^81_P NKQ%W%'Q%EQ,*LRT0H_X2=,Z%*GM)=OG-^&:X
M%WAR9A%(O2K3BV)+)?-X_P"7LJ:'ZC8C3_"E;D:Z?.]I)F$(^GSF/\Z8_P Z
M8_PYGJ;C-QE:213Q'6/EA05?@9CJN!,EI\#"@Z\_<K0AI\2R&OD<WP)5RY63
M%\/,7SR/\.9ZD=+<,GB1Z8%)22964J(I&:-J26I6+JC::6I6+31C-&Q),Q-\
MV))V[4DC?^QLR3LK)T*J2:*7T7JJG,V9)Z$R6AM22U*Q:>EM+\:Z^2E]5U-N
M5#8DG9M22-\JG6S::6I6+3T-J26I5-4-\V))F)OFRT[%H0;=%0WRL6G9M-+4
MV6GI963HC9DGH59LR3*.>)6+J;4DC?-F2=M9.AOFS).VK=#?&XM,AKY)1O*O
M*I*])+4V6GH3$Y.AOE8M.S:DEJ7KRN\RBFK-II&^;,D[*R:2-F2>EE7@C9DG
MH[,3?-B292_&NMDQ.3H;Y6+3^=1_AS/4CI;ADL"-=3L89(C>HXD!$=1># Q\
M3'0IQ7$48X)9GYF.AR:$^9=CFR\W1&$V?\:%)YG<]E#BS].@X]!Z$R6A7C$<
M.=DI%[]ODD^4ASY\67ITPR+D-YEYNBYFS/$H^Z%)9,@/4@1\&&1^9CH=446$
M48>)CH=45%H*"W8F_CH<G_T4D1U)ZV2)Z$]"5W-JA7!:DI2WAU>K-]BQT:%+
MCQ')G_V!C/$O)X<T8[R&WDBB[(VIX]"]%U1#R3\6]QR&KU*%VM<29>;HC">.
MAR:S0GS(:$?#CE%"R:.O Y]3?QT*UT:,=Y'<G9/0>EE(Y<$;<J/H7X.J7$4G
MQ=DR\W1&$\=#DUFA/G\YC_#F>IOLWV4K*1>\7!<K.Q'KC9 1'4G+M9 KS=G8
MAH5E6HDLD8SCZD;CK0[G<E+E9,>A,EH49]+LC#N5XRQ\D]2,>2L;?%B2\2&'
M4_,CZD7&46^C''DR ]2!*76R.@GSL9#06A'KC9>Y,G'N1U)ZV2)Z$]"-DJ:C
MPJF;U-17DI(I%4(Q[F,XIOJ?F1]24?:1RYBZX%.;)2[62B^)#7R2)Z63(KI9
MV(:$-"O-V*/)$>N-DD1ZX'<G9/0>A+K@.7*RC+O*5DR*Z6=B&GSF/\.9ZD=/
M+V(:60$1U):V0%9V(:%R&?%E['5FU-$:-NIW.Y.R8]"9+2Q3YB_MP-64\DOJ
MMN\V;Z-]&^B576I >I >MD="-G8AH+0AI9(EH1U)ZV,GH3T.UM5LLV:2/U19
MCO(6@IJ2Q-]&^B,KRP(ZD];8Z^21/2R8K.Q#0AH1L9#2QD-3N3LGH/0[D[7]
M=DQ6=B&GSF/\.9ZD=/+V(:60$1U):V0%9V(:$Z\R-W*EE(Y1'J=R=DQZ$R6E
MDEQ/$7[D.?+#RR^JU]<45X\58H^%++,O>)QR(#U(#ULCH1L[$-!:'LWFK%X<
M>&9>?ZC1DH/C9[-=R>A/0[67O#>HX^)+:X64>? F^ IK@>SEVL_N>11RK%9C
M2SS-K)V/]SR(>21+2R8K.Q#0AH1LCXG9GLWFLK'%;TB_PB2&G^JSV:S8]"4>
M9M:,K%U1_=P1'6R8K.Q#3YS'^',I1C@^HET\MZ$:JA%/-*R-Q5H*,E1D5!5Q
M&IJF-D;BK049*CLK"-50BGFD7X;Q2*FBDJTZFQM3)1G&A2"JZDKZI6R48YL;
MG&BH2C',;G&F%LDB*X^64E'"O.VDO4K''K$I^(5\7!<BB(W%6@U-4=2-Q5H-
M35'6R+A&N!&,L'9>A&J(IYI"<(U5",O#WJ8HN_B%?%RY6.+R9L[2Z%/Q"3>,
MZ8(E?C0DEFT7IQHK*/)E?#Q13\0K/#JR[$HROA8KD4_$*RPZR*1LO>'GR*)3
M+WC5IU(R<<*\_(X\S",M42]I>[DI1C@^HK*PC54(IYI$;BK049*CLI+)E?#Q
M13\0KXF&I=CD49L;2*?B$I>)C*F"&YQHJ67HX2,%Z,KXK[%%^ZR4HQP?45E8
M1JJ$4\TOG,?XL8E7)%7SJ_Z,E=SH4\66S9B\>"$^6+^?Q_BQ*/-&7W.;>;_H
MV]X;IT,%]S;:12/S^/\ .F/\Z8_PY<6I8#4:X<_)==:]!J*>'/W5UJ51/F)2
M3QY"DLG\3E(O1\C5)8%Z->_NE%*579=I*M:?$.3R12K\]V2E44EQ^!I7'^@(
M_P .9ZBKH_)*1/3W4B.@FFE04'P^(9@.'.V4BH]?<LAK8YWEG7XA0YD9_N$^
M.3\ST(:? 2<71DZ_T!'^',]2O[L2,K'S>!.?-T)Z6;7H;,%W-N"[%8.RLF;$
M%W/Q(]T-K(CH)7:U%.E*E64\-5ZF[$H]F5E9,V8+N8QB77LRL2NUJ1:6U)5H
M;4%V*LIX:O=3=B4>R_.R&I]+MC#N>%S=6/6RBVF;L2GB*G6VF<N1A&)=DKK(
M:V.%SC3.RLV;$/4VHHV?2RF](PC$VH(V?2SV=SC2M2GAI/JRZX]T7I.B-B/J
M8QB88/EYG31%U?H'#]UM9,V(+N?B1]"L<50AH79>'3&F=JPJV7KMTVL^1LP7
M<QC$IE+E9=N5[BXR? W8E)J[9/PKO'.HW=K4O4IB5DS9@NYC&)=>S*R])T1L
M1]3:BNQ&4%>J7J4LI!7NINQ*2V7\QC_#F>HI?M)0Y8V*"X%WE0GH.3X'5F$5
MJS*CYHQT=F&B,JOF94?-#B\T1T(Z$1>&NY[3Q%6N2*7%Z&SD\B+>9D\Z(W4W
MS,8(<5P$^:(Z%[Q,D*25*'LUW/:>(JUR12Y'T+T-UF.<?,R&I&?/ 73"RG"I
MX8]2BSD7I;J**"]"_P"&J4S1[-]B4C'5LHH(<_#5&N!"R7U68:(Q59<V4<5J
M:,DXXLVZTS9A!#I%*70CUPLE3F)^(JMC<.)=62P*S59%'!&R^J8I<_))E?VX
MV8?I8I+C9199(Q59<S*CYH<7P(:%[A(B['31"CR,4U>9111C%'TNSL>T\3'D
MBER/H463(MDI**KS)7DGJ4BDC)YT1NIOF8P0XK@)\T7%E$3FJR*.*+HM1>&N
M.9[3Q.R*7(^A?AD4><?F$?X<SU+KXH5>=&5+SU&3T&7KM3\O[GY?W'.E*E[^
MPC:^I'0CH1)ZB73R5FZ&$6S9@NY>EF0T(Z$;)ZB7L\NI^7]R[<IW)+IYF0U)
M=,1PYDF2GV(#U$NA=N5[GY?W&O9Y]2 EU)NV.MDOJ)/H1\NT\>2,(,I&*1#6
MRG]UC8I/&CJ?E_<_+^XMFE.HUU\BARQ'6M6?J%*%>HX<AOH0MU1#0?..)*'/
M$E(O?MLVW0PBV;,$AREFQ'8AI9 1(GI96;H81;-F"[EZ69#05>,K8,6I,4?9
MY=3\O[CA[.E>HUT^81_AS/6R]^X3XRP'/F,GH2'&:K@?EH_+11J%1QCE3 C:
M^A'0CH1)D7S5BO5QY#FLD=6;59&$$2(:$="%D]1.XL3\M%91BD5\*[V\S(:V
M:,C!:D5W(#U(OH)N";/RT;B%<N5Z"?)DXV5(ZV2^HDNA&UPE7 O1SED.KP69
MNUU&U%+ AK9_O8T14\JXFXC\M&THK4_#I3I;5GU,SD9R'=<JB?9C7,C7G;HB
M&EFC(P6HGQEB.7(SQ9C61LP1/41V(:60$2)Z#?(ZLVJR,((D0T/IE;"(M21&
M5Q8H_+1648I%?"NUZ?,(_P .9ZV5_:*'H*/(9/0:?$TR-IW6;+O,US90O+=>
M13Q,)&P[S*RXXD=".A$]I'AF7/$RX,WS!:(]GT$VMUE;Z[FQM,K+CB0T(Z$+
M/:1X9ER>[S-]%([J+TLY$I<D*+BL?(R&MD9\\"*=D!ZF&\LBC6'%&^7/#[L]
MH\N XOB=4;U-3V?A8UXD-;)?5959/%'XFS(V7>95ZLP_2-2R9^8CV?A<2%>=
MG^]M];K+OBX/F;U=#+1"CZVTXR'/]OD?)XBYK OK=93Q<'S-EWF7I<2&ED?$
M[$4[)1YH4FM3?13PL7S-K,6AV(:60$2'>R9*X^@FUNLK?7<V-IE9<<2&A[6/
M<N^)BN9LIME^?ZA:GM(YK,N3W3?1=CNE^6<AOD1C=6+^7+^'+DW+&QI\123E
MA9=ED-Q;QYV4FJFS-HVIME(*EE)*J-F3163O%75:"7(3DWAR%%9*RJV7T/S/
ML;*QYV5>#YH_,^Q5[3ZB<JJG(NIMKJ5DWV%%9*VJV7T/S/L5WGUL<7Q%&&2\
MJDG*JLNR+T:UZV*\WAR+L:][*M4?-'YGV-JLK=M&'B?8KF^9?3E6R]65:ULI
M)51LR:-J;92"HK*QV3'Q/L;*QYCE62XV7ZRK6MM'BC9;B8^)]C96//R)N35"
MZO(JNE!TDW4HU5&S)Q-J3D)NJIA@**X6799%Z-:];:Y/H?F?8KF^I>;:?04:
MUH7I.7845PL5YO#D78Y%&;,J#VJU*O!\T?F?8J]I]1.553D74VUU+KFJE:4T
M.+U(17!$;*[KZ'YGV*[SZV-<SPX0J_ER_B^[N#'.;K-_TA?X,IXB=>9LIMFO
MV%%</-@/Q/%=9_+E_+"C,FM#]3*15/FR_G2OYTK^(U8.CJ2ONM/E4FLTA1E*
MJ\]V]A>Y?U@OXC+4G\JHRL8T?G?U_P!8+^'-SP^[*X]V5IZ"CXCJG92,FL.8
MH>%4JX_<Q;:Y,4EDR](HJZ(JOLSV?B9ID_)SD\D8597_ (R[XKJN=ESP\^97
M%ZE<5HRYXF?!V-*32U+G@UIT+S7W+OB.L2GA5NEYIZGLYNO)V5E*32X5-FM"
MKJNJ'[3&2RZE<:&-8FUO*RYX7J7L>[*XHNRWK,9RNJ7,=$VN2&G5)<&78;W_
M  KBR]CV9<\3/@R>@DY-]['#PO4JZ]V5QU0H>(ZUR=C^OR3T&Y-RPPJR]PZE
M<5U1=EO?]LN>'GQ97&G5E:>@HS=8C2=!7Y2:K1U=K4)-)88,2;JRYX6?,KB]
M65Q6A<\3>YV22FTM2D*W>2%':CS+GA]V5?W97%:,NSWE_2*_ARI2DFJXVRNY
M5L["EQE8GS1$4.0GQE8O$6C)^1^B%%67H4295YQ0D]7;AEFB,AB?&6-DTN8H
MHH1^JRG-BBLD23Y$8V2'H2?$VLEC91Y&'Z65)ZBBBIC^IE%E96+25<"?TB'0
M4I--*S$P_=8_K\D]!1X&!1Y'TNR]*2:KC;.[D+0KPEB19*7(J^&)*1CDL7:T
MM41ES1(CS>-E9<)&S)#B^)>O-O\ I%?PYN^'CU,'+LC:K_LQQ? 1V(:60$2(
M:6/4GY%]7DD2TMCH(9#2R>MJ^NR/U62T(V3T'H=Q^RO=C_\ 3U/_ -/4JXR;
M(IYT']5D]"/DGH*RGA+N87NR-JO^S*<G8_K\D]!Z6R(Z%WP\7S-ER[(VJ]V.
M+X$="O&)*'<C#GB7OW#)Z6K0@2(Z67HNDC=]#>>C+LU27](K^'$VN0E+*S$E
M+FQ'8AI9 0I<T+FL+%#BR?DEK44EQLN^&\LS:WFA5R>%N&2P(H9#2R>MJ^NR
M/U62T(V3T'H2Z8E'^JUI0JM;']5C7,5>#QM:\-X$JYW1$J&UP5C;R17F[']?
MDGH*N3PLJS#]3)4X(BI9&%DI+F1T*,T91<Z"2X$D8Y/"UTR6!&/0D1TL47&B
M=FU%,I'A+^D5_#AQ?$TR9C!%V*I$NYD7T.Q#2R BZSE_[-U5'XWB$_)6.\B[
M]F8)(O>)N_\ ;+_AJO-%UXZEU8:%_P 147*QD-+)ZVKZ[(_59+0C9/0>EE[P
MU6/_  H]K4NK!="_XBIR5C^JV_X>?%%UXKDRBPT/:>(M$3T$.+XG)FXBF4?L
M7>0FN(_K\D]"[',NR5:<R[PY(OSWAI\3_C,8)EV*HN@EG@0?2Q3YCG^VV_X:
MJN11[6I=6&A?\1:*R1'2QS@JI_8HZ2*)4T/:>(J4R5D\7F0T_HY?PYQ-R/I[
MK$PA'T\^*3,(1]/)M13-F*7PF,4^QLQ2[>?:BF;,4NWEQ-R/I[B>@M#:BGJ;
M,4O)N1]/*H+AF+F\?)M13[&S%+SXQ3[&S%+M_22_C[.G(3E"26GNI*]*E2]-
M;/7C_4"_G2OYTK^=*_G2OYTK^=*_G2OYTK^=*_G2OYTK^=*_G2OYTK^=*_G2
MOYTK^=*]_M&4C*1E(RD92,I&4C*1E(RD92,I&4C*1E(RD92,I&4C*1E(RD92
M,I&4C*1E(RD92,I&4C*1E(RD92,I&4C*1E(RD92,I&4C*1E(RD92,I&4C*1E
M(RD92,I&4C*1E(RD92,I&4C*1E(RD92,I&4C*1E(RD92,I&4C*1E(RD92,I&
M4C*1E(RD92,I&4C*1E(RD92,I&4C*1E(P_CXO?QT_IZJS/[OX]KW\=/Z?JCK
M_'I>_CI_4%4=?X\KW\=/ZAJCK_'A>_CI_454=?X[KW\=/ZCJCK_'9>_CI_4E
M4=?XZKW\=/EZ2XC>'O+V%/-1>ZJ_)>X>2B*/RW4*]3'W54=?XZ+W\=/E[ER)
MQY#7N[EW[^:O$?N%Y?\ 7R5I4K2GE4N0L*4]W5'7XUIRQ70W_L;_ -C?1A[^
MDY4+T<O)6;HAW'6GQEZ612$J_)FWDBD)5?DVW2I>BZKY3=<L=/D]V4L=/@:3
ME1B:R?FNWL<LO(V\D4A*K^$HW5]!1VL?-4NQECIY[LI8Z6792H]"J]PK[I4K
M!U16;HAW'6GFI.5"]'+X"Y&K^?KW\=/E]7J5?ZA3LHBOB,P?HRJQ5E?$92J]
M2L,;+V-:65\1E*KU*PQ%>R-C(DTU>U*(KXC*)_<K'%6<D;7W9>\-^7_7R492
M)>3=;;TVQ1>0KO$HRBW2G'4K#TLHC;^[/PV7G6]2VJ.OQD]3?1OHP:9TXHJN
M/OHN'(C&6?D6I/XR48YC<^7FK',\1MU?Q\HK-HO26%++K>"EE9 7RF7U?)YB
M]ZWR0G-V7HK"A&+S2\UZBI>K9<BZ*A#0E%9M%Z2PI\'*2Y%*BDF\/-+0CYY2
MBL&(D0T]Q [EV.=25_CYHN'(C&6?O[BSD7GG+Y^O?QT^7)%WG9JBAV$_TV76
MJNA&HKN7&RDE6SL1J*[EQLI)5L[C',N\%8U+@.)HBK.C\O\ KY.PM!P'UQ$B
MZN)$B=A17&S'@2U*]RK*HD^GDJCK\7/45N'%$2ZTRF;Y"BXM5LHMI]#\O[E$
MZ/D['&2E437&R](=U/#F)23QY"DN-E%M/H8P^XG!\2=FT\>2/R_N4>R^MM,W
MT/R_N4>R^OEK-T-F+9CX?W-EX\G96;HC9@V;4&BL'6RCQ?)'Y?W-JL;')\!J
M*>'.RF\^A^7]RFZ^MEQ)UJ2O)X\B]'(K-T-F#9CX?W-EX\K+LDQ2EQX&'A_<
MINOK;3>?0_+^Y3)\G9B;*<C'P_N;#[>1.2>/(K&O>R[*O8O1LNM.O0]I1TI4
MNQ3%>3QY%_A>J**4JL@)S9A#[E'L^6[),3>;X'Y?W*+!\G;1XODC\O[E-U];
M')\"6:IS,(516)3>?0_+^Y3=?6VBVGT/R_N43H^3LO2'/)+F;,6S:BXE5BK-
MI]C"#]3&#*P=DOJ\NT^QAX?W*23C;1;6A^7]S:3C8Y/@2EBE'F;CIJ7HE9LV
M8/U-I.)58KRTWGT/R_N;2<2JR'+D-)-4YE(J\;4&BL'6RLG1&S!LI)728O)M
M/'D80^YM0:*P=;*R=$;,6S:@T5@ZDO#:=:"E+(=U/#F79)BDN)=:DN%JO5QY
M%8ITZERDJUH.3R1>C7+B1BU*J')\"[%.S;9A#[FTG$JK-IX\C#P_N;2<2J\M
M%M/H?E_<HG1\G9*"3J-R3R'=3PY^3:>/(_+^Y)+!TR9&RLW0V8-F/A_<V7VL
M<6I862(OE$44I8\[:2K7H*2X\[8'<O2'=3PYEV2D*4<G8Y/)%V*D)23QY"DN
M(KR>/(]H\$;,&RDE=MH\7R1^7]S#/D74GY>C?VMQ=7R1^7]RCV7U\U%M/H8P
M^Y[18H=U/#G\R7OXZ?#\/=YHX'#W3D;;C74_3ZE(->I7F51M8'!E8>EFV?I9
ML%&=K-L_2S8*,[C.XZTKH?I]#9HNPG'+W'^OD["T$Q2Y#D/H1(G86EDB6H]+
M?]?+5'7XJ>HL49HQDBO/(C'D,]IXCP%--X<SV<>Y?\3+@C<*K=X&.\B/B=F7
M?VV1AW*\98D=")<CG(OSW2EPI^EDRO'@.KPXLW"_X?='LY=B4EF.]DC<0GX>
M3X%)IX<_)ASHC:5YF[30ZQ=C7!8&*O,V5=8L'3)DI<D;3ZLW$7_#RY#C)/#(
MD2T)-9C<\D;B$X9,5].JYEZ*QJ2OJM"D<$:NB,5>9@KKZ'6+L6A>F]E8&[]R
MG!Y$6\R['.1>GNE+@J9/(3>?$]FLEF7O%X\#=IH8/1BDN-LNF)*/.R5"4.]F
MK)Z'85]5H7>%ZA>C'$@8O91N"N[K,>&'D[%_Q-TI<1@\.#$^/$PWF5ENFX7X
M;I<EFB>A<C^HQDZEV+Q?$;GDN!N(5RK3%?3KU/9Q[E_Q,N"-PJMW@8[R.Y[-
M/#,Q52_X>7(E#N.7(Q>>9NUU'<5UD>N%DOJ\CD9ZLW:ZE_P^&:'X;["@OU%^
M>7(W$*4,F.+_ $DCV<>)O2J=(HZO[&*O/J5\/!EQ[K\E%G(<I[J-Q%^&7(E'
MD3T+L?U8&WM,;\/!H2X2LHLLD;:O,_#PD8BME+D8OJV;@W!48ESLHLE@C\3&
M1LJZS'1DIM8T%&60[BI4[$-"]PD1=E%^G C$_P!R[+(I!84(R<<6N9/0[#D^
M!U9NUU*^%@^1[-Y,;Y&T\\S<+_A^@XR3IP\GLX]R_P")EP1N%5N\#'>1*2CC
MJ-35<#85*VN1B]64NU+_ (>1&S4QC74P5UBZ.R8B1#0=.#JA27&S#BRBM@=S
MN3+W[24.]BAS'/F1T(D"[79B;M12CNL<7^D;X\#%X<64N%_P\O\ @O)+T)2Y
M*S#>>0VWAQ9N%_P\N*/9RS67D]G'CF7Y[O(I<*5V63^9+W\=/A:RKY*QKYZ(
MXU,6;WV,'91^XT5J9IB4;,,K-H:K@*F5CKD2.Q=;H*F5CKD2.XQQ&^#LK*JY
M#47D8<;$O+_KY.PM+*/0ZV1(G86EDB6I3L491#73S51U^)GJ;GW-S[F-%W+S
MVI6,AI9+42Y62Z#7-$HE'QPL^IE".A$?0@NEE>3)D$76I5,I#5V1#4E'F<F;
M</0PECU\MZ5U=3>J;,6QSYD=#VBR91[2-JL2L6F./,Y21MP]#>IK9(EH./$P
MP?(VX>AA+'K9W)V7I75U,ZFS!O4<N8A:$+('<?0@NEFTD]3!4+TN>)E(RD1N
MIU7,DN3\FC)2Y(DWR$GH28Y\B>AVL?UV0.]D=26OD[$%TLKR9-"7)"BU*IE(
ME&DL41ZD]#16.*SX&&#XIFW#T,)8V2U$N5DN@US1W)NR8]+*N[$S;[&S#U(?
M59+ZO)%<V2?6RC-F*1BBEY:(P4F7;M$3)#?)64YLDY)]C*1E(<HY5J)VXE*I
M=$87F7%&B)Z$]"-L-2;Z"Z6R%Y*N[$XOL;,/4AJ2?0C;6XJZ$]"-G8AH5XQQ
M)0[DI<BKX8NS_>Q:$-">AV$N;)7D\>1E(RD.4>=34Y-9,VXUT,Z:^66HERLE
MT&N:)DM/)%<V2?6QKFB-EZ5U=3.O8V8/N7N;LF(D0T(S[#C^T?-X#GR\D#N=
MR8XOB8\'1V.FB%%<".A$@2?6SN3((KS=DET%Y(ZDWULBNA=:E4RD.-)8D/)(
MBNEE>3)_,E[^.GPF/(J46'<WY>I27W9J/S7NMF;];,V(O>=.62$H^1*69>@4
MG]RNSZEWPRJ*>)@?I]2GAV76\:%44\3 _3ZE/#LI+(>..A5%)X:E=GU*>'ZV
M4>Z5="GA9E(O'R).7 S^QG]AI/AR*RY"<7PL=[)B4'8F\B-UU*RY"<7PL=YT
M)-%4;7W13PT-O]OGJCK\1/47E9#2R7U6S'I95<<47E^L<^6%D="(^I!]+-63
M(OH*3K4R?J9/U%)<.MFTE(V6XE<US'"7#*UM\#7)&W)]C=KJ2ID1T,3=IH;$
MJZG)K-%2DDF;-8E[>1[-Y<"1+2S:2D;+:*O%<QPEP.Y,<GP.K-N3[&[74G3F
M(6A#2R!W&0TLK-T0[CJ)2RKB9/U,GZG'U'<X^12_<0_N+W-C:U/#2XXBZXD]
M#M8_KL@*R.I+7R=B#Z6:LFSL1DZU,GZG'U%*.:)Z':W:29LR:*O+F.,LXDOJ
MMF/0[D[)CT'(SU9M2;-SU(?59+ZO)%]22ZV5*1EB>SCW+TG1&-6*[%+$F2)Z
M6+4E?X&3]3)^IQ]2EJA'-EYND3&K'=BD3T)Z"TMAJ37076V0K7+CP,]6S:DV
M-J"[D-22Z$;;LI49+Z2-G8AI9]+(P7'$O?NL_P![%H0T)Z'8B^I*_FC)^ID_
M4X^ME)49A6)>3O(]F\GY)?5;,>A,EIY(OJ276QLB.3X'5FU)O0W:ZDJ?NLF(
MD0T)1YB3XX"AR(KB\?) [G<G8I_N+_%*A>?Z;(Z$2 ];.Y,@RG)V2?07DCJ3
MUL3Z"DZU,GZF3]12CPZ^21%]+*<V3^9+W\=/A$QKR:(KU\W<CW\E.@_G>2J;
MK>ABJ(N\_<51U^'GJ+RLAI9[19/,4/$=*9,K?7J78;J+SSE9>_:1AP1%61T(
MBFN&9<GEP96_'U*1W43,,XE);K*J:'&#K)E[],1TS6(U+=9A)>HX1=6R4^&5
MLDN*%)E5)&#K+D5?$CH/6J,TGR95S0[JWF."S2-K)YF$T.*=6QSX(D2T,. X
MSR9O+U+D75DI]CN24W2I.XZX"<LBJDC!WI%6(6A#2R!W%XBX9GLYX<F5OQ]1
M1ANHQS>)>64BDW215S1L[JR%>S?DK^T4>1&/)$9]B,>Q0GH=K)=)"NS560%9
M'4EKY.Q[/Q,.3*N:]1*.ZLA)YO%EY9Q+L]TK?7J7/#=:YLOO)$]#M95?I'">
M3XF\O4N1=24WQ/:+)YBAXCI3)E;Z]2[#=1>><CN3LF/0PX,:EA7B9H</#=6R
M&MDOJ\CCQX&UEQ*J:'"#JV/Q'EP*\R,:T:-J21L[J)DB>ECCS,5EFBJDC.KY
M(UQ?D4N#0H-T:,9)%V&ZB6A/06EL-;,-49T?(SJ^2&WFQ6UY,:EA4S0X>&ZM
M\2&MF&J,Z/D5<EH:O$DER(N61LR3.Q#2R/B=B*["BN%G^]BT(IR2:)Z'8<3%
M=&BJDC!UER/NR4>9CHRJFAT:;? KPCY/:+)YBAXCI3)E;Z]2[#=1>><B9+3R
M.)BNC1531[/PW5O-D2:166615212+K(QLF(D0TLJN.)CQ=?+ [G<G8^:Q+G"
MM2O&6-D=") >MG<F-<> ZK#BBM\N>'D+R2Z8DH\U959Q+LMUE5->HX>&ZME_
M@K'&X\+/:1X9ESQ,N#*WROZ43L2N/Y@O?QT^$17R]_-W$]?)7H/YW6+,8F"H
M5?N:HZ_#.7M,^GFOWZ=A1Y6497PY4Z,WHE9;3M:?$3<ZTX4M3O4IT%"M:65@
M[O0QE$N)XOB/:K6RJV682B;<O0I%45E8NZS>B?B2KT118+R7HNZS>B5F[PFG
M=PY"BW6A21LS7<QDC#%\[+RV682B;<O0NQ5$.%:5&[U:]+*P=TWHGXDJ]$46
M0XRR9LR5.I=DZXEZ#NLWHE9N\7E*[V%%NM"]?IAR%&M:61VJ4+M:V5@[O0WH
ME9;3LI)51L2]3&42KVI>5Q?$3OUITLNY%^]7M8X\R]?KVLO1=&1DY1P%M4IT
M+E:V)7J#5ZM?)V(-;,J&]$KO2MK'99O1/Q)5Z(HLAQRJ7K]>UM8.[T-Z)7Q)
M5Z%$497PY4Z,WHE9;3LNUH/:K6QPK2I>OU[65\.5.C,91*O:8YJ=,:Y6.=_-
MUR\M<I<S"43\25>B*+(I(V9+N;<UV'X<<*\2M^O8<*TJ-WJUZ6XX/F;,D;4U
MV*17DNR-B:[FU-=AQ7'B7K]>PX\T7K]>UJG?RZ64FC8FNY^)+LBJE=7*GDHS
M\.5.C,91*[TB_&=,:Y64FC8GZFU-=BD?6ROAR6C&Y-9<"]?IV%'E8XLO7J]K
M;]_C7*SDUQ-Z)<;X4J7K]>UF.$N9A*)MS78I!65W9&$HFW/T+L5Y*,KX<J=&
M;T2LMIV.%:5&[U>WEKE+F82B5D[S%._6G2RL'=-Z)6>TR\I4["3=:#G?I7I8
MYWZ=A+E9'G4E/MY5M4H7:U+M:$MJM;:W\.5+4[U*=!0K6@MJE"[6MEVM"6U6
MIB5>#YH_,^Q-K.F;.WDHS'@[:QV6;T3\279%(JBL<O:9]"A0JMDQG]B,8+B3
M?6Q/VGV^8+W\=/A*="C.%F-*&@U;FC-67;.%+.!0N]/Z(JCK_7W8AI_@QQ=:
MH5%T2%'E\+AFL1J>ZS?1<\/+BQ^(^.7E]HN&8N:P?N5/AD*'B84XF^*BPX"3
MSX_,E[^.GP.!M)F<C9J4\3!VXE(F!QLS,[*QK4NSPIAY-G/WE$4=N",?<Y/X
M?)_$U1U_KV])R["BN'^#'*_2O0KG+G\/7=?0_,^Q5[3Z^:C'*,\'PI[FCR-E
MN)CXGV*I5?-_,U[^.GP%#+[&+1P]3->IA@RE9''U-Y^MG70__DS:[F;,V8U?
M<X%Y84Z&<O4X^IO/U]ZY$G;([>Y_U^'6GNVY<"7OJHZ_QI7OXZ? 7NH]+<"H
MGK;7F5,?*N1JA^_<O)([%U%S-F,BN:LHC&5"JQ/];-E&,BJQL>-!K@N)O,KF
MK*(Q:1@ZE&*/,2S;Y&,J%5C;M.A@ZG:RD48R,,;+J+F;,9%<T)#QK4E.][^J
M.O\ &A>_CI[^EE.5F1B4ZCZ*R]8_(M"\K*<J'?WU",/)([656\S>9CFB2+SX
MFRZ(I-U1+02YF!O,NS+RXDB[',K7$I+N.)>>>9@Z(VG5%]9HB7N)O#4LT,OO
ML4@Z(Q=457*W>IH4FZHOKO95;S-YF.:&ES)5;9)7G3X"J.OP*C2-*T]UB24.
M%CC2-*T\J44L5Q%)YOX2Y2-+U/A(Q:C1_&;3[%2]&F?$E>2PY?(;T:9\25ZF
M'(E)9H<9)9</>+PTZMV*,4LN)&3S?]!N,,:<;%7&#*K)^6YX?#B;WV%7.GP"
M<:8\QN5,^'D<EFAJ26"X>Z<4HT3^!E)<$79*.7#SW*1I6EE9N@I+C[EQI&E:
M?-U[^.GO[W08W9V*]1&J'1647_?*\^!C8M2I5?\ />KH4Y>21VLC9(D/Z;?]
M1"JW@9L3JSN2)62LNF;,V7>A$C8]#L+2WL1U*,S9FR5D;)$B1+7X&J.OP$?J
M]T]2=C^KRIRJ*,<E\)_O\(I*M5\9(6A=ED.Y7'Y"M28XO)E8U]V]"-E95%%9
M+^@I$]+'S6*/9OMY4GQD427P,-1Z^29+3W4OJ^!GH=O._KLCH0]S>QK6OS=>
M_CI[Y+J)%.EK6A2RG)65'KYJ'4:*/(HS7WDI#?/R2.UD=+)$C56M="(I<K$D
M5E0D5YV.7,;'36V]@1(V/0["78:=E.A%]3#A;5TI9'2R1(D2U^"JCK[]-\)%
M/"JET*R<^Y=GA*SG)\#9K_J5?M#\3:15$E.MRO(?LJ]:(KXN=27U%WP<BK?B
M(4/%X\;(J$J8$92Q8E"5%0C&&,J8LK^(;>TA-9,J\D4\/917\0E&>]3!C4Y5
MP\]R&,BJ<^Q3Q:M=2J_=8XQE@7?#=%T%&\VN-2](I##HBOXA3Q?6R\S8K_J5
M_$+OB^MER&\55\VG+N8X20R,92PLI*>S4IX54NA63\1:ESQ./&SG+D;+E_J;
M5[_8B_#=WFB+>;7GN^%ZE5[0I/'HR]&RGA>I7\0VG):E)821^%6M>0W/>(IW
MKOTE8.CJ3ONM"36:1)^+*N&"-BM/[3&4EJ4>$E9<\//F53GV*>+5KJ;,]FOG
MC<=*D5'&?%E[\0IXCK$N>#GS+S]HA0\3&O&R](I##HBOXA=\7UL<I9%(8:%[
M;+LMY,F2E'-#4Y55++OA>I57RDZZ2+T2](IX>&A_^AM.O1BDBGAUNTY"?A[P
M_:UI3D)0E14(REFR](I##HBOXA3Q<5S*K(3@Z.IM;4ZE5?[&+>DB\O(E"5%0
MC'P]ZF++S]H*/BNJ?$N>!ZE9/Q$7/$[.SG)FS7_4J_:%/$Q5D+CI4CQFROXG
M8VG7HQ2CQ*LIX6"*_B&+E_L<I*R[X7J55\N^-BON)7]ERLIG+D;+E_J5;GW+
MLL)64A*BH*/A9\R\_:%WQ7W+O@>I63\1%SQ,^#LIG+D;+E_J5;GW+LL)64A*
MBH*/AY\65?M#;VD51.,JW*\A^RKV0_:UK7E9AP96W\.]=Z(5W>(W[UWZ2](I
M##HBOXA3Q<5S*K(<HNC).3K*N!6_(BYYNV]+(IX>&A7\0IXN*YE40U'J5>13
MP\$5_$)>'XF?,EI9=AC(JG/L;5?]CE+E9=O;-XV&U'H77*JXU)?42N.DA1\2
M54[7'PY89"KG;>D4AAT1_P#H;3KT8I*RGA8+F5_$)^'XN=,SL2:Y"C*55;&+
MEA7E8_K).&\?BUKH)0O7?I+TRGAX=$5_$*>)BBJ\CC>PO6.,941=\'U*OVA3
MQ,5S\MWP\^957^QM.:U+GB9\_E2]_'3WS?*GE3$R\BG4J./DH(U*F!5&)1V=
M/=Z^61VLCI9(D799%Z+H7I.HWS5EV>9A*A5ON89(D/PYE:EWP[+D^Q6+H5DZ
MER/<B1L>AV,<F7D^Y>G*M!M679YFRZ%YNI=CE9'2R1(:?$O//X.J.OOJ+BR[
M$H\BBX8HC+F.2I0459AQ1 >I.R>HDL^-DDA/H1T(BT/:/-V*2_4(C#NSVCS>
M5GM%GQ):>:4N1M:LP*/L176R0I4VF5IB7>$1?N>=B\2/<NO])#D46]QL<HM)
M,2>)6?[L2L7@.++SFAD+):B2*,:7!E3ZF78E'BAQX<"&GFHOU#G+AE8^? IP
MD2C#-E[Q%EE9)/D1LF+0[DR>@H\"B5$23(DI&UDL791]A+KYX#\1]K'3CB7^
M,K))<Q#7". OW/.Q>)'CF4?Z10[E][TK%./',F3'H.F;P'*64;'AM+(=Y4BR
M-RE$;2VG8I<:DT2T(6+0@7>$1/\ 4[/:1[C@^&0M1N64;+W%$UY%H>T>;LDD
M)\9%&8<)6.6%!1CPLPXXD-" _$EPRLC/CD274NPXCEXBQX62KPQ.PZ9O K+*
M-C_<LB&HWR,?U,NQ6!1FSJB,N9V+_%V22YBYO,HQ=)#?(Q_4R[%8%&;.J(RY
MG8OO>=B:_41)$]+4^:(>2/U67>$1/]3L]I'N.#X9#U-K)8E*8>2YPB*7ZG9[
M1=QP?Z2&H]10YGM'VL]HL^)+0E(VLLV41=DL#Z79/46&+S*TQ)?58Z<ZH4EQ
M)2*O]./D5RE$8K:>=D9<<B6I1?J'XDN&5E];R.Q/0C;#ZK']=D="!'4:_59>
MBTN8HMUIY)?59(4OU.S#)XD-+73,3\3=LH\C#A+Y4O?QT]]JBG7RJQ.//D([
M>1='93D[.FME5_PXHH_^G Y]O=8MOWN#:,77R82?J8NR7FP;1BV_<8.ABV_)
MA)F+;^,JCK[V.ML=")CB^1LI(PO=D?BYL@/4G9+ZK9$=".A$6A"R!W.Q#2R>
MA+3S,GI:_KLD1TLGJ<?_ !./_B79U:T)536!1Y\#=[HWGW*>(J=59?\ #SXH
M_5$QVM2F4N0R%G^]LQ_21MCH0T\T-"GAUIH<?_$X_P#B1=UY\C$IX:KU9A]D
M8WJ>A"R8M#N3)Z':QD#N3M?U^> K.Q#2R8M"6IQ_\3C_ .)2=6M"=4T2(:6/
M4F3'H0U):^2])FQ%=S9^R+WBUIU)DM"%BT($OJMGH=A:D[)$M/(M"%DB&EDO
MJLIG+D8)(PO=D?B9D-"!WL6I/4J\C\./=F'V0W.]3J=B.I+6U?43T*^'F<?_
M !./_B5FF^PJG8AI9,6EG^Y/0KX>9Q_\3C_XE9IOL*IV(:60$2)Z6P._DC]5
MDOJMGH=AZD_+/4X_^)Q_\2[*K6@ZIY$-1ZBT(63T):'<?LO^''_Q./\ XEZ2
M=="%>1/ZK9?58I\L!P_:1AW*\9>2LC8BEJ;->R+WBU[D]2!WLGH=B>A&V'U6
M/Z[(Z$!QD97ET,)/N?B1[HK'+R2^JR1'2Q:$-/)2"O,PHNQ^O_@D\Z_*E[^.
MGO4A:#\D=;$GYY=CN.WH5-DT*.I0:Z_'.M2\OF-4=?>*7*5N'# BNAC^IFS%
M:V:(@/4G8_JMD1T(Z$1:$-+('<C/G@)<8V7>,B6GFDBC_5;>YRLD1TLEK44E
MQLK(=VN',NM.HI+B;44Q7<F8\!12>/.S=H^:,.$AD+/][9E.@J_I=KIPP(:>
M:$APXJRK%%*56)+BQRGC3@8*A)]"%DQ:'<F3T.UC($NF(XO]5C;R1>YR\\!6
M=B&EDQ:$M:BDN-BO<1W:X<RO-$>F%BCS9,F/03Y,E#O8Y<BZXHN\$*359.R,
M>I,>A"Q:$"7J*2XV4XR)2Z"U)ZV2):>1:$-+)$=+)?59C^IFS%6.G# AH0.]
MBU)ZD8\QSDJF!+K@=BO[<24.=CD^!#ZB4>:(UTMNNO84EDSL0TLF+2S_ ')1
MYHC72VZZ]A263.Q#2R B1/2V*Z"\D?JLEZBDN-E.,B4N@]2?EEUQ(RLO2'=K
MAS(:CU(R[%WC&Q]<"6@^F(XO]5KC1X62^JV7U62CS$GQP,.+H47D:Y$71.3X
MV1CW)ZD9<APY629V):$;&WP(:V/Z[(Z$!7D\2\C:BF*4,*\"2Y/R2^JR1'2Q
M:$-+9-&UDL39214KSE\J7OXZ>]3):>6.MMWS=BG7RY&#1F9_:R6O](WN'O+J
MS;+GB1K0I"-.I?GN_P#;.G!FW''H4\*.(I3_ %"Z$J#HJU&Z4Q']5LB.A'0B
M+0AI9 [CBSE_[-V-27C3R1+2R2OO,7DO1W?^%)QKU+D(TJ*+X2LD1TLO1WD4
MIAR9N?<YOD7>/$O1WD7:57(W&9?_ ,"CR+T=TVXUZHI"-.I?ENK[C(6?[VS$
M>TAGQ1=S7)EV"I7D)2SH0T*Q='4:E)O#R.+XG+KS-J&/0NI41[2>?!&&:Q'A
MAQ1N,HE2)&O!V-\&1BX]*G<F3T.UC(67H;O_  HTI%U9=!+E*R-QT)WY5\D!
M6=B&EDQ:%Z&\B[2JY,P@<W_P42G%9&6J9A#'4?BRR)DQZ#B\F579FU#'H74J
M+D5EO,]HLN)=DJHV8>I+QIY$U97C$NW:8"T(%8[R*4PY,PAB<_\ T7?46I/6
MR1+3R+0AI9(CI9+ZK/\ C-N./0N^%&@G/]1'H0.]BU)ZE8YQ&J51A!F6RB)1
MEZ-;O!F*3*?I^Q#6QS@L'F4FKQL1]2KRXLHCL0TLF+2S_>QS@L'F4FKQL1]2
MKRXLHCL0TL@(DD52J-TI2QTT(QY+R1^JRL=Y%*8<F80Q.?\ Z+OJ/4GY:QWD
M4IV9N/U,M$BG'B0U'J.+.7_LW,=1S>[$EI9>CN\&;<:]44@KO4ORW5][)?5;
M+ZK:KCB.?+R^T63S+LU6AL0]1^-,FAQ?$_\ ?,QAB?VQQ.UG_&;4*LN15$17
M*5C^NR,N&1=NU$UGFAJFJ9N,2IHD4X\?)+ZK)$=+%H0TME'F98K@;C+GAQHB
MZ^!7Y2O?QT][7J:KRQUMCKYHZ#7FP?D>O](5>7O:J$:Z&W%,P@K:-5-PV8I&
MTD]39BEI95P*05"MR-=+:N$6]+-J*>J*)41M13U118*S:BGJ4BDM!53=2JRZ
MFY'T*<R<K(0@E>>=/-C!&Q%(K<C72RKA%O3R;44S<-E)6[44S<*125NXC""M
MJH13TLK<C72VKA%O2RXTTZT-J*9LQ2T'3A@170VZ4ZGB32V?+1JIN&S!6[44
MS<*+ JX1KI922J;A22374V8I:%&5C%+16U4(IZ#ER+J33,81]#DD1ZRK8WXB
M3IS)2YOR;44]2D5165E%/5%%95PBWI;M13-PI%)6[44S<*.*IR-F*6A1JJ-F
M*6BLHU4W#9BE;C!&$$496,$GI9MQJ5A&C-J*>J*)45FU%,W"D52S:2>ILQ2T
MLHU5&S%+1>3:BGJBBP5E7"+>EM;D:Z64DJFX;,4C:BGJ;*2T-J*>I2*2TLVD
MGJ;,4M+-J"-Q65N1]!SI6@TJ]S<CZ#>21'UMQ@C<,+*RA%ZHHK*N$6]+:W(U
MTMQ@C<,+*RA%ZHHK-J*>I2*HK*N!L*@Y/@7WPQ\M;D:Z6[44S<*15+*254;,
M4M/-M13-S[FS%*S:BGJ;*2TLI)5-PNW53D;,4M%;C!&$%;5PC72VKA&NEJAR
M(KCGYL8(V8(H\45C%*RDE4W"B2H5C"*T5E)*IN%(I(K<5=+*W(UTLHU5&X46
M1M13-S[FS%+RUN1KI95PBWI;M13U118+R;<4S<*12164$WH47RE>_CI[UZD>
M_E6ML=?-'0EY^QWL]?@*(KXC-C[,H_*F^0KN3MH\B37S+'+Y/19K(IET9NHY
M_P#HNJQ^)FW\C<X*J91TD45(Z%_Q%1?]LNLNQ^(:?$JNS,8IEW[(OSWK$I<"
M['+^BW%\2OW,8HN_9%9;S^,7@Q[BCQX_*91KD^1?EN_]_IE>_CI[[U\O>V.M
MG:U"T)>?L=RE*]ROP'8CR,"/E3_M*K6US8W_ &VX)F*\FZ_2S!5,4U;@;K\F
M";,O)C\35Y?*<54_+CZ?*,8I]C9BEV^.QA'T,$E_2.Y'T,%3XV]=5>=/E57"
M+[?TTO?QT]\]?*M;5J([6H6A+S]CO\$I*RK>)5^7_4NO@-<B@H+0_P!;+\S9
M52ZT89,D/Q)9LQC03XEV"J4IV,,F4X%*&,2]'.Q+FBYRY$:9"E8Y<C3XBKR_
MC,O?QT]]+7RQUM0A:%#*R.@_/V._P5Z?H467,JL^!=-KR?ZE.9>YFA3D?ZD5
MU*0-TK='T)%.2LK_ &V(B5YLD[)1'U$^ENJLKW^(QR_PEB;\?7_',^Q3Q-I?
M<K!U^)7OXZ>^EKY8ZVH0M!:VK0KU\_8[_ Q74=++DNPY<6/DO)_J)EY:CFRI
M_J1U*Q,HF41Q:6)*W_6Q$;'K9+0['^MKB7>&8H_#U>7R##F3KYX:V0U^'A@\
M_-(EI[V>OPF3W_D2A#!7J>X_XC](E[J-%P(D="!"@Z\QR? :RC3*R>#S^%A0
MQYCD^!*N"IE9(CI_13H3J.3X%,HTR^+EH1P?EA]7QCA+)E8[42L71E/&]45B
MZKX=>_CI[SM9+7RQUL6@A"T'VLKT'V._G['?X+4RJ5G@N1=KB7H9>3_6RZ^
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MS:F5S7,<99Q%M4H7.M!3OU[$M"#<'GY'._3L*%:5%._6G0NQWF7FZ+F;[/\
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M%7*A^GT/T^A1.G8?PU7E_%>=FS)HSKJ;4/0O1KW^&5LGR1&/-CN<++[_ /\
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ME.1M0:*Q=47I5[#DLF1C25<A.5>PW%/O91NKY(P\/[FU%HK%U7]63LP=#?\
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MR6GECH1(#UL[DR>@]++JS9P]3AZG#U)7^) >MG<G9#4>MD-") [DR6EDB&A
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M==DOJL?UV2$N<2-UO'F7I-YG2*,\68U8Y>&WAP9=X2+K'%$9UES&3')\#_[
MVFVR]X3[%R6Z_M96.9>\5O'@?AMUZBY/!^1R? ZO[&-6R_![)&S_ 'LD^H_$
ME*E2\Y51[..7$O>)AT-EM,_^Q%)9,NQWF7FZ1.)GHS'CF78\B,FY8G<F7OVD
MH=['SE@2GRP\G^]DGRD>T\269LR:9UB)^1M9E_Q:X\#\/!E'EQ5EU;J/Q&ZF
MRVF=8FHG%O$;DWF**X$?JLNQW?\ I7Q7CR1^&VGU+LLN*L9?FZ1,'(IQ7$C+
MF7TW6I*\WAR'3)8F+S.)>@ZQ'%_I\T"XGLHQ<C.J9CFL"JS>0\=6?J+T76)<
MEO(GH-0SE@?B-UZ%Z+P%X$>)M2;8FG6+*/\ 2.3X'7_AC5E[PW5'LY]AR68[
MSPXG$5'@\A-YK#_#.1D9&1D9&1D9?!TH9&1D9&1D9&7P2]UA;D9&1E[Q?)5\
MX2YRL;Y"<\JXF_\ 8W_L1?ANO,70CH+K9 >IMJIA2*-\<(IXDM">@NF-LJ<Q
M,E]5C^NR1'0@=RDE5%Y)1-]&%60ULD0T&3$N;)R[6RH)\T176U_5Y$N;)2[6
M2CS1&S_>R>I%=+$YY5Q-_P"QO_8BX.K*<F/H072Q7U6A2*HA:$-#N3&GQ,?T
MNR[^TBO)_O9/42L9#3R*/]UM>:(,O7%4QFC-O1#DE0AH0U'K9'ZB;Z"EXCP1
MO_8W_L7O#=4R#Z#(:61T('<F2CS1U1MQ:**2?0P\T!OF[%J3$N2(]<;'%\2&
MM">A&R0^BL6I,C'F2ONC9O\ V-_[$6N8TLS#NC:3B8.,O\-=?D=7G\$O=X?
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M/[N*,3\.327(7M&VWS%XBT8O#D\5E8HQR1CF\1:$<<CN3L?-8DX?N'/GY?\
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MPEAC@J-A3U5Y<U6N3$Z7_P"6TZF1#W,E^G3ARKD/]GS./Y4 EF*F:6I^N2E
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M<R$KL@BW5N!=>:)F9]/*P.4.,%-9F0O-3G1&EUIZ!!69D+UZ9)"2X(1#B:/
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MDK[# M 1!J+6P:*C(1*ASFQH2;I50D63R&:&E^K=CA/M@[88HA:M4+522Q$
M),PVORT2<^9NR+"@U<$:68Q.^CKX#Y*EPDZ@"2(1'UWM@IUP5=RB.*DJR$?J
MS51U26Z4,BTG6'#AHK<DHI&8F64T&2GTN4_4 -\D&@6J\6T8V%YI/?P=GV$?
M4 4"/08B;E5R<MG4.88=?01.GY!IAH(YQ/H#'OFQT&]$+M)%FF31]#?@"1#Q
M>X!&1?>;(XDHH3<JE)&SJ+_>2K78',S(.:,9(Q26R$LZ)JR""@DTQ86&-M^_
MIS="-+2Z-RC@C%;"Y!ZG@=O1\7"%I&W^\&=QT>$ ?Z8)70.R.Z[OQ\?RN"+,
M.:Q2%'-A9C5<X,:4VNF%FQ0_FQ5LKWPM<1]7BD*%\V%F-+;?7!C4<84;%#^;
M&UU6(O\ 7RHM,Q(FRI3',E2LZ$HV17TL8<3#@[9P,.><TL=2X=PD%DW/I)])
M+8C'K"I&FI8[X&8!,R!9E=$A/^H[?#G8^QT)*NG<^DGTDRQ]_3SZN3$Z>?RX
MGI._N_\ #]F_\'W0]%)6UW6''1$5IP>KS@) E9+!<S)20(U*&N090 E/L)2,
MKZ[Z"HH6#]WW.@4D09:<*IH'-1T%(3K:9H/K^I*)W_>1-44Y6%6PK)F6&/AE
M#D^]A")M*>:\%_H./.,2,TPS*T$(K*D7@^OZGU_4C[9225FI"B$/\H;LNJ1I
MOC@>V ??V.?%GW^V-+\W"_T'XR#4,Q"]5KT'U_4^OZE<+)+0?8)*'C^GOAPE
MV.-[>+PH+.@EXY6@%992N3CHB*T^#C,J[*7C(-!DG>DBY0_Q.&[*ZI,X)9(X
M? /O[8?9W)HM@I+4U:8/K^I]?U$Z5B)DFCT@XZ%A*TXGW_<X O\ :+LI(9-[
M$Z)2(FZ*0X^4(Z#,UX+8+(K)W(2JU%&LRC$9 @:NM>P2"_N? MO:+[H?.*6N
M9!6Z3\"2C?WQ[/L<<39K(1*53[@^OZB=;3-1[$3.DH0M'*,3^I]?U%OH0O\
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MR$+T))K_ !-I(+3Y%)%X8&WY1H=Z(2',R3P4:IE/7!R9F4\*;.BS8A%1)/\
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MI^)STNT?4SZF):8EL0SI)^AU!"5!*N E02_Y3Y@$"&\;)5Q=O1\/S^/Y%_\
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MZ61\6EY<$A&A2U0OSVD:_0VM,6&E2B'B[>CX?@1SUEGZQBZ\%$J5WJ/D<?\
ML&8(2$G DY$%;_EF91>Y-9CXM+PX%*:AU3:PX22/16E_&+MZ/AXUO0_Z']IF
M;+ :ZE*:U\N"6LT3Y>1Q_P"OYC($JX"H$JB7_+;X7APS.)(1>/O$#BGLAJVK
M;=3%V]'P\7<&0E%)O!/0Y@1++)]RLLJZ>PV\J'[4\<@A*.C\G2&O^MP
M                        :I M@JK&P*BQ'_+DJ)-]0Z0ET(%S62XS!!JG
M(O),S6+MZ/AXM2*Z&3VMNM3)B^*P["N"5JWNRTW4!ZSTGY?D.XE!!U?UL
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MR2W^26_R2W^26_R2W^26_P DM_DEO\DM_DEO\DM_DEO\DM_DEO\ )$LN7O\
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MHG1)TXQ3U,H:AP_!81T3()Z8I\$1X-,B^$$+E>E;P2*A0%8)>A=B^YIWQO\
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M)$B1(D2)$B1(D2)$B1(D2)$B1(D2)$B1(D2)$B1(D2)$B1(D2)$B0F$F)?\
M,SMZ/B>@8UB=1U'4=1U'4=1U'4=1U'4=1U'4=1U'4=1U'4=1U'4=1U'4=1U'
M4=1U'4=1U'4=1U'4=1U'4=1U'4=1U'4=1U'4=1U'4=1U'4=1U'4=1U'4=1U'
M4=1U'4=1U'4=1U'4=1U'4=1U'4=1U'4=1U'4=1U8B0E_S,[>CXGHH(1"(1"(
M1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(
M1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(1"(
M1"(1"(1"((_YH=O1\3S[(+JS]P?N#]P?N#]P?N#]P?N#]P?N#]P?N#]P?N#]
MP?N#]P?N#]P?N#]P?N#]P?N#]P?N#]P?N#]P?N#]P?N#]P?N#]P?N#]P?N#]
MP?N#]P?N#]P?N#]P?N#]P?N#]P?N#]P?N#]P?N#]P?N#]P?N#]P?N#]P?N#]
MP?N#]P?N#]P?N#]P?N#]P?N#]P?N#]P?N#]P?N#]P?N#]P?N#]P?N#]P?N#]
MP?N#]P?N#]P?N!/_ -O^:G;T?$\]SS2Y?UZTWJ$_\T.WH^)Y_.?U^RWJ"9/_
M #,[>CXGG\Y_8+/4 G_S,[>CXGG\Y_8;3 3%_P R.WH^)Y_.?V*TSJ"8G_S&
M[>CXGG\Y_8[1!/<7_,3MZ/B>?SG]DBA@)B?_ #"[>CXGG\Y_.3V:@TV:=UZ!
MJ'#.AX#A*8_+AQ/EVF=03$_^8';T?$\_G/17 ]$?NY^YD%_GEB'5?PW*9R'G
MQE-E)P!#2VHR$Z)"BOE+">;(&$AYEH@GN+_E]V]'Q//YST#(KA?*$,FBZ/<*
MBP@0)&YG7,<3*J$VU_"\IG("FE1%B6H#B=2CFBVK?TP4E>,4%EUNL(G<'O*'
MU4-"4N$>SC5SZJ'2@Y.Y-N;@4CMP<UBL#;!<B"DFPJNA[>',<5)2IOHL+H35
M0*55R7'U2O>I\ &LQW83R"8#2F:#T4E-?,BAP)B?_+SMZ/B>?SGH+*JG;8$D
MPDDBZ.B6TWF6LU*FAL.E GA#ZH9GM1,T?PG*9R&!,L8KP1UGU%5IAPD6E'QT
MMB"TZK!"%OVE(9)3J0UGJUF)#E-R*YI;W$+JPY:P"WU8(I0TKJ3^:#69)@GK
M) "6J;C?H9L,E2RI%=DG5"=0'/1V'G6F=03$_5-"-JZ:'ZF?J8Y^.] :P_>P
M1A,S3\$.+JT$A2=4^<T(DR:>I:$29-/32Y+JT$A2=4^<U2*LB'C2&39)/108
MFK025+O*1#F))7;)4723U+:1MN$LS;@"EXVA$F33^1WB1$/XJ#%U:"2I=Y3Z
MQM)2Z)&U$$G\0[>CXGG\YYZW-N$H'I,TB9;#;=QB$BZ52)BOJRP@LBLDZ<S7
MN*U].YM(X_@^4SD/ 0<=X7.F+-!45+"8S-,"%E)"%>$<LY:P"WU8(D=;#(F'
M7 BIKER[H(TJIG(86.IS$<]'8>?:()[B]3RXFI//N?>RR M0J,9J>0FD354_
M.8RE9!V1$T?7P<:<U><S9:EP*WB=*BU22[;V]"S9:EP*WICX#SD3E2F-_$["
M/E*W'HK_ $'X_P BV99H17["K\]4W$BA9U\KD>QQWX(Z5"PP*5N15Q567\AU
M=9C?T:'55JR$=QC5?I*+M72[.")0H%$7H,1/F1#4/L'BF35]?/Y\[_M_$.WH
M^)Y_.>?[XW<VT-\H["39\A@=#IA]!S$E0>\??^#Y3.0\!!QWAOYTC'(AH25U
MV$QKTB=^P_)+*6>#WN>ARSEK +?5@BGGFD;0T:&#%3Y4N>]@.8PL=3F(YZ+W
M1Z"*' F)^HY,X&,082!KKR4#K"3*&*U>=DN(*MJT,'-5U IK/L*J&S/!N@EU
M(0IDIU6#C",QPEE5T8I23JJ"JV6L\'4= JR*/J-"MC%JCFK"1(#0[-O ]HN@
MQM$GHKE;\(Y]DH\+/"9#4L*76B&+"Z.VXYH]R#-9ZKX3F$LAC/+D4+FA$P-I
M*71#>)OM&\/WT(Z#,UA2ZT0Q871VW'-'N09K/5?!N%+&\3?:,JKJ(BA3;!GA
M,AJ0^MA+LU-"(>/11(8Q.:B')J19L?0GT0^AOHA"F)IYKQJ,T4V$=DJ5N5(C
MJ@74&],\30Z))-59%$^B*T7VX:FA<)S)+/!Y?");.G@2&TDMPD,X3=(?5]Q$
M+:;8-[4'$2Q?PY=*QE5;C1"^FV"/*9"4L($TW'U/:0^K[B(']C!JC*XB&*I2
MMLRM'N0*J#VS\3*.D58S!K<:([F)5'X_R,3A$LLRDV8I]A*65)838J[#FE!B
M<D76@AC$DLV/H70AU#?3"TU(\UBVA["H9=5N-$5*;#]-,HQ!6>LVD699E#PM
M@GIF5OPE,5N4>,@2*L1U0/--6F=CCOP/(:-#()1PL.$,J.F"IT*>F96CW()P
MG9GB[JNH$YV-X) C JQ#<6%)R#;$^-"U@1IA9B.ALS$71-T0\A]"$*8FGFA=
M%(ECC-:4V*V'6DCCZ$)I):4\R<,&<#A**MFL6>"EU#&2&K/%X21FQG"?3#.&
M^F(.&9K!M)2Z(;Q-]HWA^^A'09FL+0I-F4X:RF;'T-]$+DFPH>+Q*8[4D6&R
M9P=>:)7Q=17]XZA]1HB?U%A$_N#ZG42'45_;C(D!H=$W1#Z*OL\"VNA$L9Y\
MF@EU Z0QI<HE$=&HQ]"]M#.)=(322G*\#>(N%X-SI!!D^B(Y)]I>V$":;CZG
MM(?5]Q$#^P7;"+#,9:S$2*T*)7*"%AU%%,(G]P?4ZB0ZBO[<5J<[B(8VCHE6
M,N&DW:(J4V&)PB6QY1DJT(!9-)"%6&I0[Y *WX2F*;T='X$V8.)B1:WKE,.G
MLI(^PR<6P4)1J;-C9)9AG?\ 8Z2)4/H?4:%U1F:P;24NB&\3?:/J^\B,O47A
MAA7<?4]I#ZOOHCLU%A-TDAW)OO0R$Z"TF#.6TJ&55N-$):;>@=O1\3S^<\E7
M@^B/T)^A/T)^A/T(@2*COU.V[EX>9KAQE+!NN[V"C1#L+^!^-VT?H3]"?H3]
M"?H1IJZCUKB=+HP\N5I%Q@S<"&633N6"C.#H\#8BF BT6Y#)M2/2N?<^.ZT%
M-Z[8B5KU#/B,F%YA:J=)*4DJHRAAFZ"-M&5YJ++4D.K8R-D.1"]U:BE53HZ-
M"<DQ;LHDL+(AMLVZMB"LO)P6!B.I1!49!E)"J2=_H%IG4$Q/T_)G PC)3<Z8
M 8RNE4X:,KK22DE=:*B$Z%5>B$L[D8Q!-7K(Y%N25MI(0)[A$-@*2>HK2Y/M
M@_=]QRF:&PS/(=7FQB+*]9&)M=&C.:A3&KLFK&Z9.[,A2#.UD;-$7FZ'-;-M
MZHBFZ5!A-A5S"G'SD:XK!YH4YR^3\.JR..A[R)/^%"2>I4J*B0VA#9%K'N,(
M"@3P;4S4<GU(<9A:'$WE/?HJH8)X3@D*J)U1QT/>1)_PH23U*E142&T(F#":
M#.J""M'72;M>$U0G*36>&I;:2&.A.B^@G*E#:1MV0_K:"26E1!7=5",Q)6YZ
M+$-.W+18RIV3AIYO(-8F2%+\(='$]PCMFJSVP=6!S#HTO01]C*$%,,I6Z&NS
MDZ$!WH?0D/-*PB%NW!$SL$PHA.XG*$E(,.DJR0ETH.N'V=\*[PE>NQ%.,LES
MY#*2)O-&HA)$LU.&IL))8L+-J+05H?6"00)EF)C58,&EZ!DWE\C&*7J=1[1P
MM?9)\#^C5L.@)?<&R*:/61ZD55HS\?Y.3.Y.3'Z7*$1H=E$D 9-EUH5=0<)(
M1;$O8'W>@+"L&N&983CBE:[$,\VR5V5JUDR0C-JK5"%)13J%(DX?>%M^UJ>U
M$,@:D5%=K(DL.=,R/:*]Q63A6CEJMO)"D6=ZR.);H3_IQWX-6CC(74)2H,H)
M37!ZRE\C&_>RIH5U=Q2RS4CD/A57HA!.Y&,035ZR*SW$9B$-[-:/!UMO(L*]
M#"-A]P=I=6":K/>1+FG<8E9U*&QR8Q;7*V"2,;<CHA!II6?,469*G)BF>2!M
MFK@)L))'K_P'@8%>7&K%$><4K#+-!<G9C>3/!@Y/J0XS"T.)O*>_150P3PG!
M(543JL!EZ#4BEM;EIJ!UD 18B3@]"NI*5Y(/M[X/+HR&;(9I'9#:HIJB*T).
M"=U0I$97;LLD/9$J(F&MQ=A!'RG>\MA+&R2+&J<$)JLVLB9 UNGD,'F_HQ4\
MLD#"0J""O<M4%?/7,74JR^@>V140MCC:)"96BN;P<,=F6U0LQ D\^'"0I[FX
MNPE*EOB)L))8L+-J+05H?6"00)EF)C58!78B3F@]=M:A^N90.S/QEE$D1E=N
MRR0]D2HB8:W%V$$?*=[RVP3JR;@;%5T*Y*-+3F,B%,(N:))%!D!":B!]N;#T
MILCB2U2O*[8XXIWD5Y(N$@;'UQU.2@3;6P)Y,L$>C2L'UA6(BVF+@G[M64$M
M69>P/$Y5J$Y,IK?!R=4BF82IQ3E/?HJH;$Z-/899))Q19"26$]A"I+NHB\8K
MJ$@<AK!EX,:^36LU26QBQI@(2HUKL13C+)=E2==,ECFOA"P>D^>[>CXGG\YY
M#4*D)J9-8>K/N9]S/N9]S/N9:4';=R\-B9JY)"')61=+"!=J(1)N*W2+^!I+
MY'W,^YGW,^YGUL32A2S;'/#_ (/A?XFT03W%Z;EQ04CZ,_1L3%> 0+TBR98<
M="4%NP:$1:B1@MO.D.61D-38E=2KK)'O@QNR=!-A)"P?N^Y-Y%(0LW8+S N:
MC8D,/RK ZCZ&&_H2+B9+-P/O@J#:TV876/E"O<($DD)1X=5D<="45H>"UCWW
M<X O]IOR,87"N6SZ&/H8R<!1!4&I''0E%:'@M8]]W(63"6PKQ>VJ+N[;!A!-
MDQU61!]EA]2I]409: D;V"++Q DP!2DU/H8^AB2%4MF3;=IXS2NLDL%.S*9L
M2$\#7OT6"3[??!U,\D#;17"<^LJ8I+D%D%4H>Q9KQ-7-:]"RE9R8?9WP7U&8
ME"A8?+,"2(A)0EAJ'(E.Z9.\1<O_ +;D[?T9 2CYPY0M+DF"QUH<6/RJ,L*0
ME&UD1&4$++-2P7KR_'^3DSN3DQ*#UG"+;B!Q4MF?0Q]##W %:14FB] ]9I<B
M)"66%K@BXLKA+(^YOAL,H.-U2Y]#"[394JN;4<B#? I9R#!+?-CCOP<+\GW=
M\*QJ662C!8Z*.')L]@C5"1<?0PGJLBJ*F11X/U2BPB331B9H=TLO/M5&!)(F
M*%OJ.3$M/+BCM$21M8DI'4]S5F(?4I2[1[$3N='@A+G)C5T +=-I2*9IFD;\
MC&%PKEL^ACZ&,G 405!J6 _+&$B>51(O=N#5R(74K"U7OA]O<;A-B9]>Q<)A
MN6J)"]B>.45&SZ&/H8>F4385E$0VB;GF4IAK45D+,6473P7^\Y I2RD);]TA
M8K2H3$_W:8\,6YVL:CH/D@)+73)WB+E_]MR=OZ,@)1\X=MV.".S/QD0A3QRB
MHV?0Q]##TRB;"<R)ULX<XK$ 5CD#O^XT1EM U)*6[&;#>J(QD'O E%O GW*#
M1/D2DSB4MQX3RF)XU#/Z\<^+4>LXTQ?<FZ(R)U5EBE(W<L,:VEB\I3+IC ^1
M$E[]NHLXZ'EVS!(.K=Q2TLE Z(:S=RVPE*%R'T,*\[%'8D/SQV]'Q//YSR.#
M_(N5K!M_!FW\&;?P9M_!FW\&,4W%LCMNY>P7 V"4-T*EMA?P*):VJIFW\&;?
MP9M_!FW\&-9>TK,J"/NN;_@Y:C*B?XI%# 3$_2\F<#P\=' ]L+ODW<3E)X5!
MI LN]'P>]TU)#7U@]Q-%EA=<7[ON1;T/@F2TX-#;H<U"U=2V*F[I'ZT_6B9.
ME.%7Z)1C?Q*/TPEDP;U-=/5>'59''1QN+]_W. +_ &B05K'%DS(_6GZT_6DI
MB3,LXZ.-Q?O^XB2$E/4JLW^!5^,91$*[9B$>3#59$464$^66G4@%LG)J;$OJ
M)/M]QW.$E!^M/UI^M%JW*S>,VEK3A!O-(Z"A@? 8=MW/I[X4C:KW%5[JOJ,5
M65;K@AR$T\F5.3M8K*CX91,LG4S%V\DGV=QV+_DG?%<8GDW!*E:5MAME9"H3
M9VR(:MK9)*[[YD5';_>'*.!AV)Q8N<:+MG[-_P"#2YF39 SU0F*TX/&]'<_'
M^3DSN3DSONV"S!H2W430_6GZT_6BF!M9F4D_5XMTF+M*!"2R:U1]S?!8W4BS
MV2?K3]:/ 'D9\R1(C3"\IY,<=^#A?D^[OBJLL. .#(%:G<3%/"?K3]:1Q1%<
M'X3#HY!V<[F41_@A"U!H;%KJ.3'AUJ^-!:P2!DA(("-G.@8VLJ744AR>!G49
MDRLN/E%:B;7(C+KJG6C#BR9D?K3]:?K24Q)F7X!I#7(,72NE9/40#8#[>XLJ
MV&K-N.U7&R@JH.-C-D?K3]:?K1(%H+H3NS&JO6R")R$!B61W/+P7^\Y 26:'
M>5'CTBDA(>W'AC4M4QZR@6"D*A-G;(AJVMDDKOOF14=O]X=MV.".S/QB5] X
MV,V1^M/UI^M$@6A]'?P*K(Y [_O@]<DV!.R]D@1HLR1CV[%[^" LL,DKU#P(
M47E0IMU@R>;OP<^=_P!L?I[BPEK*RSE<8[DEL6&:XT9.LM28,O0R1DM;(5CW
MC,EHP^GOA4PMEA0-GZT_6GZT2+=SSW;T?$\_G/(_ (VL*1+1DM&2T9+1DM&+
M"='W.T[CI49+1BFE08W*'\HV&2T8R='@9;?_ -B6C):,EHR6C+ =A0I:Z>[_
M *=:<"8O2<F<#P\=' ]L'0UJ=2&A2KF2E<@F2CED,08=G3"*+O#Z##V9DS:C
M%^[[C&E+!!SBN>8VDI;H-;F^]6<U#%)FI[#DR*R>C$B2FFA%!T$ED)<LJR"3
M-A+ED3P:69DC\-.VM!^A>$U61QT<;B_?]Q/D0O FBB2J5&K%)WF;5"8EJS(=
M$D9LFJ+22)%LR"K9QT<;B_?]RD5IE).@J(00@VDJF<:2)68VYHG#598,EL@=
M!R+&"6VLD$C2K#6HG+-=AH61#JYS"&.C 57J-$EHA#[/"<5\)HU8KF-I*6Z"
M4R72WJQD#%3VP/@,.V[GT]\)! )EE65;7:?;!I6<)-!K)(H&TE+<(;W6DJM1
MMQ*H^SO@HEV02*I(#*DC-C)4;5DZ1F&L@Y--BF=*DF\$H1NJ:!J^W#E' P[$
MXOP.4-/09GBM]B5$R-TZ62WJS\?Y.3.Y.3.^[8+MI(&J54^4*BSU6:'%9&HY
MM8W#!"X%5L>]5D'N*YHE0/"2+-FLT]PU]2O4E2V5?D@H'.C'(@.KX,D>M30&
M4&(AN[&:(@AM&[LQ"8FGFB2A1<9(X[\"STA *5!2)IV:>"JRPX X,=$7^PJ
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MN/")3&UR^0^YC[F/N8^YC[F'TPOJ\'QRM[L^YC[F/N8^YA"J%6[+$2U.2O\
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MF-^Q9Z'9=L%<[[N<-=\+1Q_8_!V]'RS.#<7C!.5B78>R)-9Y\.'0^TE"EG[
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M$&(3"(^[OX. .UPYT9"$EM)$,GN@@*J3A$&B8'A)'DQ2GL=AS6J8'7V3",A
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MI*=4'P"P!&4VFXH?HD?HD)G(Q60G#E7%+7_[^H^I2)"0E8J% 2]']??";,U
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M(1P).@D+_F-V]'Q?/>UVV8]#\DNT?];C?_\ _P#_ /\ _P#_ /\ _P#_ /\
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M\YR6X\35=F0I!G:R23R;IW0UGFDO^,;@&2U8XF63XJ[$XO\ AHNR-#C!9%_
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MQ,AY(JH4.(X;;#[>XB8G9B?0P(0EG43;B2-8KJ2M#5.HZ3"]ULU4>&E=FLQ
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M!X$6B=:HL'50;$1)HM@I+4U:8/K^I]?U$Z5B)DFCT@>VJ'&3$22-D':/W5$
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M@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z
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MRN0P)EDV//)U.,*YQO!;+?7QH;(Q-LWP18A%F%1=6$1M4D@C<Z'ZX_7$T0K
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M1B'QFZ(J0U,V-L%%ZR4B&2+1T$W.>R?\5=D(5)ZBPUD#)0RR)V%PJ6(<.TM
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M+HF52U(0D(DMA))(7$$)4-2*G1S%7O\ 822LB$$,M3,(3/+;!1"K*0]*>8B
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M\'DDP/0Q+3";C,G2?<WRCPU$6 [)>8B@EPU5LP4@U5(''?@8O(2'XS6"*&C
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M*S0NJ"&>LLKQVL3STE^07 >*(<J;,<BR@-PI9L81,A<6BY#F[&_"(P)L+9Q
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MU+&3&LBE:RC2%?>6QA@5HLQ =UH:W.S[X.A6Z7NQ5+6$*1"5EBE32*B@*(D
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MND@0J260XQ==7D55.#I-,H=;8/O;XM(6KOAP$<.<@=_WPF5RJ$-[_P# U#_
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M 9YAK2!+JQ('J[)=C;I5[A9UB]A[P2=UAF-(D)RIPF<K,T%)HB<#DR$NV1
MM5UM0MV'#=Q!F5HO.!LKVI7=!MTZ]Q8)C4H3I:S\'-9']Y."^]&#<*6+77?
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M15%]MCC\8<-!H1H@5$940Y'9]Q;7$W>B(VQNDL<4:_</R KA8W.@O[BY)O\
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M^YK"E#P:A74EHK*5+&8K(7^I-2Q^77)0QP2=:+%5'8E=J-]0;[$$9#2A]R1
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MZZ[>CX/_ !R]4VAG&:>9(:T+-RQ$TNZP@)H40TWDFU=D.8W\B"H%RM(DH?\
M*LM21=5K9%B<^X1<O).:O!8("43;2HD1*G3K"%,:2NL)N&-]!D>U83VRS)B;
MKW<("<5$/RP#)D:7B3)(VYO(<U(F2I\L20BT,NE+F$H9,&]ILIPBB>Z$# '1
MUHUA":Y633'N6YWP:]EK_P"1/*2>97JK5.4*2BEYP9,X5HD:"I9%A5RKJ&7F
M3^I>K<(4V$LR475>X,V$X:>H@'0Z/!/B$J/6),X2ZE$LTC"*&7P^AOX&;"<-
M/4MW8E"2LFY9M"(B:-2AD=+@:HH>P3C-LR01:F;C>3G$NZ'MAFJ-9"+I@28V
MD\()8T4A5;8Q]A<HK9YEDVU:A&0:-6"2$:H@ZK=+9FXQT%T>@SOB 3Q.I5^U
M:T!\H+DZ_P \[>CX/_'#M03J%MV*4=DP6#L2!&<W@E6M8>=J5R-R99]R-N<W
M@A$AMAS5X'[=DH&U]W@[MK#G4:FS>[EX*!))0J)#4J'8G%2WL$A7:J<=$1LP
M\%6$G$*95ZB)C692UE#G"TZ/(DF$"]2!3*S=1)(DE"0F;E5#T]2]#DA")TE,
MM\'M,M="MW2]" 2S4E74]Q#EE7=C)S9*14UN197"60U*AC0Z_EJ.8['$8C0:
M&U1Z%8RT80AT1N*-.J?G#Z&_@Y,F;<^@B0DA(:5RUT.:?_Q$YDLR9&5(*BA8
M+0%4T&ENPDD!K[$/J*:Y!ZZBKD#72H)4J_<"UAI(TU*9:RL"D[?L1(J,GA-(
MFJU[BI-S;,L$) KJH_GG;T?!_P".9M*97:QF82T*#F)-M%#C'8G!X<5G/9V_
M8R&GMAP!S5X*Y/N?!V?<^[OX"Y;[G'1Q^*V,/M;X?=WPY [GMX*&UTGRJG!N
M#N#,&,V(A819/M[X<[V.^[>#G^QQ&6'IU'&<5_<F]I:A"/6CSA]#?P<GX![?
ML9G2)>I(NUC.@EI4FI)O0<84G<GV*QSH($=PFFNW!S$<!X+[[N=OV. P_ !L
M;U=K6L;PJ6X(2HZT6?\ /.WH^#_QPVX$*EET:B22A*$,F-H2(4M(CC'8G%X<
M5G/8[+>84O.:P2EW4E]#FKP-V$0]&B3@MP89)J-OK?\ @BVU&*&SE(:_O$LX
MZ.-Q6QA]K?#Z.^'('<]O!0L25P0QT)(]\4PI.$U<-*-J-CZ>^$@Y()W32"<J
M5@A1-PE!+?$_!Q&-9N="BR:DAX,3A$LAM[SA]#?P<F+;:*C!#&0D,V=",:O;
M!6*:KW$)")):#<*785;CH. %/L-0QFE/3?08RI,(FTD@<OO$H4I/"<2GJZ E
MJZJ.W['$#0S2DB-<B6\(P0D;)H)^_P#/.WH^#_QPJV$@4752HV8M4'JF/-P1
M;W9,SL3D2GS0[$XO#@LY;&B@[IZ,B=5M<@V12=1.I5J)S.2O! TN89(0M,C3
M_6Y'IJ4MNX2A0B2C'5&1%A*O<B'*5^X3(15-=X<5'&XK8P^EOA]7?#D#O^WA
MH7!QE85Q#-0]Q!!.RN9%1BJS#Z>^+0J?D">*#V2"ZG[A-($58<_V.(Q=K(2Z
M&BSR8KR;J.D.$.;=0YU%VTDGT-_!R9I42A%TQ>B@U#9-QE+59:"K:2&2=3"<
MI%X.-4X+YV_^F/:ZI2(4;,(#M2^I(%DIUQ?I35I=$$TB]Q'%*\KV1D9*K<.W
M['$8,#532"*F#-W(_I^X@X"IF>"BDI;AIFT_S;MZ/B_\<M$A$UN5YK](DDH2
MA$)Y>0A(1-;C*4'JD\:J%&Z&<H/9/!SS*3CB4>D<3UX<<T/'R(*1Q/1H>%#"
M)K<2G*GZ"UB%IXN3.0.!%)P(*,6DD-2BO-?I$DD)0B$\4LVKJ(BUF/!S##@R
M4>-Q/7AQS?SYV]'Q?^?4:"2V]$0X ZN'E(6JT*[R1RW_ $T=O1\7_M9V]'Q?
M^UG;T?%_[6=O1\7_ +6=O1\7_M9V]'Q?^UG;T?%_[6=O1\7_ +6=O1\7_M9V
M]'Q?^UG;T?%_[6=O1\7_ +6=O1\7_M9V]'Q?^UG;T?%_[6=O1\7_ +6=O1\7
M_M9V]'Q?^UG;T?%\](JFW9(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_
M3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_
M3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_
M3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_
M3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_3(_
M3(GJTUD_^:7;T?%_MN)+X0TVET3_ ,SNWH^+_;L66PT(TUNO^9W;T?%_M^+3
M(:*HHMT)_P#,KMZ/B_W#%AD-"-!;H3I_S([>CXO]QQ89#0F%N%NA.HO^8G;T
M?%_N6.4R&A)6BW0F)_\ ,+MZ/B_W/%AD-"<A+="=/^87;T?%_GL;>30,BWA3
M3S(_=";^*-+;T0U#A^0E+@I#C9^!-I*B;^"@N8FHOPRU-/"U,$O4JAT/*6&0
MT)A;A;H3J+_E]V]'Q?Y[)!M9U$D]*YIY<)5I$^);"D[G*\CD%WJO!;^K>#9)
M$21-HHOX:63H/S\GRW*9#0DK1;H3$_5PIV0U(^ACZ&'-/>H(2636J\]0E'54
M8CMEK/P79"+"UM<IZQG;"78X2BJZ/^&8G");-30B'A;!^EIE&+,HS_B76"CA
MJ7\.WP4NI"<I-6?H+&A,0QB<U$_%U;HE?&XQ.$2V:FA$/TDSB+H(HD;0I7B9
M,:R$.6UE+QOL%+J0G*E#C#,I"EU$U*\CIK*%S0B8-!0F#K;*>)0E'548CMEK
M/T#BEBSBG\8[>CXO\]B]LD.U!#)D,J/!Z42V5Z?>$*D5(OD_PB4N$+?$+(LD
MFQFW-%=/!"=W%Q*7"%OB%D6238S;FBNF(UXSU(:Z<\G)M@PL4B6Q2X:(M1.Q
M0S=U8:,;LBPU>@4TJMI+O5>"W]6\%3\1-!&DAJ:BU*EKF-0X>$&I<2X)P)%T
MKKE3\1-!S6-+FQ)JA[BD[7*S86()7>@JXG> E]?K*&RA)*)Q6&0T)R$MT)T]
M7RXB.]L?IAB>VF?:JHM-9)*\Y4":4*LL1)\'&G-7K+D2(%2))PH_%3&F<23A
M,:J_7Y!H1$4I%?#+0B3KAQ6<]_U#N4NQQUYKT]V,<)='3)4PB*<"N9!H?BY$
M&4X)<PDXOAV0:$1%*17]&VY%0-LRB6QGVVFOBY [OMXTI)*5%A3R1PEV.-[>
M1SV7NLA#,#*))41#\2H$TH598B3Y]?=;9%$,[V_C';T?%_G<TKNR"2_:6'53
M_P"PQC71&[5 BB;199%B#DV0;DCUQ'QM+%A!..AU;BA;ZR/7$?&TL6$$XZ'5
MN*'?'*%-LRHAA5_FP953Y(@;6A2C?D'ELMB6IK0T7>J\%OZMX+N#+EU1L:@;
MYLA?T,!;[RZ'!Q<\&E-,H(B@B5I(9GRV)K^JU$*+.?@6&0T)A=%NA.HO4\F<
M#%CT#8Z7NN1[?M:$-!O4PR&,UH45PKY^())JT!K@DBJVB0FTDE8/\T+07"^9
MH,H6DA!;2U8-$B/8.U:6TB6HH^QS5A1)/<#DHT!:E=[,7!VUY"$Z"O2,]GAB
M]03?RC@D5%T%&@]QA&H"3H&[@:?P#DIVNV#25B-)HT!O",WL)IJ55""VUH$T
M+2<#U6G(0G04QI9@C*IF0N':("^IIM2&E.XF_D'!(J+H.2B^"NQ;4T&_1&5F
M)%1K<+3RW$S<FG(0FZ U@WAC)&VA+-D(W"R)%9+:1/*F;77@<"J@/2TAQ&!3
M0[:D5()3%<)MJ:"0,@9D(-Q-2I;D##U?Z!59J)'%9%HJX6;%77:W@)26[UMX
M91;B:#^6T2EN5+H%4<48R"0FC0%)I9E@7-FDFA1B2LMA*+M28'M344:8V+*!
M"=!1I-F6*OGX@DFK0&N"2&3:F*%33\,11;JW! MXN++4RS6"O/T7%77=8#[I
MELY*W&JT\?*L_1<D5FMX'5075":24Y3P=N1O@0.(;A=":1-.4Q!;:T&KQ [=
MVH5I1:I3)T6;%W5+> _C?+BRU,S7A9)-&0:306\;Y<66IM9H4\LDD(82V)<H
MYV0VZ)LY*&C",8$G0-6X%1AWF['.78XZ\'&9<FUWU@-.B;.2G([8/JB,V,(W
MFPTZ)LY*.@JH=R5*B<FTFPF%0E!N)H+5G"34BD:92E3%\39$'92C@=D@*+;T
M!?0BH$2T11(3*H2:$(-Q-<)%#HLV*NNUO BF^70A,33S6%"DT+CDJ-;AQ&X7
M0A3$T[->&OGX@DFK0&N"1;VU)8_H3A00"'@$7Q%QR4: ^BJ#N^V$1.A:B3^0
M<$BHEM(59RNU\']3T#0/4X2[%-6X'"Z"RAV06*LIV4A"4TK,7/9>ZR"3:F*%
M @$=LVIE(GZW,+:9)7#1,M(90M)""VEJ&@P"ZYOUN)NB;N"7+?="::E56%41
M*ET!8Y-*IE<6U[>O@;A2[(EKD!44+"B$C2:- 1)&>SQ-4JO87K2VD2K&BC2N
MA(Z'KQV]'Q?X7&V%.9#\D24(13RLH?[8OF8]6.B?DQ.YT0M6DI4[ILC?84B@
M;=XA/AH7PK?@>0Z=Q"9KIF$W(J-#*25IZH^C493;M/1C&4&BWUB;9-70RDE:
M>J/HU&4V[3T8QE!H[XY1WA36M4[0WA)HX\J6@N]5@KG>7@M_5O!=P9LVZD,_
MH2-Y412UJ%@+?>7<6<[!LCB7AWJ9#0DK1;H3]3R9LBU/W1/NF3EC0JNA#75*
MG#0V3*9Y78U&60.)HI/^1:I)^X0""Z,4VMM=H-Z->Y: K2[<83*Y5$ V ?N^
MXQ;(N=!2U-"U*!%NF5[;J)G-1,K?0-QT*E$H/=CC+"!TW3"DMR A$Y7<:U*$
M$MDG-&:!-0-X4+KP0^I4(M[JV092ZA74GJ!H'JB4.20I;ZV-VRM%%3G11#5Z
M!()T>XQ(4$OH=4,0Y$U361V??!Z)+40W39U*$%"%O+T%HA0HN4QWOD?M845(
MQPU*;T#1"VM<;'Y;H&O JJP-C/Y!9?.13#FLP_91CT.C.T1F)+DLS*(YYW>;
M09;6@<&]\QE52ZEI(![P5\BNHA63F.X*!(.6<'-U0X7L=F%CXN,IZ\[DZ"BH
MHZK0;2+,!+59Q65E(TF%6\L0\S=F<AJ92W\#L1L@X4ZG"5<6FZ52FFRG4-CT
MJV'N<TEWFV)4(B*SJ6@Y[)MO58<NH21>+K5B<JB/<5AOE%""I18UH0"%I1<<
M312?\BU23]P@$%T8IM;:[0;T:]SLQ<A3EL1)KZME?RS![ELJ!+O))"*E3:(@
M7O!A1-HLQ!*SR7BY#/)4ZC]-3KH$8K:AF7" ]+F%(8C#NZ%3M<+44()%*FB'
MD.SHH=OW$5U\LL^L(NW-0]19CL(1?= U)CRR8MMJQ#R?@9*Q0]BH"Q&K*$%4
M:I0PYOVJ1R9K+\@HPU:T(EQIB:,;MH\+_90BEN,V'AI%EDS495*G'6.W(@KJ
MBB4'NR&%J=F.56I>#S?H-18:399(?ME:(S0DX24^M\B]99,9M*NJ=B<&4-8G
MW->4H>$_65 U82KU/M[CJB6N)L2I<GU2'4<^=R65D*I>8WHB#.74/BH?8Q(;
MI[,VW-CXM8PDB+ZC$EJ+A%=7LUX'$T4G_(M4D_<(!!=&*;6VNT']&O<B7K69
M$$HI7'[<ZZKQ4SR5.H[9E0^=IL74TEUH=WV&3&[(W*\+9".I.H:]L:-2HWAS
MCA'"78XGL/6H 78B3@YFR704NPE"QY[+W6=F?C(!;MP3,Y4805=Y?0D>[PNF
M#]WW.>Q)9EQ$,]YMCAEV(>0VJ)4Z$"W4ZAN;(5*@1[MEWO6.&^W@G:NQTD,*
MAH T%'J,A$'U&B:/L#'LE,MMX'J9#KZ!%=T:BV3=,9YG9>ISUZ]V]'Q?X3--
M-/)H7$LB$D(<^PZ2F56Y:\:DB6Q<]Q*3(XJ?Z&<WL1!S>:$((I/C2;)*[''T
MI&Y<O#9MU)N+T!\:4*:%(E-4;$VG067-UHV,K!FX@3)-MF]<)GMHZ-D:&I;Z
MQ"J@F2;;-ZX3/;1T;(T-3O!&DO5B=?,H=&9J>"7ODR$H!-<3?)*ZC3:&H:'*
M%2:EWJO!;^K>"[BQ&9)2%N6+D=7@+?>7<4<[ ERKQ(9EPT)B_?00JLH^)9;#
M0K(2W0G3U'+B<I7 ?0@XHZHE3V%AQT0]:<'>UB%-DC!4G<B')#JZU3J1U)5A
MN%+LAS]F!$A++!^[[D8T)"4&G!2,P<U&R4I)$S.6TD?HU_H]D+467^DZ6PUE
M2@P1*Z-/,_UG* A:*/"E(@S&:NA"?+4'ME#R'&#ZB;^S$I:1K<IR,WJB,,V$
MO\D&ZY@M13W8I=72G#L^^#PG=5=1IJM-C_6<H"UHHPM=)SUA8$.8M+]"$^20
M,:J&TP<; ^HE.'YSOB$:$A*30\(BFV@4=)HD0=0U6/T:_P!/T:_TBBLR$^)&
MDQ.S)(3TWT.N@74)/R/UPW-3FH1*66$<F=SA]3?#BL@5ZMA]G;PGV(A1HP3J
M$''LTP&+:7A(_1K_ $RT99?Z>_"PZ%;S'@[> -&T0$_F<HJ]CH\'>UB%-DC!
M4G<B')#V9O*BPXV'W&M<>>;+1T C5GU#R[9XNC")U[A@AR)3NCAW199]46ZP
M': *&K)F3FH[?N3X9HK(0UL;4(?HU_I^C7^DYZ:"3>Q3B@A$^I4/WF1:'01)
MR3-LX0Y,J+)-X7,%C2Z<KW(WBA%9U..L6IN,96/Y9:'T PFG5S; MM697>3G
M&5W:V8YWL<)]L.Q.#)I 1,YT"F.21B:BP7V]\.-P;DSN<$F8.N$0/T:_T_1K
M_1Z;2I2-)Z=D,W,=04HO=04JOH4TU*JO [VL0ILD8*D[D0Y(>-^3[N_@C")6
M?<,%M[,1WO;#,CJ+2_0$KSJ@:QE#D%8YQPCA+L<;V)E<JB8;MP3-: D^RPNO
M@Y[+W6=F?C%6PD#5V8 ]"NI)MY(P?N^YSV19AX>Q+?:5<FK%ZAF"V^;'#?;P
M1(U*>P83Y%2$EE*7"1^C7^C%4T67^G7CCP='T%I<DP6G,'/7KW;T?%_@\DH4
MU(<VA)#Q+!M2C6_(&QS'<7HVDZE.6IEMXI5)539;"7VF'%8'ET-,"^U!-I%/
M9Z3(MNBLEEOX]4L)JXF7X)(X4L7C1.A0 MAFG*+^QG08ID-%'#9S9F;(Q#EY
M0J(;;-N[%[(D0QBF0T4<-G-F9LC$.7E"HAMLV[L4M3E65D+M29!(?#1!%-I8
M)ZKD%<_PP8UQN"I,]W#&9";:%262R\%?0D3HS:_(VOR%V);0),0A.R5&"B:%
M$W17>#EX0R9)F@S,A"=DJ,$#6/0:7*;H7()W6HJ9]I"^WTA#'<'XRPR&A,+<
M+="8O3<F<#P\=' ]L%J<I#0-6:P3O%!(S3"YM%"3!E4A?DD;V,7[ON2'0F01
MIPB=:!S4=30$(U6G7$ %PN6E8%407!_JXB48TPB:F$XDV$DL1U=M&@)*J?L-
M8-PJ+5)'$(XP:QE7)E>JZTBE5[!G!B-00E+-2(' ]<BYF?*'-&DW:R))\PG8
M=GWQ=9[L?ZVH2T-$.DEUI[%KI.>A%B)(O*9919(654_8:[;I($*DED.-X#+\
M_P"#NCJ-)DT6G"[800DZA[1W$ $=T"I$>J7X(!LG)?U8I^Q-YB?F"%$6$AJF
M]8Y,[G#ZF^'%9SWA]W;POV)%&G"F:!7Z:():J*RD5:X V@6T\BN'7^O%+[J<
MA-2 A;V0;1-A["U.4AH&K-8)WB@D9H>S+?;AP<'U?LNHW7.[,A&Y;4$LI'&=
M1PGBZ31#<RE@R8UD+*[;*!&?%)9"3-[:L[LV+QP_>=J=OWQ"1FABJ.81#Q #
M9!2TLE&+DX3+>QUL;-EP==DZY*4YX)R9R&#L\-BC65SD:QI+*$<=8P)=3J'#
MW"0N7P*B 5ZL"B[-RL\Y6+Q%=ATVK-NQPGVP[$X,:2-.S*_9@C<:W0D'NW&'
MV]\.-P;DSN2;0&,CDR>( ;()02T$T6RRJ3-F,*2;ZB.R;:T?@6IRD- U9K!.
M\4$C-#QOR?=W\$FB$N?4L) LE)WO819R26TS\20NJ]["LUO<0T&CJ*QSCA'"
M78XWL+8Y*#*854AJRR^I,FH\'/9>ZSLS\>$ 62O4S?O!H)5[XOW?<Y[Q'LRW
MVFV:H7J&8+;9,<-]O M;0M2V80:XI-U*X@@CARTKP.KZBTN:8)3F0<]>O=O1
M\?\ @\AUB?<WQ2[XJA"K0/=D[>*9%MX%5H?N)/L]RYU_FE>8E&XJ1#J$D4YL
M]LB6^3;R'J9#0@K1;H3]-R9P/#QT<#VP8E61L8M-%#+$D0A#KK&K',3&5MA%
MK=N!_,V/<UMB7UQ?N^X];ET]!.N/@$I0:B+_ -,YJ'RK-9;DE-G;$T%=1:>D
ME9%W>X\-JZZ;HQ)+:#"M>1D3CDAB^_F)"46B<,GB+J/\&4@P7VD:6[1_5S0E
M/6V$07W',5*"&Z1'L2]5K831U=1.]>(61E@8]SL^^#RB<O/L,"BO.C$I*>A$
MLYU:LA9-LZ!)Z%':FDTV-"4VB#8&/8EP+61G2LA(9MN.H\OV7@,OS_@[H:@R
MZ>@EK &N2#45@,W5C$QBN&E%:4]Q-65F[,CBKJ1M5C<):5Y[>"A[M(\KV<>^
M#Q0650CLYLO00I+)0<F=S@\IZO(Z1BPIJ<5G/>'W=O"_8D^(!18B-#Y&%"&*
M7-SH)G>.4]""&H--,6%D-LUI;O#K_7@E3RTOH3XATK0)BE1A&6>9;5D66*4,
M2K(V,6FBAEB2(0AUUC5CF)C*V.S+?;AP<'<QY!L:[!1>4M9+!#-JR+QI\71U
MNZA[8.5%)4JZBJG3-K)#FBHH&.:RJ!Q%3AIDX2=2%2/+W'MZ';]\02[R4)34
MH#VZS<,;H7+87XY:305%BY:(#RIDWF211NQ+*2Y.HU$\F<A@[/#;HR>ARB9*
MY[,;(7+870R3CK%BDUF,/21ALI32UDR5HTLAJO#-J%,HK2N>S'-@\D=6>^K8
MCJ17 ZJ+&QZTY6C.Q.#PB0SJ&[[PE%6PD8?;WP2OJ5U,(:97UYW)KN[=2?,%
M["9NHS0Y2"%5WE(LHTH,F5Q9)4ON*E+0D<BWO&_ Q*LC8Q::*&6)(A"'76-6
M.8F,K8XWY/N[^#7]VZC'- J#7J./81!W/8=>$2)MPI/0D +61P2RXR)==TR5
M(<XX1PEV.-[8.MRIB-;U#IX>>R]UG9GX\*3T16YP138A^[[G/>(]F6^TA6RO
M4+QTJ%0 MFBE3UO4X;[>"CKA%NC!BES6ZH4S_&9)A02L!-JR)]GOO!SF2BXT
M#U0]2)=/05&<0H >R10)J@D<]#<*2\D<7]:[>CX?\'E)Z]QK?0EW\#Y7FD4B
MV]O%*AJ*5M'@;LMLMQ'L>Y4W\U3((5%]' PJ?(>&RWY*RV&A60ENA.GI;)I3
M'[B0+3PRMQE45*F"4X(<A-.Z>'!%)6#W$!T>ML4VDD"8--.ICD3HS'O4(+C5
M./V$FB6TD+0V*74D%^%&#@^72S')9>Y6F=:!<41E@SSJZB@Y:0]6(3D0AK2+
M)>!CE-]&5<GJRI&TLA3>$(&4=I@@CT:NA)UB]@^Z=;5*CU+!H;+>+,<EA[E>
M:>@1H0>]0@R)T9,'R8>44*M(>K)@ 64I)9+ B+H_8&Y"Y0:9!=9%7)ZLKY=,
MA>6$0)Q!(F"-L8149?B)PZL\I-V\S$#4J&.4I\"ID^XG.AMHL&Y9F17F-:!2
M6'N(#H,W9>%5L) IY$TQGYP0UW5G%A"VIV5&%>XC$FS6(HP4U=]T[,@2&FDD
MEYP@;#.(PRE7,Q)F:IM'@[$334-=125B]QK/J/+%J?-\#EI#[D@ +*4DLD5C
MHQ)L%B*,+W'"K>PJY/5B]T$(4B$K(0Y":=T\."*2L'N(#H];8;MYF).CO*,,
MOA<G+E1% TDAJ4QHJ 2*);2.UU]V1>#T,A*$U98S8?OX6'PA(JEO*%*0!92D
MEDB&_1JZ$G5KV#[H%[AI24-S'&D:AH>_ B3)K1DQ6RNR%G5K>A.I%[CWYGF_
M \IE=A:H+V#;I%[A3]5AO<65TFLQ6:)%)$VJB*,'8N=E,8:FFCT+X%[")&AH
M+9XDL@2!:+%#D2G="FS@!(HEM(^3]1Y#&^1"R"M4KR+L2Z#0;=*O<0QO=KO!
MK$B?L#VM.$#9K$5%>YC$X)>HG/02MZ=E1CV&_?!5EY(5,GW'MK',-FL11A5>
M@"[KEO0GT"%#19O7"L.XLR15+>252C04&EX$.0FG=/#@BDK![B Z/6V'NL#/
M'411X:RZ0<EE[FP,Z(]@)@=9QW60I<CJQ09M9"&5M6$YPD3J>W4"0+1&;EE4
M5WF"4X+->T1.YT>&"OPY-R\S$&[>9B3HSRC%IDC($2$K+#(G1F/>H006ZTDF
M;MS,1ANWF8DZ,\H+@2ZE$!(3= 1;,H2(]&\"GV&H)J5D#Z8N#I]+,<E(/<0I
M2H$-1%DL+-)3'[BPZ% Z@U.@]-;O2PK5M;0(N$_.AU(&I31HZ<_<^M=O1\/^
M#RN)A?D)8B9'%V2XP<MR2M(A:5D- )7;"P-'^HG^LC6K!$UU;? AB>:&A\F"
M#6$J1"16*D)AIW_I#U,AHA;HMT)U%_?.Q.+_ /#*OLBPCG0)*_)Z5RC+0XE:
MFA0DJ@I^X))BWH\, NM'05L_)R$\DMAN+:A:A),'T$$Z-$U&7DKZ\[>CX?\
M 9"EDL4Z-%/\B-4=6AEH[):"1:$1++0A33<G=.C(LLNY4IE.I*2H[CB6+@-)
M#7R+-HR^T$H)93(C1:L7PR<LTQN?+@#+T($P],;@/H,:$:Z^3"II:QZ=-4J+
M6/4O4R&A":+="9/][A$.(J$S2$A3_P"&*"SW*H8PG6>G;$E@A)U\?$\2'(E.
MZ'>3A3PE-KIC^=LNA)-1K8-?X!([>CX?K\:E,Q*;26D%E ]&X&MQ H<S0+?1
MJ)5'1HDXNT;AW\2@E+EU<2*5$]0<K-Z!LA;0-M_F$JWS'<2*,=VLB;BDZ7#"
M/:D;F&Z;;NY\R31*#J1CQT=AY-SH]/SOEQ*F5A82K3YRRV&A>@MT)T_Y5=O1
M\/U^+=<49<$DT:"9MY1;!K+PR5JO M%G+!*7 N2E*)W$):;Q0GSR\5+"N70,
ME/()@HBG;S]V--^#CH[ G8D]Q<2()H0J*>R(LA6F"RF6QA4MER6"5:%SHPA'
MN"BHI[(6T%VP:HJ")RZ@HYW0YTK!!3+8POS@FE>VPQR(:R&)+BCNU#JI-LI)
MXI><$FT)2V+Y1MN296TH3JPJ<,=5-=%(EEUWC4.&3L2>XN)$$T(5%/9$60K0
MWL<#5&")#6(\]ZF0T0MT6Z$ZB_Y3=O1\/UV/A:2+@*"BIK!@<MJH>TD'O[=B
M5:@Z$%5";7 E[T1+*1X$H'DD9-2K6>V%2Q0A%I3F&H\V!2[<"EF?X\''1V!9
MZ,IHK*&R1-;M'N*4V3,TU4[#?)EP)4AURP)ZF[0+L-ENR=-71P*CIFS$J3"O
MZG&&0?#5;T$F!MTDQ4:IN-MF9CRDRJS*2%^3/DW4G5'/&N,V(F4UT%%5F"H%
MG41)5;!IB%)68ES9R8R98<A*7")([I5W9.I)I0+$PS>0F$K86>C*:*RALD36
M[1[EDD4%Z,S8NE56GT#U,AH0FBW0F3Y[AS,I^4AC9)+-CX)UX*3$RGX6"JDH
M$#I:'I&CVH/7T;0[T0D.9DGZR85LDNR!U*2"3.@4I:(_@2^AG0'DJ20@+:,Q
M2"E*CS'TP++!R"G*@@+2,OZ$VDEN$ABE&N3"2MU$"R^42GX7E*FYA3?Y#L[R
M3Z!!K-H"$T:AX"UT]02NJ2CRJ"T;/T+8!,BDA$*JCQH/T2>N$'J"VVE9/DH3
M$RG_  CMZ/A^NRA)7;+<DDUIGN39FYP0T2BB%M5TRV-OUSV*$.79%++80U*+
MS:"R[5./":$E"P6D(GU('6TS ZHHTFHI217<DQT2RW>;M"HV,L>#CH[ L]&6
MVV%OM.:6[*&+U'F@L[$E&38?OQ3)TY%GH0XP\^Q@U+8D3=(2QFTGH?OS]^(;
M*4HU.><[%NP*\MV+P]0D,3+:4S0_?G[\5-&B+/1EMMA;[3FG,]$RRV&A>@MT
M)T\_[N_E< 7^W#Z>_AJDDHHR7+<])=^K^C:E-:FG')?K.W['!%5M4T/<PE_P
M/&G-1O!D#I7-15^7R1WO;!4KDHHS:#)_H7;=S@,($D9*F^U?"RHUODAA+2/1
M!]O;P=MW/I[^K[GSN_']#?'>%^?)=GK9G\([>CX?K<W*1&U!#),?ZQD":P0N
M5K(P(ZJ@-I:J3N@EN[P3BI::BPDLE(E;5RA+X2T-LV0<#&K-%9+<8T2F5:D,
MX\R<>A.N:?!QT=@6>CQ"WVG-+)7A]RPE+A&VL2KLZ#&EL>%XID^(-Q1G&'Z-
M<'MMB(8LG!F+*AC)#A$W.><UXMV K3*AMP)Q@Y+7DR<,@R7,G!&A*[')\&C+
M/1XA;[3FG-]&SU,AHA;HMT)U%YJ+:D8UHT"U*"'R0B"62U9X+M,@)R?2EA$2
M0ZMB:NIS0A#)3JC:U9B:TM05L;R@:&.R?N0 :V*6RD8U<P1\.Q88R!R=!O,D
MR_<D2$K"MI'5&%.GW%%-JS<:'*)0Q/BXSI5-64O]BS"TK,B$%*WCEH<QO(JV
M+6A"JO0)4290YKYPC,JU2$/K::3<R0<;E!H;3N5XJ[)J-*F_DV(K77$334JJ
M8WU<DM1C7L)8<4G#K)#0-.FW"GJ>9O(5;.GFJ(:2!TS(IJ3,(>'+0F$LZJ%A
M:(O-%8>5[!+930:R@0X9LPPV)+"9D;40)4Z7N3),Z+&8Y^:A^*RJ3$,+.0IH
M=8*^4S344F=5H.BJ2ZTDL^9E/P&4V.U+19B6^A2H3TRO*@>N@D]GP67 I-$9
M%!B\2$R@15A=CDX="6+K6G_V3"5=1GA/PM;MD5/5K0A=5F$M2!5M*A6\:+IC
MFA5NUT!))PVE"S.LW="ESFN^!'*C6L##&%"T8.#.BU*P4=DU''-PZR1-EFXZ
MB$*B5=E<R52IWJ1J84=,SFH=)"*,@2$K8,?!2[_@03.M50E VJ!-]Q:#HZBY
M($1R22QWNYD?9"Z3,SNM!TU/$R>B%H4BOTR8DB0G8?)**L:FTTU*^5=DU''/
MDQ6[D0IMEK,L9 ,C:6C9#R\VPB&/1<$J@[-:/P2)"5B\B"CF+J1%[F2H-@SH
M]BEOH46&KF!-KMX"(DL@B<YQV6(LD.K8K]7S0G*E69JS)H-:3SS>0]!;&B.L
M57&WT$.9"5V1>W(ELC_0@H:ST"F2LPL'/BI<H9W6JH0\>9*H*OT"(5L$\%+;
M02WL$B"CHO<AS&LG1X6? XA#BJH*8Y["^5%K4?68G;2.*G&A2V4>&\P9RGN8
M)X*6V@EO8)$%'1>Y#F-9.CPL^!Q"+TXJCGL0)E7N)Z?5U0A3)3JCB@V^HX*S
MO4&IH4PIA-SU:Z"$)9UQ<TM!9H@Z55(68D%K5F U-IIJ5\J[)J..?)BMW(A3
M;+697!"J3X>$U8?Y&H:W=BQ-A"HA79)+(5^9BG[8JA"&2GG@'V]AY?"5;/=;
M9L45_L(TVCZ>^"G+68\D5-%[$1T^E)DTZ7P,U%(1"L.R6K9F2T1S<PZ%T0I1
M9X!42KB]$I04(1$/,*O%WM9+4J1V,L=[N9"6*KC8K? VDI=$AA[X9"BX>X@F
MIDH5G<[L=2#3-$PLFD+#(FAM%J&'T-R1&"I"D3G:4F!0I+1(TA*I7PF2:D'\
MC8H[LXJA"&2G;P+M2A$+7"%2Q2$=M:6^@OG5>XO/G]R+^"74FEVR$I(RUH16
M-VJ0]$$[)GZ=V]'P_6YO881.]21CMXTS?4BN1M)*^XZ=%43%1+$.H2[^!(-3
M@J29KW$-5)1CTL2U!*FFL%Z&U+N,BN%6:;>2%L5:H:VD\J;?EV6:=_#QT=@6
M>CQ"WVG-$OF;/0;U!YJJ9?N5I$I]03ARBE3*T\QB3TT:D=*S4?"HXQ%VM)$Y
M)FMW0H*;M*LL)40LQ?TZ5195^R)DRLQSSFO'NP*-NMA#1/0.*!JHA6!-/!.=
M"4EYDRZ.)&]46;HD);(YZEGH\0M]IS1W<9&/&BK.?1O4R&A":+="9/F3S:!"
MNCJ]1Y2FUTQCVQ*0AC)(OIK%7(0W9?.$B6*S*@T. +_;AS/<1A4JM6-)J'5"
M*;2<HW*1X/W?? XH2ZFRP4+$*]1TG)M#DB[A".?B+"F\(_<?=W\6T(@E4@0A
M)"60^KKFT8YA=*N<.W[#K)#,F5LDP/C/(]QY11EL$*42X#GLJU.A.#0R%<DC
MHSP=E"T9CGB243J(355^834'D@6_="SI#25S@'.P2$LW[BNZYO5B'(E/(Z'\
M5%M)/8(MD)Z82&-:9=,A_=T>/FR4-H]A(4IX3?!7-4J6&(?09!PE14<$H3--
M<$,S5!!ORN,.V['!'9GXSDR8]SZ"RDC)"B,I6S&0LY1#ETJ=1.8]X$DD)0A]
M77-HQC:Z5<^/BL>0RYC9A$"$@6&6]HAUN(H5*@>7:H=M(*;4);!2$2CJ'2TM
MH]AC7=$I"DK<T6"FH5*;G-1P<'=9*(0A.5J\$**50,",:BA,P:;S+09V#$.B
M$GN1'.'?=L/K[G!'/ED>XTBIRW@I&AS!:W:L!K"G(WPI+7OL,T,)^$XP2ZFR
MP30RF2$=*6Q#$2GD)*ME\X5-F=*V0J"$F#%&$E!(6?SD$)E$L$%5$I;CGH X
MQS=.@KA#JP@55(,@AJXYO0!R5.5J\*;4)8XL2QLDBK2K4V0C0$$,1*>3*32O
M@-A1V(D.M_1%Q-K*@>\4Y8>4RG="1%H\B6-DD5:5:FR$: @AB)3R92:5\!L*
M.Q%14V7HL%%Q"7U'3\I1VW<X#P),PT4>#Z6^#GRR/<:14Y;P4C0Y@M;M0X @
M"2N2,G;($DB24)8MA.AR- J,MZ8(*N',;AS)LZ8!]O88N=\OH2*Y<QLPIO".
M-Q]/<CFZ5.I0ZD]P0A$)9(=Y##43R.J$Y2:S.;*4HI82G1$UW&'9#;9 %V8D
MFKB5.IF\N3P6Y*TYXK2(5<)DZ%F?-'L( F4=6#VK5W1W9SO8X3[8.V.?0WQW
MA?DG0M>)-M)WGFL(J4H,W=O!]G?#L^Q%ZC+>#7&$4#'7?%T"I)!%.4MS<M8>
MTRUT)"M'SZ=V]'P_6Y5-#(BA=4F>W@246Y$^O<:20X8](=6=+!&@R!T_WX)U
MH9%$T',U"O@A5>P+S33E54R:/;=D+RI\"EMM0JW%2)NJDUU(OY13"S1OS>-Q
MC67=3\"6A/H&M1]7AQB[T7AXW&<[C\B]W0SFL?@1PCT9S>/UBRV&A>@MT)T\
MQ)FQK4+S[_<2Q4V0:4;Y,_8D*J*:N3NNYP!?[</N[X]OV.#P?N^^!\'#\YWP
M_$4QX5F4?=W\31UT)6Q+"E]3AV_82%[,';9G,W?B_P -[XO\.GB&-P>9$IH2
MK:#^6S2W2CIRTJ$LAA-(FG*8QT$KF942;JB^TFP=T[PX!SL/I[X\H:'KZ@[O
MMBOC/-2W$G$G-)F]\7^&_P#%_@DU9L,F-H2S&@<;$10-X[:LT'*?;#MNQP1V
M9^,Y,[G#A'.&X3\>*Q!]3X^*SGO"UTX_REV..';=G/N;_P 7^&]\7^%S4DIQ
M0TKH>?;["0A:<$G80YJ.#@[4-PM;P:92[C#HE[BS9GK=16=J<X=YVP^ON<$N
M>KN*V"S*'JZ\#Y2P[/OXF/@8=MV.![8?;WPKKI"S=\F?_ ([.:FKG OSG=XG
MP@\OA+LBA,@;,.D%!K4N4<%KJ&I^ ]"U]R/!E*:.BDWOB_PWOB_P5&I*"B)1
MIINYV)P>'*_!Q6%WZN/!E*:.BDWOB_PWOB_P5&I*"B)1IINYV)P>'%9SV=MW
M. QXK.^\'TM\+GJ[BM@LRAZNLX 6KLO"\]6):23BMG^&]\7^#C+,C"Z3SK /
MM[#TRL>]WP23?3W&CJ4;M*7>)&]\7^&]\7^"/MVNQ/61PA67@Z1/<)HNU.A2
M3U%8W)]O!)^-%FQET3W%NPU$IVX4L$>GLQ83=L%E3UG=G.]CA/M@[8Y]#?#[
MNYPOR6^GGH/'&\+^$XRJ'2DJ 0G2UGX/L[X=GV./\;D_1"[R.PX6:H?L'6PB
M_GT[MZ/A^LS?07IA \J=O LJV"PHO5#6@H4]1*"!Z>"X8CF&D:O%+4N35D(0
MDP]1!*).,VRXU+9$>N:6B$/;,VJ9>N=:M*R&A+2C/^1>ID-$+=%NA.HO*E"U
M055*P0Q5)1.=U4.4JPB>I"T5P5&M)G?=S@"_VX?3WQ[?L<'VP?N^_@,OS_@[
MH<L@@3.Y#P6Z60?=W\345XD5I"/?!M(V[(^0><.W['$8.]B%M1,$I3<N$D4]
M3- G[PFA8.23D\1E#;:#FKDY-"OV42&IN('*] (%-6+DX!SL%]NN/*%5,X#'
MM*Q--2JIX)G)2^-S7I93$9HS[8*?024L0Q,A4-X*%S0I3"6$)LA#_4<K\8=M
MV.".S/QG)G<X<(YPY)7!+1$*=<&)PB60;:G/CXK.>\+73C_*78XX;M(BP0DX
M,A&Y60Y%3- ;I20RKI+!&:S'-1P<'<M)$.O9@EUDD1HV);1I(T$/59EY$184
MLXY':G+'>=L/K[G!';EP$948*;G(0YY)0P/@,.S[^0QEVW8X/MA]O<;B0H$Z
MWQ42D9Q7!&B%@K\YWV)\(*/:IBLU<),00B2V$3\D"QU#'I=@M@]2PM#(/+'F
MA$UV"&*4ZL8OLXKH)@\B3L3B\.5^#CL+OU<B:[!#%*=6,7V<5T$P>1)V)Q>'
M%9SV=MW. QDTTCJEM^#Z6^#MRX",J,%-SD(<\DH' ''7A9[0$(,U7"LQRX20
M[15S0P#[>PW3P%:@P4OG2/I[CX]P5E13KBV#91*5!H'K@RMX.0UR#:0NC-BT
M+H*782CP.!:E#$J$ML$:N1P@]IYH8AYII]L%-LU".[*NK&J\Y7&"K622OI\/
MH;X[POR0QG) @+C*!='6$48C0P]N6H>#[.^'9]CCO$Y/N2((=4B2U$L)-D,F
M-1(^?.?3NWH^'ZS)>N[#^X$@_ L]/W%8>4Z"+DE97P['@@'JA\ [>&H54BXO
MX#*?11Y#WUQ%P]0:>O\ ZC$6IR)U$_*S&B!;,2C1H9:KF8JJ<'-<#:TG-R2D
MJ?NS"*:FS=67KY=1:F;-,222U4;B$N3)1D4(D^GOCV_8X/M@_=]_ 9?G_!W1
MFIV>C')5;7(=U"5G(;SZ'W=\$$6DZ*^EX&Y;FY306Y59&5K)D56QUT(3^<.W
M['$8-5_KH=GEF)V3R%VF@ED(7<U6W%E<Y.J)IMVI XZ3=2B9.R2L@I/D&5#D
MY360@J=J#&RSS,3EN29>8X!SL%]NN/*. /(9^8)Y*#V1/WA+\23VPZ1:!5"=
M977P6 ^!-+E;($W/4*T7EFQS#&8R'Q7\-R\1K@[243HS\(?*Z+P:E44TQ-+W
M:H=F?C.3.YPX1SL'M;=]!1*,W<5U1IL]S-&AS@RVS;F!)(C$3X.*SGO"UTX_
MREV..'H5J+5#IMJ<HN#.[+4DR5D$%J[MZL7EJS#RG#Y1<7J&0]3]'-1P<'23
M*(8H24>RQ/=!"U[95L<_I^B(A<PC8-3'K-71?J=PNBC7\"5G6DQ)%JBF$.LQ
MCG2]<^ON<$A/]M#N\LQ7!ZF6O+16"VE7=M7@? 8=GW\AC+MNQP?;#[>YD9C2
MF2A9=P226>=V*;VH3$U)GYSOL3X00E3E:H9LDW1=B]RMT? A<K.4(8B4[E<*
M4HR(0_U&HL32P3X^$H:LBR$.*5G-1[C&]6*Z*I>*6B$E".Q.+PY7X..PN_5\
M)0U9%D(<4K.:CW&-ZL5T52\4M$)*$=B<7AQ6<]C427$CXI)0TR>IVB)P@]40
MITP/!]+?"$_VT.[RS%<'J9:\M%8+:5=VU9P!QUX8G8]QPM9EDI@L7/V G//5
ML ^WL9K5GHQK:7""N7!VI"9V1]/<1,3JF5,52C(@,[4':O9G45TQ6KB96\//
MLRI=23[4KKX5(<_$8]#JV-7+X2)%XW$[M&6"T)NJ-6R(+O\ H8^TA#ADCNQJ
M5#,WJ')+1WA.!2URE^2O,T</H;X47LD+T2JSDT?_ /X%@@5+.ZBZ%1CWU\#[
M.^'9]CCO$Y;0J$YHH-LQ7DHPK"Z7Y,Q+H4M+-3Z9V]'P_69[,W8FUJ>%/BX-
M+.+[BL=C%7%CI^Q[@7;Q,IB]A\CO"$)411,ZZ;^H3?V"A$AJX%;R8+&I(?/H
M-9E;UQC"31C:YC\LNV:P*(6[)%#K.B,(TIVH-T$QNDSDPQWH@T$DE"HD-9?K
M<(PD9)#&6^L@A)2,EA!4NT)(,71('T<TD4I:D()3E*>L!JSNDD?"%@^AV6!(
M1:>!J5483[*A\T VSU$S"<)HAFT$H4*V/(8BO/>R(+=EBQEYJ);F/RR$$V6#
M22&I0XE^U0:S[JN*DF,TF&\29ABY-C-I@]G<,CER4G B@3?D$[Y(,D&6KA0H
M56+Y\,82:-#*6OLVAG*CUQ>2\US&\I?=MD"4FB&!DV>"!M-Q-2E^6;&(222K
M=X0(<A-.Z9(CZP8J28S2%+YA,%- 349RP]T'/<)2:"4& @599HD>H5(%X(:E
MZ)(H-!*,)$?600I"25DL'1H9M"V'RV0);F/RR,-V6*..LHEB7W;9((UE0D*S
MH@<DF9,8RWU@P@231C*6OLVB_9KGBTGV5!],[>HAR$T\F;F$6!K*6U.KZ2,9
M;ZR"DDC)8<A"$ES'Y9#BFB6$.2Z))(5G1&$83,FAO+]['@8RWUD$)*1DL-Z(
M-!))0E"6#F#KIAA!@FC0WN8_+/DL2%"43HD40M>B""I=H208NB1A#DNB22%9
MT1@WEAZV',KWJB22$H1JE>0A@R9$,$4:4P&Y+<^@HV0.BWB<3,VH/Y2^]1"0
MB2T6$J#K((4A)*R6#HT,VA:V&\29ABXF9M0?RE]ZB$A$EHL)4'600I"25DL(
M:EZ)(H-!*,(HIVH(&JZXC(P8RJJW7PJ(*U0QY"$)+F/RR'%-$L(L-!J26K=X
M1XDOS"*\]X3QTE8((4K1(EA;HD81AINBK,?EB1!T*@QE_P!#!J5#&$^RH,YE
M;UQE!-FTQ<P39PQ6NRUZDD75>%J5#'$^RH,)D:NH])3,F2X^J6$&":-%68_+
M(AVA(E0=8,(,$T:*LQ^61!NR$N&KF;L/>),,'A)F3*\Q^6+*X2B1R&(KSWA'
M'25X6Z1UTPPFB&;0224*BP8RWUD$)*1DO D^0$MS'Y9"B;(W,(PA2$DK)>F=
MO1\/UN<6WA+/2#+CC^^$L)TQ64.(&X.WCL]!V'8N]2SU] <M$ME=IYUA#K*-
MY!IO^%+CEH[F2PQ1E!2Q(3E*;_R4J?\ Z"0J"L78%;^"ZN0=(/4BC'%2<J\/
M=D%"MJ]7A4$U*G+^#:6JFEDR*L&;N11D]PLL)JD[X&M[2>:%%,+OZA=E)#*T
MX3HBL&6I3*H\NXW4++3![#4IH+B(2R_I=I]((0E19;,@U;$2$K3)W_*]8^O7
M-FHGJ!M_XF,FHI%5+1RV\W]&=O1\/UF2*W(A:/PK?0,N.(+(D)X XH?B[>.S
MT%GL[$S-4'-:;S?T"IU94#1-/(@BL:J1W:^&*,I<"-&HQ7FSLC>J6*6JZ(NH
MNN"4VPH33%AK#FV.=Q8IFA&WL-:EK73&'H<=B*L2E;#3:&HP2;<)26 UU]3]
M0D2BPD)4$J(*W\&EA2;HA<\,224)1_#N)Z\''PWKC<EM]!QV+^H-2JC>Y?QQ
M5"DV7K4B#YY_%2Y&K"22A*%_1G;T?#]7B2Q41-LMX6C>09<<$/)+#X XH[;M
MX[/06>SMZ)^4!:T=GH7J&>;&+VEIX?KZ$UL/8DW- Q"78C/ N_=L$Q,NZ3R(
MDU5G8M;;R94-D<(K:LH/18FI'%-6J,HJ\"!T'FPJ'4(?D$NQ(2K178S4I:IR
M4ZRLUF--FG=&1=$@D^ K[6H;*"^CPF9V(DTK4^HE?L"4*@E4382I82K87_)K
MMZ/A^KQ)?H6#3U_?PM\7!('/6(!RDNW UJ^]#PI7TI WIV\=GH+/9V]% +G-
M!65-K",IW:D,4:U%10KIX/KZ%666"$2RD:\JRB++!=^[&ZHA5+?8^UH7TJ3F
MZ*LO4<8:TR8#4YE^&#? SC$+Y@8XUI@S8NBCLDC[$6D;NQ.'*'&_R8*I5XEU
M&Y-N[]/*G_Z"46$A*N E02_\,0RR2U8G.%\8O_YQ1!]2B(ZGD(V=2S7B=O1\
M/U>++]!X8Y#PM'3]RI"0="CJ#2WKWP"5:(-)JQ$+;0B.B'SD[>.ST%GL[>A4
M\LT'ZI3"5-1W".J+A+%H+P?7T'++IR(T2@5GROL.>UVY+OW8>!(RDZPY/UC/
MUC(4'8<8N]%@OOTPXC.(-*[-B07DV"5 \]"%K%0?U1DU3^!$GG5^G^H2)0)"
M5!58"5/5(Z!MPL4B:M?Q7^F"7^GIT=A%C@V^+L^_GLMCT=W0V;_P2K*9F[NO
MD,MVI@DU3*;2;6*/*D$>P1I+4.O<^[N<+\D!&ZNPR$:WB%YM)-!E$D-&!EB@
MVBLO24B;O81T#55Q*LVLB*-$T)AV?8X;^E*VE)<JQ$!JBN(L1)*7UWJW)"[6
MA5RV\#MZW) -@G^I*Z]A'81FBTK[9H75&9KP.WH^'ZO+@N',>&GI!I5B"<@2
M$]>^ 3/T>"E3).Y"M$)T^[#H_%9Z"SV=O0LT-70VQ2NS(A--4,I1/D92IL.9
MJWK3P?7TP2S8>PK-%/;"[]V$X::NB*:JNS(=)-:A8:3KF1'':1QCA+!??IAQ
M&<06Q\*WJ.2IFX@2]]0,;>MV)<S9:Q:'S4D7/$&@5EZ;ZA(E"H)5$V$J6$JV
M$O-@P35L:W$?AE!>:3C(E)JQE#7V38TAYIGX'T3MJCN)V],(,-1LGJ3>6$4"
M:MC*J^R;&<2MZ87^F"7^F"08&K0-X?K<QVH@T$TU*JGX.0AB:XC\,@P35/",
M-U;(435,?Q.VJ-X<>EL$,9"5VQY#_9D7W14B+35,3F#9+$SB5M4?1.WIAV??
M!FL(/2XZB=O3P-8]E4>1,T=,;#2)6U3X],%L>%K'LJCR)FCIC#YT,1AINRK$
M?AD89LQ#&))7;-N ),6L/WL$8&HF;\(C!#9T!/0D/8>:9X7;-!E"7W3(PDU3
MPBJS:4"; G6H/X:^R;/CDP@PU&*&XG45XFU1U#STMA )6U3XY,9@MW97B/PQ
M//27A#BFK8HE:M&.HF;5&,,/2V$-6[2@0D*[/N;< 2,;24NB$AFW9)/ VT:-
MC!4DN8LM3)8/@\;*_P#L?!9.,&":MC2XC\,X '@X2=O4+*#,T?=W.%^14J[:
M1&&ZL<C<"^+G:"0I-Y2-2!,GBOV:#*$ONFB-)-5BUA!Z7&\)?=-$B4FJ\#4B
M3)IC;5](XR(FR2$=6;2(,-1,<Y'!Z+=:!+*U:I.S["."0JV58C\,B3=GX=JZ
M(?% 1!/O05;#R'FF96C;TQ;24MPAQ#]JHWAAZ6QVKHA\4!$$^]!5L/(>:9E:
M-O3%M)+0A[#]JHWAAZ6QWUQ :PEM!VA5>7$&S@%+%C#_ $@%I)F:\".>LLKQ
M'X9&&;/%]"+TN)[_ ,LF"W9X.DIO5!)/4"KBWI@CGK+*\1^&1ANS\,N!I (0
MQ-.S6#:'[V",)F:8HE:]1N\A,:Q*VJ.H<>F$&&HR<I=Y#A+GU"+DE5H)*EWE
M(VDI;A#B/95'<3MZ>&'%-6Q VA6:9")6U2D/-,\&TC;<)$L/HF16+Y$":[8.
MXG;5&<2MZ808:C<#:(_<QVH@T,R5$R2$#)8)$))9L;0U]DV3];MX,9P@]+CF
M%[U!-)*<KU,ZVBI]KZ6Q*2V:U(I6_F$Y4JJP=O1\/U>7 LB&P%3FZ)Z?)$]/
MDB>GR1/3Y(8D<4;HC=!0O[J<]8@(6ZX)CT[D6>;1'+<2$Z-XK/06>SMZ*80;
M$*BWLQ)"I=KB5$WN%]J:EGX$G#0R.#G418%&F#;AHHL"RIOHX%T)WW&.9+>8
MR-6G4A*D]O!B$%*;6HR94C3!307<;Q1)#?(T5L(^HHQ56.KOS/32I_\ H)18
M2$JX"5!+S4V$DC<6;V62$.ZV1"K4V4@>&3G:HM!@FI+FS9'XT%"+S5T-)9^1
M@[HJ#@*M>R*HV4>[*HHSLYDSLS\9;605/,M_"$&K.R'B.WI5#+/E1.PO],$O
M],$W95.ID<L$AS62D1UM5]!*%"QB-KV&>!F*X/4B8ENR%@-\8&D27G&8UV.A
M!^FW+9!B=.=JCFSK0A(,SR:I&"&5QUT8TKB@7ZKD0_02NHJ0$Y.]Y;'9]QQ+
MT%R23M$I("U#BQ,"83+!R<ZX206Y5Y$/].T5%ALM1GE@^-<D4S"15<B%LQ*J
M4:&BZ5+'@<G.N$D%N5>1#_3M%18;+49Y8-L2,:=TO\#5>Z&,TL1J"<BXOH;#
M)"6>#U*ZDI'D@^WOAL5,HG2;O8+DQ$IIYCJRI5>A[B%61=SU(AUFKK(6 WP<
M5EM*JZ=6+, D)H=P=*#J.>A=YIRKCT]L2D2$Y)U0.\B*]3\ "$-PE4&OJ5ZB
MG7M1!F<SJUD*Z<%<"3E*2'9C]5,CC,>DM/1*2&E/D&)38>PYU>RD@)7K#K 9
M!6DKMA* DK;\&>9D,UA$GM% DMC-T1/UK=5L<-)N@DIO<#K:T9DI66I;3+A"
MZ?0A-*!5_08'[ON?=W.%^3G/ 6-]?02-FIF)(J_91AJLARR:CT1<,YJMB;GJ
M1_E 999)&1PUEMA%RD458OA$*U%*"OC I9.36Z(9UP!MMSG@\:UQ")1K)R?G
M_!W8[=YH(EIJ;23773:#L^PL-PHR[(_(@U^ZK41;B3B[,R%I@5ZBK5LI?MZ1
M!4S;O%>6K$2Q0JU2=!Y4NQ["',A*K*A*X3F.<XWH@XP2ZBJ$J<\[L.S,A:8%
M>HJU;*7[>D05,V[Q7EJQ$L4*M4G0>5+L>PT.$2RM.3HC7.!Z(,\(O2J'EE3<
M[84"F5\C=K2EU"+J=!0]1#G1?03E2L&-5<B1;"1X'IS*!.P<'1S"?"%E9!%H
MB5ZS$>"L45$W,[HF/,OY%(K))R L-X74JEN.L.PM:OT0: +)."*TXT:L$F@[
M-:/P7^@X_$._[X',G#;;C,=D]@3Y2UD&!--)O4YZ[G%0^B8E1HC;I,P/K6>4
M#"QS4+-DJN#0@YP=R:J(U3,9>#LRM3,C,NKLR$?LE=#&-W=4<F9*@/0G6MDU
M2(<.X']C2TH$6K9%4;Z+F0BN;=Q4*TA08M0L$I]A*1*G5?02$*R?L=WV$.9"
M5653U0LTYH02]FOR/+]N#7&TNPFRBVK(9R:$*J:X;D,D)5/TSETD*>YVA#/R
MZ)(OFZL-RZC9730OJ7F_X%+9*)3';T?#]7E;V$/FY-&CD6LMI"2P;TP+68);
ML>\ -P)L.AG!"PH>$0+U0D:\D_J&GZ')='5+>*ST%GL[?R:K<;@J7!J(0^>5
M^E^H2)0)"5!58"5/.8DNQ&;Y487L;8),-G1F:#HAZ#48J9=N&"&(E,DSH2/L
MIH5=EB5#G04T1V9^,B+/4,2?4SF.$,*[% X3[%_I@E_IBDZH5(U8:KU)! 7C
MH\#V]' IZ#2?J9E,2(QNQA,#1J%"6$FU#YP#FQ:[LJX.SPV-;A"G8N)26$Y5
M3L^XIS:RP4B]8WR!J:[4$,:+*E%3]3/U,E#DH-BHSU";LL"Y%%E06,6IKM00
MQHLJ45/U,_4R4.2@V-B!G*%*\DPB?=&5].0)[A$F#5B*=32"KWP^WOB2$^28
M.Z.0E*$D+!>:O V,FB'%8AF?"W)1AO/0AOM8)5*-9*6"U=F<]C\@)9NJI(?J
M8HSX2J+C792[,0VKI"PJ+)3C?W-_'<Z8I%>A$IE'A&9:D)X!KP?9V*/584[-
MA,LR5Y16ELTL'[ON?=W.%^3G/$6Y7'59$S*0SL(B$D*D_4Q<=N'4H-9;0IG
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M$3!?G^3O]<%"-PY3$]$V7C%V]'Q,9Y]5-D16!K#FW6$MO6H'M+(V_CQW^O\
M8FOL353$_P#EI"<HAC[I0J6Y;4)@^<)K%[K:]L7;T?$\#<A3.HAA2:,O*O@.
M?[ ])7+NU_'?Z_V.7L*:E"?_ "TSJ,NF:-A?#YXF+R/RQ)(DD)9+%V]'Q/ Q
MD+6YD.'EE5C>J)&-TNA-(FTIV:\=_K_9&/L2)-"?_++281+)[E#C^1#&0E5L
M>F2FGNB[,.R6\#MZ/B8[ I$62KSA;U36PXF62RWV!M7&R=(\9?Z_V5K[$U4Q
M/_EAL*R4*>IPRXS,T#<(1S-A%#1WZC$II9B=O1\3%RB[9#%M$8KJ<&GK5Z"
M:4*2]A^;L_'?Z_V:7L*:E"?_ "NV59+%C(5#>PQ3E<&LR1E6H([\LYJQ=O1\
M3P0HJLM^!M<;ZC5#N*6G<S#ANE<_QX[_ %]2G*>X8U?Z:Q]B1)H3_P"5K:Y
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M[7E)GUPDP;5,<J&7;_7@=O1\3%3VLE([-4R2:AE"0DJ>]412Z-68UR[>,O\
M7RI+MG(%8>%>=B<*AXV-1D%G(U\U[^1 X>A,#HWA>ZEWN)@;.[?GI5F^1MN[
MGR]U\^;NOGP;KY_@7OL3)-"?F<F;,=)^IG'=BXZ.![843:N^.=%[K&I4,1TM
M5=!*)AHQR8OW?<[?L9#3VPX YJPU6K&^)$A2"&ZX-4P\UC0'6L@R1 *;3(/%
MW 1PYQT<?BMC#[6^.JR.0._[X6D:&J7B1;!,:74A]G?'+:?!R?@'M^Q3+I):
MBE3>(9H/80SY>2,MP<9X!KGLO=8J4:B%=<_;#]L$,J2>XXW!N#@_)G<X<I=S
MC+#[.V+ZK5C?$B0I!#=?!V?8RVGMAF-1ROP<8^SOXG[ON<]XCV9;[<&Y4N=!
M"N$+$BV"5$*J0SFLYW#LRWVX<@?7VQ#N^Y^?\'=G"_)]W?#A+L<;V+_>9C2*
MO$BAA2Y#N\&_1WP^[N<+\^"+I"62Z+3'PR0-G42824U(=A01+.B&$<O+H5"J
MOM8=GWP?ERWU'+EOJ. $1";I>)%L%I(/!W7;P#P>/&9SL?M[XI8Z8< <6<@<
MI]\'E,KL5)2Z4,;4#D$!-U[C0Y1*.<<(XZ.-Q?O^YV_8:8=.'*7<O]O@2S2V
M0RX;49&:?@CX=B/"_)2?1-7B1;!>W4''1P/;"DM$2+D@6GJ(A]3#[.YVW<^S
MOX+_ 'F8TBKQ(H84N<#W(+K(T#U<ABCA,)S49^!C(87;(2JR'O"'574<D'KT
MQ@7YSOL3X0XK+75AF=9W?\$QB64*T<*I$(^4NI\R&I<(/G)JL7;T?$Q8@NV0
MI]93$*9*=4\&-=!KY&C?GMX[_7R^0*P\%I+3;QL:%!O#>&\$,T\;PQU0L=3"
M]U+O=_4)^PIV$_+Y,X'AXZ.![8/R"@(<Z%";X2 S7LA\OM9A: K_ %;_ ."
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M4BF*4PVDI;A"<X(1Q9R!RGWP;EL)3:%OUU7KA3U)N@M16MH<XX1QT<;B_?\
M<8DU1(?4<!Y$:K"14PY%_M\$,EA!"<J4,"1-;FT%^1TY"SE)@A#)3SP4"I2N
M8CR52T<=' ]L&I4,1[7&.WY(UT$*2RIA]G?#@EU"^ O8>7PE6Q+2"MS9#4)F
MX'HQ=U8.@A(2S)?"$OFU$/)M68/M515;BNVR:<;D$,G$DDH5AN%+%5NE%A7Y
MSOL3X0:DNU>A,2&W@3LRB.[_ ()LJR65VA-6F-JSIZ?9.>L7;T?$\#EHS6%U
M B#1O9R)DL*L:CW93E^._P!?+Y K#Q%KIX[_ &%WL^Q#:C+H[OR.0\+W4N]W
M]1H#4%Y30--ZIC@>&.0%5,Q6FU#2TPMZ3V"$J>XF-6#KM459J]QB.(P-76J=
M11P;JVU!"$LJ8/1>M0--(FC6Y8J?!4D2L<*:NU1(=72YE0):L@0G-!HJCRW<
MA#^0#40ZZA(K#4!9,HAD3T+&D9--[AIX(U:A(B*KU;P/(FNEA# "JI"-!(:6
MC(8 55(5I)#2T>#%)KDPK+!)B\S+7!YDUZ85A3N96P@>W8&WNJDD5RG?2(YN
M"R+(/HE"Q.A8&N_-!18+)(774Q"$"%+E?!R8Z.X<-H50@FB4*3)>B4(72V\#
M28G9E3H2L@7RAMZB<E/<4(81ER4U)#D0::@<B?/((1;*I/!,C+YC48.174$L
M>N? T?00B((C85J-&B51BI\\ Q0;;:$B!'E6#!]B142*M6E9&"U>Z4BT>O(@
M0G-!HJCRW<A#^0#40ZZA(K#4/ VVGP5'$K'0S/D4W$[FK^X]1JIBLACK\\'A
M>B]:@::1-&MR@$MV2+QKE2,).6%$D157$0@Z*!)XL3$RZR&T3E:)B8PZ=4Q#
M0?(1Z=]YF+*X2B10*6[)']EG1(PDQ8421%5<1",$'$M9(E6N5(P;:]:@>21-
M&MRQ+F822<LJ)!M"@J\(YB*="(;0@,01#(HY&@:4:2DL/JWIJZ$<RA.@FO;A
M(72WQ#LQ:DE[;%Y9U29:X2KE+2(<S8/NII.+W]TM3+=T GG=2BT0E5:QV%B2
M7ML)U+4%5=@JC33(HEN/1>] ,2&VWA(7T"58!B0VV\)"^@2K!@QMQBBMI9$H
MM&)Z[+V<%TI<PX(EZ-2B@I-DD(N*HTBD1H)#2RGC5T!#L.[;'K$S+7",L%#6
MHY?0@S5NF$9<6"S%:20TM&4;].R1IB1T:P6AT6GJ.Q"]N4QJ25#4*7F8A"(2
ML,=AW3' (8 55(5I)#2T>#T7K4#32)HUN*@EBHE5G<?_ 'J#'LJ10LC\?@<E
MRP+;261+JA/(DI<-8,Y!JU&1;1*""#9/(EE1"55ACD!53,5IM0TM,786PDD*
MA401BD\JI,M<'MNO<$TH)9%D^T2$1J+?@0Q$IW'U;TU=".90G037MPD+I;XA
M#D2G1D![M.Y"22099-*Z0A#9<W'@9$K(5T3;9IJ9"TVT"/[7D1&ZK%$%B7,P
MDFY942,$XURI)4.6K($.1*=T0A=]1<([SWJ,M]FINR%AE6#^"MKI BJJY$BA
MNX.T4]:C/*,QZ80R6+MZ/B>!OD+L/)A\3&DWO"O\"G:S>OCO]?+Y K#Q%KIX
M[_8O8=LNCN_(Y#PO=2[W?U"X:HU!9"_IO)G(?^,VTK-9BDTZ2RP<82T^@.<;
M7]:]H!JZ$W1/8Q.=G<)J"+);P.WH^)XU"LF@5,83)>._U\OD"L/!J!:SMX)%
M#W'N-T7L.V3"'5F>XCTGP)(H'(PO=2[W>B4W&*I!^:OBD!YLD.KSY,E1W?\
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M0I7DCP\E!ZX5 H5;%;!G4,E=C+P0J>!*%+0?R=,@F&BRNZ0DBJ7;"4>F=V*
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M-B-B-B-B-B-B-B-B""/_ -1__]H # ,!  (  P   !
M
M
M
M                                                        #D
M
M
M
M
M!AT           VVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVV
MUR
M
M
M    !W8D          ';;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;
M
M
M        !W;8D          [;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;20
M
M
M            !VVVVD         ';;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;;;;;9"
M
M
M                !TDDDF          [;;;;;;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;;;;;;;;;;920
M
M
M                    !TDDDDF         ';;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;;;;;;;;;;;;;;;;00
M
M
M                        !TDDDDDF         [;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;00
M
M
M                            !P      "        ';;;;;;;;;;;;;;
M;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;20
M
M
M                                !P       "        [;;;;;;;;;
M;;;;;;;;;;;;;;;8T"9;;;;;:/:B<7;;;;;;;;;;;00
M
M
M                                    !H        "       ';;;;;
M;;;;;;;;;;;;;;;;;;;;=8'4W:M:@.;;=;8W8^U2M[;;;;00
M
M
M                                        !)))))))))))@      [
M;;;;1)))))))))))))+/;;;;:!3:@MD2A3S;;K88K71U_P VVVVVTD
M
M
M                                              2222222222228
M    !VVVVT@              [VVVVV3QTW>FD&W],W6R0?&TT<NVVVVVP$
M
M
M                                                  2222222222
M2228     .VVVP(JVVVVVVVVVVVVR ?VVVV7V^N:9Q >_IFZV[75VNFDVVVV
MVV0D
M
M                                                      3_ /\
M_P#_ /\ _P#_ /\ _P#_ &     =MMM2*0            !P'MMMM)7-<TY[
M \]MMULZI[M=-)MMMMMME)
M
M
M           $_P#_ /\ _P#_ /\ _P#_ /\ _P#]     [;;:@<
M    "(#;;;;29X:#27/X7;8C;/?#&X;#;;;;;;; 0
M
M
M                            !/\ _P#_ /\ _P#_ /\ _P#_ /\ _P#T
M    =MMM0                !MMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMD)
M
M
M                                               $_P#_ /\ _P#_
M /\ _P#_ /\ _P#_ /\ T   #MMMA  ))))))))))))( )-MMMMMMMMMMMMM
MMMMMMMMMMMMMMMMMMMME!
M
M
M       !;;;;_P#_ /\ _P#_ /\ _P#6VVV$  ';;;0.C@            #
M;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;00
M
M
M                         "[;;;;;;;;<       [;;;8D7;;;;;;;;;;
M;;<.;;;;;8/;;;;;);;;;9I;;;;;;;;;;;;;;;;00       #R!@      -@
M#\      0                  8 -L
M            !L ?@           /]@                0
M  #\    /<                    7;;;;;;;;;@      ';;;;$BYF_:E[
MV9F[>U[AS;;;;:"[;;;;;_;;;.4Z;;;;;;;;;;;;;;;; 0       #C_ (
M    E "P      >       :         #0 PX          :$     &@
M  "P              "8 (            Z(   @             B
M        "X   %3                     NVVVVVVVVW       .VVVV)%
MUP^P3T'S0VXUW#FVVVVU\&]BEP1^IFV@V$1*P;C.VVVVVVVVVVT$
M ^?B\H_'_<\>%G L\ MS@OWX[A,X?X?X\?28[? ;[_3#\ /:X_E,[@_7#TH[
MMCX#8;#8X8[%  %E"\H#A HK %_'?E!@!A'88?418\[\8,H   XC'X?(6+ L
MX "<(X'#\GE  3! <(3OXXXWL\           @  %222222222X$ $@  !VV
MVVQ(NN'V">@^:&W&NX<VVVVVR,W>F^*_LCVUFVS9P_I@.VVVVVVVVVVT$
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MMV\MW(?T/GOWV )_W%@%R V (1G'*\X7N.P!OF%ANN$P%)"Y EN'/Q!_#P
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MMMMMMMMMMMMMMMMML!    !^  V!YP'P&QQ.'.!PX ')P.&PQW^!PV/PQVL
M ]P&PVV&P I_PY_^.!^..PW^_/P .VP !2&&   /PQP&& X& /\ L-C]\?AM
M><#R?O\ 08_#' ) 'G_;3#G _#G  'C#G;; 8X %X8###83C'X#G@
M  $D@@@MMMMMMMMMO DDD   .VVVV)%UP^P3T'S0VXUW#FVVVVVVVVVVVVVV
MVVVVVVVVVVVVVVVVVVVVVVVVT$
M                 6
M
M       D@D@%MMMMMMMMMX  @   !VVVVQ(NP(T,VQVP,P(VX<VVVVVVVVVV
MVVVVVVVVVVVVVVVVVVVVVVVVVVVVWD
M                     'X
M
M             @  MMMMMMMMMK  D$   .VVVV)%VVVVVVVVVVVVW#FVVVVV
MVVLV!VVVVVVV&VVVQVVVVVVVVVVVVVVVV$@
M
M
M                D@  %MMMMMMMMM8 $D   !VVVVQ(NVVVFVVVV^VVVX<V
MVVVVVVQNRVVVVVVVUQVVTNVVVVVVVVVVVVVVV@@D
M
M
M                    $DD  LDDDDDDDDC  $    .VVVV)%VVV@    %^V
MVW#FVVVVVVV-V6U6SX=*^KRG5EVVVVVVVVVVVVVVV$$D   "P    D
M  D,     ,             ( @                 #X       $
M   _                    _@    )$$'8
M                          DD %VVVVVVVVV8$ $   !VVVVQ(NVVM'DD
MDF$>VVX<VVVVVVVQX'V-!:,OS5TW($NVVVVVVVVVVVVVV$ $@   6    #X
M      ";X    &8            Z $                  "        @
M       &X                   #P    '8@ ^
M                               D@ NVVVVVVVVS   D   .VVVV)%VV
M% FVVV/$VVW#FVVVVVVV(VVBV>75^,NF_P 9=MMMMMMMMMMMMM@ !     BY
M!6 ! !(('P _.P'PVW&]X _'P(!'P)(($T 'Y 6)!!*(/Y  !! O@)X^.P!8
M&P! 9 )(_@! !..(J&<^'Y  W&R _ WY^!.Q( "(*!  T()
M                                     ! !=MMMMMMMMF!))(   =MM
MML2+MM1"22?2?1]MN'-MMMMMML;LM1NAM;]_=,]!+MMMMMMMMMMMMM@)(
M  %Y^)!^]\.]AD .QWGT"7Q!F$Y!VD,@OPU]^P@ (F@!^N/PIL'P"^P&X (N
MPD (!V ()!GV._QT !FL !!&['\ .P(('G@V/P \]%AQ/<(L'GA^
M                                          ( *VVVVVVVVVQ!!(
M #MMMMB1=MB       /MMPYMMMMMMM@]CK>W<9>?AI;O>]MMMMMMMMMMMMA
M)      L!XY&GOAUV!@!N.\^Y^D -PL^.TPT._Y&$!D   L@-TPN!9)T!\!N
M\ !%L$  ^'@!+0&_AUV.A)-^Y/0!N .@ N /QVT/YT '@1"4 %A%@\.RP
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MAB!R ""#3]@
M0 0"I))))))))$" "    [;;;8"QP7;0/*S<+9X7" #;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;;;;;8  0                6S                 $0
M                                     2"
M             3X
M    " " 5))))))))(B 2    ';;;"@;;T/:!Z#[A;43[9C;;;;;;9HT"($!
M;;;&TW;;R;;;;;;;;;;8"2                  00                 0
M0
M                 "0
M         22 "I))))))))$ "2    [;;:!W;: ;0/0?<+:![;8C;;;;;;3]
M8'8S;#O9C-P[9[W;;;;;;;;80"0
M
M
M             "00 5))))))))(@      ';;;4&  <,0 "##@@<<  T;;;;
M;;+:!3;&;0V8_;:>UO<[;;;;;;;8  0
M
M
M                    0"R22222222$       [;;:@
M#;;;;;8S9/'8S8+\2[;1DI[';;;;;;;:" 2
M
M
M                      2 2 6VVVVVVVVTB      ';;;;_P#_ /\ _P#_
M /\ _P#R_P#_ /\ _P#_ +;;;;;&9?;[&;<GRC;5';/8[;;;;;;8"00
M
M
M                                          2 00"VVVVVVVVVD"00
M    [;;;;;;;;;;;;;4[;;;;;;;;;;;9+25S8S2;;^YWP[9[S;;;;;;8"20
M
M
M                                              "0"  6VVVVVVVV
MTB022   ';;;;;;;;;;;;;;;;;;;;;;;;;;;8_29[0ZS;1; [7:#<[;;;;;8
M0 2
M
M                                                       "VVVV
MVVVVV@       [;;;;;;;;;;;;;;;;;;;;;;;;;;;+;;;;;;;;;;;;;;1[;;
M;;;:0 0
M
M                                                         0"
M6VVVVVVVVT 2"0   ';;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;;:  0
M
M
M   0"R22222222 " 2    [;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;80"2
M
M
M         6222222220   "   ';;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;;;;;:0"0
M
M
M          0  "@          ""    [;;;;;;;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;;;;;;;;;:  0
M
M
M                " 5))))))))(  0    ';;;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;;;;;;;;;;;;;80"2
M
M
M                    20"I))))))))   "    [;;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;;;;;;;;;;;;;;;;;80"0
M
M
M                        22 5))))))))( "     %O\ ?_\ _P#_ /\
M_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_
M /\ _P#_ /\ _P#X200
M
M
M             "0"I))))))))   "   "02"222222222222222222222222
M22222222222222222220202
M
M
M                "2  7_\ _P#_ /\ _P#_ ,  22   "2
M                                220
M
M
M                             ""0"_\ _P#_ /\ _P#_ /@ 2     02
M"2222222222222222222222222222222222222222222 02
M
M
M                                         " " 7__ /\ _P#_ /\
M_P  220   9]O_\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_
M /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#^)
M
M
M                                    ! ! +_\ _P#_ /\ _P#_ . (
M(!   %__ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\
M_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ . 0
M
M
M                                   "" 2222222220 00    ;_P#_
M /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\
M_P#_ /\ _P#_ /\ _P#_ /\ _P#_ #)
M
M
M                          )( )))))))))())()   -__P#_ /\ _P#_
M /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\
M_P#_ /\ _P#_ /\ _P#^@0
M
M
M                 0 2222222220 "2"   ;_\ _P#_ /\ _P#_ /\ _P#_
M /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\
M_P#_ /\ _P#S!
M
M
M        ! )))))))))( )     -_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\
M_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_
M /\ S)
M
M                                                           !
M)(!          !(!(  !O_\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_
M /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_  )
M
M
M                                                    )( (
M      )!!(  -_\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_
M /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /Q)
M
M
M                                             )(!"222222220!!
M!!( !O\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ ^_\
M_P#_ /\ _P#_ /\ J26__P#_ /\ _P#_ /\ _P#Q)
M
M
M                               ! (  (222222222 ) )(  -__ /\
M_P#_ /\ _P#_ -4'?_\ _P#_ /\ _P#_ /\ _P#^_P#_ /\ _P#_ /\ _P#T
M%B__ /\ _P#_ /\ _P#_ /\ P)
M
M
M                )(((!"222222221)!()  !O_ /\ _P#_ /\ _P#_ *=;
MK;__ /\ _P#_ /\ _P#_ /\ W_RQ?V'V#_\ \;] ?N^B(O\ _P#_ /\ $D
M
M
M                                                $D@ A)))))))
M)( D@D   W__ /\ _P#_ /\ _P 8OZGW_P#_ /\ _P#_ /\ _P#_ /O_ (?B
MUO\ ^1_^-_CR-_\ I%__ /\ _P#\20
M
M
M                    2  0DDDDDDDDD2022   ;_\ _P#_ /\ _P#^^N^Q
MV4O_ /\ _P#_ /\ _P#_ /\ ?_=ZF/?/P[_&_MD#_?9K_P#_ /\ _P#P)
M        ! !       % !,          ^       !N     !T       'P
M      'P -@          (%     !       !@N%          H^@   ,
M              @              !D$^%            !)( (DDDDDDDDE
M))(    -_P#_ /\ _P#_ /\ Q/PX]_W_ /\ _P#_ /\ _P#_ /\ Z21'^Q[6
MW'_XWZ=_?[[-?_\ _P#_ /\ Q)             QI !      %@) (  !!!(
M/@) () ! (   )  %A !! !(!%!(  !  !!T ( ((!( (( ! ! (! !( ,1
M     (* O  !!)(   'GA!) /@(    ! (( !!(( !T  ! (    ! ()  $Q
M.A()  ! )       !!!$DDDDDDDDH  ((  !O_\ _P#_ /\ _P#5O&6_OB?_
M /\ _P#_ /\ _P#_ /\ @2\+C]<%S_\ &_Q#Z^_LN_\ _P#_ /\ _P 20
M         +0  -]AMX2?=@ @0 "#2?UQ/@:3_/X+$"1=H ;C\N01N-3AL*"^
M0=YCAN !P@"I! ;P4V-03>F )SH/Q\ #\)O[[Q.;@#/-M" ;-M_)SH?"1L
M-P2B =B":O@3KMR'/L 3^ ?X:3\;-YMS>;-K@ 2/@    2"0";;;;;;;;;0
M2"0  #?_ /\ _P#_ /\ ^4F'$F>N_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\
M_P < _\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _ D          C# ?  [
M[ CW8>;&2C_ $&X3:+ [W"?4 7[6T@D 2#X?'?82$78?'P [W"?0  7X?3
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M /\ Y6I(2-Z[_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\
M_P#_ /\ _P#_ /\ _P#_ /\ _P#_ .             !H)#L.,/-A[L22#H
M09C-XYB3,9@#==".4AD!8-#L /AH!=#H=2 #,9O  !?A]< !</Y#\0;MB1<+
M!. /@#<?G<P+C, +A40-LY[Y95P#[L2  !L;-COH=#KL=]/@T>$@!L3 :3,9
M@!O-X9R#M<+B!L    202 3_ /\ _P#_ /\ _P#^@0"2   ;_P#_ /\ _P#_
M /W3WEN-QG__ /\ _P#_ /\ _P#_ /K_ /\ _P#_ /\ _P#_ /\ _M__ /\
M_P#_ /\ _P#_ /\ _P#_ /\ $          @  0(GX!80;BS8 [$@  D T @
MT$@& %FXR $@ '<B'\EDDHR6& PLG8P"[@ RO#>P "\;$$@60_@" P"1@_ &
MP6&"D4&8 4$ @T<ZBD"8  Q$;B 'H!['Z0T&'8["<@ @V  D@@$$@& D07<4
M$GZ@0@#?0  $$@$ G_\ _P#_ /\ _P#_ -       W__ /\ P/\ _P#S/Y0U
M_P!?_P#_ /\ _P#_ /\ _P#Y7_\ _P#_ /M__P#_ /02_P#_ /\ _P#_ /\
M_P#_ /\ _P#_ /P(
M                               %P
M        %@     V          .@                             *0
M ! ! !/_ /\ _P#_ /\ _P#Z      !O_P#_ )^O_P#^D_PK\5O_ /\ _P#_
M /\ _P#_ /\ J?\ EWOYD77O_P#?JY+"91'_ /\ _P#_ /\ _P#_ /@
M
M          $@                                   "0     $
M                                     @  $DD$ G__ /\ _P#_ /\
M_P!       W_ /\ ^1??_P#YQ"RN>_\ _P#_ /\ _P#_ /\ _P#E8\B1#G?;
M1?\ #_\ \=C)#P/_ /\ _P#_ /\ _P#_ ,0
M
M
M                      "  DDDDDDDDF@      ;__ /XJS_\ _P#I]^IO
M_P#_ /\ _M?_ /\ _P#H,\+_ *'-?\G?\?\ ^T65WH7_ /\ _P#_ /\ _P#_
M /\ @@
M
M                                                  @
M   %       W_P#_ ,59_P#_ /\ _P":_P#_ /\ _P#^#;__ /\ _#V6?#4K
MK_\ Y_WO^M4S_P!?[_\ _P#_ /\ _P#_ /\ _@              _
M  "        'X                               #8             X
MX '[8            'X                       'X           'X
M                      DDD@          H      &_P#_ /BKF[__ /\
M_P!T  -L !K*?_\ _I?\[LUQ?+,=_P#J)>46/\VU_P#_ /\ _P#_ /\ _P#_
M /D             '0        %(        3 "
M         @    D         ;   Z             S               W
M       >            6                         $ DD
M%       W_\ _P 5.JU[_P#_ /PDDIXDDQ__ /\ _P#_ /\ _P#M_G__ /+_
M /\ UO\ [_\ _P#O_P#_ /\ _P#_ /\ _P#_ /\ X(     ''/PV/_\ C_@
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M@X  [X[^XW?$@ 3#[$#<DE8&X"X&4"P#[V0_^'2XP\D P'P'X G$Q(5D'
M                 )))))))))H      &__ /\ E+^VVVVVV_\ _P#_ /\
M_P /_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\
M_P#_ /\ _P#_ /\ _P#\B0    +E_!+L =!H .*.-L 4@08"=3!KAL ;B !]
M/,+KA<+J8,#8!_L  14"<?B?A_/L>>/?D#MX";@ 0<P9[KX$B"X"<  -S1_,
M+/BD +A=0#^ 2,#<!( :#8!]YL=]#K\(. 28#X#L #L8P8 3@
M        6VVVVVVVVT      #?\ _P#Q5G__ /\ _P#W?_\ _P#_ /\ X?\
M_P#_ /\ _P#_ ,#]+_\ _P#_ /\ [Z/_ /\ 3_\ _P#_ /\ _P#_ /\ _P#_
M /\ _,DD   &-ST SO)Z#0 6\[T" I @TTTG'<@8 VD%7;_3G7"X7DXX @?G
M8  @6 P&<6?F?8^8>TT0CP#'  @[8SW0_B$ TTS8   2&86\&X 7"^@SCX&?
M"X"O&$ @?CSPCZ'4\B=?DP]P#O)6&Q@7C\                    __ /\
M_P#_ /\ _P#H      &__P#^*L__ /\ _P#^[_\ _P#_ /\ _#__ /\ _P#_
M /\ ^K_Y]O\ K_)=K%];W_\ _P#_ /\ _P#_ /\ _P#_ /\ _(      %'8L
MK#?;X_ #'G?A "X #<HX_8HC #D@!C_??]8K!_'[ #\8/  ?'\(_#$L8//#C
MEWC8X9    $#S![=%E @#<HO  [#X='(,X !XK!G8<;#?A 0_P"( _&*UX0^
M.PY,'PPWY0 WVW/NP&XP                   !;;;;;;;;;0      -_\
M_P#%3MMMMMM5_P#_ /\ _P#_ (?_ /\ _P#_ /\ _P!>TR215[P\*3@6Z_\
M_P#_ /\ _P#_ /\ _P#_ /\ _( D$
M                              @            88              !
M(                      "X           "DC
M               __P#_ /\ _P#_ /\ H      &_P#_ /BII)))))2__P#_
M /\ _P#P_P#_ /\ _P#_ /\ ZNVG_+<??K4TM8-__P#_ /\ _P#_ /\ _P#_
M /\ _(@D@
M          #X           '<
M    ?            ##                                    &VVVV
MVVVVU       W_\ _P 7_P#_ /\ _P#_ '?_ /\ _P#_ /X?_P#_ /\ _P#_
M /U?_/\ DMI7]J: [&__ /\ _P#_ /\ _P#_ /\ _P#\@ 2
M
M
M                                  #;;;;;;;;:@      ;_P#_ .-;
M;;;;;:C;;;;;;7ZO_P#_ /\ _P#_ *O_ (%&BB!Q%'MM[?\ _P#_ /\ _P#_
M /\ _P#_ /R!
M
M
M !MMMMMMMMMP      -__P#\OMMMMMMMMMMMMMM\IW__ /\ _P#_ /R_#2V\
MQ[D^-&*LX_\ _P#_ /\ _P#_ /\ _P#\B"2       -P     -@    ?_@
M               4]@     !M@               !L   -@
M ?\ 8    !             >X            _ 'X    #8
M   #8                    222222222X      &__ /\ _P"G_P#_ /\
M_P#_ /\ _P#_ /\ _P"O_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /?_ /\ _P#_
M /\ _P#_ /\ _P#_ /\ _P#_ /R !(      !:'@    (0    ,\P
M          -R      !AP                \    V        !$   .B
M   %P           *F            !:*;0    ,P                "-
M                   DDDDDDDDEP      -_P#_ /\ \_\ _P#_ /\ _P#_
M /\ _P#_ /\ \_\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_
M /\ _P#_ /\ _P#_ /\ _($         _MS8[8CGX\;7#>>?X[ ':X_A;?8(
M['SX>_\ >1/ 9& WWWF'0RP./P>/_OP^.'O/8^/P P& 1^'/'> !X$6'&(X0
MM*.QYQ.8V/OP G7'/".&V"  WVP(?!R+&&QQF /]P0V!0W. .P( 807W;'P
M               $DDDDDDDDN      !O_\ _P#^=MMMMMMMMMMMMM>__P#_
M /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\
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MP\]^ (P]GF'P %Y+PAV@(G!49.& OFN'^@^ ,^P/_@DT !U0M_)YY+W&/WV
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MX-C)P"<#8-!<-]#H= -@!<9BG-L-B)?,#(!P\,00@!@)#H0#?=Z3C@
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MD          ; 'K Z         '^                     5'P
M                ; &8                        3@0
M
M  X      &__ /\ ]$W_ /\ _P#_ /\ _P#_ /\ _P#X2[__ /\ _P#_ (W0
M_P#QOR/=Y^DU_P!_O_\ _P#_ /\ _($ D           [ :@#8         \
MX                     X8                        ?  _
M                 8X
M                         $DDDDDDDDG       W_ /\ _P#_ /\ _P#_
M /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _CMV[R<W_P!N E\_]XO_ /\
M_P#_ /R))(
M
M
M   ))))))))),      !O_\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_
M /\ _P#_ /\ _P#._P#_ /\ _P#_ /\ _P#_ /\ _P#Y?_\ _P#_ /R)!)
M
M
M                                                   !))))))))
M)@      -_\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\
M_P#]G_\ _P#_ /\ _P#_ /\ _P#_ /\ /_\ _P#_ /R! )
M
M
M                                        ))))))))),      !O\
M_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_
M /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /R))(
M
M
M                                !;;;;;;;;;@      -__ /\ _P#_
M /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\
M_P#_ /\ _P#_ /\ _P#_ /\ _(D$D
M
M
M                        MMMMMMMMMP      &_\ _P#_ /\ _P#_ /\
M_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_
M /\ _P#_ /\ _P#\@0"0
M
M
M               ?_P#_ /\ _P#_ /\ X      #?_\ _P#_ /\ _P#_ /\
M_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_
M /\ _P#_ /\ _(DD@
M
M
M             _\ _P#_ /\ _P#_ /P      &__ /\ _P#_ /\ _P#_ /\
M_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_
M /\ _P#_ /R)!)
M
M
M           VVVVVVVVV@      -_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\
M_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#^
MP0"0
M
M
M!)))))))))       0222222222222222222222222222222222222222222
M222200 0
M
M
M     )))))))))(       " 0
M        0"00
M
M
M         !)))))))))       220
M             200
M
M
M              )))))))))(       2"
M                 2 0
M
M
M                  #_ /\ _P#_ /\ _P#]       9+;;;;;;;;;;;;;;;
M;;;;;;;;;;;;;;;;;;;;;;;;;;;;;92
M
M
M                               -MMMMMMMMH      !MMMMMMMMMMMM
MMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMLR
M
M
M                                   #_P#_ /\ _P#_ /\ ]
M5MMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMLB0
M
M
M                                                ?_\ _P#_ /\
M_P#^@      *VVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVR
M)
M
M                                                           "
M222222224      !6VVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVV
MVVVVS)
M
M
M    222222222@      *VVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVV
MVVVVVVVVVS!
M
M
M        "222222224      !6VVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVV
MVVVVVVVVVVVVVVS!
M
M
M             222222222@      *VVVVVVVVVVVVVVVVVVVVVVVVVVVVVV
MVVVVVVVVVVVVVVVVVVVS!
M
M
M                 $DDDDDDDDL      !6VVVVVVVVVVVVVVVVVVVVVVVVV
MVVVWBVVVVVVV[.VVVVWVVVVVS!
M
M
M                     !MMMMMMMMM@      *VVVVVVVVRWRVVVVVVVVVV
MVVVVVVVVV6VVVVVV^U6VVVV2VVVVVS!
M
M
M                          -MMMMMMMML      !6VVVVVVW3  JVVVVV
MVVVVVVVVVVVVVS#HY<M.-U-PDZ%"TVVVVVS!
M
M
M                              !MMMMMMMMM@      *VVVVVVW[,W0B
MVVVVVVVVVVVVVVVVVV6Q&57[1[_OZP*<8VVVVVVS!            )(
M   ( (      !            (          (      !   (        !!
M          )   (                       !
M              (                    $DDDDDDDDL      !6VVVVVV[
M$6^<BVVVVVVVVVVVVVVVVVR^WZWE][7]9R4Z:&VVVVVVS!           !&.
M.      (  L      /P !(       !^         !F         /0
M!TH            L )0N                       (        !(
M   !1     !(      !T                    222222223@      *VVV
MVVVW4R1^0VVVVVVVVVVVVVVVVVV6V_S_ $MV_P"]<P=-C;;;;;;;,$
M       _NX\X['?X<F'C 8X $#$XX\:88G 88B8':?   #$XR;#8_GG  XX0
MXC$\8  XB??['< X;#'G \& 'G0C \XXC\X[_C8'X&>8C3# 8'8 <8<8'G '
M$_'@ 9; XC<_8<8$8;$?' #8?#B<XCC  <'$[#'        )))))))))P
M   %;;;;MMM8.P1H]MI+;;;;;;;;;;;;;<I;_;DZO(*,KAS'Q;;;;;;;;,$
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M4 =<"/B: !  /]H ;I ?@=@/#E#%Y@ ' +O#L0 ><?\ 0$R _ $>H@. '
M    !)))))))).       K;;;&MMKAI]I!MMZ[;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;;;;;;,$            :'\W''#W<6>B6@: "_P>Z?K8^#RTB7
M'8N;G; &\3S"P<8$D4 C=/86$ W #42W>!#; F$@>"6@^ 'T7'38&7#P[TX(
M?@ '>;];"X ;$$G?')%'8 3%=3 \8G86"[R')6 7^V#0 X?8Z F=\ #X2$ @
M$@       MMMMMMMMMP      %;;;=&VV4&VV@FVPC;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;;;;;;;;;;;LD        '0  @?!@I $;$  ?!#8 9A %X? $(
M ;@#(  L@#8 W$!@(#G#\@@?@;;'_; @ Q$L @%D ?$$B\[  H [A(!_EA ?
M%^G? ;  L@#X , @ @;D BX@; $$$_ '??;'_ H BX@!(GX; 'S$$H$'\  [
M%'@#8@       &VVVVVVVVT       K;;;*FVVVVVVVVVC;;;;;;;;;L T;;
M:;;;;);:;M4;;:C3;;;;;;;;;;H$
M                &8    &
M      S  XX                         Z
M                  VVVVVVVVV@      %;;;;D;;;;;;;;;.;;;;;;;;;=
M;9+A+-I8-?9K[6=K_-M??O<)[;;;;;;L$
M                     =    CX
M          #H #(                         '8
M                      &VVVVVVVVU       K;;;<C]+=]9K;K9S;;;;;
M;;;;K)A&(Q.:?7YJB:(9@"+,6>?Y;3;;;;;;LD
M
M
M                           222222222H      %;;;;D9A;H+H[NC.;
M;;;;;;;;=M;9YA):5<?;/31%#]5H:-:/;I;;;;;;;H$
M
M
M                               "222222225       K;;;<C[+?I=[
M;=9S;;;;;;;;;K:"-K![1P3_ &VFB*,=K0T:U/&2VVVVVVV[!
M           Z      'X                    !6     .P    'P  L(
M       '0              (  !R '3^0    !V               '[P!V
M                 ^ %P                $DDDDDDDDJ      !6VVVY&
MVVVVVVVVSE)))(.6VVW6W=7SSVB[O_TDT1 1U8,E9GXR6VVVVVVV[)
M               .P      Q                     '@    !V    !$
M &1         L              !   %P _F^D  !L.P              !T
M_H.P                 'P L                 2222222230      *V
MVVW(^RWZ7>V^6=MMMM@"VVVPVW:J&JZQ2!RW746NKJUZQ\XV.VVVVVVVVZ!
M    KPW .Q!_(:!)1"#0!(&]0  >Y!/Q !!( !'P09J*!!)XXV\ .Q8_*GQ
M9((@ !: !,P)F)(^WGQ0!.P8 #!0_ !)R/Y N  ,Y!@W'WQ))"'P( 'Q 0")
M(0^.@%X W*! _P!@P 23^0-R 0"2?=L0P!L0            DDDDDDDDF@
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M'!WT-UPOV/P!^&>!^N%P!UND'H WT&G^, *_H.Y!TT,GC!2(!FV.@
M   );;;;;;;;;0      *VVVW(_*WZ60WR6<VJV8;"VVVVVVVVVWO_&VVVW5
M!/VVVVVVVVVVVVVVVVVZ))    L AX51)ITP( 'WUQGT'I@T /A '/+F$A"
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M&& !FX'P &' /./(PW^V&_&./VVQ^P-P .&!^@V/PY'^'_PYPV/PPP   /.
MU$&)VT@$  WAUP          (VVVVVVVVW0      *VVVW(_^V;7?6VV<W6W
M3["VVVVVVVVVVXVQB6%#GK>26LVVVVVVVVVVVVVZ(()
M      ,X(                           $_<
M                                 ,X(
M     $@        &7^          !$DDDDDDDDJ      !6VVVY&VVVVVVVV
MSF\V_K86VVVVVVVVVQ!7;Q:X$]8T^S6VVVVVVVVVVVVZ(!(
M           &.                             &
M                                      .$
M                    &             DDDDDDDDD0      *VVVW(V_VV
MVVWVV<VBV8;"VVVVVVVVVVXVP#;6VGK&F\6VVVVVVVVVVVVZ(!
M
M
M                                     !$DDDDDDDDB      !6VVVY
M&WP    $VSF[6SW86VVVVVVVVVW&RW0>^4]9V3&VVVVVVVVVVVVZ( (
M
M
M                                          )MMMMMMMML0      *
MVVVW(VRXK!:*6V<V222["VVVVVVVVVWZVYE'E.^:\8^VVVVVVVVVVVVZ(!(
M                    &P  #8
M
M                                              !)))))))))"
M   !6VVVY#;;,T&X;;;GXDEO86VVVVVVVVVVVVVVVVVVVV$6VVVVVVVVVVVZ
M(!           !T    N  !!NT   TF
M
M                                                   );;;;;;;;
M:0      *VVVW$DDAF@W$DE@S12*;"VVVVVVVVVVVVVVVVVVVVX*VVVVVVVV
MVVVZ( (       OT)(.X^^ $Q((()G^0!&UA !1X@
M
M                                                       !+;;;
M;;;;;2      !6VVVXI))LT&X)))&R"0W86VVVVVVVVVVVVVVVVVVVVVVVVV
MVVVVVVVZ(!(       %7YQG^.B1TA6O!!NU:$@UO^/$G^
M
M
M);;;;;;;;:0      *VVVW VVYF@W*VV<V02&["VVVVVVVVVVVVO;F^6_P#M
M-MMMMMMMMMMMNB 0        )!\"#X==SY8#."#=KL)!K=\!,@0
M
M
M      1MMMMMMMML@      5MMMU)))9(9:9)(0*" 9"!MMMMMMMMMMML1F\
MWD]+[5MMMMMMMMMMNB "        !87L-]#I\=+ACP0;M9#</;_C^D"
M
M
M          "-MMMMMMMMD      "MMML))))))))))))))))*%MMMMMMMMMM
MM5LWMMGMMGMMMMMMMMMMNB 2         + 9L]H?;CI9L""!/^"1AI?A\6@0
M9
M
M               1MMMMMMMML@      5MMMB$DDDDDDDDDDDDDDGHMMMMMM
MMMMMMVMFGNTG]-IMMMMMMMMMNP2             0    0"      " 002
M2
M
M                   "-MMMMMMMMD      "MMML3__ /\ _P#GD_\ _P#_
M /\ _P#_ &%MMMMMMMMMMO\ ;-)'9-O8+;;;;;;;;;L@D
M
M
M                                     $VVVVVVVVV(      %;;;<
M     Q*=@       K;;;;;;;;;;?;9O:'/;;I;;;;;;;;;L$
M
M
M                                          FVVVVVVVVQ       K
M;;;;;;;;;=])-;;;;;;;?;;;;;;;;;;;I;)K9-[;9;;;;;;;;;L$@
M
M
M                                              $DDDDDDDDD(
M   %;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;=;;;;?;;P;;;;;;;;L@D
M
M
M                                                   DDDDDDDDD
MA       K;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;2;;;;;;;;L$
M
M
M                                                       $DDDD
MDDDDD8      %;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
M;;L$@
M
M
M@        #       K;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;L@D
M
M
M    $)))))))))8      %;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;L$
M
M
M         C;;;;;;;;;       K;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;;;;L$@
M
M
M             $;;;;;;;;;8      %;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;;;;;;;;L@D
M
M
M                  C;;;;;;;;;       +;;;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;;;;;;;;;;;;HD
M
M
M                      $__P#_ /\ _P#_ /\ 8       6VVVVVVVVVVV
MVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVTD @
M
M
M                                   G_P#_ /\ _P#_ /\ Z
M$                                              $D@
M
M
M                                               $_P#_ /\ _P#_
M /\ _0      $  DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD@
M D
M
M
MEMMMMMMMMJ       $D DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD
MDDD@$D
M
M
M    $)))))))))P      $R6VVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVV
MVVVVVVVVL
M
M
M         @        &       ])))))))))))))))))))))))))))))))))
M))))))))))))-($
M
M
M             $         P      'MMMMMMMMMMMMMMMMMMMMMMMMMMMMM
MMMMMMMMMMMMMMMMMMMH$                 #D'       ; "0
M            #8                #C  [  [                  'X
M             &     'X  _                   "0     !    'X ;[
M_     '8          @        &       ]MMMMMMMMMMMMMMMMMMMMMMMM
MMMMMMMMMMMMMMMMMMMMMMMMH$                 \ ^      $( 9
M                 S         $       0G GX "X
M A               #0    @=  #P                   9      7
MZ $.=HI  "P-          $DDDDDDDDDP      'MMMMMMMMMMMMMMMMMMMM
MMMMMMMMMMMMMMMMMMMMMMMMMMMMM($                'X'W$[';8 _%!(
M_7''8 #E'XX\ LH/!'&]GFC_ !W^*X1WF(^ WXV !!V,_P  !<$;RBL/_P#H
M''_Y"P !#[8C##_W   <H?![\[?!'X\-#/<H> #>X(; H;G   7#???%!( <
M%^_"TH['GL<_S9\ \_&_\ ;[#      DDDDDDDDDF       ]MMMMMMMMMMM
MMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMM,@                X@G<C
M/"$'[T;V?_'_ (  T(@/QA*.QMJ$/@%\/GQ__I) "1.'"/Q   .PDN  A(^A
M.\.FWP//OT'0XE@'D)Z&:\  &A%F%^FI&H,J/F-Q%&\ G:11D-&)_  !E$_?
MO&]@ S/N:&FQU ^!N]GG#T(O\,_Q(@^     !/\ _P#_ /\ _P#_ /\
M   >VVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVTR0
M          =R>-#8!*#]Y,+=R'[O@#H20#+,+"$09IA>=YA=.0_,9K]B#OMV
M0( #!P!-.=<9B!]X=-  =#KH.A(!OO+ *X!8  ="#,+[_AI\ [@ ;O;MX!<"
M#SX #2=@ ",/=#I,+ !H?R?9!IL/=CI[/,4CAM09O[62%@    "?_P#_ /\
M_P#_ /\ X      #VVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVV
MVVVVVTR               #\ !X?@-^(/-CI@ <?D -CX@-YA(0P!]<8"?,+
M: #YC.-SP;2> 2@!*" ?PQKC,0/MAIX #H=? D5R>IY8!' /  !L=[C\1^-/
M@3<"#1_[O ;@>'AB"$ ,  ,3;H=-CH /!P"=<=.!;L/O9YBGQ9J#-&/X"<
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MVVVVVVVVVVVVVVVVVVVVVVVVVVVVT@0
M            #,
M       1\"4                              2
M                        "$DDDDDDDDX      #VVVVVVVVVVVVVVVVVV
MVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVTB0
M                 -@
M           !AX
M                             0        #       >VVVVVVVVVVVVV
MVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVV@0
M
M
M                                 "         8      #VVVVVVVVV
MVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVT@0
M
M
M                                      3;;;;;;;;;       >VVVW
MF3^VVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVTB0
M           ?@        \          #_D     ?@             3
M                    "0    "0            " "0         2
M    (@             "0                     ";;;;;;;;;8      #
MVVVVG$XFVVVVVVTWDVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVV@0
M                         /@          -      !H       9@    "
M           0            +-     ?             4 0         !<
M       #?<  !X          =                      3;;;;;;;;;
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MVVVVVVVVTP0         %X/@0-"#\*@ -@"#^ #Y(#]< 6@+@!MJG<"#,9M
M=@ ?A!C,+ !( 0!,P-DI" " " /P 3L0?#H ;#Y[N?\ 8 ^'5 >:'8ZW F8!
MH "7#X%K"PW "XS^&W<?2'>^X$';W<K U$(@$2 2  $^: HD
M  C;;;;;;;;>       ]MML0-Y6UMMMMLX'/_)MMMI-$IMMIRM-M_-MH5-MM
MI])MM+]MYMMMMMMHD         _<_8;: &X7;$P \X@ 'VP&2X IHES'[5,,
M'^8S:?'8 0SC&86@#X @"?8;"#$ _ 'XV@'_ &+>AT &P\\2,OQ)\.@ T\'Q
MTD!U0)0 $N/P:F%AN %QFV&Z9NN']]P^&WK8N \"1 (/!T ( DT-A6
M       !"222222228      ![;:>3:$+S:6S;8B5WH?;;;6L73/(CE/?*U[
M;?*;938PY(1*P++K;;;;;2)         GP,V?\!T O-X,W!&\ /@GT%P!3&@
M&N]Z1NZ\QGNV_  &WN,PM(/P! $TY^'* (N )&@!%R)!T.@ 0'FH !9$VA]W
M/WA_'QF\-Q:  DQ_!-PL-P!N$R(  !$POO)$XV\/&P!($X !,D@.W/\ X"2
M             "$DDDDDDDDP      #VVVX6\E?NVOF.KLVVLFVVVT[^MRQ'
M)IM;UVVWDVBFNY+PC6/*C6VVVVVT@0          "         "0      2
M  "D0 2 "  0    0"0        2     "00  ""  "0 00""
M00   "" "T-@0 "0     "0        ""  0+R  "" 0 "  "00      " 0
M   0              2VVVVVVVVV       >VVE:UIFWK&*EOU&VCJVVVTZE
MDKV(Y'@:VNVVRFT6TV\;D"CR7ZVVVVVVVB0
M       6@
M             'B4                        !0
M                      "2222222220      #VVTHC&5^D@T=$&8C (VV
MVVT;BF%1'+3SU_6VVK4EJFB^L@4=OO6VVVVVVTB0
M
M
M                           2222222222       >VVE#!UX?$L;5<W&
MVRVVVVV\9T4CD#4A6G"V^V\S046L"B*U'B*VVVVVVVT@0
M
M
M                               "222222222       #VVTO'R4HTNM
M%Y7YV]>VVVVVVVVVVVVVVVVVVVVVVVVVVVVVV\:VVVVVVVVVB0
M                   00
M
M                                    3;;;;;;;;8       >VVVWBW
M>WD1V_5ME3DFVVVVVVVVVVVVVVVVVVVVVVVVVVVVVUFVVVVVVVVVU@0
M               #8      #>                         9" (
M          )  !X
M                                        ")))))))))       #VV
MVTHDM6K^VVBFLVUMVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVW*
M    "!AQ@ <#AB 0#R 220-@2> !"0 :,2/C\ "#@0,"?@#P"0"!S   0111
M@>0!@"#@ #AB ("2#\20 01R "
M                                             1))))))))(
M  >VVU\&1/"T.VQ'*VVF]6VVB22VVVVH>'-\6VVVVVZ5B&SVJJ2?6VVVVVVV
MW8"0     -TB,=]X(./C\>2)SOMWJ=D@&%?\!C-MSP#\--MX 2#5MO#K>"@+
M""*C?CR1%T!E@ (.-0 9]][KH.BB.C\
M                                                 ")))))))))
M      #VVTMVVWZ?WH.(\VVIX4VVT#]6VVVU"-SVJVVVVVU2CO5"TT_\\6VV
MVVVVU*2"     !\?1-\-MA]\=^1-,9]CK\9$ 0)CL99#8;@6<-J ML0T#MX=
M,,0!801+AOR)\, ,( -A]\ #/L===!T-#M(
M                                                      9)))))
M)))(       >VVQ6VUQ]\IE<^6VOSBVVV@6VYO+4SQ^/#K,W=FU6]FZF:F^V
MW"VVVVVVUH""0     -!\ ]@#8-AU"< KC/H=/@4@"!<-BW,+#< =Q+@#P";
M ;O!J/X +""* ;S@']]M] #8-O  9]#KKH6B ?O@
M                                                          #-
MMMMMMMMM@      #VVT\VUU&B,_UJ>VVUT\VVT3_ *EYOJ C[=%9H4_=JMF;
M5,1-/YMMMMMMMM>  D      :#8@2#W8_###8@7&?0ZC8I $"X?#>86&X (V
MTC0@$WX3_"0 _ 6$$4 W;$$@4'X('8_>  SZ'76D6$ %%#P
M
M    &MMMMMMMMM       'MM+5MI@!\RV%3=MMMMYMMH%MB<.UN$?;HHOX[H
MM;K-]II!OMMMMMMMMM>@ $@     $@[GX@_;CX!H?CX  D  @^    '<_  @
M   @@$   DH %X [#8%@ WF$C\?LD$ @ ;CX  $D@DZ A0  _ D
M
M         UMMMMMMMMH       ]MI<MMI;O9-M+NMMMM/-MM MJE-YH8C[Y%
MMNKM]HUY-=-JE]MM-MMMMM:$D$@                         D @
M                                              #8    @@
M
M             &MMMMMMMMM(      'MM+EMMMS, -I;--MMMYMMHMM@JHS\
M(CA9$S=;IM#HWLLMCNMMTMMMMM>  $
M
M
M                  UMMMMMMMMI       ]MI<MMMM)WRMO,/MMMO-MMMMM
MMMMMMMMMMMMMMMMXMMMMMMMMNEMMMM>@ $@
M
M
M                      &MMMMMMMMM(      'MM/EMMMHC;UF@==MMKYM
MMMMMMMMMMMMMMMMMMMMHEMMMMMMMM-MMMM>$$$@
M
M
M                           UMMMMMMMMI       ]MIL   _4 2H$3,O
M_P#T+;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;7@)!
M
M
M                                !K;;;;;;;;2      ![;;_\ _P#Y
MZHH]L19B@ $1MMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMM>D@$@        '
M_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_
M /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\
M_P#_ /\ _P#_ /\ _P#^@        .VVVVVVVVVVVVVVVVVVVVVVVVVVVVVV
MVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVV        -;;;;;;;;:0
M      /;;;;;;7U;;;;:R+;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;7
MI )(         0
M                        ,        !4DDDDDDDDDDDDDDDDDDDDDDDDD
MDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEP       !K;;;;;
M;;;2      ![;;;;;:_K;;;;:Q;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
M;;;7@)!(         "
M                            !@        *DDDDDDDDDDDDDDDDDDDDD
MDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDN        -;
M;;;;;;;:0      /;;;;;;7VVVVVW0+;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;;6H !(          0
M                                 ,        !4DDDDDDDDDDDDDDDD
MDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEP
M  !+;;;;;;;;2      ![;;;;;;=)))))(G;;;;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;6@             "
M                                     !@        *DDDDDDDDDDDD
MDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDN
M       );;;;;;;;:0      /;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;;;;;7@ !            0
M                                          ,        !4DDDDDDD
MDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD
MDDEP       !+;;;;;;;;2      ![;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;;;;;;;;;7H !(           "                  !
M          $                    L              !@        *DDD
MDE'6M4DDDDDLDD"2>DDDDDDDDDDL234DDDDDDDDD5EFDDDDDDDE.DDO:DDDD
MDDDDDDDN        );;;;;;;;:0      /;;;;;;;;;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;;;;;;;;;;;;;7A               0      *           )
M3J@          !410    )P   !LL  +@ $39              ,
M!4DDDE$^DLDDDDDD>DL2#4DDDDDDDDDE"X>DDDDDDDDE*LI4DDDDDDDC4E,V
M.DDDDDDDDDDEP       !"222222222      ![;;;;;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;;;;;;;;;;;;;;;;;7H(!             "      !0  !H$,@
M,@@  8  D(ADM,@   $!),(@% ]AM %L@A,I< )R N,@)D(H       !@
M     *DDDDK4B4ST@W\3TDDD@DFZH[?S2VDDDD$IZ6S4:6L35PJ&@W]_2E64
M:EITI4V3B2#6DDDDN        (2222222220      /;;;;;;;;;;;;;;;;;
M;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;7I)!(             0      *  !
M# E?1'X  # $6^X^S8^@  *0 /!P#V]/,XD&TD"W+@ L (%.7Q7SP
M,        !4DDDD("4@7H*-DV^DDD$LH1E0FE^DDDD@D!1H%E5%R) A8(*-%
M]$OHC4L$DE%(,G?4NDDDEP       !"222222222      ![;;;;;;;;;;;;
M;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;7A!               "
M!0 *@(UPK.% E 8!E$&@+&@0     !X.'BE0/ -.(DM\E< (  !(D/@])V
M    !@        *DDDDEB94E!&E,DOYRD@E5Z-ELA%(DDDD$@$A^MDLN"8%E
M!&E)%D@;F:DDDDE/5DE/S4DDDN        (2222222220      /;;;;;;;;
M;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;7H(                0
M     * !P!(B,408+6# ,ORX Q0"   &P)_!P%]:)@(/1$DK>K@!0 -0/QP%
M/_@      ,        !4DDDD6D<LH DALE_CTD$OW[DMD(I$DDD@D L#%DEE
M4] LH DA LH&:S4M.EH,0MDLW6DDDEP       !&VVVVVVVVR      ![;;;
M;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;7I)((
M  "      !0 )U'T1BM%   8 , G &* 0)   )D4(!@40#1F (DM@U< !V,:
M* . 1!8      !@        *DDDDM/95E!M?-DFTDD@EISLELA%(JDDD$@$H
MW,DLM1H$3!M?(%E(RN:DAG1]']LD_0TDDDN        (VVVVVVVVV0
M/;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;6A!!(
M       0      )[:4^P&$9OP  '0)/[< 04"Q^ !B>)W>!^QY/[ >Z'O:9@
M $R.$RQ> F^       ,        !4DDDDHS5JITGUJENDDITD'T*D4&MUDDD
MJE&M>6FDT.2BH<TGTBDU&8YTDLS5CR]4D>4DDDEP       !&VVVVVVVVR
M    !7VVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVX@( (
M           "              !F(0            !
M                      !@        *DDDDDDDDDDDDDDDDDDDDDDDDDDD
MDNDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDN        (VVVVVVV
MVV0      ()                                            !!)!(
M                0
M                           ,        !4DDDDDDDDDDDDDDDDDDDDDD
MDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEP       !&VV
MVVVVVVR       ( ))))))))))))))))))))))))))))))))))))))))))))
M)))                 "
M                               !@        *DDDDDDDDDDDDDDDDDD
MDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDN
M (VVVVVVVVV0      ()(
M    ! !(                 0
M                                    ,        !4DDDDDDDDDDDDD
MDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEP
M     !&VVVVVVVVR       ( )))))))))))))))))))))))))))))))))))
M)))))))))()                  "VVVVVVVVVVVVVVVVVVVVVVVVVVVVVV
MVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVV         ,222222222
M222222222222222222222222222222222222222222222222222222222222
M24        (VVVVVVVVV0
M
M
M
M              !&VVVVVVVVR
M
M
M
M                   (VVVVVVVVV0
M
M
M     )((                                               !\
M                       !&VVVVVVVVR
M                                                !?         ^
M     !0,        !  )(&Q    ,      !@       *!@     A>
M          _!                 !>                !           !
M90                          (VVVVVVVVV0
M                                                    !$Q%Q(
M ! '@) (( +<Q ! !(  !/QPR1EG  )%@)    !\!  (  !!;F(  ((-@
M              &@%PXP!PQQPYP'& YQP&-'GF !XQ^!!.P._P""?_QSL,)!
MCC@#\!QAC@., !M,<                 1MMMMMMMML@
M                                                          #\
M :. !L!?WMS/H-0 "9C V-4QL #3CL!2 /@ @?-QI\-@#X2-_P <8\($S&
M  J\                 #PD;C"4O-[ZL<0$BL<[$ZK#L $4C6 @G8&SF ;@
MG(88G='?2"0'#X4@XXI"2G                  C;;;;;;;;9
M
M    'P(#;#8C\$">V D3  IW&_87MX   7#P#& > '8>["2?; 'WX;['SX %
M.XW 'X?V                  ?<@8@E0'_X<@[K <@_X:2"/  ?#ZP$$@ W
M @_$&XQR SJ_#9( >2H;;'](2T8                 $;;;;;;;;;(
M
M         ?'D30?DD@#SV<DBX %.86+G=($  "X[ X@'6$V'S\>'\  ^!D'0
MZ[ PIS"P 1"6P                 #0>#  . Z[ 8'#<@8'Z#20[=X#0 6"
M O &P"D @@$&'[_W8;7 #UH'Z8$I&2;?                 C;;;;;;;;9
M
M             $# 2>&PT"#"^T@?7  IS"V0_I @  7#3[  $ #8>?#0@  '
MW8DZ'60V%.86 'X?V                  : S0Y*T\_8? V02? W0:T'>8
M:BQ[6%8 TX(@$$ @P^!([ ;  >  G:#<G*D4'8               $;;;;;;
M;;;(
M                  %X#<P D"G'2D     'PPF$$EH   $P$@  B  [BTDE
M _  &(C:02$@(^&$P O#>                  $ $=$71X(@'\[;!G\[E$
MDL@  @_ A@I &G?$ *;$!H@[$ 'X   [ &,L,_!D@D                C;
M;;;;;;;9
M
M     78         2                                "P
M                 S            "'
M  $;;;;;;;;;(
M
M         I         ;BH                                $
M                     #H            !
M       C;;;;;;;;9
M
M
M
M           $;;;;;;;;;(
M
M
M
M                C;;;;;;;;9
M
M   _"   _             '8
M  ['XK                       #H    ? '-;H     @
M                    $;;;;;;;;;(
M                                               "0
M  &0   "SX  &8            'K              W
M      'DB"X          T            S    "X [S?V   W$
M                         C;;;;;;;;9
M                                                 '8[ _@?X#X
M<8 #_'?X'C \>6'\XS #?88_Z?;[  'A;C8SG?  <X#C ^ZX XX[<X
M           @ I7%F<;D$D $CZ\;G\ D   G\'>GE $@3$$F8#X;AN8 [  D
M; #\ @   ?@                  $;;;;;;;;;(
M                                                      <Z$GSB
M^Y8 8S%(2?B?F(''@U(?X>8';"T :_C_ *  &)@[0AU,!(Y$8QDV%P _$MZ@
M                !'VPE-_@VY) !6(%HL-^PV  %@]&\&L^VPNIL\\WH)%M
MY PX$AN ).,X2'@!I                  (2222222220
M
M^V'A@P&^P D *0EFP(GQ(V-J1%F\P&P ."UPQ).  'NP'B!-@)^_'))6!N!^
M!R@                   &UTQFT,G@(  NVD/X]7T   N,X_N+0Q )!OGGG
MT'QWN(D VF%P-  ') !E)^                 !"222222222
M
M     V(],U0W( &Q_2,@_!$^*6@M3VW/F T!%5&N, )P  ]V V ,,%@N7X!(
MP-P-@%,!                 )8!FN,WQD\! !^ZD@I%AXP  %P\&\Q:JXA
M&\\\^@..]Q+ /UPN!>!R/F!"8'P                 )_\ _P#_ /\ _P#_
M .0
M                 T)'!IL!2  UN &UV^(/!N*%J<(7\P..(LAUPX_.V 'B
MG6X'('$.TX^!GPN!CYE@(                 .QSUQF''G@+P'V5<V.T/@
M  N)Q/F+8Y[X^/GGFNPV^IX.'&N%P!QV#/ (/$                  !+;;
M;;;;;;2
M                     'Q18^*^.P /Q1P_?-Q #.!0*N#/V^ 'FWW'R W.
M.P!R/.P^&+" 0^'&PWX0 0V>!                  .& V&PYP^ V '& ^Q
M\P !^ &P/./P$''^$&/VVQ^X_P -P#QC\?@ ><.-LD!QC\
M  "6VVVVVVVVD
M                                 #S@
M
M       5X#L                                      =@
M       2VVVVVVVVT@
M                                      -@
M
M           !\
M           "6VVVVVVVVD
M
M
M
M                2VVVVVVVVT@
M
M
M
M                    "6VVVVVVVVD
M                                                      0  D0
M                P %22    2@         !D        -@
M      #2              8       #\         !/B     #       ) #
M   #\                    2VVVVVVVVT@
M                                                          !\
M ;                  9@!]YX   #H          4        #X
M          "/ 2       0"" ";  00"0  ="""""" """#X0 0""  "0 "2
M #J 2 "0(P                   "6VVVVVVVVD
M                                                      2#L2 2
M2 #^"3( -@ B2 !L /A^ (OAO-IB//?S]V- "" 4  0H 3^" """00 OP20
M               #VL""=KH+ "6R"-QX 40#^= !\-3/=YR2 ;I5R#?P9A_=
M>?=B  =QC<#@"3@@                  2VVVVVVVVT@
M                                                          #\
M=L ".=O)[(=B#,9@!( 9C-L/[!_H$XRB!Y[\/MAH -Y+L0-COCJ]H4#K<4 !
MY".<                /?@1(?\ 028_;X[[#P ['?8^ '03#X3W"?C_ ,VA
M(0/TPWNF'WPL .PUO^/P0&@                  );;;;;;;;:0
M
M     !V'FAL WW^]N&Q!F,P!T ,QFB$LQGW/]S! \]W/FQD  _&Y/FAVV%4
M'Y'A'P ]L V                'D@AN .@DVV6Y!L-@ D.^AT .@N!)WF,^
M_P YM"/@)+A?=<+M!L =!K=H"!<= 8                 2VVVVVVVVT@
M
M           #L-O!L" $=[L2"#,9@#H 9C/L?YC-^9YMB!YY\/MCH 6^,@/M
M 6P)$!M@,." !YL"                 /-A;(=M!H )=@!L/ !L=]#H /!>
MF!?,9R#_ #>$KX77"^ZX7>&X Z#6^$ "XZ                   EMMMMMM
MMMI
M                 '\X>#;N [#W[P$&8S&'0 S&<\$S&8@8S[D#SP<\LG0
M=WZO[: ? 71\P=V;* '[;N                 &_@  D_F187_DN 6 '8_2
M&0 $  ##0P",'84  $ "@400& D2 "0TP #X_"                   $MM
MMMMMMMM(
M                      Z#$ $' $ @ # @$ #HW  @ #C$ @''  @ DD##
M T   8 #$ @$@$ Z @8 G   \'
M                              D'8    $ I
M  EMMMMMMMMI
M                          #0               W18
M
M                                  '<_     $ (
M      $MMMMMMMMM(
M
M
M
M           EMMMMMMMMI
M
M
M
M               $MMMMMMMMM(
M
M
M         _           #8         #8      ;        _
M                    G_\ _P#_ /\ _P#_ +
M                                                    #0
M            &PP          S           #8$@          &_P
M                      !(D        !            %P     !F  !2
M   N                             !/_ /\ _P#_ /\ _P#V
M
M      .@IQ !! )P(V %. !Q ))'A   )'P), & (&!& !APP  &P(@&X)Q&
M@()!&P'@!(                  T.)PP@ ' )PL !PQ&..._&&/)PQ_&P H
M& YF&^\P^!QAXP $)P/&._XW!QP                   )__P#_ /\ _P#_
M /[
M                 '4 8_0=-@<0  "'??>S"^<W; @&SZYE];W;;U/ZKNX8
M  #8"6B$$=?+;Y0H&;T _                 "??+BM@%+$D8; &GA<D;CW
M8;F@#X;X0 1X<<'[86># Y>@G "D'T$Z_A<\\C                   $__
M /\ _P#_ /\ _P#8
M                              Z; F_'[^@R8 #XF?#>87S4'8@ W'_<
MF#6[4!5 @:<8P  ; @V @[2&;X_'8S>?[                  &SN; 4 I>
M>#_X ;#V@N>&$$'W"?0C\ "8V#!38 V/  I["P 3'?867&X38G
M          G_ /\ _P#_ /\ _P#[
M                                          '6P2$0;[X!7   CW8
MS&^:@ ? &P$_R0:W7  ($#0?   #8 &0$$&03?YX$&;Q.8
M   !'^U(>@%+SP<X ! ZX4SPRP$^8SZ$?0 7&0?*: FV8 %+82 "XS;"2X7"
M? #                   $__P#_ /\ _P#_ /\ 8
M                                                       Z["P]
M<@; BX '8:2#W8?S2 @8 RDF0?#6^D:! @:D'^8 ;  R @@R";X0 @S>&P
M                TD$Z7GX9><4_  >[$GB<&^FFS&?F#; "@S6D7'$S[@ 7
M\&8 7&?@S7"X3T>P                   G_P#_ /\ _P#_ /\ [
M
M       $CH?$ $&@1D  D$@@_+   $'X &87[' %( @'H $C\[  $      !
M  _G'2$D@_                   L_K88(H'=@$@ "T8\:/X[;E'(=#'#X
M\#CX\#S?(; $@\\ !X/'GE8K!XH?                   $_P#_ /\ _P#_
M /\ _8
M                                           3  S
M                     BX                            _@  7
M
MG_\ _P#_ /\ _P#_ +
M                                                       @  %
M                                  ,
M   #G  !
M            $_\ _P#_ /\ _P#_ /8
M
M
M
M                         G__ /\ _P#_ /\ _L
M
M
M
M                                    3_\ _P#_ /\ _P#_ -@
M
M            #\   #L            ?@ 9L          #\  #\ ?@   !_
ML    #L =@                          "                    6?@
M   4            @     " 00                      "?\ _P#_ /\
M_P#_ /L
M                         0@   =            !, -9@          +
M@  <(#8    =$     0@!8                           +
M         #MH   !<          #H      0/
M 3__ /\ _P#_ /\ _P!@
M                                 !@>SAL#SO\ \_ZP$ ([S'?X_88#
M?T?_ -QWV'P^^(T.V ..,H&YP^HBP0WV/&P1\                    !)(
M )7_ !X 42"0 )2>!/SN0 )#\00/P!L )@022 "02 "!- ;CO ?@3L@/R ^
M2"               "?_ /\ _P#_ /\ _P#L
M                                                  ,+2+O(1-I]
MTG0"E#@$\?\ XC; D>'S)[CZ\0Z^TZ$3 '_#< G\:P6^$WZ@;W$&
M            "ACZX??#P $'C?\ .\-2M'/]T'1!)-VJPV %/_H8_M^+^+^P
M@'A:V-A \L&Q,D$EP>              !/\ _P#_ /\ _P#_ /V
M
M     &AW/GDA\.NP/H!2F%^TY"X!V &LPN2&P,HATL'UQF /D@(-)W($MUP
MV'GDQ\                    !1)DPNL'@$ !L W\%A$AT.NAZ !GNT/UI)
M\!G1)@/>Y/$!D Y'^XD('EAN'H0D.Z               )__ /\ _P#_ /\
M_P"P
M                  \&!&\L.AU^!$@*5Q&Y8 ,0&P UF%C ^!W(&I ^N,P!
M]PQ*0 Y!UON/W L\V/@                   !IPHN%WQ\ 'P&@'_@L(L.A
MT\!A ,]VAV0))PF9PL S> TP&@/QOV/Q \L%P](&F_,              !/_
M /\ _P#_ /\ _P#V
M                              '@/ WEAT.OV()PBN(>(W\T&V /LPL8
M/>V_'TAKUQF /N&(-%YPBMPQ'ASGL9,+0                  + SUPN'/@
M!O\ D=P?!818=#KMPB 9[OU#@ (<ZP,]=B1_!%I &1JB? #?X+AX*-9P<8
M           "?_\ _P#_ /\ _P#^P
M                                          !^ YQ^ 'PW_P!L<>#L
M-QAM<;N< -9A]<#[\//\.1_CL =AL09Q@>3]CQACY]AR,?@
M     !CR0" ,   < !L"00"""  !1P0 02!@0 "#\!CR#" ; #\0 *< 1@?C
MN" 2-SL.                3_\ _P#_ /\ _P#_ -@
M
M                                <"0
M                                               #X
M                #/-@                "?\ _P#_ /\ _P#_ /L
M
M                                             .<
M
M                              0                  3__ /\ _P#_
M /\ _P!@
M
M
M
M "?_ /\ _P#_ /\ _P#L
M
M
M
M              2VVVVVVVVU@
M
M
M?@" !,       #[H       #X   #<           #8 %B           "
M                  "6VVVVVVVVL
M
M
M    !L#<1@"!P<!AB22=2 0 3\,0223@,+1B 2"-L<#3@0' #*31@#!3@0 "
M1P31@                  2VVVVVVVVU@
M
M
M         -@+]C=,4 ?>./Q[KL)  ";Y-[L !]>29A= 1#@P>-_L +O??_\
M<'CPZ[? WWX                  A))))))))+
M
M
M               ?  [&ZX3&?X&?#W3G_ $ ;B;WX[#2X?S"Z81X3T7?&@ W
M"X__  ^,WATV'PN/P                 !"222222226
M
M
M                     ^ !V-UPN%Y@\T'N@X& +TP 7OAT.E@OF-UP&Y%P
M+N$P!N( GV/@D\&O@ ( F                  (222222222@
M
M
M                         &P .QNN%PN(,G@]T$& !6! (]T.ATF.^P^N
M( V^($@F %Q $^P^/_QU#X! $P                 !"222222226
M
M
M                             !          )@ )( $@ "1>*Q !((!!
M(W() W&VQ^!.P 9)@  .Y_V! !R)@                   (222222222P
M
M
M                                                  /P
M                             !(                     !&VVVVVV
MVVV
M
M                                                      )(
M                                 !!^                     (VV
MVVVVVVV@
M
M
M
M !/_ /\ _P#_ /\ _P#T
M
M
M
M              )__P#_ /\ _P#_ /[
M
M
M       _ 'X    ?;           #C 'X   'X            [   _
M                         $__ /\ _P#_ /\ _P#0
M
M
M                   %@''    "TH           P8&F    V$
M  '&  '0       R                      G_ /\ _P#_ /\ _P#[
M
M
M                                2 <X^?#_ )NTX1W"'&/*  !H./,+
M/ 0L(/\ <&9@4-S@ "-@=N" =]"@B$9_N$-L>>$              3__ /\
M_P#_ /\ _P!
M
M                                               *L1>CGA2O/=2
M]L.=X!  #)\ ; +C_,0 =DS8:,3^ #;MB M9@,]KJ ;0'MA1C_ ,
M     "-MMMMMMMML
M
M                                                   !&MKLR>8#
MYX00?+YH=R\  9-I;+SO<$B) 0<=  :3L >2-(!+O8?*9</[CY<8#]F=@
M          1MMMMMMMMM@
M
M                                                        )!=?
MP"5 ?/2#P?K-" 3@ #)"/; 3_@D3(!DL(00@!@,"52 -<+A?C+A??C]*T/\
M@#              C;;;;;;;;:
M
M
M  2_B[+[8%^>X'G=>:#DF, &0>&R(#L8P@ YP@0@&B\ _ #ZC:#'Q  7"ZG[
MKS#_ '(."            !"222222224
M
M
M        ^V'P]N._^V/&&.^^ QPV 'Q^'PYX.' !WV./  ,XP ^ /_VN/P&.
MWV'VVQWQVF&&.P            (222222222@
M
M
M                               /P
M           !AQP  V            !"222222224
M
M
M
M                !YP                (222222222@
M
M
M
M                                       !"222222224
M
M
M
M                                            );;;;;;;;:@
M
M
M                                                          !
M                                                !+;;;;;;;;4
M
M
M                                         %@
M   F  !                                              );;;;;;
M;;:@
M
M                                       (&AN&RQ\ )(!  )/'\NYY
M()!!^A )A(T( !@(!,J0( )!V@(                              !+;
M;;;;;;;<
M
M                                           %@$DQ_P!AX   N20?
M@!I%L1I8>.!K@1MA<0 87BP"7*1 81<?O@
M   "6VVVVVVVVX
M
M                                                 ""#+A?8? (
M!(#_ ."PB0Z'38  "P S  @@ R 7@G_;[X"2X'\
M         $MMMMMMMMMP
M
M                                                       :GT7"
M[8> #8BP&7P6$6'0Z_ ?@+ Y>0;$ &P<HF';;V B7_#X
M              A)))))))).
M
M                                                           '
MX'>XW(#P F\"?0:&P"P^'PG^$ W:SL@F@ S_ !W1^/P V@N-W@L
M                   !$DDDDDDDDL
M
M
M     !!(         !(         !       !  !F !!( ^ !   )
M                        (DDDDDDDDE@
M
M
M                                             @   !H
M                            !$DDDDDDDDL
M
M
M
M                                 )MMMMMMMMM@
M
M
M
M                                     !-MMMMMMMML
M
M
M
M                                          )MMMMMMMMM@
M
M
M
M                                              !-MMMMMMMML
M
M
M
M                                                   )MMMMMMMM
MM@
M
M
M                                                       !))))
M))))),
M
M
M
M))))))))))@
M
M
M
M    !))))))))),
M
M
M
M         (        !@
M
M
M
M             !         ,
M
M
M
M                  (        !@
M
M
M
M                      !         ,
M
M
M
M                           (        !
M
M
M
M                               !         (
M
M
M
M                                    ))))))))))
M
M
M
M                                        !-MMMMMMMMH
M
M
M
M                                             )MMMMMMMMM
M
M
M
M                                                 !-MMMMMMMMH
M       $DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDH
M
M
M                                                      )MMMMM
MMMMM       (22222222222222222222222222222222222222222222225Y
M
M
M                                                          !-
MMMMMMMMMH      !"2222222222222222222222222222222222222222222
M2224X
M
M
M   )MMMMMMMMM       (222222222222222222222222222222222222222
M222222225Y
M
M
M       !$DDDDDDDDH      !"2222222222222222222222222222222222
M22222222222225X
M
M
M            (DDDDDDDDE       (222222222222222222222222222222
M2222222222222222224Y
M
M
M                !$DDDDDDDDH      !"2222222222222222222222222
M22222222222222222222222<Q
M
M
M                     (DDDDDDDDE       (222222222222222222222
M22222222222222222222222222224P
M
M
M                         !$DDDDDDDDH      !"2222222222222222
M222222;B22222"23<2223"3B3D23L22224Y
M
M
M                              (        !       (222222222222
M22222222222 R2222>22="222L2428B2522222<Q             /(
M   V &P             V                  &P!^
M                      /P       V    &P         V  /P  /VP  !
M_P#@ !L       0                     2222222220       0DDDDDD
MDDDDDDDDDDDDDDDDE/DM"B<JB?<U(&Z8DHDRR&84*1",E,             1
MCW@     "0 +             "0  !               ""!<
M        "D                  "@      "    ;B         ;L  ?
M3?   #J   2       /@                    "222222222       "$D
MDDDDDDDDDDDDDDDDDDDDER_^4>3JN3H36E5SDE$GOXF!N0HHDE.0
M     #I[CQCL/]CR8><!C@ ?SAO,../ACAAM#CP,!QB,, -C\>-CH3@ ,3@>
M<<;L<#QAS_CP,4@!AP<.>#L?@ ,?_M<?\4 .9C]-CO@#N,3,.,!S@ #QAE@#
MB8.#C_Q@=@=/OAOOP.#R< < ><  >!@              2222222220
M  0DDDDDDDDDDHXDDDF7]$DDDU)VW0K94K9"8Q3'DDHD]TY0-FUD@DE>0
M        "3N7]@>?A][R3!@?0! !_AB60P;/ 0<1]\X") $,-P!\-H+L-2#@
M! .*B/\ %@"8'G/#&<0I G\; C7DCF &@#S88'@H$<' G.#S2$DX2YC&CD0
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MR<0;[^ 3KE@!L=O #\"F=TP?0?@#IX(8/=!K\= !<* < ;AH
M  "                "$DDDDDDDDE*&-DDGLDQ0DDDDDDDDDDDDDDDDDDDD
MDDDDDDDD_.DDDE>0            !H/",.(//0;"9J3,#"%^'W@;Y^1?Z203
M,9O +33 !H>/</KC, )01P;]CZ)O"/H=?384@ O?MC+@/F@!9#YBE>TT!:1!
MCL19AGB#)>/@#M, /"-X !]9P#>#X0  =/!AA[H-1R( /C09AMB!?@
M       0                0DDDDDDDDFV4PDDDDDG($DDDDDDDDDDDDDDD
MDDDDDDDDDDDDG"(DDDE>          =@ ,A>$!L!\,2@Q\&-@ S]_CBSOD>?
MMBS^NCD>$-R@ =CL%@ \'@!,4#S^L#CA>$/CO<5^  4/O,%T!C\ /N-T+A_U
M@/CP=[A@\?@0&!AQL$/@!>$.@ 4?BQ_]NCL !U\*</\ 8?#E8 ? ,['<<'[
M             @                A)))))))))'D?M-"CDUY))))))))))
M)))))))))))))))))))))))))7D@
M                            "X
M                                       [          & #  ?
M0'               $                $))))))))4CL2=LMD64P)))))F
M)F))))Q)))))))))).))))))))))))3$
M                                 [
M                                           #X          #'  #
M8   &<X               C;;;;;;;;8       A)))))))W^F@.660*(())
M)))*I*)))))))))))))))),)))),)))))))3@
M
M
M                          $222222222       $)))))))*+*,(0Q,F
M<)))))))L)1R')^IP<M--\UDD+EB@F0YW)))))))7D@
M
M
M                               C;;;;;;;;8       A))))))-_,-4
M?9-_N<))))))H)**SSF$M78.R/\ 6=L?\8 UGFL22222224Q       L
M!!  !         !         "0             V                ! (
M    (*                                !(/P )        !  (
M*           !!^   !                 !/\ _P#_ /\ _P#_ /P
M !"222223?D;4Y723V3Y"22222*244#]23(#AB,P.^9S"?1*@>C"22222224
MX      %@    \( !^         (        !V             $6P
M         %NP    $@^                                -QL $(
M     \ %@   !2       $P  (&@                     )__ /\ _P#_
M /\ _P"       (222222=62/J?R2O\ :>$DDDDD@DHK'ZPZ.6BDW2ELSIDU
M2U8]&$DDDDDDDE>2     (N0$0OL?R"" /MB    !L.[N&$0"""@/B" >
M0/B"0/@!Z0 /@  ""40?R#^/0"#-N?Y@3L'P!$ 0  02242?M@00/@20  40
M"2 "5KP-@ 3L'P  =PM[^/ 00.:T /@/Q_ =@!(0=GBL  -@  "
M   3;;;;;;;;8       0DDDDDDOPE&+:DYDW8^$DDDDPDE%8]0UVC8)>=D/
MF?VJ+(K'J:$DDDDDDDE,0    !>?B ?O"2"/9CM\=  "$0!>-AOL?_@K 16G
MN<  ?C:0/#%Y3K(00  !<?A38/OAYYX"0#M(9]AO8/@#<)M!L9YCN -[#+AK
MA<+_ /#7"X?W ? 6'8;Z$ ;'[WX>P'7[E+B0 D'?8[Z#H@:[!( @S&8#X[
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MDDDDUHDD%A$FVDE&.$DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDF0
M   +/H1MO?P!9[,9V#H# "-@+@>29@(=Y80"#/OP  C_ "\@"[RX6 \0@ "X
M7 JX@#GSW[\\_9AS'$F8S &82$";;S&:(^9>PS[:X5$&?;7"^]$ "P'$G8
M\ >H'W#N%8I"P 'C;<G?;A$#?X< $&8S BCW          $__P#_ /\ _P#_
M /\        $))))))YI)<QB) Y)).TQ))))))))))))))))))))))))))))
M)))))))))))<@     ? D8@[@ @@  ;BX?  '   8X'&$#  @  @6_  DX#
M ^ $ #8;"P D$  '" 8   # 3 #X <@@$    @@4X$ @#DC<" <@@  @#D$
M@#X@ $ <@$  '' @4 $# @$ 2   \ 4D"C@@T[#  @$   <P           C
M;;;;;;;;8       A)))))-9),F,I*8)))+K))))))))ZI)*1(9)))))))))
M)))))))))))))))8@$@               $ D$                 7Z'8
M          _'@_                                     MF
M       @                    $
M   $;;;;;;;;;       $)))))-K))DR>)_Q)));I)))))))8<))))1)2,F@
M1(<(61&))))))))))))8$                  $$
M               $@                                       @@
M                                $@
M        A))))))))(       A)))))PQ),F5A-^)))+)))))))))61)-,JI
ML2!-@0/*X?(!)))))))))))8
M
M
M            $)))))))))       $))))))%))86-TW))))9))))))))J5Q
M)K?-(709\D5+$5<2)))))))))))8@
M
M
M             $   A))))))))(       A)))))?Y)-%4L!6)))+)))))))
M)+.N)--[OW[%-(DQ!I-3)))))))))))8D @            :  !!
M   M  &X     &X                         $    _    #S7SXW
M     "3HS                                    &?X
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MB8 /=B8PP =@ 2+[A=,4] 3<9]0#(#\#J !<-_K"#L=CM<-KA,9_1/L="
M$!^#/CM[IYX+MQ/A@ /L-O/H9A,"D;#=J HC8;]@:-#M( 9AN3!_CZ)@!X=+
MAO?<!A #L2/!(!^!][L&UB9@         " 2026VVVVVVVV@      "$DDDD
MDENA )=6-^$DDLDDDDDDDDDDDDDDDDDDDDDDDDFXDDDDDDDDDEB"20
M#\#8"=@!ZS?&&#^0 0 7,9KBE( 9A;\ -@;@?@ 0#?9\0") ;KA=<+A=\ ]#
MH0   @ <OL /=//!%@ _OL"2;?Y]#,+ 4A8;K@ $+#=L!* ?O@!< ;\OL?@0
M /#I<+[[AOH ?A9X; -_B/+ 1L 4          00"02VVVVVVVVT       0
MDDDDDDA%@.V)XWXDDEDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEB
M    " )="6]];=AHPP,$ !,09C-<4C_O,+0]A;L\"'L> ;AAB 00#]<+KA<+
MMB#H= #H $!\+MAM[I[L+B 20+ !\6#-H9A8"D+#?2- A8;I1[P 44 ?C>CA
M]C\" #^1+A??=#\$#X9/"-_SHAY")<\"          "220"-MMMMMMMM@
M   "$DDDDDDE :\=<\D DDLDDDDDDDDDDDDDF.0DDDDDDDDDDDDDDDDDDEB0
M"        ""$00B2"2R/DD@?@ /QN0 2#D"2 "00  #C@"  3"0"  ) L22
M  2"#N?R"0*" "D0 3&?@ "7C^\5V2  0 02%P 2 >B02 0#T2"0""  #\ !
ML231P -Q\ 2 0  0?B 0 ?Q^0"20 0 "!\&2            00 1MMMMMMMM
ML  2    0DDDDDFZ.\ MFX_>DDEDDDDDDDDDDDDDF%[DDDDDDDDDDDDDDDDD
MDEB"20                     #L
M               !\
M""                       #H                         0  "-MMM
MMMMMM@ 22   "$DDDDDT^DKO_P#MLJ))$)))))))))))))(AHBF+71Q)))))
M)))))))8@                        @
M                      @
M                               $(                        $DD
M@$;;;;;;;;;   @   $))))))*2I))))NA))))))))))))))))/A)-=8SWQ<
M)))))))))))<@D@
M
M
M  D$@ C;;;;;;;;8 $     A)))))))))))))))))))))))))))))))*))B6
M&I\E)))))))))))<$D
M
M
M       @D $;;;;;;;;;  D @  $)))))))))))))))))))))))))))))))-
MQ*E9DQ*MT))))))))))8DD                                   ;
M             #8         '#           #8             _ 'X
M_             _
M             $ C;;;;;;;;<   @   A)))))))))))))))))))))))))))
M))))*QN*.[)FQ))))))))))8@D@
M "8               @          \X          RD     &0      $@IS
M    '0           &(
M               $  @ ;;;;;;;;;@  D@  $)))))))))))))))))))))))
M)))))))))))))))))))))))))))8$@            #CGX; 8X<G \88D' '
MTX#C$[C 'G_8_ X8'G# G'[[BX@WG#D8 9'XX ? <S@\#_#XX\68;D;C '8?
M'CXVDX "?B'G##<[ \X[>?K_  Y^
M                     )(  !__ /\ _P#_ /\ _P#  ))   (222222222
M22222222222222222222222222222222222222226(!             '!N@
MDI.VP'&!XC*&!PW  T^.V &QLQ@,''X./)./\XR!  X$ T Y&_$H^![PQG$_
M,PO-;*& )& 'QV+'R\!& &&TJ ]V) U1&NQ^/NI)@
M                                  !(  +;;;;;;;;8  )   !"2222
M222222222222222222222222222222222222222222226) (
M*6YT$D@'GP]D/UQT !@X+PF^&P!'YF,!"/YX'V%FQGF\(L ^F'P G^!S@ /Q
M:,&!%GQ!Q0 &E_P H7ULQ3N-P! &F('L%@NY TQD,=QI.
M                                      ((  !;;;;;;;;; !(!   (
M2222222222222222222222222222222222222222222222226
M     %R_@DD!TV.FQVN.@!(_! ,_0V )^LQD  GP(^P.>,Q^;-@'UPN $]@%
M< !^#9FJ(LV ,2! T&^@!YQWF*<PL  !DH!\PL-^ .N%ACNFPP
M                                          ! )( +;;;;;;;;< !!
M   !"222222222222222222222222222222222222222222222226(
M         ,;GH!EH]^DX\(UQX@%A,8!FTXP/&;&X1IYWA/V!W!FWQX('XN%P
M GCYE@ /.O\ 3809QN2D"#H8+@#ALO,+YA8 =<+09YA8;N#=<+#/?J1CL
M                                                "    6VVVVVV
MVVX "2   "$DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEB0
M"              "CL65J]<=@A>$<@,  Q_P#O\ X8 \_!G #'#\(K [ /Z'
M$#\8K!X Y!#8P '(;W%?@=%G:X$%GXX '8[#HDY#H ;88,[Y#(9'G]8/ /\
M_)Q>                                                    ! (
M+;;;;;;;;< ( (  !"222222222222222222222222222222222222222222
M22226                      %@ /@                     !
M                    .@
M
M !( !;;;;;;;;;A(!(   "::222222222222222222222222222222222222
M22222222?(                        !V
M                        !V
M
M      )  "22222222<( )(  !)))
M            ) (
M
M
M         ))   222222223@  (   ()
M                 !)(
M
M
M             ()   "22222222< (!    !()))))))))))))))))))))))
M))))))))))))))))))))))((
M
M
M                  )    222222223A( !    ) ))))))))))))))))))
M)))))))))))))))))))))))))(!!
M
M
M                      !((  "22222222< (!   ! !))))))))))))))
M))))))))))))))))))))))))))))))((
M
M
M                            (( !_P#_ /\ _P#_ /\ _@      ,
M                                           $!
M
M
M                                         !  -MMMMMMMML
M!@                                              -!
M
M
M                                                !MMMMMMMMM@
M     ,                                               $)
M
M
M                                                )(   -MMMMMM
MMML  )   !@                                               $)
M
M
M                                                     ) ( !MM
MMMMMMMM@( )   (
M   %
M
M                                                          !)
M  -MMMMMMMML  (   !
M        %
M
M
M  !!!  DDDDDDDDE@!)!   (
M             %(
M
M
M      !)(  &VVVVVVVV\ ( (  !
M                  %
M
M
M           ! (          !@()    (
M                       %
M
M
M                 )           , !)(  !           !-@
M                            %(
M
M
M                     !)          !@!!(   (          (A%(
M                                 %
M
M
M                         !((          ,      !          !I$H
M$                                     %
M
M
M                             )((          !@!)!   (        !
M)L !H$@                                    %(
M
M
M                                 !!(           ,!))   !
M   !I%A)I!E(                                    %
M
M
M                                      )!)          !@ ((   (
M        %$),(@!H$                                    %
M
M
M                                           (!(          , (
M   !      !-%H$H%-I)EH                                    %(
M
M
M                                               ()(
M!@ )    (      -)A)D(!D(@!I@
M   ,(
M
M                                                    ((
M     , ((   !     (,@ HM   ,)@$!H    ( (         ( (    !  (
M        $
M
M
M         !@ !(   (    %$H$A$    (%A(%@   !H!@         R!R
M "S!         $
M
M
M (((          , )!(  !    %)A)M(      D @-)@  - ,"I.M.L'@ &0
M&0\!0D6\(T@       ,(
M
M
M     ! (          !@ )    (   -A!AH)H$  )IL,%($)@  0!JL;\OB7
M-8 \ 2YK'/BZP5^        $        ( (       H )@      2H   !O2
M             '0 ",              H  .P        %^!      :   +0
M!%ED    ,           (               @               %@
M           (           , (((  !    %$H-%%ML )EML!,-)$  /MD:(
MNQ9;4!P&]J:@.\L7> *@        $         &-( (      L!(!   *9((
M) ('@) !)  (( ! ()\ !F()() !(  ((!(  (( \  !) !!().A^  !( /@
M  !2! ,\P  !)T )    ) (  ()  !  ) !(!(  ! )    !  !!!!  )F
M                )          !@ )    (   %H@(!@I)A($I!I E L  !
MH!BP5^++:Y\ R S7/JCB[Q!4         ,(        %H  &^PV\)/NP 0(
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MPGN$WQV                !((          !@ (    (   !)@ M   (D
M ,@ H   ! !  !((!!-  (!()H)I)!) (          $      !) &@2.]+@
M]L/FY(*W !2]\%A N]G)/@" ,@%H,^N&@!-WEPN$VY( $AVT  ]T&GB)(&A\
M.AUGT&MY!2! T 'X*>QGGG_)'@$@%@((AUV'X7!\'EPD .Y&Y(&@VVLL -Y
M"U  ).\QGF&P                ! (          ,! !(  !     ,!)@
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ML$J  +X@D-!@$(%)(!: !M )!+1@%ED    $ $  )(Y@)!6)L%NXT  ) )
M@,@@!!'( W!  &&A@$Z+@               ! ((          , (    !
M   ,!-   $)D  !)@$                                        (
M                                     !F
M                                                        /P
M                                           (          !@  !
M  (    !@!$ ,D -LH $$ @       !@" *@      &@
M )))
M                                                           +
M)>                                              (          ,
M  !   !     , -(!@  L! !$ $       !:!>!:(H!  , X( !@
M     (!!
M
M
M   !A  (   (    !@!A@,@  !(! @ @       "0+]G:--9-UHNW!'%@
M         () !
M
M
M        ,)!(   !     , !!!M%@$M $$ $       !H!0E[6'>LOQWUP=
ME@           (! )         (   !( !! (     (       ! (
M (   !           (        !^ (
M                                                          !)
M (          !@ !(   (    !@ $I$ML-$L)L  @      !8 +P+3Q:;;V'
M^J*M)(           ())(         .@   %P  (!    $E        /A
M    %'@   (                    ) !F
M
M     (           ,   (  !     , !)()$!D))%  $       /P!>!;4F
MV'_A-\%7UU           ()!)     !'QYQX. XXO_ ! Q _,^.^'&%N.  Y
M, )V'&!XW%LV/P !/&  .& X] P!W Q./&XP: -)P'..^QV QP&&
M
M          )          !@      (    !@  -( EH@%,@  @      !T +
M *!] 5M^,'*A"4@          (! )      A_H^_9T.)U_,((,1=(&Q]^/-2
M[@!8!A %^.NJ'[-NPV ((WN I>;/Y8?A/Z'Q9[M P !B+@P5OY^/0QYQ\
M
M            !-MML@        -MMMM  !     ,  !!%!ME$D@  $
M           /P                ())(      %A&)/^/E!,N !!!NT *@U
MNV!#0  /PL(/CA(TP_N\V-@!  &@$@/A$,\MY)/^&FH'P  -QFV)MAL%_)[G
MY
M                 ,                (   (    !@  !),  )A    @
M               !(                ()!)       L/0!^AT'#D@ ((-V
MI.4&M_P,B! !^*1 )N /F)-W@_0 (%P\ L!X/YGEO0!_@\T/V@ !F%OP3F%A
MNJ!QW\
M                      ,               (   !     ,    -A!,%
M  $                                  (! )       %@O-)T.FQLIX
M1!!OUL.Q]O@RP0( -(T(!  !/YFF\'. ! N'@%IYY.=],0VQ\'NH T  ,PL]
M.\PL-]( L/P0
M                           ,              (    (    !@    ,-
MLA    (@                                 ())(        L V( 1"
MT */V((+ &X8!7!(WV!  (/Q!V'P V(!) $  ("1  CP0 ^+!!9 (0 7 .P
M 0*(1V0!   ']P^'P
M                                ,             (    !     $,
M   )!,    !D                                 ()!)
M                                     !+       $@
M
M                                     ,            (     (
M !)H    (L    (I@                                (! )
M
M
M                                          ,           (
M!      I(   ) ,   )HH                                (! !
M
M
M                                               ,          (
M     (      IMMMM !MMMMA                                 ) )
M!
M
M                                                    ,
M  (      !       ))))( )))))
M )!!!
M
M                                                         ,
M      (       (
M     (! !
M
M
M  ,       (       !
M         ) )!
M
M
M       ,      (        (
M             )!!!
M
M
M            ,     (        !
M                 (! !
M
M
M                 ,    (         (
M                     ) )!
M
M
M                      ,   (         !
M                         )!!!
M
M
M                           ,  (          (
M                             (! !
M
M
M                                , (          !
M                                 ) )!
M
M
M                                     ,(           ,LLDDDDDDD
MDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD@()!
M
M
M                                          -            (!(
M                                         ( !!
M
M
M
M)(                                            ) !
M
M
M
M    ) ))))))))))))))))))))))))))))))))))))))))))))( )
M
M
M
M         ! ))))))))))))))))))))))))))))))))))))))))))) !
M
M
M
M              !)))))))))))))))))))))))))))))))))))))))))))))
M
M
M                                                       /_\0
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M\>SPO_,6Q_X%AT(,O<\__P!'2/#9D>?_ .C"KW%B$(\__P!&NYPQ!U[GG_\
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M#=W$O,224+*$ACJ4PA(8_E.A_*"$A8W+1ZQN4LIB"WEJ1S!O$/G&S=OQ9_\
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M_P"*M_Q-H9DK9&Y&_ 2Y8G B:&E;'KU"Y8<-2*Z(/L)=Q.!$U(W MNXTH27
MT_<27!VA*!.#M#2I. M['L="OY'3[^Q;C#VI+-"U(MXM#IT4?0ME);D>G82Y
M8G U*D[!T+8M""Y,3@6$XZ+C0M"4&S@X,27!VA*!.#M"<J3@48=(K^?V.A;@
M>U!4NY;"X#T_4H\.X9MP)0)\,6/L)+@[0E GW$AP4XU&B2-MLH@U)6&,[0E
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M5Z>Q<*F4.7SN.T/!Z<CVTRT?Z#=_T[4=]"T6:5#Q>%HL32QJAB2FA/3&I)U
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M2/ET<"K%14O^1TZEF4?SG*_Y_0Z%_P _H="HX85G/U]\4>=M=QZ:97J-I?\
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MZ_D<9;U]6KW_ &1_\.7\*O\ BC_Y$_\ AR_A5_Q1_P#(G_PY?PJ_XH_^1/\
MX<OX5?\ %&00000000000000000000000000000000000000000000000000
M000000000000000000000000000000000000000000000000000000000000
M00000000000000000000000000000001]+!!!!!!!!!!!!!!!!!!!!!!!!!!
M!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
M!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!'\,O\
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M).XPMZ'0L+3:PE+@;CH*/*^'M]BF*+YR\2SON-K%>H5AJ!.5)(UI,K'\DO\
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M<[*AU^_L<A;4$0Q"$C9+.(0HY&YV5'0Y8M01#UAN%"%MR)+&CHJ*?C]XOT'
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M4?\ 0EOI%ECUAD=TM"P^I.1H0V>$VAI0O/6K4B6H71&AC+9"5K9!:TQP,@\
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M<Q9&)G#4"VI6)Q4ID6$Y(Q.$ER3L=));Q,9C$X2G1/!$$BW1$#<9C$YC$_\
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M6X:$HD_^PT#U(7N-1#)X6-#48;X-XB:&@V1N1N4D:3AMBD48%(H&HQ/IC0U
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M[Y>T73OES[EI%)2-0XQ)N#FA8TQ,&RC1/'$4?0Z]GX'0=!U^OC.G9Y>%8O\
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MU_3^3^U-2H8G'_=U7S-7EW\X=?(I2-1E*1J/CM-;^"TU?\!R/_,:KYFKR[^
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MAY>_4MM\&UY;<#2C9[]QN-BED0)IC4=#?"$F4)IV-0XZAOA"3)@23Q-#@D1
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MQEJ,-QA(2ABWT7XZ&XRU&)],M0-PI$I38G)&I&XRU']+7P(8J&<BQ&#4"<?
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M57QW\<[*8=E/D%.C0=]%4-)X0T)RBV;#HL.BV&V\(%BGSAO_ #0_CKX*>B!
M@0($"! @0($"! 8G! @0($"! @0($"! 8F0&4^04Z-!.1>HE%AT)P2AI$A%A
M>H827(Z+83AB<B<,E#?"+%/FS?\ FE_'7P4$$$$$$$$$$$$$$$$$$$$$$$$$
M$$$$$8@@2CX[4B49:D2CH$HPTG@D6+#29#*48:"4#4X)1@]B4?,M_*IRX0U#
M@F"OAMP1J?AMP1J1N"-3_"^AA.9&H<?&;C8A*4W_  4[@:CX#0I(U/RM_ ;B
M$1J1N((U/P_0^;F:$IT-0X^:;A2)3./;$[@C4_#G<$:G^#G<#4?SC^.OX@=_
MP*W\,W\JT(7=C9N2[X:2)Z:^'9=Q7++N*_\ "\._D=B4-L:7/QMD1$2)U'\$
MK''X+2E^H2''RA*'^GGX%E^\8M2T33X=EW\COYEX9BJ$X<KYM)4"<)XW1^^&
MMIDT^&Z?4=/K_!Q8;F"R7\W?QU\-/S@    G^CF_EK[#77H-PT)1)_\ 83VT
M-1&&A"4ILG<&D)823*&@2TWB9K"@:@;@V\:&H++N*Y9=Q7)W U"3PT*1)Z&X
M-X:YPTB0QN-D@U#&^#9H:C$S6-,:C#?!LT-1AOC"28L-=_([$Y;7H)#@G<&C
MA823&HPG-8T9H2E-Y:%(UN2=0-0DQN-&S0USA.1)-83EM"0R=P:-)"]Q(<8;
MAI$:G$[@:U.$Y;0D.">%C0U&&X-XCE85CB-P(V/V)FL:&HQHTQ[EZ=$[@T<+
M"4YF:QH:C"<X23**23J!K4]%";>%VFOW6+<-$:DH3;PE.&X);Q$UBR[^29>L
M1-8;@WA),:@;AI&B7N+W$@F:PZ;0DK$\+&AJ.BY=Q.!*4Q/;1I!"2X'HEO"4
MUAN&D:)>XI$DQN''.$IZ6^#9H:@;B#1&+W-4B4ID[@I]A*1O:1&IPG-82G#<
M&\)3AT^HZ?7H;@WAKG$S6-#4;QJGV$V]D2I&X-XCE=#0FQ*<UXVP3-8B:Q-!
MJ(%HA.H&H2?J3-8T-1_*OXZ^&2GYT    '_13?RZ3'N-RY(&VS30T:8M]F'M
M%Z#TB/$2U+'NRWL/<BJ[H5AN%R(2D;D?(OL'OL'I8J ]HRR[BN67<5S7L-DU
MC9I%=V6X&;>HVN!J3UA(<#V"T@M[%/<:%)ZPWZ"-;0\(&X7(A*1N1\A:0-"D
M]8;&O0H>HT&V>H-^@TUM#RTQV6[O"Q*_9>2(4L>Q.'!LDS9A*%+'LF'!1_O/
M0Z#H0*6>L-^@UZ8DAP<RW"L6^B_&*6I"<.<UGT-DUBK"VRPDPWW'7B;D:=H:
M$>N$>WJ-JD-2.3V)#%8:(&-RQOA#P$23]L;3T-X++#3]5TTH4L>[*<#VI-@D
MDI&Y'R-$'%"U+"E.!I@TB!+;Z>2>A[@1"'L3AP\;=WAX[-(J6%*<#3LOL'I[
MCV,TX/7ZE1\!J1UB0R%MFS@PGN#BR@2G;&,;N(DI'LF7L<QH6)N1IVAH1Z]&
MK0<B16(A2^1.')_\!J'N/9,.![4E ERQ[%IP):D/8VVB\Y:%)ZPWZ"-;0\(+
M+N)-\#V-**/]Y1!LU)0Z#K]?!LPE"ECV4X-DF+;;9II83VT<6.GU'3ZYH9MZ
MC?H->A-]2=")*<:*44:QLJ]A$M(G4"RGU'"TAJ1R8D/6;3GAE5V\8I]7^1I:
M#4COJA8:!7[+R<!Z:2_=$!V$23]L;3T-_P J?QU_$#OY).XPG/1 @0($,M!;
MZ)@@0RT71#$[CY5OY=H3%B.WC-G^\%PU*@JD:AP+*?4:7)XE%FHRJ[H5AU'3
MH;@G$;ECKW_\++N*Y9=Q7+(KX$AP+*?4>7KHDXREN2J>-D"*QN=G%"L^FWI+
M*PTBR0G":RE!?ZHH\V7?R.RW=X6)7[+R46'7Z^!T%8XK-1_O/0Z#K]?!4LRK
ME$SF6X5BWT7XQHZ6B^"2,5)_L-2?8K'J+3,LB=1E,)LHW)1"L/;EBW!825 S
MZDD#49\'3X+%2C%<HNB3T$-$>F.(K_3SAI4X2E-EF7Q98V[O#Q2=H0T1-8WG
MN6=&T=_(]O%F7#<$XC<E%^\E!YX\2BQ<<^Q9$ZC*"[-ISPK'%>V-ON78J491
MFZ]ATPK_ $\G'/%"L^BR[BOFH_WE8OW><.@Z_7P*QQ7MT-QF-R40Z?4=/KFX
MYOVZ9],-2H9SZ)X8?*-R49M.>&57;QBGU?Y+L6_7"Q*_9>3@67[QBDJ!GU)(
M&H_E7\=?!;ROFC&\4)_';A"<CHMT0("L@+"8$I&XRW DV0'Z!.,7Z'>$T-*^
M3;^824T-,=O&;/\ >"["U#U-DGZFC/'B43Q6"C95=T*PZ#IAN%(E(MN?0:C#
M<H.O?_PLNXKEEW%?%=PVK782$^G3),KH<\C<*1S>S8)!Q98LUP46M'E-VBR8
ME+96R42S9-9LG[^1V6[O"Q*_9>3AAU[/P.@M,43Q6"C_ 'GH=!U^O@K)LFLJ
MS.*.9;BS+?1?C&B_>>FNXW?N\#TB-&1M_P#7W-$D61&2W1)ID7GV'(K"Z#M.
M.4)RL1*(&XL6TU\"T3Q6#1L:)X;C8O(;&B"8<,>Y>AQ%?Z><)0HPG"@LT7G%
MDL;=WAXR-$$PX8]R-97N68G<#4*2R[^1WBS[EQML:2<$EFB_>2@=>^*+VCQ8
M<^Q9$9+=#F=YM.>%8NNRQK/<NQ6"C*#SPZ]BC"O]/)QSQ98LUP67<5^__N:C
M_>5B_=YPZ#K]? K'%X;@C4BV]1PM$BVY1?O(Z?4=/KFXWE>V4Y%!*%)(VR.>
M*X++(AE[&\VG/#0I$B%CS?Y+,6[O"Q*_9>3@67[QG$H@;BQ;37\J_CKX#98D
M-#4#?,L)20AK"<_&M&'1;J5]#<":*>7MBUER>+]#O.C^2;^:?3V$AM8LQ[:Q
M6?0>X-(P\1/4,>A)MRQZ0JNZ%825H0T,:DI'J:-H:=DB4;>-EW%<LNXKX65H
MF'_TT272[T]!P]H;Q-+%M/ ]($C:&34$FF.5C2X'+TA(2)RA#7L,:H:)$E1B
M:7 YX%+L62.6N1QP.7I"PB'9;N\+$K]EY.&'7L_ Z"<H0T,CD4?0Z#K]? U*
M@<KL<<#;XQ-+D6F0W.QSP)4+?1?C&B_>>G7?H6<0](Q)#2Y$E1B:]!SP*6^$
M-R/0</:&\32]"L<1.4*:]F.^J$->PQ*"TWOBXU3?33U#'H2;<LT03E"&HX&-
M4X%I)HT$TU#PU+0]0*B>FB-3T:,)IJ&/0ER\;=WAXZ-"94/$2Y'I0/:296QZ
M&-R-PBR[^1WBS[EP\:]"#<H;$HODH*!U[X2:- R.7P<A)48FO0<\"EOA#<[S
M:<\*Q==EA[23*V/0DVY8](4'GAU[%&%?Z>3CEJ5 Y6-+@<O2$A)9=Q7[_P#N
M:C_>5AXA^C\D2]#H.OU\&C"::@>A)MRS1!M/8<6AOT$HODHOWD=/J.GUZ'>G
MH.'M#G@1;>A0R9AB&QO]L5RV0.'L8R?<::RDIHY!^PT]!I>/-_DLQ;N\+$K]
MEY.!9$T'1(AKV&)06F]\-(D./Y)_'7P5OG1]"Q3XRV\.BW4KZ'MX3D:5A7U6
M-FS9SG1_(M_-UW&T/#6Y$-RY'I;$TI&Y<X\192$3%8:DG48CG"<8:G/J"<*!
MJ2=0-23J,K*0TN>EJ<SP-2H%K*4#<C4Y;G$<XD;G#4Y;G#4X3@V3A*)&Y<D;
MD;G$;DG4$[@?+#2DO="MT1N2=1AJ<MSAJ<)P1L-R1N1N4ETM2H&TPU(G&6LM
MSAJ<SQB-R-SA*!N2/3$C<X>VD/4.FNF]O+Q,5F,3!>(BL3&&IT)03J.F(K&T
M$Z@:F"=1A**Q,5F(K$\+'H92@;ER-3B1[<LG4#4N2=1B>!\L-0H\-9;GH:E0
M)QB-R-SF(K$Q6&I<DZC$;D;E1B-R-ST-3EN1J2=1AJ5 G$XC<H:')&Y)U&(]
M,3%8:YQ(U+DG4$;DG4=#4Y;DB1*,3P5QQBN.,M21B>.F.<3Z'I83@-RYPE$C
M<N2-R-R-3H0WJ"/3$C<X2@;ES_)._CKX#10F-C<B?,H)P2-EB4?&MAT6ZE>6
MX0IX)9MC;Q3Z&XQ?H=YO\@W\XDH:$?L]#<-(:G17=GQ*+Y1N!J="^Y_%Z-!-
M-1A,W(]+^2).PW+GIT7[R_Y)*?H)&HQ$O8]*/^,._CKX+R7S9K*^.6GAT6ZE
M>6$A9:AB<B<C9;EB4%^AWG9_';^>B'(W+G+4B<#<YC<DS\HU(M#<_P 9&)_D
MFI4$ZCIC<C<_R<8GT_XR[^.OYFTX=$B&0Q&LI.<RGH21&L/T&R&Q*,(WT-.<
M[/XS?^='?QU_,M2AN/G6T)"^*W_G5W\=?S4;GYV-S\5O_.SOXZ_L;?\ G=W\
M=?V)O_/#OXZ_L+?^>7?QU_8&_P#/3OXZ_K[?^>W?QU_7F_\ /CO_ '2[_P!T
MN_\ =+O_ '2[^/!#(9#(9#(9#(9#(9#(9#(9#(9#(9#(9#(9#(9#(9#(9#(9
M#(9#(9#(9#(9#(9#(9#(9#(9#(9#(9#(9#(9#(9#(9#(9#(9#(9#(9#(9#(9
M#(9#(9#(9#(9#(9#(9#(9#(9#(9#(9#(9#_SZ[^/3^O<Z_SX[^.J_K_.O\]N
M_CJO[!SK_/3OXZK^P\Z_SR[^.J_L7.O\\._CJO['SK_.[OXZK^R<Z_SL[^.J
M_G&BL3E2OD6X4B1U\MSK_.MOCJODI1#U(>I#U)_AK%/QW:2@J$ED-E/PE8Q,
M_$YU_G2WQU7R*%0V?0G0E_PMBDU""1DQ&CPZ!LV(+$)*PA43%ZQ#PQ(&A-F]
MA"HF(TRA"TB8D/BT)PY'R^)SK_.=OCJOD.-83O.RV0G!)_"6*2B$/;(0D]8N
M[B$A#31CZ"4H-LO"E#0\J4167EF0=Q+MXCVC<&C"TMV--!H4L5_&YU\Y?S,?
M&6Z^96Z^7CXRW76MU\I,?-QUK=?R*W7]'K^<M\=5\=X6)KPW"%@U) QX8OX.
MQ2417BS[>,/\L_G\X?I)*-$X=$5EY9ED,BUA;5#%:3DLQ9%)8K^/SKYNB&H<
M8;@33TQJ-?&2V8TQT.@Z]WX^-K$^OD=]31"$H^1:Q/KY'?RKH.OU\?&T<NJC
M-+]/'R5E^\8K*^WY$]/X^Y-_#J=GE=#0)M]/.++OY'?\AHE\FW+@2$OE2X3:
M)I\29<"1'Q["C[?S=OCJOCN)+$A=0FL47\'8I*(KQ9]O&'AW[B<J42EMBB^B
M%-3AJ6.B*R\LQ*8\P],Z!)9BR*2Q7\ASKYJJ+L\UZ%Y%NAN' E-8G$83FAJ'
M#PW!&I)W U&)PD(.O=^,3B,SB.GT,)S0].,1AT:)H-1B<-1A.:'IQB,SB(QZ
M W%D93D:C3&X)((CKD>G#Q&'0;A?KX)$IPG(U&&XL2DHG#48]#,SAJ!N!*:Q
M,9:C'H$\8CJG"PUBW%D#<*61J1.2.1N"2!J,S.&H)W!J4B4XG$9G""G9Y70Z
M0)[(C4EEW\C>\1F?3$8G<#TI8MC4$X@B!N+(U(G)&&X(U.4YH:AQEN,M1F<-
M1B9'IQSA*<SN!J"B,SAJ,-QB)S.(GH;BR+#2D-1IC<8CI;@C4B<D3F8RU!/
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M./<2E-]#<]5F:R%<=!U^OC' 5^Z\XW-&E<BPG#4D$X$AP7&R8\Q^\=%6>+_
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M'*H;[C1IE]N=]^I<77?R,:E0-4C48V9EOHOP-'T%AL3&B'$E Z]\3N!H@F'
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MTUT49XO\?QO 5_IY^4KGCXS1I$"&3%E)YRT:5B4*"_V_'3;N\+^'DE-"<3_
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M?'5?V.#^$,:G*<%E!YYT9:(]A(;0\H]!=Z%MF:Z]"J[H5B@\\-2H&E)^W@K
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M8E9&TE+&D"$V/;@.TS0\<O#<.103%V(I6*BADJ'HY&TDL9P(39*XP>W!Y!I
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M?)W_ !U75J(ZTR5)ABT0\ME\:!Z9;$A+,M W]7V=F5?T9:^XVVY?^6E\G?\
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MO_Q&6?\ (2SY)?)W_P#%$-+_ .'@
M              #2V_DTZ4+_ (=555555555555555555555555555555555
M55555555555554V:CY)?)W_[67R=_P#M9?)W_P".9G^EK=?-2)3_ "Z^3O\
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MZ&XRU&)FL0-0-PI*3"&M2-QEJ.IN%(U+3)H1J1N,M1AN"<-0-PI$ISZ&)XQ
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MP]-/&R%P6(W(W*6+0OURSD8W.ECS?Y+BS[^"XL^_@N%MF:8/;N/<O0>T1_\
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MP%?Z>?EW7L_ Z=?B4R\^N5L4?"=2@:EHFGPVI:9-.CB*_=>?YAT'7N_'\0E
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MXX&GH4]\>99AJ>@XX&R"R^>1RNQQP-O@4NPW+DV0.'L<\"4:+]%F<#DX"O\
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MY'["OH-0X_AE\G9_CFOW_(W+EX@4;8L^_A%TL*_9>3@.O9^"L5?Z>2B6+/\
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M=/\ SWKOCT?]@:G3_P ]:[X]'_86IT_\\Z[X]'_8FIT_\\:[X]'_ &-J=/\
MSOKOCT?]D:G3_P [:[X]'_.2&A]:<_!2-QT-&A]#0EB:=+<*1+0OA-3I_P"=
M==\>C_CWB'J/0_B!,F>IMI%7P%97T7="0CJS4J"9/PVIT_GLG.U\G.X&HZ)X
M(U/SC<$:G^&;2LCHG<#4?Q/H?PZ<T-0X^033&HOJHCH;2LCY1.:$IZFX4L2G
MK3FAJ-"<C4.'\"=P-03!&IZIW U'R&B?Y^[X]'_'O,$,SQ#URW#G</'"L/"\
M,:%CA6'A8Z<#MC17&/1QSZ>$)LDH>F*^B[H>)(;*1C0+>'-"&X9C6:8^Q"UE
MD]#5>$)+&RCD#9UEJ=/YW40U#C#<"'=#4./C);,:>AT'7N_'SB3 GLNIMI$0
MO=^/GUE"<)K&S9A7[+R</XF_=_#^3_)=\5H4BPNSRL)#8TN>K4IXPMMIE_M^
M!90G":^3J+21.'U6'/K6+_=C2VSF6_!T_7+&I:)IU);,:?CO:#1?SZ[X]'_'
M-PD2>S"T"<J2T=)N<2N46#);8F2A46%@R6V)DH5%D5#PH-4L*6T- .:22A$"
M"GHNZ7D+*D>8>A,;$V,L+,,S>$VF4CS 0D(:3TQJ(>_0U.G\YJHNS9HXC2X&
M]P)3B9Q'IA.1J'&&X(U).X&HPG-82$'7N_&)],)369FL1-=+<9CG#<9:C$^F
M(G#<$:G$S6$IK'!HF@U W&8YPG+@V1B)K,S6(],-P3.&N>B=P-:G"<N!J,)R
M>N)2I)W!7/ E(K]EY'B.V$IKI3F31L(],SZ8B:PW ] O<:A2)S6(FLS.(],-
MPTAZ4O$#48GC+48OW=,\82DK$S6(D:@;@>E(O<:@;Q U'3,UB!J!N%)&I$YP
MU&&XPE)Y/\EW1.6HPW&6H'HTAH3(U(G+8D%$<YG<#4*2N.1N!*&V/;0W(2E3
MB>,0-1B>,0-1TS.(],430GLB-3T3QA-VCGAO,<X8-0X.8\,Q*<IRX&HZ-/UR
MQN&D1J1.7 U&&X$I4D[@:@G<%&$IS/IC1@E,]#<*18V^Y>)],1-=2<UBCW(U
M/\E=\>C^6;(?#:+%(Q.?@MI(@HD2;8VHPWC WG'HD G5B<J468]$@$ZL3E2B
MR*BR$CK WV.393A65]%W2\AJ5 V@>("Q+U+"S#RQ1%0_SS^7I:G3^;U468;'
M5RQY>C5ON02$XDM[(:BQ[$R<":E%=QLD\+<O0T@*QQ'MP1"ECV)\,=>[\#<(
M0E(]C<#TGT/3ZB24L)M.#:'T?<#C@:]"AC4.!)2.)T.;0\KV8\+0A*?3$M.!
M[29P%?NO)Q7J))2PFY@WV4TD-:,T2^"2QOT&O0F:&6$1MR,9S!>?4>W!$*6/
M8Q.!.5R+:1I:#-PD/.L,6VQ62^P;A2)$-]RGU7Y+"-R42)P*_9>1+4L8GN&;
M0^BW=X1$;?(]C$XY$Y7)LPDDI'LEI['M25^J_(E0?L/,"$I83<P>LM[(:BQ[
M$R<":E% E.WP,F&7V#0A4#))2C>5B_=T-"T(2&-PRY>@]P(A8F'#-D99=Q+[
M!^QS8F_0<K:&A'1LQ$*7B8<#W+$E0<<#6-DT4,V]1QP.5M#3LNRT+0I+MAH2
M;)K"O;U'"TASP-3U-#:$E,G4%N[PL6C:+SZX64^H^]% U(G+9LT4^J_)8-"Q
M-CE;%I T)L4EVPVTQ[Z%O9#46/8F3@25(]$D);,G49:%H0E[#V3#AG(;A2>H
M-^@YX'DO?'F_R7',66(OH)#@;C9-?<;EST:?KEEEB](R^S#W#T'I$*QQ/$2Y
M#)APS9)C<(0E(]DPX?)3L\KHWA"TV&W"$B4CV3#V/2>A[01"V/8G.F.O=^/Y
M*[X]'\KZ0W.$X)M/K;A23L2;K V5X"<_ ;ZPM8:E0-L':2CE85)Z&:1DR'A$
MHQ6#0FR9#PB48K(J$TF3*/3%)#FI8AISM#<)*^B[I>6$B2'U(HL+,-'BB*Q8
MD(24-I;8W,O?J:G3^;PU&LS%8Y9$F/<:7..+%8K*X'E-#<*3UNXW+D5CB<F6
M+&B,=>[\"L-RDL)*:+P)*T:#1'3,92"XV0-S9!$"2L&B,<!7[KR)RN!:&B,4
M#KW?C$QC8L-(LRPNOIG1?O++-G!CW&A24>V8L.CRU*@:;Y-18EV&AW1NH]1:
M[BGU7Y+.@5^R\E%AU^O@=.BW=X18L:)C8--8244:*_5?DH\)37 M#1&$F/<:
M7..+%8HSXBMB8UAJ="0X_:Q?NZ'0=,-23B9Q$N1U[_\ A9=Q6Q0B:9E 2&71
M,X:F!7_?7%1XN/!_C!1O/H]R[HGC#4J"_P!'^"XUE^V5JBPH^WE8MW>%BT:9
M?8/"T+"?3%,+/]X+_;\%/JOR6#HB:9J)I##1'2DQ[C2YQQ8K'$5_IYZ'0=,7
M%7VQ,8V+"(9YO\EQS+2NXV29O"]1:EZ].GZY998I*@?[L);U&ER*QQ/$=,4'
MGC1+%C*=GE=#I]1U_?3"L-S&$E0<UT;?<NQHC'7N_'\E=\>C^4@0E(CDAZ',
MBF3+JXB1B18:,B9Q=<H<#E)]#&E"/0-B5@8W.#4YP$Q+$HTB4+#4YP$Q+$HT
MB$)#&ITQB<HD->$8BH3(21]#S-='ZMP0Z4Y!J<O&R:&LY%;@ATIPZ$"-08A(
M9!0F6)$5Z^>MJ=/YG51=T\BW#1'L-0XQQ0K8:4>@OZ<%=V%8XG-%CQ9#KW?@
M5A(C*<8CDV3N&/<LM"G%HD>?N_R7%D&Q3[#4.")Q,6?_  . K]UYQ!LG<,>Y
M% Z]WX&A3BT2;Q^\EF6%_M^,Z+MY9S19B=P.;$(=$ZCHT9&Z_<T20\NS$V7H
M:PBGU7Y+.@5^R\G##K]? Z=%N[PBS%&-F)#UE."OU7Y%;,&R=P/:D:(]AJ'&
M.*%8H//%5W%8;A&C#0QX^,7[NAU'3#<*606[#47AM$.O?_PLNXK]_P#W#H1;
MH;ER\O;@B%O#.4*_[ZXJ/]YQ8>+_ !@H\V;]R[+<(T8>&@M]'^"XYKVRG-"0
MFBC[>5BW=X6)J5!-?8:KZ&B2Q3"S_>"_V_!3ZK\E@ZD6Z&Y<D20-Q8MIKH:(
M]AJ'&.*%8XBO]//0ZCIBXJ^PT+!HDW;#/-_DN.9:+*T/"/46V9>/3IT_7+++
M/1D>SDT9X5CB>)18LCSQHGBQ%.SRNAU^O@=?KXQ8)$1E-KHT^Y=B@=>[\?R5
MWQZ/Y1]B;GH6&/OJL+?0NOYR=-!#&@5R? :G3^8U47=/(MPMH]1\N1Z$FW+-
M%@](RVG]"\>F%8XCU+U)@/0EN6.O=^#1A--0QZ'P%I2:0Q.5&'MHKNZ)U]QJ
M!M\"4*"T;[!KT&X.!CRPR:@HX!:9^IP%?NO)HTR948>VO8J'J61-!'L,MKU'
MH;;TA(A%Q87^WXSHNWEE2]2GN/0DVY-(1N@</:&X$;<GHZ-&F1+7V'D5W"3L
M-RY*?5?DLPT0V0*_9>3AAU^O@=.BW=X13W'H8W(W"X'IR3*ACT/["NXK]5^1
M6QHTR948MKV'J MH]1\N1Z$FW+-$*#SQ5=Q6-&F+<"AJA;%^[H3E<"&H&H'P
M*[BS1MM$B6Y>-EW%?O\ ^X25H4U[#4#;I")=ET+3&T-$P)2Y8K_3SBH_WG%A
MXO\  U*@8KX&O0;X0D0B[.B,6X%#5"WW_ U(SZ!KT&_0@L:68UHCDMW>%F6N
MX2V>HTN<4PL-G**?5?DL$Y0AKV&H&W2$MPA6T(:[C4&RA&B;Z%M'J/ER/0DV
MY9HAQ%?Z>>A.4(:C@:@?V',K(VFAZ'+TC5H=GF_R7',MPTH]!(WZ=6GZY999
MZP'N/8TC!6.)XE%BR/,3E"&H'HB7+*=GE='%BVV-&$Y4,>A\.!:4X:"8U#@>
MT^I,K8]"7+'7N_ W"D227\A=\>C^438_0TL7?4D,?H?4"?S9I-0QIPQ)RQ))
M0O@M3I_+Y W+GI2B1I-X:DVL3%925 T.<I;D;G"36-HC@G48B*QH;G"45C0W
M/0E%8E(C;?J-.QKDWB=0L)16-#<C4DZC"48TAN1J13R-RDA**Q,"6VQI<B4-
ML:7.(W(W*18DUB8K#4F\3%=*2H&ASAJ8$XG"2H$X36$HH:&1N1N8Q&Y&]1T6
M[O"%C3$Q64HK&D-R)*$X36+$FL)I#<C4FUB8K#4M,G48:D3U U.A)K$Q6-WH
MI]NF(K"A#<C4[-FL">FAJ8)U&8Y6-#<]#4FS1H@3B4)*@3A-8:E0-@U)L4(5
MRQN7.6IT*5B8HK]L-2;-#<Z'L2:T)Z:$H;?J-+G#4B<3FGVPUN4(VB<)K$<K
M&AN<1%8T-ST-2;6)BL-2)ZCICTPZ:0T82BL3%"42-+D0-RY$H&DWAT'KNZ8W
M(W*2&I:9.HPU.C2)&Y<X2W(W)&Y&Y26&I:9.HQ$5AJ(H_P!YZ$E0/.GSE**Q
MH;G"02&ER6)1AI1#K]1)30TD_P"0N^/1_*2(3AR2XC'MB0L-$-" G)S"<,EQ
M"-+DYOZ0U.G_ '_6[O"_X;)RI0YL:7\KHTR4U#Q$O8]0Z?\ Z&_=\%:[AN=X
M8W(W"X_DKOCT?R+:5C7@F+UDFT42)2<S&TK&,LD26.!DNT-026,=_$>MB:=9
MHF?@ROEY2^9:G3_OV2B1N7/_  Q*"=0OETHK$Q74U*AC0H?P6I(Q/I_)W?'H
M_D&X'-B39(;(@8DD("1#<(D8UB5$(A"&-D1Z9!D!*OBO 2$Z*C^#^3Y>SX;$
M4&R?&:G3_P U:[X]'\AQ"2Q"PTG8D,?,C@D"25=,R'IC2OCZG2J,;A2(:;&G
M"$N\M>!+L_)AM+;&GH)7>($D-B?H(TRUX$G(FGM#TI$2&O EYRU5"7DLPVEM
MC7@2\EC<*1#38TX0EWC6-!\=J=/_ #3KOCT?QV@;D@WA*$,7D>'B!0)2R)=%
MS@Q Y(G\9%WIJ,M)D"5P+H-*,V0*2V(H*F-@E"HE9E(V0B\C<$S@(5C8.X&.
MF(VX0D"4I0TP(E B)8V"-2GAT2$!#6B)BTF0)7 N@THQ4DH$-)7R#4Z?R.91
M/PFX$I4XKGGI3VT)'RE<\_)O#,2?G)X&H<#<-(BW\"WM(C1C0):;^)Z&$Y;0
MD/\ H4P+:G#[@-0XZ4YPB3)?(30:A)]#1 EL_A;5/R+0I$I3?77/.&X&H^#7
M//\ +V?QZ/X_$++$HPFQ^!913)D-)R=,1.,!)0U#)=/XKPS$U/349:6>*+!M
M]>?R%Q(E$R93TQ5^I.Y)DR1R.GT71EG0.F-*2>!/1EI9XHL-$5_(M3I_(9T<
M.WCX5E^\9WZ4;D;G^'&I4,3CYSR+AJ=DZC^!=!U[OP-23J/AVG/"4.1N?Z%=
M=Q7[XT[#_P"'0Z$TA[^1=>W_ (.G1Q%?NO/PK]WR-/M^2C^"*Q?Z+\?!HC^7
ML_CT?QFX0TN2!=$T%B0Q,A*7 D+HB#<LC4D3$Y1+L3@F7Q&A)"0+IJ,M.6*+
M#9RW,_<260\0P]*1#0L3:C#:2$A&>OQEH<#I]%T8FQI4X:6(G0\9)&X+3EBB
MPT17\DU.G\?.AX2?MX$F]LDB5*PWN$03 H=C4.&;).QN!I0H&B3$FR8$OJPG
MLA($]LV9*BA-.QJ' W DW91LM"6S_>>N9HB!-/3%B#QL]^HI>S:9&X$FR8%#
M*&XTA)DP)+3$S1$"8UJ4/#-"3AY1^CP)-V3 E@WN$)":HY]A8>NIZ%+(@33&
MH&X%+(@3&I4H<RA0J%L&]HBP\+7L/[B'R)C6I6$YHB!-.Q):3ZT]D;010H>A
M2*$J<X;@2;)@4/#<"39,"2TT.O=^!H0EL\)MD0)H:@;@2;*$T-07*H*>!)2$
M]L6'KV&X$FR8%#&HTQO1'!(B!-#4;Z$]LV9*BA0Q2)@2E8;W"()@4/0U&B:%
MH1$":&H8W"EBED0)C6I6$V(@33%GZ/&)W"$B2)4K#2V)+111IH4[$P1*UB=P
MA(DB5*PTMFS110H=C4.&+:4FX'$+#1I]AJ'&5S)H(<C<"39,"AC4:8T-%$D+
M0D/+<"390H8U&AU[?^#H-PI$FRB")H5^Z\XF:(@3&M2L-.PI>V+:;9?N':V(
MFGF7U#B=9;@2;*$T-0-QL4LHAH*,>%*$E/#TA)OT\9)<&I'+>QTS@2;)@4,:
MAP^C8IPTO?J*10H>NE.:(@DB5K^*L_CT?QGA"4]#4H2'!!H64-0+N>ACRR9C
MDH("'0G)RH3A_$U3JJ,M.6*+#"U8W5C;1$:/?#DY0GY&Z%IWB8U#$QIPM(9H
MQNZ&S+'3Z+HR) F8&[H=H\2;0U:8QJ$0[9:<L46%B:$I"^3:G3^-G0DI(:1J
M1B^@D.!(L:7C1M%_M^"R_>,TE)#;A4-2,U]!89"L<2P>DEA:9'%E]@](Q;N*
M_P!//4\+0J2GT&Y$Y5CRCQ5]S36-FV::8J'J;),5S9*,) TML@DI'/(DK0G"
M9;V.?;"R@:7JAJ=%3+":QN1J1ILO]OQU;-(6DXU4#9-"2)PGZXK/H<L>1<66
M-/JOR)R^!N353Z'-%8]1$E)8G*L>4?6K]EY*[L<UZ&B@L>O82&T+*1N%A:@;
M)!;;V-%&%IP.O=^"J[H5C:$+2G"<HFA%AO22P](.O[Z%ISQ87^WX-FV::8MW
M'N7H.@M*</33Z=@])+%8- U*@>7+"Q8TO')9M2]<5W#H)+0G'NQKLL-X7J+2
MG&FA;Z/\#0I/4&Y&I')]A(>BW=X1HH+-T:OV#4J!IA^HT*3U!N1J1R?82'HM
MW>$:*,:-HXLLNXK]\V(O.71P[>,;-LTTQ;N/<O0LOWAE&Q[L>\[-LTP_^@]H
MQU[?^#H/</0I=\6[BOW7D?4+D1)3Z#<C4DUC4."IJX6+]PR+Z"0X*QZFB;Z(
ML-ZA8H.ALTBI>N'M)1EQ1]O*Q1GB_P = K%_HOP.H]I&$H;&E]%\.9IAR71(
MVH1%8:E0-.W\59_'H_C-+%W/0QYPTPRPNNAX18D+$R&FF1Z9ID>T)M"?A(5_
M%:3L22KH:,22KX$-)V)%\!J1)*NAI.Q)*OG&IT_BYT4^GC*L779$[A8@U,%_
MHOP67[QG?+F6BL<2PO\ ;\9T7[RRS_>"^*_85_IYZK+OX%?]]<W6/,MQ5&6I
M%<:Y1)(DF-0)10F21J46]CGVQ3+S?YP<LJQ?[?CJ5_IY&WG1H;@4L@:24LYX
M\F7%EC3ZK\EF+>QS[%'1NNM7[+R<,6_7"+X\G^2XFDC,8<RW%E^\#KW?@JNZ
M%8=1TZ&X-D#A,=>__A:<\6%_M^#</%5]"P=!U^OC' 5_IYZ+"_V_&.9;B_=B
M=PL0*):1?[?C&B_>7AT'7Z^!N#9 X2EE'^\CK]? Z895=O!7[?D3:S&Y.!;N
M\+-Y/\EV2OV_(FUF-R<"W=X697[+R<"R[BOWRK]O_2B_><NCAV\8W#Q5?0L+
M+]X?5H-RY>&I%8=>W_@Z%A==EBOV%?NO)02XC*447'#OY'>+]V*[A[1E]AHD
MNAN#9!I.!U^O@5^W_I18L*,N*/MY6*,\7^.@5B_T7X&I)]233&HZ+X<^Y;BP
MO]OQT)S1&#IHU_%6?QZ/XK0A[8D="@[*R5BO0XLL596QJ' Y6)RB+:&AB<KY
MZ)"&)#_D6IT_B9T<,[ML:&_8FA,;QLVRZ[(LOWC.^7,M%8XEA?[?C.B[>6+3
M+U-H>-FD*_T\]59]#9EAN%(D-3CS+,/]@D/$[@C4B<C4."!/;0T)-Z"3AKT&
MDGZEO8Y]L4R\W^19E$WU&HQO+]2_V_'57>/:/#<*1*1[1%2QQ>ISQY%Q98T^
MJ_)9BWL<^QK#%MEAH4B0TZU?LO)PQ;]<(OCR?Y+AM/82'&)W!&I-&T;N?7#V
MB'7N_!5=T*P](R^S#0M"4ILV;9II8>T'7N6G/%A?[?@:/H)#QLTA:8=!U^OC
M' 5^Z\]%A?[?C',M[XOW#0FRA#>.;+_;\8T7[R\.@Z_7P7V%)>^-X11_O)HT
MR^S#PA8<>S_&+>5ZY3D:@MW>%F\G^2[H+>5ZY3D:@MW>%F5^R\G LNXK]\JQ
MQ671P[>,-'T$AXV:0M,67[P^JT?07>&]P1J1U[?^#H4-DGC:$*_=>3@Q;99;
M@-0X+KOY'B_=A96ATTQ)V^XW+GHVEFCA8LNOU\%=P]H\5@HRPY]L7%OH_P =
M K%_HOP3N!J""8@.CZ+X<^Y;BPO]OQGBO4339(W"D2&G;^*L_CT?Q6%A:711
MXH<N%T-L7?5&R(!R0BB_J*HCX;H6?H(;#4G)AWIRAQP0WHTF.#.+)U U"3+Y
M<RT5CB6%_M^,Z+MY8DT< QK[A7^GG&Z26>;&>@VF)F'E(QYEF&H<H4D/VP-.
MD/3DV6.0:1WH.&-3HT26]CGVQ3+S?Y+BWL;' 3MKT+C;0EL^A)P/V-GLI')9
M,6D87)CS]<:-H_\ L66-/JOR68M['/L/8SL-R*3EC2;$T(MT*_9>3ABWZX1?
M'D_R7#TY-D/VP--"<HD4#]B-/<=>[\%5W0K"2H&*Q^PI,;A0A;=QN;-C7/DL
MI+(YA*4V6%_M^!J'*%)#]L#3I#H.OU\8X"OW7GHL+_;\8YEO?%^X:G0Y=T..
M"&]&DQQ>-%^\O#H.OU\#TY)E1B(38W37L-2H8Q6,TV+?1_C"X#<CD0ENAN7+
M+=WA9O)_DNZ!<!N1R(2W0W+EEN[PLROV7DX'K$]01I/"2[L:7.71P[>,-0Y0
MI(?M@:=(LOWA]5J'*%)#-@W"'7M_X.@DU@?L1"0K]UY&I4,8K'#&I%RQ==_(
M\7[LZ2A:[NE;0-R;&M?<LI*P/V(A-BC&I4#EW'["DY8UO9_CH*#<E!P*2C$C
MD;A=%\.?<MQ87^WXRDK1H&)K"(/T8U#C^)L_CT?Q7X$E]-<(H\+HLQ==31V1
M,2DH>5_4*R^*M403&8G$D$X2@G@6JZ&YZ)G,D[@<"C9I%8I*I4AN7/3!(M5B
MB\QB<QB>B<-3E:K*U6-:CDC"S+]2X<+;)K;IC$YC*U6($XK,3E[PW!$J<-"D
M73V6-5[CTJZ(S!>%K,8G,8>[)Z(G$Y@D>R<03B9Q&)S.9Z9G+<X6JQ&)()Q.
M9Q!)8M4-Q!&IPVQK+]LQT07A:RM5F.B"\1E*"=0-"T+LZ5JLQB<1UQB<1F,/
M=DY@G*U65JL[,R\>G5!)9.(G#W>8G$BU6%JL-3AN2,3TK59O,ST1B2"9_B;/
MX]'\5I8M]-,(HQE,NBS^ 6S4^1:W CL0D]+TR0V2>7V&Q?R59?P[6Y0I*,<@
MTXT0OX/@&Y&I%RPU,#<_,-2H&*\;,F%"Q&Y&Y_I:2LBDY&X4+YQ/I#3I?Q+0
M,2W]9L_CT?Q6D7733"*,=E<T'?P"V,@E'R%I"66%GTVBSM2&HA[^<MI6)IUT
M0]<4)IUT0]>AM*R43F?F:R_["M5_%5_6K?'H_B/"ZZ:X0Z+%,T'?P"WR=J5#
M&F3'A$;IM[FR1H)X5Q^?SB#2$[VQFR*3O$S:@2]1SBV&.V(FR!)L.X3$,3E2
MCPE@9#D>'&'B'J)J?7YBLO\ ,UOCT?QE%TUPAT6*#<$!EF-UK?)X-(9LQCC1
M FG1;W$D-:'AA-2?G\DQLALSW,#0N)--XMQ>68U(2$PFDQJ%@E"C"XGT+L)0
MH^7K+_,]OCT?Q*BLHNFCQ0=%R@\+#2A=C\==ODZRDXM*R4012]>BWOA5C;2"
M0H/S^1TQ5 \TKNB/RXO+,L/*9J,NRDI,@GZ"S+T^7K+^ LNM<>'@N/#Q\M8>
M'CJX"O\ 3S\7AW\COY.O\$V)NNMZ%;WRSD:6W\)6.(K%_HOQC1#0A--O'#OY
M'?RJB_>1N!-F_;SCGW+?Z59=_#P:%(FFW\W8<NBC/%_C^7M\>C^)45E%TT8[
M*#HN4'P^A=C[Z[?)V$P)5$FI.!]%O?";DMO'Y_.':A#$4$;ET1^7%Y9D#7!2
M9[A*T:@NRU*@F$T+'RRLODYQ&9Q'1)&)(Q.(Q<>'@N/#P3TUT3B(Q)1)&)@@
M3FAZL6ZS)&. K_3R21T21T20<._D=],D96Z)Q!74MUA;HG@C$XC$\#U>(Q)[
MDR1B9(S.(Q.)DC'L:)2047T;-!I]B,3B,SB,20*Q?Z+\$D&RUZ^16(%NLSB,
MSU+=96ZRMUB#:($]OIYQS[C0^(Z5LDB<21/1)&5LDB<21/3&5NB>!ZW\&<1F
M<1B1ZL2G$XCIDKHG@>B2,20;K11YDCID]R9(Q,83DB,21B>EZLC$QA-,\7^,
MR1_)V^/1_$J(4%T^RW+'T.BQ0?#;%D:&*NJWR=I-0QIPQ+SA(I="&G"$AB:8
M:-SAI-0QIP).1)+2($,0D+"&YPU*@33"&=PFF$-+Z'6OEJR^3:%)ZV%!P/:D
M:$2#]C1E)QR#4#<"T]RRQ:%D;BS_ .!<>'@N/#P+J4/.O7#<*2*Q[RW+A"@A
M^QP"0QT&M/88MH-E)4>U[AJ!ZH\7^,(]AI(;BRGN<"&@:2)APQ[4C<"/8:2&
MX%]V$L-0286$CU'>6X$>PTD-P+[L/&_=_D4%+'["OH7,52-0XPGW#2RF#QOW
M?Y% -"9;@T0_; D,5^R\C4I#]C8)RN2W=X9$$'["V'L<#]C8)#T-PC1(_8@<
M"<HH(T7H,G<#VI(W)6)PF++(>'T4;$"<#VX-%C8)RN1HK _84' G*%8XBL7^
MB_!Q[%!7Z_EB4ILFAP[^1V6X-$/V$/3&H<%H&H'(ZTZ-&T7GU'@+5"BL>HM,
M\:+MY92"-2-Z@YD2Y<C]L20XS<)T(:#</8Y1(A+1.X8]J1N%+&-[' W%E/<N
M$Z$-!N'L<HD0EHG<,>U(W"D8[L<$Q93WP\)V% /;KDFOD:C6%^X:7.6]PA04
MC]L"0Q;>PU&AXDAP*_T\D2$+#&X%!2/V. 2*Z+/OX+L*WT.(Z]GX&M/88MH-
MDF6[O#QH)2FR=0+.1P-Q8M.B@C1#C@3)C4J47%KW#4:&U 1[#4#<#4%<#PCU
MPT*2*QI9G(;A2,=V..#33$A_1_C'_P #46.1&C&H<?R-OCT?Q$DF-D)2-EA*
M1LL0(=%B@VQ*4)PS;!Y75;^5MX(MOE:R^464(CN0->I(]H/2>^&I4#5)HFC6
M7FB"RQ:DG4$B2H11]O*+CP\%QX>,/*/06'HV:17=T;;]1I>'1E]@Z%=^+(5_
MWU*G-XL/%_@K!HF\-3H8<!:9XJ4?[RCBO4T3>9?0)$I&J;PU(]#O/%>IHF\R
M^@6&13ZO\EV+/$M0]3:&5CU-$WBF%/J_R7828GD;ESAZ1^I?8*_9>31)8=1T
M+=WABTSPZ_7P/%7^GDHC9F<$L<6C9D4%8<16^F*KKN/#QB!N22+#H7VFB2PU
M+3)U K'$5B_T7X./8H*_;\BMCAW\CL5-*>1N7.*#VC%IO<;G9 M5T:(Q[3V-
MD1JQLDR^PT26-%V\LXBO]/..98O3%F7^WXS<76;F\<17^GDV:0G#9>(D2$T7
M6;F\<17^GDV1%=V+&+Z"0R$E(-+G"TR-]^I6/46F?1LVSB],1N1N3T!LD2&R
M_P!OP*_T\FB2QO++PL)M,6^A9]_!=A6^AQ'7L_!6-EC;N\/&GV_)1_O.'T]C
M7 U*V3'105W866&GZEQ><5@T3>=&T7D>4>@L/1LTBNXL.1LTA:P24/._9_@:
M&8BA[96F.+_D;?'H_C<"PVL/#%E83DHQV:(LQ-#&D-0Q^JW\KAZ?*UE\M'H;
M$(E3C1?O.>/[R7^ODLZ++%HTA8-"E%'V\EQX>"X\/&'I&7V"R;'WKH64ET30
M=!U^OC' 5^Z\E2C_ 'G%AXO\'$5OIT<!7^GG-3L\HLOW@C4]#SOL*V;_ %\C
MO-E^\$:GH:7)YO\ )9BW=X6*L^ALR+[#2%BF'GY+,=&T9LOW@5_WU%?LO)PP
MZ]GX'0MW>'FZ_7P.F%?M_P"E%V.0D.,IQ)0>>*KN*V*KKN/#QB9<(TPW0=!6
M^AQZ%8XBL7^B_!Q[%!7[?D5L<._DY"02Z)U U)LD4K$AQE)0T'[B2?8:VN/
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M"2R@G&R W(E"Q5#4,33&$Y%Y%ZB4/;YAN?DUNA.2-3B<-1A6&AK$9G$9J/\
M>1.2"L>AT"<EDD6&E(:BR<M03 D2;,#<$:G#<8C#<;$IHG#4=,X3=G/%$8]
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MN!6_J0G19]RS"L778H+,TI(-1C=0C1-]>B_>7AT'7N_ ]2]2GOA\!:9XJ/\
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MOXVL0-,R#PXHJCXDW<8Z$!=&6PQV=O29Q4AJ3J#O#5Z!ZQBW2Z[&IY*WK!U
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MF9PH1K18FRX+*< OS'$'"?Z1X%L+:',S@9!6!L3;OFX;Y;6=,N,X. <:)R,
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M@;-NFCA3Y@EUV)Z+\3IF&S.&AOO"H@MBP6#H$PBY@"'TSC7=<PETS&OUXHN
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M\7H^CH?9G2>T=F8'N2(PQ2O5#:#3&E]'_8FI.HGA=(&6CL?1X;2!16>]!VB
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M09$4"SCI&3&EO+!<F)\.!7O49N@[R'%_,4J)I;W3TGG<$\'H;.A]TZGW9;R
M$&1ACPA+RI^ T3?+@:\ET'H9P(18JM*+6!N(9=Q4G#$?B=5V)TGOL*4D#O&8
MB78&=()"S67SE[S!4*_*P>31V/4=08O>\I76U8(''6(+.87*](PQ_46H<8.X
M8#<$4@TP&/),NJU@#3C'2<#98Y&L-RXJ9@KGQPGD]#Z,C:].[)YK2!,,1[O#
MC+FMN?9\'=RE[P#+/:+*JJ4HIB[!QU-[/%:D\+KL\%JSH6SQ&B>8TE\0J\+&
M,"!S KAI,RND:[06WP '^ CL^XC/Z$1+H&*_$K8!0*4XZRK'*Q2<B"BUA. U
MYPFP"@-Q/"Z3S^CZ4<%6[.&/6(6H#3A=1P+./M#+M8,&R_F$R^\#3$ WYA+C
MK#)*:[+G]#AU+ Y@R]I%%Q3B,O"'@+EZ$>S"!K69UN,)>/<W!/\ /HZYLN8$
M4&9-YQF-9L&KDOQ+\N,G!/;.,BU8Y@^;H-N%5[UWL\%H3J_8V>!SG4_.8]X!
M#2E,'@G'\3U*^.D#MEAJJBZ&]GA=7TF$L1T(K\P>E@P#7&.+1+."1TPL-@/-
MTH(J#&@/HY3*SE8@TX0:C&BQ75]+>L]YTVSH>SY;1GC<7T+(!".PRLJ^;X8E
MX:E>]1]B,,FZOYB_"X#?" +)<A<:YP2.58=#+C\ /:<@AM(O!9L[92K@R<\9
MX'0GDM#8GL)M;G3DQV/(/@^;YC!](*[0%H#FFWCJQ!904TZ?1X#1GA>,-E5X
M.CNZP8[^D,!^&)"#2A/>.Y4 K#B[B,*D4N3$N(#80\R+$UX#%K<F5Q-F@TXQ
M4EC?*])1.G7#0@  H'VG5^SLZ-L]!V+5J&A8N$'MDP+#E",R%DWZ.'!W/O!8
M5*<0P_,J50^J^&P=*+>9P<S03?9_T(NWC]Q<#C*:WFZV)F\KW;#?8C"MX:_1
MF<OM,,#!;EE\Q=ZOCN+I?H%<TC)&8_V"NM-1RK1^E Z'U]<[_P (-R;@ME0"
M%&*IE]-JHSB%58X+0K$5>%[29)F<IVO8^KK^YLR^?T&RT4<0,+@4O 9(J;_I
M 4!-&&,&FH>$1 HW)7_!_C(&$>F43'*-7*+3*)C P_G##[84CSJ5RB;Q3[F,
M,UC*[W+  H*#:Q>O%'WSE66<6.\X630;"@%B :>\;.+: 7Z3%B-T!?)G+"#;
MVV8+ $;'TC-]*0)/2*R M*<6I8S< Q.&,XQT6>T9HC:"CE%J%C+A0_3P\1=4
MI.SBQ[7.#NL/HC24P*-O:&4%2%B0V!8 E[FRLX,JFHO8+X!\S/+T8O?/;P0&
M3&T6<"/:Y1T.> O-V-<^BR^J0$ !0&0;"9Z4 0>LR& #0>D! $<$=\>@+K>Q
M('+&06/5@-0I"QF&W:IC4?NV8D?1CP 4H6]MB H!%CC!"0*!B/K+'.IN[1?B
MX!AC5!%.,&?:OG:]?6:+/M+$J:T=6!R+ "@VLWG,6GU(:,<E:.2P<>E4%7K!
MR&H% ?1U-&O6ZVYO6%E]:@   # #8U>O!3[YRP \0>RP8*Y4@V-)3(C3WA,N
MR$#T-F#G:H*O6'#:@4!RV9M>%E]:@   # #9C#>K%[YRB+.+'><$ D?3G%+*
MS;6]JA&T,L??<    ;C8[8LUCZI#+ H!0'TZ9-!ERTAT)+%:GU=C97W));%G
M CVN'4_O<1]<_I3X1$+&*15T#V&$A?)%IZL0MV=HB@ 4HV/3Z%+U3O:];K;R
MX8KW&,N8O /982 <@H-A0"Q -/>)G%N@+]-F+$;H"^3.6$&WM+4=]L3!?B%!
MCIB\9U>8W:6[5H3>N$6GQ>/%H_/TY@0 L9JQZ7M<*P, W!'#WF%C*0KP#HP"
M69(L>KM K'4:];K:C3+4E>=;0)(:&Z];K8" **1WP+E\&3UKZ>'B":BN8>E[
M7-0<85\]B+,$%C*:#P1[#&+TX+]SC" "W22YR%06]H4 L@-/>69%N@+]-O#U
M!-16P7P([PK&]<1]<_IQ8C= 7ZPX!;AM[;#H RS#DPI%G%CVN<#4$7,-.U36
MI@%0!0;'[OF"SZD.J)K1[+ 0@8 %!$$1+',9DM(&3UK8 D0X-UZW6P&2-#<.
MMUL?/V8V0'./2]KAET%!H1J;1.!">*H:6O\ S;83FZ0]F/GTI J]/^ANJ)X8
M:/SZQOD=/%"87ILI[($I,<(IQX(XZ3Q-N9R^TS F7;1W/HRQD <2/D9WL3<?
ME#60);'UV%-!@;UH<9FA5K5;@.4J]*DZ/U]<[_PF*!0"+I_NU"UB7@'YB54;
M8E,I6&VKR/S%9L,$AA57*MI,DS.4[7L;+N"IFWDX#RXQHP2V*Y5KLZ_N;,OG
MM9T1L S8*Q@66SK"$* :WC\RI;ANH1>E0O ?G8@B.3+FH ,V\O\ /^"WWL@@
MP=,X6.<.F<"X$#^@SD,N'&%SM4"Q\W05=6%G2"AV6(KFQ:FG2&(=/Z+ #I7H
M[F4D0P 6<+5^H4/:#ED;0IQ?]ELP!<R&A_R339C2&40HU@V67S#!O'6U[3#K
M7)./_K%+#J&7(X'_  AX+!9=BU,XDQH?ZE$1F+/2Y_\ 2F'@CZ+$@$"5NU/3
M8\V7?J"T>$4^E3R5/1VYG+[7#P%*1P!H\>,SD*!22V"U6WM \@YE^\XH)"ZQ
M&PX[H:<V @& ;@^OKG?^"X.%P11>=X['+)0Y-Y?[]&&,E5I7*&JL CLIR\2X
M\W83),SE.U[&SR6FSIOALZ_N;,OGM52Z5W(1SJL?:8%%4B%;OHKX!J@'*M@E
MD"V'\P,P,UH2@P&Z="$PM- 0ZF\0T$K$=C%ZG.LH>;LR_*!=&B>5(2%&0(K
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M;S*AA2WK=PB*PYZ,<%DU@Z(\@R(IWKRNVSRN&WIT[?N;& W!! 9D>A_-OO9
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M$,64#A_Y>8&U8#A8\'O%("J&1I$CZ4:8+^#XF7TJ9(;M6"AA;:&+O6W,Y?;
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M(EB2TL5=%A[74*&U 4'I$1]P,!%S<C.#F'A9#1MS.7VP  6T.CF=WVC<N\(
M!A3S@K8;>J>F7263IP'65,41:6NM=YBAI#)#Z^I?\\SQU=(()B.^"0?_ "^2
M -V4!JQ>VW0@?/65,-=L*#G'D&5V 52:[X6@>"=N>W,Y?: 4@[*DP2F"6XNY
M3*,>8Y,0?S+$*-.9Q./>*3;PAZ./\74O^?=YCZ3.%(D%4'_R\ORVG &@]@E]
ML+6 X<L67HT2]"L'(*,SQ+?+$A7<JG(W7UR]MN9R^T ,(@AB4C\2P3M$?2YB
MFJ&=)C.$\F778, ;*U]CA, I<MZ5%*6##=6?7U+_ *!58WZ06Q8YS(Q@\?\
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M<7I%+6LZ)%8J7 =B+LAPCM?<A$@F"8S&W0?Y&8+G]HN(;$B:@Y?_ !.S4_\
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M]>ZV"ZO&MC2K,T>K.6Z4W8YUN"QX2_47+5P6\^C/I&Y5\%WFNW,Y?T(,ZE_
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M4 UBQ:%:IK85-HO%;CH XA&2]*5<8)/ (@ 5<@A5EPYL(8QHE1.I&OT$,,7
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M UQF931(^I.]1?GI%X :EH&..6!?)W[#KZ;@E>J:0G16,VQ!"5H'+FFL5)"
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M M9C!72@OYB];F)-'@0I(%V/(2/<EV[G(?1G@<XQ?%>X&^O6&4[]]OH82MB
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M76G>1<K ZVR<'#.*L"8IP],F)K8E RBE]D3@_P!1F<OZ'&=2_@XC[[4:!O\
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M/K.DSR6K.B[/"\)XW6>!P891P'H#_=F:\;((QBQ[?&P>=O9T*)AXQ03K,P;
M*'3"'MIQ =XI"%!B6_U/"Z[7/S]H(.,#%O?0OQM16Q-^"7\1FW"T]3_)Y34A
M#F*';X^G'YLB&:H(]HX$N7549U<& (8!LAR\O>P"DQR7A'0<#/4_R,"R*3,9
M/*&MA.9#092BS?\ @QZ35S%KKGILHO<'0@ T '(V.JX+O!+^(C+@E<D&9?AB
M[&>4U(0YBAV^-F%-X3W@A0K16'##"75[R!WA&*PS&=1[)X/2>:X16.A<J&.I
MXKQ0P,-E1,'3P2OQ$L."D]S\3P.A I<D\@/SLWP"<#NZS'4"#NO_ &HH%N1
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M<;7ZI/ YSJ?GLZ;W)UON1D9B'UI^&6OQ%G!#_=B"T@]"*UX]R+G0Z2,HZD.
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M)T.%1!Q:*RJ])8BXO%IJ[TCVZ)L>]DQ^_"V_4;H;,"Q'!)4^98JO'6*D;'.
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M'K/(ZSH_G"HM@<&8&"Y?ITQW,I:5PGW(X+6_Y#'I,@("6/\ 19G+^A9G4OX
M5 Q64F^'#(Q@6!OMQ -/28#D%N443,K[EC XZ%P]:4..2 *(&[*%8G&H8N<;
M:K@?SXV-^S#6CZSN^TZMVC2)NGZQ_,0%*AD_F B*5G/UC^8]%'0V:;W;RAZ3
M95@P.//;^PQA(9&YD1+A3TE@$#N146$O#>?4>=XRV$YL%GS'W+F<OL[," N%
M64W9-R;IN3? PP@$/L!:-281@K'H^A7E]-E=\!ZIET[3/(AY_L>T52L\;JR^
M79X+0BD.#)SQV,M5$<TH[QPS!WVKYGB\2==[D8,PK?4_R*MX"O!*^-F<0%R)
M?_N@JP+W,: ,!O.5RM!+;6&JRF6#4]T)!!0@8#.K^<Z_M3SFLZ_M3SFNRC>+
M]%RZ]YBM(4'1Q.MS$&!G>WAU^AL7"'.HNXEY%IAUGZB?J(3(K +'K#0#5+67
M!<$4;B%C)Y4]6;N7(8#S"87%X>\$0I:=)'XBH5<',1^-N6*X"+=88QD!@(]:
M?AAMB81C28?,_43]5#H@8 -WRN-26OV68>#'6.,_43]1,TMQ1.L% #1DHQ*]
MHPE5///XVN=8#V ?$Z F7X8NQGBM2>%UV>)Q3SN!"%,2WB-_,,SB0YMG?8IE
M6QS<#O,ORR^CH?9G2>T05;<>F/Q&"JAYY_&TFMJ+A;_D9R5W&OB>1T163S&P
MC7$A]UG6NZ>!T)Y+0^G#+.VZGS-Z8%R&^TL0QJ/ _P!92J@K>)AVJ8F@ND[]
MI4JF/ED><8QR[#EE\RL^NCIQ[D_43]1&IM243K"U!AY*JB)W2;&.!UGZB?J(
M=0;"+>\4A;&.Q9U;O*E@#&86E'"8D45.CTB-!ZBU]8B!<UH/6(!!B 5+]1;W
ML,(S2) R&=)G,?"K@ 7>W$YLGU^CX_2&MQ<][^=B/5:/-P^8KTP<O/#YB6)A
MBOLPDN+$X./YV* K@$LV*_W0 R8$ ^\I.KD N7:JWU=,IG( -E69<X_ 1=NU
M)T+LGG\&P;AY4+?38<Q>RH"4\@BBC%AY81A+H?,PV.MQ,][^)GF\/HGBM6%
MSDC;WCE=RU@+ETL-]71P@\"6*4K=<7D*V[AO#I&2F%7V(KUG9;#Z% (N7%@8
MXTPL9UGO.FV>)TGD]"-P'H,G>85%2Q1;<[XB*TT_.YA& Z*HPGGM"97A@SJ?
MGL !@[ZF':7JW=P3_'8Z]".D5KQ[D8Y=ARR^96?71TX]R?J)^HC4VI*)UAC
M &2MVWQFDZKN;/.XLZ+N;&L&%7U",)8[UK'8CE6QS<#O$(,%/:OF>!SG4_/9
MYS2==[-G6>\\SBVH4M.DC\14*N#F(_&W+%<!%NL,9U78G2>^SS>J>?TV=5[P
MR)T?LSQVC$H,7;B/^P3.*/O?SL"M569FVL(*[2*J/>']7!Y69OO#H4*E<#6-
MBI-Y^=Q"%FH50I^-A^B]TZ#VVOGHSU&$G")ZT3;AD%8$Q+UB@-#)(2UYU*03
MU9CN(.6RWJ],H/8L)FZ>8U?0WB1>XAH:>49U/U4_40!6WPM[RCI<;B+MQ^!A
M'BM#JV(18 6P0\D;'3^Q.G]MF7X8L\II/!ZD\'K/(ZSH_G$0+FM!ZQ (,0"I
M?J+>]AA&:1(&0SI,YCX5< "[_HLSE_0LSJ7\%6M8##2C5UA'M-:$);MEX$+'
M,;SYPAH!3?Q^Y'$"Q&?"586(:HC*N?@0>1L8 01HTZPQ%8VP_F)WFEHJBYN,
M[OM.K?IZ%.N._P!%;=^!&1,]'I#=Q-;0GJ3SC.EJV[4<J86L5IJK<OI/.\9;
M$+WKA@Y]C]E9@0'"->4W)OF[-(UY0-0,OLZ05W^,8VP#U-B.F#!]4ARYLNW6
M%V0;+,F4:7[6Q(4F@CB7^912EMRW=.^SP6A':>'#?6\XDW&3% GI4 !(6J4K
M=AI,&HL6>X)XO$G7>Y%6I.+09,1G'%L*>90S6JQ!$CR.$IHK0EM^ G>;V8"-
M>N(*3M %ZRY RQB!*W8I]H="*&99S75@XS%*O>=?VIYS6=?VIYS79O6$.#NZ
MPIX"%R;^)4>L-R?[?TN02C][.O25XM35>+AE%H:<"5?B6(KIY07>RA=7>^\O
M\:8'L>DW?C ^YZP&S->.GK$]XE[>U]($JJC@C!%IDS >8,?L&P;5\&5O!2!Y
MB[X_1O3T#Y@8&9QW#*,C%;JL@-A[R1(%R.U4!PO-B.A,3Z!\PZ[8'!AM+P8X
M2RLK M>C,ABP#5\6,L2T8-\&!A!PRFY8*YY>D-",P!MQ&4$90!YO&$*!A;S>
M-SH"9?AB[&>*U)X779XG%/.X$PF@Q&X1T=7DEQO*!KWBHR*S.$,ORR^CH?9G
M2>T!@L2DU@RLUW;F0BIS,-N(_F.F'X-KU8_8V56'XB'+1AZ0_JBG0?Y'*(X)
M1-PU&S0\%!ZK%SBZVYJLN!.M=T\#H3R6A]-,%^N#'\RX74]552UR@.8XO>54
M8!>3@_$>I2#TM_V&]01Z$)>W*'VL63E^)AYP_!->C!2[, :.JS.<7VXO'U8!
MA0*"+TPD]0BJ"5@OBX9,1D58$JP>I>MC2.]:;6JSG5N\\;BE3 ("OH<0&^!O
MMMQ>8QMFA&"D#6&\$2)M/," YYYQ&0A'>8=M@,*/8",Y+$MR_P!KZ/'Z1_N4
ML\-Y, (K)5^U1KV$7F]8BP@!S&X@4 .,Z($[PN#^X/N-X(D5<#!4!PB%S?/*
MB62!2;]3VEZ!X#-&^5^!HB/M4MBF*%#6XB$,$'>-_FD8A:6]D95,8PNL1^(S
M(H+(SY_0"Q@ SWA%N 2&;UF($5D*_:I;P*P>.%IGF\/HGBM68L@J&:;SS2,$
M.US:TILCB(^U2Y,PHJZR"(\25=&_UN+/#09NKTF_N69;K$TF#6K(*^U3BY0%
M7?SF%[>#5Y4ZSWG3;/$Z3R>A%4/,8?\ 85$AA!=1B .[Q[]<I;H!2<0+UAV^
M*M<PF5X8,ZGY[,%*O8&8".DGEO@NG<<3V8KO>&CC;H$Z[N0E[<H?:Q9.7XF'
MG#\$UZ,%+LP!HZK,YQ?;B\?5@&%!0;?&:3JNYL\[BSHNYL36*BS=7I I4MXA
M?+2(Y3I3?M4=$&\<W*)2*6?^D\#G.I^>SSFDZ[V;.L]YYG%M!&Q4:C!%IDS
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MLM7!B_$6J%]%_O;Z/'Z0!A%;AD9,;8NE*^]P.1Y8U<C:==9*'K_7K$<H+7O
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M!ILJ@(6#N,LK12Q<6]WT(-P-YG$=T?NFC_" P)N*O/.&P"@*)3VFU@X-[Y=
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M(Y-G=]IU;]/0IUQWVU*RQQ%QVFDXOGS@PV7##-*%SP/**AT;AWM=CO\ 0\N
MUG&04F9])YWC+;T;'/\ GLP(,<IA?A/UD]DTGZ29&$#A#[0AK4HT]JQR?#K]
M (T@0UGOE1H8@0WU,$03'WZOQM\%H3J_8^TQ9$BAJRZBCPUBO01P&*)WF;Z?
MU;DP@&8WD8F-A@FI./?5[RO46%BNZ_Q,-T%689']BM%N4,LKUW Y^.$I2 '
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M .8A8Q#4IZ9Q3W:1;QGXCE@+$WG\R?PBFZ;F.H &)B^CR6C/%Z/\R8T(8$F
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MFCOZQYS C?C@=)@W&PJCBQR4C!:/4E,5*HR_5"<6"R=1A475."3'"/,,CT@
MEB6,<N@M="6%7NN'^ E6% < F.H-:-7C$*\M:N!>^$5Y8U\"]TN@/1\7^?KZ
M3W8Y.0T@8!K%TA3B_B4^5Y!?^P,%!@&X3I/9@Q14[H5O87-_% ]"H[@UMYXQ
MP"0MU;O2I77%]=EU[RXN-7P<^O?9=&JSR8OQ*)XKT3/KVEL0"K><B.8"1H!R
MMF"%<31?&'E> (O'\P1!,F=9V+UHL1BKV2EJ;PJ-5W1247!:/4C.T<18>64
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MB"LF%K.<, 8PX)J1K*8AO&='[LI*OV6 & $5 'M)KW@UE#\+L_$6#!CUV8-
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MI!1H  W&PC4!:P4<F&Y+0;B="V7*V! XN/XF&RT+,3P)Y?QS+SGW+$W1!MB
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MU2*CH?E+4/>J'/='#"!9UW=6>=T8#-@O8+L<2&M@ !#GYB>A!-T'9OHO:(%
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MLZMW9T_<GD=9T?SCY@>W+I@:EA<_6)^L3](F(T%#'&>3TGE]#9U;NSI^Y%I
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MB7,<H"FRHF@'M0!\UOU#8.0D/M/!Z?1T+LGG\&SK/>=-L\3I/)Z$QA!B/"!
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M"Y+8W$OK*@K7ID2GZK-=H10FLJN9";@+$WGT#VH+JNKK67]'5PEPO"HM8K$
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M!8JQ,;C@SSAG@P0*YAW[ MJ'C=TFRF[E&3VDL;:;]G<=IYG1,[L!P6,V</\
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M_$HNLP6JF](E%BK>QRTLJFG*"FD#>KJKREYXUP;9%9^FU9 $+J8MY5%JL L
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M%HT[<X#[3@/M. ^TX#[3@/M.K]B=(V'1PZ#V=G60RN<L9/M. ^TX#[3@/M.
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M,[_R]9[SIOX?%:$\%H?0,2J,@QBH05#>8_$\/ILTC "5R+*@[L*&\39C4EO
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M&/4(T@EV?B/V'8%J^##1T8)Q>>4MS>,R%VP**VK> T9_X1T:;8%KWX:3%I-
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M="EO2!:;A^8MF8"%'=EDQXN'568TJN]UQA"-UIU=\1@P8>U?$*VB6N)AG H
M<9T0)WA<']P?<;P1(JX&"H#A$+F^>5$':W!J,'6C@/#RP8K8-@VKX,262Q$!
MPU8OP;1S,39Y/!+*WE&[>Z.^G#WC-<,7L,(L(XEQ8KM%"*.3A#2.27HL\AK.
MO[VU+*<I3Y6JW8W7,AI3E -G49C99@&AXLKPVMR<;KUC.G!#45?:)TH$)=C7
MA+)IX6?:-8&JC'A#2;@\R]43Z6N\SP]8C'0Z*6#C63'-Y6 *L2$O"XT0&*3B
M&]9S 2&QAC!I&-3J'S]& C7KB"D[0!>LN0,L8@2MV*?:'0BAF6<UU8.,Q2KW
MG2>Y.M]S9YG1G1=R$'CE#'M%WY?@8)PG@G#UWQ.,A*8.XA+T$1W-_1TKN3JO
M9L)>W*'VL63E^)AYP_!->C!2[, :.JS.<7VXO'U8!A04$ZSWG3;/$Z3R>A%4
M/,8?]A42&$%U&( [O'OUREN@%)Q O6';XJUS">*T(#(-#6MYQ)A9*S*STJ6P
M(6KFN6DP^0;9[@GB\2==[D\/ILUYO5//Z;$!,2CUQB2K W!YY03BVSHBOS#>
M);S 6_2*.$E9]HU"DUK&!BW&P]$CE*ECB;S"$8B6S,ITWNGF\79:#C[/,^8W
M!+6@_P @[48.!L9BK;/+&+Z+@+$X\8WX2*K%JAPN+^V82\Z-6[T_DS>7]#3.
MM?\ 3.AC<3?%T05P?O1$[6P,^8Z2Y#HH6ZK<'TEC$60-G,8(8/Q!RY!KM*98
MHP1ZQO+05[D)N3>[!^8<-J H-K5>"H!KF,T @YGB['6!I5C+$58"5=[@TV4@
MUR,.0QE]'@O>R#VY%E\A'IZ@<1=Z;'#UNW.6D6HSN%>T*.FB^3* +YF/,=E,
M.X<E<&*$#0_P@ET0?Y2FS>.;S/T@%B#DKQ(9_A,_>&$\V3EIL%BU(6,7W'D/
MGK 7T,"[LH9#*<1>NR@%6 %6N\=8JP-"L=E?<;"&!6\B J +G05L-MM HN[T
MV>=P0KGFI@9F^!OH4!][8@IK4>IL56(\0,ZU'2$0%60N/(VOD)OJ7GN8_!M#
M=[P(<<#V'YADP* * E%:+6#@WOE]3"A*] V*,BVF=)4 *" 28G V,D/7,Y.Z
M,TMW%7M!+H _DRCQ,W-YG917"PA@5O([2B%YT;* 58 5:[QUBK T*QBYZW.[
MB.Z,TMW%3M"CIHODQ.1.;CS'9Z0O N[TVJ.S00%'6QB:%< K[!M/ 1DX<AB#
MAHEW(9!&X"]YE]4#Z*5LX 5=[QU^@X<.4"+%#M] 4ZD *OB.L42A%8_3@]E0
M HYC&C1DS4;$L)2P,^8Z14D*+%QY$S@)8HN9Z?B9LM!C[PF@LL5.1D;288@Y
M"\2 OH2E][C\[+FV)6<>BFK*JS0X1 40DSI*E_T:&&)6X^G!Z*R!LYC 1@/$
M'*] UV.L#2O&6(NP$J[W!IL+%B4/7^HXT6AQ^]P)SC$Y&Z! IQR8KO38239E
M"_:!16P19T!ZD1R.+Y$,H1N!>\W"5(=I$*LZ265PH88E;C8I[2#1=WIM!9LR
MA?M#!P)8Y@B7P4Q+:]V#U& QC(5@],H *ZX'(CK8(7V)C8G4&[B, O4*'?B_
M2 6(.2O$AG^$S]X83S9.6FS=EP?B)UEN=>I"28R1[A_L-CX$A7M'Y#!S,)@-
M(6,1V/>*GS <D*7NPJ[44O:_'IL*N9Z<.)""J&Z*OO<% MT5<.NLE#U_KUB.
M4%KW@4XW8/8?F&2 H!0&QEN U6H[HM= 'U61L3730=:@U;PS$7>FRBN%A# K
M>1VU +SH(87%0]#\Q>#:&[W@%2[L/LC$XP53!W9<(G?$+#7L1K"@L'<9?VFE
MBXM[OHS J!'H9W G: 4%N5^\W:=#YU@( B4COCT;$@]@_P!A>0@+NS>:E.*O
M6-3[0*BN\,)N@D4L' N[TV@5"D+&+[CR'OCU@.0%+W8-;K*7O_'ILP:BL@<.
M8QL$29ID[?03/<'<ZD5ND#^1#*$;@7O J$I,+SO6.%!)2D]HZP-*\98N[ 2K
MO<&FQVT0JSI*EG<*&&)6XV4@UR,.0QE]'@O>R#VY%E\A'IZ@<1=Z?0 P:5TY
MW+7FX"5=[@TVT. R<GD8I= '\B$TLW%?O#Q%N-_-W[ &;,H7[0* TV&A *(,
M.9&\4Y<U!,# 9&"<&);H8%W('H7,?/6$;H&D+&D4226!,-^! N[4L&?,8-)Q
M,N=$(FVE07WLB@,0,A<#8ZP-*L98BK 2KO<&D6X/;-3"(RJ F/(B*(]N:DJ"
ME! ),>1L#F!6;9Q-\N(#(5R><!<=,&*1N%>T)I>A7[Q0XJ,VS>QYRXI41W.&
MS/# %G%6L+$B4,2RM64(NP JUWCK'6!H7CLM2HI<QQ(?'B%"%[\ VE#:D+$C
M%R[G8?S#\B"KWB%S6K]&G\N;R_H:9UK_ *>@(U#G,!\IF8P<,_\ E?.X)X/0
M_P"L7"A@N"7<P(;C2SE&0$P"AQU97A"]W[ZYL"BB*J2LJ][&)A>X'-_?!_PP
MN\WE[HMJ5>KP.'_+9O*7+ERY<N7+ERY<N7+ERY<O^?F=:_ZB\O1J0<<X%0<?
M^4P]CP"Z*W,!&A :!_UC)&W%Q\UM,/J,+4C=@]*F7V *#_XQF\OZ'F=:_P"I
M:B&XF^/3*"N#_P"6\WE_0\SK7_5."AO#G,!\IF8P<,__ "UF\OL^G_S,ZU_#
MF:Y$Y*W@H@Q\G* ,/)RG/7>ID0YG_.WEZ-2#CG J#C_566WL%'M%873[+?M:
MC?H16#+/E>V+ AL;D&AU^VWI<'?P(H.P2QM>-;LHJ2:2J6] L]OY-Z7!W\"*
M#L$L;7C6[+[#?Y&"K#O(SMJ'53^2MEA85@:D1Q:A?;[9I?:@5E]U8?"FCA3K
M+[$& 58Z$QD>T#6)K+)4@JQLT/X[4:"UF<260A%5:GW5A[A85@:D1I85?3Z+
MVE(T7BR"%<>$SIA+EQ.\,6OL]7U"QQU)0.&A5OV>(M\T;*=28#WC0HK@0, K
M1H" %&@P&M#Z[WMHNMOB2^\[4"Z4W?;6**1=;?$FXBL!=(W?UN;R^SZ?_,SK
M7\#,+A>"+P%-VGX@\*PQ$<!T4/P%$W77 2ZJ-L*?B J (%/Y@5H%E73WHH0=
MQ^(,^1^(.V5:J*,1.9_Q340W$WQZ905P?N+)9K]-FOTV?4XS["XL"BC;9K]%
MRQ^BS7ZF"-Y]8%!>'=:WVVV2SZ;OZK-?ILU-O@-&>-T8XD<9]!<';<LU^FS7
M;X#1GC=';9J?R^=P3R>A+-3Z;-3ZNG]B='[2S4^FS4_BLU_@39K]-FOTV:GT
MW4L?KLUGDM&>+T86T])OBIO+)>6VS4^FS4V^3TGE]"6:GTV:GTV:[;-3Z;)?
MT6:[/$:)YK3Z$W=)T(40< Y;;-=MFOU6.RZEW].7X9SRFDLU^FS4^FS4^FS7
M:Z!J&XQT#6F\SP>D\UP^BS4V^0UG7][;9K]=FLLU^FS7Z;&=9[SSN+Z;EFI]
M-FVS4^_S>7V?3_YF=:_@ &\_&,2KG<3))M<!B%WQQP&(7?V8CP:Q'\REK:JG
MH@*+M_/^4 (O0F<"N\*UX0M@<0F5R]1,IT$&<_ 2G<L*K'XATF&C_BJPCJ(%
M,6 WC!PS^VP)XXXU_,MIE%0>0QD&)MZO;&!.PN2WH["@@[!R.K+$@Q6C\1#4
M8FTGH8RJT5K!'3\MC4Q9%"VZ2FV)7:N/&""L$ _F8+P U(XY7Z3)//DV(OBU
M"K(,/68LQK=!AA?K%4, (#E<Z:%$'[ \(!"[T_"BY[,X@C'$4SGB[S9?X)Q\
M3_4!;K=W]%_$WJ.;@<ZC-@\G X7CL=S;?96D-,'%$A<.%E^/>*?H,&0UVE'F
M*N<3"H#6;W86Q2\M,#R[R]\"V\ N'&][$LS ?$>AQA.=Y5QY7\2L=Y7 YU\Q
MAS*#"VCQV8Q"@ 8&Z8?!3K3542PMEH(X.W#RIFI3$BIH]X7)6U7H'&6N.,J:
MY[X^(X&3R/'8U!!M7$/YAR'GX:?B(L'QP%@X1HVWD7$C#69-1CB"PL0QK"XD
MA0Z/>)%311;5;L;@J6"D)RO8)4->.0U>,O '&F\MWM&8#$;2>AC#>*UD8Z/Y
MV/<058NW27&22+6QQW<XHS.Q+W2P8Z<_.4<:S".(+"Q#&L+B2%#H]XDIL"*U
M5X8W$_'1+G!J8L=[#8!WOP4<D?0RX)M8Q* E)Q)>$(09UDNQZ(;%)O:]I=YZ
MT"TPSX[,W_E"#/$](L^(K0-+XO2>=P0YG8;H5:[B(61BT=R6,)3K>2^T5&P$
M=1AD<K9FZO"+.,FEQ_V8TPQH8M<)KIM>S [DH;_HZ7V(>/@R5XK='[(Q:@]F
MXRVM#OBC\0 2Q+&7"&\2ZO""Q3-/QO>&*Z &YJ%*5')[D(;!K4&9,.Z85 [L
M];FY05X._KL5ERP0.)Q[0.XH*T&E\;]I0++V9OQ R6I2X[O>8Z(QJ(>QGPV/
MK"H#$,D^@BBI8;ZM!T!=V7%WL1G$#<?9C VVV,&]'\[*!9>S-^(&2U*7'=[S
M'1&-1#V,^&Q]85 8ADDJ:BUEPE*ZX3&42&>A@TC&:6)P?Q%TP<$S6C!)EI*3
M$WPQVAL#C;*V:03](981KAB7J82NVNZ%<;G]&.X8 S6XEV4S"@<?RS N..Y=
M9;0C#*<!$>,\7HS#)M2DQ-\.(DBQ=FLQ=AP&]N(A"9WT./\ L0V6:AN68+3+
M:X+E$>L0E'(\C-=P2W:%6;KB[Y;:-^JQ=-*F8AP7*8_P!GD](QG+O04M[B%6
M;C1>Z"A-I]IRO)C6TB:C#@&$7+F\)2L,S\&E2Z -RMJO-)[.7I,-NPFCO(#J
M\M*J=(E*N*59E<$UA</6XGO>MAGVB=Q>[:8^DQ6KB G="X8)U%;X].V*3)W;
M%=K"7$X3C+EW%5'E?Q*1<XOASKYC'@G#P/\ 6QPXTQL>4XP%%_1CROXF$I;$
MQ7!TAM.&JW- SS6FU!9#!=-;R9>Z8Q?.7@XXY,H>(@*RJG27;;L&@4#QQG%
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M=C/)Z0B"K5-Y'ML#($:-Z-7VB,Q(O8I"P046'K,+ 87J.Q2.  <:PJ^L9!W
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MQC:[)FO9O(A<-VT<I6_>P>76$:  W!"N'X6=-W-M+;6G+?T[15AOZ%BP  ,
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M@548ATYSP>C Y?Z=G1=B%,+P-F/QL&&K/,?H"G#P9Y338%J\4GF]9@B+CO\
M4E3&, +/S=!47SJ]H#;Y@ 47Q*P3':KH<)>D58W/X@(,8#L_GF3(\W;7M$K"
M8%%%'!HYHSGBM28UA8C>!JAI.'357M<S!K0J/0_!#9P<5S6]AOR9H:\&1-T'
M62I3)0B#S"$0$\"WT_$:XYHN[G?"! S0EHXZQ7=[A?=W2XH86.6RW7.7OQEG
M!Q/F%? QG5]Z":48#[4-:+6A0Z\)3=6*O2.<:8>@:'X(#U"&U'Z] 3$8!8ZE
MI8_),$4UCKVBUPF[!#\L6%T4I5,$8JUF#J,#7#:ER]WL3I_:!0QYLCHRV\7:
M%<S_ "9< TOH2QX='F!6?'&>9Q;1#L$34E =-#AR8=#S(K>D8<H@7+B0[*L!
M@-XATC$8F&B80KA^%G3=S81*8Q>SP@<*<PO\\4H'SJ]I8H[!91_$3_\ T9][
MG\OL^C_S,ZU]0M.$N7E47!,%\[6:1Y$O*&QGZ0C*IK%BX(;K$B$L2F/.7!WH
M](*#B[P%R+C&--7A%8]<P^('Z6(_$<%TD"Q#>Y/Q&M:JK#_(L 5J;!+'@RP&
MV&6.\@$#F15;7T J@5X1!@<1S@ES@;\R*W^$\D'=F/68&UPQ)1CP4QA/?7-W
M<MF .D%^DP$':[U'JT5IPV9'/.K=YT?XG3^\RN7Y@JC.3GE$1 MQ#&<3[/S$
M#J(J0['-M0=>%QFK5;L9U;8?3#Z.C/F=.=ICA@XMUTF'FX)N=9D\-\[#L3S>
M$ZGLZE\[&/S,/ML4'0MM(-!A6.22\</7'*#)S<AG/ :D\%K&<'*7GIL0KN7<
M&+YQ@[X;I%:9JN6Q+2\ Y3SFO\STT!-\:F,%N#]ETU?NE*(WB>WT$T+H3WG%
M"PGMMH=WTT:;:-#;P P23C7X3V^CIJ_=.)$"'Z./B%?$Z:/V?509;7[1U/NC
M=JZGV;:-/IZ9G2IP\$0ZQ:T=2[-J I!'<SBXAN[3A' 41&8'G 9 .6SA/)+U
MG"?Q!TE&AM-KD_W3C8@3VVT.[;5Y[>$\DO6<)_$'2)><M2]5?$-H?A]GU4.[
M;1H;:--M#NV\+B DXP4">T "@H^FC3;0[MMI0WDO:&T/P^R()26098#D;:-/
MHX7$!)3"U'X(   ,@^FC2<&^$DXU>(?HX7$!)3"U'X(   ,@V@$ CN9;BU/X
MIPN( ;:#=MHT^E.U9@LG ]Y/:5*K+90;MB9*W"R:@:_X0.%9 HVN!)F)9.N3
M&[0$(,@*V4:;:'=MNY&]3VE6!T([1!*2R&0!R)G*K+8&902JBG\1#QDO/#OR
ME&A#(+F]*Y])2#%E\5_>UNU=3[I?GZD=OH2M74^Z4 KN+LE&GTT:;,Y5;4LQ
MG%0BGM.#S"#;1IMH-VS.567T4.[;0Y[40@YB7%[.,QNT* &0*-MX:W"R446:
M_P"$. &0*-GBM28[_%9:)UKNT!"!D!6S.56RDPK*GNBBN.#3V3/.<1#*>TX
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M0%[B4F,#&"5_P6/E0C6%" YU_P# \B<P3-;F,J'(%B<?]E1?C*W!@K2H</\
M(16S%3%?V;0):5IB:0&NL4C'1_Y//Y?9]'_F9UKZLSE/-:0E6]_>$,0YI!6%
MN6(F-!C7BX^A7'A'%6.*$O?]):VC?.H.TPD6*PYRP"83V3')5^7&.RJUN K
M7E,7";W7+A,0-9AGNY0W@[TN\_V -FV"XP0AZMVZ8P9] O%]91^0&YFYEJK'
MXBC7DY1@OR<H%F<7A7Q#^7B&^7BC#)QW<8S+-T_A1.GM.YE9SYWE#U>H"',&
M^QMF1SB+GLZ/\05"-)B,?B-*?F9!1BM29'/.K=YT?XG3^\RN7YFC;#D@EJX[
MI-)=UG"Q*O52M#C#E-8%-["(TWS=2+'=:,QA0WA"IFQ,>A]'1GS.G.VPD8K
M:D,N(6,[#L0!1Q:$0/C4,Q@8??X'2(QBO!P-G2OC94XH4+N9BD$H,^<I"WBB
M7U0E\*<2IG@-2>"UG3.SLZQ/-XP':MYHQV8OF;X?#O"H]H"0R'G/.:_87E:$
MWRV\)@90<?\ Z/1H?_"<_E]GT/\ F9UKZF"MW1Q8VL:2T0V\24.+%NQEJ,M!
M5+2E8P%R(T&C%@2Q%&I#=;/N0 &$-_!@[R)ZD!B- QY,*=\4X$;X5X*&VN-%
M?$R0*#$)C UC@):2-:M)44LQ#HRY-VUES)5L<*SY0:;(H10O%_<4CBWO_P!@
M3'%T9G3 U92:P=7_ &5%<:R_<555NG\8H \C'4I8*\*_$"KC;BQ$]-[L;!/$
M!OOL3TVE(Y,$".1#?>66+7@;[Q$6:W&Y2 L&^\8W-"7*=EKP-]]F  \X0JQ*
M\/\ ,65MGO>^Q(*1,D@ZF[[IBFP[[ME)8IB&\?7Z%FW#=&/P"K#)MK61PHX=
M8% 9AD@9@9)*8SJ-1:(N\;8@;5XMWCL2%,JP;[[2 ";W/WC5@CQ_S,) Y0V!
M7("P;[Q:E:$N&A ;P/YV!20*T0"Q%%)22JFDB*[9*;J4I9WC& Q=O9WRB-X]
M?L7IH";XU,8+<'_R?G\OL^A_S,ZU]0VP@04!6(_F%^7M?S* ?/@\N,S%6YA+
M"DQT_P F8 PT_P @(W'!B(%=%3.]>,;^&?1_,#JC=X#^8,&\_A* MYA"63]3
M\3TS6(E4336/^I;F(QX?N+Z8RL9<9KO&OF !"N@@*#+#O 'H=B,@B]"#T-WE
M_B,)!S_4/"\.L&2XMM>GZCA.KA_D>"8:G]ZH=;S1FI@,0887TBD<J-> /LR
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M %@%O>'W[(2/J;"@2H1M[QF<M( /ILP[6S%[9RK+.)?$XZ3)^A0%6@S9A1P
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MITOL0VZ/?5CL!X5<<\OB*V^!")<G@48];B"8>(9[]9Y9\R_AT7(<'?Y4 QQ
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MEHHV5P=F^R\!>!WS%0<76WP9@(\L"\3662I#=C9H[  LPU4F9<:Q5B;G8U6
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MDXWLG&]D1<I<</LNF^SZ3_,SK7\V9RG1NQ.M_/\ 'W?:=QWG9]C_ (UWPE%
M83,PF"^$P_PF;\)A/A QR@?9Y7+V?_A_1/L^W[?_  [K/C[+IOL^D_S,ZU_-
MF<IT;L3K?S_'@]?M%?K=YV?8_P",=<)0 8$2%QRC4RC4RC8P,)7VF5R]G_X?
MT3[/M^W_ ,.ZSX^RZ;[/I/\ ,SK7\V=RB]A\2TY+ME/+]IY_M//]IY_M//\
M:>?[3S_:>?[3S_:>?[2CQ:\;XYU=?F/I]C_BW6.! "@P@%0J83%82MP@;D!
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MT_O.M.\8S-40LJRS=ZEK!KBRS>!R<;@(:W>C##.9KGI*(). W=W"--AP:QC
M.XP"/H^# Z4CD,R9K*F$NM D8MQ%R/(XRJS12_F=.SONT\SA%S$J(B6%&.\Q
M[PZXL&7;@-V12 9SJ3(Y_36+-V,MPW@^BZV8#JH.&)R&$Q]US@J!1FH;&ANM
M&=;*/*LXQ#"9J&$-G&,(PJ8;5W0!% WK#]ZY-X2Y.DR'?[#HGV?;]OXD6\<X
MA@?!3L@8+)X'"4Y%QV=01R:M>D4;;^<<*]YJ0[S<N'@MXRAIW7"+6AYP+>,+
M<R#7-3B3H42,K%+* W%3$U16Y&2*IFR^2#NOZLSFG5.T4"S+SC+(6;I+&\36
MY<NW<PS*C \YU48!=,(I8 :5,TY8Q"Z82P(<!HB]&"Q8R RB6ALX-1@+=Z#8
M;E_PIU1MZ)A+2\A,Q2M*PE;,.+6,YXAN(LVL\Y>%@,=T-WL:F7SB$R,4?6;H
M(75[P6X'KQLT-Y$?M'K#YEM-N4-TK85.E3L)=7VSIC)LWCOTBY =RSH#9AX+
M>,H:=UPBUH><"WC"W,@US4XDZ5%09)<EC15&9*TWN@H[U9 M#68DQ#N<V+'D
MAPAY7DMD:QS#9=8SKFTWSKCKC(?5;  66YL4CTN*FXBS;=SB X.5[H.ONIT*
M)&5BEE ;BH&> 5,7[EK5CQMN 86531<(G"##@Q$68U_#UGQ]ETWV?2?YF=:_
MZ%UPE  81+RE;*;LTFY-T:LH#</O,KE[/\^1SG7^WT<;P2RX**-JJG40KC=,
M\SA%3< &QNBH9TV$;PM1&W#1L6BX8DZ;\Q6D7 G[U/WJ(C24FSH\[+OM+$SP
M$%E6Y)<_:("[%>:%J@I.@=XP6=5[[;+B>D557-CIC<(YV=5L5<V=-[/UXE6_
MX?5U/Q/'X;.G]YUIWAKY S=(<1)E >*(P!ZDKL$U9UY.B.^RF%YD1DM6W8I;
MP%^L(!O$8"[TD8Y#3TV.7,!?K.G9WW:>9PA!Z&4!54-X$Z+A!B+%G@V5D<_I
MI5R&#QZ?59W"\[)O?U6$S%QE0"8LZAG6Q&#>#85O*%1>&-+PG[1/VB4%A41)
MQ()_/T3[/M^W\:*TCJ30[@A+5?&-Q$R8ZNZ=016^ ?1Q#$U:EA: ;3>>).A1
MUZ)UV]),SG$<&C64X7VCFC O+;F<TZIVU%U5CH5ME'E^T8V]KB[A(SJHJ)KL
M==%1-1LR^3,IY[.BGD<?X4ZHV]$Q8&J[2[P-8W .1%JD.%S)Y)E\XZY6WR]-
MAY@)5.^/6)0'$>!PEN"G2IV&S+\9;.@-F#$U:EA: ;3>>).D1USC9E\YT&Q+
M$37=$9+EC"YSD5 /("B.<ZQG7-MRXU#?"1^LZZ"-P#D0G<C*]D="CKT3KLH3
MK<9LPYU<\OVGE^TXK+RJ8"UO^'K/C[+IOL^D_P S.M?] ZT( 48$R,9J)J-\
MUFDQ\Y@9ROO<KE[/\^1SG7^WT*E=/>&^:=]IQ]U$6#XQGF<)VW;9TI/)XL5A
MI(KFWTV"S-$Z;\RDD:97/&OQ/&OQ 86*1V='G9=]JP/&$8(4WW/WT_?0)A1,
MYT#O.R[[?.X;.A3MN^WNF]GZP9PIB/[G:@#-:(2846@G4_$\?ALZ?WG6G?8;
M8:J9\O#$E81:/XA(=)I-)UY.B.\,R9%KVFSP4>'Q8KX-]X*-U]]@]AG3L[[M
M/,X3.1>DIY@SSIE#D%1H MO6]G9'/Z:NS*Z8E?/Z"P2@+4E54"H*IEJW,SC#
M FB!BPO6L($PPNK.I9UL\/AL74@%+P)^^G[Z?OI295EK^?HGV?;]OXK%<P&(
MI'!-J:M14IDT7.H)T1]'%ZD&,CN [ MHF*OQ)T*=KWV]),SG$(H6\2?J7\Q
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M@/M. ^TX#[3@/M. ^TX#[3@/M. ^TX#[3@/M. ^TX#[3@/M. ^TX#[3@/M.
M^TX#[3@/M. ^TX#[3@/M. ^TX#[3@/M. ^TX#[3@/M. ^TX#[3@/M. ^TX#[
M3@/M. ^TX#[3@/M. ^TX#[3@/M. ^TX#[3@/M. ^TX#[3@/M&QK @A1@3)QF
M-G-1OFLTF/G,#.!_097+V?ORB"DP:?B&EL9B8X/KLRV3 I;@E +5I/NZ]BP
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M%^DOK#*)O(%"JG2)*0A6F''^10%<B8OA#3U5FL.,U,:B>EW-Y% ?T?B\" #
M V4EZ;'#E=J;ZA$ 6XO)YF20K &!W?T;"2[J:T3*=IDYL]?Z(10' ' @4"D
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M9TMH4^VW C*[%7CN(]UF348:%K4H(MI^_#ZU"P^-A]%@1^WE_P!)TWV?2?\
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M.!>]C_D[4L'!UBL5*/%CLJ0L4[FV"=WQQ#>XD<O  I#?9[3H_8G2^T?/@"^
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M 4-KB;HRV($!;-=IFK=SIU_"&6PHO5RO&!WMZ,>=?,)LW3CSO& 0%B4D4E;
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M]SM.E=R):E6FX,X$# JQ7WSAD2K,J JK"F$BK \#:U1B@I+EG!+!>/K H"4
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MZ=ITKN0$5-GJ&Z&1TJHJN4=<%(4"X83!)%5T$,F!0!00E!-^9Q.,+1LFZ/\
M28DA!R28_BGB9C\1^K(.3*C:?JV$LSOWQ@?,\3HSS.*(A6*Z+_ERM)!+),KZ
MP *"@A9-P&>&[UG6>SLZSL>=P1&%M4Q!R(EF,/2* R%S[14[1%Y81>E6OCOZ
MP2% []?Q 0!'!'?*6B09(S)X#0^CSN"(PMJF(.1$LQAZ10&0N?:*G:(O+"8(
M!!JO\@YTZ(Y ;"ZTL![W$A+547<F?G"=)[,'F819*ROV8 %!1&M8*J8J:J&O
M8JG&Z^8SCJ0II<%AXPN&\..4SF/(@3D92A'%"4J]TRS5A!4,UA@0>/@K@0;>
M*&*_&SH_8G2^VQ?E]-B_+Z3"3 -5_G>#Q<8'(#97"((,CA;+WF_;AS/?O&8K
M)-'^U"PU5ID[W8T*DL' QY3K/<^A,+T])7YN4:J!<5OLYPRP*1,$F JN$H78
M;HHBN 6Q2C:9<2B$/!B[UJP$ 1P1WP\*U)O7B$1_:]"P9YW%C7DT+H9IQC'[
MM JX2G.4Y'^5+F7T?+I45&@5= AQ-YCP_4AET%!H3J,0!<@C0-I\.U'2"O!B
M[UJPH1J46),$X'$HS-]QA450XL#K*I&V[Q9>K P&H"@(.HM([N)%UEVO#>1W
MZNWL@?6;YF.KZPP]F"6,#ZTM/08:'=!CZ_1U'M.I]D1*D7Z+A,$D5700R8%
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MG: @,.V;N/QL8)8KWNO(AOU4TQW&<K1=OT,%I87;]X\TV&R+6\-YOH3P>GT
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M9Q0)RP.\840GX$\90" ;@/HY2SP-W7ZK0EV8V'1V=9V/.X)X/0V=-[L\3BS
MT%FW=)>-9BE7J3(7ZA]"6<B+@JQ?>>8T/H\[@G@]#9TWNSQ.+ +#;4[]1B;
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MTI J]/I>OK,+/M+@+P#JPT Y!0;5CKF"SZDN0O /98" <@H-A,D*$$'K,BM
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MN.D=D48C=UGB](8+E:,RTNN,.()8SW40J)- W08'Y]=H5HK$;U&-HQQ8-/\
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MQ\O;" RS]9Y9\QEP7B-V^5(X<P'_ &IXO2$3:K.19U^E) W8*9G%$7;+# -
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M.K8)8_<"MUS((188K/CI*9"XA[D*JN2V/T=-[,H)@K\ OYV$K:#U(A#O?J5
M" 1W,?$;%  ],67/GVM1RZE8"O0_,>-+-J7K(?,-"[QS4/G:Q1'!%WSGC<$.
M(8R<6<Q;(8\7BP 0*-"MU?3U7O#(C*W SUQ^8"U4/FX_.P"[.@1F'-?J)]'B
MM2$<8L?>OC82_>?)/ X$96X&>N/S 6JA\W'YV 79T",PYK]1-G#6,HYY?.SR
M.B&M,0#U?\V'SZIT;M%IN%*>Q^9?DH E5AFG'8<:) B28J ".2UV?ZCIOL^F
M_P#Q;PO">"T(PS)->[ H;D=6QP)RN)"64Y1L#"R<_P#C!&<Y<C+O,A)Y)P[5
M&.JO6,.]2^&%)Q?\.LL I^O<8QN3@]V.U5+)2FI^]S][@!!D%C3/%Z3RNGTD
M"-I,N*\)2*//]$2@2N"HZ0H8&0Q$,O\ 9X/!&=V Z0G?BS[&T1R1G0_&>1UV
M/!WOR3H7:>-P3HW<CDSI??82F:\F8ZS-0 NYW=98/HA_O:4!RG(_V_H\[@@:
MZGWVZON",B<P#-;B6!-YT!Q_+ !LLQ%Z$J!1< ]\=J^1T3Q>B>'T3Q6K&5,@
MW[,<&V6!;N_Q/WN?O<_>X[+:"=:*G2MO6=CSN*=6[IGG&*Q)K:>7XEXK=L1[
M/YE1,TM8>C)EN F@R=$^KK,\_I*-"4:&WPFDZIW;783+L>N=IUKL[//:3P.4
M>^K27P/3L^=9P$L&9>]+C0B[^X-S+/ Y;'A<"=,[;,OPQ=K%^7TA=8M>L+,R
MY#@_F8WU[8Q?CWE \7;P,7X]OZ7-@[](N%57X/XA1WN #K<6$I;VZ,H4 4 4
M%3HG:!;@L[D0 Q$LV6L=LQNN4HL6P$56Z=H<2#5!E/'Z3Q>A/,:SKN]LI'B[
M>#B?/O,\@5OU_F!38_"&-?$,"CZ 6RN>C!$$R=@59O![$94S!RH/B.;P1'WN
M!&@@4&Z<7=$!\YW5+>Y=*ERSUGGM"=5G@M39Y/!.,A0,:,8U873/V*?L44 *
M\KS0Z00XC*>/TF5Y9;.D]F><T9YG5/,ZME/TG-^D157?4>SA#*1C5[&YE30[
MLLZOF?1TWLP][6>X?C8J5+/0CD#*WT%CTE:IU2SVNJ5"3D:A&@%7<,..Q6+F
M![$8+;B@>B.VU^*EGSJIX7!&Q6Y/%E#!*0Z@T?B;O_:=YO\ 1]/5>\,B.MD!
M[5\1$KH^HP^-BK4H]",,W6>@OT>*U)X779Y?%.B=B.MD![5\1$KH^HP^-BK4
MH]",,W6>@NSF=X8FSS.B>.U=GD\4Z-VBFYO4'YEF5& \N\_8I^Q1"028L3^H
MZ;[/IO\ \6\+PG@M"6C+M.K?[]X<5MA<&\S8<!O!<<=_(C8'/..X]^VRD&%U
MQ,NCTF(Y#\7681H!Z$?!-5<=_4C.,!1H/\(%%$M,*2NK?[RB\W)PO>;!B4)O
MW\"4#$HX1SK6>+TGE=/I%YO'KG>/Q#CF -][NFP%"<T<ANYQ4.K[D(; $;ZS
MZ7 1F 60,IGE+J-JYBKO])2Q4N+2L [Q #$#SI^&/\"2MZTCAG"/WDLE;O2=
M"[3QN"=&[D<F$UT#:[6,F!3<[^LQ--5XUCU6'!1QZ?1YW!#CU>]-&&Q(6(V,
M ]4F_P#P0HE7GMW6#.J'H8-(&+9N*ZZ;*!U 7''"^4=KAV&N+V2.8(Y/(GA]
M$\5JP&+!7JF,8"17ZMS#)@6(V,+66U>T&U:;,!>6XEABVYF=*V]9V#BZ_)EJ
MAH'@VE!D7*.#EG*)O9]@<MA;,!.\-[RA;AM1Q<6!VS603 [5XEU]'69X_3Z?
M":3Q&K:[#D;'KG:=:[.SSVD\#E"\;7MK_4>T*MN>-; BW$MQ46RQO?9L\+@3
MIG;9E^&+M8OR^FRH-7EX,'XE]B1-=_XF80/,[^O]*6-MHU<X*28FK>WPDKXT
M*1C=*78.JR^%>R[[QN$9DMTAY#2,W'YAUC ]#NQUBD +RJ\C?+0V'>7CZP<)
M7$:K%ZS VL?;R[( %S $O6.^I05IJL)51IO8XPRGC])XO0BZ5+J2PD8.K%O#
MW@8!BC>3?((<'=U@L$:_3$_T]91O%V\#/X]OJH.<0+0=V.L:U88 5R"%%K1Y
MCG,7\,75WOO"@.,CO'&%( & KE%%8W++D1M:&YN./%A.^+V(YC.R4,)79#@X
M^TW5CFJN>3P3S.A%>82;MX^8 ]Z5KBWK&H)CEQC" P3>G-B16*EWLCVGC])E
M>66SI/9GG-&.9F$]F4EN]!8D(3,BZAPBUU;&/EB18 ,3!Z,/D# 2G*8%N1Y6
M6_1TWLQZY2H-W$Y0PZR[J5STARLG+5H:QM0!C[]7X@\J#1I2?,W&\2!+P7UB
M5Y\+440#N0W@[V;@* W[0,+8'!@-<W+R_P!B+79B!$=W!G6/'0AX-CM[=UZL
M\;@G1NY",) [R>N 4-TH1/H@*@9/JN ,:#>FE1(P$)FZ_2(F2QG7WCPEH#A*
MFZIGRK0UA5EB_?J_'T>*U)X779Y?%.B=B)& A,W7Z1$R6,Z^\>$M <)4W5,^
M5:&L*LL7[]7XV<SO#$V>9T3QVKL\GBG1NT "VHUU/:*^,$,T;X)1.$3F;H 0
M:+LX[UC,0UEX;@_J.F^SZ;_\6&;*6 5=:LM3CP#A1I#I'I,DBUCMC:Y#OF$!
M,-P]98)#,%Z9^\.8#-,UJ[*3?%86[\^"RUJ5MV(89.NR\2D*&+GYC+2LJ4M>
M>3PZ[!2"I')(W C=E<AWS"$&  #DPM:<\8>F<UVI,U^)6H$75J2BBEBL7D_3
MC"6]%T>$N1<F4'I\Q!>IP4=^$,T+,Q!@KO8U(#>J'?GK6RD8JU5CQ?$IQF !
M!RS@6D=Z-<#.$W@8IFM68:)B#-;F4;ZQ>/MF0FM/!/4%P9%PI &\+C B@L;*
MX3?9> O [YBH.+K;X.QMC#2VVZHOG!0@889[+;@>KWC@G:5!N\<V!\_3YW!,
M$!-PN]\QU:RQ>E64 @#GC Y9P"5KB^;A"6569CN27IY;^S,AU3NON$AA26WW
M1#F&N"L-F;%84I=SNE4!Q#%K)(5SC0/PE]6(L&_'.548,5=+H[ Q,##)J:,O
M#;4Z5DP<[>Z>A@2 U(R.A^8;8;R9DMP4>^V[.@[ABO/94;:+M4?F((Y<0 ^V
M$M*O,)=8^L86 W1>E^(!H5RSNM04RMX'IG[RJUOW-;UE]I4L%TFLU=4+%K1^
MC#L;8%OK*P:3:S.#]+CK2!QJ6'NMA6#H[?V] O/8?Z] O/8P6*H)BL=L**='
M9CG!"K4FKJA8M:,OA $9@3;J/IG?* &D73U2&BC>^57NE845"K?6+&\N%-SI
M,4CM!91JPJV8!V%]W8L<=65?DL73+J*&"Q.;*5@B[I#8M@,(^R=94"P]0RZ_
MT]A'VA:?B& 2U8G:#FCB5KUZP*?!1L8>INA+]U*PRP@VAH&#'U0[FP]2*KK1
M)]J(AB457ER-VP-8:LU6B;X.NM:'VI@T46!5N.L48"#&J@WWPV;GH.&-;)P.
M95=%0XI]@7;\0=5ZE#[5";GL9-; IN@HU9]9ND$>+OZ_3UGO$Y\0I;>&DI.N
M;KVHB58E9OTT-A$OQ^.'$CWCBQV94BIF.?J_B&P$2;+XZRTC5=R3?G!1 (CO
M(JXC9:/!8-PD61B-)S.,TB6FH#.^$W3#:JNBIFQ"4)8TR/+U/Q'T'J%/:*FR
M@4G V?GLKKB:3BL\0X6[-P<<J2LS6;LF;RJ]6)93E&>/>+[$CI!-%WCO#2"Z
MI*S9P=2-.)BKI<(ZBHKK48-=:?0;JLWU@FIK&<I5M-!JZ1P:_NO8&83?C37J
M=\,L"@"@(4 5)DD!NF--AR2*IK1)[$O9+(\.0@N;YQM=YW+4M;OJ&V\ 0:Z"
MHKI<0'?$*KZM0((\5WK59HAM]5(Y>DX#:R,;U=EBO65JU*E3;TU;T;OZ*<T*
M O\  RJM+&2T\HEE.4S, :6WENCACC+MVCTD8T>YO89,"@"@/HW?M*S+]2;Y
MNN^6WE;L][7K"M2<4E96%:L2RG*9F -+;RW1PQQEV[1Z2,:/<WL,F!0!0$WO
M;A75\)=9A\:XV[-ZG'=*;RN;JV*R*]79[T_6":FLXK*RL*U=BPK9G9S$%S40
M>S$J-&99^K^(9#(!W?ZCIOL^F_\ T/.K4$3G#$HL+'<.,?"77<CV^GSN"=#[
M_P#"J@\NB-1N V6P#(N*E!/8R^7^Z%1#0+:EG&,% /&*#4V-[E^?JZSWG3?_
M  'IOL^F_P#T,*IB5$3#?+E;L2U<729?35>BEH8([H=S(L6[XA_PI' I4&[=
M><L82VQP,, A,0"@-Q_=,TBVFZX2^G 'WOXA,O>+J_4 S9E"_:!0&G_P'IOL
M^F_^UNF^SZ;_ .UNF^SZ;_\ 'C:5"K.@EE<*2&!>Y_A %4(,Z"Y?_&DA@7N?
MNBSZ+@E/--(-(,&:OH#.UJ4$% (1-Y**T6$7%K?+ZF% 5Z+]O6AP +=7O27(
M=  W5[E^L+.T*#ES28"I8 +U^@Y!U 15><+S2%[S^(5G04'NDL!E@!NAW+K$
M&0"$7%K?$L)%H&?)?X\&HJ 6WFDW"'@!G>BZ?17VBPVXM2Y!@@%76Y?[A:Y%
M0I5.B:1)N0HF=ZK_ %&%7 L<0=S!3!!65I,WFB5!^L2BKJL>O\(:"9,EA%8B
MXPX<W[<&(N,N/)@: 99+2_YJ7AG%;-6Z; RM:E!'Z&MUP;O+VV&\C265=:_U
M_3?9]-_^/.Z!$7=94OYY8-MB?P^%T9T_>^Z\=J_22CH$#1:7ZSQ>B>=P3H??
M[?P.#/.X'U^*T(TKC(>)7Y)=+?MK!VWIP%'%RZ=X35!)HW_%Y32==[$5.JW&
M#</H$%7"OX\)(;9,(;N@8\*O\_1T78GB<']QY+1GB]'^HR/+>"8%2U>D+T)X
MG0G@M#^'R>C/(Z?;^1TGD]#^;%9HV?(ZSH_GLR+37AN[_K^F^SZ;_P#%D"%J
M5E5Z2HBX.V35K64!>V9-'WQF7==X+(F3.)1S,?8.A$]YCHF%EAS,X4(UHL28
M=8FFM%QQ'&WE4+E6Q$@!BU5XU7"$R>!2O1K !T3=>]LH(AC:>?A#(!O6GD$*
M:KLKJLL2/!'-:,\+HP#+5,@M$4HRMQ]"!=2W4>]S"Z&"8)Q(X$W/9FJQJZK;
MO6G)7C5UL$PAC*NP<JXQ1FXF)IAG$'Z14KT?S!S;U;D1CH*RNE0)K*RNMQFK
MP4W;,,I=5R")=+65TJ =2+4>]S*X9F"<386(_== C$!.2U7T,I6V?.P3T<X3
M)<#F_03@L\0XTS<IPW2BLZFB8]N+J/.X((@"UWXY$L@YR15]#+WA!J5:CWN7
M<W!'-:,5CH7+82)5J 73A$K&HO7BH2I5I96M?B$[.L(,=!65TJ =:64>]S$&
M31<PV>AU._2I4Y++V;J8<2X4SCNBNK+J"W+:* C"M-Y0\B!'3]U[JR]H#?EM
M\=4Y%F87I/ X,HEWO)*91KHNRNE14 +-LO1_,/:>PW_1XK0E<+K^5!\X3#9H
M?1^-@(E 6L2DM*X91T"=6V<[@"QAC1DV?H?F<DZN=V!6IEN?Z:[!;EM% 1A6
MF\H>1 &ORRZK,DRC-%;YUWL1 ,>&1=M9Q4S2-YU^FP\7./1S,=;0@3WE>*[R
MPYD*$:P;$A+CM4>K)D]7Z$Q=QX;YC@&%MAS(98%B9)'H9'B$0V.DQKOAPV6M
M-3:B\]\%=.D ^]PMU MG@Q'?/$X/ZMF5G@<6%6[D]:(13W^H82UDJD5CHFR\
M7,@QQU)@UWD%IB"7F<"E ])<F6DGK#O]85P8AO&5]S;QX$QQM0K];\0O"K%Q
M@YC');$&!I]F>+T?HT$HLU$2&Y8CWSE3]Q4 YYRHX]$4+HFQH:G$>K^(# O=
M0]2& ][BGJP54&%='CPV+"%"QF<2'R6@#8;Z3>;50#XBY1F\*=&%!C YM\"+
MAM<%=S";I[9%8<Q-=A1&%]T#P@AKE89JNZ-AW*RC[X2JL]I[%&L;AC@C#G%$
M9SQF_2%"#J&7,X1?K<:(2IDDTLAT-C@I1Y:@67RV6QG!H#JK268]0\]\(3Q(
M>YA%0L4BF]P['08-:JP[R$$5T(8N)ES@"2)PO/N(I!7+6;WXTP_2K&$<,DPW
M0G@!J8-Y@<MB(T"KH$R<%A,6]-/H\GHR_0 !O4P)0S'(0]7^S/F;A'N^(T :
M[L$U-C,K/ XL*MW)ZT0BGO\ 4,):R52*QT38#"!;N'CQF-<Y6]*B!+BS%GJP
MTC"]!X;%.J3JZO"-+FSL'M47!A<@^H?B* %NS!-388 -=V :O"90S<(]GS!9
M8X@IZI7I %;QF3R>AM<L!:NXBTL2A;\< XM=5=)AS5D0]<X@&'DYK>,=N M7
M((98;5%O(3&$6(@'TE;S;@'KG+'F$CFM& 9> 3'A6YF"6T;V/3G#>NP&+K#&
MB-&I6 &#AC4<K;3 ZZW-;XI W&?K"L*(B-(]RP5ELPRN2H+8XU'%P4>A>DXV
MT:/B- M@*5NOAL0O@.:T)25.2Q]\XGK3BMBYW<** L"5.)>6-1E[H:#"C2",
ME;,W5X1P@6@/4?+*<SBHDYYP@;%)6.B?T'3?9]-_^+>!T(R!@+!Q;<CK#[0A
MM6^=W*$[%AN;V&TMY''2N#\E:IC#JCI:#?AN8U1)OW)F3Q.C/,XHY1&TB(KB
MU!5U;%BT"*_.0M6--9PB-<AP<=\5-5@27URAJ#2!0+K*7APU>(U\SPNC 8L
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M>SH.U0E&I1Q5W<B @".".^#[B!&ZRX[JUG.B !P:GN7S285:&]V[N1$$I+&
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M,0!W>/?KE+= *3B!>L.WQ5KF$\#G,GGOC \?G.\]8T(];Y&\XS "*R5?M4*
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M,NKQ0PQ*TX[$$LQFB4ZL!*LT#2("B$F=)4;-EM4ASPJ+\UFE'*!A)H+SSA,
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MZ&#UV7DI?>SZ2M.+W@./7M.D]]A+G80:Z"LKI4*3?!:)Z-PF3*1P5HFS">.
M8IH$2:%NI]JE"T:N'HP"K4,DI/&Z(P S+*QK2.QFLUU2F?I A&M% 1BFN%OL
M&;T@[+T 'O&ZYP7R'89I.I<@BD;L**^A4/B9H ^8^/*%M.#L<\9GE8UI D$;
M@75C!LJFCUNXC0(M55<Y>A&%E>C>P=EZ #WCML,%:<'Z_-:0AEC1/1AP=A:<
M7_C"<6%CLK7Q5?#(^972O=6#I4\EH;'38(*DXL78^A$]Y=AN%M^HS(98%B-B
M;+5&O,RYNZ.N'2B?>X588*[2LKW3KW9V4@6]7C5U6QV3*#-6@1+"[BJOH?F
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M;NQWQMN1:&-\GZ*,BBS'7X@*HUM7VJ-ZMLI<'+6>-Q;*4AXCR$6 VI?E&\U
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MN'_E/,Y?T6=6[_8(@IN+;\7#(L44+JB&G(#$#>N[8UNA5T.'K#,R9@&X_,(
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M='#?QN2$)NUX._K,OPSA#;*AP,-@432&5'%[1P5OL!:G7]J><UVF*95\Q?\
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MVAJ6&06[V5Q3< 1]0 CBI1'7.=VSJNQ/.:3P.<R>>_9S.\,39UOM.K]F$K9
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MO[4\YKM'5SW/^1'I^8_S:Y,Z3L"%5BG!QB?""O!WGOLO=@"X7;VE8<%?BO\
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M?^0?$0QE@!@ 91*XQ.,7\(,/MA2/.I7*)O%/N8PS6,KO<L "@H-C]5S&QE_
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M[HXNS *9$/*XN>D$$*]4XSRXQ!X(/^TNHR#P9T?O+F8"CB[ .YD>)"JJXK$
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MPF(!M QB+,AY:S&J, #;W)G*.ARPEY$%SCTO>IQ0"3].  [H+V8&!K18FPX
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M..JWX%2[K_,LS%?=<YYW1F!@T&I,8>938JW.AB:6*TW@R^8DL.(_QPF'7++
MYZ2QM%X!>3+^@!F>I^([:<]QS'WF.H$'=?\ M;%&IR>!#6+V#-V@'* #3%/,
MXH=P:CN"'0:^0/&7!1#&P'JYRO\ C5%>@TEB;VZ[%A,,1CR3-"NQ8:\(R* P
MJ#ZD5E7W(/,8J( 1-Y]L)[ DT-@^817&Q+U8?273K@7,F/2EWB6)5WLJ\<Q+
M*N(%-QVZXZ&#N !O'$F9R_H@ZMW_ )+RMW3.MY%F(^B-C#%TYH%$+6+4R(,
M+!LN+6 8M!G% M$,!SE2X$HBA=N]8+/7N3@1?=E[JL/=F"&=RK=*TT"L,&Z6
M=C@W7O(N0B=&4(8U)$?5"S"M_P!7@=)XW%_9KNATF>,-W&,N4<9OVR3+[454
M(8, %!D$)N'3.%7.!CG!IG Q@?R9)C.:3,3;A%F\E()=V%[F$<4.4L&N4O+0
M4N(^L0ZAN(!_L.,-TT M[]-@(!(CO(0$C[8?Q+QTHG&L)4Z@L=Z9=:VU[7H
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MBP-WY$1"D?1F]HG.B4\3FE\#K/+/F*%+'AOERH<V5=E)!,94O4@+6 G"\8
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MN&1F0A  N%6[YT_L3I_;9E^&+/*:;"9H'*6Z][)FG3X!_P ("-" T#8[#X7
MG3.VP8$]9,^L-50%^(_C8-.J#AH/25@!8M&7S/%:D\+KL\3BGG<">3UG@=79
MY_%.C=MGC>$\?K,=I%NCF?,+G9Q/H'$V(1&"3%&^-[6RDM9%A/ YSJ?GLZ;W
M)UON; 8T8B[MEPZ!5T(F\0%XOT=>GC\]A..NM<J*CVF&*W88Q0+6@@TC(G),
MZ]H\'3X$N4*P:O\ :@0[NUP7>; 5M11Q-Y^)0>RE<%S?CWG5N\\;BGF\4ZMW
M3QVA.I]B&ZM<$D" XXFSJ,Z:& ^J1OHP%0 78K\; @8HPE\TI?6X,#?AQC10
MJ#+?C6L".@%F.\V9R!+O8OBH62)T=%4[_01='.>_J1&AQT=V)V)F5,P,(:K_
M !F4%=N++J[,LW@<H;IT=R.9!2C7$V>=P3P>ALZ'W3J?=V],SI6SQ^J>'U;.
MB[$\S@@,6"O5,8P$BOU;F&3 L1L86LMJ]H-JTV8"\MQ+#%MS,Z5L\?JGA]6S
MHNQ/,X(8ET#JF[VN5UF(WC)@$@CB)O@+08&]:$HH7RXO'V(8J@ 3KNV@B.(Q
MPW <5-]L(B^)]L?\(!!0%!I]&<X!H/\ .T"F!9.+N)L-O:LLL@=XG5=)715$
MRB2^IC<0"A')(><;4H(=K%5NB.UR=6>4U)XG5LP3B%H/\J%#,<.1DFQ"445*
M?W2MTXE2_0:=_H1Q@*>2D.-Q2*RZ1.0%J4$<6P+K6_WGB\4\#@SSN!L\'K/
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MS?=>!K%=TQNFFJFW5E)/I8-8NDN@2%"L.++B<P4<*-)F,-^I&E0L.M\<,2"
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M,[#I PR_K'8)T*@FP3E:]V'G1QZ?\_:(H%H6LRH3JTR.=X_\S@P7JPP>,S(
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MDX<ACA74%((%/MMS.7]%G4O^?P#BLR&%@8FH/_F7,Y?;\6.-JQU9=?X^I?\
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M=]OJ9U+[@%:,Y4F"KR1<&DX_\;@+%9DPX(Q+@X?^51(M2X<8A>KPC!U(@XZ
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M:N91Q,R "*.-E/M/6PU_?$Z\YFLZ>/J$Z1@?4SJ7\" &]J(<0)JP>C1GG#$
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MVN=*[DZKV?3U;O/&XIX+0G5^QL\#G.I^<%\[& ._O&P"%//"[(:1'$WK>.P
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M@;4;ZT@=U3>8:97$X*16\9;V=GALO89 Q#US@T\< _!1 HU*9'0F/E0C6%"
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MBDZ [[,[QNF=N.D%3ONI*_N1212E;3Z+X-([&*TU7?9UWL3J/A]DV#8"^+M
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M8S")KO:7MFXZGFZ$!*&]!QZD<+A>MW;IRAC3H11T@H:#.C^<I3N\\V#\2P>
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M0&Z,E/$IXE/$IXE/$IXE/$IXE*&'4BMVM:"VR=)XE/$IXE/$IXE/$IXE/$H
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-2<G2<D#A _\ U%__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>business5a.jpg
<TEXT>
begin 644 business5a.jpg
M_]C_X  02D9)1@ ! 0( [ #L  #_X1&\17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     P   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8    C+@  ,@
M ",N   R    1TE-4" R+C$P+C(X   R,#(S.C$Q.C(S(# Q.C$S.C$Y  $
M : #  $    !          D _@ $  $    !      $$  $      0   0$$
M  $    [     @$#  ,    8 0   P$#  $    &    !@$#  $    &
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MM[0ZA)+)?Q1LRJ&B8KVSUSSR#^77(Z 6N:VX9QD9],TM9]@EG$X2"[29@&P
MZDC<VYCQUYQ^5:% -6"BBJ@U&$W$D!5U='V@'&6XSD#.<=LG% %NBJMK?P7;
MND1^= "ZG&5.2,''?BF2ZBD5V]N4)*J&&".>>?88]SGVH NT51MM4BN;QK=4
M=64 Y8<')8#_ - )]LBG7-Y)!=1Q)"75T8Y&>HZ?Y&?Y9 +;#*D9QD5G6]A=
M0(B_;"V%VG.><<#KGL.?<DTD>IW#WB0_8W",,ESQCY@ /KC+>P'O5F]FN(3
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MJ'_7 ?\ H59?Q*_Y'*;_ *Y1_P JZH_[]+T_R%T#X;?\CE!_URD_E6K\6?\
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M=')21T(@6%E:( ?G  L %P $ "T "F%C<W!-4T94
M              #VU@ !     -,M;&-M<P
M                                    #61E<V,   $@    0&-P<G0
M  %@    -G=T<'0   &8    %&-H860   &L    +')865H   '8    %&)8
M65H   'L    %&=865H   (     %')44D,   (4    (&=44D,   (4
M(&)44D,   (4    (&-H<FT   (T    )&1M;F0   )8    )&1M9&0   )\
M    )&UL=6,          0    QE;E53    )    !P 1P!) $T 4  @ &(
M=0!I &P =  M &D ;@ @ ', 4@!' $)M;'5C          $    ,96Y54P
M !H    < %  =0!B &P :0!C "  1 !O &T 80!I &X  %A96B        #V
MU@ !     -,M<V8S,@       0Q"   %WO__\R4   >3  #]D/__^Z'___VB
M   #W   P&Y865H@        ;Z   #CU   #D%A96B         DGP  #X0
M +;$6%E:(        &*7  "WAP  &-EP87)A       #     F9F  #RIP
M#5D  !/0   *6V-H<FT       ,     H]<  %1\  !,S0  F9H  "9G   /
M7&UL=6,          0    QE;E53    "    !P 1P!) $T 4&UL=6,
M     0    QE;E53    "    !P <P!2 $< 0O_; $,  0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_" !$( UL.@P,!$0 "
M$0$#$0'_Q  >  $  @(" P$             " D'"@4& 0(#!/_$ !P! 0 "
M @,!               $!0,& @<( ?_:  P# 0 "$ ,0   !O\
M
M
M
M
M                            *W8<GO\ ;5LXXLD"!423R]K6S>BR0
M*VL>:Q_/$@K FRUMJWO<64    (EQ9'>[6NSS$D@8+B2L>6E9+>-)
M
M                                   B%5SZ/[2!L#6-?G>NL!&BMGT,
MV4#8XLH&1:V>   *Y:VQ[5L6O][UN^B]LNOVK5UB
M
M                    !K=U-CQ.SZ]LKU\WW^<_Q8,FL1AD3)V&BN[J[$
M #6UCS=CZ=40QKK&4EI7]VC20   !%N-G[M9P,W19 $%ZJSCSM&MVW5EB
M
M                                      !">HL:7+>LL1M*^VJKLA35
M6V$!K&OV/[6NR?5V/7^'+KN7'D'CR\@X;ARZYEQU\5%KW#:-;G]4V7&9>':.
M/+P8_P"/+L&3'V'CR'Y./W''WYW/GQY_CR]/CY??G2_G+N_+C]?GWHO#ER.7
M'VGCR
M                                     &MY5V.8+&MM-MZZ2U790YJK
M&L^VK>]V=?=W5V,"(4J TN-W21AMUY<<CQ\\5H<JKZ3'R5+C0\B3ME>375L5
M5K.>[J.WUMC4IPYX1DQI6S8MH\.5'6'*J[SX>IY.$LIL.TF%+@S#EY-N:F1%
M;85&XLN%)D3(,65D"[IK;JRQ
M
M      A/46,)]AHH^_,NQC&S?'#DH(EX>N4]G>EL^O1.UJ_KBMJW+,7/Q%E!
MO2BYXQUMA3;8P<]8LD8^'.T:YJ<BZKL41]JUNWJGMJ'<$CLMC7X@C2;4K.MR
MQ17-*4^'(;C]BIPYW*VE;SNM[#21;57/\>5OL^% .@O.L6U7UF'+FI;U=EU=
M/
M                                 UO*NQM6L:V,EO77$5=E21 G2UE0
MXC7-99-K&P5"[#27[Q)& *NQJ.V&DOPI;77"F8-A7+@Z356.N!9Q=JG[%HKH
MKNVG:M;KRU?9,I;3KEE=39TJPIMD.P457=)<7"6E9WV#,UT8<V_/8M?KDUK8
M<\;1KN)=6V/BMHUVU:ILJ1ZZ?E39M>MNK+$
M
M                "$]18Q VO6^C:QLEK.RZ[T;6-BBWM.N0RUC8KR]AHM>^
M%/V2LL?E\.:F*KL9J[1KE9&L;'<ELVN9RK+*G:JL<[;1KN1-5V*(VU:W+75]
MDA5M.N745=EC^))B9;5F6*JR['9UV;HDJMBNL,=;-KLU]8V.HW:-;V$:NRC#
M56-6VTZY?%5V7RQ\M;CCEV.9]=S$:4
M
M -;RKL=@N_H* <,O8@AYZ)9\2SNDMZ^=GU[-VK[' ^[IL\8,XA')Q;"%+8U9
M;)0WO5ED-=./*V()U71717=M.U:W2/K&QW[;/KG>:RS\'DP5&SP"RX\.\N,2
M,678ANJ> &L[%GC:-=KYU;9+A=GUO.5990VJ[&+6SZ[;=66(
M
M                             $)ZBQB!M>MR[U;9(Y[3KG0M:V&TC8:"
MCO7-@NILZ_7/S8I>8<H]2R.;"IUI[S9!M:+E(LZNBKL/IL^O9$U78HC;5K>8
M-6V3A]JUNT"KLP(T0I=0<N-V/)C]8LG.]W33<UC9*XMHUR[RKL8!5=E4O=4^
M><.8?,NVFQ.]0I8
M                                              UO*NQV%]FUNGW6
M=DR+9UV0K6MSEK&Q5\[/KTC=6V/I.SZY9Q6V/CBC%D^9EJ;&EK:-=V"JNR?&
MMI@E;'\ZKHKHKNVG:M;IFUC9+L=HUS+]791@BR/TR8U%/+[>-EP2(QY*"JBU
MNHVC6X ZSL6>-HUV$&J[)9EM.MR>J[*"U58QZVC7;;JRQ
M
M                           A/46,0-KUNX*BN=>>7&[YD^7XX<FN]66%
MYNQ4.OG6V>Q=+A=RCR*TH4N6%S4U-Z_>6>;1KDI:NRIAJK&1>T:[D35=BB-M
M6MS+UC9*\]HUR\FKLL35LZIW8Z+K&L[#95M.MRXJ[*JRKL>I;/KDX=8V2N/:
M-<N[J[&.-78U"[/KVP-6S_RX<E/>3Y<'FC_MQ9@
M
M         !K>5=CL+[-K<<]8V6@"\I]GS+@P+07M?.SZ];SK]UK[3(]G&7#@
MVLL,?;%17BU-E0+"G2MN*C@:JSK MH&T_CQ45T5W;3M6MX)UG8J\;ZGL A2J
MQN/*\C/'U_\ %(MVSQ\5P9M763'L!W-1"+6-CSQM&NY&UG8*A[FJLEBYZRXT
MF8E]2VW5EB
M                                                   !$*KGQ8V;
M7[9*VQIBK9^?=CH+(*ZPHBKIUS&QT4>-?NZI)T/LO#EW&?#O"CY<55\ZD61A
M[/SX?FX\K$+.N[WK=]%W9=?M3J[*F2)+PU80.$^<KC)<3$M%=5<VE=FCAR[%
MBR\K;U=A.N;! ;8Z"X2MG^/BI*!.BQ9UWX\.6>%G7V8U\X
M
M                 "-V+)(:3&]HTB-\G!)G'DZEBR8]E1\WXLG2<.2'G/CV
MV1@F'PY_IX\N.Q\H6.7>I<3L,:3(;GBP5@SY:EQN>Q98]8,V 9&"6.7%E+#F
MQ7@RQ.S8L\2,':X<OL$J-P\63STJ-WS%EP?@S1RD1Y.?/OUR\,N8L@
M
M                                        ]3U/H >#U/<  'S^/;Z]
M@>@?/=]\'D  ] >X
M
M
M
M                                        !\OGV)7WC+<]WT
M
M
M
M                                           "/\*727,B=<^.T9\=
M]F3%D.-)I,KYT=["")BSX%NT"?6Y7SJYK"#Y.[3X&P+ GXKBR*7\V/A^>.?D
M^%8A!F@
M
M
M                                 ?+Y]B5]XRW/=]             I
M,J[&?FT:Y%6JL<Z0IG:;NHF#6SM;V3CV0,?T^^Q[E"M78W$[/KF7*RR\GT*'
M:RQM%V;7)(U%IKQX9%[UQ49*@S0
M
M
M                                                    (_PI=)<R
M)USX[1GQWV9,60XTFDROG1WL((F+/@6[0)\!8$RNZ?"Y'E\MJDQY(1)0%8M;
M/^FR4-FU;/     J;J['J^RZ_P O EVZ\<@Q=5V-!E_22X@3NR2HMGWS[VK#
MEUJ\$B>G/#TN1BLIRXLU19&L[RY;,/W%[?.=1E78R!VC7)Y5=D
M
M                              ,5X<E<N7'8!GPYNPYAX,?\.7+Y<?:N
M/( =>X<F7'V'CRX/Y]^'WX!R'WYR?SZ
M
M     !295V,_-HUR*M58YTA3.TW=1,&MG:WLG'L@8_I]]C@H<G7DLX.Q1P^X
MZJ+*BO9J+8LK)XC[ F4%2L-BES46QU=B    !QN+G6'BRUGYL6=9D6[[[QZ!
M3VU:-Q56@X,L.JRQB'LM!?107%#TW!:GDP]5KYU+\Z)LC8^.M[(Y[,D?D*M*
MNS[;L^MV/5EB
M                                                   !&JOFTPVU
M;WG!DZM'DVI75/,BILZ&X\CL5E7XXB2IH7%5:%6V ^./EKU0IMB>RZ_815V-
M)M=-PE8PA@_%DLVN:BUFKLP
M                                                         *FZ
MNQZOLNO\O EVZ\<@Q=5V-!E_22X@3NR2HMGWS[VK%E^9Z?$**V?7QL^OWRU=
MCQ.#+0QEX3;BR<?;!1VQU=B    !P7#ER^7'5)P^Y5K+.-.T:W=#5V0\GKP^
MZP.7[L_?,3YS]@4(U-C:QM.NT:UMCLO_ #YY?:EJNQS;M&NS\J[$
M
M                               "I:KL<W[3KF&*FQL CR,=64#G*2WK
MTV.@N5KK#\F+GK.2L6S;B>7*KFLL8%V5?9E:UMA%78@8AA2Z,+6NV%^'WEL6
M4
M                                   #C<7.L/%EK/S8LZS(MWWWCT"G
MMJT;BJM!P98=5EC$/9:"_BKL17U"EUP9L,Q+JIM@K+&G:NGS,V*@Z-K6QX2V
MC6[8ZNQ     H*J[&T_:-<B)56,AJRSACM&MROUC8L ;-KUO-98XBKYE$=_3
MWQZ_=4=[!2;"T&7^/#EUPN&785M*NC6BO+E-AU_-E;8:^D&==1L%%F6OG@
M
M                                     1+K9U.UU59?X?;L/G+MV/(
M,$5\VD'8*78UKYL?8$RL.]I\VZ[?9)VC7+"*NQ H3K;"SO9->EC6V(
M
M              '73L0             ."X<N7RXZI.'W*M99QIVC6[H:NR'
MD]>'W6!R_=G[YB?.?L>G'[K>P9UN]A6TN2.%@L?-@2+)Z1:5MQ_Q(^-)
M$=(,NE.;%ZN^=PR\+S\^#(];/HTX9.#EQ. ^KDY4:1D*74U7SHDVE=\\62Q>
MQ@6$0)T?(4JER7&Y3C]E=:UULE=/
M
M         P/'S4Q<N./>?RW2SK9QU\\87B2:)9."\"="S966%"67C>E*B5OT
M=WDG:-;L(J[$80K9U)NQT6Q#73CZ
M                                               !PN')5'QYP9SQ
M[$ID:T2-G^W'F/7C]K1^\K+.>#Z<<G2,&6O7GQ_;)CV&G9\67C<?.O?ARZI*
MCV <^&1<.8    "@JKL;3]HUR(E58R&K+.&.T:W*_6-BP!LVO6\UECB*OF41
MW]/?/K]U1QL%)L*P9?Y,.76WQY[[;&LQ9'DB),"=B^^I+>8LC)6+*    !Z_
M%8KY9U]>SZ!\SW/(!Z'D]@#U/![@
M                                                      P)\9[^
M@            !'F/FR?/A5JQ\U@-99T@;/KFP_66,6H,NF:QA7DYX^=8LJ
M-78T_P!S4Y@Q9<4XLO)2HUZ,F-)&#-J;JK')6TZY8U5V0
M
M     J4J['LNSZ[U:IL<6P+"8VS:[/NKLA7-5V-+&R4NUQ#Y?HQ9]=F%-LUN
M*C@*:U@CL-+?]6SZ-ZNQR]L=!*RJLJE)&/8$S1^RQY     CI!ETIS8O5WSN
M&7A>?GP9'K9]&G#)P<N)P'U<G*C2,ARZHZZ=$*TKOABR6$6,"QB!. A16V&(
M-DH+-JV>
M                                                .B1L]('/CA#+
MBS)GQ7B<^&08TBON%+@C,B\_EQ6R9<6;XTD"J^OFRAOZ25\"=T*/FJ!Y?.G9
M\%ADN-."'+     J<JK'\^TZY^FJL<_UEE!7:-<MXUZ\UVYT6[K/'R''D>_/
MCG3A]^+Z*M*NRR1M&N6%U=A[ONO=5V-U^T:YF*KL@
M                                             /'Q#_!GKVSQ[+I.
M"3D>0 ([?.4A^6/C,67#.3@ ,S<\?*\,@P[ARY(EQ>:Q90    *3JJQF_M.N
M1PJK&TU]_=R^?;Y]PW"EU&7-5@.!9;)>>!]\$C6;9-DZ1$_!7S=<NU@[*\"3
MK)R/FS9QX>_SE435V,B=HUR=M79     >OQ6&^6>?7L^@?,]SR >GQY^O8
M
M                                         %3558Y3VG7,7U5GF6OF
M\;L-%(_7+ZF?8J38!AR,+5L^D>^J-CB!,$4:V=07/B7<V]3.FKLZ*ZNQL#VC
M7);TUKKK8LVP);U'?X4X    <)ART_\ #G#*3&D[FQ7%\OD?ZJRKXFQ /VR\
M%V\;G[\<@A9"F=NNJB4L*6*A,,BV^77_ +,4@
M                           8$^,]_0             KKJ[&'VQ47ZJZ
M9B3!)MWNZ:5]=8"+5=.UZ+VKVM(_S'%;95#SH@XW%DA1)P;-$F+DB%-PI$D:
M\OW[L4WM+ERLL0    ,&PY5&\C#P\F-:KDX3YCYOAART*_.=V-A7Z^4&SV29
M%?\ HQYZO:JQKBNZC\425:O;U5BE78ZTN"3L*V=9D6)*H<K+&5VT:U9M5V@
M
M                                                      JVJK'I
M>T:[RM986T/HZ7BR=4DQ\OX\G6(<C7)MJ[9=BR>K1L]%4R-GBNFR=V*AG35V
M?4>/+M63%PF#/KOX\NP#;5/?H4T     0B^?)N_?H
M                                      PQ#DTL2,.(.7&1$N->/PY<
M]AS#KL?-2+/AWMX,GERK[@RX/SH@R#-B71PI>'(LBH[+C_%(P6;2,$JXDH
M  "CNKL;(-HUR(558V"8LWUF1<L8<O6X^:B>5@PDR;,/*+^C'G IZJK'-.TZ
MY8Y5V45H$VI"UK>F5T^^^^I,N5EB     /3XIAPY.A8)$I=BH>M:OL?-[-KT
MZ*VPU^,<C8*E5W*55KK\V]9L,<?O'09FOGFX;%$R%%JFMJ@)T3)O+ARL?/,2
M[J+):NR
M
M  '#X<E1>/+ "3'E])CW&F0(^<?CQ\J+H<R8VQT%B]78TD0IME-Y20>UV^D-
MM&N3IJ[,81A3*4L\?E+2OORBY^5QY0
M                 !Z\4-<.> 4C!9S(P20CYP!'0D6^'T##&+)D.5&[)BRC
M&^+)B'-AD9R^<UPY@    4?U5C83M.N14JK/G8$W/VP44QZ^>*68$V"5]2[2
M4"7Y<J"*RQM=V+7^_P "?^SEQR=PY:XD*;<U>4N?:NQU_P!ROGLJ[OT.6
M (7UTZH^WK,E_%SQE?%E?%*,&;8U?4E(59;[),BO_1CSC#-?,HTO:C8LB2/K
MQY]:^?>P<N% U5:W1;/K>7*RQ     J3@3+);VEKE@39@5EG6EL^MYUH+S!4
MR*(3<>=A$^NL&U[8*O-HUR]RKL10+56-Q&TZWB^IMI>\\/O\YTJ5=C/_ &C7
M)75=D
M
M/ *G./W)M;813VC7+PZNRZQ@RT58\LQ[RELUKK"&E5852;#2V*PY4&H<K*=S
M4VRXLW?H^8"H"JL<I[3KEEE79                                 #P
M8%,]@             K-JK&.6QT/'UT_#.'-=!<U$E:^>(@UL^A39*+:HK9G
MER&/8DC6I^_=@J^HY'5=G"6NG5C7%7*Z')A1,C[$3CS6#.    *6ZJQS]M.N
M="JK*V/Z A#5V$?=GU^!%98;*SB^<M;/AEM ^<>L2<%@?WYV.KFZUM]7;,$"
M2*=JFQDYM6N3MJ[(    #%V'+2C\^8QY?;?;6KXO6[^/VSZ];+66.M=CD[),
MBO\ T8\XI@JK&5^TZY/"KL@!0#5V=T6SZWERLL0    *SZNQB'L-%S$"9TR-
M*L<O:2==;8@:UV.3LDR*_P"$27KO_,D^)\#\]=.A);5VPG&S4TU%KVG8:+O]
M39PKM:[8#BY_MQY@                   5F]T10        !G/6.<O^OLX
M
M                        I=J[&<NT:Y%JJLYPUEA41M&N7PTEOKY\>=H=
MQ4S@@3A@N-FBW)PB#L.5E.XJ;9\>6F&LLKIK:H[Q$F5255CV+:=<LYJ[(
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MK^<I)<L?M\Y<%CYPT/O(P3+^?>6X<_S<.4,N'+\4J/,_Y]Y3AS
M          &LW[0JP        !.7K'/;_P"?9H
M
M  C; F4C6$+F/GW\O#G<195V$M<OZ>+BJS5CR#LT^#L,0)OE]%2=782$VC7)
MT5=G!VOG5:VE;FV-GQ=-BWT_'9\&<
M "B"KLK1MHUN&U79?6OFRNOZ25\"=X^*1(4R'UU3;/L.;CZ!,U_;FKV(</.+
MM/;5U[1KE[%79"/\"9KUR<%MUS4635ED    !!6MGU97-5DGARN?^_,GXLOC
MXH]AS+1;NFHF@S=E9Q\N5;558_HVG7(I:OL5GFT:YGS6[S7#N($GJ^;@;-AF
M98P;7($SR^@   #U^/;ZJ6X<OG7SOKL^NX,U;8\O;#1YLARZB2YV1'G5'D #
M7GJ[*ZC:-:]Z&[J1RX^5EQ>QUMA*[8*.>M79    "FFJL>][/KO!U=C^*OL.
M\;-KMI=79 :U^.3LDR*_]&//B2JL:0MIUS88J[( "@&KL[HMGUO+E98@
M 8G,L              K-[HB@        #.>L<Y?]?9P   !K-^T*L
M   3EZQSV_\ GV:
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ML!DX+1,.7]G#F!6MQRV2Y(WTXY,719,:;.MG/&D@ 0 BRIHVE;VZ+(
M              &LW[0JP        !.7K'/;_P"?9H    UF_:%6
M )R]8Y[?_/LT
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MJP        !.7K'/;_Y]F@   #6;]H58         G+UCGM_\^S0
M
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M                                   #6;]H58         G+UCGM_\
M/LT    :S?M"K         $Y>L<]O_GV:
M
M            !6KMO;?5<\T        #*L*EG_K'6(                 U
MZH,Z\N\HJYX,_-%58Q[VG7)*T=SU"1@?%1[Y=+)P9BIK:NO8:*Y6OG_DQ<]9
M_CEOQE0XP\,@B'!E?HNJJW7'SRO'D    #K>#+5C\^P@D8;#Y4:SJ/F_1QY@
M5IEE;YY?0(-19$GK2MR/%E<)BR5@\.>*946PN1AE)%D@     >I[
M                                     UF_:%6         )R]8Y[?_
M #[-    &LW[0JP        !.7K'/;_Y]F@
M                                            8R,F@
M                 %:NV]M]5SS0        ,JPJ6?\ K'6(
M     @E73JMK:L8,WX>?&^&5%S'$EA\:UGSYLI\OOY\?.B:-)_?95V/(LF<%
MK66:U\\"M"IL?U[3KEDE99      1.^)8_0
M                                  &LW[0JP        !.7K'/;_P"?
M9H    UF_:%6         )R]8Y[?_/LT
M                                        #JL?-35]13S89<2H]S&/
MES>+-#J))@E)C][D8;0'SN^'-A:-GK+RX^>E1[0/O'O^#.!%F%+QK<U$\(<P
M                    5J[;VWU7/-         RK"I9_P"L=8@
M        =6Q\JE,O"W_[\Y7CR 'S/H#P8^X<N>RXNR<>8 ]?A]>P
M                                           -9OVA5@        "<
MO6.>W_S[-    &LW[0JP        !.7K'/;_ .?9H    UF_:%6
M)R]8Y[?_ #[-
M                     J3JK+)6TZWCZKLOK66&3]EUZ2>MW]*E]3WIQ\T9
MZFRKLV6AOVI;36]Y_;PIL'I-+;59;'1[!E;/'58V?7$X9)R7]%<#660    &
M*IMT         .5X8,@1:P    5J[;VWU7/-         RK"I9_ZQUB
M             /4]@
M                #6;]H58         G+UCGM_\^S0   !K-^T*L
M  3EZQSV_P#GV:    -9OVA5@        "<O6.>W_P ^S0
M                                                      *?JNRS
M%M&MX\J[*V$\F),&;JLZ%(7!GZY!DZY-Y6[*%=+PEFQ9VX<\=P)5 =]5[($"
M4^*2(4W+>:-UJ[J;@:RR     JKW3N@         95A4L_\ 6.L0   !6KMO
M;?5<\T        #*L*EG_K'6(
M                            QY;\:*O3]>         )D]=Y[3^C98
M  UF_:%6         )R]8Y[?_/LT    :S?M"K         $Y>L<]O\ Y]F@
M   #6;]H58         G+UCGM_\ /LT
M                                       #H,;/29]1TEQ;%\V*TS%S
MYG'E'SX_:4*Z?GG9]=LZJ[(0(@RZ?9&&TFYJ+,*RR@;5V.']HUW/FJ[%%3:=
M<N!K+(    "JO=.Z         !E6%2S_ -8ZQ    %:NV]M]5SS0
M,JPJ6?\ K'6(                                               '
M!2OD-NQ,          RM1<Y(:=E    QE=<->CUM7         "<O6.>W_S[
M-    &LW[0JP        !.7K'/;_ .?9H    UF_:%6         )R]8Y[?_
M #[-    &LW[0JP        !.7K'/;_Y]F@
M                                            5#<.?P@S/39=>N#J
M[+BL62DJ+)RQL-%;A6S_ &?1X.NX<NN7QYWHRX=&[E<>XQGJ[&/]_27$1I.3
M\64    55[IW0         ,JPJ6?^L=8@   "M7;>V^JYYH        &585+
M/_6.L0                                               ,977#7H
M];5P         G+UCGM_\^S0   ,977#7H];5P         G+UCGM_\ /LT
M   :S?M"K         $Y>L<]O_GV:    -9OVA5@        "<O6.>W_ ,^S
M0   !K-^T*L         3EZQSV_^?9H
M                                       %.-;/L3V.A@Q73YK55C5-
MM.MWK4UO07@SSJO*6QFOGCHT&75E=U%PT*8->RJL;3[^FBA%D#"T21BRTKKC
MOOR4,64    *J]T[H         &585+/_6.L0   !6KMO;?5<\T        #
M*L*EG_K'6(                                Z+9\:;O1,(
M 2LT3+8_T]*    QE=<->CUM7         "<O6.>W_S[-    QE=<->CUM7
M        "<O6.>W_ ,^S0   !K-^T*L         3EZQSV_^?9H    UF_:%
M6         )R]8Y[?_/LT    :S?M"K         $Y>L<]O_ )]F@
M                                              ?+Y]B5]XRW/=]
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M.7K'/;_Y]F@   #6;]H58         G+UCGM_P#/LT    :S?M"K
M $Y>L<]O_GV:    -9OVA5@        "<O6.>W_S[-
M                                   $?X4NDN9$ZY\=HSX[[,F+OL.7
M4!%DX"G0G+Y<!(P2"B2J^X$ROB?"]"QJ=#GI!FQYAR:>).#D.?">TZ'8/!F@
M    #%&')4?FQVV9<66\67IW#EU7GQ _5RXY1X\OGQ^QWX\OUR<&?\7/V?0.
M$X<N*RXNX<>8    %5>Z=T         #*L*EG_K'6(    K5VWMOJN>:
M    !E6%2S_UCK$                #&5UPUZ/6U<         )R]8Y[?\
MS[-    QE=<->CUM7         "<O6.>W_S[-    QE=<->CUM7
M"<O6.>W_ ,^S0   ,977#7H];5P         G+UCGM_\^S0   !K-^T*L
M      3EZQSV_P#GV:    -9OVA5@        "<O6.>W_P ^S0   !K-^T*L
M         3EZQSV_^?9H
M             I,J[&?FT:Y%6JL<Z0IG:;NHXO7;V$.TZY=K5V."JRPI2V:@
MOOUV[UZKJKV-\&7\T61K<_>6R'/KM=JHN+RKJESG7SJ"(DRY&]H\V0)X
M ZF=L             !57NG=          RK"I9_ZQUB    *U=M[;ZKGF@
M       95A4L_P#6.L0                ,977#7H];5P         G+UCG
MM_\ /LT   #&5UPUZ/6U<         )R]8Y[?_/LT   #&5UPUZ/6U<
M    )R]8Y[?_ #[-    QE=<->CUM7         "<O6.>W_S[-    &LW[0J
MP        !.7K'/;_P"?9H    UF_:%6         )R]8Y[?_/LT    :S?M
M"K         $Y>L<]O\ Y]F@
M                "INKL>K[+K_+P)=NO'(."X<OQ9<7:N//"%7/I-V>@V%Z
MJQZ;SX=\^<OP8<FM3]Y;(TF!K9_9&S7B^BI"KL,L;1KMB]79
M        55[IW0         ,JPJ6?^L=8@   "M7;>V^JYYH        &585
M+/\ UCK$                #&5UPUZ/6U<         )R]8Y[?_ #[-
MQE=<->CUM7         "<O6.>W_S[-    QE=<->CUM7         "<O6.>W
M_P ^S0   ,977#7H];5P         G+UCGM_\^S0   !K-^T*L         3
MEZQSV_\ GV:    -9OVA5@        "<O6.>W_S[-    &LW[0JP
M!.7K'/;_ .?9H
M      XW%SK#Q9:S\V+.LR+=]]XY+C21TF/FH%^_;A[6JE3!G#\W#E21!FYY
MV37K1ZRRU]ZVPG?L-#(^JLJ.L&:Q?8:&SBKM                    *J]T
M[H         &585+/_6.L0   !6KMO;?5<\T        #*L*EG_K'6(
M           &,KKAKT>MJX         3EZQSV_\ GV:   !C*ZX:]'K:N
M      $Y>L<]O_GV:   !C*ZX:]'K:N         $Y>L<]O_ )]F@   8RNN
M&O1ZVK@        !.7K'/;_Y]F@   #6;]H58         G+UCGM_P#/LT
M  :S?M"K         $Y>L<]O_GV:    -9OVA5@        "<O6.>W_S[-
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M.7K'/;_Y]F@   #6;]H58         G+UCGM_P#/LT    :S?M"K
M $Y>L<]O_GV:    -9OVA5@        "<O6.>W_S[-
M                                   %!578VG[1KD1*JQD-66<,=HUN
MV"@NZ )<>\^5$SO%E#XX^>OS'DV-WE)/&OGCV*<XTFV6QK>QQ96O?$F7;WE'
MEV!/                    JKW3N@         95A4L_P#6.L0   !6KMO;
M?5<\T        #*L*EG_ *QUB                !C*ZX:]'K:N
M $Y>L<]O_GV:   !C*ZX:]'K:N         $Y>L<]O\ Y]F@   8RNN&O1ZV
MK@        !.7K'/;_Y]F@   8RNN&O1ZVK@        !.7K'/;_ .?9H
M UF_:%6         )R]8Y[?_ #[-    &LW[0JP        !.7K'/;_Y]F@
M  #6;]H58         G+UCGM_P#/LT
M        82PY:_<N&QO/CRIARCT^,<?/O:\G#G^/(#I'#E[9<?=>/( <3PY<
M1EQ]MX\@    (Z09=*<V+U=\[AEX7GY\$&Z*ZK>LZWL?SD,JV,*TC7+VC"SK
M>Y?.0&P-8PHOZ]=5;V,'D\?.<-G7V85\X    #JF::         /U_.'8,44
M    55[IW0         ,JPJ6?^L=8@   "M7;>V^JYYH        &585+/\
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M66.8]HUVV.KL0    !Z_%8;Y9Y]>SZ     !Z_'CZ]P     55[IW0
M   ,JPJ6?^L=8@   "JO=.Z         !E6%2S_UCK$    5J[;VWU7/-
M      RK"I9_ZQUB                !C*ZX:]'K:N         $Y>L<]O_
M )]F@   8RNN&O1ZVK@        !.7K'/;_Y]F@   8RNN&O1ZVK@
M !.7K'/;_P"?9H   &,KKAKT>MJX         3EZQSV_^?9H    UF_:%6
M       )R]8Y[?\ S[-    &LW[0JP        !.7K'/;_Y]F@   #6;]H58
M         G+UCGM_\^S0                                     *.Z
MNQLEVG7(>U-C-J/(^]C!Q/2VV$-CH+1ZZPZ763=>S9:38)UR[I<V&DOAKYWC
MXULX,[8@OZ'MM?802J["K2S@S5M:RV.KL0                   !57NG=
M         RK"I9_ZQUB    *J]T[H         &585+/_6.L0   !6KMO;?5
M<\T        #*L*EG_K'6(                &,KKAKT>MJX         3E
MZQSV_P#GV:   !C*ZX:]'K:N         $Y>L<]O_GV:   !C*ZX:]'K:N
M       $Y>L<]O\ Y]F@   8RNN&O1ZVK@        !.7K'/;_Y]F@   #6;
M]H58         G+UCGM_\^S0   !K-^T*L         3EZQSV_\ GV:    -
M9OVA5@        "<O6.>W_S[-
M   KZJ["O"_I<G8,MT_SES_#F (;U5C7%M.N7RU=D!C^)(UWK")LJL?0:ZPI
M:M($\:6VPULVO6QU=B                    *J]T[H         &585+/_
M %CK$    55[IW0         ,JPJ6?\ K'6(    K5VWMOJN>:        !E
M6%2S_P!8ZQ                 QE=<->CUM7         "<O6.>W_S[-
M QE=<->CUM7         "<O6.>W_ ,^S0   ,977#7H];5P         G+UC
MGM_\^S0   ,977#7H];5P         G+UCGM_P#/LT    :S?M"K
M $Y>L<]O_GV:    -9OVA5@        "<O6.>W_S[-    &LW[0JP
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MT'W-3G;%EZ!BR\'*C7228TU8,T                   "JO=.Z
M!E6%2S_UCK$    55[IW0         ,JPJ6?^L=8@   "M7;>V^JYYH
M   &585+/_6.L0                ,977#7H];5P         G+UCGM_P#/
MLT   #&5UPUZ/6U<         )R]8Y[?_/LT   #&5UPUZ/6U<         )
MR]8Y[?\ S[-    QE=<->CUM7         "<O6.>W_S[-    &LW[0JP
M    !.7K'/;_ .?9H    UF_:%6         )R]8Y[?_ #[-    &LW[0JP
M       !.7K'/;_Y]F@                     #%$232;GPX=Y<,]2L%Y/
MQV>/GK5ARX:S(G<,^*W+EPRG'D1$ARJTI4?SDQ6<R8\KHDOIT?-3W]=$DQ[*
M94:8\.6    !2#56,KMIUS%M58]DK++I>T:Y-[6[^BFWK;R^/SL>+-R7/AD6
M'*UN.?RX"QK\X1)0S9SX?7AS$#:NRPIM&N6R5=A]'T
M "JO=.Z         !E6%2S_UCK$    55[IW0         ,JPJ6?^L=8@
M"M7;>V^JYYH        &585+/_6.L0                ,977#7H];5P
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M        !V#%%S!!H@   !57NG=          RK"I9_ZQUB    *J]T[H
M      &585+/_6.L0   !6KMO;?5<\T        #*L*EG_K'6(
M      &,KKAKT>MJX         3EZQSV_P#GV:   !C*ZX:]'K:N
M $Y>L<]O_GV:   !C*ZX:]'K:N         $Y>L<]O\ Y]F@   8RNN&O1ZV
MK@        !.7K'/;_Y]F@   #6;]H58         G+UCGM_\^S0   !K-^T
M*L         3EZQSV_\ GV:    -9OVA5@        "<O6.>W_S[-
M'4,?.#63'/CGQYSAS ^9['L #\1^T ]?CQ]>X     *>:JQR'M&N]?K)]L;D
M,>XLGX)4;*.++C"LG4,;-1;#M/98>DQ\]8\ORX<M:C!(V.+:HUPX%CLMY8_U
MXY*@*NQDUM&N3EJ[(     0B^?)N_?H             JKW3N@         9
M5A4L_P#6.L0   !57NG=          RK"I9_ZQUB    *J]T[H         &
M585+/_6.L0   !6KMO;?5<\T        #*L*EG_K'6(                &
M,KKAKT>MJX         3EZQSV_\ GV:   !C*ZX:]'K:N         $Y>L<]
MO_GV:   !C*ZX:]'K:N         $Y>L<]O_ )]F@   8RNN&O1ZVK@
M   !.7K'/;_Y]F@   #6;]H58         G+UCGM_P#/LT    :S?M"K
M     $Y>L<]O_GV:    -9OVA5@        "<O6.>W_S[-       AY73:E+
M:M]H^;@<GR_&5$R!6V%&G'GPTJ+U'Y]M]FQ)70I@PG#DT;W-;L:0I(B=!F5"
M3H?.8^<D;6MM_KIQ]    '5<&6H#AS@Y*C39DX+B>'+M6',.'Q9*#X^>RB^I
M)P5U@/'Q4?66/ [1KEQ5':ZS\_'LRX/HJSJ[/M^SZW8[66(
M      %5>Z=T         #*L*EG_ *QUB    *J]T[H         &585+/\
MUCK$    55[IW0         ,JPJ6?^L=8@   "M7;>V^JYYH        &585
M+/\ UCK$                #&5UPUZ/6U<         )R]8Y[?_ #[-
MQE=<->CUM7         "<O6.>W_S[-    QE=<->CUM7         "<O6.>W
M_P ^S0   ,977#7H];5P         G+UCGM_\^S0   !K-^T*L         3
MEZQSV_\ GV:    -9OVA5@        "<O6.>W_S[-    &LW[0JP
M!.7K'/;_ .?9H      %$M58VG[3KD)ZFQE%&E=FMJS"VOWF%-IUNV^KLL15
M5A1CM.O;%=78P9@RZN9L+I5E'V8:Z4-?2KL;F=IUW.-38ZY%?87X;%K^2*ZP
M    'J>SY4UP^\I7V'2=GUVX>KLNAQ\U$3[8M<55@=?.'Y,?*F.%,_1L5%<Q
M F_7#SUH,WS9AX_#[4]5V67-HURP6KL0                   *J]T[H
M      &585+/_6.L0   !57NG=          RK"I9_ZQUB    *J]T[H
M     &585+/_ %CK$    5J[;VWU7/-         RK"I9_ZQUB
M      !C*ZX:]'K:N         $Y>L<]O_GV:   !C*ZX:]'K:N
M$Y>L<]O_ )]F@   8RNN&O1ZVK@        !.7K'/;_Y]F@   8RNN&O1ZVK
M@        !.7K'/;_P"?9H    UF_:%6         )R]8Y[?_/LT    :S?M
M"K         $Y>L<]O\ Y]F@   #6;]H58         G+UCGM_\ /LT
M "JJJL<)[)0]MB9[DL>7V??4]#ZD5JJQJQVG7+]ZNRC/CY9]X_-<.RQ[*\/F
M*J:NPZ7L5')VJL:PID;87^\.3PYP   !1#5V-KNSZY!^KL91UEG +:-;N/HK
MG7SR<;@[*NEK"F#UX_:,($Z1>QZ_:+6V'E]&O'!G7HWE'DN#.H3K+&VW9M=S
M_66(                   %5>Z=T         #*L*EG_K'6(    JKW3N@
M        95A4L_\ 6.L0   !57NG=          RK"I9_P"L=8@   "M7;>V
M^JYYH        &585+/_ %CK$                #&5UPUZ/6U<
M )R]8Y[?_/LT   #&5UPUZ/6U<         )R]8Y[?\ S[-    QE=<->CUM
M7         "<O6.>W_S[-    QE=<->CUM7         "<O6.>W_ ,^S0
M!K-^T*L         3EZQSV_^?9H    UF_:%6         )R]8Y[?_/LT
M :S?M"K         $Y>L<]O_ )]F@      ?'A]@-ASU-\L?.S(U[N;%FF)*
M&$HDFB65'O9FP\W0Y8^,;)K76N#97A\Q5/6S\(753E^%+C/,BWLOG9\&<
M 1"KYM/-I7\CAY\;]^W=3H4*]=OJP+FIR]CR#*MC"M!UF^UYKFJD'CR ; EC
M"P-KUS4+9P,M19'/7-7=K6SO+Z                   !57NG=
M RK"I9_ZQUB    *J]T[H         &585+/_6.L0   !57NG=
MRK"I9_ZQUB    *U=M[;ZKGF@        95A4L_]8ZQ
MQE=<->CUM7         "<O6.>W_S[-    QE=<->CUM7         "<O6.>W
M_P ^S0   ,977#7H];5P         G+UCGM_\^S0   ,977#7H];5P
M   G+UCGM_\ /LT    :S?M"K         $Y>L<]O_GV:    -9OVA5@
M    "<O6.>W_ ,^S0   !K-^T*L         3EZQSV_^?9H      &&,?/,&
M?!5'BYYVK;*(NT:[=/5V,3H,NG2Q@WEY\.<8LD#XQLFM=:X-E>'S_%"SZT%Q
M"V:8N3W^<JE:JRR[M.MV&U=D    !U[ARJ+Y<+>>?'G.//T/4 \GL>@ /H>3
M@N'+K67'D'CR\@                    JKW3N@         95A4L_]8ZQ
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M6?\ K'6(    JKW3N@         95A4L_P#6.L0   !6KMO;?5<\T
M #*L*EG_ *QUB                !C*ZX:]'K:N         $Y>L<]O_GV:
M   !C*ZX:]'K:N         $Y>L<]O\ Y]F@   8RNN&O1ZVK@        !.
M7K'/;_Y]F@   8RNN&O1ZVK@        !.7K'/;_ .?9H    UF_:%6
M    )R]8Y[?_ #[-    &LW[0JP        !.7K'/;_Y]F@   #6;]H58
M      G+UCGM_P#/LT      #"4233'GPX@Y\,\2,-W7WY7]46D%9\+V!ENP
MA7B5\T?/!SI"L,-X,;F(NPI53<N-]/OR44^':]"E>WSD
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MSV_^?9H    UF_:%6         )R]8Y[?_/LT       "O3Y\L+^_0
M                      *J]T[H         &585+/_ %CK$    55[IW0
M        ,JPJ6?\ K'6(    JKW3N@         95A4L_P#6.L0   !57NG=
M          RK"I9_ZQUB    *U=M[;ZKGF@        95A4L_P#6.L0
M           ,977#7H];5P         G+UCGM_\ /LT   #&5UPUZ/6U<
M      )R]8Y[?_/LT   #&5UPUZ/6U<         )R]8Y[?_ #[-    QE=<
M->CUM7         "<O6.>W_S[-    &LW[0JP        !.7K'/;_P"?9H
M  UF_:%6         )R]8Y[?_/LT    :S?M"K         $Y>L<]O\ Y]F@
M                                     55[IW0         ,JPJ6?\
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M<O6.>W_S[-                                      JKW3N@
M   95A4L_P#6.L0   !57NG=          RK"I9_ZQUB    *J]T[H
M   &585+/_6.L0   !57NG=          RK"I9_ZQUB    *U=M[;ZKGF@
M      95A4L_]8ZQ                 QE=<->CUM7         "<O6.>W_
M ,^S0   ,977#7H];5P         G+UCGM_\^S0   ,977#7H];5P
M  G+UCGM_P#/LT   #&5UPUZ/6U<         )R]8Y[?_/LT    :S?M"K
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MUPUZ/6U<         )R]8Y[?_/LT   #&5UPUZ/6U<         )R]8Y[?\
MS[-    QE=<->CUM7         "<O6.>W_S[-    QE=<->CUM7
M"<O6.>W_ ,^S0   !K-^T*L         3EZQSV_^?9H    UF_:%6
M  )R]8Y[?_/LT    :S?M"K         $Y>L<]O_ )]F@
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MJO=.Z         !E6%2S_P!8ZQ    %5>Z=T         #*L*EG_ *QUB
M *J]T[H         &585+/\ UCK$    55[IW0         ,JPJ6?^L=8@
M "M7;>V^JYYH        &585+/\ UCK$                #&5UPUZ/6U<
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M.7K'/;_Y]F@   #6;]H58         G+UCGM_P#/LT    :S?M"K
M $Y>L<]O_GV:      !57NG=          S_ %>L35U_KX    55[IW0
M     ,JPJ6?^L=8@   "JO=.Z         !E6%2S_P!8ZQ    %5>Z=T
M     #*L*EG_ *QUB    *J]T[H         &585+/\ UCK$    55[IW0
M       ,JPJ6?^L=8@   "M7;>V^JYYH        &585+/\ UCK$
M        #&5UPUZ/6U<         )R]8Y[?_ #[-    QE=<->CUM7
M   "<O6.>W_S[-    QE=<->CUM7         "<O6.>W_P ^S0   ,977#7H
M];5P         G+UCGM_\^S0   !K-^T*L         3EZQSV_\ GV:    -
M9OVA5@        "<O6.>W_S[-    &LW[0JP        !.7K'/;_ .?9H
M   %5>Z=T         #/]7K$U=?Z^    %5>Z=T         #*L*EG_K'6(
M   JKW3N@         95A4L_]8ZQ    %5>Z=T         #*L*EG_K'6(
M  JKW3N@         95A4L_]8ZQ    %5>Z=T         #*L*EG_K'6(
M K5VWMOJN>:        !E6%2S_UCK$                #&5UPUZ/6U<
M      )R]8Y[?_/LT   #&5UPUZ/6U<         )R]8Y[?_ #[-    QE=<
M->CUM7         "<O6.>W_S[-    QE=<->CUM7         "<O6.>W_P ^
MS0   !K-^T*L         3EZQSV_^?9H    UF_:%6         )R]8Y[?\
MS[-    &LW[0JP        !.7K'/;_Y]F@      55[IW0         ,_P!7
MK$U=?Z^    %5>Z=T         #*L*EG_K'6(    JKW3N@         95A4
ML_\ 6.L0   !57NG=          RK"I9_P"L=8@   "JO=.Z         !E6
M%2S_ -8ZQ    %5>Z=T         #*L*EG_K'6(    K5VWMOJN>:
M !E6%2S_ -8ZQ                 QE=<->CUM7         "<O6.>W_P ^
MS0   ,977#7H];5P         G+UCGM_\^S0   ,977#7H];5P         G
M+UCGM_\ /LT   #&5UPUZ/6U<         )R]8Y[?_/LT    :S?M"K
M    $Y>L<]O_ )]F@   #6;]H58         G+UCGM_\^S0   !K-^T*L
M      3EZQSV_P#GV:      !57NG=          S_5ZQ-77^O@   !57NG=
M          RK"I9_ZQUB    *J]T[H         &585+/_6.L0   !57NG=
M         RK"I9_ZQUB    *J]T[H         &585+/_6.L0   !57NG=
M        RK"I9_ZQUB    *U=M[;ZKGF@        95A4L_]8ZQ
M        QE=<->CUM7         "<O6.>W_S[-    QE=<->CUM7
M "<O6.>W_P ^S0   ,977#7H];5P         G+UCGM_\^S0   ,977#7H];
M5P         G+UCGM_\ /LT    :S?M"K         $Y>L<]O_GV:    -9O
MVA5@        "<O6.>W_ ,^S0   !K-^T*L         3EZQSV_^?9H
M %5>Z=T         #/\ 5ZQ-77^O@   !57NG=          RK"I9_ZQUB
M  *J]T[H         &585+/_ %CK$    55[IW0         ,JPJ6?\ K'6(
M    JKW3N@         95A4L_P#6.L0   !57NG=          RK"I9_ZQUB
M    *U=M[;ZKGF@        95A4L_P#6.L0                ,977#7H];
M5P         G+UCGM_\ /LT   #&5UPUZ/6U<         )R]8Y[?_/LT
M#&5UPUZ/6U<         )R]8Y[?_ #[-    QE=<->CUM7         "<O6.
M>W_S[-    &LW[0JP        !.7K'/;_P"?9H    UF_:%6         )R]
M8Y[?_/LT    :S?M"K         $Y>L<]O\ Y]F@      55[IW0
M ,_U>L35U_KX    55[IW0         ,JPJ6?^L=8@   "JO=.Z
M!E6%2S_UCK$    55[IW0         ,JPJ6?^L=8@   "JO=.Z         !
ME6%2S_UCK$    55[IW0         ,JPJ6?^L=8@   "M7;>V^JYYH
M  &585+/_6.L0                ,977#7H];5P         G+UCGM_\^S0
M   ,977#7H];5P         G+UCGM_\ /LT   #&5UPUZ/6U<         )R
M]8Y[?_/LT   #&5UPUZ/6U<         )R]8Y[?_ #[-    &LW[0JP
M   !.7K'/;_Y]F@   #6;]H58         G+UCGM_P#/LT    :S?M"K
M     $Y>L<]O_GV:      !57NG=          S_ %>L35U_KX    55[IW0
M         ,JPJ6?^L=8@   "JO=.Z         !E6%2S_P!8ZQ    %5>Z=T
M         #*L*EG_ *QUB    *J]T[H         &585+/\ UCK$    55[I
MW0         ,JPJ6?^L=8@   "M7;>V^JYYH        &585+/\ UCK$
M            #&5UPUZ/6U<         )R]8Y[?_ #[-    QE=<->CUM7
M       "<O6.>W_S[-    QE=<->CUM7         "<O6.>W_P ^S0   ,97
M7#7H];5P         G+UCGM_\^S0   !K-^T*L         3EZQSV_\ GV:
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M<         )R]8Y[?_/LT   #&5UPUZ/6U<         )R]8Y[?_ #[-
MQE=<->CUM7         "<O6.>W_S[-    QE=<->CUM7         "<O6.>W
M_P ^S0   !K-^T*L         3EZQSV_^?9H    UF_:%6         )R]8Y
M[?\ S[-    &LW[0JP        !.7K'/;_Y]F@      55[IW0         ,
M_P!7K$U=?Z^    %5>Z=T         #*L*EG_K'6(    JKW3N@
M95A4L_\ 6.L0   !57NG=          RK"I9_P"L=8@   "JO=.Z
M !E6%2S_ -8ZQ    %5>Z=T         #*L*EG_K'6(    K5VWMOJN>:
M     !E6%2S_ -8ZQ                 QE=<->CUM7         "<O6.>W
M_P ^S0   ,977#7H];5P         G+UCGM_\^S0   ,977#7H];5P
M   G+UCGM_\ /LT   #&5UPUZ/6U<         )R]8Y[?_/LT    :S?M"K
M        $Y>L<]O_ )]F@   #6;]H58         G+UCGM_\^S0   !K-^T*
ML         3EZQSV_P#GV:      !57NG=          S_5ZQ-77^O@   !5
M7NG=          RK"I9_ZQUB    *J]T[H         &585+/_6.L0   !57
MNG=          RK"I9_ZQUB    *J]T[H         &585+/_6.L0   !57N
MG=          RK"I9_ZQUB    *U=M[;ZKGF@        95A4L_]8ZQ
M            QE=<->CUM7         "<O6.>W_S[-    QE=<->CUM7
M     "<O6.>W_P ^S0   ,977#7H];5P         G+UCGM_\^S0   ,977#
M7H];5P         G+UCGM_\ /LT    :S?M"K         $Y>L<]O_GV:
M -9OVA5@        "<O6.>W_ ,^S0   !K-^T*L         3EZQSV_^?9H
M     %5>Z=T         #/\ 5ZQ-77^O@   !57NG=          RK"I9_ZQ
MUB    *J]T[H         &585+/_ %CK$    55[IW0         ,JPJ6?\
MK'6(    JKW3N@         95A4L_P#6.L0   !57NG=          RK"I9_
MZQUB    *U=M[;ZKGF@        95A4L_P#6.L0                ,977#
M7H];5P         G+UCGM_\ /LT   #&5UPUZ/6U<         )R]8Y[?_/L
MT   #&5UPUZ/6U<         )R]8Y[?_ #[-    QE=<->CUM7         "
M<O6.>W_S[-    &LW[0JP        !.7K'/;_P"?9H    UF_:%6
M )R]8Y[?_/LT    :S?M"K         $Y>L<]O\ Y]F@      55[IW0
M     ,_U>L35U_KX    55[IW0         ,JPJ6?^L=8@   "JO=.Z
M    !E6%2S_UCK$    55[IW0         ,JPJ6?^L=8@   "JO=.Z
M   !E6%2S_UCK$    55[IW0         ,JPJ6?^L=8@   "M7;>V^JYYH
M      &585+/_6.L0                ,977#7H];5P         G+UCGM_
M\^S0   ,977#7H];5P         G+UCGM_\ /LT   #&5UPUZ/6U<
M  )R]8Y[?_/LT   #&5UPUZ/6U<         )R]8Y[?_ #[-    &LW[0JP
M       !.7K'/;_Y]F@   #6;]H58         G+UCGM_P#/LT    :S?M"K
M         $Y>L<]O_GV:      !57NG=          S_ %>L35U_KX    55
M[IW0         ,JPJ6?^L=8@   "JO=.Z         !E6%2S_P!8ZQ    %5
M>Z=T         #*L*EG_ *QUB    *J]T[H         &585+/\ UCK$
M55[IW0         ,JPJ6?^L=8@   "M7;>V^JYYH        &585+/\ UCK$
M                #&5UPUZ/6U<         )R]8Y[?_ #[-    QE=<->CU
MM7         "<O6.>W_S[-    QE=<->CUM7         "<O6.>W_P ^S0
M ,977#7H];5P         G+UCGM_\^S0   !K-^T*L         3EZQSV_\
MGV:    -9OVA5@        "<O6.>W_S[-    &LW[0JP        !.7K'/;_
M .?9H      %5>Z=T         #/]7K$U=?Z^    %5>Z=T         #*L*
MEG_K'6(    JKW3N@         95A4L_]8ZQ    %5>Z=T         #*L*E
MG_K'6(    JKW3N@         95A4L_]8ZQ    %5>Z=T         #*L*EG
M_K'6(    K5VWMOJN>:        !E6%2S_UCK$                #&5UPU
MZ/6U<         )R]8Y[?_/LT   #&5UPUZ/6U<         )R]8Y[?_ #[-
M    QE=<->CUM7         "<O6.>W_S[-    QE=<->CUM7         "<O
M6.>W_P ^S0   !K-^T*L         3EZQSV_^?9H    UF_:%6         )
MR]8Y[?\ S[-    &LW[0JP        !.7K'/;_Y]F@      55[IW0
M   ,_P!7K$U=?Z^    %5>Z=T         #*L*EG_K'6(    JKW3N@
M    95A4L_\ 6.L0   !57NG=          RK"I9_P"L=8@   "JO=.Z
M     !E6%2S_ -8ZQ    %5>Z=T         #*L*EG_K'6(    K5VWMOJN>
M:        !E6%2S_ -8ZQ                 QE=<->CUM7         "<O
M6.>W_P ^S0   ,977#7H];5P         G+UCGM_\^S0   ,977#7H];5P
M       G+UCGM_\ /LT   #&5UPUZ/6U<         )R]8Y[?_/LT    :S?
MM"K         $Y>L<]O_ )]F@   #6;]H58         G+UCGM_\^S0   !K
M-^T*L         3EZQSV_P#GV:      !57NG=          S_5ZQ-77^O@
M  !57NG=          RK"I9_ZQUB    *J]T[H         &585+/_6.L0
M !57NG=          RK"I9_ZQUB    *J]T[H         &585+/_6.L0
M!57NG=          RK"I9_ZQUB    *U=M[;ZKGF@        95A4L_]8ZQ
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M?_/LT   #&5UPUZ/6U<         )R]8Y[?_ #[-    QE=<->CUM7
M   "<O6.>W_S[-    &LW[0JP        !.7K'/;_P"?9H    UF_:%6
M     )R]8Y[?_/LT    :S?M"K         $Y>L<]O\ Y]F@      55[IW0
M         ,_U>L35U_KX    55[IW0         ,JPJ6?^L=8@   "JO=.Z
M        !E6%2S_UCK$    55[IW0         ,JPJ6?^L=8@   "JO=.Z
M       !E6%2S_UCK$    55[IW0         ,JPJ6?^L=8@   "M7;>V^JY
MYH        &585+/_6.L0                ,977#7H];5P         G+U
MCGM_\^S0   ,977#7H];5P         G+UCGM_\ /LT   #&5UPUZ/6U<
M      )R]8Y[?_/LT   #&5UPUZ/6U<         )R]8Y[?_ #[-    &LW[
M0JP        !.7K'/;_Y]F@   #6;]H58         G+UCGM_P#/LT    :S
M?M"K         $Y>L<]O_GV:      !57NG=          S_ %>L35U_KX
M  55[IW0         ,JPJ6?^L=8@   "JO=.Z         !E6%2S_P!8ZQ
M  %5>Z=T         #*L*EG_ *QUB    *J]T[H         &585+/\ UCK$
M    55[IW0         ,JPJ6?^L=8@   "M7;>V^JYYH        &585+/\
MUCK$                #&5UPUZ/6U<         )R]8Y[?_ #[-    QE=<
M->CUM7         "<O6.>W_S[-    QE=<->CUM7         "<O6.>W_P ^
MS0   ,977#7H];5P         G+UCGM_\^S0   !K-^T*L         3EZQS
MV_\ GV:    -9OVA5@        "<O6.>W_S[-    &LW[0JP        !.7K
M'/;_ .?9H      %5>Z=T         #/]7K$U=?Z^    %5>Z=T
M#*L*EG_K'6(    JKW3N@         95A4L_]8ZQ    %5>Z=T         #
M*L*EG_K'6(    JKW3N@         95A4L_]8ZQ    %5>Z=T         #*
ML*EG_K'6(    K5VWMOJN>:        !E6%2S_UCK$                #&
M5UPUZ/6U<         )R]8Y[?_/LT   #&5UPUZ/6U<         )R]8Y[?_
M #[-    QE=<->CUM7         "<O6.>W_S[-    QE=<->CUM7
M "<O6.>W_P ^S0   !K-^T*L         3EZQSV_^?9H    UF_:%6
M   )R]8Y[?\ S[-    &LW[0JP        !.7K'/;_Y]F@      55[IW0
M       ,_P!7K$U=?Z^    %5>Z=T         #*L*EG_K'6(    JKW3N@
M        95A4L_\ 6.L0   !57NG=          RK"I9_P"L=8@   "JO=.Z
M         !E6%2S_ -8ZQ    %5>Z=T         #*L*EG_K'6(    K5VWM
MOJN>:        !E6%2S_ -8ZQ                 QE=<->CUM7
M "<O6.>W_P ^S0   ,977#7H];5P         G+UCGM_\^S0   ,977#7H];
M5P         G+UCGM_\ /LT   #&5UPUZ/6U<         )R]8Y[?_/LT
M :S?M"K         $Y>L<]O_ )]F@   #6;]H58         G+UCGM_\^S0
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MSV_^?9H      %5>Z=T         #/\ 5ZQ-77^O@   !57NG=
MRK"I9_ZQUB    *J]T[H         &585+/_ %CK$    55[IW0
M,JPJ6?\ K'6(    JKW3N@         95A4L_P#6.L0   !57NG=
M  RK"I9_ZQUB    *U=M[;ZKGF@        95A4L_P#6.L0
M   ,977#7H];5P         G+UCGM_\ /LT   #&5UPUZ/6U<         )R
M]8Y[?_/LT   #&5UPUZ/6U<         )R]8Y[?_ #[-    QE=<->CUM7
M       "<O6.>W_S[-    &LW[0JP        !.7K'/;_P"?9H    UF_:%6
M         )R]8Y[?_/LT    :S?M"K         $Y>L<]O\ Y]F@   <?RXX
M[E8  ,4S;H         =@Q1>[1Z\    8IFW0         Y7A@R#%K    !B
MF;=         #E>&#(,6L    &*9MT         .5X8,@Q:P    8IFW0
M      Y7A@R#%K    !BF;=         #E>&#(,6L    &-)=O\ DY<P
M    .5X8,@Q:P ?7XR?$D@           </SX=#DX0!Q>;Y'C;L8
M [U6<LPZ]S    XO-\CQMV,         =ZK.68=>Y@   <7F^1XV[&
M   .]5G+,.O<P   .+S?(\;=C         '>JSEF'7N8    C)NF(
M  =ZK.68=>Y@   ",FZ8@        !WJLY9AU[F    (R;IB         '>J
MSEF'7N8 _=Q^Y&BR !X/E]^
M
M           ?;Y]            ]7SY_0
M
M                    \GU^?0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                          !X
M/(              /!Y              !X/(              /!Y
M        !X/(                                /!Y
M            /!Y              !X/(              /!Y
M    !X/(              /!Y                                !X/
M(       !U./FI;^NI9\/.Y\-TWWYWJ/GK8KYL'K"#S.7'=1DX9'C2!BZ)(I
MRM:V]Z+*$/*^=4-80?)Y^_-A"="[5 G    #KN#+2[\Y='SQ^3SX[H^7#(T>
M17? F0&GPN3R<+H<N+*L:2,>1<]*MK OMB2!BB+(ILRX^O<^$N+&!:G G
M  <-AR4P\,F.9,;]F7'<[DQY4C2:[X$R T^%R>3A=#EQ95C21CR+GI5M8%]L
M21Z8N6NUAE\3+A#T+;9\&:D"<    .&PY*8>&3',F-^S+CN=R8\J1I-=\"9
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M*OFPUL8/8,N*ZWEQ[U'D##T.34E;UMYT22(25\ZIZP@^3WR\-B3)&Y2-,
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M)K43X^R]@R0DPY9)Q>=!.Q4^Q]6V I*JK&3&S:]GVFMJ79L;8V8_V8LX
MZGPY<CEQ\WQY08JK&'NTZY+O5]CCKM&N6\5=EZ\/NL_EX[,/%"[#EDFQ:]=I
MAV4X.?KE7.UV-GH=DJLL!2G5V4T=HUN;=79    #J?#ER.7'S?'E!BJL8>[3
MKDN]7V..NT:Y;Q5V7KP^ZS^7CLJ8_O5.?'O/SEP^#+K5R.&RE'X:X%G@V68<
M@4H55E/K:=;EK5V0    ZOPY?IRXN?X\X;U5C7_M.N3:U?8XZ[1KEO%79>O#
M[K/Y>.RIC^]4Y\>\_.7#X,NM7(X;+^6+'N!/Y>Q@4NTMQ>[L^N]_JK(
M   8"ARJ,YT38 D1X':_=_LVG6K+JRS?&LQ\X[,W+[Y?>&JINNUL]%L?5M@*
M/8<J>MK6=SKYU'?)?Q9UN9H,T     82B2:(I<>_"7$A]K]UTW:]=M-J;(:S
M?S+LOY(GUX9OA$RZV=S#V4X.?'E79:RMO66H2HF?:RPJ$S<-B"7$[W$E
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MPEL^N6UUEB-:F)/V0[2CY.--_-PY4D09N>=DUZT>LL@* :NSNBV?6\N5EB
M                !'"%+I(L(.P7FPUPT5WDG9]<L0K+'QB^ZS,ALS\/@Z15
MV=">SZWL1UEB^*+(LJQ.SK>=KYU'N3AL*6,#*,*8     (X0I=)%A!V"\V&N
M&BN\D[/KEB%98^,7W69D-F?A\'#54W7:V>BV/JVPQY5V6LK;UEJ$J)GVLL*A
M,W#8@EQ.]Q)0     CA"ETD6$'8+S8:X:*[R3L^N6(5ECXQ?=9F0V9^'P=(J
M[.A/9];V(ZRQ A956,$=IUR\&KL@     !@*'*HSG1-@"1'@=K]W^S:=:LNK
M+-\:S'SCLS<OOE]X:JFZ[6ST6Q]6V K3K9T'[BL[_"E>]K77@1)'ZN&0
M 82B2:(I<>_"7$A]K]UTW:]=M-J;(:S?S+LOY(GUX9OA$RZV=S#V4X.?QQ^Z
MX\27:5<T^4ZRQHIQY+==AI9^U-B     ,)1)-$4N/?A+B0^U^ZZ;M>NVFU-D
M-9OYEV7\D3Z\,WX<?.C6)+E=L5!8!J^PZ]>T:[L?5ED*>:BQE)M>M3BJ[0
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M;8A@RL65TZC?8*?8>KY@\8VM/GY;+/#B*<XTFV6QK>QQ96O?$F7;WE'EV!/
M   & (,ND"S@7X\\>2X\CR8WKIM$FP4VQ#!E8LKIU&^P4^PM5S]?F/)L;O*2
M>-?/'L:_M=87*;#K^;*VPU](,ZZC8*+,M?/    & (,ND"S@7X\\>2X\CR8W
MKIM$FP4VQ#!E8LKIU&^P4^PM5S]?F/)L;O*2>-?/'L 4 U=G=%L^MY<K+$
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M9\5+2MXI]NEE1I PY8^,7)K^6T78)AYA%F#+J$FQ>5X?9%VM?<!73?+Z
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M.AK:UW&\>5RDR)QU!>486=;W+YR V!K&%WRNFBD&NL;;MBU_*%=/
M          H<K;#!EG6\I\Y"<MC"M<K)M-$&=@^RKN(^KP<^#+T64.GUUC2C
ML6OWO5T\5QU\VO2R@<EBR3%LZZU"OG@    4.5MA@RSK>4^<A.6QA6N5DVFB
M#.P?95W$?5X.?!EZ+*'$UDNA_8Z:_:OG"+,&74)-B\KP^R+M:^X"NF^7T
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M3:F:V?%2TK>*?;I94;H-#=4FV==V_P"<AYY?-AZ9!['!GBB>OG70['0]WK+
M          #YGN>0   >IX/<         ]#R>P   /4\'N         >AY/8
M              ]#R>P   /4]3Z         'H>3V   !Z_'CZ]P
M#T/)[    ]3P>X        !Z'D]@                          #YGN>0
M   >@/<         ^9[GD   'J>#W         /F>YY              /F>
MYY   !ZG@]P        #T/)[    ]#R>P        !Z'D]@   >IX/<
M    ]#R>P
M
M
M
M
M
M
M
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MR9BX^BA\%25O+F*I7E0P:SOW?DVO=^3:@\^,B4RJ5IHL!=U,_P V&V-J1I>
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MB:?]Y<[3_O+G:?\ >7.T_P"\O]-F^0U 6Q1O%#Q)%U'&#4LE<O$2.)R2,#7
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MOAA.Y_P9KLWB:?\ >79-=F\33_O+LFNS>)I_WEV379O$T_[RYVG_ 'ESM/\
MO+G:?]Y<$:!R=OFC_3PG<_."=S\X)W/S@G<_:??K?#"=S_@S79O$T_[R[)KL
MWB:?]Y=DUV;Q-/\ O+LFNS>)I_WESM/^\N=I_P!Y<[3_ +R_V$)W/S@G<_."
M=S\X)W/VGWZWPPG<_P"#-=F\33_O+LFNS>)I_P!Y=DUV;Q-/^\NR:[-XFG_>
M7.T_[RYVG_>7.T_[R_V$)W/S@G<_."=S\X)W/VGWZWPPG<_X,UV;Q-/^\NR:
M[-XFG_>79-=F\33_ +R[)KLWB:?]Y<[3_O+G:?\ >7.T_P"\OQWK88KUL,5Z
MV&*];#%>MABO6PQ7K88KUL,5ZV&*];#%>MABO6PQ7K88KUL,5ZV&*];#%>MA
MBO6PQ7K88KUL,4B*&)Q4\X)W/S@G<_."=S\X)W/VGWZWPPG<_P"#-=F\33_O
M+LFNS>)I_P!Y=DUV;Q-/^\NR:[-XFG_>7.T_[RYVG_>7.T_[R_T()W/S@G<_
M."=S\X)W/S@G<_:??K?#"=S_ (,UV;Q-/^\NR:[-XFG_ 'EV379O$T_[R[)K
MLWB:?]Y<[3_O+G:?]Y<[3_O+_0@G<_."=S\X)W/S@G<_."=S]I]^M\,)W/\
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M4'LSK]SA3:_"/Y"9@!K3IBR83(2%VX/8=3OQ]/Z9/AZ7\%?_ !)/@X_3X?\
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M9R.>GJ_<NQQVY'DYGCY#9L&TRE,?QVR@#96HQ)F41_I>4Y?AX*,//))\+O\
M;CG[E^.I8@Q5/\!#F#(!]V1Y.9X^0V;!M,I3'\=LH V5J,29E$?Z7E.7X>"C
M#SR2?"[_ &XY^Y=7[G1LL:?.:GZ=/92V*U+CR1(XZ>7>^Y ';D>3F>/D-FP;
M3*4Q_';* -E:@4F93&^E]5ERN7@6X^<23;R_HM^ W]S_  (!YH*&Q\TR*>NQ
M:9+_ %Y^;V45$M-R+,G!NW(\G,\?(;-@VF4IC^.V4 ;*U I,RF-]+ZK+E<O
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M3 7)14+TYC=QR+_!Q^GP_P#<SP.FE6!2(+$C<6,=3Z6I24OB<?NC0%VI@DC
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M;__$ &P1  (! @($!@D-"@H'!@,%"0$" P01$B$ !1,Q(C)!47*Q!A 4(S5
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M&- Q((PH&?#D,Y'N3E:*#9SU4Y;$U0\=K_>X8HE1(1GF!)MI;V7A3-EH 3D
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M&)RK2:N:&D!Q';PU=6V_!'3RK41AL^//41QJ%WF,3-Y(OI#"\\J0QB[N;#D
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MZE<&\M''*\H3>7B50+D:*RNJNA#*P#*P-PRG,$'E!&D<;S.L<:XG<V4?:=P
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M NLE8>@;QT_\MBD'M&=;]Q5)Y'HY)%/NDEIS)&XYU=&5U.YE((R.E+]S4_\
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MT22552/</(L<<4#?#ACC+N/(>=HS9D;2+PQ7CD.KM5G]/=.MQU6]'^VF/O\
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MT2-%"HBJB*-RJHLJCS "W:Q-LY8KG9S*J2J#82*LB2A6YUQHI(W&UC<:*JJ
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M1VBW^;3LBQ%:[:;VKHQ/?W#:QB%1B\VS+XK\E[]M_!-/?_[QK,'_  U#M/\
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MXYIS%"!RE]*[A3ZMA&9:L,K<XBIZ:=V?XMJ88R>>51RZ0PO42I#&+NYL+FP
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M.(11[R0,.5KGV2LSH]4D;A35"-S;45]4S#X]G)"3YBOFTU7E3RQGVR.NU@)
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M4@%6!!TI:<3N3(V""%=K42>XC! LM\C)(Q$<2^5(POP0Q&M*N2LG6E@O$9$
MX!RH:!#A 0_C9,XXFXS2F6I-RCW1$B1(XU"HBA$4;E518 ?$-.R_=V0_+_\
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MJHZKO<AL.(':[FSX/GTJJZR)';);[&D@%RSFP9K$W9V-@\TK844 ,Z1( M+
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M]G&HSDDMR#);@R,BG%H^SW)CZ3$"_GP &WQ8V^/1ML,U"/\ !-T]#\(7\V$
M\XTBG2;$!B62,@21.+.A.ZX!((/DNI9&L<+&W\2&!##-4SEEB0&.(+DTU2R\
M%%N",$0.UF-LEPIDTJ'1IW%?#3679R4E3.3GBQPS4L:@&]L-IVOE>X&?/^"M
M6^#J#\BI?U">*=D/@>L^3_6H?P,'<#"&.'E7R3\8W'37(V6MZ.&/O<3QDO&G
M!1CW!!)PE%@>&S-\9)T"JM\*JM]]@!?X[>PEF;C,6^,DZ8$OBPK?=>POZ?\
M8'3\<]$]8\?I^.>B>L>/T_'/1/6/]AGM.JL0XU=621,>78T4<$F#GPRRU2,P
M]U3IS:0^NJFHFDSBIINYZ9/)QQJAFG(\J3:LT*$\18CAL9'OK_B:A^0_6*O3
M$M10RM(1MZ+9,LC'A24LCB%D8^4897AV7*(Y)%XJ(%A4QU]1@!-/4PQSX@.
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M*>]L*VX\YL[#@I@3$93BK\N$E%RG-7J_,.5*8\K<:H'%M#PI0      + #(
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M]A?GL.WK 2&E81!R^TIK"/$6L*F(OQ<[8,6+X-[Y7TH'6+NR<LJRPT;]S@L
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MO)I/@U?>(8>ZD%ZF9K$4[6N8(O)5XOOTW&$@*1E%1FE2H-1WQ5=D;,2R<':
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M^GXYZ)ZQ_J= 144K41($J2FHI"<@SNJI407W S+'"T=\L<.#?+H],\4\DT7
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MG9EW,+Y$'3LA^Z]0_P#A_P"PZK35HVIJJ9O:Y:&LE(YI**EEK(7',P:#!?\
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MN6_G8\$?I.FL/6]11I2]_AEV'=4G&V./5LE1+;#[BM"4^XY'].BNCWPL#;>
M<QYB.0^8^Q'+,Y \I^.W7E\?B3=^U9&5S>BJ)5E'+L*H1F%^BLT<RN>1I8AY
M0TB!HI9T<'N6:9ZB*49K"\QQSQ2^X5I2\R2G@=\:-BI5,?9 0:O4!!N#_!]B
M/S'5=M975'B#<"1D9UL"&:/&$.8\G:/Z=!#&)Y*@+:66**%S<V*0/.\8MN%F
MJ)-UKW%]P[6K4#5D+OE#3L*JH;W,$!$C_P!)["./W4CHN\Z:W<SB-/OM9K&E
M-O-'5)63G^C!!*?C &\C2.1XFQQMA;"ZW^#(C1N,_=(S+^G26*.9H'=;M32F
M:(C*SF&: D@9'O<\@S&\@[P.TJL[*B L[L%51F69C8 #E).0TUQ/% TAQ Q:
MOI(X7=<PQI8?7#+[I3,)=G;C+AMOTU;"\%!10R"TD=+ L@YI!&N,?H:XT[*I
M&I_X9P9/14\]+%;W5#3=RQ?IO"OZ=(HUABBA062*-(U',J*% ] [1X>J4_[M
MK"0?HK*>,@?%>B8_I.E%P*G6D7)W7',@YEGI*<M_6G29CYV)]EUIZ^GU9+%P
M5HNY=KM,BVPU=-2-@PXKWDD!7$5X%R;'+\(]D/@>L^3_ %J'Q_LA\#UGR?ZU
M#X_V0^!ZSY/]:A]CU;X.H/R*E_4)XIV0^!ZSY/\ 6H?P(_$?HMU'Q6GXYZ)Z
MQ[$_$?HMU'Q6GXYZ)ZQ[$_$?HMU'Q6GXYZ)ZQ[$_$?HMU'Q6GXYZ)ZQX_3\<
M]$]8\?I^.>B>L>/T_'/1/6/$*>)$A>LG7'&CB*"(Y">HMB(:UCLH4L\UC<EX
M8\A)B6>M>6<Q"\TP4%@"$B@C-\ :PPQ@Y[.*-";9A%3A"OMJ^KU;32$N*_N:
M[H/:C4:HDUKDI(QX=GL>,E[X\N+I6T&4;XK8U+4U7#OR-F +#>K "6"06.6)
M2K*323M,CK* M13R&"=5XN,*KJZ7SP2QNDJ7S ?"3B4Z00O42I#';&YY395
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M1A&^1CGI44O"B2=.$N&:'/,8HF*R1LIY87?-3Q&;DOHRS)G$VTM]ZDRN.9)
M."?YP/B( +)<MI#,DZ8DN"K%)$86>.1>-&XSLPN#O(92'4LC*Q[444DSB.-<
M3'X@ !FS,QL%11=G=B%502Q &E340TT#P1.NR'?*NI/!$QCN0!>V&FBS* V,
MC=]D&4:1P(T\W=LJE0%,='$PLR1-8O,X.:RSX5LIX4<2JIL[RK_$'_9X/O\
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MD49!Z^I3SKC>H2WQK:W;4X=43#\=K*F(\_<U-5XO1W4OITIN%7:S;W#4E/\
MI2F$_55#\/=D/@>L^3_6H?'^R'P/6?)_K4/C_9#X'K/D_P!:A]CU;X.H/R*E
M_4)XIV0^!ZSY/]:A_ C\1^BW4?%:?CGHGK'L3\1^BW4?%:?CGHGK'L3\1^BW
M4?%:?CGHGK'L3\1^BW4?%:?CGHGK'C]/QST3UCQ^GXYZ)ZQX_3\<]$]8\07U
MU0B$9ST3RRHO+)2RA3*%RN332(92M\TFE>UHF.BPO3RRO",<4[[62"X5DE(
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M[6Q3Q(W!>5E-U8C,'?<9^/\ 9#X'K/D_UJ'Q_LA\#UGR?ZU#X_V0^!ZSY/\
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M:V)VY-P"JHX*(JHH"J-'EC[@@IT;A]TU$]0+$>1#'3W-K-A G*V)P[5[VO\
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M_EL?ZBH\?[(? ]9\G^M0^/\ 9#X'K/D_UJ'Q_LA\#UGR?ZU#X_V0^!ZSY/\
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M45W6:H@CL$58U)PJ9+22R'?RC#BWV6- ;9$M;$1$TX)57-A<A+JP S)P+9K
M;S:PY=)))*/ODC;6EOWQR.^4XW8VM8/ ,L;6#Q"\C&1<13V.&%YY%BC%V:^\
M@   LS,QR5$4%G8Y*H+'(:2O3P8A&1)@XU3)DF6\QQFP6/?G-B9A9L,1X(5Q
M-Q2+'<19%/G#<%2//>VDU/-'Q&>)R,0$H+QN.0G%PL.^QC<"]CP@+&GJ-MC1
MEV<\)"S1$WPWS5E;+'%( 3&]A>Q5@KJZ+IL4IXT><8Y95#Q4]R L;<66<CA
M2#.*)2K,I$K,J%!)MEF8JI3(V.S50%/N2P&1',S7Y]^DU/,EF1GB9AB7'>2*
M0?$3FN_.)U-]Y-K:4]1ML:,NSGA8+-%>^$D75U;+'%(.%&]A?-6"R(Z+VJ>
MSL<Q'$@Q33-Q(DYSSL=R(.%(]E7?IKR<-#BIU,$:3ZNAB"V5]GW=3J3(RVQ2
M38G:4[B79!P  -$S91SL.O364:0ZQKXH@%CBK:J.-1N5$G=4 \P4 ?Q()'>L
MK4Q%HHA3*GN5D*.TJW]U8QEA>X!7=?V.&%YY%BC%V:^\@   LS,QR5$4%G8Y
M*H+'(:2O3P8A&1)@XU3)DF6\QQFP6/?G-B9A9L,1X(5Q-Q2+'<19%/G#<%2/
M/>VDU/-'Q&>)R,0$H+QN.0G%PL.^QC<"]CP@+&GJ-MC1EV<\)"S1$WPWS5E;
M+'%( 3&]A>Q5@KJZ+IL4IXT><8Y95#Q4]R L;<66<CA 2#.*)2K,I$K,J%!)
MMEF8JI3(V.S50%/N2P&1',S7Y]^DU/,EF1GB9AB7'>2*0?$3FN_.)U-]Y-K:
M4]1ML:,NSGA8+-%>^$D75U;+'%(.%&]A?-6"R(Z+VJ> SL<Q'$@Q33-Q(DYS
MSL=R(.%(]E7?IKR<-#BIU,$:3ZNAB"V5]GW=3J3(RVQ238G:4[B79!P  .U!
M3AT>>5BE/$0I8<:21@2L,0.1<@%F)X,: LUS@5Y:F)2%"QQ!N(GMDKVY;M=F
M:UL6!57EP+IL&E4LH<@"YP,UU&_$RJ<E\["W(=&FDI67;G'3NP03V"M$[FR"
M<"RX'8X5E4*%)577[X?8X87GD6*,79K[R   "S,S')4106=CDJ@L<AI*]/!B
M$9$F#C5,F29;S'&;!8]^<V)F%FPQ'@A7$W%(L=Q%D4^<-P5(\][:34\T?$9X
MG(Q 2@O&XY"<7"P[[&-P+V/" L:>HVV-&79SPD+-$3?#?-65LL<4@!,;V%[%
M6"NKHN@A2")):@%GE&*"GN5O'<@33$9K&Q%HT6SR"[XD3 9#.LC%%,=UR*H%
MX'P68#(V]VV([\]^DU-,H#*SQ,V:,>^1/;S$V9;[]DZ-R8AI3U&U,D4B[.HA
MMM8[W%FO@EC;+%%)9L+6!!5D8!E([<$#3OA!"(HQRRM[7%&-[N>;D %V=BJ(
M&=E!U[.II)C3 Q1P1)%"PX,K 2 F61E^^2LS,V9P!A$IPH.W# &1IYF,=.AP
MW N\LEK[&(;BUN$['@Q)9FNS1H\U1$M@%CB4FR*;/(YMSMFSD#,1A1RJ@TV#
M3 LFTX(+' 3B4#,L4SR6V>),(W'(Z&9Z=E6HLT+L$2H MA=C94G49+C-@LJV
M0N<#+&<./V.&%YY%BC%V:^\@   LS,QR5$4%G8Y*H+'(:2O3P8A&1)@XU3)D
MF6\QQFP6/?G-B9A9L,1X(5Q-Q2+'<19%/G#<%2//>VDU/-'Q&>)R,0$H+QN.
M0G%PL.^QC<"]CP@+&GJ-MC1EV<\)"S1$WPWS5E;+'%( 3&]A>Q5@KJZ+H(4@
MB26H!9Y1B@I[E;QW($TQ&:QL1:-%L\@N^)$P&0SK(Q13'=<BJ!>!\%F R-O=
MMB._/?I-33* RL\3-FC'OD3V\Q-F6^_9.C<F(:4]1M3)%(NSJ(;;6.]Q9KX)
M8VRQ126;"U@059& 92.UL4IXTDJ+M)*H>*G!M:,YI+.V]5D&<<:V=T.T+1J8
MS(:A&<H-G<9%$4$IR@,<V&6XN;GG.C0,REQM !Y:,2$/)B&: \P<9\VFV>"5
M(JBS1RM@AJ +=\/%BF7<KOY$BV21N!AC8HKZ4]/MB[,VS@A7'-*1? I-E51E
MCED/!C2XQ',E45W6:HA0A45(E8V7':2:0[^4<;X,2J+;P;7TV+2J64.0HNQ0
MD%1[I@IR&[-AAOEH9I*:1$G..&5@D=18!DE8V2.<#@]\;@QRJ%4L1&RABK/[
M'#"\\BQ1B[-?>0   69F8Y*B*"SL<E4%CD-)7IX,0C(DP<:IDR3+>8XS8+'O
MSFQ,PLV&(\$*XFXI%CN(LBGSAN"I'GO;2:GFCXC/$Y&("4%XW'(3BX6'?8QN
M!>QX0%C3U&VQHR[.>$A9HB;X;YJRMECBD )C>PO8JP5U=%T$*01)+4 L\HQ0
M4]RMX[D":8C-8V(M&BV>07?$B8#(9UD8HICNN15 O ^"S 9&WNVQ'?GOTFII
ME 96>)FS1CWR)[>8FS+??LG1N3$-*>HVIDBD79U$-MK'>XLU\$L;98HI+-A:
MP(*LC ,I':V*4\:25%VDE4/%3@VM&<TEG;>JR#..-;.Z':%HU,9D-0C.4&SN
M,BB*"4Y0&.;#+<7-SSG1H&92XV@ \M&)"'DQ#- >8.,^;3;/!*D519HY6P0U
M %N^'BQ3+N5W\B1;)(W PQL45^TB-(RHBEW8A551=F)R  &9)TJ-E#$M(F"2
M3'M*F868;0 JL$3C?'$&;&ZG#+*QMB2.-CJUF>CB9V+,6GNS$DY5$H&9YAD/
M-^!H(&J'*@JBHIDED?B11K;$[VN;7(4  L[LJ*"S :334\0. !4&1FGPXFOE
MQ23'&&RLO#93EM&T'?=W+_N_1Q?F_1I-#41$[,D.N9@GOA;EMC(,D;'*S<-1
M^+-[B"=:A,:@J58I)&^3Q2+QHW&>8N"""592KJ2C*3H\4=*H$R[2I90QA)(2
M!6%UVMB&:8J<6S!41<':%F+1J)5G/!9&SM= JK<&Q&)0%N#O%\N72:GJ(C>-
MFC>V(1S7:*0<F9X:@CBO&2HXQ22UC3SBH0FQ1XV,<T3<:*06)4\AR*LC#)T9
M77(]NF@$I+RL8Z:*QFEY0#NCC!X\TEB(T^-VM&CLNMYS))3R1KL%>OHXQ'&;
M!800BQDBV/@*,;'.1KLV9/;@C3N.OG=;E>Y:>$^XFFE,N(?[BEG3^GVW-D8C
M>%8CT::ND>75]#+(<4DE'322,=[.\*,Q/QL2?8X(&J'*@JBHIDED?B11K;$[
MVN;7(4  L[LJ*"S :334\0. !4&1FGPXFOEQ23'&&RLO#93EM&T'?=W+_N_1
MQ?F_1I-#41$[,D.N9@GOA;EMC(,D;'*S<-1^+-[B"=:A,:@J58I)&^3Q2+QH
MW&>8N"""592KJ2C*3H\4=*H$R[2I90QA)(2!6%UVMB&:8J<6S!41<':%F+1J
M)5G/!9&SM= JK<&Q&)0%N#O%\N72:GJ(C>-FC>V(1S7:*0<F9X:@CBO&2HXQ
M22UC3SBH0FQ1XV,<T3<:*06)4\AR*LC#)T977(]NG@VS$NVR@CLTTQ%PB\RC
MRY7W1QC-FYE#,->U&-8G@78)_"&IX8T0V(A_A&CBPNPMC:2.^V8^V,[DBQMV
MX(-MC=FV<$0!FE(N%!R55'ERN;B.,$8K$DJBNZS5$$=@BK&I.%3):260[^48
M<6^RQH#;(EK8B(FG!*JYL+D)=6 &9.!;-8#>;6'+I)))1]\D;:TM^^.1WRG&
M[&UK!X!EC:P>(7D8R+B*>QP0-4.5!5%13)+(_$BC6V)WM<VN0H !9W944%F
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M'=8Z"9X94AJ+%93A@G L'< G8RC<LI4$H19);-8(P"GV.&%YY%BC%V:^\@
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M+54U58K:44%4/Y.H?!%B^%#6&(#W"2S^Z/:6 +&D\[%(I,6S"\*27 ;-A\E
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M]^"T:"GA_%-+%;BC1$2-%CC4(BBRJHL -*!A+(M#*>\U3"-2WWBH?@0SJ?)
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M&KY_355$ !]%(P_2>T"001D000?.-.RT>'706/KRKA\S#%5P$=%L!'-;0'$
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MCYGF#SRX<4LILJ(N>""(!:6!H]I+,0U34$-,5XJ!;B.".]CLH02 ; N[22D
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M?Y* 19_9X( P,TS&.F0V9AQY&W[*$'C2$;SQ8P<3^2&UA7G@!4NUME14B'(
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M\.M8N675W!_W%;15+>B."0_%?23@ZVI>:35]</Z4510%1^D2.?T=OLFEV/\
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M$6L]72-Q4KJ5FZ(G0M\U]-<JT='60M=2?6TG(5$LJT\I\V%7;XK:    9 9
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M3QE:=L21MYX(=E!_NO8Z6%'VD\]^YJ<*9+&S2NU]E3H>1Y2K7:QV<2226.
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M83NM>W"-\*XBUAB( +6S(6Y4$\PQ-;FN>?MU@E,^J]F'*BN<S8;V$?\ !U>
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MBQQI$B1QJ$2-0B*-RJHL /T>QU#JM%001LIQK/5SA6!(G>>2G5) -Q2"FC=
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M>PC_ (.KP#);+!M3$.%EC*<MNU(Z5JAG8)5JJH[.;)5*HPJY<Y)4!0 Y>R3
M8RXEOM5INYC95:--^SSV7] ;E7S1E5Y;7-])JTX!$MY IND$ %L6[$YXH:V6
MUG>]N#BW#2G@97DJ)R&J9@H;#FD,2W*01$@$JI8L[D RR$N0JX$3M0D"6(DV
M D0DG<!B&9T[( 9FJ]B-KBUG Z[/AXD&LX9"XPWNH0%RPRP@MN[:RQU$$=/,
MV"6"XIICQ3&S%S3RV!(4.S/%)G@9V1Q@8-$:38NS*I3&2SX#>)V.]\L498\K
MIFUN$3H:S9*R*P7$+,(E+2N.5>#BEPGRD6RD"[#+0125$J2SK@CA;'!3D@G:
M;A/.1=<29[*-2RH>^%F? (O8ZIT%-001LI"PR3S82#ZYGF<-BL<F6GBIDPG=
M:]N$;X5Q%K#$0 6MF0MRH)YAB:W-<\_;K!*9]5[,.5%<YFPWL(_X.KP#);+!
MM3$.%EC*<MNU(Z5JAG8)5JJH[.;)5*HPJY<Y)4!0 Y>R3 8RXEOM5INYC95:
M--^SSV7] ;E7S1E5Y;7-])JTX!$MY IND$ %L6[$YXH:V6UG>]N#BW#2G@97
MDJ)R&J9@H;#FD,2W*01$@$JI8L[D RR$N0JX$2B=(8ZZ7$HF%+LJ>Y&+'42Q
MQ2E!>Y(I6G&5\.+%R7T*JV3 ,+ALQ?-2&4_&& (/(1?^)JL2C5NKQ,'$PHJ4
M2B2^T$FQ3'CQ<+'BOBOG??I!,FR:EJ+[%FVD;@7:GFL%+J/*210JS)EB"HP.
M*-09:*TFV6Q:UMO UPZ#,![;[ DA)DQ1XB<*$Z"J[G4A66-F!5F'MK Y%5.;
M#$+J5B"EP<)!!MH8WJY$:13'30N)$B;)YY5-XY)%\B.,V>.,\)I,+R!-F%/L
M=0ZK14$$;*<:SU<X5@2)WGDIU20#<4@IHW0-F!.S;I-,*XL5ABL%Q6X6$$D"
M^^P))MSGMU@D+46S#D"M0R8,64>QGN7MY&+#?%P;VY;=J1TK5#.P2K551V<V
M2J51A5RYR2H"@!R]DF QEQ+?:K3=S&RJT:;]GGLOZ W*OFC*KRVN;Z35IP")
M;R!3=(( +8MV)SQ0ULMK.][<'%N&E/ RO)43D-4S!0V'-(8EN4@B) )52Q9W
M(!ED)<A5P(E$Z0QUTN)1,*794]R,6.HECBE*"]R12M.,KX<6+DOH55LF 87#
M9B^:D,I^,, 0>0B_\358E&K=7B8.)A14HE$E]H)-BF/'BX6/%?%?.^_MUCJR
M4.%E;!0HC82#A;;U!PM;<UB#8YV(/+IJM'CU=1)(K(ZTT2LC@JRD*+AE-B".
M8_\ ^K[_ /_$ &\1  (! @($!0L*#PH- @4!"0$" P01!1( $R$Q%"(R05$&
M$",T-D!"4G61M <D,#-387&#L](5%C5056)R<X&AHJ2RT=07($-4=(*2H[73
M)41@8V9PDY2EL;;5Y97!9(3$Q? FA>%%@)#"H+#B_]H " $" 0$_ ?\ ^A;1
M57#(6ER:O+55M/ES9NU*R>ES7L.7J<]O!S9;FU](Z;6TM54*_'I6I\T67?#,
M7C:;-?8(YM1&1EVF=3F%K'KT]3PB2K54LE-.*<29KZUQ%')+89181M)JCQFO
M(C@Y<ND=-GHZFKSVX//2PY,O+X2M4V;-?9DX-NRG-GWBVWV'"G^B;0BVIUU;
M+1^Z9=56R4>L\"]]7K,NRU\N;PM)$U<DD=[Y'9+[KY6(O;;:]NG2FJN$35\6
M3+P*J2FS9KZS/14E7GM89;<*R6V\C-?;85E-P2<P9]9:.!\V7+[=!'-:UVY.
MLR[]MK[+V]CX1Z\:DR<FF2HUF;QI7CR9;<V2^;-SVMLOI44VHBH9<^;AE*U1
M:UM7EK*JERWN<W:V>^SEY;;+GKSU.IFHH<F;AD\D.;-;5Y*6>IS6L<U]1DM=
M;9LU]EB:>U&M7GY52]/J\N[)%')GS7Y]9;+EV6O?;8?ZS:^1TJ\&5795EQ&5
M) I($B#"L2D"N!RE#HCV.S,JG>!UL4C056OB14@K8HZV)$ ")KQ>6) -@6"I
M$U. +6U6X=?$'<FDI(G9)*NJC!9&*NE/3^N:E@5LP#I$*:X(LU0O38Z8PB18
MKB$<:+'&E9.J(BA551(P"JHL !S >PR.XQ>ECSMJVPZN=DS'(72IP]58KN+*
M'<*;7 9@-YTJD1:+#&5%#2151=@H#.5JY54N1M8A0%%[V L-FE>[I58*J.RK
M+B<B2!20'083BD@5P.4NLC1['9F13O T5$^A,LF1=8,1IT#Y1G"&FJ6*9M^4
ME02M[7 /-_K,P,7I)!TXIC(\^,5VF$NO#I*.3BK/)6X-4!AL2=9Y*2[>]3U\
M,<M_\U?1E9&9&!5E)5@=X938@^^#UJF=*6GGJ9.1!%)*P&\B-2UA[[6L.DG2
M@IWI<.B,W+S1\)?F:NKI6ED4'9M:5IW4>YQM8672#ZCXE_+<*^3Q/V+J5Y=%
MY;J_[;J-*GMB?[]+^FVE/2B":ME#%N&U*5)!'(*4=+291T@BE#_"Q'-I5U!J
MIS,5"$I"F4&_M,,<(-_?$=_P^Q\''"VJ\QN:=:?);999'DS7Z>/:WO:3U)GB
MHHBH7@=,U.#?EAJNIJLQZ#>I*VZ%!Y_WE?V[@O\ +I_[+K]#]1HO*<_HM/\
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M\P(XD(/0+9C[YVZ"%%YXE/O7/XT4C\>E54)!-00QAG-94R0LS635K'1U-1<
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M<4TK*<5=+44Q.771.@?GC<CB2#[:-\KJ>9E!&F!UZRT<CSC**O#:B*=!X%9
MNN6(?;)B-*D)OS9ASWTZFH'H:-ZR;V^DI9*AVV;<5Q!V RGQHZBHFJH[>#2F
MV[K87R*SRG7^D-IU1PI48CC-/)R)ZBMA?[B4NC?B)TZG:[5K235 S-"'H<1C
M'*/$>CKU7;ODC:1HB3M5XWW'2JIVII3&2'7E12KR)HFY$J'Q7'-O4W1K,I T
MIJAZBHJ2H4T<62&-]MY:A2_"61KV,4?8X0;$&59AM"C2KITIA2K=M=+3)/.A
M(.J,K.T*; -K4VIF-]HUMMEM*#UO4UU&=EJAJ^GW<:&M8RRD>^E;PD-XJM%?
MEB^*=GF^B,>V*O.N>VZ*K:QJX6\4B8L\8.^!XV%[]:'UUB,M6-L%+ U% _-)
M++*DM:R^,B&"FB#>Z).O@Z5?:&$_>:OTV73$NV\!\JR_V+B^B_4:;RG3>BU6
MF(]ADH*WP::IR3GHIJM&IV8_:QSM332'FCB9N;2G]<X?/1C;-!-PZF7GD4QZ
MJMC3IDR)3S!>=*>6VVP.F*2.*5Z>%B*FM]:4^4D.K3#*\XMM IH\]0S;+".U
M[D:44:<'KIYE#I3THBBSV):JJ&$4(S<HLD6OJ!M_Q?;I0;:S&6;EBOAB]\1)
MAM"\:_<YII7'-FD?G)TQ7BO21)LITP^A>$#DEIZ6*6ID]]VJFF#MO!75[HP!
MH?76)0E-L.'),9'\$UDZK$D:GG:&G,YEL>+KHAOO8?49_M<3B_+I9OF'3%.1
M1>4Z#Y<:0?4?$OY;A7R>)];%1DCIJT;?H?5QU+[+^MV22EJF^*IJB6;W]4-*
M%EJ*:IH+C-4&&II#?8U33B51#?=ZX@GE5/&F6!?"T(()!!!!L0=A!',1S'2:
M6."-YI6RQQJ68_\ L!O+$[%4;68@ $G3"HZFMX+%-&$J:F3D@D:E99"T:2GC
M#UO"5$[@ 9D=^3I.(EFF$#,T(ED$+-L9H@QU;,.8E;$^_P#ZN<![6;RMC']L
MUNF,_5?%/*-;Z3)IB787HJX?XK4K%,;V]:UMJ>6_VJ3&FJ&Z%@.E/3M6U=)!
M?LC%:2)VVZF*6;6/\$8=FE?FV%M,0J%J:R>6,6AS".G7=EIH5$-,GPK!'&#[
MX)TQ'EX9Y3B]'J=(/J/B7\MPKY/$]*VF-3"!&P2>&1*BFD.Y)X[Y<UMNKD4O
M#*!M,4C@;3IAV([) T?+015U%(;$;<PVCG5AK*>H2ZFP9<RET,HBWPLQ7Q)!
M9Q[UQ=&MNS77-OR+NTG@DJ^Q26CI"1K4!O+4*/X)[<6.%B.R!2[2H<A,8S9J
M?_!\353\6IFB:*BCW,B3*4DJV'@@1,R4U]K2/KEXL7&95=61P&5@592+AE86
M((YP1L(TPR>;#I8J4R,LU,;T,Y_AZ=/:U).QIH4[%.C7UJKK;%)&"SM3RG61
M+J&;:\%B8@W/J7VL%)W1N.(-FL?2:GGK2*:Q2"4Y)%3C3U ;9J%"^UK)R696
M:1E+(H0D/IAA3Z)4T29?6V)QTCA+9%EIJI8944KQ2(W5DNO%XO%N+:5/;$_W
MZ7]-M,.[<Q[RI#_8N$:8QV^_WBA]!IM*A6IJKA\:EHWC6"N11=LD;,T%2BC:
MQ@,DBRJ+LT4F8 F%59*N&IIHHY3G6-3P6IBRN1$Y,FJ;:!)"78O&0V:,N]LZ
MD*),RW$:B0\W&R)_.)&8#X(V/O:8=ATDDTLKNIFFR&IJ&NL%-3Q7"*-^6&+.
MY VR332-8%Y$08WDQ.&HHXB8Z8T3X?3%AQDB,;KK6 _A))9)*F0#^$D8 VMI
M@V(E=74-&-:BR4U=2DV*F6%H*N D;1GCD?52;BC1S+=2+RK$"3"Y=#R0ZY9
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M2Q(1Q9:;"Z,SNA-]<RLD,(EMRM?5S1&<["RM*;WTEEDFD:65B[L;DGS  ;@
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MPTR.8T"\:6HFL'=5S&[$9E>HGD)RZP,=9(X5L)_PE7XQ2MV*.AX7J".,YU&
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M>'#.J1)%*-?%6LPM=7ZKH)$8=*NC!T8;&4AA<'KXSMPZ>'^-F&A_W^>*C)_
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M%0:F$>_"=,4[-,,07;'7@3.1N6LRKPV)NAA.6D4<\,L3[FTZE?J3U2?=XO\
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M5E)GS*?MIZ5D*;=HI)/PMZ^I8,FVKHXS T?AU%*'>2*2/QW@SM%)&+MJ%A9
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MH&Z6C:S&Y$:#9I1L:R>L6E)>H03<,\!^)0+/-K6;+G]8%;[3FBL@ONTBCIT
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M.TPD.UE-B]]:\0;EZM6<!21O *9]@8]$^9*4K2@<#9TUTJDM))(+F-:G8IC
M.8Q191&6!96F9,X90RLIW,"I^ BQTZFJHTD6'M(,[X:ZT=5'?;)P0\'F4] J
M85SK??',K<^E73\'E(5M9 _'IYQR9H3R6]YO!D3E1R!D:S*="0 238#:2=@
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MGH(#RA& NK6VU((YJ@]D)S=3$\E368;/*;O)C3,;;%'^%Y JJ/!1% 5%W*H
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MIWIV6Y5XY%UD,R;8Y8[D9E)L=A!5T8!T<%74,.O++'"C22L$11<L?_S:2=@
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M#5WGGE9S%/;,80U:9U S$'BTY%/L(V#HTX.Y1I(BLRH+ODOG0=+QL ^4;+N
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M$R"+!/\ !V'XW!.+R5;8@:=8]N<5'5''B$>ULH6]*I?C6L>*=ND-)+/5)/,
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M"/>TDD>5L\C,[=+&^P; !T #8 -@&P;/K_ZJ_<[1^6J?T'$?]5=5!)K(JRG
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M)-3]3,+^[Q#Y2'V2>-Z>JX=$K/')$L%9$@S/DC9F@J(U S.T)DD61!=GB<%
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M=HW4\SH2K#\!&A( ))  %R3L  WDGHTPB&2MJ)JE$)DQ*>*&D4[":6+L5+O
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M5BK1'?),P4*M0C<=U495$C#,LN4"P:VLL &<@ :-1FK(C?/,A/:Z+Q)+;;2
M9GD'2EQ&PV.C#1&3#T?(RO6R(8PT9#)1Q.,KY7&QJF1"4!0E((V;C&9NP^RX
M5_@RDQ*E]N^B!K#GY&JX5C"8MNXV?)EU&];WS[.3_DAZJ_<[1^6J?T'$>_\
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M2K(PY+HZD,CJ=JLI!'3HBSQ\4NLR\SOQ)/Y^0%'/OJL=K;B=$">&6'W*AO\
MFRZ-4VC:&!=3&]M:;YI9@#<+))9>QAMHC140D*7#NBL/\O/57[G:/RU3^@XC
MW_ZJ_<[1^6J?T'$?]1U/ZZ$[4_9!2Y]>1LU>KD2)[YK7RNZKLOOV?7RF[7@^
M\Q?H+WIB':<WQ?RJ?666.2GJ360J9(Y@JUL*[7.06CJHAX4B+V.5!QI80F2[
MPJDD5:LU.(CEGA4MJ]MI(&.UE1MZ7.UXI%90USD5R6TH\U%A<F&Q$$.\#:YQ
MM40&H(X@(!)U^^]AEW&]M*+#E&>3-D1V!J:V?:6*C=L SL%]KIX5%MI5%7,V
ME94+.T:1*4IJ>/4TZ-RLF8NTCVV:V:1FEDML!;(O$1>N=Q^ Z=1/M'4[_(*/
MT(=:6*.>*2&50\<J-&ZGPE868>8[QM'-I2U$]"R)/(X:$C@]>#8.HY.O<>U5
M Y+EK1S&S1F[M$DLJS<?5HCG>8N*C$[<VK'%4D\T>1 -@0:+1-4RJS!YS&<Z
M1VM#$1NE*]*[#GF9A&>,F336)1Q21PL)*F=#%-,IND,+>V00MX;R<B:8<75W
MCB+([,>O-]6\/\EXMZ5@VE3]3,+^[K_E(?9L-_P?0U=%[;PII&UG(R:S$&KK
M9./FMFU7*'C_ &O^H[U5^YVC\M4_H.(]_P#JK]SM'Y:I_0<1_P!1E14)31YV
M#,681Q1IMDFE;D1Q@V&8V)N2%50SN51680QU,MM:>,VZ"G!('VI>VLD8>,@B
M'VO.:4\&6KX-9$[+PW+Q@MY8S-PB]PG9M7GSVL^4;"1I"U--99+0YN341W9
M3X4L=S="=YARE%)(CEL$TGADIY6AE%G6VX@J0P#(Z,-C(ZD.C#8RD,-AZPJ=
M:S+3+K%1BCS$Y80ZFS(AL3*Z'8P09 0R-(KJ5T7-X14_<J5_YLVB"!MC%XOM
M]DB_SE 5@O2RYR!N1M)X)("N:Q5USQ2(<T<J7(S(W/M!# V9&!1U5P0-):D)
M(((U,L[#-JU-LB7MK)6W1QWV F[/9M6CE2-$UN]RGP*#L][,3QOAR+?H&B:A
MMCEXSXXM(M_?3B$#G)#,0-RMI-3O!E+69)!FBE0WCE7==3LV@[&1@KH>*ZJV
MS]Y-4/PF&E@"M(;35#,"5@I02+FQ'99V!C@6_-)*0RQ%6X.GT/:JNVL%8M/;
M9DR&%Y+VM?-=1X5K<W/]:Z;M>#[S%^@O>F(=IS?%_*I]9C'&QS%%S;LUN-^!
MM_X],#.MZG9JB7LDXDH )GXT@#FN#V8[1FR)>V_*O1HSN]LS,UM@S$FP_#["
MJ(G)55^Y '_+0NY&4NQ7?8L2/-_J#]5?N=H_+5/Z#B/?_JK]SM'Y:I_0<1[_
M /57[G:/RU3^@XC_ *C!V?%Y,VU*"CAU0YM?6O/K7^Z2&FC5#S+-*/"TJ?6=
M/3TT?%DJ*:.JJY!RF%2-;3P!MXA6G,4C*-CRR$OF$<67J;]HZH__ -H_VC1:
M*K4N(1Q1@\&KHYCJP"5AJX<KW0#8HJ83*SJ+#609QQI7)J&67#Z-G8<)IY)Z
M5E)[(:6R34S%=]DD>ICOS((U&P#3$I'R04L3%):^H6E$BFS1Q:N2>ID4\SBF
MAE$;>#*T9THJ6GAI)*AXQP:EU5-3TZW599W5BB$K8B&*.-GERD.>QQ@J9<ZR
M2-*>-E \155$'P(H"_BN=YVZ5A>CC>LAS&.$&2IIKW5Z=!>5H0?:YHTO(@2R
M2V*.N9ED3#R*N"HHB0RM3S5U(V_5STT)J),I\6HI8I(V'A2"G8\@:5$Z4U//
M4R7U=/#),]M^6)"[6]^PV>_I@>'O*8UJ&"3U >LQ&;E:L)$9IPO2E+ AB@3P
MA&HY3DF><.2L,8@@&Q$&URO,9I.5*YWDGB@DZM$2RBM#T\4E937S4ZM+)!<Y
M*B) 6DCR[0DQ6YBD4!M8$#YH[KIACK603T=\\<]-+6TC>)44T#5(9.@5%/')
M P\)FA8[8EMUJJH6EA,A4NY(CAB7ES3.;1Q+[['>=R*&=K*K'2FIS20K-4,&
MGK:I8I9O!EK'IYZA8(K[=7#34LHC7P8X@S\>0EA]1G\IQ^BR^R?0^L]Q_K(O
MGZ?0^L]Q_K(OGZ?0^L]Q_K(OGZ?0^L]Q_K(OGZ?0^L]Q_K(OGZ?0^L]Q_K(O
MGZ?0^L]Q_K(OGZ?0^L]Q_K(OGZ?0^L]Q_K(OGZ?0^L]Q_K(OGZ?0^L]Q_K(O
MGZ?0^L]Q_K(OGZ?0^L]Q_K(OGZ?0^L]Q_K(OGZ?0^L]Q_K(OGZ?0^L]Q_K(O
MGZ?0^L]Q_K(OGZ?0^L]Q_K(OGZ?0^L]Q_K(OGZ?0^L]Q_K(OGZ24=3$ADDCR
MHMKG/&=Y &P,3O(YO8Z;M>#[S%^@O>F(=IS?%_*I_JU]5?N=H_+5/Z#B/?\
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MHL!\M87Z=!WKZJ_<[1^6J?T'$?8NIONBP'RUA?IT'>OJK]SM'Y:I_0<1[_\
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M<3>$[SR#BR+I-ZYQ."F/M5'"*^5>9YI)'AHK]*H8JJ6WNL<+;UTBGDA698[
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M>"0BQXIRR12#<)H6XK@;""DB\21">M45)1A!"NNJG%UCO946]M;.P]KB!O\
M;2$%8PQO;#L.-Y&:09C:6NK9!90!L&P;E7D4U.I))V"[L[FKJ%FU<4*F.EIP
M5@0\HYC>2:6VPS3$ N=R@)$O$C7KUG:=5_)I_DFTZE]]-Y$Q'^PJSKQ2/7L[
M([1T2.T:&,Y9*MXV*2.''&2G5P535D/,5+YQ%82-1Q4*B%[)*-IIH@!J<W&M
M,^Y923F:,*[ DB5DD#+I(95XT:K);^#OD8_<N;J6Y@K!%)WNHVZ4=?!6(HJ,
MSQ#L)DM:KHV3BY2#M?5;+P2&QCV0O&&632IIWI9GA<JQ7*5=3=)(W4/%*AYT
MDC977GLVT W'L=1#)'.M=3KG<((:F &QJ(%8LA2Y"Z^!G=HKV#K))&Q&9&2F
MKU>$P\6:#-FU3W62"4@!F2]I()2H =67*]EUD;9$RX=?#:3$J6(Y_H@:LYY!
M?5<*Q=,5.Q<N?*RZK>MQQO>TH\/O))+>[-83UDY 5(Q<JN8 *B+MR0Q+FD:Y
M"R3,2U74(ZPTU/<4M-GR%A9YI9,NNJ9!MLTN1%5;G5Q1Q)<E2S>WXNP;D8?1
MQ21CF-17/4(S_=104V1#S"IEZ=%ED2.2)6(CE*&11X>K)* G?E!.;+N+!21=
M5MUL+BCFJRDJATX'B4ECX\6'5<L1^%9$1A[XTQ/LIH:+P*VL$<_OT\$,U7(G
MW,QIT@<<\<KC2*62!Q)$Q1U#!6&]<RE25Z#8FS#:IV@@@']YB\4<&*8A#"H2
M**LJ(XU&Y465@H'O :5$,B3I6TRYY%34U$-P.$TX)90I)"B>!F9H2Q"L'EC8
MKG#I!7K-!J=DT2FZH^9)J9FVL%O9XBV]HI%*$\;5YN-I-!PCL9=Q$VQHX]C2
M#Q'<<;*><1Y&.XME)!IE3#%$I"K5(N6CIP!ZU-LJU$J[HVB':T/+U@65U5$0
M2_7[$.TYOB_E4[_Q#M.;XOY5._\ $.TYOB_E4]CINUX/O,7Z"]Z8AVG-\7\J
MGUDZF^Z+ ?+6%^G0=Z^JOW.T?EJG]!Q'V+J;[HL!\M87Z=!WKZJ_<[1^6J?T
M'$?8NIONBP'RUA?IT'>OJK]SM'Y:I_0<1]BZF^Z+ ?+6%^G0=Z^JOW.T?EJG
M]!Q'O_U5^YVC\M4_H.(]_P#JK]SM'Y:I_0<1[_\ 57[G:/RU3^@XCWA'(DI"
MQ'69G,0*<9=8'U;*7'$4JX*O=AD((:UCI)&\4DD4BY9(G:-U.]71BK+LZ""-
M.IGZBXW]U6_]3C2L];U-%51\76U*4=2!NEBG5UBS#G>*HU11MZHTJ[G.D79,
M(K%;?35E)-%]J)XZB*H ^^&.F)^]#K2SO)(U-26,JVU\Q%XJ4$7 /ND[#:D(
M.Q;/*54H)*'#D2-I'<QP9[U%5)QYIY;#8O)UTY%@J#+'$F4=BA M/4ZP+#$F
MIIHS=(@;DMNULS[-;,W.U@J\F-43B_O*SM.J_DT_R3:=2^^F\B8C_859UL1F
M:GP^NJ$Y<%'4S+]U%"[K^-=.IRGCADHXP 4H*&>HC4[0SX=ATU3"&\8-) F;
MI%[Z,S.Q9B69B69B;EF)N22=I).TGK#L.,95Y-;0/-(.;6T4T,0D^ZDBJU1C
MO*P1CP=*SLE!A4QY:QU5(3SE8*@RQD_<K5:L="QJNX>R-&C&[(I/,;"X^ [Q
M^#3J;[/AN.R3]ED@.)B!I>,T8BZJ8J:+(6N1EIKQ ^YDC=HSNU@S,UMUR3;X
M+^S%$8@E%)&XD D?AT5W7DLR_<DC_E_D!B':<WQ?RJ=_XAVG-\7\JG?^(=IS
M?%_*I['3=KP?>8OT%[TQ#M.;XOY5/K)U-]T6 ^6L+].@[U]5?N=H_+5/Z#B/
ML74WW18#Y:POTZ#O7U5^YVC\M4_H.(^Q=3?=%@/EK"_3H.]?57[G:/RU3^@X
MC[%U-]T6 ^6L+].@[U]5?N=H_+5/Z#B/?_JK]SM'Y:I_0<1[_P#57[G:/RU3
M^@XCW_ZJ_<[1^6J?T'$>\,.[!)741V-#5RU47-F@Q"1ZL./>6I>I@V;M3S7&
MF)>N7^B4>U*LAZBW\#6E;U*./!$DF>>$[FB< $LD@7J9^HN-_=5O_4XTJ/7=
M92P1[8Z.;A56XY(=(W%-3WW&0O(M0P\!(5S :V.X[!A#YN77UD31CGU%#'.)
M'^YDGJ513N+4\@\'2MGD4Q4M.;5-46"O;,((8[:^I8;CJPR)&IV-/+$IXI8C
M#J&GAA9G)2DIK9[-V>IFE+$(&:Y:69@\DT[!LBAY"&?(CSU#U# D!$098H4V
M10IXJ+<_"S$EY&N\C,Y)ZP!;8 2;$V OL4%F/P  D] !/7K.TZK^33_)-IU+
M[Z;R)B/]A5G6FB6>&6!^1-&\3_<R*4;\1TZGJYH5I)9US2TMZ/$(N=RL9IJQ
M!T"H@=GB;GCFC?GTJJ8T\G%;6P/=H)UY$T?,P\5@+"2,\:-[HVT:$A068A5
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MZ+ ?+6%^G0=Z^JOW.T?EJG]!Q'V+J;[HL!\M87Z=!WKZJ_<[1^6J?T'$>_\
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M0<1[_P#57[G:/RU3^@XC]9,6[73[\OZ$G?\ B':<WQ?RJ=_XAVG-\7\JG?\
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M-AXH(CDRGE(X5SR=9'O%33M32!25=719894ODFB?DR)>QVV*LI 9'5HW =6
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MXQ6"$[8Z&F-:R\QGJ7>GI6^+CBK?YS*V]1:3UG04V39/B*2SRR>$M(LTE-'
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MPX.$/*KZY)P.?4X?%/"LGW,DM9.@/33OI-Q\8H%\&*AQ&?XPRT$*-\.22<?
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M6T%O]\2VDGMC_=M_S/6EECA1I)6"(N\GS #G+$V"J+EB0 "3I#!+63QSS1L
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M7TZF^4GD3%?["K?WE/V?$ZZH\&D2+#XO><JM75,/N];2QG[:FTQ'L,5#0C^
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M%$4$=Q# O)C!WDG>\CV!DD;C,;#8JJJZ2\7&:(^#+A^(QW^W2?#I$']$RD?
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MB6-Y)I"-AFF(!<[E54B7B1KU\91Y<'Q6.-6>23#:Y(T0%F=WI95554;2S,0
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MZ1':MQ*HE1E.NAI:<LI%Z6&GBENEQM5JJHJ;L-C90O@;,S90F8Y02P6_%#,
M&(&ZY"J">>PZ.O0F(0XKK#&&.' 09\MS+]$* VCO_":H2GB\;('YK]:.-Z%V
M$:M)12.TBH@O)2.YS.%0;9*=V)<*EWA<E51HB-2U7PH#,Z2/8#6;-=8<SG>Y
M&[LH9Q8+< 6T@H!K#*UD9A9ZFH8[$O?*@VME\+54Z;3QLA-SI4U"-''2TX9:
M:$LW&V//,P >HE ) ) "1QW811C+F9VD=\01YGP^ (S0/6J]40I*B.FAFJ8@
MYL0JM5Q4X-[!N1X6BLRFZL5-F%P;&S JPV<S*2#T@D?O,7,38IB!@,9A-94&
M(Q93&8]:V7)EXN6VZVRVE33NTD=53E5J80R\;8D\+6+T\I ) + /')9C%(,P
M5E:1'@KSJS"UXPQN]-4J+9]V9#<J6&[6T[[N+GMLT:D%41F1Y4N#J]NJN-O'
M V.!L-I2R"P:UQ?2.1*!&,;+)6NC1J\9O'2(XRN4<;)*AU)560F.%&+*S2D:
MGV.D1VK<2J)493KH:6G+*1>EAIXI;I<;5:JJ*F[#8V4+X&S,V4)F.4$L%OQ0
MS !B!NN0J@GGL.CKT)B$.*ZPQACAP$&?+<R_1"@-H[_PFJ$IXO&R!^:_6CC>
MA=A&K244CM(J(+R4CN<SA4&V2G=B7"I=X7)54:(C4M5\* S.DCV UFS76',Y
MWN1N[*&<6"W %M(* :PRM9&86>IJ&.Q+WRH-K9?"U5.FT\;(3<Z5-0C1QTM.
M&6FA+-QMCSS, 'J)0"0"0 D<=V$48RYF=I'?$$>9\/@",T#UJO5$*2HCIH9J
MF(.;$*K5<5.#>P;D>%HK,INK%39A<&QLP*L-G,RD@]()'[S%S$V*8@8#&836
M5!B,64QF/6MER9>+EMNMLMUZ%'2;%"RLHDQ'.A92 Z<!H4S+?E+F5ES#9F5A
MO!TQ9TDQ*L>-UD1I25=&#*PL-H9;@CX/K-AJ.$J9YD9)ZJMJW<.I5M7%,]-2
MBQ (7@D,)7F.8N.7H68A06)""R@FX47+6'0,S$[.<D]>$Q?0NO#&/7&LPTQ
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M<MY-\T!HH-A9PQ+,"*[6G'S6,XXJ.5NN27U%\D7?!&3*\^_DVIW,$C@J:O6
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M5+^[&Q2M$HKJAVQS5*IY5LIQ6#U<1@OP''T<=).=6 PFFM;B-S'WWW&Z+'D
MCC,=J.>K<G:LD43?-\3!DB1=4+><=\2*A-.--N-&*@;9@) 0*EE$A5%115-B
MHJ6Q$TCH3 Q:557SCRX3268AU#*KH$P/ VQ*;%Q=4F];<;) L)((Z8_[E_\
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M-_\ -T&_L]M _P"_9T4\O;"H_)H^*SY/WPN6_0(-_P#M_*4_46,A528XD"E
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M$F4W+I3HN?857ISY+%>)-MFI3*I951-]'>1MQ0X[65</TRL*":0TIL#<<!$
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M*BJ6]!$3>--BET8BM;]U;K95SGA(=,;ULQY!6H51T4W5-=3RK]R8%;ZJ."Y
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M-BIF9DNQ!$4557R8B4:BH:TQM\H=(;6^K;C(OV75Y*>+G =:2KM!D6F4W_#
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MQE5-CNJUAOR#'F;(60O95-4N*E4JEN@Z4DW=M=JKU_LDR/6G$9-=CDB0N]5
MV,-+G6V\$@::% ;: 6VP%+"  B"(BG,@BB(F/WZT^.3M/J ,M5;5"J[CFLBC
M+;[J)P,R6A;'6<"/ J$MW!O$HVE\::3L!D(T>JPP&1KV&DRM),9)QMP76P1
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M.91M5]-*TT_3X-9:GW:919I1799QR%"41;-QL=45S!K-P=SQFH%:A5 D',3
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M'VG_ -H/_"8^T_\ M!_X3'VG_P!H/_"8^T_^T'_A,?:?_:#_ ,)C[3_[0?\
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M</<N9A-9%"(1A'4E%"U8(J7S#FNN6VS"3I+4^8KZB+U9J0''IT5F_ T2@#*
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M)>CMZQ6?5B\_J+;23#&DVE@M'5FM_3J6!"\W3S5/3,EP;MN2Q^Y VI-L+O\
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MM-1&6&I[<MD&MB,'*99FD 6XJ-NNED1.*B(B<&*-->]%ETJGR7?YQ^(TX?\
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MIK\5:G0WGE==@&:LR(;Z[UQV(XJ$@J5DUK#@Y'"'831*1K*TPDR2I5'J#4A
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M%TN4W+J,]QKMLK!HX$&*PX+VYW#&Z;I?=;!%:XS;2$KELX7K>E;[:A')E*/
M(DMKB5P)$TP\HMZN.W=-F8C3A%</U!K*55FEN&D-%M3=1BJE((>=N*VBNDG
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M767$L8$H*)6)/(J82M4*C) GHR['U@S)[H:I_+K$U,B2ZTE\J;1!%3L$X9(
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MRJ_U_'@3XRJ_U_'@3XRJ_P!?QX$^,JO]?QX$^,JO]?QX$^,JO]?QX$^,JO\
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M$2HU"4@IK94F6P+ZYSXR@TCFJ9&^4 '8EU6[L>2TV^P\!-O,N@CC;C9IE(#
MKB0DBV5%3%7@4DB89A3(\ZG927-&&0TS.9;$N'[')S("\-@'%%J;FQRH4J!,
M<_G)$5IT_P#F)>]T;1]@U!*Q*>E3,JVSQJ>C6K:+\ Y#X&J>5E,2],YT<)$Q
M9;D"DZT4)(K; ANB2VB\#SKAZI'.$ ;)!MG+L5*JZAL:Q08KE0B3!%$=)B/W
M25$<)-ILN,YR$2OD=02&V^O)HN<MR5FFOD35][NJ!W=IVW!FU.Z 5>="3R)B
MKUM[:%,I\F7E7QS:;56F_P#:.Y _I88:JQG("9*DUBM.JJYG([1:YX,WBH^X
M3<8?4"YO>!,,Q8C+<>-';%IEAD$;::;!,H@ #9!%$2R(F)L)YAOME'8=D4B9
ME371Y@!F $/C:F0HHT\W?*0KFMF 52/2WS((5>O2I31+81F)F6$XJ<&L&0FH
MOPY7R3L-LS&Y$ZKRF%?ATY@5!#;S$VCK\HTU3+6L$A7+K7MFQE4VX9B@TY*7
M,NY*;%S!3:6PJV)]TB51&R>C2WR4SX@[,C6-&HKBHIQM*::P:CQ5-FI--DHW
M1%M<=ET39S=FJ$"D\ U'M+2646Z(Q'?W*R()P?9#V9XO*3JXC0(K+95!UIMR
MJS\J:Z7+4;GO^%&&B508:3>B*7MG(R4FW %QLQ43 Q0@,22RB0KL5%38J+L7
M$:;1$6' JH=LH(,JH[AFQW4W0TPJ<0 <5I]E$]#1W(FP$Q1*VXJ;I?C:F=;_
M -]B$L>2MN;6.-ZU$]2XG>Z-H^P:@E8E/2IF5;9XU/1K5M%^ <A\#5/*RF)>
MF<Z.$B8LMR!2=:*$D5M@0W1);1>!YUP]4CG" -D@VSEV*E5=0V-8H,5RH1)@
MBB.DQ'[I*B.$FTV7&<Y")7R.H)#;?7DT7.6Y*S37R)J^]W5 [NT[;@S:G= *
MO.A)Y$Q5ZV]M"F4^3+RKXYM-JK3?^T=R!_2PPU5C.0$R5)K%:=55S.1VBUSP
M9O%1]PFXP^H%S>\"89BQ&6X\:.V+3+#((VTTV"91  &R"*(ED1,383S#?;*.
MP[(I$S*FNCS #, (?&U,A11IYN^4A7-;, JD>EOF00J]>E2FB6PC,3,L)Q4X
M-8,A-1?ARODF*S6%V]K*9,FHB^,;#!FV/](T$?=Q"AU1QQYN;*DU2KN*2ZQY
MEK-*D#FX460YE9OPBCFS@3#,.%':BQ8[8M,1V %MIIL$L(@ V1$3$BG5**S,
MA2FR:?CO@AMF!>LO J<(DEB$D0A5%1%Q/ATYXQ*A55J33GK]T1KN<R)F7G)&
MG !SU5BYEQ3Z@*62=!BS$3R))8!ZW_/A:(TXJP-'6@C"VB[TI\@ >ENJG.8H
M34?UM47E7%/#4 E6J4=F=5I*BFN-]\$<&-GMF1J*!(T <&9#.V8UP[&DLMOQ
MWP)IYEX!<:=;-,I 8$BB0DBV5%3!)1R<C136/6Z*8JN:,BNJNJ$^%=RR6C -
MM]7J\V*+70M>HP&77A3@"2*:N4W_ $) .#["=[HVC[!J"5B4]*F95MGC4]&M
M6T7X!R'P-4\K*8EZ9SHX2)BRW(%)UHH216V!#=$EM%X'G7#U2.<( V2#;.78
MJ55U#8UB@Q7*A$F"*(Z3$?NDJ(X2;39<9SD(E?(Z@D-M]>31<Y;DK--?(FK[
MW=4#N[3MN#-J=T J\Z$GD3%7K;VT*93Y,O*OCFTVJM-_[1W(']+##56,Y 3)
M4FL5IU57,Y':+7/!F\5'W";C#Z@7-[P)AF+$9;CQH[8M,L,@C;338)E$  ;(
M(HB61$Q-A/,-]LH[#LBD3,J:Z/, ,P A\;4R%%&GF[Y2%<ULP"J1Z6^9!"KU
MZ5*:);",Q,RPG%3@U@R$U%^'*^28K-87;VLIDR:B+XQL,&;8_P!(T$?=Q"AU
M1QQYN;*DU2KN*2ZQYEK-*D#FX460YE9OPBCFS@3#,.%':BQ8[8M,1V %MIIL
M$L(@ V1$3$BG5**S,A2FR:?CO@AMF!>LO J<(DEB$D0A5%1%Q/ATYXQ*A55J
M33GK]T1KN<R)F7G)&G !SU5BYEQ3Z@*62=!BS$3R))8!ZW_/ARLUMUQN*+@L
M ++1///R'$(FV&Q'9F- *Q.$VVEM\8X[1T>/(I]'D.HTU3(F9Z?4R5;-I,-K
M:YF7:,1E-4B\=7E$20:76&1CSEB1ICD=#0R8&6WK&VW53>H\@VU@BI(*[V]T
M7&B71VC_ "%G[S431ELU2-&B+59((NQR3)<<8CY_+J6F7%'^?7$;29Z.VY6*
MZCCPR#%".+3Q<)IAAA5]#1Y U[JCM/. KL!.Q^^^.PVQ5*8_&9F/-B@K,@R7
M$CBC]N.Y'>-I6C7?(VIA>V6VD>CKAD4<&X]6B@JW1IQ3W+*R^1'+QU5/*%^=
M<5NKLEEF(PD. O.DV:21V33UV<Y/_P"RP<JJM[JIU%:[92VW=^,N6X[EB-/7
MOG$G-8^X)>B(RHE="7""*((BEA$4LB(G B(FQ$3$ZL,QP2N4&,Y-CR0%$=?B
M,=TE0W53:X&JSNM(M\CH[VR&=ZAHH^XNY*K'.=#!5V-SX:7=0$YM?%S*5N%8
MX=AZD1X[M4TA%H#W+8F8<77!G:.5(5+G<2$T:C(:DF],V>'$ZJ/:V=N**_)D
M/+F9I=)A,-F^K3?"VRBB"HVT.=]\]\6L+,>-'/\ >75<SLZ,T="V18$NH.#^
M%,?%AN_]&(?Y<4-2!$<J.ZJFY=-J[JD'J5_1VV;>MCBC^1,<4?R)WRB:,MFJ
M1HT1:K)!%V.29+CC$?/Y=2TRXH_SZXC:3/1VW*Q74<>&08H1Q:>+A-,,,*OH
M:/(&O=4=IYP%=@)V/WWQV&V*I3'XS,QYL4%9D&2XD<4?MQW([QM*T:[Y&U,+
MVRVTCT=<,BC@W'JT4%6Z-.*>Y967R(Y>.JIY0OSKBMU=DLLQ&$AP%YTFS22.
MR:>NSG)__98.556]U4ZBM=LI;;N_&7+<=RQ&GKWSB3FL?<$O1$942NA+A!%$
M$12PB*61$3@1$38B)B=6&8X)7*#&<FQY("B.OQ&.Z2H;JIM<#59W6D6^1T=[
M9#.]0T4?<7<E5CG.A@J[&Y\-+NH"<VOBYE*W"L<.P5-1AZIU\F!>:@BA,QV0
M=OJG94HDMD7*JHVPCKBVL6KNA8<>)')IL-FXJ"A,TFC0TN9>J!D+#SJ<F02?
M=3QHI_K[OR.3V7J1$(WH=&?2BTZ."W1V:IB$MQ!X%<=E]P1?4- F(\5MILZO
M):;=J\_*BNOR2&Y,B?"D:.JZMEM%ML5Q=^9+@@,1,#11(21"$A78J$B[%14V
M*BXEEHA0)TJDS1:J$?<+"[GA/NJ6OBBYL!K5O 3C873(VX")L1,4,JXPY&JZ
M4V,W467;:Q)30:ITCRJ27<4-9L7Q^]T31ELU2-&B+59((NQR3)<<8CY_+J6F
M7%'^?7$;29Z.VY6*ZCCPR#%".+3Q<)IAAA5]#1Y U[JCM/. KL!.Q^^^.PVQ
M5*8_&9F/-B@K,@R7$CBC]N.Y'>-I6C7?(VIA>V6VD>CKAD4<&X]6B@JW1IQ3
MW+*R^1'+QU5/*%^=<5NKLEEF(PD. O.DV:21V33UV<Y/_P"RP<JJM[JIU%:[
M92VW=^,N6X[EB-/7OG$G-8^X)>B(RHE="7""*((BEA$4LB(G B(FQ$3$ZL,Q
MP2N4&,Y-CR0%$=?B,=TE0W53:X&JSNM(M\CH[VR&=ZAHH^XNY*K'.=#!5V-S
MX:7=0$YM?%S*5N%8X=AZD1X[M4TA%H#W+8F8<77!G:.5(5+G<2$T:C(:DF],
MV>'$ZJ/:V=N**_)D/+F9I=)A,-F^K3?"VRBB"HVT.=]\]\6L+,>-'/\ >75<
MSL\4?R)CBC^1,/U(A:<J4G-%I$0D3NTPA]$-.'41D[J\O/86^,XF)-1K3CSU
M.8?[85Z85\TIQP\S<%LN 3D*BHJ#Z#&$LJ)W-,,Q8S3;$>.V#+#+0H#;338H
M(  IL$1%$1$3O= T8:-18)IVL301=CA9RC0T+RHWDDE9><D7FP&ETF.#M5J[
MD@8CS@H2PX##I1\K%^(<AQMPW33?$&K"]D6^']*6F&VJO1"85R0 H)RH#KP1
MW&'U3T34DZ+K)%M#*8IL-<5_1TC58K\$*JRVO W(CO-1GB'R:UN0WG\NJ'%<
MK@JFOBPR&'?GFR52/$]FSSH&J>I%<(560I<& +M9JFMN6ZW-:B,LO+XR2)+B
M&ZB\=L'$Y\"VV MM@*   *" "*6$1%-B"B;$1-B8GR@CAV[HT5Z=3I0BFN,6
M!5U^$9)M-I]L2R@M\KV0QMMN_HV\XNXJ]',V6U7>A4H8*Z!"G,KT9'FR]4HM
M>3L%348>J=?)@7FH(H3,=D';ZIV5*)+9%RJJ-L(ZXMK%J[H6''B1R:;#9N*@
MH3-)HT-+F7J@9"P\ZG)D$GW4\:*?Z^[\CD]FM-.F2M4S<M.B@J[&VFXS3IY4
MYL[[SKB^6^*3 @,MBX["C2ITA!363)C[(N//.GPEOBRMHJV!I!$=B8>AS&&I
M,60V33[#P(XTZV:6(#$KHJ*F*K"I3I-I1JLW)IQH2YV07538HYN&[(N VJ\^
M7;PXI\ZUMV0HLJWDW0P#MO<S=[H.C3)J+<XWZG.1%]$"*HLQ +RCK3><MZIL
M%YL.:93([;]1FR7XU--P4+<<2,NJ=<9OQ7I#Z."3B;Y&VT%%1".^)ND L-MU
MB@-C*;E"*(X_"1P1DQ7B3T0$ U>:S7U9AO;(9WJU 4R6)4::4X6[[T9<%UH<
MZ)S*;#YB?ER!?@3%;KI65:= >=9%> Y))JHH?TY!MC[N&AJZG*C"4BMUHC55
M62(.(2MF7_JI3K;9_P"C([8;88;!EEH!;:::% ;;;!,H@ #9!$42R(B61,3A
M5@.W%.C/2Z1+04UPO,@KBQ<W"3,I!U1 NS,H.(F8$PE#=<5(.D311B;)=Z%0
MCB;L1RW AD@NQUYUUH^1.PD)YE^HUQ^,DF-3VD5MI&S(P;>DRS'(VVIMFF5I
M'GM[Z&*+FP((#DPQOJ8K*$U2:/&5=\X2KF!H;)OWG5-]]4044RR!C1(%X0K\
M05MP7%VVSL&X2V$!(R7R"*75?R)A]P25R37:P$* )746(QOI'AMIY&V6,JE;
MR&7"JXCTBDL "  K*E94W1.DY>Z29!\)$2WRCQ6PL (@IAV++9:D1GVR:>8>
M 7&G6S2Q 8%="$DV*BX0J(X<9C-'KE$-"7-&$G2[AFX2%B0TXTE^,SE0[W7%
M&KK:(B5. Q),$^YO*-I#?^S?%P/Z/>Z#HTR:BW.-^ISD1?1 BJ+,0"\HZTWG
M+>J;!>;#FF4R.V_49LE^-33<%"W'$C+JG7&;\5Z0^C@DXF^1MM!140COB;I
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MW$:DMMMDVXN]UN<%6^6\"BZ35!JD5:FQVH:29BZN'/88!&V7MTKW)E[5B(O
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MGC17VP=^22>QI(0\(T&K*GL[@?PLZEO+'F+&E1 ?#T5H9C!QG295-H.ZIPD
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M637F[+GXA?W5QHOTDC_XZ_P*^XVJFLNO%3HO/W-AX:='1/9%H?RXI]-83*S
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M9UZ6#<=-4S%KE-5Q^,@[$ #D-A)RCL0&S,P!$1 %$PR[)9J51VY0E265A4>
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M4;:$1NNU5[%;99 W77:14FVFFQ4W''#AO"   W(C(E01%$NJK9,4&;4M&J]
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MBI-M--BIN..'#>$  !N1&1*@B*)=56R8H,VI:-5Z!#9[8:V5,I$^-';STV6
MZQYY@&PS&0B.8DN2HB;5[-;*(TZ]*2DU'<S+($X\Z_N1W5 TV"*9N$=D 115
M(K(B8T<EU71FO0(462_*=E3J3/C1FR9AR#9SO/L V*J]D0;EM)41-O?J@Y%T
M:TBG4RGLQ8%.>BTBH2(I-"R#SQLNM,&T>>2Z[F(%7@1%XN%:@4'3F$T19R;B
M4VN1P([(F91:9%%*R(E[7LF/!W[H?Z+I#\S'@[]T/]%TA^9B2>DT32MBG]I9
M8@=;8JK<3=&Z(>1!6:*-:[*CF5$W]LUN?L2M)=#(VZF99E)GT9FPR(\@ES.O
MP V(\TZ5S6.'=FW%[D+@E9L:0](DVCIJFF:W3=9*CH.Q 1Q]L))9> 1>)Q!1
M,HHB;,-29;-1FWWG;&>T4.DP657?:KN;<8!3C*U$;)YSAR$NW#5(A+KY!KKZ
MC.4<IS9:BB$=MN5IM.YL-W7(";54B)5[$P112(HD@1$4N1$K)HB(B;555V(B
M<.-&IL_1C2"%#8G.F]*E4>H1X[0K%D"A./.QQ; ;JB7(D2ZHG9[>T(F8ND3;
M: ^TZNKCU5MM.YHX?W*6 [QMXMX8Y6W5%$$Q<B-MUBDQT-5.+,A[KI;B^,;"
MNMO1=]SO1'$4K<=<%3(C\S*^FK-F@TQ6Y+J%LRZYAIR4-^!4:<"_ MTQ'K>F
M["PH#)B^W1W20IL]Q%S#NU$5=S1[[7&S7=#NT"!M%S*( *" (@B(I81$4L@H
MB;$1$V(G-WMP8.CFD$^E4N%%BP7H=)GR8ADZVDF4XVZRP;1$KSNJ-17[B@KQ
M<&W3Z!IQ!!PLQA$IE<CB96MF(6F10EMLNNVV/!W[H?Z+I#\S'@[]T/\ 1=(?
MF89<TCAZ7,TWM;4$(ZRQ5VX6N4 U2*4P49UBK?)XWJ>Q)THT.CI(*62OU.BA
ME!W="[7)<!%RBYKN.]&NCFLN3*'GR"-&=>E@W'35,Q:Y35<?C(.Q  Y#82<H
M[$!LS, 1$0!1,,NR6:E4=N4)4EE85'@-DN^4%1MJ(ULVDC(E(=R\5PL#3F"2
M3/DD+]5GY<JR9.6R""<(QF$N# +MXQEOS+LG^(7_ $QHY-EZ+:0QH;%?8>>E
M2*-4&8[32/*JNN/.1Q;!M$VYR)!]?LII%H\C:5YEE&I40R1H*HPTG<LKA6 )
MC2;P5<5 =;R@1@H"JK2?\HP(K1%EI]7IRO1VUOM6,4AO,#:KOOL9Y&3OFLM[
MX&F(%4J$-PAO"ID'<L!=NQ9;K38 K:+9;S'U:!=NS"5_2!69.D)MJ,9AOND>
MD@XECRN<#LPQ7(;H[QH<P-*>97%[VX,'1S2"?2J7"BQ8+T.DSY,0R=;23*<;
M=98-HB5YW5&HK]Q05XN#;I] TX@@X68PB4RN1Q,K6S$+3(H2VV77;;'@[]T/
M]%TA^9CP=^Z'^BZ0_,PRYI'#TN9IO:VH(1UEBKMPM<H!JD4I@HSK%6^3QO4]
MB3I1H='204LE?J=%#*#NZ%VN2X"+E%S7<=Z-='-9<F4//D$:,Z]+!N.FJ9BU
MRFJX_&0=B !R&PDY1V(#9F8 B(@"B89=DLU*H[<H2I+*PJ/ ;)=\H*C;41K9
MM)&1*0[EXKA8&G,$DF?)(7ZK/RY5DR<MD$$X1C,)<& 7;QC+?F6)%/T?I]1J
M,JJ38L*0U38LB6^$'NC[Y*W&!PT;-6 9,E3+9W*O&P$B-HII='?:7,V\Q1*N
MTZVO!<' CH0K;G1<>#OW0_T72'YF/!W[H?Z+I#\S'@[]T/\ 1=(?F8I:2$<1
M]*="1Y'<R.HZD9O6(YGWVLSWSYM]FO?;AM&C;B5VG(94V8:=S-"VG"E***6Y
MW51%0D159<WZ"2*8E(!EBJ4H"+NXE&W;1YF78C@DH/0W%MP.M$+XIO<P[4QV
MG0ITJ.]O'8%$IQ-I(]:0L9LGC;]4VX[J><AV7PWI1I4VVE6 5[64RXN]KU-+
M+*DF-P67E51:;!21A%4E)7;(WWN-'INCU>J-)I=-9".]!I4^5%*3*57I1BZP
MP;:GZ"T6VXZJRX-*?H_IO!1U45Q(E+K<='%'BJ:-,AF5+K:_!CP=^Z'^BZ0_
M,QX._=#_ $72'YF*4YI!#TQ:I:,U#7G5F*P$%"6"^C6M*6*,75S+DS>/:VWL
M2=*-#HZ2"EDK]3HH90=W0NUR7 1<HN:[CO1KHYK+DRAY\@C1G7I8-QTU3,6N
M4U7'XR#L0 .0V$G*.Q ;,S $1$ 43#+LEFI5';E"5)96%1X#9+OE!4;:B-;-
MI(R)2'<O%<+ TY@DDSY)"_59^7*LF3EL@@G",9A+@P"[>,9;\RQ(I^C]/J-1
ME52;%A2&J;%D2WP@]T??)6XP.&C9JP#)DJ9;.Y5XV D1M%-+H[[2YFWF*)5V
MG6UX+@X$="%;<Z+CP=^Z'^BZ0_,QX._=#_1=(?F8\'?NA_HND/S,4M)".(^E
M.A(\CN9'4=2,WK$<S[[69[Y\V^S7OM[-<FTW1JO5"&Z--U4J%29\J.YDIL0#
MR/,L&V64Q(2L6PD5%VIB@,/-FR\S1J8TZTX*@XVX$)D3;< K$!@2*)"2(J*E
MEY1Q4_(F-G>=J(ON8V(B>YR3:*?D3&S9WG;MQL%/R)R3:*?D3&S9R[:*?D3&
MS9WG:B+CBI^1.2;43\F-B6[SM1%]E,;$1/<Y)M1/R8V);O.W;C8*?D3DFU$_
M)C8EOOQQ4_(G>MJ(ON8V(B>YR3BI^1.];=N-@I^1.2<5/R)R_BI^1,;.\[41
M?9QL%/R)R3:*?D3&S9WG:B+[F-B(GL)R3:*?D3&S9WG:B+C8B)[G)-HI^1,;
M-G_ZV_\ _\0 ,! !  ("  8! P,$ P$! 0$  0 1(3$005%AP?!Q(#"1@:&Q
M0'" X5!@T?&0L*#_V@ ( 0$  3\A_P#PM_T0D_8_EPHM7ZI%;++!'7NO&FI6
M@A1<NU2<Z/\ ;RXMCH/L#[/J=W(?PW5CN^"O!S475U=%]"?H:=/S=?;^8]Y<
M0&8^WQR )7+E&7>W22+_ '4XX_\ @('!NW)GRY9.A_<YKUREB=!B"U.80G#,
MX];= MBB6NQ%R>"P9K.DX6L,80>&)1_''/QZ,4A5^RM0+JO=[7D*%P>W1=WL
M9E!5DH^!5L_BT0.@C LZ& @MV*(2!_<V>P5A)&?NMD\? ,2,L5CE#:!'F/!T
M+ITR\Z6.Q 0]8::MS1C1;7VX_N.O ]N*F:<Y3C' 5IS*M\/WC<LH!U^W?KZT
MK/[V %U4^$T;6 <5D;6'TT?V/\O[GH8YSFS1X.8ODC+=->0S<71Q=76XJA+^
MNQ4NEM=$+ZEXMY\= $Z<1,'=RU%;K#>>9X,-O6+!:".3)U.*0;:2UJZ;I6>R
M%T)01DV%].($]-QX*>H\2+"KE$?*#;3',)L"\QX*&5HZL<^@1)I!3>*=I1$S
M+%JQ]\K>/8RP71V[H(T%6PV]&T=JB*CE.[U82^6>&@GB9U90#+66<E/YE765
M5TU>ZB$B#)7@=E7C*P+8EPK7("(BB9X*]'COR=_$+'-E@U:&%]?[>#-2LX6\
M3O5FQR9N?P6^X3=2[RX8?&&!:MF@S]6)U3Q*=3G S#V>,=6:#0>Y553LN\-H
MHGYNU .:4@0NP$0VB"M4LJJ2E*HPPP0<U:G!?$9J6I+POU -$19?HNH.+LA1
M<$H* UP+[XM!8P4MO"#)!%L[5TE-%"I((]0]-U.,^T*6UQ50P*U^8[H8VY^Y
MI!?!4@*^B7R7&50@+8X;V"&=46Q"&"2 ETU;,J7 >#)-< ZJY03.0 %@849$
MPF2%LF8>J^-%]F$!=0/R5[ 6QQCSU]",>:+RNG3G"0XL,;NZB*2W>34=C T#
M7[?*M1ON@@?\,^?6*YR%-C'< !/=:!02^P[D(#K9>:BRCJ;(V>?ZP"O%YN@D
MB($1Z_(9_P!C_+^YZ&1\?0A IYVUT:8D]0VVOA1VFCR@B"9'(FD8M(N[>:X%
M@Z"'[C+VN*Q$FGO\0),BG >24-J"A'RG@FPO[@=.6B@LUG6J7:<7L!:BZ31X
MGVE2X).T@_<C;$;!5L()$IOA;40+PG+HC% ]:$M0RL\ODREL_@WS)$LTETH0
M. FGZ2S4;@!:]:I([AIGC@-Y?S074AFU?"=\@8Q6ZVC+JF*-K16AJ4V@WZR\
M[@;%Q$'=;[2A K(5QF;*Q:4H2.13L]-Y<X$) 0:&K"P_86?041V^W>YN/]58
MW<^F7>ZO80*^)$\B,7[#DNA G$7IHPH[AIF\KU4DD*0&VA);';4&+<B,,B[$
M1O!\3V UX1!2Y2?,@HUEMLFQ!&ZV4TL)S8WDQDJ]-I/JT7,J^#/0NTBAO[=B
M8AB,["8L$C16.::)AIQI+SG78,]*X/<;SX3I5^2F#-- +3:VVYS2'+A'UZ*6
MT1N^4JDX9?H\0S-E0O*BM!?<C**.I\JM6BJP/NQ7"L1&2,(J *3X?T^3F&]Y
M5DCF]67SSPN\-;ORNP.#&NFPV*^6,V)1+7943:F-  T %3%%4@?;#A,D*ZO)
M*S1Y\7J;T'3%CX_%;QPZP*!;#:+9*@L=/%#"2Q7;YM0D4")A(^Q0%J"").-Z
M8(.)<;KYW(@8MM>$!;G91E2@*R#J8\D#S.&GAM(-J0]YB$NB0P%L#4#4G>Y1
M0&4 JL<ML<U7@-UQ:37)K!G*_>+JRXPB'=)AD#!)DW>*D&Z;,*1&$J8NHF:Y
M% -!ICG['^7]T$.@J-61.JL9'^2&"2*]=GO0%9Y>=3HUH!N9K+C\HF$?.6SK
M>>J?IC/V,]X1NU^@4C+&)S9>@Z<^H%%N'F#J9JVYJ49Z5YC.9,@?J]!7MRU%
M'%.H>3F(S90ABM%!'[1&@&M<(;1=NPJ&'@903\TR\(M9,6OT/3,X:1IZ+!4W
M78F.XNAK'CY!#<7C '@;HRV[K]R]#0M&<SZ;?HYO76@7-"@18+NBH *NT;WR
MUJ?&-DH*L"^>A YF#NI"PR=GO8(&.HJF<\Z_+)?QP*3$OQ&-O44(G#4N60"5
M9#=D(U*!H4R,?IS;YGCTKS!FFKB5V*0B(B5$]@]5]@R/KK "D][?4N5_;H8(
MUQ[+.YI'9B1Q)=I?NHX[*5/H"H%:-H/.#^ Z+[3:CPE"E/VO!QV&')4M4U=3
M\X$$QJ7GA,:FH\4R8!%@40^1]" 1F-*WEM9EW>0?K"](]_&8RXY#GQ' <"C]
M4G7)'B]3>@Z8KHUIY#W0OY%/.!6>2BBT'6K_ %^AE<P1%,Q@!\2E@OKU!16]
M>A]4$,A1,Z#5O%1Q)# "<=D;J("L1SP.C=<5=R+.J"_*^\+@CSF9U<W'-*\!
MY+*,DWH+\ZD_8_R_N@AT,D.H7R'SJ!=SE-KO0$8/0?S"A_G*Y).YT52DW$L!
M8"BTFVN7-7E/V,X M<\F7 K-XU4S5#1O7(P#%-OF<6C3DH:MU^8*>LO?#8,V
MC@-P.N?JASY-/A*[7D\N:=K%<.0?U2M'],OT^AZ9G-N,2NMG_%8XE?!1K=L?
M]?HYC84#B!DKI"A);ULK)A)O:-$U$[ETZ\EQT*#BJ.+HB"JKW+Q'JD%]9*'I
M=G );:'JY?%KOG7.&Z:<NB1IV&M^(T:*K6]5'\L]+ZA$]90:LP-?V[&!<@IT
MK*^=>F;'*:LDGZP>;?/+&$UZ!:=O+E,6^1/VO!QS4,PN]N\LOU7VDYS)*>48
M.+30YP@F0P*J0!E5T W*J 4Z(D H.@(Q))X,K=7'1S0@$RC4)):PSYAWQNGM
MG"IL*^84)CB]3>@Z8J)*S+6N=[Z5 +B$.Q"EYSCASM^_A*68;'(0XV2NW=I9
M9=QB.[;Z6 0XQRDL%0%PW0N.J6"*KR+"'PPN:-,^()/4=%^CDTYBR1"YT?P/
MC@-UQ:15:-EON,V(YQX@R!(XVA9VOGP+ZT%&#LM/03D3]C_+^Z"'0#"8@141
MZFEG!RQ=7/D'0G*'_0@W&:RUSPO@_8SB&632/=E)*V5$@]4%B48K>$A=<<B*
M-NI:*XI%C69FZF\UAM T6TF1RJ4AN %S@8)#57!2C'KNP;2U?H9/OWJWNV52
M&MV8/*7FHZB*<7IF<]AW%: %0(,HG.'(G@+)PZ92N87 ;1*+]F,M"KJ8!KR^
M"V9/#HAR]$?&@L:M#-U.DJ"LIUZF;7=,"S+*5W%U,X$PI"(#_P 0GOW/T*8Z
M#S/X#W:1#(N:4K%P V0'U==C(<1RX L#"C(F$B!ZD %8H X"9XHR@S@\8DA;
M8V<E4DK:[=2B6W_;L8%N73(4BCG(4_1"#=FR_"C"'2K;8D V4+E[D.:S]KP<
M?"PEB04\L&*M-L<&+KX+8G)F7!P)PO\ ;+;:"KF!>ZT_$)73L![N8FQW7-D+
M!@Q+"B@$!$1'(CA$YC*HR\&>ZHU8%P B<TQ+"59B=XB7DPPS:GBGG4#S)I&#
MT*>A <'J;T'3,8W^SWRM#MB=&YPA=BW69G6*$6,UM9G0<%'6NI;3UBO)ML%P
M 5\HNK#F<U/R'@2Q[.B2JL@'T:.EOS'4-FW32[!!VWBKUD:8Z8%LNDC:C:@8
MVQ(9BMM]N(GAS2//@-UQ5*$R)WS0!J&V!S+2*T%V6JMA9R/53E!E(+JDH%&D
M6RVWEJ3XK_3G['^7]S@EB=!B"U>90$0X7C3&_CR%BN&G[KUP+H\Q)9 EH@?Z
M28A ""<#:U\<<7F*5(11_''/QZ,4!$CV&"#ED7 >J1BTTL6#4;0 $RCP->F9
MD;+1O IU:E$+FEEA&R9Q8L I8J(CX'CH9S+)<3!4RHDBA]P)E>W(&D?-YYNS
ML,\U@="^25A):FN&8XQ' 4G 7MT7=[&9459 OC5C+\M$!J 7'="51@MV*8 )
M  _(<K<3*!$49?6JR2*Y"&NHWJDK2P::? 0Z-,10J=@Z J^=$4$BU" 2X*<+
M58^ AO2G3 -'G^<)!:ZF4Z%X=0&M.O;]%$)=J.NNY?,O$ZB3T0B<JJTI<U14
MD%-*/@ ?X7K,@.8%B#2*V*Z4AVO$\1+^%=G(JD79!R5EKPQ>9053#F&::MG1
M$;=CQ(SNA2BGV@?5=?\ VZ:&Z#-<<>>,9*OQ(D;;RO*K06#PLJQA>?:4LRQD
MS^V^0< BPJ?_ ')J3(S5!JZN4&5R?WDM!BZWT, I0Z&64*L4[Q!KV#.7?%B9
M$A'5V[G-#)O8\H D4#@*#AMOW?(?_JB6"QM,K0YW2:H@9R@Q#@78H$N?MI<C
MA$32X5$BO2NUH0+56@,JO5FHNJ3; F_",5^F2RDT K]S> 43SWU1BE% BE#
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M=#_-47>/]#I2K'M?$]*\1"UNH#^Q#9/"OEU:)(+F$^9FN49LUT2I!P9XB%P
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M0CNA%KXX O(D?R8@1!$:84Q/B43A[2C(M&?M4 >3:R9NPY>+WC)L* ^!!/\
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ML '\?0Z ^0/\PR O4#^#^UZY!SB7'8ITHH+N_P"MKA\G-"N266T# ,(76W?
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M&*LK1 ; +:.+3BS*#5$9D:$EAG+P2T 6U%4W\3 3+,H2C'IRB HW)6(--)N
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M%RC)#,D0<77"L#.1+Q^@081NRYSG,EJ#2^4,6VI">R+=Z%B"BT1=40\   '
M^5Z%,FG*=H" :M))!D&    ?>Z.T.=-4]RZT+ !8;7J"+>,0D" !7 JE$KTQ
M-'8 *R&HF!]@A>][5T!W;I MUS8,K609)L1PZ]32'U47839WZ8A8:R.CC62:
M@(RUDQ6K^7<HC_TA"TB\HQG"<4W@0-*J<D[E7YI+X&/AEXY**G55-9%YD( U
M5.%P%:BR(,0R($1AH'P _B',*BH;+N$<BKSBX&9#?;9,B.3^]*AM#Y:@CDR.
MDA,@0!!N$<)V8=JW=]&D:ELQX09$GIG)VF06O!&2N^'D70DWHE2M%7UYYU4
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M<O8+UY9(XC)C'$$%4^C.U2@GXG78$HN5:AT5^9@R5N@FRCHDD.;R0',P(!@
M(J=TJBR5OAHYHU-Y%TK"%T$DV3VM!%IIAKU):N#N,&"@.:%MLX-O)B4;@4F
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MX66-9VJ$(5H1'];AC#7)8*I6;6*8W]EI-06-@" TBF#)>)KP7/=2W'0&F8A
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M+R=5=%JS5UJWA;+?J#MQ-.N<CFC2K[K@YKC^H'X:22[?/C'/GJAIV:^ ';_
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MI&X & H.1'/#S%C>F4DI  P"6L(KA*F:1BPOSD+)[.*_0+ M;H0N1JPJ761
M$#.AG;:K!4#8TI$6U560$6:^O%X^VVVG86D[.SJ&_04C#Y/%K,@V8WS8$9&0
MT,"L7BA?5$O.ELD%5\@(*)4H/>PD\T2 P*96**EJ=+HCEN1^[VJ]$Z.1Y?\
ME@"7-*#+@RX,N#+ERY<99'?62@_RRR8,!U!Z'=GE F@KK[EQ*;Z9I#BPHC?J
M:R6H!LEU"&R0\![2OO2N H4<&^GES!D.H<VU)Z;H"[S!=IB[[!5/.;8YD $'
M6(!1W@:=. *RLX5/*1[=8>ZUI(DB]$<U.(_V=G V RN^TL1'Z$YOT;XK$N'=
M^ISH/(M&F*/1!<5VZ#\BO\O9<TH,N#+@RX,N7+EZV(Z+@@YTF&DI!F6N3 '3
MMK7.1!%;=R1LNIVT0"HIH890+$T93[,.DB@6X'):4>3BNRRL*AHFE5*FX#"Y
MN+7]U(*H7!3TC17AH[PDHIO&4 T7T.@:C@*LY2&B_EAD(2F941>J4PS:<8&
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M4C,3T95,9]6F@:OC_P#ZC-E50]>3 7UB:0F]!&AUQ1%(F@I]-OU,C#D_1_\
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M!\@Y*E;!:)\H+0)++-?W/<^E=<!SBB8#>KG-6!MD!7P 26#EX!:M(V5$'4(
M5Q*B1JAC,J#]T"?[P3,$*9<!3%>2?X:Z 0@1YJ%&.0 !TX'?!L95!W)\D;[<
MS+\"2,<@K[J#&2'0"1@]09#_ )(2RRYI09<&7!EP9<N7+J6S0,F]#:@.">5,
MEM8S1(UDHC18W6X(ZUQ001F/.M$ N43^ A!>:]-4<@0:N8Q.^9TD?SH,@P*0
MT@$6S6WLURPN3!$QT:+7EL:%PI\]K0-B.(D.<9EVY07<\)FF+Q'(MA:P<T+K
MB,.2N74L)%[/\4L<-$)- L1N!ND1S%2239ALEISP,-HN &O\B1Q#X5Y;C81.
M086E_<7R1)33AX .*%%2Q2(54"++TB-K5A$G]3&-Q>R.<I>U $+)9GF81^BP
M29PD&#BAQ-EM1^UVWFS4$7BI(("1N-1(I6AX]ZT.AQ87"JS*<2H"J %JX -J
M])E? KE-%9-JU8-_DU0UA]\H-<^JG-B_N@Y@VOG8WQ=$ 7G9/[B*=M/RW\/\
MGI99<TH,N#+@RX,N7+E["EEJ&'K>.=2 IS+9)9S96=$(3A8>FF;4\I,"@RU?
M1Z5?0K"8OP!/CD%N"_;B.1D@M2FJI<Z9"LM60H \IX$4B:,JD7AVEB0-65:<
M<"+4.51S=J:DN:7."Z?-A54]0$^SU+N_/,5;5U;Q3[0IPUW!<QM@YW7F<*C0
MBXZ@@B((E(Y$=B<QA_1_**RE(@5H!$TL5\RIFPO?[9V ?*'\\ KC_"!Z TB(
MD-&@]5/1COD!"&/G)YA:.Y -E<*FCL#R0&R*!@@&69"Q<EZ%PLD%D/4"O?PY
MMJ5YAQ-Z*)HZ:&HX"UEP,/LAI-D[L3,09N8+$VA:YAR3'[27'X1!@ !4%B=1
M/S.M#_ U6]%C\<0U5LODJ9T4Q[,;T)[UE.WZTO\ )Z667-*#+@RX,N#+ERY=
M>HBQ+G<.R@T1#_U$0T?L%:SK98:<J57(HB:L8**61 )U$P\'0/D#_,^$JBYA
MC "V: Y<*& J.S'IS[6VB6NU\NUSYHG1N!$8B= !8;5*B450M1+1&\VK*JVJ
M_014:=JH&+P.55D79A;/TOFIXK(W/O*TK"QTQMWD (Q/(A 8:I:%.WX\>+7S
MW]N@,%@#@D*)O:V@X?H;/"=B1S[P*Y7=%%$:'@JJTRQN&Q^)CX,6CA#;3S12
MJ-G KN6>,T;DOBS"1"""2V5)!"6>NDXRP3 4  M1P 95P$7\$$MLZ$2Z#O*-
M]0  .5)1'!4)   4& -!T.)D.2K(-%)IDS=(!1VX&05S$"-J9?WVTT^T!32>
MJX5%,;PZY&G+_)Z667-*#+@RX,N#+ERY=ZU+D!:I(RA$J-<]@<@<Z V6V!6\
MQ"'G1UM:=%TCY>-;2JW5=#(8:P !>3"ICCQ:Z9X>O%6J*VY+.90;QN7FEY%<
M%52$%8S(1;52UXW]UU_00W<W&T&NL5B*AFMX=Z6KA6GHC2\N/P8=86F7) @J
MSBMXE7+3YL4)GSOQ0YC0MY<_;+J I @@Z5UV)+/43JI6D,L-D4+\E)T-KVN9
MH5>SCJD^YGE.#^W?:WX67@9FFAB9%E3*0.F()XK7:39FGW_3@5:$<.(<.?B(
MX>1V**K21VUU@:X( G)9L(U#GJO&K]$0#5A]"<.'.%TH&" ,P!6@U.:]0% P
MJ4H%82ZW'_/WI?7.4'*44@S,D@&1  3BM(/'+4(2T\6L&O\ )Z667-*#+@RX
M,N#+ERY>H!)F <05'"T:IAUK767L!HQ8-.3AP,8%ZCH%[&EEH@FMCVB%H,38
M+Z<&Q[^R*=O@VRCD, O"-"=(@ *3"-O+>G=MD15?H^]UU\2&)6"=4(_5A(%W
M5MKBZ96\( <X!E3@     X%4219'F;PMO(@)?@O"EW_5'&!?7[F[-N:DI<MK
MGE$73W+^FD)1B"%!5L(&JLM-8X,DIV'^2>E>)Z5XGI7B!M@)I+C]H!0#H!/W
MGI7B>E>)Z5XGI7B:P8#1PJJ*I=SA<H3$=E_C(B_<6FL'^3\LLN:4&7!EP9<&
M7+ER^3.BNDC<T(@*T1: UPN==!=' X"HFD1FG'WM,S*N8^!*MT28$MC-+ "A
M)FSVV$*\R:WOHBW&H!!PT5UTD$*"I;0.#$3!6YV=9%N0*\?==?$@HN[TX/U%
M("WAQ"D;T6+7"C0*4=\/;$H(O;LPS*8 RJ4 &UAW"LC#+2 5!08<AQX@"%A<
M'(*/W?XP#LWO_D99999999999999999999?_ +]AX /_  -/\?I99<TH,N#+
M@RX,N7+E\K17"RQV5%I 8-LW79KA6.74I5L%6YL%*0(NU]DX05-(I:&BN*DP
M.*+:1X\+B(70R;=2T&7&\L@"UAK,^!XOGS?C)M[#@YNY/BF6(1U5!N?D4CCV
ML'6BPXC^(ORFM6)KJI)"N*+CUH4'M$Z+,;@;\^:0'J3K%Y9W"KZ&6?B) )G#
M "@, "@,!@_R_EEEES2@RX,N#+@RY<N7VT,&2N1/Y9UO_P#-'++++FE!EP9<
M&7!ERY<O++++FE!EP9<&7!ERY<O++++FE!EP9<&7!ERY<O++++++++++++++
M++++++_]_P '!!_X&G_^5.6667-*#+@RX,N#+ERY>66667-*#+@RX,N#+ERY
M>66667-*#+@RX,N#+ERY=$B1(D2)$B1(D2)$B1(D2)$B=>0PLPQH"S0A_P#U
MEA+++++FE!EP9<&7!ERY<NREEEEES2@RX,N#+@RY<N792RRRRYI09<&7!EP9
M<N7+LI9999<TH,N#+@RX,N7+EV4LLLLN:4&7!EP9<&7+ER[*66667-*#+@RX
M,N#+ERY=E+++++FE!EP9<&7!ERY<NREEEEES2@__ .I27!EP9<&7+ER[*666
M67-*#+@RX,N#+ERY=E+++++FE!EP9<&7!ERY<NREEEEES2@RX,N#+@RY<N79
M2RRRRYI09<&7!EP9<N7+LI9999<TH,N#+@RX,N7+EV4LLLLN:4&7!EP9<&7+
MER[*66667-*#+@RX,N#+_P#];0N7+LI9999<TH,N#+@RX,N7+EV4LLLLN:4&
M7!EP9<&7+ER[*66667-*#+@RX,N#+ERY=E+++++FE!EP9<&7!ERY<NREEEEE
MS2@RX,N#+@RY<N792RRRRYI09<&7!EP9<N7+LI9999<TH,N#+@RX,N7+EV4L
MLLO_ .A<N:4&7!EP9<&7+ER[*66667-*#+@RX,N#+ERY>R9M*C#-!/U'Z@00
M00>XE[B7N)>XE[B7N)>XE[B7N)>XE[B7N)>XE[B7N)>XE[B7N)>XE[B7D2-[
M!S;K*,0 ?M @@@@@@@@@]Q+W$O<2]Q+W$O<2]Q+W$O<2]Q+W$O<2]Q+W$O<2
M]Q+W$O<2]Q+W$K+_ /00$#_@(?:!!!!!!!!!![B7N)>XE[B7N)>XE[B7N)>X
ME[B7N)>XE[B7N)>XE[B7N)>XE[B7N)67_P"@@('_  $/M @@@@@@@@@]Q+W$
MO<2]Q+W$O<2]Q+W$O<2]Q+W$O<2]Q+W$O<2]Q+W$O<2]Q+W$K+_]! 0/^ A]
MH$$$$$$$$$'N)>XE[B7N)>XE[B7N)>XE[B7N)>XE[B7N)>XE[B7N)>XE[B7N
M)>XE9?\ Z" @?\!#[0(((((((((/<2]Q+W$O<2]Q+W$O<2]Q+W$O<2]Q+W$O
M<2]Q+W$O<2]Q+W$O<2]Q*R__ $$! _X"'V@00000000061]U:5S^+*("=Q+W
M$O<2]Q+W$O<2]Q+W$O<2]Q+W$O<2]Q+W$O<2]Q+W$O<2]Q*R_P#T$! _X"'T
M @@@VM!BBPB66UT_JJHZ<#.8$#S/I!!!!_3,?.;(G3-!WDG>2=Y)WDG>2=Y)
MWDG>2=Y)WDG>2=Y)WDG>2=Y)WDG>2=Y)WDG>2*;^%$IVZLL^T$$$$$$$$$']
M,Q\YLB=,T'>2=Y)WDG>2=Y)WDG>2=Y)WDG>2=Y)WDG>2=Y)WDG>2=Y)WDG>2
M=Y(IOX42G;JRS[0000000000?TS'SFR)TS0=Y)WDG>2=Y)WDG>2=Y)WDG>2=
MY)WDG>2=Y)WDG>2=Y)WDG>2=Y)WDBF_A1*=NK+/M!!!!!!!!!!_3,?.;(G3-
M!WDG>2=Y)WDG>2=Y)WDG>2=Y)WDG>2=Y)WDG>2=Y)WDG>2=Y)WDG>2*;^%$I
MVZLL^V$$$$$$$$$$'O).\D[R3O).\D[R3O).\D[R3O).\D[R3O).\D[R3O).
M\D[R3O).\D4W\*)3MU99]L((((((((((/>2=Y)WDG>2=Y)WDG>2=Y)WDG>2=
MY)WDG>2=Y)WDG>2=Y)WDG>2=Y(IOX42G;JRS[80000000000>\D[R3O).\D[
MR3O).\D[R3O).\D[R3O).\D[R3O).\D[R3O).\D[R13?PHE.W5EGTA!!!!WS
M.;+98#]$?I0" 1V)8_)/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3
MTGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2
M?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\
M3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/
M2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])
M\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ
M/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$]
M)\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TG
MQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$
M])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3T
MGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?
M$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3
MTGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ/2
M?$])\3TGQ/2?$])\3TGQ/2?$])\3TGQ*\@II_P!/]4#0'0"?AGI/B>D^)Z3X
MGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>
MD^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3
MXGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B
M>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z
M3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/
MB>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)
MZ3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI
M/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^
M)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XG
MI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D
M^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3X
MGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>
MD^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3XGI/B>D^)Z3
MX@P4C2 GPA__ !+;/Z^S^OL_K[/[:V?\]9_7V?\ 5<G!@<P7VQTTYHR$%@<>
MQ1\.I+G*X5%T#6Y;<NF5DBJA"FFUHV*/CA0;L-6ZU+K@.+'6!7>89@<:Y;YI
M7!7>4^G%-=+Q$H<E F^,'O"-A7"E <'0!#2J);A85S7+6FC:*3$LM5*9+50#
M,N9,\;PONR<NY@JC"FF 6-JUE_IQ4* 8P? JH C@!< 8^VCXE\)I96"2X9&Q
M*.1WCEC(LUU)+)AGXFL%@5PK2^J25Z8CDUE*/ M$K@P9=(BWA,,4*K R@.VB
M(K^5.(FP#>7,2T2\\B9I$IMJ-8,C\.O6\Q3MD:J' =SA(X.H#@' KI_D)C);
MZ]%UXD//<M:#BZ7 (0!&3\O=H#WT%FH7&M6K'3%IRBE7(O$0]!!Z'K$&%.8^
MW:5C-2QM:*98 CG5EL)#C 64CGF1Q<[#P:CLL!5$2'K"I:F5CRBVMC@28B$&
M!2>7JT$)ABA58&4!VT1%?RIQ$V ;RYB6B7GD3-(E-M1K!D?AUZWF*=LC50X#
MN<)'!U < X%=/\A,9+?7HNO!(YL8^0945)S"&VT(6KC?$0(44AT2?PR\1;C<
MME8%;%JGVK2L9J6-K13+ $<ZLMA(<8"RD<\R.+G8>#4=E@*HB0]85+4RL>46
MUL<"3$0@P*3R]6@A,,4*K R@.VB(K^5.(FP#>7,2T2\\B9I$IMJ-8,C\.O6\
MQ3MD:J' =SA(X.H#@' KI_D)C);Z]%UXC7A1,41F4Q6.\/0Y6@I+B[R!:B1:
MU!I?'K%MF"IAUWE ,P8 *Y5]QNM*QFI8VM%,L 1SJRV$AQ@+*1SS(XN=AX-1
MV6 JB)#UA4M3*QY1;6QP),1"# I/+U:"6/E.IU+F+2!,%NTC SH7C0XK;G$H
MITTU,F!P<L6PYV;B@]=!#Q3(3XD4#GPGEE,!LO$\KK8F 7Q8.#H!G"I:EU9G
M 66L1YVZ'K;)8,;//\[9GYW%DH@H88K( 1<Q ,&/N5I6,U+&UHIE@".=66PD
M.,!92.>9'%SL/!J.RP%41(>L*EJ96/*+:V.!)B(08%)Y>K02Q\IU.I<Q:0)@
MMVD8&="\:'%;<XE%.FFIDP.#EBV'.S<4'KH(>"8EA+8#M$  %)ZB#H*AT..B
M^F6K@7%="D#P0+,'4"AC.[W\PX:A975F/WL9!SB%6%.\X8%!Z/AFP#49W^W*
MEK6!>N#%+EPVR(EP[2?<1;2L9J6-K13+ $<ZLMA(<8"RD<\R.+G8>#4=E@*H
MB0]85+4RL>46UL<"3$0@P*3R]6@ECY3J=2YBT@3!;M(P,Z%XT.*VYQ**=--3
M)@<'+%L.=FXH/700\$Q+"6P':(  *3U$'05#H<=%],M7 N*Z%('@@68.H%#&
M=WOYAQU"R3P0RHY*I< JU%@[;'! ^X4%Q1*9D=!!;,@RBO\ PQ&KB >9HJ4B
M6F+YV?G<J=(\S>(82'"H*V#TY^SIA .7>E,FL@T60#,?;!D-!QUV2EAW;GK*
M_B!E)YJH"M&MK1KH@Q4((MDZFB#B QK\'48B:H.67DL.,^KM2HLW3!9,L8Y6
M:O=DB^_KL3B%:.#GZ22<@Q2X)8W59^W!02+4D]!2%WJ)0O[0%J6@,X/MD:N(
M!YFBI2):8OG9^=RITCS-XAA(<*@K8/3G[.F$ Y=Z4R:R#19 ,Q]L&0T''79*
M6'=N>LK^(&4GFJ@*T:VM&NB#%0@BV3J:(.(#&OP=1B)J@Y9>2PXSZPKFN6M-
M&T4F)9:J4R6J@&9<R9XD//<M:#BZ7 (0!&3\O=H#WT%FH7&M6K'3%IRBE7(O
M$0]!!Z'K$&%.8^V1JX@'F:*E(EIB^=GYW*G2/,WB&$APJ"M@].?LZ80#EWI3
M)K(-%D S'VP9#0<==DI8=VYZROX@92>:J K1K:T:Z(,5""+9.IH@X@,:_!U&
M(FJ#EEY+#C/J[4J+-TP63+&.5FKW9(OOZ[$X%\53D/A$4A8EF2-SU7B! A-I
M!-B3*SYB_ @J:>K[9DX,#F"^V.FG-&0@L#CV*/AU)<Y7"HN@:W+;ETRLD54(
M4TVM&Q1\<*#=AJW6I=<!Q8ZP*[S#,#C7+?-*X*[RGTXIKI>(E#DH$WQ@]X1L
M*X4H#@Z (:51+<+"N:Y:TT;128EEJI3):J 9ES)GB26HH(,218,!.?(^%"B+
M&9QO.3!*L^.;SLZ60%,84GS5<M>H<7D_N9'Q+X32RL$EPR-B4<CO'+&19KJ2
M63#/Q-8+ KA6E]4DKTQ')K*4>!:)7!@RZ1%O"88H56!E =M$17\J<1-@&\N8
MEHEYY$S2)3;4:P9'X=>MYBG;(U4. [G"1P=0' .!73_(3&2WUZ+KQQ:AY]<)
M;8H7HL''%%&%JU>'3B!('!0#4X\U(EC1#$JX**02(D^X1\2^$TLK!)<,C8E'
M([QRQD6:ZDEDPS\36"P*X5I?5)*],1R:RE'@6B5P8,ND1;PF&*%5@90';1$5
M_*G$38!O+F):)>>1,TB4VU&L&1^'7K>8IVR-5"6IYLWY(Y&S7R,>D4R&'*/T
MH#?5 I(YJ GXJO\ - C#D3*HT>)_;@P1-3YRWWE"HFT%N_;VO7.19.F\M7B)
M"MS25)Q;94*!@-,WMUPZ_P!S#6E8S4L;6BF6 (YU9;"0XP%E(YYD<7.P\&H[
M+ 51$AZPJ6IE8\HMK8X$F(A!@4GEZM!"88H56!E =M$17\J<1-@&\N8EHEYY
M$S2)3;4:P9'X=>MYBG;(U4):GFS?DCD;-?(QZ13(8<H_2@-]4"DCFH"?BJ_S
M0(PY$RJ-'B?VXL%%ZOHZ8JE@ @X*@#O.%V\JD_8?@Y[35B52BO\ 0O3@$4[S
M%)V'.S#H=5+2%Q*>B)P$S9M+@#D,&F$C$_(4V'5=IMTY1X/M,#N3GBY&&>.5
ME\N41,WWASI7)"4- 0  5#""%@>"O-5F"5NUH[WXU2>6>Z\!&WS)Q_\ )1W2
MC?Q-207+62J71#3Z%^.+;H%[T'?H6ZTYP>I .SNVEJY8JW.>E>)Z5X^X\OJQ
MA)\T'AWAFK(;=6:5#@7%PF[*,P #ED%7"E")12(-9%"G=8N3\1I%]EW93:]+
M(?VK)@Y,HH.?E<(@(CP "5-<R/&)=JR;PD6-S0+JW0BPKPK^(#Y,B[8#D$;5
M([*,T##&KR5+%.M9+; TIBP:Y'%] 9A5;+N;3G<J_P &5&8O@!T"H%<)XJ-*
MQ 1%$B::]),!RS>U)%.L"S:"M]M_5]L=\ZBPP.4DPVX^*85V*I2=G9E1G%=/
M5#!AL,M(V#KR*D'U#%+ ;P<GXC2+[+NRFUZ60_M63!R910<_*X1 1'@ $J:Y
MD>,2[5DWA(L;F@75NA%A7A7\0'R9%VP'((VJ1V49H&&-7DJ6*=:R6V!I3%@U
MR./K7B>E>)VC5])VQ@)UZ!M=B<9RP//PE"Z)YCYT&.HOEL1^T.^=188'*28;
M<?%,*[%4I.SLRHSBNGJA@PV&6D;!UY%2#ZABE@-X.3\1I%]EW93:]+(?VK)@
MY,HH.?E<(@(CP "5-<R/&)=JR;PD6-S0+JW0BPKPK^(#Y,B[8#D$;5([*,T#
M#&KR5+%.M9+; TIBP:Y'%$Y[+R3(<\0;@R[6-Q;4T]@BH7#Q7Y615!+!%&,=
M/"7@*K>3E%7*"U#M )!TQNWVQWSJ+# Y23#;CXIA78JE)V=F5&<5T]4,&&PR
MTC8.O(J0?4,4L!O  QID/G9J>XEXFA,&Z:$$H%)'EQQ'%!,!HF_(E#@)E#(&
M%'0*V)4UHKBIP+NU0_@E)0$X@ .5<Y@AH62I1$JBO58@0;+0TL..+#Y/%K,@
MV8WS8$9&0T,"L7BA?5$O.ELD%5\@(*)4H/>PD\T2 P*96**EJ=+HCEN1^V.^
M=188'*28;<?%,*[%4I.SLRHSBNGJA@PV&6D;!UY%2#ZABE@-X &-,A\[-3W$
MO$T)@W30@E I(\N.(XH)@-$WY$H<!,H9 PHZ!6Q*FM%<5(1?G(63V<5^@6!:
MW0A<C5A4NLB (&=#.VU6"H&QI2(MJJL@(LU]>+Q]MMM.PM)V=C4%^@I%^R6K
MC+0!4NL<X)W[0"RH:J'-BLRS(!70)8(U"*E!Y=[(XJFQ5NO903AFK0:.A]L=
M\ZBPP.4DPVX^*85V*I2=G9E1G%=/5#!AL,M(V#KR*D'U#%+ ;P ,:9#YV:GN
M)>)H3!NFA!*!21Y<<1Q03 :)OR)0X"90R!A1T"MB5-:*XJ0B_.0LGLXK] L"
MUNA"Y&K"I=9$ 0,Z&=MJL%0-C2D1;559 19KZ\7C[;;:=A:3L[&H+]!2%G]7
MAC!9V;IJAQ))$T)JILI"&6VT6 I:-*G9D/\ AG:R_P#A4,&E:NK=P9#KZ,A4
M--:*<F(<X.B4S =C*I1*U##+<%.4+;(_O4Y% \ Z*;U6+I8X]8E!*@_@0/4$
M ,  !@AD4-A(D)-U'Q"5XL(^JAI5D<"L-F-8S\&4CA(:2N7^IN=@K8"XAZP@
M#ID'4I7R=;CZZ8- TLO/Z0GI7B>E>/N++_X5#!I6KJW<&0Z^C(5#36BG)B'.
M#HE,P'8RJ42M0PRW!3E"VR/[U.10/ .BF]5BZ6./6)02H/X$#U! #   8(9%
M#82)"3=1\0E>+"/JH:59' A&WS)Q_P#)1W2C?Q-207+62J71#3Z%^.*^@,PJ
MMEW-ISN5?X,J,Q? #H%0*X3Q4:5B B*)$TUZ28#EF]J2*=8%FT%;[;^K[:R_
M^%0P:5JZMW!D.OHR%0TUHIR8AS@Z)3,!V,JE$K4,,MP4Y0MLC^]3D4#P#HIO
M58NECCUB4$J#^! ]00 P  &"&10V$B0DW4?$)7BPCZJ&E61P*PV8UC/P92.$
MAI*Y?ZFYV"M@+B'Z5XGI7B;&+$80/PLH!(0(O3"8B8%0-44-FT4@_  % ?;>
MG (IWF*3L.=F'0ZJ6D+B4]$3@)FS:7 '(8-,)&)^0IL.J[3;IRCP?:8'<G/%
MR,,\<K+Y<HB9OO#G2N2$H: @  J&$$+ \%>:K,$K=K1WOQJD\L]UX"-OF3C_
M .2CNE&_B:D@N6LE4NB&GT+\<4S1OF8 Q;$Y-Z)590=MB5BN!<034K:(9+R(
MG<S.I1\Y"+, W>VM&0M>ZZ?ZE?MO+ZL82?-!X=X9JR&W5FE0X%Q<)NRC,  Y
M9!5PI0B44B#610IW6+D_$:1?9=V4VO2R']JR8.3**#GY7"("(\  E37,CQB7
M:LF\)%C<T"ZMT(L*\*_B ^3(NV Y!&U2.RC- PQJ\E2Q3K62VP-*8L&N1PN!
M>6DW?",:M%0 =?2N+3E1)HNP$5.YMQL)%<JJ"&JB@(D#M\HI)30L:Y8MR0DP
M!R[^W$\OJQA)\T'AWAFK(;=6:5#@7%PF[*,P #ED%7"E")12(-9%"G=8N3\1
MI%]EW93:]+(?VK)@Y,HH.?E<(@(CP "5-<R/&)=JR;PD6-S0+JW0BPK*H^N'
M344YB).D8:ZG6X/GWWL!# I14$&X$" &(:GHQ.$3 &1F)@D_ZM#Y&XZY@F.L
MJZ?M6QWHC@0WA&USJ\*]B&*0I>4&D)DU$O5 @FDY,5!#1+8HJ==G=?:1DMK+
MIY?*Z+'VQWSJ+# Y23#;CXIA78JE)V=F5&<5T]4,&&PRTC8.O(J0?4,4L!O!
MR?B-(OLN[*;7I9#^U9,')E%!S\KA$!$>  2IKF1XQ+M63>$BQN:!=6Z$6%95
M'UPZ:BG,1)TC#74ZW!\^^]@(8%**@@W @0 Q#4]&)PB8 R,Q,$G_ %:'R-QU
MS!,=95T_:ME=1U!8V/B<Z$'ET?\ +PZ 00!\[,SF BX4$!4M_0A01+';"2@8
MH$!;&:]BL_4L$6JSPM$5D;@5=8K/,QJ2T C9VK=7J]Q&(+CS6=0Z/8[1 G&3
M(%7=*DY]C@2X2%B;',4$EACI&')O8PTB-<#BA@.6.7AW#4K*/$H[C4#0P8+J
M^A?BN&W^"5_F.H0?PWH,LK/>8+L2HCYP'Z$R<M+4+-UC.XT-&?VV185R39S)
MA6+5QJZAOQ/SV8[QX*.(<,K;HMQ1"V-05&1R5(/RV^U6.5PZU1<ZEMY8(=5Y
MM0$Z";UK>C@"!8%#I$I&*H1U<#X!5&K5J&0>L1KB;0A7$)$@)D6Q+=H.8HNJ
M !P#X(E%UF3]%$-W*T%W[M"[S.:DH]Q=P3Q[^5D_ =;-'C-RO'7.03]MHH%F
M&"-%'VS  <U0CO$$T$%ZEK_$%,-EA;9>"FP-U"GJ6>I]Q1%ORM6/1=D6*=(Y
M7#K5%SJ6WE@AU7FU 3H)O6MZ. (%@4.D2D8JA'5P/@%4:M6H9!ZQ&N)M"%<0
MD2 F1;$MV@YBBZH 'TAU1"6HFYP @-ES(]BH"H/.T1V(ON#  <U0CO$$T$%Z
MEK_$%,-EA;9>"FP-U"GJ6>I]Q1%ORM6/1=D6*=(Y7#K5%SJ6WE@AU7FU 3H)
MO6MZ. (%@4.D2D8JA'5P/@%4:M6H9!ZQ&N)M"%<0D2 F1;$MV@YBBZH '$.3
MXT(T-5+.<0*%FLX&&J8-EDDK;1-CD6IB+9MI<X;'!SCYW2<D(D&G?[V@[_;,
M !S5".\03007J6O\04PV6%MEX*; W4*>I9ZGW%$6_*U8]%V18ITCOVRFE^!O
M9!;Q 8M!<FM]*:^CQ/P0I<*: )6C$ /17P0_F.< /-="[.ST#&1HQ,&M8;FJ
MGC(' N%'9(^::E=]I8B/T)S?HWQ6)<.[]3G0>1:-,4>B"XKMT'Y%?;, !S5"
M.\03007J6O\ $%,-EA;9>"FP-U"GJ6>I]Q1%ORM6/1=D6*=([]LII?@;V06\
M0&+07)K?2FOH\3\$*7"F@"5HQ"-Y$[48XY8YD $'6(!1W@:=. *RLX5/*1[=
M8>ZUI(DB]$<U.(9?_;HD%H]W3>V!_$$FJ U"2H0&@* ^#@0+B46C+M$QR[DO
M[IA;K=Z%ZN_VS  <U0CO$$T$%ZEK_$%,-EA;9>"FP-U"GJ6>I]Q1%ORM6/1=
MD6*=([]LII?@;V06\0&+07)K?2FOH\3\$*7"F@"5HQ"-Y$[48XY8YD $'6(!
M1W@:=. *RLX5/*1[=8>ZUI(DB]$<U.(4W_:(D 88A5R!VJ6QHF!+H#5+3D[J
M10_X@GH[UR6 WU!KU5$K2<W*4$_A>&'(X"(<LTR66/TMR6^6\,K3B@Z7FV45
M.!#J0>H?.!SJ4(Z'S0+;JW6LG !APK'L'"+"2M$&-*B>HN.?"W!,X)+:@1H<
M$$NP0U,/77S&$?0'62B#J[V^/(\XS70@L;K"B;5I1FGO5F'7-IVF,P6W0N8M
M3?W [7)8#?4&O542M)S<I03^%X8<C@(ARS3)98_2W);Y;PRM.*#I>;914X$.
MI!ZA\X'.I0CH?- MNK=:R< &'"L>P<(L)*T08TJ)ZBXY\#BA@.6.7AW#4K*/
M$H[C4#0P8+JXK\$2BZS)^BB&[E:"[]VA=YG-24>XNX)X]_*R?@.MFCQFY7CK
MG()^VT4"S#!&BC[>N2P&^H->JHE:3FY2@G\+PPY' 1#EFF2RQ^EN2WRWAE:<
M4'2\VRBIP(=2#U#YP.=2A'0^:!;=6ZUDX ,.%8]@X1825H@QI43U%QSX6X)G
M!);4"-#@@EV"&IAZZ^8PCZ0S[8\9*D!E#0"L+FV-<6O%BSPNJFIH8@0SRF)>
MXK?;!$L=L)*!B@0%L9KV*S]2P1:K/"T161N!5UBL\S&I+0"-G:MU>KW$8@N/
M-9U#H]CM$"<9,@5=TJ3GV.!+A(6)L<Q026&.D8<F]C#2(UP.*& Y8Y>'<-2L
MH\2CN-0-#!@NKZ%[BFQK["M VZ8S+OK]B2E0H(,,/E#*TZ;F9%0@+T$B@:\4
M*47%*C_02BZP/MLBPKDFSF3"L6KC5U#?B?GLQWCP4<0X96W1;BB%L:@J,CDJ
M0?EM]JL<KAUJBYU+;RP0ZKS:@)T$WK6]' $"P*'2)2,50CJX'P"J-6K4,@]8
MC7$VA"N(2) 3(MB6[0<Q1=4 #@'MZZQ,3][TC*TPX@);_ER<5W0\KNN2ZAY6
MYQ0F26\#XQ:OMLBPKDFSF3"L6KC5U#?B?GLQWCP4<0X96W1;BB%L:@J,CDJ0
M?EM]JL<KAUJBYU+;RP0ZKS:@)T$WK6]' $"P*'2)2,50CJX'P"J-6K4&<^]H
M#CY U@UB(?$W.AKZ0IY' +4:D=UVX"RQ($?HI81-UUM$9015Y_7M+?I7/F=2
MK*UWDVWGB!<# SA/5,]R"):DL6T^$8ER U]LP '-4([Q!-!!>I:_Q!3#986V
M7@IL#=0IZEGJ?<41;\K5CT79%BG2.5PZU1<ZEMY8(=5YM0$Z";UK>C@"!8%#
MI$I&*H1U<#X!5&K5J#.?>T!Q\@:P:Q$/B;G0U](4\C@%J-2.Z[<!98D"/T4L
M(FZZVB,H)ST<]_P.S._!^I112C&T7-8!=!U75"ZP"7_I.X4[^9 % Y/6DQ*F
MBMWR%'(8E= ;<B]$>[M>R($J=,W_ $#^.R;)L'P/.XOQD.V'7Z0^H^OQZ+=B
MB$EY3J&[.&9T%)?83,H,F3S$44^)YZR6I&U(+8H19&+]09Y!CTT7SB[7W?NB
M)AH:U17BAE6>M&,LLKDB<. MY0EH#+K(5!ZYE0-OPO\ T0=2F_!/W/%\0QNN
M&OUE\F\WS3Z5@>Z;$FZ4U C>,V8T=">L /X]E(K3X&J@IQ.[/G*45-S"@"A*
M3=N[K/D+NC@U=QZ,I\VIS;\_NIV(_+9MO*Q1>W+\B5E. _#CD$9JGM-_?D21
MV< J!M^%_P"B#J4WX)^YXOB&-UPU^LODWF^:?6L#I35* Y\E;@T#D@;TYF-4
M1V-=!A]^G8C\MFV\K%%[<OR)64X#\..01FJ>TW]^1)'9P"H&WX7_ *(.I3?@
MG[GB^(8W7#7ZR^3>;YI]2P/GI.ZEL@BJ5I7V8=[,VT'70%N4;>$8MU485TN$
M,'>63K@XM^G5',JA<1'V2<\TT_=3L1^6S;>5BB]N7Y$K*<!^''((S5/:;^_(
MDCLX#4[?I\'\(+'4?P\[XU.Z_P!5'^42IL3Y-O[\'3\/T%[L1=!%W+.K3F(6
M2QU5!RJ[ND5F H>++K*#*V H_-XM0,T?B4L%1UE] L_V?=$[$?ELVWE8HO;E
M^1*RG ?AQR",U3VF_OR)([. U.WZ?!_""QU'\/.^-3NO]5'^42IL3Y-O[\$
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M-PL\67)024)5E%V%J&4&C',L0MOL+ ]>%V<NRJJ!C]4-B!8 PT=;7N_=HNV
MK #CG)784.64;*Y>2) H1TKF8=1:0M&C!'L/R2SJ?F&_1KFI>UV>CG1!UD(6
M@TY6<0!  @(.1$PB9$W"SQ9<E!)0E64786H90:,<RQ"V^I8'R[ W7]^"7V D
MLZIH4;$R#Z^*@6PZ0(-$.%911*Q:46@VZ(PS$0*DID.M[.?VZ+M@*P XYR5V
M%#EE&RN7DB0*$=*YF'46D+1HP1[#\DLZGYC@[K ']!L](OW'+D!8^6!^% '_
M  "=O* 041LBT][@^TP&'%;(Q;* <N"XQNBQ5P=/P_0783##N5B@V<H17&=
MIMNP>P&$A\)F$5>!B@ %L>U[6GE)"E&-X$(J*@:.A-#G5]M47; 5@!QSDKL*
M'+*-E<O)$@4(Z5S,.HM(6C1@CV'Y)9U/S'!W6 /Z#9Z1?N.7("Q\L#\* /\
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M1XEKD4=MK1+['&J!=''_ /V21 1I>V8RQU'!E,[.E<6U-8AJ1!I7(JJ\( Z
M8"LL 6;>&&64S;%!PS[LMD8;(N(N@_U!$>4P J0"XF$)YR.H]Q86G',(VI.+
MCA7443F;3LNF98&E0-4W3A%JS>*U6R&'1TJ!TJ%<T?N)=B3MAS2"4VU(7$AI
MM(N< (PNN/\ _@"Y%'(2T*V;VX,\I7:,;2P6*ERK@?AEB\9A-"<2O2GVU2
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M1ZW@4*X*2<4FE.5DU?4@FD)O01H=<412)H*?3;]3(PY/T?\ _P#Z*ZRNXT
M@KV3)ITL:8QM(;(=&0-HKUZ"M/M9;&1O!98_&N)J3C0/"R%4UTP)4'[F*253
MC@\ICH59(,]EV" 8H*Z%#?'_ /SFJCX""-%]J.OA;T+-=BA"FFQ%DOC4*0-
M*:%)SE4!P4+1ZW@4*X*2<4FE.5DU?4@FD)O01H=<412)H*?3;]3(PY/T?_\
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M _@_I'(2]5/Y(: ^ '\?_MO_ /_:  P# 0 "  ,    0
M
M
M
M
M                      &0 7    !S(    "@ S
M
M                       '7 ((    >H
M
M               Z8K8    F=     \ 'H
M
M                ]0%#&$ 6]<$F ]P9$&P
M
M        5'C%] VSR03$R&]8AM
M
M        'SR >E5_#JQEFX3/=.-
M
M#X#;SUV3>690 OQB,BH
M
M Z2=LHA<H]6_%*^,]#,4
M                                                     GGKRD;X
M'RSH@1<,1X%
M                                                     '7W]A '
M5!JV0 P$/8T B
M                                             %N5>8<="^6 $G[1
MB0'H
M                                              ZK0L"&Q@]6O"LP
MH[$H:H
M                                      J_KZCKR5RS%Y4E\0[-
M
M                                      '(K'("#W48O/[Q<DH\*@
M
M                              K[ @?T#BK<$%']O# Y@
M
M                                   $@     T E$   @
M
M
M
M
M               !X
M
M
M
M       CN0TE TH(:
M
M
M                                             /
MU/U< ?@ -$
M
M
M                                    $=R&DH[2 !(     (8 P>6*?
M+%8
M                                           '! B0 &0
M
M                             &I^K@V@@!'     '8-$I@)E1 L
M
M                                   %VWS!(#O& -
M
M                     !# &#PE)&9X     4LL T$ <^%
M
M                            @M.8H0CX %@
M
M              [!HE, 'H)G     $%-)&UZ)6?:
M
M                    'I(   */ %P
M                                                    @
M      "EE@&@ &H%K     PL&BM1'(O\
M
M             %H(&LTTX%9
M                                           '"= WX=I ZP     @
MII(V#[&DA(     ?H      @
M                                                   X
M     &MB"G"H$0Z
M                                    *<8%F0Y NL@    &%@T5HM_
M#(
M                                          %K( BX 2!OP     ])
M=1$TC-!H
M             XW   0 # 7     "5I$(P_.FPU     #]    0
M
M                                   L"7'( 08I;8     EX( 1 U N
M                                                   P
M     %C+ RT B@\X     $"?5N'-?-:H
M
M                           'O *"85# ,0      X
M                                          #W\ #XX&&<@     FL
M ). 'H*?      K%I'>-.-5$
M
M                    8& '10?8$JX
M                   '"@ %( - G@     L H#B"0UT]@    ! 07%P']!;
MX     KI9D_T )3E0
M
M             GC"]' -  [                                  F
M            [Z0$" J8&<@    '+ "&5DJS ;     $XS8N ^  ?     !:
MG %WV_I4*                              !
M
M     - ZY \D=C"X                                 C5P X&0@ [
M    !@A'Q0@[6 (     65=&RQT2OB(     UOK%P%( #X     ]O  (%?P#
M^                               H
M                                                         &TA
MHDV ?$NP                                 $ZZ%Z"KO MP     PR%
M!R'/:YRX    &%SV"X  %?+     ; <DJ'X  ?
M         (              %
M                                                  &C D@  @"O
M                                  !P @P AHHN      J@A&61[=V-
M     @ [DS #5!K@    'I0 $X'
M %               H
M                                                          6V
MVVVVVVVVP                 ![%F^ 'K'HP     6 !@BR&K5#0    '];
M "0F%#K(      8                                       H
M         %
M                                                  &
M                    X$Z* !N(OP    ',NDFPD_#:9     !/  @$2 '8
M                                              %
M  H
M                                           P
M           !:L\QHX44G%     31X F %8FX
M                                       H              %
M
M     "                             &
M    /38 0DUX &      #
M                               %               H
M                                                         QV8
MU&%P( Q                     P                            ;@
M$ F8 "@
M        %               H              %
M                                                 &^SYOZ%/ 0P
M               H    &
M
M H              %               H
M                                          A0$8QM#@0F
M             P
M                            MMMMMMMMMM@              %
M         H              %
M                                  $G/ NX /  P
M     &
M    $MMMMMMMMMMH    H         %               H
M %               H
M                            &@R6 @I5W                     P
M                                                         H
M       %    %          H              %               H
M         %
M                   '2IB0"X#LE3                    &
M                                  P         #    %
MH    H         %               H              %
M  H                                                      !X
M            7.#P%EX1 &                     P
M           EMMMMMMMMMM    %          H    H         %    %
M        H              %               H              %
M                                                 CN4Y8#Y(9Y
M     >H  02'  8                    &
M   %          H    H         %    %          H    H
M%               H              %               H
M                                          U/9H9,IT7S
M                            P                           H
M      %    %          H    H         %    %          H
M        %               H              %
M                                  (8"XZ*"/X#@
M                    &                           %          H
M    H         %    %          H    H         %
M H              %               H
M                          '8- (8%S$.Y
M             P                           H         %    %
M       H    H         %    %          H              %
M         H              %
M                   4LH]  3X*#H
M     &                           %          H    H         %
M    %          H    H         %               H
M %               H
M           $%-BTD!D!1C                                    P
M                          H         %    %          H    H
M       %    %          H              %               H
M         %                                       & %: &0 &P
M    PL$<DGDD2T     &VVVVVVVVVP                    &
M                  %          H    H         %    %
MH    H         %               H              %
M  H                                      N(;)'3P("O      ?H
M     4                                     P
M           H         %    %          H    H         %    %
M        H              %               H              %
M                                 $%6B&RH-8ZX
M                                   &
M   %          H    H         %    %          H    H
M%               H              %               H
M                          =4  ] %;RW
M                            P                           H
M      %    %          H    H         %    %          H
M        %               H              %
M                   7L D0"[9$X
M                    &                           %          H
M    H         %    %          H    H         %
M H              %               H                       #
M           1I(SH&S&($0
M             P                           H         %    %
M       H    H         %    %          H              %
M         H              %                       7S%E" C82H
M   '-KLX04 \G)
M     &                           %          H    H         %
M    %          H    H         %               H
M %               H                      $52D.+DX5"O     HQ9
M#( # U     &VVVVVVVVVW                                    P
M                          H         %    %          H    H
M       %    %          H              %               H
M         %        1H $  @ P      Z(  L[$(2%8     '
M                                                  &
M                  %          H    H         %    %
MH    H         %               H              %
M  H       [T:M\ O $U(    %9Z +H%\V L
M                                           P
M           H         %    %          H    H         %    %
M        H              %               H              %
M   "@5"@/@%!6     A=HI@#>FQ$
M                                   &
M   %          H    H         %    %          H    H
M%               H              %               H       \+$ Q
M#T <#8    $=M0 &/X%@@
M                            P                           H
M      %    %          H    H         %    %          H
M        %               H              %       ''X A $@"T*
M   4]F<@9D@? X
M                    &                           %          H
M    H         %    %          H    H         %
M H              %               H       X5 3P D&Z"      OXDD
M$DD@0@
M             P                           H         %    %
M       H    H         %    %          H              %
M         H              %       '"[5P $@P2A
M             #
M     &                           %          H    H         %
M    %          H    H         %               H
M %               H       C& @" ! U((
M                                                          P
M                          H         %    %          H    H
M       %    %          H              %               H
M         %        $
M                                                  &
M                  %          H    H         %    %
MH    H         %               H              %
M  H
M                                           P
M           H         %    %          H    H         %    %
M        H              %               H              %
M
M                                   &
M   %          H    H         %    %          H    H
M%               H              %               H
M                    %
M                            P                           H
M      %    %          H    H         %    %          H
M        %               H              %
M
M                    &                           %          H
M    H         %    %          H    H         %
M H              %               H
M
M             P                           H         %    %
M       H    H         %    %          H              %
M         H              %       &VVVVVVVVVS
M
M     &                           %          H    H         %
M    %          H    H         %               H
M %               H                 P
M                                                          P
M                          H         %    %          H    H
M       %    %          H              %               H
M         %                 &
M                                                  &
M                  %          H    H         %    %
MH    H         %               H              %
M  H                 P
M                                           P
M           H         %    %          H    H         %    %
M        H              %               H              %
M            &
M                                   &
M   %          H    H         %    %          H    H
M%               H              %               H
M     P
M                            P                           H
M      %    %          H    H         %    %          H
M        %               H              %                 &
M
M                    &                           %          H
M    H         %    %          H    H         %
M H              %               H                 P
M
M             P                           H         %    %
M       H    H         %    %          H              %
M         H              %                 &
M
M     &                           %          H    H         %
M    %          H    H         %               H
M %               H                 P
M                                                          P
M                          H         %    %          H    H
M       %    %          H              %               H
M         %                 &
M                                                  &
M                  %          H    H         %    %
MH    H         %               H              %
M  H                 P
M                                           P
M           H         %    %          H    H         %    %
M        H              %               H              %
M            &
M                                   &
M   %          H    H         %    %          H    H
M%               H              %               H
M     P
M                            P                           H
M      %    %          H    H         %    %          H
M        %               H              %                 &
M
M                    &                           %          H
M    H         %    %          H    H         %
M H              %               H                 P
M
M             P                           H         %    %
M       H    H         %    %          H              %
M         H              %                 &
M
M     &                           %          H    H         %
M    %          H    H         %               H
M %               H                 P
M                                                          P
M                          H         %    %          H    H
M       %    %          H              %               H
M         %                 &
M                                                  &
M                  %          H    H         %    %
MH    H         %               H              %
M  H                 P
M                                           P
M           H         %    %          H    H         %    %
M        H              %               H              %
M            &
M                                   &
M   %          H    H         %    %          H    H
M%               H              %               H
M     P
M                            P                           H
M      %    %          H    H         %    %          H
M        %               H              %                 &
M
M                    &                           %          H
M    H         %    %          H    H         %
M H              %               H                 P
M
M             P                           H         %    %
M       H    H         %    %          H              %
M         H              %    '            %               H
M             %               H              %
MH    "         %  X            X 'VVVVVVVVVV@    ^VVVVVVVVVT
M    'VVVVVVVVVV@    ^VVVVVVVVVT     VVVVVVVVVV@    &VVVVVVVV
MVT     VVVVVVVVVV@ $
M
M          $            '
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                              $
M  @              $               @              $
M                      @                         @
M   $               @              $               @
M                       $        'LL&;@#@ $*     M<0*3 X F3
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MP\H;M(L^MX       "HKV&(BH#8(     >'!8AQ[#><      X:+$./8 3@
M    '#18AQ[ (,@     X:0"?@X' <     '#2 3R")+%8     X:0">01ZC
MX                  ,#2 K#W >'     !@:0%8BH;S@     ,#2 K#W  0
M     "HKV&(BH#][     >'!8AQ[%(!P    #PX+$+8MW 1     '#18A;%L
MVG          'P5P% )UP     %D9 1 8X-4      9#("(# #X      #(9
M 1 8 :W      9"X'P? AW(     #(7 ^%SI L      9"X'PN8 ?
M             ]7"8#X2Z\      'JX3 %'!J@      ]7"8#X =
M'P5P% 83H     %D9 1 8'-8      LC("(@'H&X     #(9 1$  $X
M   /87"@ H$ _     &/!PY8#!? H     _ .'+ 8 =      'X!PY8##*%(
M     _ R C#X!0=     'X&0$83[^%      _ R C"? #X
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M@*RP 8406     +T!661<@(BP    !U@*RR+D $X       "\E2AX#(#Y9
M   3D@R, ? P<X    $\D&1@#X 0      GD@R, ? ?!P    $\D'!H!H"6@
M     GD@X-GDDO\      !/)!P;/)( "                   Y(XG@ 0++
MP     ')'$\ R!@YP     Y(XG@ 0$0      O)4H> R L[@    $Y(,C 'P
M$V0     G)!D8G(6(^     )Y(,C$Y"P!0          !
M!    (          (              !    !          (    H
M  !    (          (                           (    )
M !    !          (              !               !    (
M    (              !
M
M
M
M
M
M
M
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M(5V$ I"!T3. %XHSTPAK.8)PW8$4D4L=%++HD,U.R:@O1,R Z5F!4Y5&[S[
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M. 2.])Y4@&"B*\Q-C?6] ):1!0$9% UB18!0HHIV\56H; *LY@;R/5)!!\H
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M@[@Z."D6Q+56K03BX28^AB102I:YV56BN ;7H-"$&%&ON!?B$7@  8@@PT@
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M* @B:V)T200L(%C0@TKC07$ V2O)K%=,@FJ_M"<P=D-VI;*J("YN$022A_E
MN6RH @Z *KZ "N,>1!?O#O/+:G;1 "@((B(CL==DX_K'M8(!UH1YV0O$"JM?
M62FV>\U?@Q*L_EY-!V(4&[0,0LW*,DG=W,H0=RA(P  J$*N1 /FH#&7[ "2,
M[:)JKQ@    X (!\@)TAK7&SY,2GV4^B]&5(*CM$OI*7D'B8+XC*$'S%OI4]
M$$1*.D>$]'HQ:,M0I0Q3.KV18,!,)V=AA%WZ@BY-#)@!W$_9&B*(BF3I!T29
MW%)1WL,A<3>H&P4B0G;?Y/ V_>"D10M<W(PC3*?VH!=F6JZ,EI0T05MA%B)"
MI!!1-0!R0JJLYBBJI*6@\AO,*=(X@3U55 P8(  TM7H#A@ CMD4 B(Q+%' S
M!A*HH0CH0&!.5_\ 76$H)Y*JV$4A@$ UI"<)-S2'4I<>,%J(0;"U@#^BW1/"
M.4=L44.9).!4VE2=VXCG05-?$D=QXB9IR!(,=@0\. D\NX50B.8 OYR91>2A
M I@3K!YS)$ZHD!V=YBV=U'59H"5V+CD>SV<\"7B6B$Q;4 4PVZ$VTD".*T-C
M?!;@008-$= SZH>DV/;7Y0!9YQ?4<B\7F!7F@(YS*YL'N(FVZ'U.5[%I$4:*
MJ*)RR!4#E0/JXLP-JC$422A-ZI7!W H "&#0  &@T=(U31BFQ=-]&X7D68'^
M#-#CT4]E'*_W+&LH1QJ"UH=6P$J"8Z+!V<@24U+8$30OP(;-MC0-(&J;3K:T
MO*9Q>4#C>:.TL[:5Y71OC])'5%DRQ!@8"%4,3>Q1&$:IQH[@;Z(@P@ BB%>4
M"<(B:?T)L"Q2F5R4%&A)Y/[@/:P0#K0CSLA>(%5:^LE-L]YJ_!B59_+R:#L0
MH-V@8A9N49).[N90@[E"1@ !4(5<B ?-0&,OV $D9VT357C    !P 0#Y 3I
M#6N-GR8E/LI]%P:J.2@&H1NMD%07D!""ZN2OOTA5!V% JA51+Q< P4FF#].S
MI*00"9@4 19'>PVA-3NX.BQ77BU@6CK:V]R7B0/AP_5H)7B*?$4KH18N$ 1#
ME+S 5E^\J;"R&M<JP@8*J#D2+ 'YT"%TA"DB+!H3F*I6A%(*!.-D211P:8/)
MA8=(%L)"D<^YDT:3N)35:&]]X1S 2T"JJ@U5@> -8@,Y6DB>&#0Q;BSHEL0*
M"H#*:!+A/PJ24EZ!EW88\&B-Z\.FR !B@H_[=;[V XH>""EQ"B5G<@-*882+
M$,B?'FAU.[LS)8N<VRP1.)JX4B#HISD'S J^JH[\1XZ_LI?>W_E?;*^H_N+[
MH_C_ '*K:O5 R NJ("3 506Q T0@Q2RQA0"#4&L9C4";%@'6Z/NZ"(6DRRP+
MN>)JY>)S%YNRJ4Z'"J B*H%JA7!8:*@NJFPK?0HSQ#F):ECM+ [Y4S J8JVE
M-!HYJ)^4JW1Q+20 -A.L-3IQ0XVH =UPO5$;\F+INT8.OWQBV0QFQT@.TD72
M+3@(O@PR(YML OIS\ETL@X1*7^X I'<>(F:<@2#'8$/#@)/+N%4(CF +^<F4
M7DH0*8$ZP><R1.J) =G>8MG=1U6: E=BXY'L]G/ EXEHA,6U %,-NA-M) CB
MM#8WP6X$$&#1'0,^2R[B"]D$)\P >PIWP0")T *KH@&W:?N>I@W075;<R$L2
MZ;+,N+H9% 3"82'0%JEZ@@5/ BGZ(@L@/DUC-EUT[NR*$.@G%T%*%F(!?$4C
MJ644 248/J?O@7J;%CLI@"B(C'/Y>0,D.VL@]QO!",\,X,%A;+%9I9LA^AR0
MS**!!-B((FQRQ0+;5 7I )Q$XS^16$W\K^A=['+5"M?4>@)H,<B7DW%)/0 /
M23Y8:TH<?*4X17"!(8B5$APA1^XWHEK2S]0OV:[U/KFI-!NHT)]0?,?H?W)H
M[.@'#NGS(+N<YJ[]O] 0?4D\O0_1@DA0DX' 6H(B<6,"P+4T-@ N:M@$D#8E
M:!6$: !P%\=2(KNS)5'*ICBIL*1$T00HB"B(I@[TL< ZQBA%X1PJQ%L]$$?9
M9T1?W-1 4*)C2(4',AMK 07C&CEH!^D#VX[4D($.!#05C@'6&VBN2BE6;'-&
M& LR..[&CRG]P%T(L7" (AREY@*R_>5-A9#6N580,%5!R)%@#\Z!"Z0A21%@
MT)S%4K0BD% G&R)(HX-,'DPL.D"V$A2.?<R:-)W$IJM#>^\(Y@):!550:JP/
M &L0&<K21/#!H8MQ9T2V(%!4!E- EZI6%\"H2#-0119A*RKOF(9?+8:\2>8+
M'1[*/%P(99N>,; HE:>UCJ1#C1J%DR@3Q.1#<)/Q@%3Q>I@]]YJ+?X9"PZ3N
MCHN"A=-D-K'\O(G7QRAN1=U80M4^Y07%[4\5B1TQ(1UH5#,38AM)RQ>-IB-B
M=-1*9:V5[82AW34&):I$9>."O4D=50301N(H2485SI0@\1<(3?UJ]WE2#["^
MQ,-#\H2#J("(Q&F/>,+"O*H@PKBK!&K>E%1P;Q1-S$PUPAA &4*+0%U%><(A
MLL8%IJ+*NL=6'C.ZQL!%&H0I9P "@ 5#  VJZ VNC&UMD4P74YR#10+LT8P,
MBJ!BIL4@?W*()6B+;=O*B)+AZ:T#44@<M"YA53<A'\CZ)1N7CAV*M<E&"I$*
M(FD_2P:V^JZ@15S4 J<X\K4JAE[D" Z, "! T!P'IBQ77BU@6CK:V]R2!*$:
MP$&PT#@( & "   # #0!H#0?I]LR .I1A+2!7A1T0"X*P>8.T+DA_:/^$M!5
MMI[8FHG]8.I910!)1@^I^^!>IL6.RF *(B,<_EY R0[:R#W&\$(SPS@P6%LL
M5FEFR'Z')#,HH$$V(@B;'+% MM4!>D G$3C/Y%83?RO5_('EP 10"(B((W$.
M] <U@UW :(1@)@'&<I5H70:"179.#V4FE$270OXF>K@>!YV0G]A>^_?Y9.[C
MZZS/IB_ZSOAB.2D -* O$?(CL*VWB6@HA=B4Q!TT(6P!2VEBD0%!K-A%.T&)
M#LL<6<5E.0T<;4L>2F2S()!H;: TEQ0R(&B$:YC2%DW0L&!PJ&#E+6+P+OH
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M)9D$@T-M :2XH9$#1"-<QI"R;H6# X5#!REK%X%WT "-L(P E6P#&(9,=FA
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M064RS1EECWZU3W-1-" 0%^-]'1+$+DH @0#?.Y528DB\@PM2A]P/@ RV<B8
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MCC$Z!J1)@KW"%,&9,\-\33DC6U2/0<L))TW>AI#O&72:0 :/!$HQ:*%@+(2
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M;\!:#@AU-6Q9O(&X&'$6*1>\H" Z9@)Q$Z\ MT/H/1"4E:#(VJO"E2S@*!4
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MU6COZ?D(&.#ZCB-L1*WTBQA*DJ *E>57?1\PAD4(AF00EH)A.DM@N[LM_1'
M!K%H%Q)1O0+EYI! 4RS40"/SQ*5K<A5Z-K*/%W4)\Q,6Z)M!V&@(<H5;$5>Q
M2)4!U)X]FM]F;L^H 77DFE5<HJO]ZO>] ZRLKFH5(>&D224Q4U@F9!(T D8L
M MNS)T$"L$N*L#D"54 YC-VH^.BW4:-@:1&GT9("YIJ:5P1XV)%T[>:B&'7
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M5/7=B[KNO!W 9O$;OVRJVB@-+<;WABD3O##"*TG9"""HXJ,$)%MO#^^X<SC
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MCPGH_I_WSU3<-!*:*#%#0\F4=USL?K#< "  < 0/L?\ 17S1+$4#-A@H$=,
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MQPI0+!6;I>D WYT@LE!:$TN"*G"+RL4A ='#_D2_2Q[ZLF%L:*">2":I4"
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M"(T03$U.O0UNZ3<>C&2#E)(1#:&1N566N';'"^C!15O0=880JE*K"K%^A4J
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MMB1!:- JJJKJB653!;V:T!DAI9+@3),%T@:.BKSC6:[X7@.2 0*P,BNIMQA
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MD7&M;GZU<H);P7D J?P)+@ *@  JH&&F) ($/:$UNY8N0;S:4H4BL*" 0/\
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M 0A=#:&21X#S-U "MJM52NX XR(6)P]:T:;5?L!WF[0YK02V"4D]&L1.T8J
M#$K !Q XT&2UO(2LC4 B-(.Q.,&4SQ4#"Q*)><H)!IA?$@JAMS@&48UVQU)
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MV;7EU<#[ A5+$V5H"1I^CCG]6DTBF@15BP2'Z"<_IH<OQ0:X8"@6=N#09-+
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ML B"_P!0 WHJAR008%.(WP&0@LCLY@!,XV146;-$M]0MU@20Z!24?VD( &#
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M1$&S;"YJBGS5K;"4JE$B@ZZJJJU=J\KZO29F9D@<R-=0I&$4^!$9+OD"D*@
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MN@\6:(""ILT.3X52JTJ64MZNB[PK!39<JON"[\!U ND4HG  C#&$V*9H9M=
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M K$@V8(=8=%AJ)"HB)1.<M_>YP$+)X"1 ,@,0\ JNVJJJ"A155^Z*$EA72N
M3B 0QC6TGZ,"R#1 1AP0>. -]A'VRPJ(#9(;-&BFP(,W-KG:@LW8( V<)?\
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M6Z?)*!RH8N[Z?#46S!3A%0/!% JN"SH(T5 6)-@VO0FAN^$2RV^(1HB9KRM
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M'D(0U"Q%R5H&SRH0J  J()DCTFSZ;,V]<[]2POR_4]?V$/OZCY=GWSL?5?\
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M\? /?M JP+82<-%U+#,\",;/:%M920$%:_%C_2IN1(,=8.(FGOBZ=J(!(L:
ME@)*!$45,7K0)>F>H;FH[WT/E2\'W,I3)1KN0[O,34._058G<H"^ZA@ %*]
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M3%A*F0&A&-(L@DUV_7$$KH?\;ZX_5<%^ 8 BFM%"IQW+=$Z"S5$(K#J10SW
M;V !QU+/D-!>4371* $*4*@*KJ0)9=2JP1SG/&3.I#N8CM87*D9Q\PD^ADHW
MA8(-_4/?@5!G!.T8L1NS)]'])0*%49%+N-FT(1E7Z'!%H0Q_('EP %0@ *J
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MYA)]#)1O"P0;^L>_%'\C!S^X&&'TU109(+$G*W=S[E9H5%=&<OU^+?ZQM.K
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M4@IT!C80#0G+:4C4/(3_ $,/2%&K%:"#-%@ ,@#!\F"%6J4QJ0XE;)CD#"H
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M%U-!F9M2G6 RO-C5U%0H*(3+>$D#A@2P\'3PG*)):J@6 3 =5\-1'W$!('*
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M29$CP)FA1T0"0(,$ XB(<HP B#U>&>CA-@!(2!T" UWRN+XY[78B1KJPX@)
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M 8:#2H&(DHCL$UZB(GJ(CPDPD)=#Q="V@$$(=+BFGYL2:)!VCH'*EHZ(C@
M! ^R,Q!H"+VSJE0!(G.G240B%H4@&/ AZMD  1HEU"FJA8"*9*RC@H3^Y<)9
MOO2*_I<8H!D:<ET^!V$48F#/I% SL B.Q$Z&XL:+E-YU/LCOG%C0(Z541Q!'
M:$^Y;2NDV@F!<P>12";0#E5X\ *H!4C)I0:+]L+<OP@;OM*<0 VLP\(7I4L$
M(25&I4']TQL/SWER^#P=QA\$]-A[H9Y!.G=;!!E@.A83<DD@6F/@@+@,6V
M*4._;+"!U'"T@H4BI1-2B:.SZ.!J8;44/5AGT70KJP@PHLBSBGKC,7!P%0"
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M #PL$BY ;O)$?D1G@51 S^W8KXOV2K"43:AN-YX>1[\V3'AH\!@M:"EP]-N
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M1P%P<;^LBOTQTE]YWZA_C''7; P:! )/H=;K1_651*3O2_H(T!E<$[&CN_\
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M38K5&BH%6@#0<,U5^PW[R[ZAJF<O18R*Q@Y"["$AS2,C 6BV54%I Q,%7+V
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MJ1P")'27$DNB28L6V5:.!@Y5<[D*T7HEPU*?I04@H8+"Z"NC@</@1(;F5"B
M0#='>!2M6 VJK555Z7TR?30/%,<H)*2.DP.*$<%B88#TA""N\E;\'@Q)E(V2
M: 8^H ?YDS&,<YT)!"(V)FE (XFB2U$ & +]TM_G:K[ITZ" ^6*X<H<PH@-<
M6QU,UI2L!8,5L3Q,TQC@ZK8DN"(%\E'\$GR#! 1 1$2X :O!CJ!5H E,!?%G
M62(Z[>LQ2BT^SQI 4LH@!@I]""_#W7V7#:*$JT+'8P!B76N ;$P:8TNIJECV
M,:\2 X2$;QQ!I^B>2\@3I3ZJ#]1<T@<H(2B<HQPJ'.6:F(BS[";;'X& B H
M!53  VJP.<1"2(B6Y5 C0+@S#5\A_P 5/P,GJO>_WH)H#,&[N(L%+)0,3:>$
MZ'P'TUC",D<ZRBH 1.XE.I];)"/6;;6ZQ*X&+H*RB%Z* &2@-,:]_JBA/-9/
M#I#!U;'0#OB!.+1NCHP[OPVKJ6 I(L<YH@PV@^BVYR.0-N\ IOT&*/H =+@8
MH'CX  0 (\N<=ICQ@9%64*JJM<7R-DY*APP;^T+"@1,H*:66E% Y93BC8FV-
MA=B1X^Z?'1^] =D%0_\ FC52"$,9!3#'%8L!,"M\VUN(# 01@7VZ67\Q%FH
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M=>B2-A<QU0'8:"1!5*-,(L@9.%8%IQ<R9!K-*!2R3K4V@H#% 50 55@!M5=
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M(#HP5A,MP@"Z0@I-!R_3O(Z %3  $  '2WR?R_\ >%KJ@I+(C L;%04C89;
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MP6[P4*R$5JH""4:<+05"%:PE9F@Y!2RM6R+:;W809MZH%@;: +1H#J::M+>
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M"I34!R'$^I<=[*E83KA.:2Y[UJ@]L\K,)X[OBOH;GNUTRN9CFKT\>9Z%<O\
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MI0J4*E2I5 *8%)*P%5>&CG7.()=&<*1R& (@B=(GMXZ+!P F''LOE1)JGT\
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MCD4>+=D)D7"447GA5708'!:Y/2-$U@WR>$*QPI[FZI.C*AOC=KT4N\-85=9
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M*!0JJJUZ;.L0ZT^6:G]A((ME4@U<!VQ<\1!#[88A$5KMXZ5M0CL;C=-,5PU
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M; S=24EAJ!&HS6+DK[@["FO)TQNE!!(NIN+%P2ABH"R#Q&G!%V32@(Y= =T
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M<",0:T+F[>00!=#N:'4$^PP"T8DWE#1:AO77*?$)$5,-M! I3?$M.P"A"'J
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MRREEBC<::(#B@"/A X1^WS2O4X/#N(60&;L\[&FGO#$WH'2^)4C/3WN(;"\
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MFYRB!)K79CVI1>:4OBDD@#2LZ(^G-*HD6*2IH<!SX=2$B*$ @+(,@U  6 H
M @I;%YZ*XC^<B,>^IA(M""QZE5+8FTR%SZ U(]@4N]P']1J9A @Y2J9 &YT1
M%@"9\(0T&*VDG77H5/J2$)/MOD;S6E[N#44@C'&:%7:D(;LL Y F.^T3"8 D
MMH;8 PN=)!O8,O!!*0S2;J6X(!X%HTP*&D#N!X[%5 [(70E.9J8J%57"483<
MY1 DUKLQ[4HO-*7Q220!I68F1'2,8FPY'?"(FGJ7^ 6ND[TAN:+<JOZ!V
M QC>90<2<J55M&!<83DP4V9$(H (81VM/JM?JMPN9!J2E=G! 4W $32KD80
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MO^H(\W BGB@J9GPV'I>;FH8HB5101O==J*$/0/Z*-E$3-'N%>!YUL_/0*Y3
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MIZX2WZ,'!+\":4"H#[<C$@"((@E06@ 0#"V-O0"B[R( @!T[,E:T( 3:YH@
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M-8 $X!/QJ^G)^-=L'>I>^V][=L #T!PK8,Z!6DV&T?TO 4V+\V6N>"(^CY@
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MM?=M]6%'K *<QBU1L@:5=Z,%$W ^8M R O0 4 #1 <X;?^[_ )ROY_K^@O\
MK-_@ZK.[_92G7H$U@ 3@$_&KZ<GX7I/"H.=*%#I&8ZK$7=]J45<L;L8[%*G4
MXZ1. !&:1F$GV(MHBKJ1;4G>Y-UQ1V32"+0GF3\C/Y^Z6^K"CU@%.8Q:HV0-
M*N]&"B;@?,6@9 7H * !H@.<-O\ W?\ .5_/]?T%_P!9O\'59W?[*4Z] FL
M"< GXU= :F-W*@!58D4P$MPJLYR(S$$5;(0Y95A8,3F@Y'O^$W\C_A<T0Y(^
MP_C-Q^*</7B=EG\S_P"@_C.5W;_H)_TGW=Q+ G&AZI%04R2WL('Q^*S0S:9.
MY&(BMG2J42 Q-?\ N_YROY_K^@O^LW^#JL[O]E*=>@36 !. 3\:N@-3&[E0
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MK]X8/$ $%+$><T]RB3*Q#4@) M,941UJP"I ") #HPO0D,I]A'KZ*0=T3C(
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M82. W*OH6I&V/#*%(_0H_G>H]$KC2QVS($-"8?I/G  R@.E$,"]31@7@ H0
M5PJLN0I'+(0B!![2M:*N@J2B=W]M21V,GZ4HZ"-95%0F+<A(D0!:QAB<@2P[
M#"%) J ZD[&"7N_@+ =/2:4;QP.O"I"U? P$]@:7( $!$01(F:7"YV<0%(VP
MD<!N5?0M2-L>&4*1P@E0R/S H!@*0% H'<@;U:NTHBB!FW5H*(Z4@1'2._0T
ML*D>.SO)H2"KHQ)1-!?K #!Z #B ]@:'*@ !54 *N&GNA'V#&#B1 0I2R!>,
M=1<+M;7;]I21V,GZ4HZ"-95%0F+<A(D0!:QAB<@2P[#"%) J ZD[&"7N_@+
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MM#U%*DPLA7TF@E@P"@U03H=$),7L=W0*J\>E-H FW7U5QK7AU$PSH('A<H[
M N802H!*$#LU!6!$452#R,;HF&!QZ;22Q4,T-WT53HU27BA@OA113Z%O/HD1
MNTY6ZB:ZN+QO")@.7G88B:2X'.I6$J37/_#'4BD"D(=.K6I539<(N-49,@7-
MJ]1E#0@E1=BZ,<DY#^$(^CB@4"(HB.-5.E*8T*@"0Q8A;V1 NU(6.U&JZX55
MQ)Y2 Q0+TI!.-ZW=B060A=1,*G@#N)7( 5=!ABF7:!2A%=6,1)T6BPX:&LDH
M%CD.BN'3+&2:.(13AWM2=<!<R@E,&"1NJT5,%LIL^YTQU(I I"'3JUJ54V7"
M+C5&3(%S:O490T()478NC').0_A"/HXH% B*(CC53I2F-"H D,6(6]D0+M2%
MCM1JNN%5<2>4@,4"]*03C>MW8D%D(743&/3J0.(@Y0 5,0#7XCN'# KP%!U*
MJUV%!XU/J<001LI($ @-V0P&&"[$J)MTD&H=S;0 *+H8E"HZ44LAE5555:KM
M5Y5[K]LZD4@4A#IU:U*J;+A%QJC)D"YM7J,H:$$J+L71CDG(?PA'T<4"@1%$
M1QJITI3&A4 2&+$+>R(%VI"QVHU77"JN)/*0&*!>E()QO6[L2"R$+J)A4\ =
MQ*Y "KH,,4R[0*4(KJQB).@9<3U9$H8@VB N*&N2EH$,WMH$<^Z)H0 @B2D;
M,H+"0:4E%'B!R-=]0"FY!8R54';)[6((B"(B)1'2(Z1-(\X0GJ>]K-R'Q_\
MBPKBZ:J\]0J^58FXNLS*N0$I=1XH<WP%/!(-E'JS'IU('$0<H *F(!K\1W#A
M@5X"@ZKDB$Z !( 6@/.#)%HS%#+J&XA8;W,@;M1DPTO7%RG0>%[;0NI08#'
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M,ZLTJZ:EM0!JA..J./\ 8EDR^04.0IX'-$(A+L.,XO@,K.;%L^NQZ"IRR''
M>/H37"].AUC%\8^9Q(;G2>LP&?R,%@KGLU&[,H1^98I^X8EF>PR8%'F52;@.
MJWYV5( 90",>!Q^08F@).H"9>ICK>X"$D0"1]5*X- 3<):(&U/\ 1*A#PLU!
M&<\%(O3%2NFV \G'T!-,C%O>M(MO;H"_FGK$#06(;Y"A+H>.%SN)][% 6 I2
MM#9X:P6(I.K5$18'D5C)2*0=&< "RKSP2807DTK2$8U\X,K2N+!5CH:G07 !
M!"B"(](FD^9SN[VY1(6##<+T93DP5"BT&@TC[<BG#UCXP^*P ) 1Q[3UR]8\
M(O :8 @ J@ >ZL ^N0)H<:3;- 3276.2T-=UZL'1L99R\F!Q;$6ZQ*>^3Q=)
M%DDUY7\L;[@2.W6L%HWQP8<1-A 3&@$!4.TQ@-A%PR8251&R6.*B>Z."5<"5
M)!N!.2X2<5)X *(XH"J %5T =J^ Q+M127H:SX$W W&9V0(J0"@5#O\ +S,[
M"'-&0@/;0NV-_ ERJRO9$/YW$--+B5J-4@!J-NM5W 7IL66G:Z\)3PX;0:LQ
M1%8Y;]-+&ZFLZJH5,</RMNBKQG3@\$/N$1H>,0YJA 7;=#['><7R*C-GY()_
M Y(8)<>!::$E*JQ2JX=,"]'!^?T<:@ZV2*-*O>R0, ?&F-=?LU")W@;C1FBK
M#'B7P 4?X RDD)0WW(\638P3@!9@U59;[F2;\&+YH'P!^<85V+*!$1Q<&]E4
M?:YE3IWX&DY9@00AV$P<KR56QN0; VECB&R>,M0F$9G$0""@1$1$HB:1-B:3
M)@9LSW""V&&\VYICLBW^J)K'#)R7@Y(UINX*)$S"M$@!!_'D42 DP(%$@#5J
M.)Y>P.C 3/\ F@YQ! V6*P"/Q-BTTAL,:OYZ )0B(I*(+$2 " @41-(B(FDW
M@.Y3H!H7U I6&%>O&=Q4)(( 5X $   "   !H T!UQPC6?!6C&9UQ!BIVC3!
MC$J 83N)5HSNK)44"O@/@^6H0DO"E&P/M(M 7*KZB$3%O>\W(%.WF\N-I\N<
M34T0_08CQP$H"G(B@"IGZ\U/.M*W@'K@;J@H*3$1**.]C,Z$Q:6UE,L+.YF_
M&$$78'WML=HQP ^@"Y3NJW7I$ZIJ@Q$8KW#36S;MZ<E,"7/K&FS-+Y&F+B<3
M361""G8 1SCS;_)])R$>L%YN*D>\(\F)K\BH='0?D3Q(+3PLMD\:P[L<RD@*
M3$1**:>F8N\VRJ$*5NA"$J/_ !(21[&IA08_6B$ 0X1S3"[?A:C,LB=BND&)
MWL."(7!55S#)^FVZ ?4%S9S"Q73D5&!?EW9MI_C:H8>F<1#JD8OD!P3$;U(4
M28U_U#80B+\$!!)#54(7L"'J5R@X2DB$YV\8*=C!*9<*U%6!A_!K B%UT4HE
M2&^AA<K:?9&/-9D$\/W_ -;T^\-4<C3,*(-& C5I0><[/JK3)#0ATQ04/=A*
MXZN]#'4E>[)\CQ?),Y4"_FB/0A8XN9!\!H@(+!$R_L@UY9#".(C>+.+(GD'C
M82B]64T'=0*8,[M6.ZIJ(V%@.W2P,Q& DK2C'@WS@B-W,9"I=4-[FW#^1"<0
M8=\%U9\G+B?A+_ O4\F%9Z]8JS<03C5&WE8"M/<-UI344(@0YY%P%+X+16GV
M3I\E,]L :A)DEXF"_-$'>VN/X@;"0Z>8"" 5LHEU,-OU=X-U0//(0*[/;G2%
MB'L)](TTZDP:)JJ&XJ*@9N/IWJB%\G'R,N6;=8J(,N%@AB=4H4X(,S17(67P
MX(BSI@7.HV-R[NZ2:M19%A/$R/7@009H"RM,@^<YWJ)/%6@8. T<H$'(.4GD
MERX2'4%-E8(AICHZE*#!W:=F D(;0+!R<8+#):T ,!@<^0X!3EHJF@4+\T94
M816"M3/'C^(-C88=,S/<]KH*OY$/+AR_@:)" P](@P]OO]B2G59K*@=PF? B
M\2O/ 4%&1!.'/4L?5 TE&@-#"^[D",#,0-(\7Q51&;?%X:)1)C,7(G<2">A4
MJ*N*.-(&/D WS/RZS AP0R]: =[4Q.1M0?+" Q2+92UZDM93(',$BTQ$0YGY
MEC8>!"''M*%BGJ'%-@S6A VH.,^GP(%H(4L</WX+D)< GT-..N^NM  8T%[>
ME?."VG$6O[?0X[2(>#6WPT3@-OFJ15OP&B @N6N&'9=4 &MA4X)DB0OP *;3
MM2[>$%%!3I39]/;@(3:=F]_!PR482^IK3$FR*J#*UA!E'L/!L+9^6!:.(1"<
MO]BEP[;V/L)_KE8"0Q7S'0N@>IV=[,-MD '2^/8,D*KP(_J"OXC3Z1:44?S0
M$#879H[JA9!CLTKNJ=1(S\@:R7)7FUB$+;-RHJQZ"A8L$"RO$[3<1=AXW?+.
M]B-XVMP;(W'#!@"P>-^48*>2!"%W+R5+*RPL[A@SR,<O<5;BO" +($-'G!?D
M%I!)B$-Y"UYFEMC4G"@VMZ??&>'_ -/@<)#I%,NQ-LS71A[776(#(I-@_+S?
M5U\\]]9OL>,P')&[%2)Q&3.+O)H].; #@)=-W<\8/L;@LF(M3S1'X<8Y<?CF
MA'\@B'UA?H<&8V=T,$:VG87'3 ES@26";$V"V>2!!PSRO$ *A8 %= '1FHQO
M$\7%C-16'Y=9O:.).@S+ 6F2 MQ;P2J6DS96?=-;MSXL01A+[-0NKCVE7>"\
M% .^V!503!*P/8("ZC\B\(A65/W*  "I0 59B@UJ3D 2A!?,N"#N<<-G>%,C
M,.6R5T^@3[8DHY!'R.X*BE"7XH?@-$!"S-B"/33@?8B;JTF^1'TJ:<!M(G#9
M58*5M&#H]0B^]JU N0''#8!?:<*YZ,W 6K#F.R"34@,$0%C>+J'Z-(F"&I-8
M;0B= 40[%0 0%8IO'NY_M<K 37HUIA9BZ_0M"!H^L#+4-H1.APTG% H>]-6M
M0"_F@(&PBG1 <8$9*FE'LR9U0SJ$OONBL$B :#-#1@,@@CQN$LGP@X-%4$1'
M> Z%^$5#E;:::U;0AD]W?3UQ89\?,KY[M06D2'??X(#P/+298P1<8W3U()&N
M>WC51ZD[1Q\ZS.#<=J^)U^#YPD.S,<-&4FP8+4&5:L\_@0C)\L8Q'05; EV,
M+2F$Y9=P,0,H)+L.%AN*R&>MA@*GPZP>^N"EXTZTZ9#N;./0.H["#/*S3V!?
MO\'Q+IE2I?V.B/C40KRY$;CLQ($V@.LQ.,*Z%E BC<-I@V@4?6A#WK#!$)*0
MHO1"0"2?6<9R!B!9+^7>;WNU_A$3F7U=@*@;1YYC =-EI *X Q::%."KL5![
MY]I0[=?BQ(M>0&L)Y"^ 34H0I;'F'DRJ&@9P3;$P!N0G$Y7C)N9IY,I[@;12
M@0#!T'. R@H!1$1%'6$O,#(CZY29T0WE>8L9(04##!+76^V+"+-*;*J@\!WG
M6H,L?!,:("+"5C!+J=Y :$@)@&; /D,(N*1W/0.M*M0HF987(W*U*S-QZ_)/
M#K=G/U1Y*U&((:6()2(58*7#D,]*.DS*A-<K*HX48OVX!Z"[PV!.(+.5&&(E
M5[1QAO5D)4'*P$8D=L)G#W2*F:ON_A&S14DO%:)6)$A^67R (FANWJ&Z#B-Y
M^9P@FE734MJ -$+@9@ EP%,.H;O"DRL+3N ZM^3)L+[:9<)$;-X/%$IYCQ':
MS@#P&5G-BV?78+ZC98:DDHSN*",A%8#6!'CORL+,3>O%J#X-K96.)\^1(VXC
M C%,C6TV0CL2E2*-OP_F/\\<;&8VZJ2K\ Y8)B#33C:I>L%88]^@LPYOWF9)
MMZ=#K&+XQ\SCO9)(M)B,]D%(*I&(!<S*$FQ/I2?!,)P13"R4,7SOEB<]YN=D
MGUMA6 J!"94JTTY&+8#U3)H'-2^4R_"IE+L0?9:&I(7PR2?;+BL&=8P<E58_
MS!2-'/?"8UONL,8I(R,+?3L>WDG3"* 2'2*N\=6$&/J-N&;=LN;%8@B((B(E
M$=(CI$[,''(>9>4,?<9M[OEU)R_0]$Q&TE'PU&2):!(/Q4O(('DE5#\NO\P)
MJW[A*?:LI^XKGE[GW&\")BV <2(:B*81WA.IG/SAZ%W5/". C3^</E7L^1>&
M9H3$%H/&MC@J%&@4QPE05YR;<J.0-*%VMY(8(LL+DT8MM@@__P#KY<W#2$ <
M&ERF/-%9M," @X^&*QU#>%(;B0235;4'N!H"NW-+\>6636#?LRVT:*25$J*N
M>5,^<9WNSIP'CY>-V8#8]V:=\06L*+(FQ%*!F'=J&M2'T;,GHTEVSN0'8>T.
M-. NH)6(O#D) !CE\'=4H,';Z"A)Q"9;K+2K+LRJ=8P"Y);>3Y9M]3L+F<62
M,7$,5UH57ST,=#+-1XO.1C0+7"2*&4:K ]0'._6+H-(# .#=,5#(/[[G>?)R
MQIE2F(Z"UJ7Y]?FOK(@7L9]@XA5#I _<#\#Q:[$GU$3'(TT77WH&_&G6WM4^
MZG"(-[$?8!R_6O=O76TS^S5^PXA['V^)BJ>[WW1QVI>[?MX'C_P*!OUG=$GR
M@ ;7 @<]!FD=K,KW(0'A@@A@"(BB(FOUG*+?D%Q;566<:HYG#V #KPT_" /0
MU9$T( CW..;D<5NT#XEQ.Q'(9D-H#@,E;A>7U!NHDL*):<SYXQ@ L_6W?H90
MC(?:AG /:EU) 4Z_+$8P,=B:>SB>QJ J YM+C3@8^=4F7Q'BHRC,445+6NP"
M*30+J,! 5?G84QC!=>'61]D4[^J $H;]9W1)\H &UP('/09I':S*]R$!X8((
M8 B(HB)K\8")/G+FKE&&U%,C[2.8LH/Q,@<-XUON64C5GH;P C8-C&\<>?*K
M? @%XG0DET N*S!)+#D"^$8$B8" 8  3 (!\IQ?T)A-',I08PI9HX6=(R/ #
M1\P0: & T4#&-HF][5>^+XX "(@(C1$H1V)L>$6!-O!"2L</,D,JHL$(LB19
MYG"2 U)>R<A'*(%'&[,EA)$_ O//)* D0\T2]_J>46_(+BVJLLXU1S.'L '7
MAI^$ >AJR)H0!'N<<W(XK=H'Q+B=B.0S(;0' 9*W"\OJ#=1)842TYGSQC !9
M^MN_0RA'&7AM.)RVO\JEQ:AXW$P* VXM>(D,#V/XJ"*:LA?MJ27V;3?!:O!:
M9,QPTEC BQ<3<X"A*4OU,YR6U%R9'H&2'$;A6$ "[^X$D *B%NLOT:1<$.[R
M#3T,J&TA5#-E?Z4<Y(!9;A@%\8E+CZ6(91SGO8F^[V\W+WH=$<!ZL2/E9PX=
MX8"AIR05(BBH>J-#.1A3BB&8 X&J5)8(L0/D@/8P)QC3C-0*Z!7Z!7+05:U+
M>H]30@  +XS0"##0  &@)P70>@@>J)C&QMY)#ATKIV!_0W.W\R[ ,K\@7:T7
MTNF&(D,OR!"-FR.*3=#:B8<[$RPN$0@50 ]U8!]<7MPQI1NA$01$N&@HJ:C!
MQ50J'S^%HE6L@6NI2M0*_P"Z> UXY3I<.1EVP*-=P02(_!DR9#EU,5 L@@ E
M'\P 1)\Y<U<HPVHID?:1S%E!^)D#AO&M]RRD:L]#> $;!L8WCCSY5;X$ O$Z
M$DN@%Q68))8<@7PC D3 0#  "8! /E.+^A,)HYE*#&%+-&,U4UXLQ0K$08L.
MUG9BD1Q0$"*()&2>\K*2R%(5PV$A,9FF.&<G)=](@PHT"G#BN9%8\,(@0ZN)
MF,INMI&!+7JH]4W@W<]RPJ@H0;\HDC'("=JBEF%Y^K)+UM0V#WC0YWG/'\88
MBBS2K1\F-XURSUYWT,*72D!NED+SRXR+E=8)\!Z!0JNPB@ZS57->O&T8ZA&B
M8_U/)#2SQV.W^3!IA9["$D1@L-QZM(Y@K."'6%G F<.EP<G5[ ;"*"=FU0Q&
M,&+B!W@I,P;T\Z0HH4 R/H[!!## VU1@LG<W[<T\(8\V#>YL^[/8Q0S;6XZ)
MXT4GN7\RD5AMT\$+:9ZX4]K20:*^$<XT+6.K'BD-3R,YYK<"Q0I&&Z_%("HZ
M#*)F46%2$FI%+ --&(;84E9 (;DW&$G'>"A?0J =CT^["]NKE:C-PB;XF!C3
M@!OMR#R?J0638!+!</G"T&W@0)CH$Y_1TYY ]C5"^OE"O7 :"<V+V,( 5M+X
MI$JX)8?F 27.2VHN3(] R0XC<*P@ 7?W D@!40MUE^C2+@AW>0:>AE0VD*H9
MLK_2CG) ++<, OC$I<?2Q#*.<][$WW>WFY>]#HC@/5B1\K,[[RGUOXCRRFHC
M33#OQF%$SS11E%2XQ(+S2APYC[:%E@M)<0F!5 ."*\U+T19E"6K/G4?,\-L2
M+(.*RK1-'P#'>8 >H]1&(NE4*!M63SAAA#UHZ<;N$H$DHDCTG0YHO<WX36JP
M]ZSDF0NU0RPA-@(* ]U ^[@ZFC% #[*+'Y<!L6(3E%%"(B(HY0464/R1M(R=
M"8CJ%6GI0N_KD (52![P;/G.3NMA2!04>NQW2.*F2J5I4OD.3-)C$5Z!*<T(
M]DE^S@@$V((_)*<4Y*[TU-:0I-I"QBE%0$C9\"IJ+L?S*"1 R:<3V )T/!0X
M.^.H)GKMX#P75J5-\M*.%'8K,+$:X5N"^S;>#>N6T/V'2E8B*_;>CR$[]02X
M2>\O_K4.4F)CO54EZTALQC",66(H'LH,_;@L!>S<&'$QKFL-T.-V 0/LR0?#
M[ZELCN 6H14*^@LW%H&HP<VELAERTV"BG64_F Z=E-X-W/<L*H*$&_*)(QR
MG:HI9A>?JR2];4-@]XT.=YSQ_&&(HLTJT?)C>-<L]>=]#"ETI ;I9"\\N,BY
M76"? >@4*KL(H.LU5S7KQM&.H1HF/]3R0TL\=R.R-_:R** @AP=+R48E!"^K
M9A5GP8-,$HNG@.Z#M'CIWW8W)L-N@/!J1*34K^M,/:3JNU=:T BO C<4)Z":
MSB'X9N\1XF2YRM;4L&"#@L(@XH>5<@N&=@\MG6D91B0W+^@2>*<1\UP8UU)V
M^$NPTIL(67L_XOZ,B$L!8JL/4,;-6TS2<P.I5B8$  NIK879L!B@0Y6N0FSI
M9$& *!1+.':X@R84$!'(),$N'@-FWOO(4B%*7 F$;<1DR2[S]:,R-N 8#_4
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MF")Y!0-%JHU]3QU%Y0N,=E!A=]33%_B+FNX:4( 4+_+F*D& R U<S?J7[1;
MKD=2630YJRBE1C(+PA?L<%A8114 M%BR+>/I/:=%0PN3YF)&T':!ZE!/@D4Z
MEU!FW4%Z%&.<I$7&!LT($,>)<= )=5))9*6"Y:] 3;)MKP8E]RWFA?ZR7QDM
ML^UD.D-4$!$42.)POMA+;6259OI%C$G6*G:FX&F#"_HK5%1X[?P7M+$$@G5S
MX$2.>V>6R$A./XK,X([GA!T$H+CMYMAA%&(+ 3[4.CU$1U>;H;F6'$;%2E:U
MD%AK6BI[CV07*M WEG:+4]($6)IHG\I0B"@EH[A#K8:*,@75@U4.L SIZR:Y
MPRP;.N)O'9(RHUP) "0GV;P'WDK $B.M;NIIC^MRQQ=X*8O($F@#L?SI2M6!
M,L@-9X,\#]@1R$44,6H;2<#A\US 08'$1-$#0@WP5I6<#K=TYR2E&9Z-7*2(
MV+@Y7'R8YIR5"(G19M-?"/Z!=^*>"J JP-J]![N(P$ID&O9Z+YQT%%5&XJ!,
MJ'4F?!KY/I?;9@IT2V)<73L% </"8@@YCWTJ5*&U#DS9]PTMQ!B0#$_R.5D
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M294"'\EGGEWLZ,AZS;M73"XVNS"#W1HT #2V^HP$JBW8)X,T!,5ENFJ,*!-
M7S=D^J/=WAES-NCSVHR1I$\23:TI >#2$JV5PC(Z3MY5OA""FDE^&9(:CL:]
ME >F]4<)\8*>@$%BG!5/P*"VA<!*6P2F@8M%20]$DE']N8AC <97L>CFDA,Z
MAGF4NU*ME 0'7(F*OROBMM,D%(R,PZ=_)"TWC@-NM1#/N9PBD.:&EJ[JW<61
M6HI>37%GL"F;CZ0L;K:Q-<!<JTA9 "X'"&,PNHILRZ(\)P&*ZFO^<%$9*H3)
M$@'D"!1('"Y+C+LO\DV)/(:G!!/R'104 'YTYF9F9F9F9F9F9B8[<PFM0'I6
M+/R/!DA)C#]TN=5M28!D!62+H:+?2!/:0C($":&@9-&$!8%&9U-I0ZQ=$:DU
M[;M;#AVZW1ER#'2MU^98= !#02@J\)E?"Y<4QK50=0(U&;( +&V7<BBIB"->
M/S/*4QJ <>$SV2*:D5M=*9F%*%/%*._52*<,[2$&4B)H"9UT9%4S &]WMR@?
MX&MA;J@SP>59J7KPG%7F,K+:+]M =C#;-NB<'O83Q @9OYNXFI,@0![%X8;V
MXV)($'4#8D+(L#H7F)HFP8)<YC*#*#Y@X@;,=-6RGM1Z*!@AHHV=; ]7&[5
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M?2&,7B4;(&A0'%MJP9B\UH4#H!<VW$2%(WLN10@+A%$G&U@"8PVU=OX)!;
M! %!$&B(HB1-.+L5@PSQ0PK]0M,UB"S;6=T:L >%]4&J*-7/A_3(I--&J*0-
M6]DF,!<*@"I655WQ A5<&X(0.6<+WSBMQ0A*+V0%T=<6(A4B2YC@0NLQ)9P(
MLD HQ;SC"QES'TH4Q89VT59"PL@"X@/%C$Q"HR<HS9,3&+; J%62B_G4:(%H
MR5<;_&+NLMO<(EIRF!$51*DE$3K02,8)30\RB2PZ)A30?F @I%-N(Z50!.T
M>ILB!<3/P/RO,G"[=B3)<!(P$UX<<JB(='T.?G'["EH98R]QG3E&,]),F 8^
M&<,:A0_'E:EDWZJ+0IB'W*RN2PE=O78.MY! B8&;M/!<6[$57;8#[D3'@E32
MF!_@:,2_>_6Q"+8D<7B<?O\ P%+C'E8ZC+#"87(RJQ4[+ ID @0$<(Q0* !5
M4  JJZ -JZ#%X<Z#D%0<HOG UKPA1%):&PS# )\PI[IM.YNDR6=O,FO!M@E&
M$,W3[ 2C<.Z3BF7 ,M$ZI0UA=VBX3=HB((2<H9F+(.MM,X02>'/0%UPV6_;S
MU<D2PN*E1I O:; ,:$>E;8NJ7QPOP2@95FS*QP(Z!7T! KDHJ4>$" %  %57
M0!M70;<8 = XE*? S@SBJ&L$;#4+ =7X#O[CV.->!1[YI%PK<):K,M@H@6Y'
MESW<%%Q @F!O%\!Y84"QKX?0]AYC2;>(2DMD)<A+VNG0-MI(1H"L<-L>7E[S
M064$   @*"B%$1$1B;/3,H7N9]T<)%2R8.2R+((IA/M*=MZS^PYDJ)!*QC2>
M W"B[!$R7T8G0IP%K5%6W"T< +C=Z!I=3]*B BU+,?8$1P[8%182R'<V=/M>
M^0RS8DW("35755:&% YD:*&U?.-UY#\:5P1*Y\TPRP*"3PK41-"]O(*;*@@F
MW1*7'T6F8+B..74E"$@;>X!ZV!9Z;1\EN\#8;!,\!H9$D(=<)2'"NJ+IC(,.
MQ!"C-!PZ9Q!N=,%!*8<<D<,K RUR0]C[9#V/L9#V/L<7"=1](X%G^TZ$3#5(
MZA&.#I)FZ_P@C&P[9^%06_G)U4^W<W;K\_)LS,S,S,S,S,S,Q,=N836FD&/7
MDC7F4'I3I<83%I/@;^VK1 M7BG5"."!:5WOB!W[R%+(986=PO1\%^_?!1 1$
M0T38B4(]/P0._>0I9#+"SN%Z,V)1=A/; %?+.0;< 9 %P"*0!T8Z[@*W1(@0
M.QN SD$,Z  '@ #_  5,!^X70O28* S-MRQ5>!V,<: -D8"!$*(B(BB-/@);
M \J?,0I3*6RJ=#293))XN].?[/V<?7,T):<XX\F2,/5,ZW+.2!Q050#M4#[O
M \/^SBF4+1.-UQA@.'.P".'>%>MN\ZV6)ZR.B73_ !+((+'K7YO#9"Q.V00>
MK(TEIQX:+W0/I%$7-Y!$X4GM8L9'=A5@@:7)5:]>-U;1LMW_ ,R!4R0BMQ H
M2L4RI)3M<.?4PH#R@=_<>Q@/\BJE-"R08&2#NQ3,L*V;WHW("76DBT1/!  !
MSN"VQ=_-.'F*'EQO:[.E^JL1NZM'(@CX5Q:^S&&Q8EJ=IA9P@R3(J5?4G-T,
MA\ITS@"9)R]-7,JOI2%/^(56T8(:6 \QWOL=7.Q>Y"-@W%*<:=[ P"FA="83
MC5N@!1=?U=0%127 7*7+B;RW$DNI3T<)/I\8Q/T!Q( O1TFM.19?,U+&T.,2
M$>%%*&#@WR>K/P"4"X,,7,$LRPP2!4 $_9B)H4,,KL[Q4-'(,#J&L&%Q10R(
M9S66R#1W@)@*  JC  %50 KDHX#,L(F%=BXP%@@1JG1SU=N>F+_?CI7)F&L\
MXN6T>(*58+M/)WO=@.F8D@ TA2%E-AER! N1CYX'T_[#-P'P?WF8HV>::Y7\
MMHS!Y#H65EX6T O?STJW78#">U(D\;)XZ23XA_>PAC-Y9^@R9$/R() :-*!L
M>F@U-3&M=]:Z_&K^2,A_!"9-O_,CSY\^?/GSY\^?/GSY\^?/GR847OC>F.&(
MHI>&$G)PGJF!9W9=+BN%G#5-IU"=RI4*4M2HB,!$@:3C/YR2OW+#8+'@;PE9
MXNP)HJ!9A+URC37W;1=K%!E8Z#<3PA; 9_9^SX'5L3A:R:%T@(*V<R6_'"#+
M3B2Q"(#(]\@N%<O^!;]\W!-RLQ7BG_-/JQB/4OZTK(CGL@+)MEML(3V-DD
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MV*K<G)*<///*GJ)N[B4ZUDQ +9,3,7,1=F"#.@7,E>MK:L ^#^FY%Y_Q[-"
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MC1HT:-&C1HT:-&C1HT:-&BB^%^M7<P>.*-"C0HT:-&E%OR"XMJK+.-4<SA[
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MU=LZ'\&3)DR9,F3)DR9,F3)DR9,F3WS!IOA6,37I....\+I< <14E0EHCO\
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M<? BDV*L>=\NE;?GA'*15'7K38352"6L7BMW9UQQUVNN<LQR@6L9%"6( JP
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MA%0YDS>&)L(4(8]&!445U.E I8S6N?WD$ 4?(.>&A:;+46=<I&-5)VYOWP
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MJIT; $1MXX%-L>:&(06L%Y #EDB#8I&.MT"4PGY).F!P,0,X0#%L%HJ @X
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MT#V\OQS")L7PP8<_8\^IYL(0R%6WP%8/29^W(:;K\!5U8C2);!SYTV+M]!%
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M!P2,96SN(P49]6CL37O;=OO'IH%5N"N3'<S,E)5PP%'06*L_A:982U3S**H
M'%<P83OQ:S(*RX((S%2XS"02B3&!0;1NDI)Y2'ZN&A>(+?KS+*_.?/AJCMYT
MW,'38"?MG0OL?]?%V^@\A=GCX4 :^8HZCV8"( (V,WJ&ZTI7#3^F1%T1>B=+
M6',X,]E0 $ 8C=4YO;Z@81]*M!#LVF+G:Z=TR)EM9/BHYJ2U4Q%1W O$-"UW
MEVW[L7_X<D\!WZL)IW0V=O,2^\?8<1^PF)-V)6VG:_7X2G)S@QJ!1(V([/\
ML[RGNO5P0->@8"OVQ 2&U;Q0<#OF*[ M<)E8#$3B:IP[YA<1<%-L$CY%1)47
M2 ]5Y1"DYR02, 3A'NYF!8-@\Z56:<8$)4->WX-YP-"UWEVW[L7_ .')/ =^
MK":=T-G;S$OO'V'$?L)B3=B5MIVOU^,IR.8,DD73H0GR-&INA'_K:N8R=GK/
M*(4G.2"1@"<(]W,P+!L'G2JS3C A*AKV_!O.!H6N\NV_=B__  Y)X#OU833N
MAL[>8E]X^PXC]A,2;L2MM.U^OQ%.73\"%"NFRSI*-N7Z3D&[(#?84$UB4K<R
ML99 48T27M35 )EVQZT-;4;/0( 0]1Y1"DYR02, 3A'NYF!8-@\Z56:<8$)4
M->WX-YQD+@;=E0GG5_MF@S?,+"!>Y6G5]O/ $) 0'TI[55Y7?;@=H&/8P6[M
M-O']Q[/P/Q4#W-#HK@$58I0?.+2L.FO\M47J9HHC'+8,D.<(U!Z;C5RX- US
MY!?GL^Q/?U7E$*3G)!(P!.$>[F8%@V#SI59IQ@0E0U[?@WG&0N!MV5">=7^V
M:#-\PL(%[E:=7V\\ 0D! ?2GM57E=]N!V@8]C!;NTV\!>351\P_E&!<!UI\L
M)F*$ <NJAX!2]9UNL$KT]Z_KK_W@@AA@;:HP63N;]N:>$,>;!O<V?=GL8H9M
MK<=$\:*3W+ZKRB%)SD@D8 G"/=S,"P;!YTJLTXP(2H:]OP;SC(7 V[*A/.K_
M &S09OF%A O<K3J^WG@"$@(#Z4]JJ\KOMP.T#'L8+=VFW@+R:J/F'\HP+@.M
M/EA,Q0@#EU4/ *7K_C>MU@D@MBGG*@E*9*H5<!*#2GI$/'8$#D$$8H&@4#H"
MR%2K:;:D]>J/;YX0 NL"J.GMDR]'7RR-_6[Z1N-([ACV) ZT$G7P$/\ ?Y[=
MJERZ_).E5/>,Y:R/%T&+ !>[S?#*%<V2DYKM'-9L+(OF, J^"_XJHJ'YN]4*
M><J"4IDJA5P$H-*>D0\=@0.001B@:!0.@+(5*MIMJ3UZH]OGA "ZP*HZ>V3+
MT=?+(W];OI&XTCN&/8D#K02=?%V^N<&-0*)&Q'9_V=Y3W7JX(&O0,!7[8@)#
M:MXH.!WS%=@6N$RL!B)Q-4X=\PN(N"FV"1\BHDJ+I >J*><J"4IDJA5P$H-*
M>D0\=@0.001B@:!0.@+(5*MIMJ3UZH]OGA "ZP*HZ>V3+T=?+(W];OI&XTCN
M&/8D#K02=? 0_P!_X.DL8+JJP5(%P!R#0]NZM4* 'H^NEJGF450 .*Y@PG?B
MUF05EP01F*EQF$@E$F,"@VC=)23RD/U<-"\06_7F65^<^?#5';SIN8.FP$_;
M.A?8_P"OB[?8W/\ ]F+EHR+:[33F-%R0,&+#":JP4T(2%M+^"3(E7\4U'F>E
ME5_3H4Y\R$3U0PCZ5:"'9M,7.UT[ID3+:R?%1S4EJIB*CN!>(:%KO+MOW8O_
M ,.2> []6$T[H;.WF)?>/L.(_83$F[$K;3M?K\)3D=@YPA(#I HCI&84-/6&
M84M660*_PC ]ZF!3!!F@++%LUKVTC+@^GB*QP(]+( ":7GI2#W)+[B=CZH81
M]*M!#LVF+G:Z=TR)EM9/BHYJ2U4Q%1W O$-"UWEVW[L7_P"')/ =^K":=T-G
M;S$OO'V'$?L)B3=B5MIVOUX%EP?HVF3P=V&"$RZ<# _,X!0PWN 3#.#^$)$E
M1L.PLCYR3":87M^Z'F(>[\^N"'EN0JC3W"(ZJ_/*V;NNT]+J3ZU1\WU7E$*3
MG)!(P!.$>[F8%@V#SI59IQ@0E0U[?@WG T+7>7;?NQ?_ (<D\!WZL)IW0V=O
M,2^\?8<1^PF)-V)6VG:_7@67!^C:9/!W88(3+IP,#\S@%##>X!,,_AQ_"$DR
MPHBU70$&R329!%D,M9'-06T\E'MB+<9JL:ZXHA$CT8^$2RT !N8L8=HW-'<!
M75>#*.^@,$N@0JZ N)\R95(3:[/T.4K\?;[N-DPVE]@M7Z<@A-@- &C#IA$%
MT^XX!T*N2I!J^F.X-H,8 .XT G2 UMEF ZT'%A,&BD%O7M*'$5=RBZD$!O=.
MD?:88"2C[JT5;X3\\*!5@"JZ "JKKK&.JDIR35"#Y7<WA&] ?0 ?]?"4Y: I
M"NJXVJ #=ZP&""DAZU2?]08        0 - &@-!P#4(P7@ LC84 F*G^$HO*
M^W" @;'U"F_7=[["!3&%UH68G7,6$G+>#SRK(',+*DC.)P[E%U((#>Z=(^TP
MP$E'W5HJWPGYX4"K %5T %5776,=5)3DFJ$'RNYO"-Z ^@ _Z^,IRW/CZB&L
M8%]!#P</?@-8&]Q:\M?5*;]=WOL(%,876A9B=<Q82<MX//*L@<PLJ2,XG#N4
M74@@-[ITC[3# 24?=6BK?"?GA0*L 570 55==8QU4E.2:H0?*[F\(WH#Z #_
M *^$IR^\RTQ Z,[.^\9N*"&:.[9UP $\VV=0@90,X/6<N*L@X2T'"$#J("U5
MVYQ*)ZA3?KN]]A IC"ZT+,3KF+"3EO!YY5D#F%E21G$XNI55*7(,*J $>\ T
M4+]&P.ON?.O I< \5B3:W6IG^H(0W^CQ_<>S\#\ %P#]OPUQ/GU6H"A%>:0D
M  CDEI228+@"-X9M<U5H1W ("7!'B7PI=(!J"AJE>H4WZ[O?80*8PNM"S$ZY
MBPDY;P>>59 YA94D9Q.+J552ER#"J@!'O -%"_1L#K[GSKP*7 /%8DVMUJ9_
MJ"$-_HX5TO24V2-R??V=25(G+\]PZ<\B2+*UBSS3CC       " !H T!H,!#
M8B'I$1OWQB*] E.:$>R2_9P0";$$?DE.*<E=Z:FM(4FTA8Q2BH"1L^!4U%V/
MJ%-^N[WV$"F,+K0LQ.N8L).6\'GE60.865)&<3BZE54I<@PJH 1[P#10OT;
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M!#JUHQ#)!!=A-F,86E5B'CP,>&BHX 5X4!45 "W"TNZ0V#;;CH5=7X"'^_\
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MW&@$Z0&MLLP'6@XL)@T4@MZ]I0XBKN474@@-[ITC[3# 24?=6BK?"?GA0*L
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M;2& K"R*Q&$/-EOD?G*@8:#^W$;&T)*K )6;B,'@@Z20_AN">6:,<'C:N*
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+PB#>Q'V ?^;?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>companylogo1a.jpg
<TEXT>
begin 644 companylogo1a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !K =D# 2(  A$! Q$!_\0
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M+?1HA_Z$6KY4HKZ".6X."LJ2_/\ ,B[/J2S_ ."F/[05FR$^*M/N0IY6XT>
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M7/CSX'_\$]/C#\;+6VU,:/'X.\/SC<FH^(@T+R+V:.WQYC ]06"@CD$U]/\
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M/X:V*L/JKW$BMO/^ZB@<\GK7T=H?_!-G]G[0[=8CX*DU)L8:;4-3N978^O\
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MO/\ T0M?HI7YU_\ !9#_ )$OX7_]A6\_]$+7L91_OU/Y_DR9;'Y>UZE^RO\
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M<:5*H.2K0SN!GT)0HWT85],U^1XR+CB:B?\ ,_S-X[(****XQA1110 4444
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M\)VS_P#C=>D45^2^WJ_SO[V;GF__  S7\(O^B5^"?_"=L_\ XW1_PS7\(O\
MHE?@G_PG;/\ ^-UZ111[>K_._O8'G"_LV_"-&#+\+/!2L#D$>'K0$?\ D.NW
MT?P_I?A^'R=+TRSTV'&/+LX$B7'IA0*T**B52<_BDV 4445F!Y/^U-\;(/V?
M?@7XG\9,5:_MX/L^FPM_RUO)3LA7Z!CN/^RK5^ DLTUS-)-<327-Q*[22SS,
M6>1V.6=B>22223W)K[R_X*R_'(>+/B5HWPRTZX\S3O#*"_U%5/!OY4_=J?>.
M%\_]MR.U?!5?H^287ZOAO:2WGK\NG^?S,9.["O</@_\ MG?%7X#^#U\+^"M7
MT_3-'%Q)=-')I<,TCRN<LS.PR3@ #/0*!VKP^BO<J4J=:/+4BFO,D^I_^'FW
M[0G_ $-.F?\ @EM__B:/^'FW[0G_ $-.F?\ @EM__B:^6**Y?J&$_P"?4?N0
M[L^I_P#AYM^T)_T-.F?^"6W_ /B:X+XS?MA_%#]H#PK#X=\<:KIVJ:9!=)>0
MK%I<,,D<JAE#*ZC(X9@?4$BO%:*N&#PU.2E"FDUY!=A2,HD4JPRK#!%+178(
M_;__ ()\?'9OCE^SGH[7]P9O$?APC1-3:1LO(T:*8ICZ[XBA)_O!QVKZ*UK2
M;?Q!HU_I=XN^TOK>2VF7U1U*L/R)K\:?^":?QT_X5'^T-::%?3K%H'C-4TJ<
MNV%CN@6-J_7'+LT7_;8>E?M'7YCFV%^J8I\NSU7]>3-HNZ/YOO%?A&_^'_BC
M6/#&J(4U'1;R73[@$$9>)RA(![';D>Q%95?;W_!57X%R^!/C/:?$*PM=FA>+
MHE2YD3[L>HQ+M8'TWQ+&P]2DE?$-?HF%Q"Q5"-9=5^/7\3*UM#]%_P#@D/\
M&B+3=;\6_"W4+A8QJ&-<TE7)!>55$=S&.Q.Q87 ZX1SSV_3^OYQ? _C76?AO
MXQT;Q3X>NOL6MZ/=)=VD^,@.I^ZP_B5AE67NK$=Z_=S]F/\ :4\-_M-_#BV\
M1:+(MMJ<(6'5=(=LRV-QCE3ZH>JMT8'U! ^,SW!2IU?K,%[LM_)_\'\RXOH>
MO4445\H:!1110 45QGQ>^+GAGX'^ M3\7>++];#2K%,XZRW$A'R0Q+_%(QX
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MN21G,A&< 5[)_P .O?V?/^A9U3_P?7G_ ,<KZL@ACM88X846**-0B(@P%4#
M 'IBI*_,*F9XNI.4U4:N]DWH;<J/D_\ X=>_L^?]"SJG_@^O/_CE'_#KW]GS
M_H6=4_\ !]>?_'*^L**S_M#%_P#/V7WL.5=CY/\ ^'7O[/G_ $+.J?\ @^O/
M_CE'_#KW]GS_ *%G5/\ P?7G_P <KZPHH_M#%_\ /V7WL.5=C\X?VQ_^"<_P
M^\ ? 77?%GPTTC4+/7M"*7\\<NHSW0GLU.)UVR,P!5"9,C!_=X[X/YCU_2A>
M6<&H6<]K<Q+/;3QM%+%(,JZL,%2.X()K^?W]I?X,S_ 'XX>*O!3(XL;.Y,VF
MR/\ \M+*7YX#GOA3L)_O(U?79'CIXA2HUI7DM5?M_P #]2)*VQYI#<36L\4]
MM,]O<PNLL4T9PT;J0593V((!!]J_??\ 91^-47Q_^ OA7QAN7^T9K?[+J<:G
M_5WD1\N8>P++O'^RZU^ M?>'_!)OXY'PC\4=8^&NHSK'I?B>)KVPWMC;J$*C
M<@'_ $TA#'ZP*.<\=6=X7ZQAO:1WAK\NO^?R%%V9^D/[0/P3T;]H3X3Z[X(U
MK]U'?1[K6\"[GL[E/FAG7W5@,C(W*64\,:_!3XE?#G7_ (1^.M8\(>)[)K'6
MM+F,4R$';(O5)8S_ !1NN&5NX/KD5_1A7SI^V)^QKH'[5/A>%UG30O&VFJ?[
M,UH)N4KSFWG Y:(DYX^92 1_$K?,Y3F7U.7LZOP/\'W_ ,RY1N?AI76_"WXK
M^*_@MXQM?%'@W6)M&U>W^4M'\T4\?>*:,_+)&?[K=\$8(!"?%#X5>+/@SXNN
M?#/C+1;C1-7AR0DHS'.F<"2&0?+(A_O+]#@Y%<G7Z%[E6'>+^:9D?K%\$?\
M@K-X'\46UO8?$O2KGP9J_P J-J%DCW>G2GIN^4>9%SV*L .KU].Z!^UA\%_$
MZJ=.^*GA"9VY$4FLV\4G_?#L&_2OP H90W49^M?.UL@PU1W@W'\5_7S+YF?T
M"^(OVIO@[X5@$NJ?%'PC; C(0:S;O(P]0BN6/X"OG#XP_P#!5[X9>#[6YMO
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M85]"_L&?!JX^,W[3'A6 PL^C^'YTU[4I-N45('5HD8]/GE"+CN _H:\8\"^
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M)\1RM[E*WJ[_ *(.0_*/X._\$C_&?B&:&\^)'B.S\*Z<=K'3M'/VN^<=U9V
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%E3W/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>companylogo1a1.jpg
<TEXT>
begin 644 companylogo1a1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  ] /@# 2(  A$! Q$!_\0
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MQ'JFNZ=J%V+P1ZDL8\B38$8IL X8*N<_W:]KHKNJ8[$UJ?LJD[Q%9;GXI?\
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MX=-?!7_G_P#%G_@QA_\ C%'_  Z9^"O_ #_^+/\ P8P__&*^T:*^/_M+&?\
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MR3S+/=W$C?JS,:_<7]C#]G<?LV_!+3M N_+?Q%?.=0UB6/D?:'4#RP>ZHH5
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M);:[LF)==(\0,8Y8Q_=2=%*O[;E7W)ZU^GM%=&%QU?!O]U+3MT$TF?A5KG[
MOQ]\/S&.?X<7]R,X$EC<6]RI]_W<A/Y@56TG]A/X]ZU,([?X9ZM&3_%=O#;*
M/QD=17[O45[7^L.(M\$;_/\ S)Y4?E;\%/\ @DGXIUB_M[WXGZ[:Z!I:D,^E
MZ/(+B\D]5:0CRX_JOF?AUK[=^(WP#CL/A=X?\&^ M+BL?#^ER!?[)@?:""0?
M-.Z1/-8'?N#R*29"^[<JY]UHKR<1F6(Q,U.H]MET'RHY#X3>']4\*_#_ $O3
I-8D:2^A,Q*O*)3%&TSO%$6  )2-D3Y0%^7CC%%=?17G2DY-R?4H__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>mda1a.jpg
<TEXT>
begin 644 mda1a.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X18&17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     @   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   !(     0
M $@    !    1TE-4" R+C$P+C(R   R,#(T.C Q.C(S(#$R.C,R.C$R  $
M : #  $    !          @   $$  $      0   0$$  $   "3     @$#
M  ,    , 0   P$#  $    &    !@$#  $    &    %0$#  $    #
M 0($  $    2 0   @($  $   #L%         @ "  ( /_8_^  $$I&248
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M')?^PA_[4KZ\K>O34+6ZB04445@,**** "BBB@ HHHH **** "BBB@ HHHH
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MZ  ! !< $@ = "MA8W-P35-&5
M]M8  0    #3+6QC;7,
M                      UD97-C   !(    $!C<')T   !8    #9W='!T
M   !F    !1C:&%D   !K    "QR6%E:   !V    !1B6%E:   ![    !1G
M6%E:   "     !1R5%)#   "%    "!G5%)#   "%    "!B5%)#   "%
M "!C:')M   "-    "1D;6YD   "6    "1D;61D   "?    "1M;'5C
M      $    ,96Y54P   "0    < $< 20!- %  ( !B '4 :0!L '0 +0!I
M &X ( !S %( 1P!";6QU8P         !    #&5N55,    :    ' !0 '4
M8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@        ]M8  0    #3+7-F
M,S(       $,0@  !=[___,E   'DP  _9#___NA___]H@   ]P  ,!N6%E:
M(        &^@   X]0   Y!865H@        ))\   ^$  "VQ%A96B
M  !BEP  MX<  !C9<&%R80       P    )F9@  \J<   U9   3T   "EMC
M:')M       #     */7  !4?   3,T  )F:   F9P  #UQM;'5C
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M  $% 0$! 0            @%!@<)"@0# @'_Q  < 0$  04! 0
M    ! $" P4'!@C_V@ , P$  A #$    =_@
M                                     !C"RL.]KI[L@;2M;32S-U&]
M
M    P-?C]M^.D%PW69BCRP
M                         +:RTI]P"X\2I6U
M                                          '-QU*-KV]-8!T6<PD;
M)/+9
M       !S<=2C:]O36 =%G,)&R3RV0
M                                 <W'4HVO;TU@'19S"1LD\MD
M                                                          '-
MQU*-KV]-8!T6<PD;)/+9
M                       !S<=2C:]O36 =%G,)&R3RV0
M                                                 <W'4HVO;TU@
M'19S"1LD\MD
M              '-QU*-KV]-8!T6<PD;)/+9
M                                       !S<=2C:]O36 =%G,)&R3R
MV0
M     <W'4HVO;TU@'19S"1LD\MD
M                              '-QU*-KV]-8!T6<PD;)/+9
M                                                  *%1&^RM/V6
MIL:5;/;3[8J  .;CJ4;7MZ:P#HLYA(V2>6R
M                                 #!=;/ADC6)*MEM G   <W'4HVO;
MTU@'19S"1LD\MD
M       IU%(RX_S;6ZK;P       !S<=2C:]O36 =%G,)&R3RV0
M                                           4"RD<)\7Q0[L8;G7[
M"M-N0  .>GI<>%^^L Z%>9R)HZ*\  <W'4HVO;TU@'19S"1LD\MD
M                                            "C%%]O[KAI&>W-<6
M4  !S.]6C01]%8!TP\HD3O\ /9  !S<=2C:]O36 =%G,)&R3RV0
M                                           87G6T+( S)!K<..H
M YG>K1H(^BL Z8>42)W^>R  #FXZE&U[>FL Z+.82-DGEL@
M                                       Y:.NQ8C;NT#I\Y+)FIH;P
M !S.]6C01]%8!TP\HD3O\]D  '-QU*-KV]-8!T6<PD;)/+9
M                                       !RT==BQ&W=H'3YR63-30W
M@ #F=ZM&@CZ*P#IAY1(G?Y[(  .;CJ4;7MZ:P#HLYA(V2>6R
M                                        #EHZ[%B-N[0.GSDLF:FA
MO  ',[U:-!'T5@'3#RB1._SV0  <W'4HVO;TU@'19S"1LD\MD
M                                         '+1UV+$;=V@=/G)9,U-
M#>  .9WJT:"/HK .F'E$B=_GL@  YN.I1M>WIK .BSF$C9)Y;(
M                                          .6CKL6(V[M Z?.2R9J
M:&\  <SO5HT$?16 =,/*)$[_ #V0  <W'4HVO;TU@'19S"1LD\MD
M                                            '+1UV+$;=V@=/G)9
M,U-#>  .9WJT:"/HK .F'E$B=_GL@  YN.I1M>WIK .BSF$C9)Y;(
M                                             .6CKL6(V[M Z?.2
MR9J:&\  <SO5HT$?16 =,/*)$[_/9  !S<=2C:]O36 =%G,)&R3RV0
M                                              <M'78L1MW:!T^<
MEDS4T-X  YG>K1H(^BL Z8>42)W^>R  #FXZE&U[>FL Z+.82-DGEL@
M                                               Y:.NQ8C;NT#I\
MY+)FIH;P !S.]6C01]%8!TP\HD3O\]D  '-QU*-KV]-8!T6<PD;)/+9
M                                               !RT==BQ&W=H'3
MYR63-30W@ #F=ZM&@CZ*P#IAY1(G?Y[(  .;CJ4;7MZ:P#HLYA(V2>6R
M                                                #EHZ[%B-N[0.
MGSDLF:FAO  ',[U:-!'T5@'3#RB1._SV0  <W'4HVO;TU@'19S"1LD\MD
M                                                 '+1UV+$;=V@
M=/G)9,U-#>  .9WJT:"/HK .F'E$B=_GL@  YN.I1M>WIK .BSF$C9)Y;(
M                                                  .6CKL6(V[M
M Z?.2R9J:&\  <SO5HT$?16 =,/*)$[_ #V0  <W'4HVO;TU@'19S"1LD\MD
M                                               &$:V?7-@RG9FJ
MV/(  !RT==BQ&W=H'3YR63-30W@ #F=ZM&@CZ*P#IAY1(G?Y[(  .;CJ4;7M
MZ:P#HLYA(V2>6R                                          15SX
M+N69ZPY_U2\   :]JVY+V.KRA@D9NB3@  .6CKL6(V[M Z?.2R9J:&\  <SO
M5HT$?16 =,/*)$[_ #V0  <W'4HVO;TU@'19S"1LD\MD
M                         "B#&3'E:9!D=!F_NF4        <M'78L1MW
M:!T^<EDS4T-X  YG>K1H(^BL Z8>42)W^>R  #FXZE&U[>FL Z+.82-DGEL@
M                                              &J;V.+&$N@&TOR
M&3+L*X  <M'78L1MW:!T^<EDS4T-X  YG>K1H(^BL Z8>42)W^>R  #FXZE&
MU[>FL Z+.82-DGEL@                                    AG*@W+
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MIH;P !S.]6C01]%8!TP\HD3O\]D  '-QU*-KV]-8!T6<PD;)/+9
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MS"1LD\MD                    LZ^RX+:U&EP   _-E8L3H5_X<F:L4@
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MHT$?16 =,/*)$[_/9  !S<=2C:]O36 =%G,)&R3RV0
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MMD         M^E??EQ5''D    QS?BQCDMDCAO\ W3(  !Q7]XA@#M0X/,
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MH!)W4WY2B5
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M1%Q]N-;,#R^]Q;O]%9-;]@VHW( $;+:X=EPL6["+-G0[G$NZTF").#9_H=^
M!'JV["4W68MSW7XP>:M*U5/?5[< #!%EV -GJ,>XIMT2M?G>W)3(N25D;8
M87Q9(S[O0VWK-OZ]IJ;YBRL9SX6RS1[LJ ,3X<L2/0>>:3;4W;P,G8,F(I.+
M9;J-E^Z9
M
M                     !IP^AM7A[U&$    ;5?G3:WCJ[QY<B$W6(.2]#E
MCE[F-/?C4^[M;>
M      ,/>GPXR]!CQ!Z;#E'SV67G,Y8 UQ_2&IC[[6.    -X_R+O,@Z7((N
M="BWIJK\W^2ST_-2)/2HF4O/9<Z>0S@
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MBY&O699/_#"]>'8:W>[:W9%PG9   0IQLL;S49^T^W    AW8O/=:F2.HVP
M  $7+:>#;ZN66JVH   $>:,3;;43?U6W    B;=CHVRU\R]7M    (*Y</GV
M.LGEJ=R   !"6^EK[;1[ M-O0   *+BOA#NM1/C5;0   "EV706VVJG[K-F
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M*]@@[.. ;*K1K@
M    !;LZV&G4H6:?*9[_ --DB5TJ)D/1Y);\UE@:>?I_3Q]]K'    &\?Y%W
MF0=+D LW:61Z]M'SMX_/?.HO]%E0
M                    (Z^XC?PS9Y//7X=P A!Z+HF-)>W    $M='RZY<,
M3Q74^5;H[[3U5U886-)F[D%J_'Y'B1K7S4K6.M%R4K6.OBNH/;;7Q74 ]MM:
M+DI6L=?%=3VVUHN2E:QU\5U![;:T7)2M8ZT7)2M8ZT7)2M8Z^*Z@  ]MM:+D
MI6L=:+DI6L=:+DI6L=?%=0 >VVM%R4K6.M%R4K6.M%R4K6.OBNH  /;;6BY*
M5K'6BY*5K'6BY*5K'7Q74'MMK1<E*UCKXKJ>VVM%R4K6.OBNH![;:^*Z@]MM
M:+DI6L=:+DI=&&MKYJ5K'7Q74 'MMKXKJ>VVM%R4K6.M%R4K6.OBNI[;:^*Z
M@ ]MM:+DI=&&N'9VQH6798HF[+*4/79IU_FA[;:^*ZD7=UU"T<TZW<\FJX<=
M%S9P*SCCT;)(%8QX-B/E>5W7AA##4_?U:S!D^'I_%=DP9L?1WQ'UV2(FI
M                                                %N99>'9^^SOK
M?->ZW'1[\\6]S[.7FC\*!!3U'19 :+SL:]_Z?*FOU%,NSUV/B^S!Y<U?-=E^
MV)C^5M9>Z3P=UX85C2-CB6=O))ZGR6&[K<H7X_=CSX2V'HLYZ[S@  &(:TR/
MDPU?%G    LB^SYJ7W9D    PW6VKR8^38LH   #']M?7*BWK'D@   63?CL
MN^W-.'+_ %4   61?98]69J6^FS*   !8M^.^K,@   $9LEERY,>7[*U7%F
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M9VOQU_!(    LR_%>=F4   "S+\=ITOR3?BJV+,   +,OLQW2M]9X]^QI0
MPIL/0Y%BZFP,<+V5MNG+BL:1ZG),34W!BBB 'I^G8\E;2G7Y;_B:RNV1;6S3
MJ>S>Z[!_;:_*E]HR9NRGR/)+KPPA@'9^GN+%$J%F+TTLC1M_7S.\_P _]E+
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MWE(OIER#J_O3 /;;7Q74B=O:8EG4    &SOQU]VX*@
M                                         :\?568EG4    &SOQU]
MVX*@
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MEEQXLH &/JTHF;!>&++]:5]MMWWRXZGCR  6T6WFP7?CR^2V[VJ?K)CJV/*
M!0:5L[/&N3'E]-F2JY,7BMNK5+@ *1;6PI$6^L6?Y4K_ "ZVL5IZ+,@ 'CMN
MQU?;7<T>KX,WWNI3KJ7/CR  >:RZP*V^B9#NV),IU]B^VY,64 "BUM]5E]AR
M8U=Q9:Q;D^U+?KDM]EEX HMUOFMNMK+@KEF2N8\E*R65.ZVI8\@ QE=;6*TI
M=^.X,>3WTK^[+_IFQ5/'D&O'U5F)9U    !L[\=?=N"H
M                                           &ACH^"QY(    3%T%
MU<Q@
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M,=R![@24B?#)3D4-9GLEKIVBW?AECZUUS0S_ .E\0MM#6Q-9#])Z0T_K]K?
M6;0P#,3XZ"O4F\(P@ 7P2H\^RVS!11LIG1\,A8L;G=+L&-DJ1AI:G6QW\$QM
MH;84OPDWFT6C9JJ6<U-UA"MPR#3B3&E<AK7"6>2J$OHVPSUO];#<8OU.K>T>
MWW.WDW14:%7;))U#R!V^[\*!O)1]MIA4>/TENHT^%KB,9;MX!=)G,:6ZTZ!?
MLE8O]O\ 4 [EJ@U1Z*F$YR8("*;0NY>M6:!-=<A<.]S,!GO&X/'(1*+X4+>$
M#2BYO""13X33?$.&S\3C:;==R-OML&UD'PXV^(N'3,=,IP%NG3ITZ? L;PA>
M7+1!'9PB+%H0H[X1[?$"R'P]OB.AYS,)H/'&A0HQB3X#3?$.*TY(S9+N7MQL
M VD.W/(T6"V!!1.80../F:[51QBM)QC@8 .VA[M%JW"B%(<(T=H]ON=*L4(L
M?3KUZ=;KJ<%Y+8=*@>%1N$T@NW"Y*[:Z. QT57'"9NKB)XL6MT"_9-'<TNI3
MKA+8VX$M/!N7<)=QI!8S#://I:GL]$]C\H7(DY%*WFT:!G>CV ?J49P20OGW
MHMN7V:W%0C!J[Q)12XO0C=>A&Z]"-UZ$;KT(W7H1NO0C=>A&Z]"-UZ$;H.\V
M?81WGNRT]I-(##6*+L@,.Q@5NJ,CMA=@B5,J2'X\N"<$C1O;PX'<U+F/W)CJ
MN]V7]#W)CJE;W9:"K$@,-5COR PTN-(]V6OJ[(##L8+4@,._@4R PT:BR]V6
MHM>Y,=5>>[+3VDT@,-8H[W9?T/<F.J5O=EH*L2 PU6._(##2XTCW9:^O<F.J
M[W9?T/<F.JLO=EJ+7N3'57GNRT]I-(##6*+L@,.Q@M2 P[^!3(##1J+$@,-5
MCOR PTN-(]V6OKW)CJN]V7]#W)CJE;W9:"O<F.JO/=EI[2:0&&L479 8=C!:
MD!AW\"F0&&C467NRU%KW)CJDCW9:^O<F.J[W9?T/<F.J5O=EH*L2 PU6._(#
M#2XTT@,-8HNR P[&"U(##OX%,@,-&HLO=EJ+7N3'57GNRT]KW)CJN]V7]#W)
MCJE;W9:"K$@,-5COR PTN-(]V6OKW)CJN]V7]!3(##1J++W9:BU[DQU5Y[LM
M/:32 PUBB[(##L8+4@,._@5O=EH*L2 PU6._(##2XTCW9:^O<F.J[W9?T/<F
M.JQNYJ6\?N3'57GNRT]I-(##6*+L@,.Q@M2 P[^!3(##1J++W9:BU?D!AI<:
M1[LM?7N3'5=[LOZ'N3'5*WNRT%6) 8:K'>>[+3VDT@,-8HNR P[&"U(##OX%
M,@,-&HLO=EJ+7N3'58'<U+F/W)CJE?M4KM!S,3A5=YTQ^*OV) 8:K'?D!AI<
M:1[LM?5V0&'8P/G[I^(!^Q?G+Y^Z?B ?L7YRYQ]\H]EPR^/MCVF0()<#9*8T
MJ=N+E. BV\0ZP(;Z@O8+ E0G!2<4H4CJ ?L6JZ8VH@).F1P;65JY,&X!S*?(
MU](MSR?3?8J##BZ8\/66VOT...6&XVRIZ2&^#MM=T"G>)VNF1@K57@#PQSB"
MDI(1YMTR4$:JTQ(K<$"6F[A+Q'[7;((=H*6\X!;H$.)^-YLDG9(8=I+",C-D
M>WVD\A3Q2[7:]Q+/IK.D2\!)Z66RWRCDD0$V^C:=(AV!F@]@SWL;7:[4+.'M
MAR]S)GD^F^Q4#J?0AI8,$F"5;<:,D#7@5VN9SB6D,:3Z$N_$['XA:2Q=(XL8
M"'R&VES9:TD!'42VN)QBFJ*:;^$NY0ZI$"M-:LD)O)F>EDH9C%-61 KK6[2;
M\;PMRNESBV>$%D+)8;CF-IX"SR>@9BB'"[0C7"!RE@V)V.)^-YLDG7( =IJ6
MXX1;J#K)A::$PZ70*9X0U((H(#;+B[E1;'#*[=;I0])[<!X&\X!;H$'I7;3?
M+N.1+#=4X9:;N-LM9U"W>-TPW^J=R/\ 5]+ZYN6UZD184I0*#'926%+A,_J[
M[,P*K@:YA2X5!G$@_6EO6?1#^%:L @/V+5SGVNZR[G2)K,I]7JY,4(-AOHVN
M!W3N#$=F^HCTV*XO1=(V>U_#=<A=]@VPV8N%"A#:VR2\Q;=*,2VU6NV#*U")
MQ7#:,$_;8U2E10^7)$D>U]F6;C*Q ;2)H_E0&(0ERQ46W)?LCE=AN1&6(++V
MU\GFHB7PZ7'#&T^[^$$N7850]0+,%.D<0(O3_5VR[@$7ED:.?JGJ=P8CLQXG
MFHB41L?PMZ/(I!]131VSQ84=4,>.+H@<#\PMPA( MPD%%T[:4%V0PS"BR_\
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M+3%3G1J2IA0#6CHW,UK+(CC;Z^8Q,:.M[.G^IL[7AS%]G[_WK+.5M6!FDVA
M"]4Z7(]8!&:"F)A;34)I%T1NHW9?7)5E:7+5ZO%O2X%R2HGTCQ>O$K(EF"VU
MD(+:8$PQ+(64[;E$#DEI8E@,$3BQ7TL]&%U4JBA3Q>*2IC(6CB&*X?-:E48G
M*%)PII*LKF5.>UMQ5!K555R6FRT'85Z16:T[N'.QFQB]FX>I5NO73Z5!B-BU
M6KZ6#:*I9#938L.I-C"89<90EX3A+.>R9@O;/CQJ+ZT^,\:B^M/C/&HOK3XS
MP'2//9VO#F+[/W_O8(B-G%+,C#/EBU=LW4LB#KG&()Y/;K0$QGR9J-2Y R,]
M)EZS/+($:#J2+G[5!X6J2).""O:4EM95G>(9N6')KO<E17+5C1N&V(Y09N)M
M1+%OKA$UZ=IDMMTD:1K6)*R-TUS!BQB:YVP!QUJC*]<M.S*N3&U)\]G:\.8O
ML^//9VO#F+[/W_O7J&/ICC4/?'&H>^.-0]\<>WGL[7AS%]GQY[.UX<Q?9^_]
MZS[4\Q?8C[_SGGL[7AS%]GQY[.UX<Q?9^_\ >L^U/,7V(^_\YY[.UX<Q?9\>
M>SM>',7V?O\ WK/M3S%]B/O_ #GGL[7AS%]GQY[.UX<Q?9^_]ZS[4\Q?8C[_
M ,YY[.UX<Q?9\>>SM>',7V?O_>L^U/,7V(^_\YY[.UX<Q?9\>>SM>',7V?O_
M 'K/M3S%]B/O_.>>SM>',7V?'GL[7AS%]G[_ -ZS[4\Q?8C[_P YY[.UX<Q?
M9\>>SM>',7V?O_>L^U/,7V(^_P#.>>SM>',7V?'GL[7AS%]G[_WK/M3S%]B/
MO_.>>SM>',7V?'GL[7AS%]G[_P!ZS[4\Q?8C[_SGGL[7AS%]GQY[.UX<Q?9^
M_P#>L^U/,7V(^_\ .>>SM>',7V?'GL[7AS%]G[_WK/M3S%]B/O\ SGGL[7AS
M%]GQY[.UX<Q?9^_]ZS[4\Q?8C[_SGGL[7AS%]GQY[.UX<Q?9^_\ >$YF;)T:
M\J.ZI-5S8LLY-25-U4V*M9ER ?(VCKRFRP>3\G0BY4)MD2-P(Y5$HPID)>#L
M6&ZU=:PO8.NK#U8<=B;6<D0,%F)UD;0@?K-77TQGPN6S!;H+"=4P,+838D/V
M2*24G24_2$04#]#"^8/M3S%]B/O_ #GGL[7AS%]GQY[.UX<Q?9^_]UK3-MUR
MO#D4>0E7K,O7X(Z;<2?3K7N1P"B6Q2T!;K5FV8.P[E1OT49&J$6VN:O"K-R4
M2-P,&Q?$0J20L&LW"\+.^SE[E%*P2+(%"Q41.Q!VH*L!67=Q"@LI-8'/M(!*
M<O9G,1/1\S,5?Y0VG8OL1@MV<!L#-N1C"F*1AU.A<AD-RKEBM5U1B"F1Y:-7
MY+V,@96CBE-@<-P(L4AQ3\EV5R^Q,PBOJ?3:ZIBT,(5QB+A33LR5I9PR$NA+
M\T65+J0$6<8Y+E&&3C-R<)@,MF*62H/DN7_L,WXNE0R]5-(D36_FLH^8/M3S
M%]B/O_.>>SM>',7V?'GL[7AS%]G[_P!U@E%+',8Q2V@[=+%'+NR"U1<990W#
ME*OX"5<8DUKF]R\%!:%>'FG$M\K,P5]BJB+"/1JY3L%NW1]#L7I'D4L.Q=+T
M>M5X!<]IS7V)@%1&;',,8B),HCA,3"E1,93"PB8GVQ.F.B?ZF?:GF+[$??\
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MKPYB^SX\]G:\.8OL_?\ N!?:VO5Q6\D1&OA0ZP%_69BP T$95R6812=>,_\
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MU+8XKA!VSL8AC^$8N#[+HD&V7G5&NII,D!0D%VVT4I3F"4ITK (2!S%BW#,
ML82U1ABV,)I82="1+76&+M-^)66%UE;%6O6=.6N2(B6!#!%H+'/_ %5],/\
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M=AE7^8_*:*;(()7<?A^^*9@HUCN(_P ]Q;.FP,.137 XPK%JSLQ3(MIX7"+
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MZ(^F>.4UX)82],&XY6H-T-33@#;(+'5F9PM;&2(YSH69Y:1*8^9@2+/2,EI
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ME; G+VBP"(#&>@A*1F)B9CBVE-G'&TP4L*GHV05VR"Q$K>/&$-M$XH$3-6'
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MF9]D#$1G,S/T1Q2]%'-B#N&->)_S0#!MR_UI[ =_^<F/IB)]E&AAWRE<JWV
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MW7EU8/7J@>K$Z>CBIAU.C)E53"I8(B>1L+. [/09E&??,=,_3,_HQ+^D;_\
MVVU_WY_IP/&XI_S2WG-4IZA^W8DIZ8F/I47MG+I&<YB)B9RFB.+8C:'"P!2
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MRMD1)#GI(#&1(@-9@8$0%$S=<%"BV_8G2H.PN/UUB<\CY.$Y04*CI:9$"@Z
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MIY?1JB>%Q"0VE1"E[>SMKC0&SEIVM Y#MZ>KHRTY=&67"TJ3!"E2U01DPH6
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MY9'O0?B-VP@[C'Y[R2KBR&E8,O)*3!20K7U<9LJ3'* \-BGHJ5,3OJH[@'6
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MY]#E3VU8^)7]@'3Y)]D!\N_]<=#E?VJ/S1/VW?VKY.]BT?B,]NWH<INW+O\
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M3[(#Y=_ZXZ'*_M4?FB?MN_Y)\!8O^0/_ -T?O;> L7_('_[H_>V\!8O^0/\
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MBD5\Z)MJ6%736DJU=):-_B$N5H*V?"8J5T"TMT&]BTQF[:L!$6C:ME9P/&[
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M:8_65"F[F\U5%*WXM8&()RN<< K8<@IA-M@'-NPW>UDBD5FXV-LT<9P'&\1
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M3O*8*J%O#20^+"WUI9.^L7<H4""6TS>)*%F<P1EE)3(QE$S.4?BC/A'^S_\
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M5-&_<,$(SIDH$1#5,0;3ZT@N)U' 'IB9C*2_E&OT<#KX-3P]>&XE5@JCWPN
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ME,K3&B8SF,0LKN7KEM2(JKM676 K0>\%$.83-T)Z%YB&K(>H/5RC+[O\GO\
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M7]N?]P=.J-4S YQJD8@B@<^,Q$R,3.7FB2&)GX8\^W*/D'2I\GJN,X"ZQ?
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M.NRXLU-T[U<YG/DV:!UAZ)Z1U1.4;1B6(C)2-^Z,F6HYBT^),M(AJ*8/K%H
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M<^1U^ENO)YZ>&WA7$_SC?^F6/XFP7[R\MW=MADL%1HLN')2M6Z7&1QY->LM
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M(B/F&-IQ+$2D9*_=*0+4$S:?,@6D@U#,GU2T&89QQTD0^8IV'$L1 1 +]T
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MQ*89+8F^>39\[(W2<CG+*,R]+S?#M9_"'_+-^V7W*B][84$^;5G/]PQJF/\
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MA'2)%,P.>>6<^;X/NX=PJ)_^/VI["I8R.A81(C*PTA$3 F>L@'*. DR=<C'
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M-9E)/&08F92:].F9*#F</'5;7G$3$0<S$QG'H%'ZYC;$LN=%$<,A#A']V?\
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MJK2J"'T8(9^ 0CAQCA.<Y3GY^'&./WBN4U7E81.[:R!WG]9;-&6DF)/4EAC
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MBC8*F+5R'13O+)A:!B:KO*% D>F!)>1E "9Y93,")EYHG998T0"8X?8:!C!
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MI.(JOF0+2)Z2B ZI:# \IXZ2$O,4;3AN(C(P5"Z,F6D(FJ^),M)'I&)#K%H
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M6D^%A, 6@@L#E( R)\X@QF7FF8GATE:G6Z])0&;K 66QIC,5IJ)WSW-RZPK
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M[JC=BUHC7@)ZV2./ECXNUZHG3 Q&(;CG)F;74WPE<18$2E5D17&@1E<Z\QB
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M+ZTH_P"?MZ?POK2C_G[<ZE:K7$\4AS:KU6%\<;ID.-1&/%$3$R._?&^/Z?\
M<#;^1</^Y9W'_.C*?5,7_N!M_(N'_<L[C_G1E/JF+_W V_D7#_N6=Q_SHRGU
M3%_[@;?R+A_W+.X_YT93ZIB_]P-OY%P_[EG<?\Z,I]4Q?^X&W\BX?]RSN/\
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MLC']S2']X/\ %&;[^=^)8/[(J=S!?'<Y]KV^_;^1</\ N6=Q_P Z,I]4Q?\
M4O3B\+:.K@*6M</ALG;KL("S.2<3IM8U9K*.+'XT%\O(?G+L7F])/C1LC.M
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M3LJNC6>'8Y[5I2L6-XF-:4 L!]R]\BF(C^V>_G_D7*?47]RA\=J_OP_T._\
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M6D;7L=YW"ZZ!>ZT0'AZ?DR)L40+DQ%/%8"M3KHJUU1N6BNH$J"/]E:X$8_\
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MX9_)&YS 2I0R;&M,5K6 ^)&9E,"(Q'C)%,1&Q6,/E,=ED ?+-^-NUKR09[_
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M5;*IG@?7<U+8);"&8;:T3I&RP4UJPL?IO#.,:].NJG31!,ID4)JU$)JUE1/
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MJ@+("D2XNK2<[BB8G^3 ]^[]6_\ 5L@V212RQ:*"*9F9CFR'OS_M 4?PY/\
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M_FVZE@0WS/**Q1L5G-1Q$10AIFF"*2@.*9G:O0Q]9-.E56*:U6NL5)2L?>$
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MP&=/&YS(AJ4Z2\7C<321<R[67J9W5!TG6*$B%0;F"ASIYDQ 0<>=LV[V%J/
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M@54S!<+&5" %P'*^%I+#F<,=U6&PH8"IKC4-,:C,_E9HX^OAL1,GNLY/*6(
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M5-.[=RCKL$E$O=$1P2'#N_5L6.H8K'4<>?,XZ-.C6K4RYO\ *\55*@27,_\
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MR#SL$K>ZX5?1*=X3]O)(]N2"G>$_;R2/;DD\[!*WNN%7TZ NT9".5BLH_P"
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MJ5*E2I4J5*E2I4J5*E2I4J5*E2I4J5*E_]H # ,!  (  P   !
M                                                     (X@
M                                                           #
MK@
M      5),
M            !@!
M                   , (
M                         !@!
M                                , (
M                                      !@!
M                                             , (
M                                                   !@!
M                                                          ,
M(
M    !@!
M           , (
M            <,D  !@!
M                   ,(   , (
M                    *L        !@!
M                          &)@  !DG   , (
M                                 ;P   , <  !@!
M                                       ?;,  !@#@  , (
M                                             #@    , <  !@!
M                                                    <    !@#
M@  , (                                                    #@
M    , <  !@!
M     <    !@#@  , (
M           #@    , <  !@!
M                  <    !@#@  , (
M                        #@    , <  !@!
M                               <    !@#@  , (
M                                     #@    , <  !@!
M                                            <    !@#@  , (
M                                                  #@    , <
M !@!                                                     <
M  !@#@  , (
M   #@    , <  !@!
M     /    <    !@#@  , (
M      !@   "0   #@    , <  !@!
M            (K@        <    !@#@  , (
M                        0 ,  #@    , <  !@!
M                    >,   <DL  ! !@  <    !@#@  , (
M                          <'   ! #   ( ,  #@    , <  !@!
M                           )L         ( 8  ! !@  <    !@#@
M, (                              #_@   0DT  ! #   ( ,  #@
M , <  !@!                          7          @ @  ( 8  ! !@
M  <    !@#@  , (                    0@   'L   !$D@  $ $  ! #
M   ( ,  #@    , <  !@!                    :@@        , (   @
M @  ( 8  ! !@  <    !@#@  , (                   #6    #_ ,
M 8 0  ! !   0 P  " #   X    # '   8 0                   #;8
M  8 0  # "   ( (  " &   0 8  '     8 X  # "              %HX
M        # "   8 0  ! !   0 P  " #   X    # '   8 0         $
M    #C         8 0  # "   ( (  " &   0 8  '     8 X  # "
M     &0              # "   8 0  ! !   0 P  " #   X    # '
M8 0         <   " #         8 0  # "   ( (  " &   0 8  '
M 8 X  # "         ;9   0 8        # "   8 0  ! !   0 P  " #
M  X    # '   8 0        O_X  !_[   '_P"   '_ ,@  ?\ ]   W_(
M &_]   7_P   !/_ (  "_\ 0  !_P"@
M                                              !?Y  !$9$  !'=
M  !J=Z  ->2P  OY$  +D9  !1&B  .LMP !6!,  'V 0        XP"  'V
M;@  [VL  !.G0 !#AP   VWP  IH8   R.P !93Z  /&2B  UTI@
M
M
M     .2222321Q^222222222222222222222222222222222222222222222
M22222223PL22     $!()D
M             !0@H       @V)"@  !(    %0   !(    /     8    ,
M     &    *P    V   #Q1"!;H79V$*@"    #0   !B    /@    <
M.    !F    (P   !(    (    0>#0 6C-.TAZ(IP   F    (0    0
M &     &    #P    R    %@   !^   .RQX      $!V,"
M                                        '@,       @ DF
M                                               *\  =MMMMKK=#
M$<=;K;CKCK<<<=;;;CCCK;<<<=;;;CCCK<=<=;=;CBCK;=<<==;;BNL[=0M@
M! %@-1&                                                    $
MF&@ &4IHB,'A+6   'P    N    *     ^     <    A0    @    E@
M !Z   0X"0/<FC+/AT)A@  !B   !."   !&    /    %[    .     D
M  '(    OP   ,]  ,-;# ,,PGT   )@   !L    "    !X    #H   !B0
M   !0   !Q    #B  !KDZ !=P,3!@$<1P
M                         $[TP =MMMMKK5,$<=;K;CKCK<<<=;;;CCCK
M;<<<=;;;CCCK<=<=;=;CBCK;=<<==;;BB8[=0     0
M                                                "
M                                                 '<3&!00!Y8
M  1W*  !24P  <L<  %U?@  08&  ((70  =]P  '9X&  ORS  (MRX!WSPB
MFR HBP  .$TP !;#   &,B0 !BPP  -![0  R;4  )DA0 !_KB0 -OF8  ,!
MZP      0!Q0  ! ER  %'=   \,"  (\%P !WA:  !XX0 !D'0  /\ I9
M [>0 "[+^       @
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MKNTXN6-?OSL>F1GZ=FC'U[M>?IV:.^^/XL4WD_37<MN'1&235O=&2,\KCR$
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MZ09A&%1!:#N94,]-RA%R ?1GR&-@"H-@!6!@%P4Y<9"]X4:01W"_I'Q$N>0
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MB&(<<@4KT4@X4I6I1$#T@1ZZ[/D?QF4&+M'3R4E44@&!SZ4R?.+6%948Q73
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M'0.4"Y#7(.$8@'"2T&&&5<16"H1!!T.&F";VSM@$@&%P[)($;?(!(-"5M&J
M$T<R&67# < NE8*V"D2A(,MLS3LRH4LLC1"\\M14)P921LAB$'&<\&1 0"B"
M(HD5+MJAH!  4D#.% =8N8K(#P ,:@ :(2L(<I4H)!77'GTD!4E)44TTLMHV
MB2DY5Z&0*! G-Z6!MI $EBT)39@YT$4%40ZK&=)4P91;7*7M<I!6#5&EA<H+
M0A(Q90ZBXX,"+SL!Y4;A#09J.4E\YF),DLJQ4:H1&;$HD(&X2B*@@QEWDL+
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MN\GG I$H (OD#$.IZV$E4(L)RVPN=@$<PP&QX:_S[A2[\E0#J@O3#R^J\-K
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M$[T1 M<(E$E@XQO'^BLH)"B#*^IP8TL$<L+Q(Z+#.Y-A&$=Z?@481Z$C(Z2
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M9]=H2PLQN'M@0H0H_$\I#"%4V6EV#)XI =D M3//*K]=<Z @MKA3$G[7]E+
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M0JC9DP\PO)8=U8A8GM2$';L;43Y0OK!CE'V0Q/UJ >=VBLJEVP60+"B<&QE
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MM:@!PE/.W%NA'$0X8.(MY_!Y\C7ARL]D(K4"S0@Z"8.2G*L,O<[UF""'9(4
M8E5 57<N*'(Q6X1Y'=-KP4)A&=*;YP050]@P##OD;L\9$MV@2X]V0)[)&PKC
M#Q91@I(& H.I0R&HM$[%&XW=\^@O@[(UCJ>>_DAK,B@U%LR#:4G::A)TA?'R
M,'@*+*(2*(C)+YCS,B* R  IB&N _P"^B'W4(6@8 BQ2)%&@*7;IM=6T ! 8
M,4%38': 4,24 (A,B2"E((*)(I2=, +<2*Y<.HA*T"#/3.#XT+(Q!AH,+AKE
M"+M*7C7!+U*^AOA5+@L3Q3&F")I15DFK"'U=$IML:2R[EA9Q=7-2*A!( !X
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M*(C1$V([$V.65@P="1A0(-:FG+'2F]#A&(Q;LBS9SBFK?3AT&S$BX, 2@$G
M:I3H;.BR<B&@$B$I[SL3>2,( ,*  )H;.#A(*K%@M6$GDCT.A%U1UJ:T&U2J
M J5!$"#/M*(B=B752<@28N%7"Z]ZL^#]3!0PA0"/48.%*\,TQA4BOE&B6A.+
M%ZS"U07%BT%@. #[IW<B/#X0U4(>4F*ND-D7I$$.(6U1!#C-+*@D1;4)11YD
M945&4-A0E78MR:EN,S8QB0A0CN::0J8'8C(LY()$UI8D 7UYJ20XD$5 IL1-
M)VW3ITZ=.G3ITZ>+$-;9C,1-+!\_&7-D-'@Z9B9N#,X0R*L 4 7"&F=A*I4
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M1'/'QES9#9X&V8,8>?C+FR&CP=,Q8P_<Y _P)Z!L/ESD$%-+>Q" -8T@_!$
MV%4B@*UA#^2"!L*A#X<Y!!3:WN0L8?N<@?X$P,FX,SC#8BR@1$<\?&7-D-G@
M;9@QAY^,N;(:/!TS$S<&9PAD58 H N$-,["52H 8C"Q8:8V%HE! T.%A\N<@
M@II;V(0!K&D'X(@&PJD4!6L(?R00-A4(?#G((*;6]R%C#]SD#_ GH&P393DO
M),"&H513T8>?C+FR&CP=,Q,W!F<(9%6 * +A#3.PE4J &(PL6&F-A:)00-#A
M8$W!F<8;$64"(CGCXRYLAL\#;," K6$/Y((&PJ$/ASD$%-K>Y"QA^YR!_@3T
M#8?+G((*:6]B$ :QI!^"(!L*I'S\9<V0T>#IF)FX,SA#(JP!0!<(:9V$JE0
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M"9TH*P*RX;>RFS:'\^/F]TW$L2E3ZE*;W08!N1ME6 I@U@UM'WA!+M&0 :^
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M@)&@\,'1\?_:  @! 0 !/Q#WZWO+&4EWHT8RL9>S7/9B<X0[O7IID#.)-7^
MW0T,IC@E)G9.$.CCA@I@_P "ER!_7"Y9/TXS>R>PE'04SD>Y//"OX*6VM[U5
M_P "MD()2#L[]^ZE_4MZ8#1:L7_&H@]H/:#V@]H/:#V@]H/:#V@]FW2]?Z,4
M:K*<B92*,QT,38@=D8L2.</"* ;AAZ&>]!,M<R#]?@*#V/"E4=7XA#(]]A?J
MF2,C4?)]B%^JX*8#R2"#VL2?\=((JOW;"2BYQ A!6Q$ZR:R8;NN'\2!7X!@]
MD&C>AUW<@M0.P+SZ=?/N,Y Q1  (11.2IZ!*Y%#K3O@)#[B]GM]UJ%PI4.;M
MVZL)^="5PI4.@]G(GUC9F44TCV]COLZA=)&]2P3D*DOX"C4C(,&", $K^@]G
MYN;Q+=IP=+'4Z=._K(L.NEVIT%_F<%?T'MKH*_H/;705_0>VN@K^@]M=!7]!
M[:Z"OZ#VUT%?T'MKH*_H/;705_0>VN@K^@]M=!7]![:Z"OZ#VUT%?T'MKH*_
MH/;:QL"-9!B1:N(.>S-Y$;/.0'9KAGE)E+WP^#UT%?T'L]#*C,"\;<IQ3$+S
ML[3&<1-NK0MAU8+5JU;BU_/#0"=PQ<*K![$*--.\X-6";2 J0:2(Q)::C^^<
MM=!7]![#QU!0'9G:[]9I6R$OK!'"4%"1$)$I$)$<B.$>OGW705_0>TFGS'0D
M$1[X/4=KVN@K^@]A9_S@.=(*!T;3VY.@YN96N)+$_P#8QXB'!+C\KF&F&I0Z
MHBFP;MVY^(KHNA'H@*KWK!*ZZ"OZ#VJBK%^N9Q,8A4$IWU##2Y7WT()!.DW#
M;3-!048H?-D3D2IQ[V[78)7705_0>STXO[%6_;*']T/OJZ91>=7VBK2.H2/%
MN!#V?\JP'"A_/@+3.,=KL$KKH*_H/9NF@6FA:%]!04%[0:[IZC;U#?SPD3$-
MQ5# A?RL?4"FQ5@6+S22A8*'10][:!SSZ]?/1\!NW;^'S[Z]?/1\#M=@E==!
M7]![,L HU6M%*- .+1"D&;]<"T^"-?,[!])E!]\N<*4&W;]KL$KKH*_H/8?D
M,CD)<93M4W<+.!;(B4M9+H *D6 (IODL%)";/GE$"=H C<TY[ -4"NU>3,%P
ME"/ 2P@^B<-[O3=NWV O<1/!W><S=OVNP2NN@K^@]@O8R]*57+/8[#)P6P<F
M7-NIQ[GTO2&26,"NX8K^L MSJ"GP#W1-V_:[!*ZZ"OZ#V&%+T6"\PHCXGYIR
M_P#G(W1OQ+WV1:QHPHBER:_8&4$36ED%==6K4T>=ZV0$/T%A\W]T3=OVNP2N
MN@K^@]H,&#!*=^Z)NW[78)7705_0>S=-@HTHH-84$4OL$4]3O27E87*,@TQD
MMR JAM.6-9J4>]*H7J)MI:!<^^"G?NB;M^UV"5UT%?T'L[H%=X-P$"2(.QXN
MZ@T=Q Z1MIXN_P!7^;+?TWJQ<6:;169U%\?L5"N&2*I;!6@S[X*=^Z)NW[78
M)7705_0>SD-Q@2T@%;X%2?2UWB2_Q:06E._=$W;]KL$KKH*_H/:W@>DC"S;1
MA9*_>:J?;$T-HX^ >Y0IW[HF[?M=@E==!7]![(Y<8R<L><J '6#!@B*\47 1
M[0 @S\ ]RA3OW1-V_:[!*ZZ"OZ#V-S_?U8'Q-B]K^_?G<"ZG"H@X"T;A]R;'
M"H@Z T:_OWY7'S4A(%A,04GA_OW[\+CYJ0D"PFT #9^_?G]R;'"H@Z"T;C<"
MZG"H@X T:_OWY7/]_1@?$VKW@R,G]R0=44*;]^_>.GQP0=44*9,O]X<RL>0-
M@:_OWY,#U@,VL>0NU=RQ</#YNSBBA=+K^_?D#+'+X4%)9WM&&7-6@H*2SQM?
MOWZRPZ0C?ONRLX9O?! );#_7]^_&/B8V@0"6P/[@"Z<.V=XU6W!-?W[\&X_Z
M.1*/&.;X7*8,FUY>'+CV4QS>_4B'8!!D'%;^=\>NW(<.E7$]FUEL!3T,EY*@
M,3LUL,NRP8T#ZDW1,)7RK+\,K21UPP^0@=I[R"F!W/%BVO5F^H0#59(4MIC"
M41BM!K5V+*BTK01IN\0(<406X\ANR4>UFI.!&\15PE9H0$N@ &4Y7AR=$W0C
M<(KO])=-*[>X<^=JV'+]-;HIV=<$85/)^Q0_!0L]FE\8+1T7U/SGF63A%E8B
MLGH8+>6A@C*%6'\AD$.013X9%L>_\=S+5M6WF 8NQ@["]"B:#1C((V%,D8OD
ML=X.-32S9^)7)FO45?U?7O!))OBWC_?N;TT'E'?[=:D.J4<#E9>HK9&S,O:/
MO&;MJJ1V>HFH64FD\O.,\@4)Y=%M326)D)=\Q8U9K1B.M4P"#%00V_?DQQ&#
MP"QY>I5*ZA/P9T?!O3 \1\N?;'3J>3QF#!%K^HC-X'G)=V<T5.S2]OP\I_U6
M2!W'O;X\Z&;XCI;L#:;D$1\GX3[U<U<-8(I:''ZY59K7MD51)A\A [3WD%,#
MN>+%M>K-]0@-HO&S_N_BV6JP#,NNWQ.\97;!#QB.ECEX6B7?:8=4@J38QE@N
M+=OI/W!=SC:8O0)7<YNHJLG..6)2CQK< @ ?0FA4U$Y@:/F5EZ!%&,([V> (
M1AUS)FGO/Q]QX;>8"@1 V#4E<;] !XI[L$3@!E%_")94$L5FD=5-9'(-E.'I
M!.NS@FSI@5!$P8NS(8,:L4F::9OMHEJM/CPO:JZR\XG[1>Y_=Z^L>U&@K.5,
M>_ -S12-IG6 (Q?E%LH;Z:";OK"<[>/M<B]H7TWE_;7PG3T-]*S2V\N6,Q3Q
MQXCIE;?^)XZR'< <C*@V<?\ ]_#N?Q8K>Z:\E#5YU4!0SZEB;Q)B),>N3KH\
M:6QF^/4%!W1FK*&VH#;#'?V3KJG4>1_7/_1]C$5,%C?_ ,,DX)PYP-9PA+C^
M@$X0!?RCKK5**!(H,D''UJ 8 *[A#1@Z:X=?P42&(L$B(YJH)/.M7WD&29GC
MNRI Q  ,       Z (BDL)5,Q5J8%]IS#F[9E9B6)6Z7ZRYV5EB<85!"^29/
ME.QD<9B3UAZ<M 0S$)8&H@$&ZL84  &]K<K]EWHRB-,:=M28FA$$8TF,L/V)
MJI=!23PGAQ$BJC!Q.[!680BYT@LCB9?'Z[BF@! #Q@WJG3F?"PH(%@'J,L=W
M;N08"2-%T$-#U00I^3N(3 AT(R^8]LO'(;$]GLGC$3LGV3^#?2LTMO+EC,4\
M<>([LK;_ ,3U9>D]<;01)CF27Z335_[DOO)^J64X 2<%PHM4JZ:J,R)R2>D?
MA7-B^,T+X:;^D%AM-4UX@-4E=_5,<2@4O5_#6E32UC#<"SB%DB'D%53!Z LB
MKIAYQDU'[R>+>+CO:1A5^S8Q Z0G[0KX$V+S'?N'#)OCF!).MFX8D](8NTSX
MF,3/.DQP-,6XDQTY;F-=CH62<A9"3!- ( -  M04?T&KFS![P?\ P4
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MU3%Z1X( #IY-:(-4D!"K*<8?@*7^+WMD$0'[JLK8%K,<2EM1)80"8R,S9T,
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MS7C"E+,SJYY-XYHM-KD(^R'9(:D]Q(O0H(&*W8(O] @RPH'" >![,X\#45A
M_(@#E]#$@WF A?DQ,&O*9NB S.9:2)ZXZ2:SMC0%TG;W([A)5C6-Q$O-8ASZ
M#QN[GF9:1X"]M:0EU<AV%>AVI*BS,Z-=@NQ?>LABMYZ'[5;@+5"E.!%L"4*+
MEX"*@-;6VQGEJ&W9K Q!L'@*F_9-L,&(3&%U<N0,RX&^3>>1.*%' B]7EI+8
M8AP\7,H+XW!7[TE62TER7TK53&<KIL>Q=DX8W(H*G>2J.5,&(>U)$)$X O>
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MP551DF=<NOHJLUIBVAPFP_R9-]U02ML!J2^JZ0!/";RBGL8 /BWB?'A%;(,
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@V[=NW;MV[=NW;MV[=NW;MV[=NW;MV[=NW;MV[?\ _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>summary1a.jpg
<TEXT>
begin 644 summary1a.jpg
M_]C_X  02D9)1@ ! 0( .P [  #_X1>017AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     P   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   "=!   %
M )T$   4    1TE-4" R+C$P+C,R   R,#(T.C Q.C(T(#$V.C4R.C4Y  $
M : #  $    !          D _@ $  $    !      $$  $      0   0$$
M  $   "*     @$#  ,    8 0   P$#  $    &    !@$#  $    &
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MW-:75E&1$A)]6Z5FRS/.^^1LFHZ*\^OBZM;2;T+44M@HHHKF*"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HJ6"VEN#B-<CN3TK0BT@8S+(<^BUTT<)6
MJZQ6A+DD95%;Z6%M'_RS!/JW-3+%&GW44?05W1RF;^*21#JHYQ8I'^ZC'Z"I
M!:7!Z0O^5=%6P_A;6HVPUD>"@R)$(RQ*CD'U4CVQSBM/[+I1^.?Z"]H^B.'%
ME<G_ )8M6EH]O+!+=F5=@>SF1<GJQ4@"M^70M1A>)# K-,CR1B.5'W*HR2-I
M/;\^U2IX:UEWD0:?/N1]A&WJ<D<>H!!R1TJXY?AXM2Y_Q0<\NQQ/V&Z_YXM^
ME(;*Y'_+%J[*70-6AD*-IURV!G<D192,9ZCCH:@73;QYIH?LTBRPKOD1QM*C
M('(/N1^=+^S*#VD_P#VDNQR1MIUZPO\ ]\U&593A@1]179W6F7=E")+A$C!=
MD"F12Q*D@_*#G&01G&.*ID ]1FI>4P?PS#VCZHY>BNC:WA?[T2'\*KR:9;O]
MT,A]C6,\IJ+X6F4JB,2BM";2I4YB8./0\&J#*R,58$$=C7!5P]2D_?5BU)/8
M2BBBL1A1110 4444 %%%% !1110 4444 %%%% !1110!T%F\3VR>5C &"/0U
M8KF8Y'B;<C%3ZBKT6JRKQ(H<>O0U[V'S.GRJ-16_(QE3?0V**H)JL#??5E_#
M-3K?6S=)E'UXKOAB:,_ADB'%HL5M)XLUI&8B\8AG\PJ0"I.5/3IP5&/3GU-8
M2S1/]V1#]&%/K1J$]]1:HUI/$>HNL2H\4*PB3RU@B6,+O&&Q@>E=9I\OBO4K
M.WO8;ZQS=%B$DB&Y_F*DGY2#@)W[ 8S7GM:$6N:I!:16L-]-%!'C:B-M'#%A
MT]R3656BFER)#3[G07GB/6M'NI%N)K:Z^T6P@)$9"[4=EXX!R"&_.L>7Q+?3
M7;W16W$TD1BD80K^\!(//N,#!]JS[R_N;^1)+J9I75=H9NN,D_S)JO3A1BEJ
ME<&V:.HZU=ZH@6Y6#ARX9(55ADDD9 SC))QZFLZD) ZD"HVN8%ZS)_WT*TO"
M"ML+5DM%56U"V7_EIGZ#-5WU=!]R)C_O'%8SQ="&\D-1;-*LC5GB9T"X,@ZD
M5#-J-Q+D;M@]%JI7EXS,(58.G!;]32$&G=A1117D&H4444 %%%% !1110 44
M44 %%2I;3R#*Q,1ZXJ9--N6ZH%^IK:.'JR^&+^X7,D5**T5TB7^*1!],FGC1
M_6;_ ,=K99?B']G\B>>)EU)!;S74HBMXGED/(5%+'\A6B-'7O,?^^:M65H+*
M21T=B7B>/TQN&,UI'+:]_>6GJ'M(F?\ V)JW_0,O/^_+?X4?V)JW_0,O/^_+
M?X5<^P2?\_<WYTW[!-VO)?S/^-7_ &=4_E?WH7M$5?[$U;_H&7G_ 'Y;_"C^
MQ-6_Z!EY_P!^6_PJR;"Y[7C_ (D_XU&UE?#[MR3_ ,#(J'@:B^P_O0^==R+^
MQ-6_Z!EY_P!^6_PI1HNKCIIUX/I"W^%-:#4%ZF4_1\_UJ!Y;J,X>29?JQ%82
MI\FLHR7]>@[W+?\ 9.M#_EPOO^_3?X5JZ!IFI+?3?:K.Z6,V\@'F1L!DKQU[
MUSOVF?\ Y[2?]]&C[3/_ ,]I/^^C1"M&,D]?O!HN_P!DZU_SXWW_ 'Z>D.D:
MR>MA??\ ?IO\*I_:9_\ GM)_WT:/M,__ #VD_P"^C4^TCY_>.Q:_L35C_P P
MV\_[\M_A1_8FK?\ 0,O/^_+?X5666Y<X229C[,34RQ:@W0S?B^/ZTXTU/6,6
M_P"O0+V'_P!B:M_T#+S_ +\M_A1_8FK?] R\_P"_+?X4Y;34&ZRLOUD-2"QO
M.]V1]&-;1P<Y;0?X$\Z[D/\ 8FK?] R\_P"_+?X4AT7554L=-NP ,DF%N/TJ
MR+"Y[WC_ )G_ !J[IB2V%^EQ).\JJKJ4R><J1_6M(Y?-O6+7S0<Z.;HK3_L<
M_P#/8?\ ?-)_9#]IE_*LGE^)_E_%!SQ,VBM Z3,.CH?SJ)M-NEZ(&^A%9RP=
M>.\&/FCW*E%3-:7"=87_  &:A((.",&L)0E#XE8JX4445(&C::9YB"28D \A
M16E';0Q#Y(U'OCFJ=GJ,918Y?E8# /8UH*P894@CU%?38.GA^1.EJ_Q.>;E?
M46I[.*.>^MX97V1R2*KOG&T$X)J"BNU[$'9-X;T"2*-[74VE=MW[HSHI8A7^
M4$J .5')]>G3*CPQH37$BQ:KYZ&*:2)5GC4LR$*$)/&6;.#Z8/-<916'L9_S
MLJZ[';#PIH1P#K"A7+".3STP2'(P>./E'7)R2.@K/U7P_I]GI]Q/;W7F-%*J
M(WVA&$B'_EH%49 /H3D5S-=9;V?AT6-B]S+"K%$DGR[EV7G<%"\;L@KST&#4
M24Z;3<F_D-699D\)Z,D3$ZH@8RQ+&!<HVZ-G"ES\HQQD]>/>FIX7T3'F3:GY
M2K&?,C-S&627Y"$R!SP7Y _A_"L/7K;3;=[<Z;*)(Y%=N">GF-MSGD'''X5D
M4X0G)7YF#:['3Z=H&DW-SJ*7>HM;11,GV9W9071PQ5B#[;"<<X/K577]%M=,
MV&RG%S%D@SB=&!.<8"CGCUZ'M6$22<DYHK14Y*5^;Y"N@I" PP0"/>EHK4DJ
MS:?;R_P[&]5K(NK5[63:QR#T/K6[+<10C,C@>W>L6^N_M4B[1A%Z9KQ\RAAU
M"ZTEY?J:TW+Y#[33WN '<[4/3U-:45A;Q#B,,?5N:@L;Z-HDB<A648&>AK0!
MR,BNG!T,/R*4-7_7W"G*5]1  HP  /:MWP]H-OK3.)]16SQ-%"F8]^]GW8_B
M']WWZ]JPZ4,5Z$CG/%=LDW&T78A'8-X&3)6/5"S,"87:WQ&Y)PB%MW#,2,#!
MX.<U)#X"BFACE75GV/(ZAA:Y&U64==_WCOR%] >>*XSS'P!O; .0,]#2B:10
M )' 4Y&&/!]:R]G6_G_!#NNQU<G@J-(3.FHRS($W%(K7,H;Y/E*[_P#IH">>
MGY5$O@]'UB\L$OIF%LBMO^S89R>/N[ON_P"UFN9\V3).]LGJ<]:ZS1M&TN^L
M(+G4+Z:&208:07*IM&9!T8$M]Q%P.F_-1/VE.-Y2_ :L^A8?X?PI=^3_ &P2
MA;;YHMOE7!()8[^!\I ]3QQ6?=^$H;*UMFGU/9=3R(@MVAPRY*Y_BSD!L]/Q
MJMXCT^UTXVWV.:79,K[HY)0YX<X8E<#!^G8UAEW8Y9F)ZY)ITU4DE+GT]$)V
M70ZV^\"FULI+B+4DG8([QQI$=TH!0#'/??\ AC'/:M:>#Y[N"TF2=O+G$1+>
M22%#B0G'/)'E@8XR7 XKG%FE0@I*ZD="&(Q2B>4)L$KA?[NXXJU"K:W-^ 70
MMU"+>ZEA E 1BH\V/8_XKDX/MDU \:./G16^HIY)8DDDD\DFDK:UU9B*4VF0
M29*9C/MTK*N+:2V?:XX/0CH:Z!W6-=SL%'J36/J%XMP52,?*ISGUKR,PH8>,
M.9:2_,T@Y7*-.21XSE'*GV--HKQ$VG=&Q;34KE.KAO\ >%3KJ[?Q1 _0U=\/
M^#M8\3033:;%$Z0L%??(%Y(SWK8_X5/XJ_Y][;_O^M==/%8J*]UO\Q^P<E=(
MY]=7C_BB8?0T\:K;GJ''U%;O_"I_%7_/O;?]_P!:/^%3^*O^?>V_[_K6ZQ^*
M73\!?5I=F8O]IVO]\_\ ?)J6"ZAN6=8FR41I&X(^51DUJ_\ "I_%7_/O;?\
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M>(*^;_B'_P C[J__ %U7_P! 6OI"OF_XA_\ (^ZO_P!=5_\ 0%K'$_"C#%?
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M)$236][JN1!C)Q_?KUSSX?\ GK'_ -]"ODRBMX5^6-K'33Q')'EL?6?GP_\
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M,   ;6YT<E)'0B!865H@!^@  0 8  \ -  $86-S<$U31E0
M                     /;6  $     TRUL8VUS
M                                           -9&5S8P   2    !
M8W!R=    6     V=W1P=    9@    48VAA9    :P    L<EA96@   =@
M   48EA96@   >P    49UA96@   @     4<E120P   A0    @9U120P
M A0    @8E120P   A0    @8VAR;0   C0    D9&UN9    E@    D9&UD
M9    GP    D;6QU8P         !    #&5N55,    D    ' !' $D 30!0
M "  8@!U &D ; !T "T :0!N "  <P!2 $< 0FUL=6,          0    QE
M;E53    &@   !P 4 !U &( ; !I &, ( !$ &\ ;0!A &D ;@  6%E:(
M     /;6  $     TRUS9C,R       !#$(   7>___S)0  !Y,  /V0___[
MH?___:(   /<  # ;EA96B        !OH   ./4   .06%E:(        "2?
M   /A   ML1865H@        8I<  +>'   8V7!A<F$       ,    "9F8
M /*G   -60  $]    I;8VAR;0       P    "CUP  5'P  $S-  "9F@
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M P$1  (1 0,1 ?_$ !X  0 !! ,! 0             '! 4&" $#"0(*_\0
M' $!  (# 0$!              0% @,&!P$(_]H # ,!  (0 Q    'W\
M                                  ."D^_,9D?(]M=6/;6!V>O'9&-I
MV?,3GX67?C;<WQ]6S9\ZOH<'(+GK^]GQ7X+AC]RZNV7S1]O.MG5;MRF+]S"%
MGFT#.\8?>0<@
M                     %#E\ANYU0I>Z88O-,1W.J*+?7&%KJBNXU1I::\&
MG88#:ZP            !D$/+.H&<HT^V1:[9*-3LE6HVS#2;I>IMLT4>Z;J'
M=E\;+DY
M         !C>_'6CJ(^L_41];NIC:^]%H@#HM$*W^FBV_
M        )$JMD_<Y(V"YO?L3S>_9+EY.T7)R98J]GV
M                                       #Y("O]&E_<1-.^UB:C=E$
MUYZ;12[/@                            $FT^W:WD)6X7$R]RN)E[<<?
M*ONK[R                                                     "
MR;OFB_>0O/?TB!HCZ!"AR^T@                                "_1<
MMS^$F;^>=SO0_P WGS%4;?H
M              U8ZF-Y0>OUGF[ZA78788
M          #LQ;G<'-]3?);+TB\TL+UJ^\@
M                       UGZ6/X6>_4NAWHL$            >J/DEGET/
M+R?]>K/;+PJX\6_<J?TM\ML=5.OC;H</+\Z_2H$.7>GU.\ELXNM=6G';1,ZK
M]G+YC<KY;-N/T^U^IGE?LUPZ>./0_P VGZ7=Q#F"EVZV=1'VHY*5J;U\7CZ
M           $N4>[VC\*N/5'RBRK
M                >1/L-7X5_H&DMN[X            !ZR>/VD=V6OY^MKN
M0DZA]G%UYZ2/KKTNCT%\XG8M,QUPZ:/M5R,J?.>W8#88:)>@0M^//)W'UC<G
M&LQ^YM SQ^1CYE^IUM-F])_+["KP^Q?;:]J^1D^:7J-=$EQJZL@
M    W8\^F_HX_,O027"SY
M       /,/U&N_._^EZ              #<KB)>FO;Q-S>(EZ>]I$W:X29,-
M+NURZ:/*M1MBZVU:A=G%]*/+[#,86>N'31]->WB>DGF%A'MEKR:+EF$+.0:W
M9'-GKBFWU:1=Y#W*XB6(1OM.PW-R,YK\]=^ECZV=1'              W!X*
M9^GS\J=)?P                                             #\K7Z
MRYK4CMH@                      $[\_O@CH-&?5V> V.
M     'Z=OQ[U&\/,R.T
M    'YH/T_SV@7I,                    91$RQ>7B ,GB98S+QX
M             *C7]_4%^,.KW)JME2
M               #6'I(_P"7?]9<WA-EK                   ](?,;"4Z
MG;B\K"'+O5,]'MU'[*+>]&6IG810                  /5;P2Y]K/$K>5S
M[                                             !\FJ_1:/SP_I:@
MUK["*                 !=]/WT'\XGU.#3WM(GI3YA8QA:Z_,WU*M])/,;
M'S.]2K@                 ,A@Y^N?Y^N_5;R:RF(N
M                              /DQ3+YY9>HU_D9[=40AT\<
M        #GX]+?+K&CV?.[%K9U$?8CFI&H_91-C>8D:&^A0@
M    +W$R]!?(K/U<\3M]E*O9(!6
M               %,8H:'=S#\UO5:W1KTJ!BUA@               !,U'MA
MF\U "4JG9'MEA;]GP               =N+9?AYF_/EECZ&^7V$TQ,\Y+L?0
M                                                !P=1:# =GS2?
MMXFD'?PM/.^A:_=;%Z<P                               $@4VW:O@Y
MFX' S=W?/9TWUFS-#(RL/H
M             '!TEN,?(LF8:D]C%U6["+K#V46 NHCQ1T.@
M               9' SGGE).PO)R=G.,E;4<=+V!H=V5F2EX*L^P
M                                              #Y.@HBTEC(ZE8Z
M[]+'@+H]$#])'A7H=,0W^B+KK5@UQJ                    %\A92?1[I6
MHMTNT&^:>>W3OS4C8'F9$R5&W(2_%[+B5)V'(
M                                   .#Y.LIRC+<6LM1BNSY$%WJBFX
MTQM:ZX]LL(VM]."V6&(3L,-LM>.2L<7G88O-PLTCYCT["CW?       ,CKL[
MU&RONC++ZS9>M/W-JK9DT7+/*G;G==G(-7LDNHVR?4;97IMN?PL[N74NA<BN
M*L[C[.0
M           <'R?)UG2=)3%,4I3%*4Q3%*=)0/EKS6C=\I\F/SL*39\A_KX\
M1=?'V[\AL!DD#.HP^W'3]NNO[<_CO.XJ"J*DJ2I*HJBI.\[CM/L^CDY
M
M       !P < X. < X-=^VC:\=M&]#O$[(?0!R#DY!R#D
M
M        &NW;1M=NVC>B7B=D
M                                                     -=NVC:[
M=M&]$O$[(
M                                      :[=M&UV[:-Z)>)V0
M
M                       UV[:-KMVT;T2\3L@
M
M       !KMVT;7;MHWHEXG9
M                                                    #7;MHVNW
M;1O1+Q.R
M                             '!U&+R,8UMM6,R/D>VNK']K K/7CLC&
MT[/F)S\++OQMV;K^K9L^=?UA-OKPBXUS9R$CDN6O[V_%?@K\?N7UVR^:/MXU
MLZK=N4Q?N80L\W@9YQ SSN!G<<?HY
M                                      *3[\AZYU0;?:85O=,+WFF)
M+G5$]OKC&UU17<:HYL]=NW_               ) J=DBUVR4:G9*M1MF"DW2
M]3;9IH]TW4.Z<Z'=E$?+D
M                       Z/J ;_1J[UD;6CJ(^MO4QM?>BT07T.BTR/@
M                     $L4F[8#F]^Q7-[]DN7D[1<G)V;Y:1E4?+D
M                                                    QW?CIOVL
M32[N(FG?:Q-3NQBXG.P                             %3K^[#<S(W"X
MF7N5Q,O=;AIDTTVWZ
M          !$=MJ\[/28'GQZ1 TQ[F'9Y'P
M        #8+EY&_GG<[T3\UL-P^-E5
M                     .CZ\]/18'D_Z_6:/=_"IMGP           =N+JR
M??Q]_ ^/KX^@ +MI^U6'W'Y..:P<\8E8T.SX     *K!2Y@         !-O/
M;_4;R6R]6_([.3:[9R
M      #0WO87A#^@J37/J8X           ]0/*;+/*[/S ]6K?=/P&Z\ OT5
M1^K_ )!9ZK=;&VUX^5H3Z%!UWZ71Z3>7V%EW_-'>^A;@\5+BRWU7R/EET/.5
MJC;KWT<?)(V4"]!HEFGVX])QRV'GJ[UD;'I..W?&2HOMM>W?&2O-GU"O]/\
MRFRPB?AY\>C0./H          #(X>7KCXO;>T'B5MD^C+D
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M**                      !]_&YW#RX'Z'3$UQJRJ)EBLO$
M     #],7Y"Z??7E)/:
M    #\XWZ4H/-SU2N                   $@5N<?V6  SRNSP>PPZ_H
M               "ZQLOU$?C#J]MZ_.H
M                 !"-QJ_+I^L.:ASH-(                  'I+YA82S
M3[<9E8QA:Z\V@YZ<=K#E"JVZ;]M$                  ';@]F?S??>M_E5
ME)I]                                              X(3L]?Y^_T
M31Z*>F5X                 %XT??07SF?58-1^RB^C_F5A&%KK\S?4J[TD
M\QL/,[U*N                  DNBW>SOYRO?1/@9LK%6
M                                #@LQH/VT3Q^]NJ-.?0H/QD
M           ]+/+K'&I6%?K^ZO=7&V>Y63K3U$>8Z3;H_P![#
M      DZAW>E7C%KZ>^1V<V:,LT.\
M                 ZBQ&L5[I\T?5*W0#T^O@_J(X               $EU>
MR-+36 )"K=F"S]=/F               &30,]R_-Y_H!Y98[R<%,DGY]R\KC
MD                                                 'P4!C1K7?:
M=&^_A::=]"U1[F'A=IK                               %;I^["\?*V
MPX.9N/P,W</BI<@8?<N+T=YR
M                =92%G,7-=.@T:I=A%U;[*+KYU$> .KC8A9ZP
M                 !<(_P!F3FY$_<I)V*Y.3M#QDK:#E).?Z,LH+^7$[SD
M                                                      X/@IBW
MEG+$1)9:]?NCT0)TD>$>ATP[?Z(LNM46WFG [C5\_0
M&1U^<E4VV4Z+=+-%NF"@WS9SVZ?.:D3I0[LGQ^WTO9="L.X^@
M                                                <'R=13%&6XMI
M;#&\_D4V^J-+77'=EA&=OIP.RPPV=AAEEKQN5CBL[#%YN%CD?,?G86G=C09K
M=N^=62PSL*?9\  R"!GW8?:_3]N&O[6_&35V=YC97_1EE]9LOFG[F]5LRB+E
MGM3MSZNSD.KV2;4;92J-N:QLKF70N9<2N*L[S[.3D
M                                              X/D^3X.HZ3I*<I
MRG*<IBG.@Z3J.DZS@^"'.MCP)W4;=OQBQY.PY/H[CN.T[BH*DJ"H*@J#O.\[
M3L/LY.3D
M                      X .  #@@3KX^L??Q/1;Q&S'T  <@'(
M
M                ($Z^/K%W\3T8\1LP
M
M!!?61]5_0XGHYXA9@
M                       :J>A1,0L\                     !'EUJA;
MJM&UGG<P                     #:#@)6=5.P
M                      #Q-_55%O\ >-6(
M                    UM[J-LEPLG;3SJ8
M                  !XR?J*D]F_R[=@
M               #27U6#DU?EMIYU,
M         ' !T?5NR^4V2CR^4F8>2_Z.J/6?\XV_)5X*S'[4XKCC][OCD Y
M                                      !I+ZK!R:ORVT\ZF
M                          #X,&FX1/;ZXFN=,6VVN.;+7&]GKCVSUX?,
MQP2RUXQ)QPJ=AB$["T[&.2L+#,Q      OL3+)(F=UULNA9YM SR6-EGM;LR
M^)E(=9LD:LV2/6YRE4;98IMLL5&W.H6?8<@
MX*;[\PZ7\CVSU8C+QP:QUX]N^1Y;:[+L^6C;\PZRUVS9\MN;@M&WX(KZ'57:
M?LC4FP7?5]%RP7/7]S&MV7C5]N^'V1*G9D6C[F]?LS"'E(%9MS.)]JOGT<@
M                    Z?J&;C5KET\?7_HX\#=!I@R_T0E?:88O-..3,0
M                 ,AAY3)2;ILH=TZT&^>>>W; <[(V-YB1,]-MJ/CD
M              MF?R%;O5!M_HA6]TPS=Z8DN=44V^N+K;5&5IKCJUUTVSX
M             *C#[(E5LDRJV2C5;96I]DMT^V8Z3=-=%NG.@WS71[;KA]Y
M              .KZUXZ'1J'V475#L(FK/6QM9^JCXQ-P
M            R2'ELORLG:3DI.UW(2MO>,E[%<[OJ/@            "@R^:
MW]-HUBZF-K)U<;7/IH^OO1:(3O\ 32;?@                       JM?V
M:J#=L#SF_8GFI&SO*2=G>5D[)<SON./WD          $*7.K07T2#HSWT+2_
MN8<?6FL                               #.ZS9N?PTS>;@)N_'GLV<J
M3=]         &$S,-*^XB:8]Q#T\[2)JWUT:Q2L0
M        !>XN6T')2=P>+E[G\/+W4X>9GD+/D       BBUU^8GJE;YL^GU^
MK?810                                   -G.0E>DGF%AZ=^5V,OU.
MWZ      ("O]/G/Z77^??HT#4CLXM'M^
M     "KU_=LN,E>@'G,_T9\SL-A*#=]     URZ/1XM>XT_G)Z?7T&WX
M   -E^6D3QS^_7/I8^S/+2=)^[A[3\E)O<?[$-SJU7ZZ-LYRLGK^_)ZY[?AT
MW"-;37+=/MC2TUX//PR2+E<]7V9:3=%-OJRN)EH_WD.OU_=_?.YT86NJ[Z<L
M@C?=0NSB[O<',@^^TT6SYK;T\?9+F)&S7*R=7>LC:W]/'&S'+2)QH-^E?<P\
MKB9;2<G)B6XU:J]=&        K=7WT0\QL/:+PZWV;YN1]    M.WYYI>G5_
ME+Z]5Z@=O$        'U\?/T        .SXZ_H ?7Q\_0
M&VO$R_5?R&T],O,+"^ZOO( !;-GSQ$]UI_'[VJIHMOP        >EGEUAP^Y
M/%RR6+EK[T>CY?,6EXRM4;86O=,F56S)(N0Q:7C.U!OUFZF-)E5LO\?*P2,;
MKJ^^8?JM=ZF^2V6M_3Q]0NSB^B?FL_5_JXTBUFS;/CY601\HOM=7F1ZI7>GG
ME5E9MV/G+Z9 ]&O,Y\X4.^([G3YB>JUP])_+["8J7=@T_"_1_NC7?0M=NET
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MHI<GS]91$RL$C'M^+%(^          ?H$_,'0^J'FT^H!X)?H&D\D/9ZH
M     ;;\;*U([*+MOQLJ#K_3*U1LV:Y63'EEKT,]"A>GWE-EYH^I5VTO)2=I
M^2DZ]=)HJ<'5DQN3C$ESJV&YO?E,3/%9>%^CY1[9:]0NSBS!2[=ON,EQC:Z[
M-NQN&O[C4K&=N?W:X]-HE"JV275[-/>TB<D-W>H;;\;*FBCW0K>Z=:^HC[+<
MM(SROST,]"A>@_G$Z+[77LGS$C4+LXNTW)2=:^HCZP=7&        'J#XW:?
MH)_/=Y<CR7]<K/ O]&40
M  'L=^>KSVU\<M+R#\<'[3Y/ K76                             ,KA
MY8I,Q            R*!G^N[\3=;)9%=GK_)K^PN7P*SU@
M    ;C\3+A2]T[;\=*TN[B'M[QDO0#T6#N3Q,O3;MH@
M &75NS]*'X^Z?<RJVW(X/RN?K'FM1^WB                   #/:[/ K'
M 9Y79X'8X                   #8;C)?Z=OR5TLO')IYU4;\WGZBYZ*KS2
M                  /2GR^PN>K[YA^JUUYT??7_ ,8MO/WT6!LURTGS/]2K
M@                 !(M)M]W?R]T6_')R9 /H&IW4QOS%?JWG,)LM8
M             SROSV>Y23NUPLR/K'#!I^O$)N..R<=5>NBX!8X
M         #*J[/\ 0!^4ND]!.5DY<#X(HF8>*/N%1YA^QU=GDX@
M       #TL\NL?KXAN[TSE0[L)G8275[<?D8^9WJ=<                 +
MI&R]$?'K3US\.M]BH6>:G: ?)K%?Z/SY_H^BU.[J&                 !M
MUQLK ;##:SD9-@D?)>IMNM741HIM]>?5^>HO910                 -E>'
ME^W'YOOMR^?WR =@!P6\@2SU^5GK=9YO>LUL1]#H                &[_!
MS-(>[AR;5[,-FX6.1\OL?[N%Q<O2#O(8                E3G]_H!Y-9>E
MGDEGL-5[) +J<@ 'R8\>;7HL'R)]MJ-8>VB                 295;-D>8
MD391;HOMM>$3\,PA94F;6;J8T8VNL                #8OBI?J+XG;>AWG
M$^5C)3[  !\E"8F:9=A%T ](@:3^AP8%ZR-\_0
M          '/Q.7*2=Q?/)V\OF\_<'CI6?&6EP/L    Z#'34'J(_FGZI6Z$
M>G5\6WVD               "4JG9%MMK $IU&R++?6               !)5
M%NWA\QL/0ORNQVUY:3()DY4'(   !P=9;C'2%++7I=W4/4?MHFK_ &46 >LB
MVV1\                             N,?[.O*R=EN,E[5<3+W#X69--9L
MRTR0N9VG(     !UEM,6-4^FCZ.^@0M-N]A:M=Q$QZ;@
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MFE?LSRJV2'4;9#J=DF4^V4:;=+U'MF2BW2_3;L@^+R7<NI7%2=A]
M     '!UE*6XLQCY#%OJU]Z31 G21X5Z#3$%]HBN[U1?=Z<-M=8
M          S*IV293;I4HMLM46^8Z#=.7-[Y]YJ1,E1MR$OA>BY%6=A]
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M0\L[J]DAU>R0ZS9)M3ME6FVY/K^W,NA<RXE:51VGV?0
M    !P<'!P?)\GR=9\GP?!\GP<'!UGC[^HJ3V"_+MV/L^CD^C[/H^S[/L^SZ
M/HY.3D'(                        !P#Y/DZSJ.HZ"G*<ICH*8ICI.DZC
MI/@X.LUX[Z)0[6R?GDOD[3D^CN.T[CO*@J2H*@J"H.\[CM/L^SZ!R
M                          >,GZBI/9O\NW8
M                  ' !P  <&H'I4*UR?FZ7ED[DY  .0#D
M                           \9/U%2>S?Y=NP
M                       !I_Z5"M<GYNIY9.
M                      \9/U%2>S?Y=NP
M                  !I_P"E0K7)^;J>63@
M                  /&3]14GLW^7;L
M               :?^E0K7)^;J>63@                            -8
M>R[NS[Y              &K7H==M+YY8@             7/1'V5XWA*X
M           CNUN8.Z3JN              1E?QZ?-*O.R
M)CYOE90JJ;[             .#0/U#U[')DX
M    "OAP=Q/+_(9,.0             0ET74:F=UZ(
M           )CX7SO:OG>7N0            !P:!^H>O8Y,G
M                 5D.#M[Y?Y#*I]              A'HNHU-[KT0
M                        2QPOG>V?.\O=0            #@T#]0]>QR9
M.                             K(<';WR_R&53Z             !"/1
M=1J;W7H@                             ECA?.]L^=Y>Z@
M  '!H'ZAZ]CDR<                            !60X.WOE_D,JGT
M         "$>BZC4WNO1                             !+'"^=[9\[R
M]U             .#0/U#U[')DX                            "LAP=
MO?+_ "&53Z             !"/1=1J;W7H@  N.G10[=U7KU4.W< !7:M5%L
MV5VO4*/9MJL-=]BQ,;F3>G+.NU:J+9LX^_0   !D,2'CTN9=M$>U;M]5AKX?
M:79L         ECA?.]L^=Y>Z@            '!H'ZAZ]CDR<
M                  !60X.WOE_D,JGT             "$>BZC4WNO1  !-
MG.<M0[-O;\QL$J9T99UNO5\??L<6]W+5%SL?VEQ)M-1=>7V,KB]DBHI+AJTU
M>&N!NGZZ6J+G<:F3LFA0<*LK2]QHEJWR.?BIPUBZ:=&.RYN5P:[)(<*".GZV
M?.7Y##+"SRB% QZ7-[L<<1GV.>U=1>XT2++OH,RKZS$9]CDT.#@=G;R)4TN%
MV-ID\*!A5C:6*5+  $L<+YWMGSO+W4             X- _4/7L<F3@
M                       *R'!V]\O\AE4^@             0CT74:F]UZ
M(  )CY_F?G[]K=6JESV<?7W\^=.6>*S9^9U]999,K)(<&AV;HWM[O/*RHI\\
M[S'C0KT742U1<[<M.B.[:ZS:MJNWY\^/OWMQQ^GR*;OH)TYKD\0GV7S]^W/1
MHACHNGF/G^9K->OK^Y7C1&BJ[Z#-:ZJ[/GSK^_<+L;22J>CCFVNLO@5UYCQO
MGZQB9/O$>-B,^QP.TMP !+'"^=[9\[R]U             .#4/N_1H<Z'II
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M1'M>^1D,2'1;-EKWR +IHCVO?(           $L<+YWMGSO+W4
M   X- _4/7L<F3@             !D<.%F5?68[+FX98V>1PX695]9CLN;AE
MC9@         "IAP=N?+_(9</H             $(]%U&IO=>B         #
M8/E>.AOH.EK=>KGXE6DY_![*UM^W=:-\F]QXEUT1\DAPL&L[7OPQL\B3EL&N
MIL\\'LK7/*NIQ:=/JM>&$V5H         )8X7SO;/G>7NH            !P
M:!^H>O8Y,G                             5D.#M[Y?Y#*I]
M      A'HNHU-[KT0         9!$A2E2T-MW;^W''[8_#*QR95'LVYO756/
MRIEST:.O+[29[;IIC]6677]^]V.-LW;Z;/948815>=          )8X7SO;/
MG>7NH            !P:!^H>O8Y,G                             5D
M.#M[Y?Y#*I]              A'HNHU-[KT0         2A2T-ED2KIIC_/W
M[V8X_'W[1;-M!MW#*84"S2)-OV[LGAP+')ETF>P6[=NS>MJ\=ES*_5IC^UN0
M        !+'"^=[9\[R]U             .#0/U#U[')DX
M              "LAP=O?+_(95/H             $(]%U&IO=>B
M                     "6.%\[VSYWE[J             <&@?J'KV.3)P
M                           %9#@[>^7^0RJ?0             (1Z+J-
M3>Z]$                             $L<+YWMGSO+W4
MX- _4/7L<F3@                            *R'!V]\O\AE4^@
M       0CT74:F]UZ(                             )8X7SO;/G>7NH
M            !P:!^H>O8Y,G                             5D.#M[Y
M?Y#*I]              A'HNHU-[KT0
M2QPOG>V?.\O=0            #@TT[ST?!Y,K@
M      %5&B[3\'YQ*1]              BJZOM6^K[.C
M             )+Y3C-IJ6AN@             +28J?
M            .3)2^@             '68D6T
M      K#,#O              .                              <@
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M7A)GG$BVTO+.,S0CFL.<:$K$BC^CC3R2+7#)./FLQ=J*Q&BO7:LH"1>LU?\
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M%!PH.%!PH,GTIR)@6G&_LT'9H.%!PH.%!P'#^KLG_8F!/U/ZTR7;VX-@6O\
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M+("6DNT%HR[!2RVGX];:5!B4N\*&@HRDCPM!G^K[I=25#Q@?(S0'!H=6F_R
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M1=D'PX;V24DH)Q(J1A7G'UN*'_W&4[9?E5$O^Y3GU8:6INSG%(-%9:E=(J$
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MA1 .V.;$\WEW?:$RR^VE$TE=Y HEUNEZG#7P[:IQH(;=DY8J6TIUU924@$
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MO;G<*_2,B]O3O>U?I&IW]X>[VO\ 2-3S&\/=[7^D:BFMY5X/UC4,UO7VD>=
ML^:)IDPGA*T4\"B?!'0R8W6A]8^;'0N8ZMGNE^CCH4K?AW!\X1T*W7\-/N=/
M#?/D,"RV=*W>0I'])A-FRPSWU=LKS0F!(RHQR7.I9\!53P1J:7WAKO:3Y1 2
ME."4A/$ /)_=%-8,.4W!]X1($G*U).TSGM_[M9K]W<XA]X19_P#%^I_5_=K-
M?N[G$/O"+/\ XOU/ZO[M9GWASB_,19_\7ZG]7]Q#DXTVLHHHE.!H!2NYB1&K
MVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&K
MVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&K
MVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&K
MVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&K
MVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&K
MVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&K
MVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&K
MVNI<YD^=&KVNI<YD^=#LXVXVM 2NJA3&[3[T2KZ6+]X*-Z[M::*[I&[&KVNI
M<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI
M<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI
M<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI
M<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI
M<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI
M<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI
M<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI<YD^=&KVNI
M<YD^=&KVNI<YD^=&KVNI<YD^=#;B74!:<QW<X/S:4 J:*3F4^0>(N4C43'9=
MU&HF.R[J-1,=EW4:B8[+NHU$QV7=1J)CLNZC43'9=U&HF.R[J-1,=EW4:B8[
M+NHU$QV7=1J)CLNZC43'9=U&HF.R[J-1,=EW4:B8[+NHU$QV7=1J)CLNZC43
M'9=U&HF.R[J-1,=EW4:B8[+NHU$QV7=1J)CLNZC43'9=U&HF.R[J-1,=EW4:
MB8[+NHU$QV7=1J)CLNZC43'9=U&HF.R[J-1,=EW4:B8[+NHU$QV7=1J)CLNZ
MC43'9=U&HF.R[J-1,=EW4:B8[+NHU$QV7=1J)CLNZC43'9=U&HF.R[J-1,=E
MW4:B8[+NHU$QV7=1J)CLNZC43'9=U&HF.R[J-1,=EW4:B8[+NHU$QV7=1J)C
MLNZC43'9=U&HF.R[J-1,=EW4:B8[+NHU$QV7=1J)CLNZC43'9=U&HF.R[J-1
M,=EW4:B8[+NHU$QV7=1J)CLNZC43'9=U&HF.R[J-1,=EW4:B8[+NHU$QV7=1
MJ)CLNZC43'9=U&HF.R[J-1,=EW4:B8[+NHU$QV7=1J)CLNZC43'9=U&HF.R[
MJ-1,=EW4:B8[+NHU$QV7=1J)CLNZC43'9=U&HF.R[J-1,=EW4:B8[+NHU$QV
M7=1J)CLNZB:EVVD)4BM2JF)KA0G\HDO>/K*^;7^^?\3_ -7YMS_O2?Y@^ZJ)
M+WCZROFK4;L5&Z.>+PW1SQ>3U0YQ%Y/5#G$75:JO757=45O4-*92M:YJ4TQ>
M3U0YQ%Y/5#G$7ANCGBHW1SQ4;H^:T_[TG^8/NJB2]X^LKYC*6A(JI:4C=4H
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M!LCRD^3YE-SDPUF<*AU*]F/#B.0B&K42<'D%/9(Q'#L3B!Q%4-O-.BK:TJX
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M5 /^U:5B0V*)MT;9MK8G<J%'RI'M-;.SYA)_AK"D\&*3AX>Z.["/@U[^>/\
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MF)ER7;EDMW:*922"D'0(;4W/!3:T(0^$E2'$"@5QCRY\*D4BSMBX\>F2RJG
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MZ^VWYT)LZ:.="4]LM./<E4=#)CJFA]97F0++>KBMH#@*R>:X/+'0HZ7QWO\
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M4E?_ ,4 RY2W5QUV84G$I )!"BMPW1@50XE6M8)NF]J)O8T-=LG1GBR\+-D
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MIZWD@S8>R;W*F4"4@K5T4H$5Q*;IU.VU*%/JM-JK7&ILZ+.; 0I1C/MNEOB
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M^&5'_P!(?]5SL<L7_)W_ $O_ +L_O:\G7\,J/_I#_JN=CEB_Y._Z7_W9_>F
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MEQQ:FHX      %@!L !U #L ^ZN4H255')"82VVYBJY:(X\"IEN27Z>&%NI
M)4VEW2I8 )*00!B3E+,^8"Q'S17HBZ4TZEYV#28RF3+4@W0EUY:6U)3U^Z!.
MQ2@.:7&\_P!2%%RI)8BC0].#='A--#<!])0XEM*=QHAH>2C2.BOA@6)&%UB
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M?%4:7^?>:/\ OP_D?-L=:VW*#/4I%KEA"92#<!0T.1EO-N;'?0I6DW2JRDJ
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M,A*\G:R>S$G(F492RMV@PDDVN(P=AHV&D6;B.,-IVZ]*1J/25=6^)/)?D^0
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M)8HMR>L^O13OX]\4O][:?^(Q/]G;Q1_^-'-W^*J=_LM(_P"\_G^J]_QKQ?\
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M,)CO):EN5-ME2E).K4R8X=%U$*0L$$)TJ2>D,M9>BY9IB:?&6M]2G%R)4IP
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MK66H/21SJG-(ITML;%)C("&'""I2K/QPVYKV2IWC)0!H*1]Z(=5I\^3/B0Y
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MV^$Y+88;2-NM2@.KQB[%=HDI:6XU8I4AQ:@E"&*A$>6I2B$I2E+;RBI2E$)
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M2MK'=I%C<6-KE/*]E=5KQZRC>W2BQ=O*=$Y>WQ7/DQ'Y4<G/:N).D1--K"1
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M48S@/6-'@7_S;)^-)Q5SSR4B$/L<5AV;(_E);/"2?SC_ #7+]F*$0FDL*40
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M_P#['9C+]N'.U?9N>N<7QVL--_\ .XG].*@+UFDZ/LOKNOQ\(>/R6XODZ\,
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MBMQ&MUYSPWWE:W%=I%[  $[G:YVU$V'U*A"$^.8Y<+8*TJU!.KP>RUQ^G$Z
MF=';CEPMAMQ#FH)"B="5)M:XZ]6'VN.P\R3I#S3C6KKT\1!1>W;:]\=SK0F8
MB)+S2F"%(?;Z*M0U^$F^Z2%D%-]]M\-TM9>:>FS79A85K906TM-I7UA12DJU
M$6!'5N!>XVQ/IR)I:6'5L/L&[3S?A)O;8C:XN+C<6-_&05T,/!*I$QY^0E:%
M!Y8V"$W);0UJTH"B;DW)N!;MO+@B4]#>+A1S-WBA(3?7N@V)N+>!U[]?U#2%
MM..+@S78275:U-!"76M1ZRE"E)"?Z;=0V  B15QN(7)3TI;A3=3IZ*=-[!M
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MZ- M;J )&P Z*0FUS0DK1(JR75\1Q,A"5N6MK4%/@JMV:CO]2I?OK1_Y;O\
M\&*7]9S9U,.R-7.8W^#7:Z1\0*.KM2O'V]4I;_6S3F%L->(OJ2KB*_S>FG\B
M#BD/\VHBG[7X7.%V\9!-A^4V&(=,$^.B9/>?=>D#B)"7"A#23X&A(V!TV/M=
M[6VN:6X\Q,F4QYU3R8X0XPXLW7PU:>B3UFP6CR)(4!M8"F055%,@2'W>:M27
M=+2%V*GE:=2UDWV0G3I'C)ZM]5>A--L17072L.QXMU+)!;2T[N1L-9TBZ@!V
M[;XYJW3(LQV+Q"O@K<'$67.DTA918'LN>D.W"*?'?I9GO/NKDJ8<>,@O*Z*Q
M?H:;Z; @(*>LG86V HS%J:E22XVY)0HJ45%>E72;2X@*ZK@!=L2(-*;0L.3U
M<["56=<F O!RUQ=&K8:@-B+V]E??$&8^NBJDDE;[+,BRE=(J4UKT%7MM@G5V
MJL>TX13X[]+,]Y]U<E3#CQD%Y716+]#3?38$!!3UD["VP%-*8=',RR]1:6\M
M*UJ4%+;U)3:_@AS2D[>VQ'[FR&@_4:@M4MRZS9Y:.!?9*6TI&D$"W81?:UNN
MAREO-R&5N\<17N&T^>MQDWT$]I\$FYWL0.S#S27VG&5WT.H4VJW798(-O+OM
MY<-N5&B(X;S//(""=+S6RVDDWW'8-[V7T038.VQ/DMR:/(D,+NA38L>I23Q$
M@I/B4.HC\UP0<0-X,(GKYI'_ %*,4A152)Q423Q)>Y-_[0CQXI-,3,@MKE//
M*:NX&&&UE"&[.*U+58=)PKU$'L3;KZDTM;S$J=35N*>$>SD=3ANK0L Z5'Q6
M6@^0ZK;&P@M0YI6*@^\FI<5=PMY32D&]DAD>!MV)%R.P:;8K]VJ6E(6LE+C*
M-9/359*A=1'63:Y\N*Q)=CQ&D,*TO276V$KO8HU"ZE ]AV";]8U7&X&)-'3'
MB/.L2I"7T,.%U2UZD/I#9XB5H_C)N$^UVZR+X;)&6+@D'A.;C8_;2L1FU/TJ
M,V'5LJ7$8'%0>FGH)N0>PD7%^R]\38U+CL.KCSB)K0U(4)FMU2T&^E0"O".]
MK!)"M_(9+ZWJ"I]1]<7%;4HC;I70%';JN;_GQ3J;QFXDZ4^\M\)9<9"5V;;:
M0!PV[$&^I(!<ZKE1[;J+:CZH9";FP@C:^W6SV8F269%2=C2Y1CPXJ$]!*RCC
MO* )U%.^E(44D?Q=K:B<,OQHE0B-T^47HTDEIY@K4M+:M@A:2L73<J_YJ@38
MBTO@.U5YFJ..-Q^&WS-.M;;!N!K45)L-6J^ZB!>Z2=DX<CMQJ5-;:<6XV8LI
M:"M?$LE3"NBA7M.U/7U]9^[\L_;[OXHY^N8^]Q 4"E0!!%B"+@@]8(/6,=RZ
M=JU<S8O_ (,:?YO@_P!&  D    ;  6 'B [/J$!0*5 $$6((N"#U@@]8QW+
MIVK5S-B_^#&G^;X/]&  D    ;  6 'B [/[#F;[?:_%&_US_P!W3@33*)8$
M]*%U"_\ ]W'U*.")=9N"+SE$7%KCB/\ 5B3Q:;4UU ,K>BR6DH?X2=2FE)"1
MJM_F W-@=2AX5KRZEW285#I[#[BW^@MQ3>AMI&H:RI1/DMO8"_639)DL<&D.
MQT766H2F]ANHI;L3;RD$VQ K#$>&PP6):W6F])#;.JYOV$K'CQ$8E39XJ4MH
MQVV4E$6.OP]P>FL;6\)1W )5I[$ DL,J))9:).Y);023Y3;%>2>'!"4[":UL
MD; :5>+J&*TDE^DV!-IR+V%[=-KKQ6033)8 ).A.PW_MB,"8B%!@EYIU3:X[
M2'%(1K#5F4?9$]=E;C\G5AG@2*K&?I;2VVDI69;B6U-,*!%@G2;#4>T ;FRM
M])(EK-/JXG.-N*BOQN"MQM.K0H6/2\VD]8N"2+E)&)4E<V;2W6X[J(S<M*4.
MN)TJ=4I;940CK#:0@64>LD^*V):3W=IAL;<)[>VW@/=N);/.8S[%[%UI: 3U
M D=$GXC;$.;$AL(BU"*69#/K9*HW$#N_0*5!)N2/R&UP;'">%4(,I##"XZ7$
MN-(+C09UJT#2X$CK1J-KGQ'$&J")&1"D1Y/.V-3:6D-%7%LHZ-)_*$D]6VH7
MO;%$#W.:JI]OA.+?:6I'6$E?&64A74K3JM<?4J0)JM((!("W;FVP\#KQ7$.L
M.1:E&'KK)+*["]T+"M-QX@2M)\JQBGQ3%IFA0/%=;<>=OX1<=3>Q\J4Z4GRC
M%+CE^AKCGHEWG"1J'42HZ2?)JMB%5$08Z(DYE]I]@<, -%8< \#01M?3MUZ3
M;4%6-A3&GG94NIO-J9$D);8;7LOA)">DH=EPA'QG4>JQ.7TE+$O4"/KYWK%O
M8-^/%?:<<@I4TDK+$AMXA(N=*4N))L-R!K!-NH7/4#A=1;FP)JHREM*;8W6\
MGAA*EA=TA6XU#24FU[**;7Q':C%EI:Z/4%IX:%*+2W%,NJ2!Z[HNG95M6VUC
MVC? DHG4U\TZZ5!I;3;=N&MM81L@ &R5:2-!2;"XL=L0GX*(B8PIZG9^DH6T
M8UUJ=-QJ4ZM)T([25$: "+;8@!Q% >LH,K"9-E+Z(3N>WL)ZDGVUL1VHQ9:6
MNCU!:>&A2BTMQ3+JD@>NZ+IV5;5MM8]HWPAR/5*>ZW%Z"%-K8"5)TEE03T4J
M2+@!/1/1)%NHXAS8D-A$6H12S(9];)5&X@=WZ!2H)-R1^0VN#8XA/M2&U.,Q
MUL(UZ1K:#7$L =:4CK3O8$^(XDNK98<=;94^I !#2#92]Q?3LK<)NJUC>UNW
M"J]&4A2$1Y2WRD@1RSTBH[:56)VOL;7-NH$[8BTY]%$?BK39]X..ALG=).DH
M0?$3H%QV%5CVXAU;1%9B"+)7.:;2P&.&0+H&A*EK-M"+)Z1(N-^P:L4A"TTF
M<A22%\26+6/7P$#;Q[]6*94A3X;3,QAY"#K4P\A&I+@4M1*#N-+@7J%NT6)M
MUJIJ7G'Y]5<96CC@!AHCUQ;;:=MO&H(0D>-5[;6)GS:=.86CFSRIQ39I'-U"
M0ASV(*D]:0>M.H@CJ%[8JC;Z:''0[J4\DQPY[(W"5=9%[D; GM/;BLQG7H;3
MC"2IV*ZA\)&Y4$@ZK#M(V58;D @;X?JPEQG6(L9];[C2T.)6@I0P%((<+B^K
MH@G2/9&PVO;"$J]3)3I.KA+VL;_;2CU=?5OB0W(7E]I# 47.:QM24WUE 2CB
M) &_5UI]DFZ;&]L+D0'*>MB' *I' *5_6X!8(1=QQQY2>M.Y!N5+-AL3A:5>
MIP)L=7-&]K&_AI[.O%.V@0P?>S'ZM.&TGU0R%6-C!&]MNMGMP^D4^IORGXY?
MART)Z:6@[P74@"RAY;$]EPH6OI4,1I\"0^VB+'6LJOZ\F,$-M623=2R$D7(T
MBPZS;$NHT_4Y&GL.=!12D.,%:7!V+94 3OV$:2/'B$TZW2*GJ2XVRM$Q<5MV
M^M+)97:X.XO_ $D%0N%7/W=EG[?=_%'/US'W*_*CQ@"^\VU?JUJ )^(=9_(,
M,R&)*=3#S;H'7H4#;^4.M/Y0/JHF,KENPAJXS+8<7MT-*M%K*ON>FGL_<,2&
M)*2MAQ+J0HH)3V*%B1^8@_$?J-S&7)3T1.KBL)2I=QT;*"2-)OOX0OL,-26'
MENMM.)6MA6AU(ZT*W%C^5)&W:#^X?D,1D!;[B6D%00%*ZM1N0/S G\GW3F;[
M?:_%&_US_P!W4_[0A?BD;]2C[OG1>>Q'HVO1Q +*Z[%*TK%QV@E(!\F$=W&F
MTLAJ K0@(0]K< LD6!4CK)L.P)%^SLQ38/,65I6OB//.*>>6!9)6KL2/:C^D
MDG86 Q.B\]B/1M>CB 65UV*5I6+CM!*0#Y,([N--I9#4!6A 0A[6X!9(L"I'
M638=@2+]G9BFP>8LK2M?$>><4\\L"R2M78D>U'])).PL!]S5#[0F_BDG]2O[
MORS]ON_BCGZYC[E!C=W)0J00=24")QP"R$V%@-?0%^PG;7K]F<,PXL=Q3K#*
M&E.)"5<,:4$ W'0'0'Q@ G$2:)3LQH-E'-'N"257U[K&H"PMX/5OUX5.":@W
M X9U+9+W$U;"VOHZ;?Q.N_;U87*3$KLU90XZI<=IMIII.I;CA3'(2/%LDDD]
M0!ZS8%BJZI"(LJ*[#==OPN(0I#GB 4 G<_E%^C>]KRJCP'TQ6(SDN24<4MH4
ME"4(ZKK6J]KGR=HWN0#$D.2$KXT5V*XA6DH<LH&XO="P %CL) V.*2]'?C+7
M'CIC(#ZTE";;J"4$KV ZP0/):W5A58*G'4Q(4B8VRK2XZWLFXZP@:3K/B&Q/
M6-K$TM]$FL5!]O5I<8:L%#2H$!I*DJ'84J!!^+;;$!Z.[)J*&8Z65M/Z7G!:
M[ZM3HUFP':E1WOX1/63ARI/\1Q$:G2)"6EJ0IPJ2R@E!LKAZ@>( ?%:_].(,
M]N<A9"%M.,KX;S+GA-J_[MB-P#=)! MA5;3QGXS45UZ0V\ME#2#]D"+ZG"=)
MX:1;Q*Z_(<3I;0@,/S()6''D#FSMM32[.=(ZD]@2?8BX5XCB5)9ALJ?>-D)L
M-A=2B=@E([2?S=I( )P:NZT$NR*=)8C'3Z\5)44!6P*V@-21\9OV $V!ESVH
MK+;UE/<=2$QT-;J>4L71I\A';OUBP)(&(TR2Z[PI%/>C:DJ4APK2ZV=/8M20
M-"CV WO]RYF^WVOQ1O\ 7/\ W=3_ +0A?BD;]2C[^5#[0F_BDG]2O[ORS]ON
M_BCGZYC[EE0HTU.F0T%V\%74M%_:K&X^+P3V@X@<:!4UTP.J>C%GBMZ]U,]H
M'D[00 $FZ5!(OBD?;M:3V\[O^0J?M^C#A!S&Q8C:$0?(?7C8^(V(/Q$'#&GU
M13;VOS5&F]KWT1[Z?+IO>W9?LQ7;:Z9I^S<]1P_':Z-7_.X=_P F)D"0J2)T
M%Y+4D-\-:'!=IU [#L2.H#J[$D%)%\4Z>Y*+[$AH,RHJ@EU*3=!U7LI'7[7J
MNKL(4;[435W*F:?"XTK3_*X+=OZ<9?T]S&M-K\1[7_*UGK\NC1^2V(6GN[5-
M-K<-'@VMJLUJZNW5?5VZKWWQ2/MZM?C8_KR,-S9\];W,$16X[+A9XLGB*6XM
M-B=*6S9(L0>E?8C>]P*-Q1/JP>*"[K8XA;!""KU[=(.]OCQ2$I[H5I5AJ$K2
M%=H27'R1?Q$@$^.P\6,Q_:+7XVU_4=Q7]?\ P<$E*09B>DL70%]'05#M2.D2
M/%AZ'5WVG&7)D0H<24* 84#8^(]A\6':478,2/Q]$B'H4R^D;!:.KH^UZO*-
M(/D,>=,9EMP*BALK=2HLR6?!<T@DZD[6.QZ@BQMT+'5]RYF^WVOQ1O\ 7/\
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M\D]S9R)1<PUJDQ7).6Y9R#CTZI28;!R":K#+9/$VR*NDVTT"FJJ+8#84IO=
M=BT^FGWZ8DU"%1XRPZ>$%\$@U-F+')UY6T>@.2+ZW7%5YPG2557&8H# H$&<
M^-;@"B6$(]6O)-D1]Z$:8LJ*VF_@V07XD_ \;.&88Q-&%G:%3W4L:*0]6IR6
M^8V%?O)DTU(J])(446%PA*GXOI'JK"M38XGWOJT:PS8)ES02Y/QR7=V(]J9-
M>N/#>$'0-:G%Z725<TQZW"$SA.(IJ+0R-M<&0::;LO\ 54U46'I"#K_ T)M[
MR+DN,#MTNG#-X!.Z=O55=L(+B6!K+=);C_&SQ9SJJGQ<=QY/E1<9(_QAR_\
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MH]_R?&7L3'7SQ0UZNOP+YR=M_P#S=MWK;>)X_+J[I=-.:G'+_ H&9$M\O$I
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M^&;$R/D2E!PG0T.-26G$3AN-NIU3;='28.#L2*)ISP#?=![WEF%*53VVTIG
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MD)E;$XZU$&P?@:#QO(],C<7EY/C!KY[>+?GMCPOB)ERD]&_,\6<J_P#M"O\
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M(20A7DHK=%^14_"^IYUMH;*NIPQ!+#N2W)4V1.?FP;D[,5"A-MCK<.75H$<
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MW3&I II'J[8-W+-8CU!J]QAU4%ARA#3R26P+L:0XI\M;,(-*[K<>N7?R@5&
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MO)C)AOM)\?AH!/;]MWU3S:<7I^:GF@MY.92!?*]RWX[,^,EM.A-/1^:$6K=
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MO"ST>*Y*N0J>KAD Z-E2U]?/LMR7$U8[@HY$%E1;4?+$\IH@ZKHC=M"JI+?
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MB6UE3S8X\:3WMJ[J)KC2-VI#B"@II+9"+:R$VNM4344>^^(4.8VB.-O]9-B
MD5HU$Q7D0$EE1?U*B$BHE41-D2HS41$Y(G27,4I $13@T[841$]EN^;#[4"+
M&&0J,E+EO-(ZZ]=AO0T%UZC(M:4)$\8U)>KXQ4FN-,A&6;J9F R-@5UM2%3
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M20E^Y,?Q51?X1[S8('W!:&5#>BB1*@IK,V7$34NR*7"5!OS*PINJ8I83P;D
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MB^].&VN8 \A"1&\*:N3?&,+_ &$':?CRMXV=[B@)$2[6\"R:90=\@H=SJ+*
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MVV+%G,,K_C*_XP_H? #U_9A_R8>EGH6>C8#I\8/I\8/^+"]'@SHCQ@, ?XC
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M=@%T*LZ5FO>'V/PIU5511^SJ]R5%/=&"/KTE0='$=5X*?@JJ%BO6AUU_O?\
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M<VR=TRZ,M"+";&Q%%P&D0T!4L<9J%C+"QS!;0(#4B*<AP#-T!;/1Q911=C?
M%F6IZJ2"WZQ-WOQ>G5P/8R=1XS^%,_B3/XNPX@\8!T^<AZ8\HSE_%G0'C*,\
M6!RF!MZ 4=DS<[2=*X\"C@N3=8=)(8>NL=H<(!I.HS@VN2$1!A7"R*G(<C9!
M749#F8)43%P@E?,$SB3R",^U2]%:X&?GSJI2VPFHB?2$6L5BCD'")&D<"W%!
MGAOCTD14F?;XM+P+3GB (<:FQ^X#D(:B;@(*;X$E;1;H-+'9IPB!V=L!6?(@
M;I4K1!!/4%6EB/&P@WH(!=Z.<%,.3.NV=$>,X?+A!@#I]![&+],5Z/&<AXL_
M@HSICQG\<9T+XQ' Q?&(@3M;'T&&UD)CB-+QBNB J!-AG"^QU4)UQ]Q=VJXA
M?1^9OH/F\(T=!-U-MFTGHW3U&W4-1SB V^Z)M6CO$2HP2B;Y#=>R\\9<NTQ.
MQ*WJK]NN-"KNC4Z0_6EKT,?P*]KO0?E>0FFW.'$K]3/VV\+I0ZO+'<^6?ZX]
M^J9)W/EGN?+/+$]#OWV_@53UYZ7W">J/0X&Z,%V76BGKX5-.]U W+L<'<M=Q
M/MDR9,A",LB79I9@T<Z2D^P5;R+C&.;9)-I?U9OT#3=6&8-']1 .BL\V]#QV
M[2=<1YH,1H11"3#E8F( JKO.K-^I3N0;.:W&Z_LSJ?V8+D9T+XS^,,Z0\'PX
M_A+.A/& ],[&3Z-#TQ7IG)#QG\;9T%XRQ_HSC#XQ/'[,! ^SO'D=ADVZ.K$5
M6JJ35JN5=EOJ0R:! D.1!%AF-U ^P4- 2XB=B'%+*@)-Q*>P,M+G@J"@+XNZ
M!P.2@,]1/RR3;8AL&J*U"S!1])0W$@UJB#I9UM,>@7P.\E)42)@96]%4:6(;
M+C!@JK-C>XD=P'2XU2LERC/L)"&TF(N,X"&8I.*(N2Y$441-$Y$X)U,14032
M)H^B?XR^E2I5T.O!F$0&5@#JO ')<-V=@($.1>80JBY22G50YD-,M %P%3U&
ME^@D=PF&)I3RIL59'0!90XNRML0>CKL[0QPMNF2/:-H1L$LPOEA+AL;;,>5
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M;Q[9VWCVSMO'MG;>/;.V\>V=MX]L[;Q[9VWCVSMO'MG;>/;.V\>V%0:[9/\
M1K_T7__:  P# 0 "  ,    0
M $9.0;>!MIHG6S#/D@
M                            +[ZMM              K\_2FD
M                                                        [Q;@
M                       ,5T
M                        $H!@                             (UT
M                                                      CI
M                              CY@
M                        X(
M  %Q$                                                 [
M        1V+!UK:X(: C9"             FP
M                        &H             2#!'%Q^PP&8_E?
M       >@                                              8
M          X)KZHH8]-J8[06              'P
M                          X                        H
M          4
M                 "  P                   "4
M                            8                    C3H
M           #D
M                   L_ X                  "D@
M                               *@                 2%LO
M           %^$
M  $U_                '  H                *+$
M                                  DBF%
M           9$@@
M       $A-@                            RC  @
M                                        D@U7UP
M      #=3[T@$
M            $D $E#(:'OYH       [@UZ+=<  @
M                                               $ @D@D$#:$F0E
M&0  @D DDD
M                       D$ @D@$DDD@D@
M
M
M
M
M
M
M
M
M
M                                                         $U]
MJT_ZE+],#R7GKK$
M                        '/?>-8               \;V"(
M                                                     _5[
M                     Q0X
M                     #,@                              41@
M                                                   _-
M                           '<P
M                     <P           '$[@  & @     '
M%H                                                 ?
M    G[G]8^*+BT_: XX@P           ^,
M                     R@            W>7% 1YO,4/<@<X
M    >                                               (
M       HQM  Q#!IW_,%S60             <
M                       (                       7@(
M       H                                              X
M              '  X                   $
M                         3                   !KPX
M        ?                                               %P
M                \\HP                  $\@
M                            BW                  9=3
M        %9@
M"]                !  '                "K
M                               $ B%
M       (]L@@
M    D&)DP                          '2#, @
M                                     $$%W55
M   Y]7Y$$@
M           $$ +(:C/=+Z@  !F4?$5>O]$ D $
M                                             D$@D$@D$$#D$D D
M$D@@@$@
M                     DDD FL@ D$@
M                                                        "(
M
M                           #H
M                                    TDDDDDDDDDDDDDDDDDDDDDE,
MDDDDDDDDDDDDDDDDDDDDDDH
M       [;;;;;;;;;;;;;;;;;;;;;;[;;;;;;;;;;;;;;;;;;;;;:8
M
M                       $8
M    $D'G)E/"$D@                                       $8
M                             "H:V\,YG      %!4P@A;.@
M                 $8=;&9(A.1(%;4OKS$                      &!3
M-                    #GC $                  %7/:.0
M     EC<TH                6=P                           9M0
M            'GI>                        A>2<           TA
M                             &"(         !U\
M              S[H        J
M  $I@      %N                                  !R     $H
M    HV ?$-=)"<E C#C994 *QM        $_     1         P
M%  P                >D  &*         N"'6+_P +[R/02X#!UY0/EZ
M       !$@ !$       !4B/68G==Y&B#9UU2?D)F* 06@       !< (P
M       "A"2.NS,FJ=1*OQCV=$/P\B         !F -@        @=D),TTF
M*Q6(LU0^::'F$ PZ         &@*          ",7V$#X>@E1 !#*RX"$"4!
MR          - *        !AH>Q!K/-#&N+!LOK?0-E%Q59(        !X$
M                                            *
M               P           !@                    !(300
M             +!.                    P .                   !(
M P                   2+&                   .H +
M      +0'%0                  'X!#P                  MZXP
M             %K(  <                  "GMU0                 !
M>  ()X                 46"0                !I    ,"
M        /V(80                !B@   ($G0
M            %$M!    ! /0                0 &                (
MC((    ) ,@J                             '=  !      !(,M
M                            .D@         )("_FN
M         &%(?)          !((\E4                          !%.6
M))           )((,ZK;T@             !T2W"0!                !
M-<\=0                   //!UA!)               !!!)))&.<KNP)+
M)!6JUL+) !)((                   ) )%&&5 G"5(  !)H0]$#[8))!!(
M                      )(!! ( !!) ())  )(
M     (()  (!)!  5(!)(!   ) (
M                                          ))) !Y  ))(
M
M                 !X
M                                                !X
M
M                   !X                             -__P#_ /\
M_P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ ]
M   !W_\ _P#_ /\ _P#_ /\ _P#_ /\ _?\ _P#_ /\ _P#_ /\ _P#_ /\
M_P"             !.                             /
M   P                             .             !&
M                  .(             !P
M    /             !&                             .(
M    !P                             /             !&
M                    .(             !P
M      /             !&                             .(
M      !P  &.  $R1-0F     @'\         /             !&
M                      .(             !P  'S5"!$?_0 A3OY*Q/6I
MNM:L,@  /             !&                             .(
M        !P  "7ZQR3L2 -&EH[3P6HK*7TGMP  /             !,-4TA0
M    !!8& $    $.)@)!:   .(             !P  !\IJ&PC5 [C(,"D@'
MYOACLSU0  /             !((;WC#,D!AS15K)-AUQQ5'/GT#T373\(
M          !P                      " "    /             !.&N6
M!W6_F06Q&C,\%M$!A+H#F;64W_N(             !P         *P. &$P
MX           /             !&              !DAD@          '(
M            !P          3L\K7=G2B@         /             !&
M                            .(             !P         /UBO@>
MUX[(@         /             !&                             .
M(             !P         $B'^LEC-B#0         /             !
M&                             .(             !P
M                /             !&
M .(             !P                             /
M !&                             .(             !P
M                  /             !&
M   .(             !P                             /
M   !%                             -(             !0
M                    +               ))))))))))))))))))))))))
M))))))              !!))))))))))))))))))))))))))))))
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MI*O%@CAB_6T&,(6%@2Q2^%.^/AD0$8.P64P5=#RJI0:7%HPQ,D=Q+3@@"4@
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MR%8E88I"( '1%M3=!_05E(D"F!*!<E!S%"(FK(VA4^U5?R$% *  558 &57
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M"\?ND: $OF31D6KCZ!(X(0 1E*9*A9"8O!1>$*@!H3&<_L\,FHBT+Q1=CAS
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M,!+<VX37#8C#>%7Y"!@$"#';B.,\'.E7H7"R\$A/54.%4L RY>^9D"J ! (
M *I,+P3B2Z26QZ 28@'Y. !0 *A@ 95< 97!R8$AU,$2ZDQ%R-L_3[=)R RH
MG20H(,4L4<6BKDA69TB7VA/R:$=,WQ%_MSN:\KM]PQ^]Y]W\<EVTN-@_WV/0
M\>F(+29<&.P5V*.N!T(S 8Q<*J%58<P 40(*K!F!8'1RZ;?W&;>=W;^35<!^
MT>TES8J52/""&:P%DJ711>YRD_J*M:5P(^8.@J,, XFPNBP,;%MSB %1Q$41
M$41(B81'(CA'7Y)A+0TMC*%[8+O.AQ)\*!*L90X 233>%P/)XW>(%W2@(\<
M4!L1L#4#59<O?&))J11 U*L.N$W2TJ4H&0I4@R\"U1#:6DDU SU<+/R1$.W(
MG$&P:6PK!BCS$-QS ^, =XCI!P.)08'@  _4W0 #!$&@. -Z,HD6JM#85R<@
M<!H*J%R48;CH^861&2&+@1#\AWA<)HPE0@EH9E2J_P!!IA!,$4@$JDLTO%4H
MJ*JU5:J]JY7\AFA$,2B)A"QR !5@\EJ ?!1A10E:),#2S)ON@,]8'Q5CY/
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MZ,H6)%MQ00@(=,QCO#C/LEXBRRQTX9U@ONK57\*\9JD@T@B)Y&\,JI@ $I
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M2&$+A:$=&Y2!2BL;@A$7#%2Z3%H%CN(EBECF+\\"@8108(28+2HQ<<<J>7T
M+L[K"IFHXVG =Q$JD15 1(WHF,3%6R&NN)C]^.#:%V"%0*45)T<Q)HUL8@.$
M+7+U-SQXPX,4SH$#"*1'"ODDI A@,Q8P0_@U3G*58"'<+!0#0J?4#"@$B@.0
MP$ 7H-C],.E 3;$O1K:0VQ_0:PJ&[\#\&(8)#'Y[BFDG6HB %Z/Q1D(>;  ]
MJ0]_45<Y("K=6(CV!<<H:/65>&BR,$R $?D] R(R8=Q%*5#0H<"&4*$.@O&
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M&11*'G^'?Q^2G=+G)^P+#MT=\ZHQH+TP*#I+(X<YI#(,+VO:=HIRJ_UY\4'
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MG+HA-,/8@G98\<<9^)\DH =:5]3-<,T%230"Y O *EO8  ! 2*)(((!R J\
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M[4XH;R5R@K+:- DE69D<*<($6=58!9P":(#Q5]D0IJ""E I@H/T?1<XTUM6
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M*QX5T<!Q+4#5Y-H5/:JO&/P0Y&(!@! @ 0XCO9@&]0((+68'P\9$I I&8 K
M5QH7CCM,[3*6,*5):Y5:IA6&5&, 07$U,.7>B@3%> EW+LYO2N"\AN0&"<,4
M+H00X86Y/)R=A5E$!&4L3,,9X.(X$HK2$%RT0 %,)/9=4S!"PPB< P".FZ[
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MX$0U"HJU.JKV[NY3[C)?O5Y+4T40R@$:B5;Z#_H?'+QTQ84D@2BC>L #0 #
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M[<XLX+U>5)K2 . M;$VVM*5D0.%:R^5YK:@1/ JF,PU8/!SC0#/.JNLEFR!
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MS.A;0K::&D[NM'$D)K:M0;#2L:BK4'51#RL%-, *.^PD)^BA13*E44RK"Z\
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M<2@DMD&)*3,X!495?L6X<E:E @!5=<8JZ@(=[5F"0%&@=@!I[2'%QJX!^A*
M H"/TGK(.^7+((X]Z,5=47*813(>N[WC0/5W#&]JXE9HMIR&DJPI8[@> "^I
MXE4Y<0H%#F.J)P[FSDV!4*Q-C\7QK$S? 4F$L!$F "NG<Q"-PY*U*! "JZX\
M M0'4Q:+@/N2G4F?&752$EJ\,U_%D3]AS$Q*R(U!]HDE:*,=)E+949UF5I@"
MU;%8_85MF[6&-9\!G]#%B',F:8^N!X0P)X@4F&%G/I<+R(AV8Q2E:@$.1>Q"
M<<NITQ*<\H(^?L7*A'FCH2$Y9!7#A(@$&""FJ!96W0<6T]2#B,@3:MO&2?R
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MVS\$%H'J:I'Q.M(+'R+%#5'4GVP5^XG,)T8 @!SU5-P0EI/T<"'?)F<+1$>
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M2T!7D@"AH'8S8\/#KVZTWA=J?:@13\MK5! ,+B^C*(,^G#C!*";3[/?5(8\
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M99XD?K$2\PJU8*@:U(Q[6Q@50= ;> . _P!14X78B-$D=!P%PYON#NV$;U&
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M"'A0:%*N./6 )$75"=B#;D+. :%(CD9$]@G)C^&4&&EB Z@2#K 1DP1#<4Z
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MI$1-)GJ/LY7]]:X<9P, 0   T  &CP>BX<,@!$-(B)I,]1]G*_OK7#C.!@"
M  &@  T>3V]>ZK2#D8,/5\%PQH@1A2%$1I2(]<.H%D+:L(S-<T#QJ$=$90 %
M$] M' IX +,636R*RS"G8'BGK$TVAV!8**>D9D6#T1= &0:,RF!RHU7JJKBG
MR()C  $ ($ "&)YS$@%*@0(+N</9Q$0B"F.P*L!7T+B7NSU+M.T+4*PN\UJ0
M8.M :F+.OD B[J:":3@J%O!XK*<Z2.1I8:%R24EX6(.S2]3N9%0495X VE2&
MX,P1<R@A*M;"[VN .KK TR2@&LLM(A)W$ % F0-A>R0*"A,T6X- D2^_A&2
M)V<@0_;B9&N.YI#6 WV>=2!64KKMW%55Y</),M#3,@P$SH,WBG/-+UKTD<@6
MAP/VB0!I=7($&#7D"UZ1E(V 91/UCX:><T21Z"51 BY5TY(*&XQ;)(1Y@S:1
MN*D*5 P0*CA&B)8"++M /*D)R)I30!"=R>Y*=36B@H!:1681Y@S:1N*D*5 P
M)Y#5)1F 0$9&1 1<R@A*M;"[VN %*[KYK0JJ*%2@B$$#E%(H94 9SB$;X->*
MF#M5"5B4H0Z F7%>C%*)".SH38LB(E*&*8-4'<P(E*$(BWI<L9UG?61()X89
MD4FBX2(430V6I& M@O$9 VV.DA9!C\O!@)S!KH-JU+0RR*@:*'< A08OO^JD
M5$Q*.N07P O0_@<;XQ!\EPL0B4H0H<P DAFX,HH S4H8P#^PE'AP-NN-\8$8
MB$B(B4$=B=1PK#)&AL81%HFGD>SB 95P@)&%YVH5@4>33@USX@*55!:=*UZ"
M)"4J5)I1GF<2Y$(:P=28>:5L(_<Q45NZYNFX<ICR9A.MX :/(,3<\=A,9) M
MHPL)-L6?0K\YU!HT&@C(@BC?#A6[H]H)03.Q8L<HIPJJ=R&]DDBM$^ATXPHC
M!@M5&0$J!<YX_%;9K<!Z^B,Q$41M*;#.D+F>YP8"EQP-$ =2! 8Q!-4&";P6
MX#U]$9B(HC:4V&=(7,]S@P%+C@:( ZD" QB":H,$WX6C5L2V6:DA"P60! FS
MICN^LG&K8QRN+T&"%D 8UM*TWK$BHV02%;%1.G8.%Q;9]#M)H#>B@8!S/EJH
ML5!$  -7&&1AT04%!P L!$86<"E X.>"  F\=6WS' 3V&C!#!%;B?.I$I-@E
M)+P#@&$TN'HG**E*%$"]UIV%#J%390I1X>6WM 0=@T1,25L -W3)4B0DEL0"
M\]4D^R'*<M"#Y <28<B@FR=B"IO7+#V\KX* $R'+F%B &JD.0HAP5] 40*3P
MP65H0 L'H 0R<BKDA#O_ *CMFC5L[-$.NBLI*"TJ$Q,*1\:@#8$"[:*"C$#-
M L]V?NO^.^ :$Z(K @;20QZ B]B_\\$W[DYN64.!6'""$W*T==NF&?XS:".*
MHB,=PO@<HMZA4%511((PPEI0EJ-6;NG&^V$\A2>=<_0P>];]P?#OW[!X6WD$
MS"##.""GF)%%JI=3H6VN57OC$M8 DSY ,-)FQ,OE)(#P*5P I)0@E<1L>D'&
M#0Y1P@XD50*A:*1X$:-&QR83XJ2\Y0$ND='_ %&MFC5L(!V(( IN:A*E0 QJ
M!A$8;HHBKC,B\0A #43!4F(#6%80*\M4P(A5*L"([WUZ)EM 6+$>7GOH"*I$
MJ0U+ 7+#>%+EC2%1=,PHCJYQP#3'I:S(P7C>$AU\4!=MJZ,A/0UA$P5X90Z!
MQUD.[9M .X@ !/$(@LGB&LHT&MN!C;"KJNODDP1!!6Q?/4M)O33!)$\0B"R>
M(:RC0:VX7C.$EU\0#=M(:<4F:O:[PE2;%!$%=." C0##  E7?ICW]'G=VH&H
M6^P]B9:8B3B9C*3_ ,A=;-&K=LT:MVS1JW;-&K=OL4G5;*25$J"/GG''''''
M'''''''''''''''''''''''''''''''''''''''''''''''''''''8I.JV4D
MB+0!?O\ D<:^EE==0&B%#YYQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQ
MQQQQQQQQQQQQQQQQQQQQQQQP,-?6BN.A+02 _P#SW__$ "\0 0 " 0(#!P0#
M 0$! 0$   $ $2$Q44%AD1! 4'&!H?!@L<'1(.'Q,'" D*#_V@ ( 0$  3\0
M^B[-SJ3B1/\ SPB?IB"FE#B)F(%H- *+I?(L-?,=KM$BX3-.60$%QK $4P_M
ML,/$B'<EB<6'6UG#W)#LUU'B)GJ+!1LJKNT0Z_L6,)G9=F4G+P>U,+%13%4I
M%P]*)Q;EZ% @-%1L]"_.4-DTIS<G%=0.2CMM6C0.J^GV+5K9-I=X%<WUJ8 H
M(:WPY<MTLJIQR5JU*+9AQ@)W HRIB/[)FQ4R(Z%,99=G1TF-429EI(  P3YV
M +7HI=S8\P'QE,$#=@X\&JB!O("0L4$N@7HY7CM7',!645+E*%1!Y0.@PM3.
M2EG$ZDLW.O\ X<N&Q+E&8R"L1-I%NN*6M=B8%VH1(E#)HPN22BQE&)S3$ZH)
M@ R?23$9TV,I32&.+*8I_38MPKH)Q312G,2R"[#0%\?'MRW&]&^RO">*!BDO
M65&P#8U B*1QX0 $@@ "%'AQWPM4MX180L@B"" ! A(8Q5 #)!(! G@40!>?
M$5]RH;$VD?\ (",=I=+S>'-W"I5IANR,S",O$!;-%$]/C*-3@K>W05!T_?Z"
M-,W8\X !FE,KUK8(6E*</]V'3<.@)*%"070-\Y8Z(^OU^-D-.1G!$BB%P;;*
M\80VE0HR3WC%:V3SBX>SF)21' 6^O0[6BG5U]?RQH3!EE1:^Z"XQ@LY"L@E-
M#8B+<]>(O+08+\ GC3 !6("=G)9T?H8,A-*,)H4G:QP0U@"":NA@A%1L)!8Y
M)@?SU@L4E1BHE:J-0LX=P@O/$ +0*!$%$1&I8Z(_6@#^@)J\#%  *H$'!8RL
M?V"8%LA-3[(,)A :E:\IRPE-@5*]CV  ;4$C278F*$R"P>N9I3&\PP !XV$6
M5P()72'@.P"@KU.,U.I&K$H""^2DBAJCEXNB.AW:IC66(;1/3IF_<M@L&($0
MFB-\_JUL@HFIAS0.N:0%7UI2U)H+="L"0H=69P%003BK.> BUK)('Z%. 4*L
MDC8!S7S,P0 #'%YEMT3I5FI"1:$@6% \!0DZNR5$KJI@XK&3!]?JA[8B$4$E
M4#4L =F@WNM;&W\8_1CI6 OEJH,[',>!Z3MMH=RDOAA6D,IQ\FK"UG^FHY&.
M-BD6/L]J0Q5@D")8V?4= YC$HB,D6Z5J7?,V)SA/8[V'SJK7:D'GE7L.;BZG
M\+\D+N<31"D0-=EC0CC*@#BQBR$TUQNSX:(D,I@)H=EX#2/;S$H8C\/6X1J_
M>H!+L;1^Q0@2?PD@<)&W^";ISX<LR?-7<IG'%!9<S]U$5)U[[0&1$E142*XO
M J8*F!K#K,AR0P01EQ,R+34(M0&!%-A(=%C[4* RB"4&3'3QWBN3_1EDB.Q&
MH,0'F%_5F(NPW+:?X 2K=F69$1A'500+-L]D0G$.;ZV2YVC!4P-8=9D.2&']
MJ2X9T\I0)Z46(M&1' AM!,R98@(5#+=@<HG^(#M'@(@"A$$[VR>:!RNZ42;%
MV(R+"%6C*_(?%\H]0>S1,&#]0A[3=!*;M62LQO=)< &0@4"*$=\XEP@T:I)P
MQF"4L-?PR/9J;D[;@)V2;]S&A62;PD:FM1UHU5K?"@ )D0Q:.U; 4:7'5,14
MO?0 *9@G,#]I+B0PFD652IC)G3$$<X"$E2<,Q7J,[%(D["$ZD&?%UP+,S">D
M4-$$UD1''HX:$ZW+CDJ;"0^*W(.*&T[7CV:L<%I>,HRA]A?99@HK"(1=L[&>
M(%O_ )) V[XJ7#],#9KFED2TPM!MSP5K[1@M\_$,P;X(@6&X&_KF:0)U,WD7
M.$S$0K@3F6'8H7BOC$)HR4W]@6N29 %4%'?4C')!;W 7)*JD+3H[=S@D@L:
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MT)DJ0]$\"NG+:E(G>.YA4GPB1/\ +J)4.,<-1(VU)#K5?"EI8*+7P$_X'O\
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MZ1943= 5"%",$DI O6!*3 F; \&#"X+[DVQU!9<MA@82;E(P "*@CJX%,!2
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MJC\L2 JPY-0"<O+Z(VU5RAEE-M%B%D"9+5;%(*+:Y; BTA81,,D"&$V9C9X
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M'6G' 6I2;>&PQP8*ZH*#4ICP:&S:H[52,13U*&JJ"[LJB(?0##W)C"S H(%
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M-!6*@&-YIF5KP=F)"1&H$R1I<\@/!M*:?9%@C!P=SMT!75&#<*$KRR(:T0R
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M2O1, OCJ&-I;9*5MYFNYBFI"@@5HKO<$$X*QZ^[<86E/08-H+>SIU>'D\@:
M9+\K41WR^"1XVHQR(=MC[)")./\ (:C1)D1LY* 68H6R1=*O@KF.;>0QK'K
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M)J-?35;K@:W*N[/*::83UE#6#C0OVWA1056@]>%9]IIPTT!IHRDH8Y=.DH-
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M)%Z@ L!2LR&)Z0"BY" %O'+0I:"4%]M.L27Z1:]$@KZEX+1PVNC/$:LY^Y$
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M3CB6->H?7]?,7U;Y73P],\*TF(/P/;[:=;<6!PT/E?;A-*+F&G+3YSJ9^&U
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M!,"APTNVY$>B4$P:7;3E>A^H"V'H?J?YT_SI5H7I.2G)2C@="4;'0E&QT/\
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M,QE'[PKH8.UD:61K4Z)IXK/@/6[(D&6ZZ$] 1))3!<;$RAH0(PBW!1LPD+$
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M!;Z>7!@,'!NHEP0C!4=[?UHUH2FTP"I*PT4-QJX'24VX02TQ/+2@VQ0CF)J
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M%)KVE32$[(Y/8/4,WE</69C5F*^<V<!YM$[6RXH2Q9J4?4YST#42-X]5GN#
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MQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQ 7C\Z'OB#!E8P51\./*&
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8.A*-CH2C8Z$HV.A*-CH2C8Z$H- .X?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
